Citrus Sinensis ID: 018128
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 360 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.819 | 0.646 | 0.702 | 1e-125 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.827 | 0.719 | 0.685 | 1e-121 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.85 | 0.723 | 0.646 | 1e-116 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.805 | 0.680 | 0.554 | 4e-93 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.813 | 0.594 | 0.539 | 3e-91 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.811 | 0.685 | 0.537 | 3e-91 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.813 | 0.597 | 0.526 | 6e-89 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.847 | 0.784 | 0.5 | 5e-88 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.811 | 0.712 | 0.536 | 3e-87 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.872 | 0.762 | 0.477 | 5e-86 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 447 bits (1150), Expect = e-125, Method: Compositional matrix adjust.
Identities = 208/296 (70%), Positives = 244/296 (82%), Gaps = 1/296 (0%)
Query: 32 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIV 90
A +F FRELA AT NF +GEGGFG+VYKGRL+S GQ+VA+KQL+ GLQG++EF+V
Sbjct: 71 AHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLV 130
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 150
EVLMLSLLHH NLV LIGYC GDQRLLVYE+MP+GSLEDHL+DL PD+E L WN RMKI
Sbjct: 131 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKI 190
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 210
A GAA+GLE+LH KANPPVIYRD KS+NILLD F+PKLSDFGLAKLGP GD +HVSTRV
Sbjct: 191 AAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRV 250
Query: 211 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270
MGTYGYCAPEYAM+G+LT+KSD+YSFGVV LELITGRKA+D GEQNLV+W+RP
Sbjct: 251 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFN 310
Query: 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326
D++KF+ L DP L GR+P R L A+AV +MC+ E+A RPLI D+V AL YL +Q
Sbjct: 311 DRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQ 366
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 205/299 (68%), Positives = 246/299 (82%), Gaps = 1/299 (0%)
Query: 31 GARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFI 89
A++F+FRELA AT+NFR+ LIGEGGFG+VYKG+LE +G +VA+KQL+ GLQG++EFI
Sbjct: 63 AAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFI 122
Query: 90 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 149
VEVLMLSLLHH +LV LIGYC GDQRLLVYEYM GSLEDHL DL PDQ PL W+TR++
Sbjct: 123 VEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIR 182
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 209
IA+GAA GLEYLH KANPPVIYRDLK+ANILLD +FN KLSDFGLAKLGPVGD HVS+R
Sbjct: 183 IALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSR 242
Query: 210 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 269
VMGTYGYCAPEY +G+LT KSD+YSFGVVLLELITGR+ +D ++ + EQNLV+W++P
Sbjct: 243 VMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVF 302
Query: 270 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328
K+ +F L DP L G +P + LN AVAV AMCL EEA RPL++D+V AL +L + D
Sbjct: 303 KEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTAPD 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 418 bits (1074), Expect = e-116, Method: Compositional matrix adjust.
Identities = 199/308 (64%), Positives = 246/308 (79%), Gaps = 2/308 (0%)
Query: 32 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIV 90
A++FTF+ELA AT NFR +GEGGFGKV+KG +E Q+VAIKQL+ G+QG +EF+V
Sbjct: 88 AQTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREFVV 147
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 150
EVL LSL H NLV LIG+C GDQRLLVYEYMP GSLEDHL+ L ++PL WNTRMKI
Sbjct: 148 EVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKPLDWNTRMKI 207
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 210
A GAARGLEYLH + PPVIYRDLK +NILL D+ PKLSDFGLAK+GP GD THVSTRV
Sbjct: 208 AAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVSTRV 267
Query: 211 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270
MGTYGYCAP+YAM+G+LT KSDIYSFGVVLLELITGRKA+D +K + +QNLV W+RP K
Sbjct: 268 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPLFK 327
Query: 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR-DS 329
D++ F +VDPLL G+YP R L A+A++AMC+ E+ RP+++D+V+AL++L S + D
Sbjct: 328 DRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLASSKYDP 387
Query: 330 HPVSRNAG 337
+ S ++G
Sbjct: 388 NSPSSSSG 395
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 168/303 (55%), Positives = 219/303 (72%), Gaps = 13/303 (4%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNHEGL 82
++FTF EL AT+NFR+ NL+GEGGFG V+KG ++ SG +VA+KQL EG
Sbjct: 72 KAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGF 131
Query: 83 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 142
QGH+E++ EV L L H NLV L+GYC G+ RLLVYE+MP GSLE+HL+ +PL
Sbjct: 132 QGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF--RRGAQPL 189
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
+W RMK+AVGAA+GL +LH +A VIYRD K+ANILLD DFN KLSDFGLAK GP GD
Sbjct: 190 TWAIRMKVAVGAAKGLTFLH-EAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGD 248
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262
NTHVST+V+GT+GY APEY +G+LT KSD+YSFGVVLLELI+GR+AMD S G E +LV
Sbjct: 249 NTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLV 308
Query: 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322
W+ P+L D++K ++D L G+YP++ A + CLN +A RP +++++V L+
Sbjct: 309 DWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQ 368
Query: 323 LVS 325
L S
Sbjct: 369 LES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 3e-91, Method: Compositional matrix adjust.
Identities = 165/306 (53%), Positives = 213/306 (69%), Gaps = 13/306 (4%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNHEGL 82
R FTF +L ++TRNFR +L+GEGGFG V+KG +E +G VA+K LN +GL
Sbjct: 128 RKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGL 187
Query: 83 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 142
QGH+E++ E+ L L H NLV L+GYC DQRLLVYE+MP GSLE+HL+ PL
Sbjct: 188 QGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPL 244
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
W+ RMKIA+GAA+GL +LH +A PVIYRD K++NILLD D+N KLSDFGLAK P
Sbjct: 245 PWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEG 304
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262
THVSTRVMGTYGY APEY M+G LT KSD+YSFGVVLLE++TGR++MD ++ GE NLV
Sbjct: 305 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 364
Query: 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322
W+RP L D+++F L+DP L G + + + A CL+ + RP ++D+V AL
Sbjct: 365 EWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKP 424
Query: 323 LVSQRD 328
L +D
Sbjct: 425 LPHLKD 430
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 3e-91, Method: Compositional matrix adjust.
Identities = 164/305 (53%), Positives = 218/305 (71%), Gaps = 13/305 (4%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNHEGL 82
++FTF EL ATRNFR +L+GEGGFG V+KG ++ SG +VA+K+L EG
Sbjct: 69 KAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGY 128
Query: 83 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 142
QGH+E++ EV L L H NLV L+GYC G+ RLLVYE+MP GSLE+HL+ +PL
Sbjct: 129 QGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF--RRGAQPL 186
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
+W RMK+A+GAA+GL +LH A VIYRD K+ANILLD +FN KLSDFGLAK GP GD
Sbjct: 187 TWAIRMKVAIGAAKGLTFLH-DAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGD 245
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262
THVST+VMGT+GY APEY +G+LT KSD+YSFGVVLLEL++GR+A+D SK EQ+LV
Sbjct: 246 KTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLV 305
Query: 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322
W+ P+L D++K ++D L G+YP++ A ++ CLN +A RP +++++ LD
Sbjct: 306 DWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQ 365
Query: 323 LVSQR 327
L S +
Sbjct: 366 LESTK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 6e-89, Method: Compositional matrix adjust.
Identities = 161/306 (52%), Positives = 213/306 (69%), Gaps = 13/306 (4%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNHEGL 82
+ F+F +L +ATRNFR +L+GEGGFG V+KG +E +G VA+K LN +GL
Sbjct: 122 KKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGL 181
Query: 83 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 142
QGH+E++ E+ L L H NLV L+GYC DQRLLVYE+MP GSLE+HL+ PL
Sbjct: 182 QGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPL 238
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
W+ RMKIA+GAA+GL +LH +A PVIYRD K++NILLD ++N KLSDFGLAK P
Sbjct: 239 PWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEG 298
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262
THVSTRVMGTYGY APEY M+G LT KSD+YSFGVVLLE++TGR++MD ++ GE NLV
Sbjct: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
Query: 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322
W+RP L D+++F L+DP L G + + + A CL+ ++ RP ++++V L
Sbjct: 359 EWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKP 418
Query: 323 LVSQRD 328
L +D
Sbjct: 419 LPHLKD 424
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 5e-88, Method: Compositional matrix adjust.
Identities = 160/320 (50%), Positives = 231/320 (72%), Gaps = 15/320 (4%)
Query: 28 EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQL 77
+ + ++F+ EL ATRNFR +++GEGGFG V+KG ++ +G ++A+K+L
Sbjct: 49 QNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRL 108
Query: 78 NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP 137
N EG QGH+E++ E+ L L H NLV LIGYC + RLLVYE+M GSLE+HL+
Sbjct: 109 NQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGT 168
Query: 138 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197
+PLSWNTR+++A+GAARGL +LH A P VIYRD K++NILLD+++N KLSDFGLA+
Sbjct: 169 FYQPLSWNTRVRMALGAARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLSDFGLARD 227
Query: 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 257
GP+GDN+HVSTRVMGT GY APEY +G L++KSD+YSFGVVLLEL++GR+A+D ++ G
Sbjct: 228 GPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVG 287
Query: 258 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP-RRCLNYAVAVTAM-CLNEEANFRPLIND 315
E NLV W+RP+L ++++ + ++DP L G+Y R L +AV A+ C++ +A RP +N+
Sbjct: 288 EHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALK--IAVLALDCISIDAKSRPTMNE 345
Query: 316 IVVALDYLVSQRDSHPVSRN 335
IV ++ L Q+++ +N
Sbjct: 346 IVKTMEELHIQKEASKEQQN 365
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 162/302 (53%), Positives = 208/302 (68%), Gaps = 10/302 (3%)
Query: 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLV-------AIKQLNHEGLQGHQE 87
FT EL T++FR ++GEGGFG VYKG ++ V A+K LN EGLQGH+E
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 88 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 147
++ EV L L H NLV LIGYC D RLLVYE+M GSLE+HL+ PLSW+ R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLF--RKTTAPLSWSRR 174
Query: 148 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 207
M IA+GAA+GL +LH A PVIYRD K++NILLD+D+ KLSDFGLAK GP GD THVS
Sbjct: 175 MMIALGAAKGLAFLH-NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 208 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267
TRVMGTYGY APEY M+G LT +SD+YSFGVVLLE++TGRK++D ++ EQNLV W+RP
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327
L D++K + ++DP L +Y R A ++ CL++ RPL++D+V L+ L
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTG 353
Query: 328 DS 329
D+
Sbjct: 354 DA 355
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 161/337 (47%), Positives = 221/337 (65%), Gaps = 23/337 (6%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----------SGQLVAIKQLNHEGL 82
+SFTF EL ATRNFR +++GEGGFG V+KG ++ +G ++A+K+LN +G
Sbjct: 55 KSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGW 114
Query: 83 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 142
QGHQE++ EV L H NLV LIGYC + RLLVYE+MP GSLE+HL+ +PL
Sbjct: 115 QGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPL 174
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
SW R+K+A+GAA+GL +LH A VIYRD K++NILLD+++N KLSDFGLAK GP GD
Sbjct: 175 SWTLRLKVALGAAKGLAFLH-NAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGD 233
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262
+HVSTR+MGTYGY APEY +G LT KSD+YS+GVVLLE+++GR+A+D ++ GEQ LV
Sbjct: 234 KSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLV 293
Query: 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322
W+RP L +++K ++D L +Y + CL E RP +N++V L++
Sbjct: 294 EWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEH 353
Query: 323 LVSQRDSHPVSRNAGARGVPTSASDVSQGSNSRRSSS 359
+ + + AG R + D+ Q RRS S
Sbjct: 354 IQTLNE-------AGGRNI-----DMVQRRMRRRSDS 378
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 360 | ||||||
| 255539234 | 381 | receptor serine-threonine protein kinase | 0.938 | 0.887 | 0.791 | 1e-158 | |
| 224061871 | 313 | predicted protein [Populus trichocarpa] | 0.841 | 0.968 | 0.868 | 1e-157 | |
| 51971074 | 381 | unknown protein [Arabidopsis thaliana] | 0.902 | 0.853 | 0.794 | 1e-154 | |
| 145335950 | 381 | protein kinase-like protein [Arabidopsis | 0.902 | 0.853 | 0.794 | 1e-154 | |
| 297850486 | 381 | protein kinase [Arabidopsis lyrata subsp | 0.902 | 0.853 | 0.794 | 1e-153 | |
| 359491840 | 401 | PREDICTED: serine/threonine-protein kina | 0.933 | 0.837 | 0.778 | 1e-152 | |
| 297745557 | 433 | unnamed protein product [Vitis vinifera] | 0.933 | 0.775 | 0.778 | 1e-152 | |
| 224086050 | 338 | predicted protein [Populus trichocarpa] | 0.913 | 0.973 | 0.789 | 1e-151 | |
| 449485117 | 385 | PREDICTED: serine/threonine-protein kina | 0.922 | 0.862 | 0.752 | 1e-147 | |
| 449455605 | 389 | PREDICTED: serine/threonine-protein kina | 0.905 | 0.838 | 0.752 | 1e-145 |
| >gi|255539234|ref|XP_002510682.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223551383|gb|EEF52869.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1455), Expect = e-158, Method: Compositional matrix adjust.
Identities = 269/340 (79%), Positives = 303/340 (89%), Gaps = 2/340 (0%)
Query: 20 NGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNH 79
NGK NG ++SGA+SFTFRELA+AT NFRE NLIGEGGFG+VYKGRLESGQ+VA+KQLNH
Sbjct: 39 NGKDNG--KRSGAQSFTFRELAVATNNFREMNLIGEGGFGRVYKGRLESGQIVAVKQLNH 96
Query: 80 EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 139
+G+QG QEFIVEVLMLSLLHH NLVTLIGYCT+GDQRLLVYEYM MGS+EDH++DL+PD+
Sbjct: 97 DGVQGFQEFIVEVLMLSLLHHSNLVTLIGYCTAGDQRLLVYEYMQMGSVEDHIFDLDPDK 156
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
EPL+W+TRMKIA+GAARGLEYLHCKANPPVIYRDLKSANILLD DFNPKLSDFGLAKLGP
Sbjct: 157 EPLNWSTRMKIAIGAARGLEYLHCKANPPVIYRDLKSANILLDTDFNPKLSDFGLAKLGP 216
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
VG+NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D SK GEQ
Sbjct: 217 VGENTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAIDRSKRPGEQ 276
Query: 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319
NLV+W+RPFLKDQKKF LVDPLL G YPRRCLNYA+A+TAMCL+EEANFRPLI DIVVA
Sbjct: 277 NLVAWARPFLKDQKKFYQLVDPLLQGCYPRRCLNYAIAITAMCLHEEANFRPLIGDIVVA 336
Query: 320 LDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNSRRSSS 359
L+YL SQ + + G+P S+ ++G+ S+ S
Sbjct: 337 LEYLASQCHGSESNSSQVRSGIPQSSMATNRGAVSQEPMS 376
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224061871|ref|XP_002300640.1| predicted protein [Populus trichocarpa] gi|222842366|gb|EEE79913.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 265/305 (86%), Positives = 287/305 (94%), Gaps = 2/305 (0%)
Query: 22 KGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEG 81
KG G +E GARSFTFRELA ATRNFRE NLIGEGGFG+VYKGRLE+G++VA+KQLN +G
Sbjct: 1 KGQGAEE--GARSFTFRELAAATRNFREINLIGEGGFGRVYKGRLETGEIVAVKQLNQDG 58
Query: 82 LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP 141
LQGHQEFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLEPD+EP
Sbjct: 59 LQGHQEFIVEVLMLSLLHHSNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLEPDKEP 118
Query: 142 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201
LSW+TRMKIAVGAARGLEYLHCKA+PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG
Sbjct: 119 LSWSTRMKIAVGAARGLEYLHCKADPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 178
Query: 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261
+NTHVSTRVMGTYGYCAPEYAMSGKLT+KSDIYSFGVVLLELITGRKA+D SK GEQNL
Sbjct: 179 ENTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYSFGVVLLELITGRKAIDRSKKPGEQNL 238
Query: 262 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321
V+WSR FLK+QKK+ L DPLL G YPRRCLNYA+A+TAMCLNEEANFRPLI+DI+VAL+
Sbjct: 239 VAWSRAFLKEQKKYCQLADPLLEGCYPRRCLNYAIAITAMCLNEEANFRPLISDILVALE 298
Query: 322 YLVSQ 326
YL SQ
Sbjct: 299 YLASQ 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|51971074|dbj|BAD44229.1| unknown protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1418), Expect = e-154, Method: Compositional matrix adjust.
Identities = 263/331 (79%), Positives = 293/331 (88%), Gaps = 6/331 (1%)
Query: 20 NGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNH 79
NGK N GARSFTF+ELA ATRNFRE NL+GEGGFG+VYKGRL+SGQ+VAIKQLN
Sbjct: 51 NGKVNSPIPSGGARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNP 110
Query: 80 EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 139
+GLQG++EFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +Q
Sbjct: 111 DGLQGNREFIVEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQ 170
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
EPLSWNTRMKIAVGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGP
Sbjct: 171 EPLSWNTRMKIAVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGP 230
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
VGD THVSTRVMGTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DL + QGEQ
Sbjct: 231 VGDRTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQ 290
Query: 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319
NLV+WSRP+LKDQKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVA
Sbjct: 291 NLVTWSRPYLKDQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVA 350
Query: 320 LDYLVSQRDSHPVSRNAGARGVPTSASDVSQ 350
L+YL +Q SH AR V + + ++S+
Sbjct: 351 LEYLAAQSRSHE------ARNVSSPSPEISR 375
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145335950|ref|NP_173489.2| protein kinase-like protein [Arabidopsis thaliana] gi|8778594|gb|AAF79602.1|AC027665_3 F5M15.3 [Arabidopsis thaliana] gi|8886951|gb|AAF80637.1|AC069251_30 F2D10.13 [Arabidopsis thaliana] gi|51971194|dbj|BAD44289.1| unknown protein [Arabidopsis thaliana] gi|332191880|gb|AEE30001.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-154, Method: Compositional matrix adjust.
Identities = 263/331 (79%), Positives = 293/331 (88%), Gaps = 6/331 (1%)
Query: 20 NGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNH 79
NGK N GARSFTF+ELA ATRNFRE NL+GEGGFG+VYKGRL+SGQ+VAIKQLN
Sbjct: 51 NGKVNSPIPGGGARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNP 110
Query: 80 EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 139
+GLQG++EFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +Q
Sbjct: 111 DGLQGNREFIVEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQ 170
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
EPLSWNTRMKIAVGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGP
Sbjct: 171 EPLSWNTRMKIAVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGP 230
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
VGD THVSTRVMGTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DL + QGEQ
Sbjct: 231 VGDRTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQ 290
Query: 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319
NLV+WSRP+LKDQKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVA
Sbjct: 291 NLVTWSRPYLKDQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVA 350
Query: 320 LDYLVSQRDSHPVSRNAGARGVPTSASDVSQ 350
L+YL +Q SH AR V + + ++S+
Sbjct: 351 LEYLAAQSRSHE------ARNVSSPSPEISR 375
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297850486|ref|XP_002893124.1| protein kinase [Arabidopsis lyrata subsp. lyrata] gi|297338966|gb|EFH69383.1| protein kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1410), Expect = e-153, Method: Compositional matrix adjust.
Identities = 263/331 (79%), Positives = 293/331 (88%), Gaps = 6/331 (1%)
Query: 20 NGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNH 79
NGK N GARSFTF+ELA ATRNFRE NL+GEGGFG+VYKGRL+SGQ+VAIKQLN
Sbjct: 51 NGKVNSPIPGGGARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNP 110
Query: 80 EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 139
+GLQG++EFIVEVLMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +Q
Sbjct: 111 DGLQGNREFIVEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQ 170
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
EPLSWNTRMKIAVGAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGP
Sbjct: 171 EPLSWNTRMKIAVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGP 230
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
VGD THVSTRVMGTYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DLS+ QGEQ
Sbjct: 231 VGDRTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLSQKQGEQ 290
Query: 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319
NLV+WSR +LKDQKKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVA
Sbjct: 291 NLVTWSRSYLKDQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVA 350
Query: 320 LDYLVSQRDSHPVSRNAGARGVPTSASDVSQ 350
L+YL +Q SH AR V + + +V++
Sbjct: 351 LEYLAAQSRSHE------ARNVSSPSPEVTR 375
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491840|ref|XP_002271454.2| PREDICTED: serine/threonine-protein kinase PBS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1400), Expect = e-152, Method: Compositional matrix adjust.
Identities = 267/343 (77%), Positives = 296/343 (86%), Gaps = 7/343 (2%)
Query: 18 AENGKGNG---GK---EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQL 71
++NGKG G GK + + ARSFTFR+LA ATRNF+ NLIGEGGFGKVYKGRL++G++
Sbjct: 49 SDNGKGKGSLNGKAHPKSNAARSFTFRQLATATRNFKATNLIGEGGFGKVYKGRLDTGEI 108
Query: 72 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 131
VAIKQLNH+GLQG QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE H
Sbjct: 109 VAIKQLNHDGLQGFQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMAMGSLEHH 168
Query: 132 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191
L+DL PDQEPL WNTR++IAVGAARGLEYLHCKANPPVIYRDLKSANILLDN+FNPKLSD
Sbjct: 169 LFDLGPDQEPLGWNTRIQIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNEFNPKLSD 228
Query: 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 251
FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D
Sbjct: 229 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAID 288
Query: 252 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311
SK QGEQNLV+WSRPFLKD+KKF+ LVDP L G +P R L++A+A+TAMCL E+ NFRP
Sbjct: 289 TSKRQGEQNLVAWSRPFLKDRKKFIQLVDPQLQGNFPVRALHHAIAITAMCLQEQPNFRP 348
Query: 312 LINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNS 354
LI DIVVAL+YL S+ S RN R +S S S+ SNS
Sbjct: 349 LIGDIVVALEYLASESHSSEPHRNQ-VRLPSSSPSQGSRNSNS 390
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745557|emb|CBI40722.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1397), Expect = e-152, Method: Compositional matrix adjust.
Identities = 267/343 (77%), Positives = 296/343 (86%), Gaps = 7/343 (2%)
Query: 18 AENGKGNG---GK---EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQL 71
++NGKG G GK + + ARSFTFR+LA ATRNF+ NLIGEGGFGKVYKGRL++G++
Sbjct: 81 SDNGKGKGSLNGKAHPKSNAARSFTFRQLATATRNFKATNLIGEGGFGKVYKGRLDTGEI 140
Query: 72 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 131
VAIKQLNH+GLQG QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE H
Sbjct: 141 VAIKQLNHDGLQGFQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMAMGSLEHH 200
Query: 132 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191
L+DL PDQEPL WNTR++IAVGAARGLEYLHCKANPPVIYRDLKSANILLDN+FNPKLSD
Sbjct: 201 LFDLGPDQEPLGWNTRIQIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNEFNPKLSD 260
Query: 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 251
FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D
Sbjct: 261 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAID 320
Query: 252 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311
SK QGEQNLV+WSRPFLKD+KKF+ LVDP L G +P R L++A+A+TAMCL E+ NFRP
Sbjct: 321 TSKRQGEQNLVAWSRPFLKDRKKFIQLVDPQLQGNFPVRALHHAIAITAMCLQEQPNFRP 380
Query: 312 LINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNS 354
LI DIVVAL+YL S+ S RN R +S S S+ SNS
Sbjct: 381 LIGDIVVALEYLASESHSSEPHRNQ-VRLPSSSPSQGSRNSNS 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086050|ref|XP_002307795.1| predicted protein [Populus trichocarpa] gi|222857244|gb|EEE94791.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1396), Expect = e-151, Method: Compositional matrix adjust.
Identities = 266/337 (78%), Positives = 293/337 (86%), Gaps = 8/337 (2%)
Query: 29 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEF 88
+ GARSFTFRELA ATRNFRE NLIGEGGFG+VYKGRLE+G+LVA+KQLN +GLQG QEF
Sbjct: 3 EDGARSFTFRELAAATRNFREVNLIGEGGFGRVYKGRLETGELVAVKQLNQDGLQGDQEF 62
Query: 89 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 148
IVEVLMLSLLHH NLVTL GYCTSGDQRLLVYEYMPMGSLEDHL+DLEP +EPLSW+TR+
Sbjct: 63 IVEVLMLSLLHHSNLVTLTGYCTSGDQRLLVYEYMPMGSLEDHLFDLEPGKEPLSWSTRI 122
Query: 149 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208
KIAVGAARGLEYLHCKA+PPVIYRDLKSANILLDNDF PKLSDFG+AKLGPVG+NTHVST
Sbjct: 123 KIAVGAARGLEYLHCKADPPVIYRDLKSANILLDNDFQPKLSDFGIAKLGPVGENTHVST 182
Query: 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268
RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D SK GEQNL +WS+PF
Sbjct: 183 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAIDRSKKPGEQNLAAWSQPF 242
Query: 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328
LKDQKK+ L DPLL G YPRRC NYA+A+TAMCLNE+A+FRPLI DI+ AL+YL +Q
Sbjct: 243 LKDQKKYCQLADPLLEGCYPRRCFNYAIAITAMCLNEQASFRPLIGDILGALEYLAAQ-- 300
Query: 329 SHPVSRNAG-ARGVPTSA--SD---VSQGSNSRRSSS 359
H N G RG S+ SD VSQ +SR +S
Sbjct: 301 CHVSEPNTGRVRGTNPSSPYSDRKVVSQERDSRSRAS 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449485117|ref|XP_004157074.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 528 bits (1359), Expect = e-147, Method: Compositional matrix adjust.
Identities = 258/343 (75%), Positives = 288/343 (83%), Gaps = 11/343 (3%)
Query: 19 ENGKGNGGKEKSG-------ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQL 71
E GKG + + G ARSF FRELA ATR F+E NLIGEGGFG+VYKGRLESGQ+
Sbjct: 32 ETGKGKESQNRGGNNRKCGAARSFPFRELATATRGFKEVNLIGEGGFGRVYKGRLESGQI 91
Query: 72 VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH 131
VAIKQLNH+GLQG+QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE+H
Sbjct: 92 VAIKQLNHDGLQGYQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMSMGSLENH 151
Query: 132 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191
L+ L P + PLSWNTR+KIA+GAA+GLEYLHC ANPPVIYRDLKSANILLD+DFNPKLSD
Sbjct: 152 LFGLFPKRSPLSWNTRIKIALGAAQGLEYLHCTANPPVIYRDLKSANILLDDDFNPKLSD 211
Query: 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 251
FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY FGVVLLE+ITGRKA+D
Sbjct: 212 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYCFGVVLLEIITGRKAID 271
Query: 252 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311
+K GEQNLV+WSRPFLKD++KFV LVDPLL GRYP RCL++A+A+ AMCL E+ FRP
Sbjct: 272 TTKKPGEQNLVAWSRPFLKDRRKFVQLVDPLLEGRYPLRCLHHAIAIAAMCLQEQPMFRP 331
Query: 312 LINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNS 354
+I+DIVVAL+YL SQ SH + G P+ S QG S
Sbjct: 332 IISDIVVALEYLASQ--SHASEQPREGVGSPSKLS--PQGDRS 370
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455605|ref|XP_004145543.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1343), Expect = e-145, Method: Compositional matrix adjust.
Identities = 255/339 (75%), Positives = 285/339 (84%), Gaps = 13/339 (3%)
Query: 19 ENGKGNGGKEKSG-------ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQ- 70
E GKG + + G ARSF FRELA ATR F+E NLIGEGGFG+VYKGRLESGQ
Sbjct: 32 ETGKGKESQNRGGNNRKCGAARSFPFRELATATRGFKEVNLIGEGGFGRVYKGRLESGQG 91
Query: 71 ---LVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 127
+VAIKQLNH+GLQG+QEFIVEVLMLSLLHH NLVTLIGYCT GDQRLLVYEYM MGS
Sbjct: 92 FKEIVAIKQLNHDGLQGYQEFIVEVLMLSLLHHSNLVTLIGYCTDGDQRLLVYEYMSMGS 151
Query: 128 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187
LE+HL+ L P + PLSWNTR+KIA+GAA+GLEYLHC ANPPVIYRDLKSANILLD+DFNP
Sbjct: 152 LENHLFGLFPKRSPLSWNTRIKIALGAAQGLEYLHCTANPPVIYRDLKSANILLDDDFNP 211
Query: 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY FGVVLLE+ITGR
Sbjct: 212 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYCFGVVLLEIITGR 271
Query: 248 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEA 307
KA+D +K GEQNLV+WSRPFLKD++KFV LVDPLL GRYP RCL++A+A+ AMCL E+
Sbjct: 272 KAIDTTKKPGEQNLVAWSRPFLKDRRKFVQLVDPLLEGRYPLRCLHHAIAIAAMCLQEQP 331
Query: 308 NFRPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSAS 346
FRP+I+DIVVAL+YL SQ SH + G P+ S
Sbjct: 332 MFRPIISDIVVALEYLASQ--SHASEQPREGVGSPSKLS 368
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 360 | ||||||
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.847 | 0.800 | 0.833 | 1.9e-138 | |
| TAIR|locus:2014604 | 381 | AT1G76370 [Arabidopsis thalian | 0.844 | 0.797 | 0.769 | 1.1e-126 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.861 | 0.604 | 0.706 | 7.9e-117 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.861 | 0.820 | 0.700 | 1.6e-116 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.813 | 0.642 | 0.704 | 2.9e-112 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.822 | 0.714 | 0.686 | 4.3e-109 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.841 | 0.834 | 0.664 | 2.4e-108 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.802 | 0.748 | 0.656 | 9.5e-105 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.825 | 0.763 | 0.630 | 2.6e-102 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.819 | 0.695 | 0.628 | 2.4e-99 |
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1355 (482.0 bits), Expect = 1.9e-138, P = 1.9e-138
Identities = 255/306 (83%), Positives = 282/306 (92%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEV 92
RSFTF+ELA ATRNFRE NL+GEGGFG+VYKGRL+SGQ+VAIKQLN +GLQG++EFIVEV
Sbjct: 64 RSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDSGQVVAIKQLNPDGLQGNREFIVEV 123
Query: 93 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
LMLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +QEPLSWNTRMKIAV
Sbjct: 124 LMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAV 183
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
GAARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGPVGD THVSTRVMG
Sbjct: 184 GAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMG 243
Query: 213 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272
TYGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DL + QGEQNLV+WSRP+LKDQ
Sbjct: 244 TYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQ 303
Query: 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 332
KKF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVAL+YL +Q SH
Sbjct: 304 KKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE- 362
Query: 333 SRNAGA 338
+RN +
Sbjct: 363 ARNVSS 368
|
|
| TAIR|locus:2014604 AT1G76370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1244 (443.0 bits), Expect = 1.1e-126, P = 1.1e-126
Identities = 234/304 (76%), Positives = 268/304 (88%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEV 92
RSFTF+ELA AT+NFRE N+IG+GGFG VYKGRL+SGQ+VAIKQLN +G QG+QEFIVEV
Sbjct: 61 RSFTFKELAAATKNFREGNIIGKGGFGSVYKGRLDSGQVVAIKQLNPDGHQGNQEFIVEV 120
Query: 93 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
MLS+ HH NLVTLIGYCTSG QRLLVYEYMPMGSLEDHL+DLEPDQ PLSW TRMKIAV
Sbjct: 121 CMLSVFHHPNLVTLIGYCTSGAQRLLVYEYMPMGSLEDHLFDLEPDQTPLSWYTRMKIAV 180
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
GAARG+EYLHCK +P VIYRDLKSANILLD +F+ KLSDFGLAK+GPVG+ THVSTRVMG
Sbjct: 181 GAARGIEYLHCKISPSVIYRDLKSANILLDKEFSVKLSDFGLAKVGPVGNRTHVSTRVMG 240
Query: 213 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272
TYGYCAPEYAMSG+LT+KSDIYSFGVVLLELI+GRKA+DLSK GEQ LV+W+RP+LKD
Sbjct: 241 TYGYCAPEYAMSGRLTIKSDIYSFGVVLLELISGRKAIDLSKPNGEQYLVAWARPYLKDP 300
Query: 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 332
KKF LVDPLL G++ +RCLNYA+++T MCLN+EAN RP I D+VVA +Y+ SQ S+
Sbjct: 301 KKFGLLVDPLLRGKFSKRCLNYAISITEMCLNDEANHRPKIGDVVVAFEYIASQSKSYED 360
Query: 333 SRNA 336
R A
Sbjct: 361 RRTA 364
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1151 (410.2 bits), Expect = 7.9e-117, P = 7.9e-117
Identities = 221/313 (70%), Positives = 260/313 (83%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVE 91
++FTFRELA AT+NFR L+GEGGFG+VYKGRLE+ GQ+VA+KQL+ GLQG++EF+VE
Sbjct: 69 QTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNGLQGNREFLVE 128
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151
VLMLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLEDHL+DL PD+EPL W+TRM IA
Sbjct: 129 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWSTRMTIA 188
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
GAA+GLEYLH KANPPVIYRDLKS+NILL + ++PKLSDFGLAKLGPVGD THVSTRVM
Sbjct: 189 AGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTHVSTRVM 248
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271
GTYGYCAPEYAM+G+LTLKSD+YSFGVV LELITGRKA+D ++ GE NLV+W+RP KD
Sbjct: 249 GTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWARPLFKD 308
Query: 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR-DSH 330
++KF + DP L GRYP R L A+AV AMCL E+A RPLI D+V AL YL SQ D +
Sbjct: 309 RRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTFDPN 368
Query: 331 -PVSRNAGARGVP 342
P +N+ + P
Sbjct: 369 APSGQNSRSGSGP 381
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1148 (409.2 bits), Expect = 1.6e-116, P = 1.6e-116
Identities = 220/314 (70%), Positives = 258/314 (82%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVE 91
++FTF ELA ATRNFR+ LIGEGGFG+VYKG L S Q AIKQL+H GLQG++EF+VE
Sbjct: 59 QTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLVE 118
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151
VLMLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLEDHL+D+ P ++PL WNTRMKIA
Sbjct: 119 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIA 178
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
GAA+GLEYLH K PPVIYRDLK +NILLD+D+ PKLSDFGLAKLGPVGD +HVSTRVM
Sbjct: 179 AGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVM 238
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271
GTYGYCAPEYAM+G+LTLKSD+YSFGVVLLE+ITGRKA+D S+ GEQNLV+W+RP KD
Sbjct: 239 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLFKD 298
Query: 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR-D-- 328
++KF + DP+L G+YP R L A+AV AMC+ E+ N RPLI D+V AL YL SQ+ D
Sbjct: 299 RRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFDPL 358
Query: 329 SHPVSRNAGARGVP 342
+ PV + A G P
Sbjct: 359 AQPVQGSLFAPGTP 372
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 207/294 (70%), Positives = 243/294 (82%)
Query: 34 SFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEV 92
+F FRELA AT NF +GEGGFG+VYKGRL+S GQ+VA+KQL+ GLQG++EF+VEV
Sbjct: 73 TFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEV 132
Query: 93 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
LMLSLLHH NLV LIGYC GDQRLLVYE+MP+GSLEDHL+DL PD+E L WN RMKIA
Sbjct: 133 LMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAA 192
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
GAA+GLE+LH KANPPVIYRD KS+NILLD F+PKLSDFGLAKLGP GD +HVSTRVMG
Sbjct: 193 GAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMG 252
Query: 213 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272
TYGYCAPEYAM+G+LT+KSD+YSFGVV LELITGRKA+D GEQNLV+W+RP D+
Sbjct: 253 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDR 312
Query: 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326
+KF+ L DP L GR+P R L A+AV +MC+ E+A RPLI D+V AL YL +Q
Sbjct: 313 RKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQ 366
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
Identities = 204/297 (68%), Positives = 245/297 (82%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVE 91
++F+FRELA AT+NFR+ LIGEGGFG+VYKG+LE +G +VA+KQL+ GLQG++EFIVE
Sbjct: 65 QTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVE 124
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151
VLMLSLLHH +LV LIGYC GDQRLLVYEYM GSLEDHL DL PDQ PL W+TR++IA
Sbjct: 125 VLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIA 184
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
+GAA GLEYLH KANPPVIYRDLK+ANILLD +FN KLSDFGLAKLGPVGD HVS+RVM
Sbjct: 185 LGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVM 244
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271
GTYGYCAPEY +G+LT KSD+YSFGVVLLELITGR+ +D ++ + EQNLV+W++P K+
Sbjct: 245 GTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKE 304
Query: 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328
+F L DP L G +P + LN AVAV AMCL EEA RPL++D+V AL +L + D
Sbjct: 305 PSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTAPD 361
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1071 (382.1 bits), Expect = 2.4e-108, P = 2.4e-108
Identities = 202/304 (66%), Positives = 245/304 (80%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVE 91
R FTFRELA AT+NFR+ LIGEGGFG+VYKG+LE+ Q+VA+KQL+ GLQG +EF+VE
Sbjct: 33 RIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGLQGQREFLVE 92
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151
VLMLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLEDHL DLEP Q+PL WNTR+KIA
Sbjct: 93 VLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDWNTRIKIA 152
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
+GAA+G+EYLH +A+PPVIYRDLKS+NILLD ++ KLSDFGLAKLGPVGD HVS+RVM
Sbjct: 153 LGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTLHVSSRVM 212
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271
GTYGYCAPEY +G LT KSD+YSFGVVLLELI+GR+ +D + EQNLV+W+ P +D
Sbjct: 213 GTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTWALPIFRD 272
Query: 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 331
++ L DPLL G YP + LN A+AV AMCL+EE RPL++D++ AL +L + +S
Sbjct: 273 PTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSFLGASSNSSN 332
Query: 332 VSRN 335
N
Sbjct: 333 TGSN 336
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 9.5e-105, P = 9.5e-105
Identities = 191/291 (65%), Positives = 240/291 (82%)
Query: 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLESG-QLVAIKQLNHEGLQGHQEFIVEVL 93
FTFREL +AT+NF N +GEGGFG+VYKG++E+ Q+VA+KQL+ G QG++EF+VEV+
Sbjct: 70 FTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLVEVM 129
Query: 94 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE-PLSWNTRMKIAV 152
MLSLLHH NLV L+GYC GDQR+LVYEYM GSLEDHL +L +++ PL W+TRMK+A
Sbjct: 130 MLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAA 189
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
GAARGLEYLH A+PPVIYRD K++NILLD +FNPKLSDFGLAK+GP G THVSTRVMG
Sbjct: 190 GAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMG 249
Query: 213 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272
TYGYCAPEYA++G+LT+KSD+YSFGVV LE+ITGR+ +D +K EQNLV+W+ P KD+
Sbjct: 250 TYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDR 309
Query: 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323
+KF + DPLL G+YP + L A+AV AMCL EEA RP+++D+V AL+YL
Sbjct: 310 RKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYL 360
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 2.6e-102, P = 2.6e-102
Identities = 188/298 (63%), Positives = 242/298 (81%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVE 91
+SF FRELA AT +FR+ LIGEGGFG+VYKG++E +GQ+VA+KQL+ GLQG++EF+VE
Sbjct: 57 KSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDRNGLQGNREFLVE 116
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151
+ LSLLHH NL LIGYC GDQRLLV+E+MP+GSLEDHL D+ Q+PL WN+R++IA
Sbjct: 117 IFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRIRIA 176
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
+GAA+GLEYLH KANPPVIYRD KS+NILL+ DF+ KLSDFGLAKLG VGD +VS+RV+
Sbjct: 177 LGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSSRVV 236
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271
GTYGYCAPEY +G+LT+KSD+YSFGVVLLELITG++ +D ++ EQNLV+W++P ++
Sbjct: 237 GTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPIFRE 296
Query: 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329
+F L DPLL G +P + LN AVA+ AMCL EE RPLI+D+V AL ++ ++ S
Sbjct: 297 PNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSFMSTETGS 354
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 986 (352.1 bits), Expect = 2.4e-99, P = 2.4e-99
Identities = 186/296 (62%), Positives = 232/296 (78%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVE 91
++FTF EL+++T NF+ +GEGGFGKVYKG +E Q+VAIKQL+ G QG +EF+VE
Sbjct: 84 QTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIKQLDRNGAQGIREFVVE 143
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151
VL LSL H NLV LIG+C G QRLLVYEYMP+GSL++HL+DL + PL+WNTRMKIA
Sbjct: 144 VLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKIA 203
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
GAARGLEYLH PPVIYRDLK +NIL+D ++ KLSDFGLAK+GP G THVSTRVM
Sbjct: 204 AGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTRVM 263
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271
GTYGYCAP+YA++G+LT KSD+YSFGVVLLELITGRKA D ++ + Q+LV W+ P KD
Sbjct: 264 GTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPLFKD 323
Query: 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327
+K F +VDPLL G YP R L A+A+ AMC+ E+ + RP+I D+V+ALD+L S +
Sbjct: 324 RKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQPSMRPVIADVVMALDHLASSK 379
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.II.2013.1 | hypothetical protein (313 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | eugene3.00031887 | hypothetical protein (230 aa) | • | 0.434 | |||||||
 | CPK18 | calcium dependent protein kinase 18 (556 aa) | • | 0.410 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 360 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-57 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-51 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-41 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-37 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-31 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-18 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 4e-57
Identities = 79/195 (40%), Positives = 111/195 (56%), Gaps = 12/195 (6%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYC 110
+GEGGFG VY R ++G+ VAIK + E +E + E+ +L L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
+ LV EY GSL+D L + E LS + ++I + GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 171 YRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLT 228
+RDLK NILLD+D KL+DFGL+KL + + + ++GT Y APE + G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 229 LKSDIYSFGVVLLEL 243
KSDI+S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 8e-55
Identities = 75/199 (37%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 51 NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIG 108
+GEG FGKVY R ++G+LVAIK + + ++ +E I+ E+ +L L H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
D+ LV EY G L D L E + LEYLH K
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILSALEYLHSK---G 117
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 228
+++RDLK NILLD D + KL+DFGLA+ + ++T V GT Y APE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLGKGYG 174
Query: 229 LKSDIYSFGVVLLELITGR 247
DI+S GV+L EL+TG+
Sbjct: 175 KAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 2e-54
Identities = 76/199 (38%), Positives = 107/199 (53%), Gaps = 12/199 (6%)
Query: 53 IGEGGFGKVYKGRL-----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FG+VYKG L VA+K L + Q +EF+ E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+G CT + ++V EYMP G L D+L P + LS + + A+ ARG+EYL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK-- 122
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
I+RDL + N L+ + K+SDFGL++ D V + APE GK
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180
Query: 227 LTLKSDIYSFGVVLLELIT 245
T KSD++SFGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 1e-53
Identities = 73/199 (36%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 53 IGEGGFGKVYKGRLE-----SGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FG+VYKG+L+ VA+K L + Q +EF+ E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+G CT + +V EYM G L +L P LS + + A+ ARG+EYL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK-- 121
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
I+RDL + N L+ + K+SDFGL++ D + APE GK
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179
Query: 227 LTLKSDIYSFGVVLLELIT 245
T KSD++SFGV+L E+ T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 3e-53
Identities = 79/199 (39%), Positives = 107/199 (53%), Gaps = 13/199 (6%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109
+G G FG VYK + +G++VA+K L E + Q E+ +L L H N+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
D LV EY G L D+L PLS + KIA+ RGLEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAMSGKLT 228
I+RDLK NILLD + K++DFGLAK + ++ ++T V GT Y APE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 229 LKSDIYSFGVVLLELITGR 247
K D++S GV+L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 3e-52
Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 12/200 (6%)
Query: 53 IGEGGFGKVYKGRL-----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FG+VYKG L + VA+K L + +EF+ E ++ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+G CT G+ +V EYMP G L D L E L+ +++A+ A+G+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
++RDL + N L+ + K+SDFGL++ D + APE GK
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 227 LTLKSDIYSFGVVLLELITG 246
T KSD++SFGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 5e-51
Identities = 72/205 (35%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 51 NLIGEGGFGKVYKGRLESGQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVT 105
+GEG FG+VYKG+L+ VA+K L + + ++F+ E ++ L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHL-----YDLEPDQEPLSWNTRMKIAVGAARGLEY 160
L+G CT + LV EYM G L D+L P++ LS + A+ A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
L K ++RDL + N L+ D K+SDFGL++ D T + APE
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 221 YAMSGKLTLKSDIYSFGVVLLELIT 245
G T KSD++SFGV+L E+ T
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 8e-42
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN-HEGLQGHQEFIV-EVLMLSLLHHDN 102
+ L+G G FG VY ++G+L+A+K + + E + E+ +LS L H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 103 LVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPL--SWNTRMKIAVGAARGL 158
+V G + + EY+ GSL L EP+ + TR + GL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQIL-----EGL 114
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
YLH +++RD+K ANIL+D+D KL+DFG AK + + V GT + A
Sbjct: 115 AYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELITGR 247
PE + +DI+S G ++E+ TG+
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 5e-41
Identities = 80/247 (32%), Positives = 116/247 (46%), Gaps = 34/247 (13%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 105
F IG+GGFG+VYK R +G+ VAIK + E + ++ I E+ +L H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAV---GAARGLEYL 161
G D+ +V E+ GSL+D L + E +IA +GLEYL
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES-------QIAYVCKELLKGLEYL 114
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H +I+RD+K+ANILL +D KL DFGL+ +T ++GT + APE
Sbjct: 115 H-SNG--IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEV 168
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGE---QNLVSWSRPFL 269
K+DI+S G+ +EL G+ KA+ G +N WS F
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEF- 227
Query: 270 KDQKKFV 276
K F+
Sbjct: 228 ---KDFL 231
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 87/298 (29%), Positives = 142/298 (47%), Gaps = 35/298 (11%)
Query: 45 RNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLL 98
R+ + +GEG FGKV R + +G+ VA+K LNH G + H+ +F E+ +L L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63
Query: 99 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
H+N+V G C R L+ EY+P GSL D+L ++ ++ + + +
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICK 120
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST--RVMGTY 214
G++YL + I+RDL + NIL++++ K+SDFGLAK+ P + + +
Sbjct: 121 GMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL----- 269
Y APE + K + SD++SFGV L EL T G+ + +
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFT----------YGDPSQSPPAEFLRMIGIA 226
Query: 270 KDQKKFVHLVDPLLHG-RYPR--RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324
+ Q L++ L G R PR C + + +C E RP D+++ +D L
Sbjct: 227 QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 77/206 (37%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 46 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 102
N++ +LIG G FG VYKG LE+G VAIKQ++ E + + + + E+ +L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V IG + D ++ EY GSL + P E L ++ +GL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL----QGLAYLH 116
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-Y 221
VI+RD+K+ANIL D KL+DFG+A + D + V+GT + APE
Sbjct: 117 ---EQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGR 247
MSG + SDI+S G ++EL+TG
Sbjct: 172 EMSG-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 53 IGEGGFGKVYKGRLESGQ------LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVT 105
+GEG FGKV+ G + LVA+K L ++F E +L+ H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD----------QEPLSWNTRMKIAVGAA 155
G CT GD ++V+EYM G L L PD L+ + ++IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 215
G+ YL A+ ++RDL + N L+ D K+ DFG+++ D V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 216 YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ PE M K T +SD++SFGVVL E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 25/274 (9%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL-QGHQEFIV-EVLMLSLLHHDN 102
+ IG+G FGKVY R G+L +K+++ + + +E + EV +L L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
++ + +V EY G L + + + +P + V L+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+ +++RD+K NI L ++ KL DFG++K+ + ++ V+GT Y +PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282
+ KSDI+S G VL EL T + + G+ L K + P
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLELA----------LKILKGQYPP 222
Query: 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
+ +Y L V + L ++ RP I I
Sbjct: 223 IPSQYSSE-LRNLV---SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-34
Identities = 77/225 (34%), Positives = 113/225 (50%), Gaps = 26/225 (11%)
Query: 39 ELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQL--NHEGLQGHQEFIV 90
E+ ++ F E +GEG FGKVYKG L S VAIK L N E + QEF
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-KVQQEFRQ 57
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPD 138
E ++S L H N+V L+G CT +++EY+ G L + L E
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 139 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198
+ L + + IA+ A G+EYL ++ ++RDL + N L+ K+SDFGL++
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 243
D V ++ + + PE + GK T +SDI+SFGVVL E+
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 81/222 (36%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEG---LQGHQEFIVEVLML-SLLHHD 101
++R +GEG FG+VY R +LVA+K L + + + F+ E+ +L SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
N+V L + LV EY+ GSLED L + PLS + + I LEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 162 HCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKL----GPVGDNTHVSTRVMGTYGY 216
H K +I+RD+K NILLD + KL DFGLAKL G + + +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 217 CAPEYAMSGKL---TLKSDIYSFGVVLLELITGRKAMDLSKG 255
APE + L + SDI+S G+ L EL+TG + K
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-32
Identities = 68/199 (34%), Positives = 109/199 (54%), Gaps = 7/199 (3%)
Query: 47 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106
F +G G FG+V++G ++ VAIK L + L Q+F EV L L H +L++L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
C+ G+ ++ E M GSL L P+ + L + + +A A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQN- 124
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
I+RDL + NIL+ D K++DFGLA+L + ++ ++S+ Y + APE A G
Sbjct: 125 --SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 227 LTLKSDIYSFGVVLLELIT 245
+ KSD++SFG++L E+ T
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-31
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 40 LAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH 99
AI ++ + IG+G FG V G GQ VA+K L + Q F+ E +++ L
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLR 58
Query: 100 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
H NLV L+G G+ +V EYM GSL D+L + ++ ++ A+ G+E
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGME 116
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YL K ++RDL + N+L+ D K+SDFGLAK G S ++ + AP
Sbjct: 117 YLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAP 168
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELIT-GR 247
E K + KSD++SFG++L E+ + GR
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 75/211 (35%), Positives = 114/211 (54%), Gaps = 18/211 (8%)
Query: 45 RNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH 99
R+ + +G+G FG V R + +G++VA+K+L H + ++F E+ +L L
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ 63
Query: 100 HDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
HDN+V G C S +R LV EY+P GSL D+ L+ +E L + A +G
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDY---LQKHRERLDHRKLLLYASQICKG 120
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG---TY 214
+EYL K ++RDL + NIL++++ K+ DFGL K+ P D + R G +
Sbjct: 121 MEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIF 176
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
Y APE K ++ SD++SFGVVL EL T
Sbjct: 177 WY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 2e-31
Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHHDNLVTLI 107
IGEG +G+VYK R ++G+LVA+K++ E + F I E+ +L L H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 108 GYCTSGDQR--LLVYEYMP---MGSLEDHLYDLEPDQEPLSWNTRMK-IAVGAARGLEYL 161
TS + +V+EYM G L+ Q +K GL+YL
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ--------IKCYMKQLLEGLQYL 116
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H +++RD+K +NIL++ND KL+DFGLA+ N+ T + T Y PE
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPEL 172
Query: 222 AM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 260
+ + + + D++S G +L EL G+ +G E
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIF---QGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-31
Identities = 71/202 (35%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIG 108
+G+G FGKV R ++G+L A+K L + + +E + E +LS ++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 109 YCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK-IAVGAARGLEYLHCKA 165
+ + LV EY P G L HL E R + A LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFYAAEIVLALEYLHSLG 113
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
+IYRDLK NILLD D + KL+DFGLAK + + +T GT Y APE +
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 226 KLTLKSDIYSFGVVLLELITGR 247
D +S GV+L E++TG+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 16/200 (8%)
Query: 53 IGEGGFGKVYKGRL-ESGQLVAIK--QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG- 108
+G+G G VYK R +G++ A+K ++ + Q + E+ L +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ-LLRELKTLRSCESPYVVKCYGA 67
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
+ G+ + V EYM GSL D L + EP+ IA +GL+YLH K +
Sbjct: 68 FYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVL----AYIARQILKGLDYLHTKRH-- 120
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 227
+I+RD+K +N+L+++ K++DFG++K L D + T V GT Y +PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESY 177
Query: 228 TLKSDIYSFGVVLLELITGR 247
+ +DI+S G+ LLE G+
Sbjct: 178 SYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG+V+ G VA+K L G + F+ E ++ L HD LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ +V EYM GSL D L + + L + +A A G+ YL + I+R
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHR 127
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 229
DL + NIL+ + K++DFGLA+L + D+ + + G + APE A G+ T+
Sbjct: 128 DLAARNILVGENLVCKIADFGLARL--IEDDEYTAR--EGAKFPIKWTAPEAANYGRFTI 183
Query: 230 KSDIYSFGVVLLELIT-GR 247
KSD++SFG++L E++T GR
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 48 REANLIGEGGFGKVYKG-RLESGQLVAIKQLN--HEGLQGHQ---EFIVEVLMLSLLHHD 101
R+ L+G G FG VY+G L+ G A+K+++ +G G + + E+ +LS L H
Sbjct: 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN-TRMKIAVGAARGLEY 160
N+V +G D + E +P GSL L EP+ TR + GLEY
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEY 117
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-----GTYG 215
LH + ++RD+K ANIL+D + KL+DFG+AK V G+
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPY 166
Query: 216 YCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 247
+ APE G L +DI+S G +LE+ TG+
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 83/249 (33%), Positives = 116/249 (46%), Gaps = 37/249 (14%)
Query: 53 IGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IGEG G+VYK +G+ VAIK++ Q + I E+L++ H N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA--RGLEYLHCKANPPV 169
GD+ +V EYM GSL D + Q + N V +GLEYLH + V
Sbjct: 86 VGDELWVVMEYMDGGSLTDIIT-----QNFVRMNEPQIAYVCREVLQGLEYLHSQ---NV 137
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR--VMGTYGYCAPEYAMSGKL 227
I+RD+KS NILL D + KL+DFG A S R V+GT + APE
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQL----TKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 228 TLKSDIYSFGVVLLELITGR---------KAMDL--SKGQGE-QNLVSWSRPFLKDQKKF 275
K DI+S G++ +E+ G +A+ L +KG +N WS F K F
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF----KDF 249
Query: 276 VHL---VDP 281
++ DP
Sbjct: 250 LNKCLVKDP 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 45 RNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQE-FIVEVLMLSLL 98
R ++ ++GEG FGKV + +G++VA+K L E Q + + E+ +L L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 99 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
+H+N+V G C+ + L+ EY+P+GSL D+L + L+ + A
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICE 118
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH-VSTRVMGTYG 215
G+ YLH + I+RDL + N+LLDND K+ DFGLAK P G + V
Sbjct: 119 GMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 216 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275
+ A E K + SD++SFGV L EL+T + + E+ + + Q
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-----GPKQGQMTV 230
Query: 276 VHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
V L++ L G P+ C + C EA FRP ++
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 46 NFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDN 102
+F N IG+G FG V+K ++ ++ A+KQ++ + +E I E +L+ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLED--HLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
++ + +V EY G L + P E W + + GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
LH K +++RD+KS N+ LD N K+ D G+AKL + DNT+ + ++GT Y +PE
Sbjct: 117 LHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPE 171
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280
KSD+++ GVVL E TG+ PF D L+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK------------------HPF--DANNQGALIL 211
Query: 281 PLLHGRYPRRCLNYAVAVTAM---CLNEEANFRP 311
++ G +P Y+ + + CL ++ RP
Sbjct: 212 KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-29
Identities = 85/284 (29%), Positives = 121/284 (42%), Gaps = 42/284 (14%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FGKV+ + LVA+K L Q+F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE-----------PLSWNTRMKIAVGAA 155
G CT G L+V+EYM G L L PD + L+ + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 215
G+ YL A+ ++RDL + N L+ K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 216 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275
+ PE + K T +SDI+SFGVVL E+ T G+Q W Q
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT----------YGKQ---PWY------QLSN 230
Query: 276 VHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
++ + GR PR C A+ C E R +I DI
Sbjct: 231 TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 47 FREANLIGEGGFGKVYKG----RLESGQL-VAIKQLNHE-GLQGHQEFIVEVLMLSLLHH 100
+ ++G G FG VYKG E ++ VAIK L E + ++E + E +++ + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMKIAVGAAR 156
++V L+G C S Q L+ + MP+G L D++ + + Q L+W V A+
Sbjct: 69 PHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNW------CVQIAK 120
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
G+ YL K +++RDL + N+L+ + K++DFGLAKL V + + + +
Sbjct: 121 GMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 248
A E + T KSD++S+GV + EL+T G K
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 62/196 (31%), Positives = 97/196 (49%), Gaps = 7/196 (3%)
Query: 52 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYC 110
IG+G FG VYKG L+ VA+K ++F+ E +L H N+V LIG C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
+V E +P GSL L + L+ +++++ AA G+EYL K I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTF---LRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 230
+RDL + N L+ + K+SDFG+++ G T + APE G+ T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 231 SDIYSFGVVLLELITG 246
SD++S+G++L E +
Sbjct: 176 SDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 17/201 (8%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 107
+GEG +G VYK R ++G++VA+K++ EG+ + E+ +L L H N+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKLL 64
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
+ + LV+EY M L+ +L PLS N I RGL Y H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHSHR-- 118
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 227
+++RDLK NIL++ D KL+DFGLA+ + T+ + V+ T Y APE + K
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEILLGSKH 175
Query: 228 -TLKSDIYSFGVVLLELITGR 247
+ DI+S G + E+ITG+
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 105
F +GEG +G VYK E+GQ+VAIK + E QE I E+ +L +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLH 162
G +V EY GS+ D + + + L T +IA +GLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTL---TEEEIAAILYQTLKGLEYLH 116
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
I+RD+K+ NILL+ + KL+DFG++ G + D V+GT + APE
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 223 MSGKLTLKSDIYSFGVVLLELITGR 247
K+DI+S G+ +E+ G+
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 104
F IG+G FG+VYK + Q+VAIK ++ E + E I E+ LS +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYL 161
G G + ++ EY GS D L E IA GLEYL
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDE-------TYIAFILREVLLGLEYL 114
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H + I+RD+K+ANILL + + KL+DFG++ G + +GT + APE
Sbjct: 115 HEEG---KIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 222 AMSGKLTLKSDIYSFGVVLLELITG 246
K+DI+S G+ +EL G
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIG 108
+G+GGFG+V +++ +G++ A K+L+ + L +G Q + E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANP 167
+ D LV M G L+ H+Y++ EP R A GLE+LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVG---EPGFPEARAIFYAAQIICGLEHLH---QR 114
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 227
++YRDLK N+LLD+ N ++SD GLA G GT GY APE
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVY 171
Query: 228 TLKSDIYSFGVVLLELITGR 247
D ++ G L E+I GR
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 14/199 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG+V++G + VA+K L G ++F+ E ++ L H L+ L CT
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ +V E M GSL ++L L + +A A G+ YL + I+R
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 229
DL + N+L+ + K++DFGLA++ + ++ + + G + APE A+ + ++
Sbjct: 128 DLAARNVLVGENNICKVADFGLARV--IKEDIYEARE--GAKFPIKWTAPEAALYNRFSI 183
Query: 230 KSDIYSFGVVLLELIT-GR 247
KSD++SFG++L E++T GR
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 72/197 (36%), Positives = 108/197 (54%), Gaps = 11/197 (5%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG+V+ G VA+K L G + F+ E ++ L HD LV L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVS 71
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ +V EYM GSL D L D + L + +A A G+ Y+ + N I+R
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE-RMN--YIHR 126
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 231
DL+SANIL+ + K++DFGLA+L + DN + + + + APE A+ G+ T+KS
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 232 DIYSFGVVLLELIT-GR 247
D++SFG++L EL+T GR
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 51 NLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLI 107
N IG G FGKVY L++G+L+A+K++ + +E E+ +L LL H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
G ++ + EY G+LE+ L E + + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDE----HVIRVYTLQLLEGLAYLHSHG-- 119
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM----GTYGYCAPEYAM 223
+++RD+K ANI LD++ KL DFG A + +NT + GT Y APE
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 224 SGKLTLK---SDIYSFGVVLLELITGRK 248
GK +DI+S G V+LE+ TG++
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 70/203 (34%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYC 110
IG G VY L + + VAIK+++ E Q + + EV +S +H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKANP 167
GD+ LV Y+ GSL D+ P IA +GLEYLH
Sbjct: 69 VVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTH-VSTRVMGTYGYCAPEYAMSG 225
I+RD+K+ NILL D + K++DFG+ A L GD T V +GT + APE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 226 K-LTLKSDIYSFGVVLLELITGR 247
K+DI+SFG+ +EL TG
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 53 IGEGGFGKVYK-GRLESGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVTLIG- 108
IG+G FG V K R G+++ K++++ + Q+ + EV +L L H N+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 109 --------------YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
YC GD L+ + ++ Y +E E W +I
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCK-----KERKY-IE---EEFIW----RILTQL 114
Query: 155 ARGLEYLH--CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
L H V++RDLK ANI LD + N KL DFGLAK+ +G ++ + +G
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVG 172
Query: 213 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
T Y +PE KSDI+S G ++ EL
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 87/312 (27%), Positives = 138/312 (44%), Gaps = 48/312 (15%)
Query: 32 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQL-VAIKQLNHEGLQGHQEFIV 90
++S T ++ + + E N+I G G YKG+ + +K++N I
Sbjct: 680 SKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIA 735
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 150
+ + L H N+V LIG C S L++EY+ +L + L +L SW R KI
Sbjct: 736 D---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRRKI 785
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG----DNTHV 206
A+G A+ L +LHC+ +P V+ +L I++D P L +L G D
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCF 839
Query: 207 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266
+ Y APE + +T KSDIY FG++L+EL+TG+ D G ++V W+R
Sbjct: 840 ISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWAR 893
Query: 267 PFLKDQKKFVHL---VDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
D HL +DP + + +N A+ TA + RP ND++
Sbjct: 894 YCYSD----CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT----DPTARPCANDVL 945
Query: 318 VALDYLVSQRDS 329
L+ S
Sbjct: 946 KTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 73/226 (32%), Positives = 111/226 (49%), Gaps = 24/226 (10%)
Query: 39 ELAIATRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQL-NHEGLQGHQEFIVEV 92
EL ++ F E +GE FGK+YKG L + QLVAIK L + Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 93 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------ 140
+++ LHH N+V L+G T +++EY+ G L + L P +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 141 -PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
L + IA+ A G+EYL ++ +++DL + NIL+ + K+SD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
D V + + + PE M GK + SDI+SFGVVL E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 67/199 (33%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG V+ G+ VAIK + EG +FI E ++ L H NLV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+V EYM G L ++L + + W M V +EYL I+R
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDV--CEAMEYLESNG---FIHR 124
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 229
DL + N L+ D K+SDFGLA+ V D+ + S+ GT + PE + +
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFSS 180
Query: 230 KSDIYSFGVVLLELITGRK 248
KSD++SFGV++ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 51 NLIGEGGFGKVYKGRL-ESGQ---LVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLV 104
+IG G FG+V +GRL G+ VAIK L G Q +F+ E ++ H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
L G T +++ EYM GSL+ L E D + + + + G A G++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGK-FTVGQLVGMLRGIASGMKYL--- 122
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAP 219
+ ++RDL + NIL++++ K+SDFG L +++ + G G + AP
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKG--GKIPIRWTAP 177
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELIT 245
E K T SD++SFG+V+ E+++
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 32/282 (11%)
Query: 53 IGEGGFGKVYKG---RLESGQL---VAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+G+G FG VY+G + G+ VAIK +N + ++ EF+ E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRMKIAVGAARGLE 159
L+G ++G L+V E M G L+ +L P+ E P + +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YL K ++RDL + N ++ D K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279
E G T KSD++SFGVVL E+ T A +G + ++ F+ D
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLSNEEVLK----FVIDGG------ 238
Query: 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321
H P C + + + MC RP +IV +L
Sbjct: 239 ----HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 50/229 (21%)
Query: 52 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFI-VEVLMLSLL-HHDNLVTL 106
+IGEG F V + E+ + AIK L+ L + +++ +E +L+ L H ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 107 IGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-------- 156
Y T D+ L V EY P G L ++ + R
Sbjct: 68 --YYTFQDEENLYFVLEYAPNGELLQYI------------RKYGSLDEKCTRFYAAEILL 113
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM---- 211
LEYLH K +I+RDLK NILLD D + K++DFG AK L P
Sbjct: 114 ALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 212 -------------GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
GT Y +PE SD+++ G ++ +++TG+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 52 LIGEGGFGKVYKGRLES--GQL--VAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTL 106
+G+G FG V +G + G++ VA+K L + L +F+ E ++ L H+NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEYLHCK 164
G + ++V E P+GSL D L +S + ++IA G+ YL K
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLESK 116
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST---RVMGTYGYCAPEY 221
I+RDL + NILL +D K+ DFGL + P ++ +V +V + +CAPE
Sbjct: 117 R---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171
Query: 222 AMSGKLTLKSDIYSFGVVLLELIT 245
+ + SD++ FGV L E+ T
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 53 IGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FGKV+ + LVA+K L L ++F E +L+ L H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ------EPLSWNTR------MKIAVGA 154
G C GD ++V+EYM G L L PD +P + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
A G+ YL A+ ++RDL + N L+ + K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ PE M K T +SD++SFGV+L E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG+V+ G VAIK L +G + F+ E ++ L H LV L T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ ++ EYM GSL D L P+ L+ N + +A A G+ ++ K I+R
Sbjct: 73 -EPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHR 126
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 231
DL++ANIL+ K++DFGLA+L + DN + + + APE G T+KS
Sbjct: 127 DLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 232 DIYSFGVVLLELIT-GR 247
D++SFG++L E++T GR
Sbjct: 185 DVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 69/211 (32%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 52 LIGEGGFGKVYKG-RLESGQLVAIKQL-----NHEGLQGHQEFIV----EVLMLSLLHHD 101
LIG G FG VY G SG+L+A+KQ+ + + + E+ +L L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
N+V +G D + EY+P GS+ L + +E L N +I +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-----LGPVGDNTHVSTRVMGTYGY 216
H N +I+RD+K ANIL+DN K+SDFG++K N + + G+ +
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
APE T K+DI+S G +++E++TG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 5e-24
Identities = 71/198 (35%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IG G +G VYK R + +G+LVAIK + E + E+ ML H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
D+ +V EY GSL+D +Y + + PLS + +GL YLH I+
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIH 124
Query: 172 RDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYA---MSG 225
RD+K ANILL D + KL+DFG+ A+L T ++ R +GT + APE A G
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQL----TAT-IAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 226 KLTLKSDIYSFGVVLLEL 243
K DI++ G+ +EL
Sbjct: 180 GYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-24
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 31/207 (14%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLIG 108
+G G G V K +G+++A+K + E + Q+ I+ ++L + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC--NSPYIVGFYG 66
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
+ + EYM GSL D + + P KIAV +GL YLH K
Sbjct: 67 AFYNNGDISICMEYMDGGSL-DKILKEVQGRIPER--ILGKIAVAVLKGLTYLHEKHK-- 121
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM--------GTYGYCAPE 220
+I+RD+K +NIL+++ KL DFG VS +++ GT Y APE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAPE 169
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGR 247
++KSDI+S G+ L+EL TGR
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 7e-24
Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 53 IGEGGFGKVYKG--RLESGQL--VAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLI 107
+G G FG V KG ++SG+ VA+K L E + G +EF+ E +++ L H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
G C G+ +LV E P+G L +L P + ++ A G+ YL K
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYA 222
++RDL + N+LL N K+SDFG+++ LG + + G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECI 170
Query: 223 MSGKLTLKSDIYSFGVVLLELIT 245
GK + KSD++S+GV L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-24
Identities = 72/197 (36%), Positives = 111/197 (56%), Gaps = 11/197 (5%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G+G FG+V+ G VAIK L G + F+ E ++ L HD LV L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ +V E+M GSL D L E D + L + +A A G+ Y+ + N I+R
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLK--EGDGKYLKLPQLVDMAAQIADGMAYIE-RMN--YIHR 126
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 231
DL++ANIL+ ++ K++DFGLA+L + DN + + + + APE A+ G+ T+KS
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 232 DIYSFGVVLLELIT-GR 247
D++SFG++L EL+T GR
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-24
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 46 NFREANLIGEGGFGKVYK-GRLESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDN 102
+ + ++G G FG V+ R +LV IKQ+ E + + E +L LL H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMKIAVGAARGL 158
++ ++V EY P G+L +++ L + L + ++ +A L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------L 114
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
++H K +++RDLK+ NILLD K+ DFG++K+ + + T V+GT Y
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYI 168
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 251
+PE KSDI++ G VL EL + ++A +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 29/210 (13%)
Query: 53 IGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIG 108
I +G +G+V+ + +S G + AIK + + + + E +LS +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 109 YCTSGDQRL-LVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKIA--VGAARGLEYLH 162
Y G + L LV EY+P G SL +++ L+ D R+ IA V A LEYLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED------VARIYIAEIVLA---LEYLH 110
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS------TRVMGTYGY 216
+ +I+RDLK NIL+D++ + KL+DFGL+K+G V +++ R++GT Y
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
APE + + D +S G +L E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV------EVLMLSLLHHDNLVT 105
IGEG +G VYK R +G++VAIK++ + + E+ +L L+H N++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI----KLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCK 164
L+ LV+E+M + LY L D Q L + +GL + H
Sbjct: 63 LLDVFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-S 116
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEY 221
+++RDLK N+L++ + KL+DFGLA+ PV TH V TR Y APE
Sbjct: 117 HG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 222 AM-SGKLTLKSDIYSFGVVLLELITGR 247
+ + DI+S G + EL++ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 84/300 (28%), Positives = 129/300 (43%), Gaps = 46/300 (15%)
Query: 39 ELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVE 91
E+ ++T F E +GE FGKVYKG L E Q VAIK L + +EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ------------ 139
+M S L H N+V L+G T +++ Y L + L P
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 140 ---EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196
EP + + I A G+E+L ++ V+++DL + N+L+ + N K+SD GL +
Sbjct: 119 STLEPADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 256
D + + + +PE M GK ++ SDI+S+GVVL E+ + + G
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQPYCGY 230
Query: 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
Q+++ R V P P C + + C NE + RP DI
Sbjct: 231 SNQDVIEMIRN---------RQVLPC-----PDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-23
Identities = 81/294 (27%), Positives = 137/294 (46%), Gaps = 37/294 (12%)
Query: 47 FREANLIGEGGFGKVY----KGRLE---------SGQ--LVAIKQLNHEGLQ-GHQEFIV 90
+E +GEG FG+V+ +G E GQ LVA+K L + + +F+
Sbjct: 9 LKEK--LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE--------PL 142
E+ ++S L + N++ L+G C S D ++ EYM G L L E + +
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
S + +AV A G++YL A+ ++RDL + N L+ N + K++DFG+++ GD
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262
+ R + + A E + GK T SD+++FGV L E+ T K S EQ ++
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VI 242
Query: 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
+ F ++Q + ++L L C + + C + + RP N I
Sbjct: 243 ENTGEFFRNQGRQIYLSQTPL-------CPSPVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 68/197 (34%), Positives = 108/197 (54%), Gaps = 17/197 (8%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
IGEG FG V +G +GQ VA+K + + Q F+ E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ +V E M G+L + L + ++ ++ A G+EYL K +++R
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVG-DNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 231
DL + NIL+ D K+SDFGLA++G +G DN+ + + + APE K + KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178
Query: 232 DIYSFGVVLLELIT-GR 247
D++S+GV+L E+ + GR
Sbjct: 179 DVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-23
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH-----QEFIVEVLMLSLLH 99
N+R L+G+G FG+VY +++G+ +A+KQ+ + E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 100 HDNLVTLIGYCTSGDQRLLVY-EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
H+ +V G C D+ L ++ EYMP GS++D L L+ K G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGV 117
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 217
EYLH +++RD+K ANIL D+ N KL DFG +K L + + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELIT 245
+PE K+D++S G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-23
Identities = 60/196 (30%), Positives = 105/196 (53%), Gaps = 8/196 (4%)
Query: 51 NLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109
+ +G G +G+VY+G + VA+K L + ++ EF+ E ++ + H NLV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
CT ++ E+M G+L D+L E +++ ++ + +A + +EYL K
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 229
I+RDL + N L+ + K++DFGL++L GD + APE K ++
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 230 KSDIYSFGVVLLELIT 245
KSD+++FGV+L E+ T
Sbjct: 185 KSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-23
Identities = 86/294 (29%), Positives = 136/294 (46%), Gaps = 52/294 (17%)
Query: 51 NLIGEGGFGKVYKGRL--ESGQLV--AIKQLNH-EGLQGHQEFIVEVLMLSLLHHDNLVT 105
+IG+G FG VY G L GQ + A+K LN L+ ++F+ E +++ H N+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 106 LIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG----AARGLEY 160
L+G C + L+V YM G L + + + N +K +G A+G+EY
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE-------THNPTVKDLIGFGLQVAKGMEY 113
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK------LGPVGDNTHVSTRVMGTY 214
L A+ ++RDL + N +LD F K++DFGLA+ V ++T V
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK--- 167
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274
+ A E + K T KSD++SFGV+L EL+T R A P D
Sbjct: 168 -WMALESLQTQKFTTKSDVWSFGVLLWELMT-RGA-----------------PPYPDVDS 208
Query: 275 FVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325
F + LL GR P C + V C + + RP +++V ++ + S
Sbjct: 209 F-DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 53 IGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTL 106
+GEG FGKV R + +G+ VA+K L E H + E+ +L L+H+N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 107 IGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
G CT L+ E++P GSL+++L ++ ++ ++K AV +G++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST----RVMGTYGYCAPE 220
++RDL + N+L++++ K+ DFGL K + + T + Y APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEYYTVKDDLDSPVFWY-APE 182
Query: 221 YAMSGKLTLKSDIYSFGVVLLELIT 245
+ K + SD++SFGV L EL+T
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 3e-22
Identities = 79/303 (26%), Positives = 140/303 (46%), Gaps = 46/303 (15%)
Query: 47 FREANLIGEGGFGKVYKGRLESGQ-----------------LVAIKQLNHEGLQ-GHQEF 88
F+E +GEG FG+V+ + + Q LVA+K L + + +F
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66
Query: 89 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEP----- 141
+ EV +LS L N++ L+G C D ++ EYM G L L + L+ +E
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 142 --------LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193
+S+++ + +A+ A G++YL ++ ++RDL + N L+ + K++DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 253
+++ GD + R + + A E + GK T SD+++FGV L E++ K
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243
Query: 254 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 313
+ EQ ++ + F +DQ + V+L R P C + C + + RP
Sbjct: 244 ELTDEQ-VIENAGEFFRDQGRQVYL------FR-PPPCPQGLYELMLQCWSRDCRERPSF 295
Query: 314 NDI 316
+DI
Sbjct: 296 SDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-22
Identities = 65/195 (33%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG+V+ G + VA+K L G Q F+ E ++ L HD LV L T
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ ++ EYM GSL D L E + L + + A G+ Y+ K I+R
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIHR 127
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY--GYCAPEYAMSGKLTLK 230
DL++AN+L+ K++DFGLA++ + DN + + R + + APE G T+K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARV--IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 231 SDIYSFGVVLLELIT 245
SD++SFG++L E++T
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 4e-22
Identities = 77/295 (26%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 47 FREANLIGEGGFGKVYKGRLESGQ-----------------LVAIKQLNHEGLQ-GHQEF 88
F+E +GEG FG+V+ E + LVA+K L + + +F
Sbjct: 9 FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 89 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP------- 141
+ E+ ++S L N++ L+ C + D ++ EYM G L L EP +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 142 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201
+S++T + +A A G++YL ++ ++RDL + N L+ ++ K++DFG+++ G
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261
D + R + + + E + GK T SD+++FGV L E++T K S+ EQ +
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-V 242
Query: 262 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
+ + F +DQ + V+L P C + + C A RP +I
Sbjct: 243 IENTGEFFRDQGRQVYLPK-------PALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI-GYC 110
+G+G FGKVYK + E+G A K + E + ++F+VE+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLE-PDQEPLSWNTRMKIAV---GAARGLEYLHCKAN 166
+L+ E+ G+L+ + +LE EP +I L +LH
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEP-------QIRYVCRQMLEALNFLHSHK- 123
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM--- 223
VI+RDLK+ NILL D + KL+DFG++ + +GT + APE
Sbjct: 124 --VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACET 179
Query: 224 --SGKLTLKSDIYSFGVVLLELITGR 247
K+DI+S G+ L+EL
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-22
Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 44 TRNFREANLIGEGGFGKVYKG----RLESGQL-VAIKQL-NHEGLQGHQEFIVEVLMLSL 97
R+ L+G G FG V+KG +S ++ VAIK + + G Q QE +L +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 98 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY----DLEPDQEPLSWNTRMKIAVG 153
L H +V L+G C G LV + P+GSL DH+ L+P Q L+W V
Sbjct: 66 LDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNW------CVQ 117
Query: 154 AARGLEYL--HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
A+G+ YL H +++R+L + NILL +D +++DFG+A L D + +
Sbjct: 118 IAKGMYYLEEHR-----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ A E + G+ T +SD++S+GV + E+++
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-22
Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG V G+ VAIK + EG EFI E ++ L H+ LV L G CT
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+V EYM G L ++L + +P +++ G+ YL K I+R
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESKQ---FIHR 124
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 229
DL + N L+D+ K+SDFGL++ V D+ + S+ +G+ + PE + K +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFSS 180
Query: 230 KSDIYSFGVVLLELIT 245
KSD+++FGV++ E+ +
Sbjct: 181 KSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 7e-22
Identities = 65/196 (33%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
IG G FG V+ G + VAIK + EG ++FI E ++ L H LV L G CT
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
LV+E+M G L D+ L + S T + + + G+ YL VI+R
Sbjct: 71 RSPICLVFEFMEHGCLSDY---LRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 229
DL + N L+ + K+SDFG+ + V D+ + S+ GT + +PE K +
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSST--GTKFPVKWSSPEVFSFSKYSS 180
Query: 230 KSDIYSFGVVLLELIT 245
KSD++SFGV++ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 7e-22
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FGKV+ + LVA+K L ++F E +L+ L H+++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ---------EPLSWNTRMKIAVGAARG 157
G C GD ++V+EYM G L L PD L+ + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
+ YL A+ ++RDL + N L+ + K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELIT 245
PE M K T +SD++S GVVL E+ T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-22
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 46 NFREANLIGEGGFGKVYK-GRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 102
+F+ +G+G +G VYK RL Q A+K+++ + + ++ + E+ +L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 103 LVTLIGYCTS---GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
+ I Y + G++ +V EY P G L + + ++ + +I + RGL+
Sbjct: 61 I---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
LH + +++RDLKSANILL + K+ D G++K V T +GT Y AP
Sbjct: 118 ALHEQK---ILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKT-QIGTPHYMAP 170
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGR 247
E + KSDI+S G +L E+ T
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 8e-22
Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 15/205 (7%)
Query: 45 RNFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDN 102
+ + IG+G G VY + +GQ VAIKQ+N + Q +E I+ E+L++ H N
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPN 77
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V + GD+ +V EY+ GSL D + + D+ ++ R + + LE+LH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLH 132
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEY 221
VI+RD+KS NILL D + KL+DFG A++ P + + ST V GT + APE
Sbjct: 133 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEV 186
Query: 222 AMSGKLTLKSDIYSFGVVLLELITG 246
K DI+S G++ +E++ G
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 16/212 (7%)
Query: 46 NFREANLIGEGGFGKVY----KGRLESG--QLVAIKQLNHEGLQGHQ-EFIVEVLMLSLL 98
N +E +G G FG+V+ KG E G LV +K L + Q EF E+ M L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 99 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL-----YDLEPDQEPLSWNTRMKIAVG 153
H N+V L+G C + ++ EY +G L+ L D + PLS ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 213
A G+++L +N ++RDL + N L+ + K+S L+K + +
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIP 181
Query: 214 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ APE + KSD++SFGV++ E+ T
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG 108
++GEG +G V K R +G++VAIK+ + + + + EV +L L H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
+ LV+EY+ LE LE L + + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--- 120
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE----YAMS 224
+I+RD+K NIL+ KL DFG A+ + ++ V T Y APE
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNY 179
Query: 225 GKLTLKSDIYSFGVVLLELITGR 247
GK D+++ G ++ EL+ G
Sbjct: 180 GK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 69/197 (35%), Positives = 107/197 (54%), Gaps = 11/197 (5%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G+G FG+V+ G VAIK L G + F+ E ++ L H+ LV L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ +V EYM GSL D L + L + +A A G+ Y+ + N ++R
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE-RMN--YVHR 126
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 231
DL++ANIL+ + K++DFGLA+L + DN + + + + APE A+ G+ T+KS
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 232 DIYSFGVVLLELIT-GR 247
D++SFG++L EL T GR
Sbjct: 185 DVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 53 IGEGGFGKVYKGR---LESGQ---LVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVT 105
IG+G FG+V++ R L + +VA+K L E +F E +++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------------DQEPLSWNTR 147
L+G C G L++EYM G L + L P + PLS +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 148 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD----- 202
+ IA A G+ YL + ++RDL + N L+ + K++DFGL++ D
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 203 -NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
N + R M PE + T +SD++++GVVL E+ +
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIG 108
+G+GGFG+V ++ +G+L A K+LN + L +G++ +VE +L+ +H +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
+ LV M G L H+Y+++ + GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 228
+IYRDLK N+LLDND N ++SD GLA + D + GT G+ APE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 229 LKSDIYSFGVVLLELITGR 247
D ++ GV L E+I R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 72/202 (35%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 53 IGEGGFGKVYKGRLES-GQLVAIKQL--NHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIG 108
+G GGFG+V +++S + A+K + H G QE I E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 109 YCTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
Y T D++ +Y EY G L L D E + R IA EYLH
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEYLH--- 110
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
N +IYRDLK N+LLD++ KL DFG AK G T GT Y APE ++
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNK 167
Query: 226 KLTLKSDIYSFGVVLLELITGR 247
D +S G++L EL+TGR
Sbjct: 168 GYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNL 103
E + +GEG G V K RL +G + A+K + ++ + E+ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 104 VTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRM------KIAVGAA 155
V G + EY GSL D +Y ++ R+ KIA
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIY-----KKVKKRGGRIGEKVLGKIAESVL 115
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTY 214
+GL YLH + +I+RD+K +NILL KL DFG++ +L T GT
Sbjct: 116 KGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTS 167
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
Y APE ++ SD++S G+ LLE+ R
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 42/217 (19%)
Query: 51 NLIGEGGFGKVYKGR-LESGQLVAIKQ--LNH--EGLQG-HQEFIVEVLMLSLLHHDNLV 104
+GEG + VYK R E+G++VAIK+ L E G + + E+ +L L H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAV 152
L+ LV+E+M DLE D + T
Sbjct: 66 GLLDVFGHKSNINLVFEFME--------TDLEKVIKDKSIVLTPADIKSYMLMT------ 111
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD-NTHVSTRVM 211
RGLEYLH + +++RDLK N+L+ +D KL+DFGLA+ G N ++ +V+
Sbjct: 112 --LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNRKMTHQVV 164
Query: 212 GTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
T Y APE + + D++S G + EL+
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 26/213 (12%)
Query: 52 LIGEGGFGKVYKG-RLESGQLVAIKQ--LNHEGLQGHQEFIV--------EVLMLSLLHH 100
LIG+G +G+VY + +G+++A+KQ L H E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
N+V +G+ T+ + + EY+P GS+ L +E L ++ GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAY 123
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM---GTYGYC 217
LH K +++RDLK+ N+L+D D K+SDFG++K D+ + + + M G+ +
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNMSMQGSVFWM 177
Query: 218 APEYAMSGK--LTLKSDIYSFGVVLLELITGRK 248
APE S + K DI+S G V+LE+ GR+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-21
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 53 IGEGGFGK--VYKGRLESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIG 108
+G+G FG+ +Y+ R E LV K++N L + E+++LSLL H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 109 YCTSGDQRLLVYEYMPMGSLED---HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
+ + L+ EY G+L D ++E + W + +A + Y+H KA
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW---YLFQIVSA--VSYIH-KA 120
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
+++RD+K+ NI L KL DFG++K+ +G ++ V+GT Y +PE
Sbjct: 121 G--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 226 KLTLKSDIYSFGVVLLELITGRKAMDLS 253
K KSDI++ G VL EL+T ++ D +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-21
Identities = 74/280 (26%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 52 LIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTL 106
+IG G FG+V++G L+ VAIK L + Q+F+ E ++ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
G T +++ EYM G+L+ +L D + + ++ G A G++YL ++
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SD 125
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
++RDL + NIL++++ K+SDFGL++ L + T+ ++ + APE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 226 KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHLVDPLLH 284
K T SD++SFG+V+ E+++ GE RP+ + + ++
Sbjct: 186 KFTSASDVWSFGIVMWEVMS----------FGE-------RPYWDMSNHEVMKAINDGFR 228
Query: 285 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324
P C + + C ++ RP DIV LD L+
Sbjct: 229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-21
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 17/211 (8%)
Query: 47 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHE------GLQGHQEFIVEVLMLSLLHH 100
+ + ++G+G +G VY G GQL+A+KQ+ + + +++ EV +L L H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
N+V +G C + + E++P GS+ L P EP+ +I G A Y
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----Y 117
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----LGPVGDNTHVSTRVMGTYGY 216
LH N V++RD+K N++L + KL DFG A+ +G G ++++ + GT +
Sbjct: 118 LH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
APE KSDI+S G + E+ TG+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 50/289 (17%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV------EVLMLSLLHHDNLV 104
L+GEG +G V K + E+GQ+VAIK+ L+ + +V E+ ML L H+NLV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDH--LYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
LI + LV+E++ DH L DLE L + K RG+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEY 221
+ +I+RD+K NIL+ KL DFG A+ L G+ V T + T Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPEL 171
Query: 222 AMSG-KLTLKSDIYSFGVVLLELITG-----------------RKAMDLSKGQGEQNLVS 263
+ K DI++ G ++ E++TG + +L Q +
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH--QEIFQ 229
Query: 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLN-YAVAVTAMCLNEEANFRP 311
+ F + V ++P L R+P+ L+ + + CL + + RP
Sbjct: 230 KNPLFAGMRLPEVKEIEP-LEKRFPK--LSGLVLDLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-21
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 17/210 (8%)
Query: 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH 100
A+ + + IG+G FG V G G VA+K + ++ Q F+ E +++ L H
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRH 58
Query: 101 DNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
NLV L+G L +V EYM GSL D+L + L + +K ++ +E
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAME 116
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCA 218
YL +AN ++RDL + N+L+ D K+SDFGL K D + + + A
Sbjct: 117 YL--EANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTA 167
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELIT-GR 247
PE K + KSD++SFG++L E+ + GR
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-21
Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 8/192 (4%)
Query: 52 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYC 110
L+G+G FG+V+KG L+ VA+K + Q + +F+ E +L H N+V LIG C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
T QR +Y M + D L L ++ L +K A+ AA G+ YL K I
Sbjct: 62 T---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CI 115
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 230
+RDL + N L+ + K+SDFG+++ G + + + + APE G+ + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSE 174
Query: 231 SDIYSFGVVLLE 242
SD++S+G++L E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 72/229 (31%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 43 ATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQ-LNHEGLQG-HQEFIVEVLMLSLLH 99
R++ +GEG FG+VYK R +++G++VA+K+ L H G + E+ +L L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 100 HDNLVTLIGYC-----TSGDQRLLVYEYMP-M-----GSLEDHLYDLEPDQEPLSWNTRM 148
H N+V LI S +R VY P M G LE+ L Q M
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY----M 121
Query: 149 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL---------GP 199
+ G+ YLH +++RD+K+ANIL+DN K++DFGLA+ G
Sbjct: 122 LQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 247
G T T ++ T Y PE + + T DI+ G V E+ T R
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 32/273 (11%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG V+ G+ + VAIK +N EG ++FI E ++ L H LV L G CT
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+V E+M G L L L Q LS + + + G+EYL + I+R
Sbjct: 71 QKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 231
DL + N L+ + K+SDFG+ + V D+ + S+ + PE K + KS
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 232 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR---YP 288
D++SFGV++ E+ T K PF ++K +V+ + G P
Sbjct: 183 DVWSFGVLMWEVFTEGKM-----------------PF--EKKSNYEVVEMISRGFRLYRP 223
Query: 289 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321
+ V C +E+ RP +++ A+
Sbjct: 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 74/199 (37%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIG 108
IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L L H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
LV EY +GS D L E ++PL I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLH---SHE 135
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKL-GPVGDNTHVSTRVMGTYGYCAPE--YAM-S 224
I+RD+K+ NILL KL+DFG A L P N+ V GT + APE AM
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFV-----GTPYWMAPEVILAMDE 188
Query: 225 GKLTLKSDIYSFGVVLLEL 243
G+ K D++S G+ +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 107
++G+G FGKV+ L+ + Q AIK L + + + +VE +LSL +T +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 108 GYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
YCT + + V EY+ G L H+ P + +I G L++LH K
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSKG 116
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
++YRDLK NILLD D + K++DFG+ K +GD + GT Y APE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQ 171
Query: 226 KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261
K D +SFGV+L E++ G+ G E+ L
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 17/242 (7%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IGEG G V +G+ VA+K+++ Q + EV+++ H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
GD+ +V E++ G+L D + ++E ++ + + + L +LH + VI+
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHAQG---VIH 138
Query: 172 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 231
RD+KS +ILL +D KLSDFG V ++GT + APE +
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 232 DIYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR 290
DI+S G++++E++ G + Q + + P LK+ K V P L + R
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK----VSPRLRS-FLDR 251
Query: 291 CL 292
L
Sbjct: 252 ML 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-20
Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG+V+ VA+K + G + F+ E ++ L HD LV L T
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ ++ E+M GSL D L E ++PL + + A G+ ++ + N I+R
Sbjct: 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE-QRN--YIHR 126
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAMSGKLTLKS 231
DL++ANIL+ K++DFGLA++ + DN + + + APE G T+KS
Sbjct: 127 DLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 232 DIYSFGVVLLELIT-GR 247
D++SFG++L+E++T GR
Sbjct: 185 DVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 65/223 (29%), Positives = 115/223 (51%), Gaps = 26/223 (11%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIV----EVLMLSLLH 99
+ + N I EG +G VY+ R ++G++VA+K+L + +G F + E+ +L L
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQ 62
Query: 100 HDNLVTL--IGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAAR 156
H N+VT+ + ++ D+ +V EY+ E L L E ++P + + +
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
G+ +LH +++RDLK++N+LL+N K+ DFGLA+ G T+++ T Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWY 172
Query: 217 CAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGE 258
APE + K + D++S G + EL+T + L G+ E
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP---LFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLN---HEGLQGHQEFIVEVLMLSLLHHD 101
+F +IG+G FGKV + ++ ++ A+K +N + + E +L L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 160
LV L + LV + + G L HL E ++K LEY
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWICEIVLALEY 115
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
LH K +I+RD+K NILLD + ++DF +A T T GT GY APE
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPE 169
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGRK 248
++ D +S GV E + G++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 6e-20
Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 45 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIV-EVLMLSLLHH 100
+F +G G FG+V R SG+ A+K L+ + E ++ E +L + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 101 DNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--- 156
LV L G D L LV EY+P G L HL + AR
Sbjct: 61 PFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHL------------RKSGRFPEPVARFYA 107
Query: 157 -----GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
LEYLH + ++YRDLK N+LLD+D K++DFG AK V T+ +
Sbjct: 108 AQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LC 159
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
GT Y APE +S D ++ G+++ E++ G
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 6e-20
Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 10/205 (4%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNL 103
NF++ +GEG + VYKGR +G++VA+K+++ + +G I E+ ++ L H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
V L + ++ +LV+EYM L+ ++ D + L NT +G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCH- 117
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
V++RDLK N+L++ KL+DFGLA+ + NT + V T Y AP+ +
Sbjct: 118 --ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLL 173
Query: 224 SGKLTLKS-DIYSFGVVLLELITGR 247
+ S DI+S G ++ E+ITGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 9e-20
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 51 NLIGEGGFGKVYKGRL-------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDN 102
N +G G FG+VY+G VA+K L Q +EF+ E ++S +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP---LSWNTRMKIAVGAARGLE 159
+V L+G C + + ++ E M G L +L D ++ L+ + I + A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 160 YLHCKANPPVIYRDLKSANILL-----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
YL I+RDL + N L+ D D K+ DFGLA+ D +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ APE + GK T +SD++SFGV++ E++T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLN----HEGLQGHQEFIVEVLMLSLLHHDNLVTLI 107
IGEG G V+K + E+G+ VA+K++ G+ + + E+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP--NQALREIKALQACQHPYVVKLL 65
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGLEYLHCK 164
G +LV EYMP L + L D E P+ + S+ RM + +G+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSY-MRMLL-----KGVAYMHAN 118
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM- 223
+++RDLK AN+L+ D K++DFGLA+L + S +V T Y APE
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174
Query: 224 SGKLTLKSDIYSFGVVLLELITGR 247
+ K D+++ G + EL+ G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 54/305 (17%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQE-FIVEVLM 94
+ + +G G FG+VY+G VA+K L + + F++E L+
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 95 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE---PLSWNTRMKIA 151
+S +H N+V LIG R ++ E M G L+ L + P E L+ + A
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVS 207
A+G +YL I+RD+ + N LL P K++DFG+A+
Sbjct: 123 RDVAKGCKYLEENH---FIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKG 178
Query: 208 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI----------TGRKAMDLSKGQG 257
R M + PE + G T K+D++SFGV+L E+ T ++ M+ G G
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238
Query: 258 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
+ P+ C + C RP I+
Sbjct: 239 RLD--------------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
Query: 318 VALDY 322
+ Y
Sbjct: 273 ERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 53 IGEGGFGKVYKG------RLESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVT 105
+G+G FG VY+G + E VAIK +N ++ EF+ E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRMKIAVGAARGLE 159
L+G + G L++ E M G L+ +L L P+ E P S +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YL+ AN ++RDL + N ++ DF K+ DFG+ + D + + + +P
Sbjct: 134 YLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELIT 245
E G T SD++SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 52 LIGEGGFGKVYKGRL------ESGQLVAIKQLN---HEGLQGHQEFIVEVLMLSLL-HHD 101
+GEG FG+V K VA+K L E + + + E+ M+ ++ H
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHK 76
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMK 149
N++ L+G CT +V EY G+L D L D P +E L+ +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 209
A ARG+E+L A+ I+RDL + N+L+ D K++DFGLA+ + +
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKT 191
Query: 210 VMG--TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
G + APE T +SD++SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 71/204 (34%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109
IGEG +G V+K R E+GQ+VAIK+ + + + + E+ ML L H NLV LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 110 CTSGDQRLLVYEYMPMGSLEDH--LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
+ LV+EY DH L +LE + + + KI + + + H K N
Sbjct: 69 FRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH-KHN- 120
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNT-HVSTRVMGTYGYCAPEYAMS 224
I+RD+K NIL+ KL DFG A++ GP D T +V+TR Y APE +
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL-LV 173
Query: 225 GKLTLKS--DIYSFGVVLLELITG 246
G D+++ G V EL+TG
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-19
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGH--QEFIVEVLMLSLL 98
+ + +G G F Y+ R +++G L+A+KQ+ N Q + E+ +++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 99 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
+H +++ ++G L E+M GS+ L +E + N ++ RGL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGL 116
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLA-KLGPVGDNT-HVSTRVMGTYG 215
YLH +I+RD+K AN+L+D+ +++DFG A +L G +++GT
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 216 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+ APE + D++S G V++E+ T +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 51 NLIGEGGFGKVYKGRLESGQL---VAIKQLNHEGLQG-HQEFIVEVLMLSLL-HHDNLVT 105
++IGEG FG+V + ++ L AIK L + H++F E+ +L L HH N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYD---LEPD---------QEPLSWNTRMKIAVG 153
L+G C + + EY P G+L D L LE D L+ ++ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 213
A G++YL K I+RDL + N+L+ + K++DFGL++ G+ +V + MG
Sbjct: 128 VATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMGR 179
Query: 214 YG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ A E T KSD++SFGV+L E+++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 84/295 (28%), Positives = 127/295 (43%), Gaps = 43/295 (14%)
Query: 53 IGEGGFGKVYKG------RLESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVT 105
+G+G FG VY+G + E+ VA+K +N L+ EF+ E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRMKIAVGAARGLE 159
L+G + G L+V E M G L+ +L L P+ E P + +++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YL+ K ++RDL + N ++ +DF K+ DFG+ + D + + + AP
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279
E G T SD++SFGVVL E IT EQ L KFV
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL------------KFV--- 234
Query: 280 DPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 331
+ G Y P C + MC RP +IV L + D HP
Sbjct: 235 ---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL-----KDDLHP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-19
Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IG+G G V+ + +GQ VAIKQ+N + + I E+L++ L + N+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
GD+ +V EY+ GSL D + + D+ ++ R + + LE+LH VI+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHANQ---VIH 138
Query: 172 RDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 230
RD+KS N+LL D + KL+DFG A++ P + + ST V GT + APE K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 231 SDIYSFGVVLLELITG 246
DI+S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 28/207 (13%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHHDNLVTL 106
IGEG +G VYK R +G++VA+K++ L+ E I E+ +L L+H N+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA---VGAARGLEYLHC 163
+ S ++ LV+E++ + L+ ++ D PL+ I +G+ Y H
Sbjct: 64 LDVVHSENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYCAPEY 221
V++RDLK N+L+D + KL+DFGLA+ G PV TH V+ T Y APE
Sbjct: 118 HR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEI 170
Query: 222 AMSGKL-TLKSDIYSFGVVLLELITGR 247
+ + + DI+S G + E++ R
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-19
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 51 NLIGEGGFGKVYKGRLESGQL---VAIKQLNHEGLQG-HQEFIVEVLMLSLL-HHDNLVT 105
++IGEG FG+V K R++ L AIK++ + H++F E+ +L L HH N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYD---LEPD---------QEPLSWNTRMKIAVG 153
L+G C L EY P G+L D L LE D LS + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 213
ARG++YL K I+RDL + NIL+ ++ K++DFGL++ G +V + MG
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGR 172
Query: 214 YG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ A E T SD++S+GV+L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 46 NFREANLIGEGGFGKVY------------KGRLESGQ-----LVAIKQLNHEG-LQGHQE 87
NF E +GEG FG+V+ K E+ LVA+K L + ++
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 88 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-------DQE 140
F+ EV +LS L N+ L+G CT ++ EYM G L L + +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 141 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200
LS++T + +A A G+ YL + ++RDL + N L+ ++ K++DFG+++
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
D V R + A E + GK T KSD+++FGV L E++T
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 4e-19
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFI----VEVLMLSLLHHDNLVTLI 107
+G+G FG VY R E+G+LVAIK++ + +E + V+ L L H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKK-FYSWEECMNLREVKSLR-KLNEHPNIVKLK 64
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE--PLSWNTRMKIAVGAARGLEYLHCKA 165
D+ V+EYM E +LY L D++ P S + I +GL ++H K
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH-KH 118
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN----THVSTRVMGTYGYCAPEY 221
+RDLK N+L+ K++DFGLA+ + +VSTR Y APE
Sbjct: 119 G--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPE- 168
Query: 222 AMSGKLTLKS-------DIYSFGVVLLELITGR 247
+ L+S DI++ G ++ EL T R
Sbjct: 169 -----ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 72/214 (33%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 51 NLIGEGGFGKVYKGR-LESGQLVAIKQ--LNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 107
IGEG +G+VYK R ++G+LVA+K+ L++E I E+ +L L+H N+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 108 GYCTSGDQRL----------LVYEYMP---MGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
T L LV+EYM MG LE L D + MK +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI----KSFMKQLL-- 126
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
GL Y H K ++RD+K +NILL+N KL+DFGLA+L ++ + +V+ T
Sbjct: 127 -EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181
Query: 215 GYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 247
Y PE + + D++S G +L EL T +
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 104
++ LIG G +G VY+G+ + +G++VA+K +N + I EV +LS L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 105 TLIGY--CTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
+ Y RL ++ EY GS+ L P E I+V L L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKY-------ISVIIREVLVAL 114
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
VI+RD+K+ANIL+ N N KL DFG+A L + N+ + +GT + APE
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEV 172
Query: 222 AMSGKL-TLKSDIYSFGVVLLELITG 246
GK K+DI+S G+ + E+ TG
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-19
Identities = 80/275 (29%), Positives = 127/275 (46%), Gaps = 29/275 (10%)
Query: 45 RNFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDN 102
F + IG+G FG+VYKG + ++VAIK ++ E + E I E+ +LS
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+ G G + ++ EY+ GS D L +P PL I +GL+YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPG--PLEETYIATILREILKGLDYLH 118
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+ I+RD+K+AN+LL + KL+DFG+A G + D +GT + APE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVI 173
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282
K+DI+S G+ A++L+KG+ + + R K P
Sbjct: 174 KQSAYDFKADIWSLGIT---------AIELAKGEPPNSDLHPMRVLFLIPKN----SPPT 220
Query: 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
L G+Y + + A CLN++ FRP +++
Sbjct: 221 LEGQYSKPFKEFVEA----CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-19
Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 35/220 (15%)
Query: 53 IGEGGFGKVY--------KGRLESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLL-HHDN 102
+GEG FG+V K + VA+K L + + + I E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHL---------YDLEPDQEP---LSWNTRMKI 150
++ L+G CT ++ EY G+L ++L Y P Q P LS+ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 210
A ARG+EYL A+ I+RDL + N+L+ D K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 211 MGTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
T G + APE T +SD++SFGV+L E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-19
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 51 NLIGEGGFGKVYKGRLESGQL---VAIKQLNHEGLQG-HQEFIVEVLMLSLL-HHDNLVT 105
++IGEG FG+V K R++ L AIK++ + H++F E+ +L L HH N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYD---LEPD---------QEPLSWNTRMKIAVG 153
L+G C L EY P G+L D L LE D LS + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 213
ARG++YL K I+RDL + NIL+ ++ K++DFGL++ G +V + MG
Sbjct: 133 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGR 184
Query: 214 YG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ A E T SD++S+GV+L E+++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 73/212 (34%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFI-VEVLML-SLLHHDNLVTLIG 108
+IGEG +GKVYK R ++GQLVAIK ++ +E I E +L +H N+ T G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 109 ------YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+ DQ LV E GS+ D + L + L I RGL YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAP 219
VI+RD+K NILL + KL DFG+ A+L D+T + R +GT + AP
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DST-LGRRNTFIGTPYWMAP 182
Query: 220 EYAMSGK-----LTLKSDIYSFGVVLLELITG 246
E + +SD++S G+ +EL G
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-19
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 46 NFREANLIGEGGFGKVY--KGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 101
+ IGEG FGK+Y K + +S V IK+++ + + + EV++L+ + H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSL-----EDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
N+VT + +V EY G L DQ LSW ++ +
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSWFVQISL------ 112
Query: 157 GLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 215
GL+++H + +++RD+KS NI L N KL DFG+A+ + D+ ++ +GT
Sbjct: 113 GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPY 167
Query: 216 YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
Y +PE + K+DI+S G VL EL T
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-19
Identities = 66/196 (33%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 53 IGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IG+G G VY + +GQ VAIKQ+N + + I E+L++ + N+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
GD+ +V EY+ GSL D + + D+ ++ R + + L++LH VI+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSNQ---VIH 138
Query: 172 RDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 230
RD+KS NILL D + KL+DFG A++ P + + ST V GT + APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 231 SDIYSFGVVLLELITG 246
DI+S G++ +E++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 8e-19
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDN 102
F + IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+ G LV EY +GS D L E ++PL + GA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+ +I+RD+K+ NILL KL DFG A + + +GT + APE
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVI 183
Query: 223 MS---GKLTLKSDIYSFGVVLLEL 243
++ G+ K D++S G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 8e-19
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IG+G G VY + +GQ VAI+Q+N + + I E+L++ + N+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
GD+ +V EY+ GSL D + + D+ ++ R + + LE+LH VI+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSNQ---VIH 139
Query: 172 RDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 230
RD+KS NILL D + KL+DFG A++ P + ++GT + APE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 231 SDIYSFGVVLLELITG 246
DI+S G++ +E+I G
Sbjct: 197 VDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 52 LIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDNLVT 105
++GEG FG V +G+L S VA+K + + +EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 106 LIGYCTSGDQR------LLVYEYMPMGSLEDHLYD--LEPDQEPLSWNTRMKIAVGAARG 157
LIG C +++ +M G L L L E L T +K V A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD---NTHVSTRVMGTY 214
+EYL +N I+RDL + N +L D ++DFGL+K GD ++ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ A E T KSD+++FGV + E+ T
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 107
++G+G FGKV L+ G+ A+K L + + + +VE +L+L + +T +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 108 GYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--GLEYLHC 163
YCT + + V E++ G L H+ Q+ ++ A GL++LH
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHI------QDKGRFDLYRATFYAAEIVCGLQFLHS 114
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
K +IYRDLK N++LD D + K++DFG+ K GDN ++ GT Y APE
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQ 169
Query: 224 SGKLTLKSDIYSFGVVLLELITGR 247
K T D +SFGV+L E++ G+
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 53 IGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVT 105
+GEG FGKV K VA+K L ++ + E +L ++H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHL--------------------YDLEPDQEPLSWN 145
L G C+ LL+ EY GSL L Y PD+ L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 146 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205
+ A +RG++YL A +++RDL + N+L+ K+SDFGL++ D+
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
++ + A E T +SD++SFGV+L E++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 53 IGEGGFGKV-YKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IGEG G V +G+ VA+K+++ Q + EV+++ HH+N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
GD+ +V E++ G+L D + ++E ++ + + R L YLH N VI+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH---NQGVIH 141
Query: 172 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 231
RD+KS +ILL +D KLSDFG V ++GT + APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 232 DIYSFGVVLLELITG 246
DI+S G++++E+I G
Sbjct: 200 DIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 71/247 (28%), Positives = 118/247 (47%), Gaps = 32/247 (12%)
Query: 53 IGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IGEG G V ++S G+LVA+K+++ Q + EV+++ H+N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
GD+ +V E++ G+L D + ++E ++ + + + L LH + VI+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQG---VIH 139
Query: 172 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 231
RD+KS +ILL +D KLSDFG V ++GT + APE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 232 DIYSFGVVLLELITGR---------KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282
DI+S G++++E++ G KAM + + NL P LK+ +H V P
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR----DNL----PPKLKN----LHKVSPS 245
Query: 283 LHGRYPR 289
L G R
Sbjct: 246 LKGFLDR 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 22/201 (10%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
+G+G FGKVYK + E+G L A K + + + ++++VE+ +L+ +H +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
+ ++ E+ P G+++ + +L+ EP +I V + LE L + +I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVICRQMLEALQYLHSMKII 132
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAMSGKL 227
+RDLK+ N+LL D + KL+DFG++ N R +GT + APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 228 T-----LKSDIYSFGVVLLEL 243
K+DI+S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-18
Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 38/285 (13%)
Query: 52 LIGEGGFGKVYKGRLESG----QLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVT 105
+IG G FG+V +GRL+ VAIK L G Q +F+ E ++ H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
L G T +++ E+M G+L+ L + + ++ G A G++YL +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---S 123
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPE 220
++RDL + NIL++++ K+SDFGL++ + D+T T G + APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRF--LEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHLV 279
K T SD++S+G+V+ E+ +S G+ RP+ + ++ +
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEV--------MSYGE---------RPYWDMSNQDVINAI 224
Query: 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324
+ P C + C ++ N RP IV LD ++
Sbjct: 225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 65/195 (33%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 53 IGEGGFGKVYKGRLES-GQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGY 109
IG G FG+V+ GRL + VA+K E L +F+ E +L H N+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
CT Q+ +Y M + D L L + L +++ AA G+EYL K
Sbjct: 62 CT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYAMSGKL 227
I+RDL + N L+ K+SDFG+++ D + ST M + APE G+
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 228 TLKSDIYSFGVVLLE 242
+ +SD++SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHHDNLVTL 106
IGEG +G VYKGR ++GQ+VA+K++ L+ +E I E+ +L L H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+ L++E++ M L+ +L L Q + +G+ + H +
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQY-MDAELVKSYLYQILQGILFCHSRR- 121
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SG 225
V++RDLK N+L+DN KL+DFGLA+ G V T + T Y APE + S
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 226 KLTLKSDIYSFGVVLLELITGR 247
+ + DI+S G + E+ T +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-18
Identities = 69/215 (32%), Positives = 116/215 (53%), Gaps = 20/215 (9%)
Query: 47 FREANLIGEGGFGKVYKG-RLESGQLV----AIKQLNHE-GLQGHQEFIVEVLMLSLLHH 100
+ ++G G FG VYKG + G+ V AIK LN G + + EF+ E L+++ + H
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD---QEPLSWNTRMKIAVGAARG 157
+LV L+G C S +L V + MP G L D++++ + + Q L+W V A+G
Sbjct: 69 PHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKG 121
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
+ YL + +++RDL + N+L+ + + K++DFGLA+L + + + +
Sbjct: 122 MMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 251
A E K T +SD++S+GV + EL+T G K D
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-18
Identities = 80/273 (29%), Positives = 120/273 (43%), Gaps = 29/273 (10%)
Query: 47 FREANLIGEGGFGKVYKGRLESGQ-LVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 104
F + IG+G FG+V+KG Q +VAIK ++ E + E I E+ +LS +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
G + ++ EY+ GS D L EP PL I +GL+YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPG--PLDETQIATILREILKGLDYLHSE 120
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
I+RD+K+AN+LL KL+DFG+A G + D +GT + APE
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 225 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 284
K+DI+S G+ +EL G L+ + P P L
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLE 222
Query: 285 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
G Y + + A CLN+E +FRP +++
Sbjct: 223 GNYSKPLKEFVEA----CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 66/198 (33%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 53 IGEGGFGKVY-KGRLESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIG 108
IG G FG VY + ++VA+K++++ G Q + Q+ I EV L L H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
LV EY +GS D L E ++PL I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---G 225
+I+RD+K+ NILL KL+DFG A ++ +GT + APE ++ G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEG 195
Query: 226 KLTLKSDIYSFGVVLLEL 243
+ K D++S G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 21/213 (9%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHH 100
NF++ IGEG +G VYK R +G++VA+K++ EG+ I E+ +L L+H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IREISLLKELNH 58
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
N+V L+ + ++ LV+E++ L+ + PL + +GL +
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAF 115
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYCA 218
H V++RDLK N+L++ + KL+DFGLA+ G PV TH V+ T Y A
Sbjct: 116 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRA 168
Query: 219 PEYAMSGKL-TLKSDIYSFGVVLLELITGRKAM 250
PE + K + DI+S G + E++T R+A+
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 52 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLL-HHDNLV 104
++G+G FGKV L + +L A+K L + + Q+ VE M L+L H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL--QDDDVECTMTEKRVLALAGKHPFLT 59
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHC 163
L + D+ V EY+ G L H+ EP R + A GL++LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLHE 114
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+ +IYRDLK N+LLD++ + K++DFG+ K G +G T ++ GT Y APE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILS 169
Query: 224 SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261
D ++ GV+L E++ G+ + G E L
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 4e-18
Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDN 102
F + IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+ G LV EY +GS D L E ++PL I GA +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+I+RD+K+ NILL KL+DFG A + ++ +GT + APE
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVI 193
Query: 223 MS---GKLTLKSDIYSFGVVLLEL 243
++ G+ K D++S G+ +EL
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-18
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 53 IGEGGFGKVY--------KGRLESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDN 102
+GEG FG+V K + VA+K L + + + + E+ M+ ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKI 150
++ L+G CT ++ EY G+L ++L P +E L++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 210
A ARG+EYL A+ I+RDL + N+L+ D K++DFGLA+ D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 211 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ APE T +SD++SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 6e-18
Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSL-LHHDNLVTL 106
++G+G FGKV L+ + + AIK L + + + +VE +L+L H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 107 IGYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
+CT + + V EY+ G L H+ E + +I G L++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK 115
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
+IYRDLK N+LLD D + K++DFG+ K G+ ++ GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 225 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261
K D +SFGV+L E++ G+ G+ E L
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 6e-18
Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDN 102
FR+ ++G+GGFG+V ++ +G++ A K+L + ++ G + E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAAR---GL 158
+V L + D LV M G L+ H+Y++ P E + AA GL
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE------EERALFYAAEILCGL 115
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
E LH + +YRDLK NILLD+ + ++SD GLA P G++ + RV GT GY A
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMA 169
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELITGR 247
PE + + TL D + G ++ E+I G+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 53 IGEGGFGKVY--------KGRLESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDN 102
+GEG FG+V K R + VA+K L + + I E+ ++ L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY-------DLEPD-----QEPLSWNTRMKI 150
++ L+G CT ++ EY G+L + L D D +E LS+ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 210
A ARG+EYL + I+RDL + N+L+ D K++DFGLA+ D ++
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 211 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ APE T +SD++SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 22/201 (10%)
Query: 53 IGEGGFGKVY--KGRLESGQLVAIKQLNHEGLQGHQEFIVEVL-----MLSLLHHDNLVT 105
I +G FG VY K R +G AIK L + + + V M+ +
Sbjct: 4 ISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAK 61
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
L S D LV EY+ G + L P W + G+E LH +
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAK--QYIAEVVLGVEDLHQRG 117
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
+I+RD+K N+L+D + KL+DFGL++ G + + +GT Y APE +
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGV 168
Query: 226 KLTLKSDIYSFGVVLLELITG 246
SD +S G V+ E + G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 29/215 (13%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-------FIVEVLMLSL 97
F + N IGEG +G VY+ R SG++VA+K++ + E + E+ +L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD-----NERDGIPISSLREITLLLN 62
Query: 98 LHHDNLVTLIGYCT--SGDQRLLVYEY--MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 153
L H N+V L D LV EY + SL D++ P S + + +
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQ 116
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 213
RGL+YLH +I+RDLK +N+LL + K++DFGLA+ G T + T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVT 171
Query: 214 YGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 247
Y APE + T D+++ G +L EL+ +
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 29/273 (10%)
Query: 47 FREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 104
F + IG+G FG+V+KG + Q+VAIK ++ E + E I E+ +LS +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
G G + ++ EY+ GS D L D+ ++ T +K + +GL+YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLHSE 120
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
I+RD+K+AN+LL + KL+DFG+A G + D +GT + APE
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 225 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 284
K+DI+S G+ A++L+KG+ + + R K P L
Sbjct: 176 SAYDSKADIWSLGIT---------AIELAKGEPPNSDMHPMRVLFLIPK----NNPPTLT 222
Query: 285 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
G + + + CLN++ +FRP +++
Sbjct: 223 GEFSKPFKEF----IDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 19/196 (9%)
Query: 67 ESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL-VYEY 122
+G VAIK L + + + F E + + L+H N+V L+ + L V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL- 181
+P +L + L L ++ + L+ L C N +++RDLK NI++
Sbjct: 61 VPGRTLREVL----AADGALPAGETGRLM---LQVLDALACAHNQGIVHRDLKPQNIMVS 113
Query: 182 --DNDFNPKLSDFGLAKLGP-VGDNTHV----STRVMGTYGYCAPEYAMSGKLTLKSDIY 234
+ K+ DFG+ L P V D +T V+GT YCAPE +T SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 235 SFGVVLLELITGRKAM 250
++G++ LE +TG++ +
Sbjct: 174 AWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFI---VEVLMLSLLHHD--NLVT 105
IG G G+VYK R + +G ++A+KQ+ G + + I ++V++ S HD +V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVK 78
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
GY + + E M + D L L+ Q P+ + K+ V + L YL K
Sbjct: 79 CYGYFITDSDVFICMELM--STCLDKL--LKRIQGPIPEDILGKMTVAIVKALHYL--KE 132
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---- 221
VI+RD+K +NILLD N KL DFG++ G + D + TR G Y APE
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPP 189
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGR 247
+ K +++D++S G+ L+EL TG+
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 53 IGEGGFGKVY--------KGRLESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLL-HHDN 102
+GEG FG+V K + + VA+K L + + + + E+ M+ ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHL-----------YDLE--PDQEPLSWNTRMK 149
++ L+G CT ++ EY G+L ++L YD+ PD E +++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD-EQMTFKDLVS 141
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 209
ARG+EYL A+ I+RDL + N+L+ + K++DFGLA+ D +T
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 210 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ APE T +SD++SFGV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 12/205 (5%)
Query: 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDN 102
FR+ ++G+GGFG+V ++ +G++ A K+L + ++ G + E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V+L + D LV M G L+ H+Y + + + A GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
++YRDLK NILLD+ + ++SD GLA P G + RV GT GY APE
Sbjct: 120 ---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 223 MSGKLTLKSDIYSFGVVLLELITGR 247
+ + T D ++ G +L E+I G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 73/219 (33%), Positives = 109/219 (49%), Gaps = 25/219 (11%)
Query: 52 LIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 107
++G+G FGKV R + +L AIK L + + + +VE +L+L +T +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 108 GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
C RL V EY+ G L H+ + +EP + +IA+G L +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLHSKG- 121
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE---YA 222
+IYRDLK N++LD + + K++DFG+ K G T TR GT Y APE Y
Sbjct: 122 --IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQ 176
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261
GK D ++FGV+L E++ G+ D G+ E L
Sbjct: 177 PYGK---SVDWWAFGVLLYEMLAGQPPFD---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 46 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQL--NHEGLQGHQE---FIVEVLMLSLLH 99
N+R L+G+G FG+VY ++G+ +A+KQ+ + E + +E E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 100 HDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
H+ +V G +R L E+MP GS++D L L+ N K G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEG 118
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 216
+ YLH +++RD+K ANIL D+ N KL DFG +K L + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+PE K+DI+S G ++E++T +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 69/203 (33%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 52 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDNLVT 105
++G+G FGKV RL ESG+L A+K L + + Q+ VE M LSL + +T
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL--QDDDVECTMTEKRILSLARNHPFLT 59
Query: 106 LIGYCTSGDQRLL-VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHC 163
+ C RL V E++ G L H+ E R + A L +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEITSALMFLHD 114
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
K +IYRDLK N+LLD++ + KL+DFG+ K G + + ST GT Y APE
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTST-FCGTPDYIAPEILQ 169
Query: 224 SGKLTLKSDIYSFGVVLLELITG 246
D ++ GV+L E++ G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 14/229 (6%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIG 108
+G+GGFG+V +++ +G++ A K+L+ + L+ G + ++E +L ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
S LV M G L+ H+Y++ + L + + G+ +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLH---SMD 115
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 228
++YRD+K N+LLD+ N +LSD GLA G T+ GT GY APE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYS 172
Query: 229 LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277
D ++ G + E++ GR K + + + R L+D+ KF H
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLEDEVKFEH 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 60/223 (26%), Positives = 113/223 (50%), Gaps = 26/223 (11%)
Query: 40 LAIATRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQL-NHEGLQGHQEFIVEVL 93
+AI+ ++L+ EG FG+++ G L + V +K + +H + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 94 MLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYD--LEPDQEPLSWNTR--M 148
+L L H N++ ++ C G+ ++Y YM G+L+ L L P + +T+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 149 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGP-----VGD 202
+A+ A G+ YLH + VI++D+ + N ++D + K++D L++ L P +GD
Sbjct: 121 HMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
N + + M A E ++ + + SD++SFGV+L EL+T
Sbjct: 178 NENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 52 LIGEGGFGKVYKGRLESGQL-VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
++G+G +G VY R S Q+ +AIK++ + Q E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA--RGLEYLHCKANPP 168
+ + E +P GSL L PL N + I GL+YLH +
Sbjct: 75 SENGFFKIFMEQVPGGSLSAL---LRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQ 128
Query: 169 VIYRDLKSANILLDNDFNP--KLSDFG----LAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+++RD+K N+L+ N ++ K+SDFG LA + P + GT Y APE
Sbjct: 129 IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPCTET------FTGTLQYMAPEVI 181
Query: 223 MSGK--LTLKSDIYSFGVVLLELITGR 247
G +DI+S G ++E+ TG+
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-17
Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 20/200 (10%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
+G+G FGKVYK + E+G L A K ++ + + ++++VE+ +L+ H N+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
+ ++ E+ G+++ + +LE PL T +I V + LE L+ +I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELE---RPL---TEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 172 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAM----- 223
RDLK+ NIL D + KL+DFG++ NT R +GT + APE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 224 SGKLTLKSDIYSFGVVLLEL 243
K+D++S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 40/218 (18%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQ----LNHEGLQGHQEFIVEVLMLSLL--- 98
+ E IGEG +G VYK R L +G+ VA+K+ L+ EG+ + E+ +L L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLKQLESF 58
Query: 99 HHDNLVTLIGYC-TSGDQR----LLVYEYMPMGSLED-HLYDLEPDQEP-LSWNTRMKIA 151
H N+V L+ C R LV+E++ +D Y L +P L T +
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVD----QDLATY-LSKCPKPGLPPETIKDLM 113
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
RG+++LH +++RDLK NIL+ +D K++DFGLA+ + T V+
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVV 167
Query: 212 GTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLEL 243
T Y APE YA D++S G + EL
Sbjct: 168 VTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 31/281 (11%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQL---NHEGLQGHQEFIVEVLMLSLLH 99
NF+ IG+G F VYK L G++VA+K++ + Q+ + E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 100 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
H N++ + ++ +V E G L + + + + T K V LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
++H K +++RD+K AN+ + KL D GL + T + ++GT Y +P
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279
E KSDI+S G +L E + + PF D+ L
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLYSLC 217
Query: 280 DPLLHGRYPRRCLNYAVA----VTAMCLNEEANFRPLINDI 316
+ YP ++ + + C+N + RP I+ +
Sbjct: 218 KKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-17
Identities = 68/249 (27%), Positives = 112/249 (44%), Gaps = 23/249 (9%)
Query: 46 NFREANLIGEGGFGKVY----KGRLESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSL 97
NF ++G G +GKV+ G ++G+L A+K L + + + E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 98 LHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-A 155
+ + + Y D +L L+ +Y+ G L HLY E E + +++ +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVRVYIAEIV 115
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 215
L++LH +IYRD+K NILLD++ + L+DFGL+K + + + GT
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIE 171
Query: 216 YCAPEYAMSGKLTLKS--DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273
Y APE G D +S GV+ EL+TG + Q Q+ + SR LK +
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSKP 229
Query: 274 KFVHLVDPL 282
F +
Sbjct: 230 PFPKTMSAE 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 8e-17
Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDN---LV 104
+IG GGFG+VY R ++G++ A+K L+ + + QG + E +MLSL+ + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHC 163
+ + D+ + + M G L HL Q + M+ A GLE++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHMH- 114
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCAP 219
N V+YRDLK ANILLD + ++SD GLA K P H S +GT+GY AP
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMAP 164
Query: 220 EYAMSGKLTLKS-DIYSFGVVLLELITG 246
E G S D +S G +L +L+ G
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLN-HEGLQGHQEFIV--EVLMLSLLHHD 101
+ +G G FG+V+ R S A+K + E ++ QE V E +L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 102 NLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA--ARG 157
++ L + T DQR L + EY+P G L +L + ++ + +
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL------RNSGRFSNSTGLFYASEIVCA 113
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
LEYLH K ++YRDLK NILLD + + KL+DFG AK + D T + GT Y
Sbjct: 114 LEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYL 165
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITG 246
APE S D ++ G+++ E++ G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 53 IGEGGFGKVYK------GRLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLL-HHDNLV 104
+G G FGKV + + ++ VA+K L +E ++ E+ ++S L +H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
L+G CT G L++ EY G L + L + L+ + + A+G+ +L K
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEY 221
I+RDL + N+LL + K+ DFGLA+ + D+ +V + R+ + APE
Sbjct: 161 N---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMAPES 214
Query: 222 AMSGKLTLKSDIYSFGVVLLELIT 245
+ T +SD++S+G++L E+ +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 46 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQLN-HEGLQGHQEF----IVEVLMLSLLH 99
++ + IGEG +G V +G VAIK+++ E HQ F + E+ +L
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFK 61
Query: 100 HDNLVTL------IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 153
H+N++ + + + D +V E M E LY L Q LS +
Sbjct: 62 HENIIGILDIIRPPSFESFNDV-YIVQELM-----ETDLYKLIKTQ-HLSNDHIQYFLYQ 114
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG-PVGDNTHVSTRVMG 212
RGL+Y+H AN V++RDLK +N+LL+ + + K+ DFGLA++ P D+T T +
Sbjct: 115 ILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 213 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGR 247
T Y APE ++ K K+ DI+S G +L E+++ R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 53 IGEGGFGKVYK-GRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH---DNLVTLIG 108
+G G G V K + +G ++A K ++ ++ I+ L ++H +V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR--ELQIMHECRSPYIVSFYG 70
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
+ + + E+M GSL D +Y P+ KIAV GL YL+
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHR-- 124
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAMSGK 226
+++RD+K +NIL+++ KL DFG++ G+ N+ T V GT Y +PE GK
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFV-GTSTYMSPERIQGGK 178
Query: 227 LTLKSDIYSFGVVLLELITGR 247
T+KSD++S G+ ++EL G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 46 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQL-----NHEGLQGHQEFIVEVLMLSLLH 99
N+R L+G G FG+VY ++G+ +A+KQ+ + E + E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 100 HDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
HD +V G +++ L EYMP GS++D L L+ N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQG 118
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 216
+ YLH +++RD+K ANIL D+ N KL DFG +K + + + V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+PE K+D++S ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 83/266 (31%), Positives = 122/266 (45%), Gaps = 35/266 (13%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLV 104
F ++G G +G+VYKGR +++GQL AIK ++ + +E +E+ ML HH N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIA 76
Query: 105 TLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
T G DQ LV E+ GS+ D + + + + W I RGL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYG 215
+LH VI+RD+K N+LL + KL DFG+ A+L D T V R +GT
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPY 186
Query: 216 YCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR---P 267
+ APE +SDI+S G+ +E+ G A L + L R P
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG--APPLCDMHPMRALFLIPRNPPP 244
Query: 268 FLKDQ---KKFVHLVDPLLHGRYPRR 290
LK + KKF+ ++ L Y R
Sbjct: 245 KLKSKKWSKKFIDFIEGCLVKNYLSR 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLV 104
F L+G G +G+VYKGR +++GQL AIK ++ G + +E E+ ML HH N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 66
Query: 105 TLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
T G DQ LV E+ GS+ D + + + + W I RGL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
+LH VI+RD+K N+LL + KL DFG++ + +GT + A
Sbjct: 125 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMA 179
Query: 219 PEYAM-----SGKLTLKSDIYSFGVVLLELITG 246
PE KSD++S G+ +E+ G
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHD 101
+F IG G +G VYK R + +G+L AIK + L+ ++F V E++M+ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
N+V G D+ + E+ GSL+D +Y + PLS + ++ +GL YL
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHV---TGPLSESQIAYVSRETLQGLYYL 122
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H K ++RD+K ANILL ++ + KL+DFG++ + +GT + APE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEV 177
Query: 222 AM---SGKLTLKSDIYSFGVVLLEL 243
A G DI++ G+ +EL
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 3e-16
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 26/211 (12%)
Query: 51 NLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLI 107
IG G +G V +G+ VAIK++++ + L + + E+ +L L H+N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 108 GYCTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK-IAVGAARGLEYL 161
+V E M D L+ + +PL+ + ++ RGL+YL
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLT-DDHIQYFLYQILRGLKYL 119
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY----GYC 217
H AN VI+RDLK +NIL++++ + K+ DFGLA+ D + Y Y
Sbjct: 120 H-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGFLTEYVVTRWYR 173
Query: 218 APEYAMSGK-LTLKSDIYSFGVVLLELITGR 247
APE +S T DI+S G + EL+T +
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDN---LV 104
+IG GGFG+VY R ++G++ A+K L+ + + QG + E +MLSL+ + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHC 163
+ + D+ + + M G L HL Q + M+ A GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVFSEKEMRFYATEIILGLEHMH- 114
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCAP 219
N V+YRDLK ANILLD + ++SD GLA K P H S +GT+GY AP
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYMAP 164
Query: 220 EYAMSGKLTLKS-DIYSFGVVLLELITG 246
E G S D +S G +L +L+ G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 109
+G G +G VYK R L +G+L A+K + E G ++ E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
S ++ + EY GSL+D +Y + PLS + +GL YLH K
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHV---TGPLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGK 226
++RD+K ANILL ++ + KL+DFG+A + +GT + APE A +G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 227 LTLKSDIYSFGVVLLEL 243
DI++ G+ +EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 46 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQL--NHEGLQGHQEFIV---EVLMLSLLH 99
N+R L+G+G FG+VY +++G+ +A KQ+ + E + +E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 100 HDNLVTLIGYCTSGDQRLLV--YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
H+ +V G ++ L EYMP GS++D L E ++ +I G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EG 118
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGY 216
+ YLH +++RD+K ANIL D+ N KL DFG +K L + + V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+PE K+D++S G ++E++T +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-16
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDN 102
FR ++G+GGFG+V ++ +G++ A K+L + ++ G + E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLE 159
+V+L + D LV M G L+ H+Y++ D+E + A GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-----YAAEITCGLE 116
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
LH + ++YRDLK NILLD+ + ++SD GLA P G+ + RV GT GY AP
Sbjct: 117 DLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAP 170
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGR 247
E + + T D + G ++ E+I G+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 22/216 (10%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQ----LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHH 100
F++ ++G G FG VYKG + G+ VAIK+L + ++E + E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 101 DNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPD---QEPLSWNTRMKIAVGAAR 156
++ L+G C TS Q L+ + MP G L D++ + + + Q L+W V A+
Sbjct: 69 PHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
G+ YL + +++RDL + N+L+ + K++DFGLAKL + + + +
Sbjct: 121 GMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 251
A E + T +SD++S+GV + EL+T G K D
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 48/247 (19%)
Query: 53 IGEGGFGKVYKGRLES---GQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTL 106
IG G +G+VYK + ++ G+ AIK+ + Q Q E+ +L L H+N+V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 107 IGYC-TSGDQRL-LVYEYMPMGSLEDHLYDL--------EPDQEPLSWNTRMKIAVGAAR 156
+ D+ + L+++Y +DL + + + + +
Sbjct: 68 VEVFLEHADKSVYLLFDYAE--------HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKL------GPVGDNTHV 206
G+ YLH +N V++RDLK ANIL+ + K+ D GLA+L +
Sbjct: 120 GVHYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD--- 173
Query: 207 STRVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265
V+ T Y APE + + K+ DI++ G + EL+T +G + + S
Sbjct: 174 --PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF-----KGREAKIKKS 226
Query: 266 RPFLKDQ 272
PF +DQ
Sbjct: 227 NPFQRDQ 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 68/222 (30%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 101
+F ++G+G FGKV + + +L AIK L + + + +VE +L+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 102 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
+T + C RL V EY+ G L H+ + +EP + +I+VG L +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFF 116
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 219
LH + +IYRDLK N++LD++ + K++DFG+ K V V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAP 170
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261
E D +++GV+L E++ G+ D G+ E L
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 71/215 (33%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 47 FREANLIGEGGFGKV----YKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLM-------- 94
FR ++G G FGKV YK +G+L AIK L + E VE LM
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDE--VESLMCEKRIFET 55
Query: 95 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 153
+ H LV L C + + V EY G L H++ + S + A
Sbjct: 56 ANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAAC 109
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVM 211
GL+YLH ++YRDLK N+LLD + K++DFGL K +G GD T ST
Sbjct: 110 VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FC 162
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
GT + APE T D + GV++ E++ G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 9e-16
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 53 IGEGGFGKVYKGRLESGQLVA---IKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIG 108
IG G FGKV G G A +K+L Q F+ EV L+H N++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSW----NTRMKIAVGAARGLEYLHCK 164
C LLV E+ P+G L+++ L ++ ++ + ++A A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNY---LRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-Q 118
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-- 222
A+ I+ DL N L D + K+ D+GLA D + APE
Sbjct: 119 AD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 223 -----MSGKLTLKSDIYSFGVVLLELIT 245
+ T KS+I+S GV + EL T
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 78/296 (26%), Positives = 133/296 (44%), Gaps = 42/296 (14%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQ---LVAIKQLNHEGLQGHQE-----FIVEV 92
I + +IG G FG+V GRL+ G+ VAIK L G+ E F+ E
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----AGYTEKQRRDFLSEA 56
Query: 93 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
++ H N++ L G T ++V EYM GSL+ L + + ++
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR--- 113
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
G A G++YL ++ ++RDL + NIL++++ K+SDFGL+++ + D+ + G
Sbjct: 114 GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRG 168
Query: 213 ---TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 269
+ APE K T SD++S+G+V+ E+++ GE RP+
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS----------YGE-------RPYW 211
Query: 270 K-DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324
+ + + ++ P C + C ++ N RP IV LD L+
Sbjct: 212 EMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQE-------FIVEVLMLSLLHHDNLV 104
IGEG +G VYK R + + +A+K++ E QE I E+ +L + H N+V
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLE-----QEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM--KIAVGAARGLEYLH 162
L S + LV+EY+ + L+ H+ D PD + N R+ RG+ Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRLIKTYLYQILRGIAYCH 119
Query: 163 CKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYCAP 219
V++RDLK N+L+D N KL+DFGLA+ G PV TH T Y AP
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAP 172
Query: 220 EYAMSGK-LTLKSDIYSFGVVLLELITGR 247
E + + + DI+S G + E++ +
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IGEG G V R + SG+ VA+K ++ Q + EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
G++ ++ E++ G+L D + ++E ++ + + L YLH + VI+
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TVCESVLQALCYLHSQG---VIH 140
Query: 172 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 231
RD+KS +ILL D KLSDFG + + ++GT + APE +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 232 DIYSFGVVLLELITG 246
DI+S G++++E++ G
Sbjct: 199 DIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 47 FREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHH 100
F ++G+G FG V + +L+ S Q VA+K L + +EF+ E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 101 DNLVTLIGYC--TSGDQRL----LVYEYMPMGSLEDHLYDLEPDQEP--LSWNTRMKIAV 152
N++ LIG + RL ++ +M G L L +EP L T ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
A G+EYL ++ I+RDL + N +L+ + ++DFGL+K GD
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 213 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ A E T SD+++FGV + E++T
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIK----QLNHEGLQGHQEFIVEVLMLSLLH---HDNLV 104
IG G +G VYK R SG VA+K Q N +GL + EV +L L H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP--LSTVREVALLKRLEAFDHPNIV 65
Query: 105 TLIGYCTSG--DQRL---LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
L+ C + D+ LV+E++ L +L + P P T + RGL+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLD 122
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCA 218
+LH +++RDLK NIL+ + KL+DFGLA++ + ++ T V+ T Y A
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRA 175
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
PE + D++S G + E+ RK + + +Q
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDN 102
FR ++G+GGFG+V ++ +G++ A K+L + ++ G + E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V+L + D LV M G L+ H+Y++ + A GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
++YRDLK NILLD+ + ++SD GLA P G+ V RV GT GY APE
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 223 MSGKLTLKSDIYSFGVVLLELITGR 247
+ K T D + G ++ E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 67/202 (33%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 107
L+G+G FGKV R + +G+ A+K L E + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA--ARGLEYLHCKA 165
+ D+ V EY G L HL +E + R + GA LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARF-YGAEIVSALEYLHSRD 115
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
V+YRD+K N++LD D + K++DFGL K G + D + T GT Y APE
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDN 170
Query: 226 KLTLKSDIYSFGVVLLELITGR 247
D + GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-15
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 17/211 (8%)
Query: 53 IGEGGFGKVYKG--RLESGQL-VAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIG 108
+G G FG V KG ++ Q+ VAIK L +E + E + E ++ L + +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
C + + +LV E G L L + D+ +S + V + G++YL K
Sbjct: 63 VCEA-EALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQV--SMGMKYLEGKN--- 115
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAMSG 225
++RDL + N+LL N K+SDFGL+K LG D+++ R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 226 KLTLKSDIYSFGVVLLELIT-GRKAMDLSKG 255
K + +SD++S+G+ + E + G+K KG
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 53 IGEGGFGKVYKGRL---ESGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLI 107
+GEG FG V +G+L +S VA+K + ++F+ E + + H N++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 108 GYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM--KIAVGAARGLE 159
G C + +++ +M G L L P T+M K A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YL K+ I+RDL + N +L+ + N ++DFGL+K GD + A
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELIT 245
E T KSD++SFGV + E+ T
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 22/216 (10%)
Query: 47 FREANLIGEGGFGKVYKG-RLESGQ----LVAIKQL-NHEGLQGHQEFIVEVLMLSLLHH 100
++ ++G G FG VYKG + G+ VAIK L + + ++E + E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 101 DNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLY---DLEPDQEPLSWNTRMKIAVGAAR 156
+ L+G C TS Q LV + MP G L D++ D Q+ L+W V A+
Sbjct: 69 PYVCRLLGICLTSTVQ--LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAK 120
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
G+ YL +++RDL + N+L+ + + K++DFGLA+L + + + + +
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 251
A E + + T +SD++S+GV + EL+T G K D
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQL-NHEGLQGHQ--EFIVEVLMLSLLHHD 101
+F +G G FG+V + + +G+ AIK L E L+ Q E +L L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLE 159
+V ++ ++ + E++ G L HL P+ ++ + +A E
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA------FE 132
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YLH K +IYRDLK N+LLDN + K++DFG AK V D T + GT Y AP
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLAP 184
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITG 246
E S D ++ GV+L E I G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 52 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFI---VEVLMLSLLHHDNLVTLI 107
IG G FG V K SG ++A+K++ + Q+ + ++V+M S +V
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVKFY 69
Query: 108 GYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM--KIAVGAARGLEYLHCK 164
G GD + E M + SL D Y + + KIAV + L YL K
Sbjct: 70 GALFREGDC-WICMELMDI-SL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL--K 124
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+I+RD+K +NILLD + N KL DFG++ +L ++ TR G Y APE
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPERID 180
Query: 224 SG---KLTLKSDIYSFGVVLLELITGR 247
++SD++S G+ L E+ TG+
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 53 IGEGGFGK--VYKGRLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIG 108
IGEG FGK + K + E G+ IK++N + +E EV +LS + H N+V
Sbjct: 8 IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ--- 63
Query: 109 YCTSGDQR---LLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMKIAVGAARGLEYL 161
Y S ++ +V +Y G L + L P+ + L W ++ +A L+++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHV 117
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H + +++RD+KS NI L D KL DFG+A++ + ++ +GT Y +PE
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEI 172
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGRKAMD 251
+ KSDI++ G VL E+ T + A +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 46/230 (20%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGH-QEFIVEVLMLSLLHHDNLVTLI 107
+IG G FG+V+ R ++GQ+ A+K L + + E +L+ +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 108 GYCTSGDQRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
Y + D+ L V EYMP G L + L D+ P++ + + +A+ + L ++H
Sbjct: 67 -YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH- 124
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----------------LGPVGDNTHVS 207
RD+K NIL+D D + KL+DFGL K DN V
Sbjct: 125 --------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 208 TR-----------VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
R +GT Y APE L+ D +S GV+L E++ G
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 52 LIGEGGFGKVYKGRLESG--QLVAIKQLN----------HEGLQGHQEFIVEVLML-SLL 98
+G G FG VYK R ++ L+A+K++N E + + + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 99 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
H N+V D+ +V + + L +H L+ ++ + I V L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
YLH + +++RDL NI+L D ++DFGLAK + + T V+GT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGTILYSC 181
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELIT 245
PE + K+D+++FG +L ++ T
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 65/277 (23%), Positives = 117/277 (42%), Gaps = 35/277 (12%)
Query: 52 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQ----EFIVEVLMLSLLHHDNLVTLI 107
LI E +YKG + + V I+ +GH+ E+ L + +N++ +
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIY 84
Query: 108 GY----CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
G+ + L+ EY G L + L D E D LS+ T++ +A+ +GL L+
Sbjct: 85 GFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKD---LSFKTKLDMAIDCCKGLYNLYK 140
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
N P Y++L S + L+ ++ K+ GL K+ +V+ V +Y ++
Sbjct: 141 YTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS- 197
Query: 224 SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283
+ T+K DIYS GVVL E+ TG+ + + +L+ +
Sbjct: 198 --EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNNSL-------- 241
Query: 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320
+ P C + C + ++ RP I +I+ L
Sbjct: 242 --KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 46/275 (16%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGY 109
+G G +G V K R +G ++A+K++ Q+ ++ L +S+ + VT G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 110 C-TSGDQRLLVYEYMP-MGSLEDHLYD--LEPDQ---EP-LSWNTRMKIAVGAARGLEYL 161
GD V+ M M + D Y + E L KIAV + LEYL
Sbjct: 69 LFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYL 119
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H K + VI+RD+K +N+L++ + KL DFG++ G + D+ T G Y APE
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKTIDAGCKPYMAPER 174
Query: 222 ---AMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277
++ K +KSD++S G+ ++EL TGR D SW PF + K+ V
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWKTPF-QQLKQVVE 222
Query: 278 LVDPLL-HGRYPRRCLNYAVAVTAMCLNEEANFRP 311
P L ++ ++ CL + RP
Sbjct: 223 EPSPQLPAEKFSPEFQDF----VNKCLKKNYKERP 253
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 69/215 (32%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQ--LNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIG 108
+GEG + VYKGR + +GQLVA+K+ L HE +G I E +L L H N+VTL
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 109 YCTSGDQRLLVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
+ LV+EY+ ++D L N R+ RGL Y H +
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRL-FLFQLLRGLAYCHQRR 123
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-S 224
V++RDLK N+L+ KL+DFGLA+ V T+ + V T Y P+ + S
Sbjct: 124 ---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGS 178
Query: 225 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
+ + D++ G + E+ TGR S +Q
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 53 IGEGGFGKVYKGR--LESGQLVAIK----QLNHEGLQGHQEFIVEVL-MLSLLHHDNLVT 105
IGEG +GKV+K R G+ VA+K Q EG+ V VL L H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 106 LIGYCT-SGDQR----LLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLE 159
L CT S R LV+E++ +D L+ EP + T + RGL+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
+LH V++RDLK NIL+ + KL+DFGLA++ T V+ T Y AP
Sbjct: 125 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAP 178
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGR 247
E + D++S G + E+ +
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYC 110
+GEG + V+KGR + + LVA+K++ E +G I EV +L L H N+VTL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 111 TSGDQRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
+ LV+EY+ + D+ +L +S + RGL Y H +
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNL------MSMHNVKIFMFQLLRGLSYCHKRK--- 123
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKL 227
+++RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + S +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181
Query: 228 TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262
+ D++ G +L E+ TGR S + E +L+
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYC 110
+GEG + V+KGR + + LVA+K++ E +G I EV +L L H N+VTL
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
+ LV+EY+ L+ ++ D +S + RGL Y H + V+
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VL 126
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTL 229
+RDLK N+L++ KL+DFGLA+ V T+ + V T Y P+ + S + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 230 KSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262
+ D++ G + E+ +GR S + E +L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 65/200 (32%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVE-VLMLSLLHHDNLVTLI 107
IG+G FGKV + G+ A+K L + + +E + E ++L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKAN 166
+ D+ V +Y+ G L HL EP R + A A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLHSLN- 116
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
+IYRDLK NILLD+ + L+DFGL K G T ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 227 LTLKSDIYSFGVVLLELITG 246
D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 107
L+G+G FGKV R + SG+ A+K L E + E + E +L H L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKAN 166
+ D+ V EY+ G L HL +E + R + L+YLH +
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLH---S 113
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
++YRDLK N++LD D + K++DFGL K G + D + T GT Y APE
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 227 LTLKSDIYSFGVVLLELITGR 247
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 67/245 (27%), Positives = 111/245 (45%), Gaps = 49/245 (20%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHHD 101
+ + IG+G FG+V+K R ++ Q+VA+K++ E + F + E+ +L LL H+
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLKHE 71
Query: 102 NLVTLIGYCTSGDQR--------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 153
N+V LI C + LV+E+ +H D L N +K +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFC------EH------DLAGLLSNKNVKFTLS 119
Query: 154 AAR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK---LGPVGD 202
+ GL Y+H +++RD+K+ANIL+ D KL+DFGLA+ L
Sbjct: 120 EIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 203 NTHVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 258
+ RV+ T Y PE + G D++ G ++ E+ T M + Q +
Sbjct: 177 PNRYTNRVV-TLWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232
Query: 259 QNLVS 263
L+S
Sbjct: 233 LTLIS 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 45/281 (16%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHD 101
NFR IG G F +VY+ L G VA+K++ L + + I E+ +L L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
N++ ++ +V E G L + + + + T K V LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H + V++RD+K AN+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281
KSDI+S G +L E + + PF D+ L
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLYSLCKK 219
Query: 282 LLHGRYP-----------RRCLNYAVAVTAMCLNEEANFRP 311
+ YP R+ +N MC+N + RP
Sbjct: 220 IEQCDYPPLPSDHYSEELRQLVN-------MCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 52 LIGEGGFGKVYKGRLESG-QLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 107
+IG G + KV RL+ Q+ A+K + E + ++ E + + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 108 GYCTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCK 164
C RL LV EY+ G L H+ P++ + + IA L +LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLHER 115
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYA 222
+IYRDLK N+LLD D + KL+D+G+ K LGP GD T + GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPEIL 168
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 260
+ D ++ GV++ E++ GR D+ + N
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-14
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109
++GEG FG+ + S Q A+K++ + ++ E ++L+ + H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
+ +V EY G L + L P+ L W +M + V +++H K
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV------QHIHEKR 120
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAM 223
V++RD+KS NI L + KL DFG A+L P + T V GT Y PE
Sbjct: 121 ---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTPYYVPPEIWE 173
Query: 224 SGKLTLKSDIYSFGVVLLELIT 245
+ KSDI+S G +L EL T
Sbjct: 174 NMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 74/256 (28%), Positives = 114/256 (44%), Gaps = 38/256 (14%)
Query: 46 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL------QGHQEFIVEVLML 95
NF ++G G +GKV+ R ++G+L A+K L L H E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR--TERNVL 58
Query: 96 SLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
+ + + Y + +L L+ +Y+ G + HLY + E ++ G
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGE 113
Query: 155 A-RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVM 211
LE+LH ++YRD+K NILLD++ + L+DFGL+K L + T+
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFC 167
Query: 212 GTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WSR 266
GT Y APE GK D +S G+++ EL+TG L +GE+N S SR
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTL---EGERNTQSEVSR 221
Query: 267 PFLKDQKKFVHLVDPL 282
LK F + P
Sbjct: 222 RILKCDPPFPSFIGPE 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 53 IGEGGFGKVYKGRLESG---QLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIG 108
IG G FGKV G + SG V +K+L +Q +F+ E L H NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLY------DLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
CT LLV E+ P+G L+ +L + PD P T ++A A GL +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPD--PT---TLQRMACEIALGLLHLH 117
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
K N I+ DL N LL D K+ D+GL+ D ++ + APE
Sbjct: 118 -KNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 223 --MSGKL-----TLKSDIYSFGVVLLEL 243
+ G L T +S+++S GV + EL
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGYC 110
+GEG + VYKGR + + LVA+K++ E +G I EV +L L H N+VTL
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
+ LV+EY+ L+ +L D ++ + RGL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VL 126
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTL 229
+RDLK N+L++ KL+DFGLA+ + T+ + V T Y P+ + S +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 230 KSDIYSFGVVLLELITGR 247
+ D++ G + E+ TGR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 67/202 (33%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 107
L+G+G FGKV R + +G+ A+K L E + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA--ARGLEYLHCKA 165
+ D+ V EY G L HL E R GA L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF---YGAEIVSALGYLHSCD 115
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
V+YRDLK N++LD D + K++DFGL K G + D + T GT Y APE
Sbjct: 116 ---VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDN 170
Query: 226 KLTLKSDIYSFGVVLLELITGR 247
D + GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 49/215 (22%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF--IVEVL-------MLSLLHHDN 102
IGEG F +V K + ++G+ AIK + + F + +V + L H N
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 103 LVTLIGYC---TSGDQRL-LVYEYMPMGSLEDHLYDLEPDQ-EPLSWNTRMKIAVGAARG 157
++ LI +G RL LV+E M M +LY+L + PL +
Sbjct: 60 ILRLIEVLFDRKTG--RLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH------VSTRVM 211
L+++H + +RD+K NIL+ +D KL+DFG + G + +STR
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYISTR-- 162
Query: 212 GTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELIT 245
Y APE + G K DI++ G V E+++
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 52 LIGEGGFGKVYKGR----LESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVT 105
++G+G FGKV+ R ++GQL A+K L L+ +E +L+ ++H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 106 L-IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEYLHC 163
L + T G + L+ +++ G L L +E + +K + A L++LH
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+ +IYRDLK NILLD + + KL+DFGL+K + S GT Y APE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVN 171
Query: 224 SGKLTLKSDIYSFGVVLLELITG 246
T +D +SFGV++ E++TG
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 70/249 (28%), Positives = 111/249 (44%), Gaps = 23/249 (9%)
Query: 46 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSL 97
NF ++G G +GKV+ R +SG+L A+K L + + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 98 LHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-A 155
+ + + Y D +L L+ +Y+ G L HL E +E ++I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIYSGEIV 115
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 215
LE+LH +IYRD+K NILLD++ + L+DFGL+K D + GT
Sbjct: 116 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIE 171
Query: 216 YCAPEYAMSGKLTLKS--DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273
Y AP+ G D +S GV++ EL+TG + + Q + SR LK +
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEP 229
Query: 274 KFVHLVDPL 282
+ + L
Sbjct: 230 PYPQEMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 68/224 (30%), Positives = 110/224 (49%), Gaps = 23/224 (10%)
Query: 46 NFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 101
+F ++G+G FGKV R + +L AIK L + + + +VE +L+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 102 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
+T + C RL V EY+ G L + + +EP + +IA+G L +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVM-GTYGYC 217
LH K +IYRDLK N++LD++ + K++DFG+ K +N V+T+ GT Y
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYI 168
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261
APE D ++FGV+L E++ G+ + G+ E L
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNL 103
++ + +GEG + VYKG+ + +G+LVA+K + + +G I E +L L H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 104 VTLIGYCTSGDQRLLVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
V L + + LV+EY+ ++ H L P+ L RGL Y
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------FLFQLLRGLSY 118
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
+H + +++RDLK N+L+ + KL+DFGLA+ V +T+ + V T Y P+
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPD 173
Query: 221 YAM-SGKLTLKSDIYSFGVVLLELITGRKAM 250
+ S + + D++ G + +E+I G A
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 47 FREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNL 103
++ + +G G +G+V ++G+ VAIK+L+ + + E+ +L + H+N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 104 VTLIGYCT---SGDQRLLVYEYMP-MGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARG 157
+ L+ T S + VY MG+ DL + LS + + RG
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGA------DLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
L+Y+H A +I+RDLK +NI ++ D K+ DFGLA+ +V+TR Y
Sbjct: 131 LKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYR 182
Query: 218 APEYAMS-GKLTLKSDIYSFGVVLLELITGR 247
APE ++ DI+S G ++ EL+TG+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 31/276 (11%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN---HEGLQGHQEFIVEVLMLSLLHHD 101
NF+ IG G F +VY+ L + VA+K++ + Q+ + E+ +L L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
N++ + ++ +V E G L + + + + T K V +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H + V++RD+K AN+ + KL D GL + T + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281
KSDI+S G +L E + + PF D+ L
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLFSLCQK 219
Query: 282 LLHGRYPRRCLNYAVA----VTAMCLNEEANFRPLI 313
+ YP + + +MC+ + + RP I
Sbjct: 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 107
IGEG +G V+K + E+ ++VA+K++ + EG+ + E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
S + LV+EY L+ + D +P +GL + H
Sbjct: 66 DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDP---EIVKSFMFQLLKGLAFCHSHN-- 119
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVSTRVMGTYGYCAPEYAMSG 225
V++RDLK N+L++ + KL+DFGLA+ G PV S V+ T Y P+
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---RCYSAEVV-TLWYRPPDVLFGA 174
Query: 226 KLTLKS-DIYSFGVVLLEL 243
KL S D++S G + EL
Sbjct: 175 KLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 107
L+G+G FGKV + + +G+ A+K L E + E + E +L H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA--ARGLEYLHCKA 165
+ D+ V EY G L HL +E + R + GA L+YLH +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARF-YGAEIVSALDYLHSEK 115
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
N V+YRDLK N++LD D + K++DFGL K G + D + T GT Y APE
Sbjct: 116 N--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDN 171
Query: 226 KLTLKSDIYSFGVVLLELITGR 247
D + GVV+ E++ GR
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 24/202 (11%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVL----MLSLLHHDNLVTLI 107
+G+GG+G+V+ + ++G++VA+K++ L E + VL +L+ + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTKSEWLVKLL 67
Query: 108 GYCTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCK 164
Y D+ L L EY+P G L +L + + M AV A L Y+H
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH-- 124
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
RDLK N L+D + KL+DFGL+K N+ V+G+ Y APE
Sbjct: 125 -------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRG 172
Query: 225 GKLTLKSDIYSFGVVLLELITG 246
D +S G +L E + G
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 42/228 (18%)
Query: 51 NLIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQE-----------FIV--EVLML 95
+GEG +GKV K +G++VAIK++ E + F E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 96 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAV 152
+ + H+N++ L+ GD LV + M DL+ + L+ + I +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA--------SDLKKVVDRKIRLTESQVKCILL 126
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-------LGPVGDNTH 205
GL LH ++RDL ANI +++ K++DFGLA+ + +
Sbjct: 127 QILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 206 VSTRVMGTYG-----YCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 247
+ R T Y APE M + K D++S G + EL+TG+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDNLVT 105
++G+G FGKV L+ + ++ AIK L + + Q+ V+ M L+L +T
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL--QDDDVDCTMTEKRILALAAKHPFLT 59
Query: 106 LIGYCTSGDQRLL-VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
+ C RL V EY+ G L + EP S R A L +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS---RF-YAAEVTLALMFLHRH 115
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
VIYRDLK NILLD + + KL+DFG+ K G + T +T GT Y APE
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQE 170
Query: 225 GKLTLKSDIYSFGVVLLELITGR 247
+ D ++ GV++ E++ G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 52 LIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNL 103
++G+GG+GKV++ R ++G++ A+K L + +Q+ E +L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEYLH 162
V LI +G + L+ EY+ G L HL ++E + + + LE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALEHLH 117
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEY 221
+ +IYRDLK NILLD + KL+DFGL K TH GT Y APE
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEI 171
Query: 222 AMSGKLTLKSDIYSFGVVLLELITG 246
M D +S G ++ +++TG
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-13
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 52 LIGEGGFGKVYKG--RLESGQ--LVAIKQLNHEGLQGHQE--FIVEVLMLSLLHHDNLVT 105
++G G FG++ +G +L S + VAI L G Q F+ E L L H N+V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
L G T G+ ++V EYM G+L+ L E L M + G A G++YL +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMKYL---S 124
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAM 223
+++ L + +L+++D K+S F + + T + G + APE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 224 SGKLTLKSDIYSFGVVLLELIT 245
+ SD++SFG+V+ E+++
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNL 103
+F + +G G G V K + + L+ ++L H ++ + I E+ +L + +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
V G S + + E+M GSL+ L + + E + K+++ RGL YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
K +++RD+K +NIL+++ KL DFG++ G + D+ ++ +GT Y +PE
Sbjct: 122 KHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQ 175
Query: 224 SGKLTLKSDIYSFGVVLLELITGR 247
+++SDI+S G+ L+EL GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 53 IGEGGFGKVYK-GRLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109
IG G FG V+ G+ VA+K++ + + L + E+ ML HDN+++ +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
Y+ ++ L+ + +PLS + RGL+YLH A +
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH-SAG--I 124
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLT 228
++RD+K N+L++++ K+ DFGLA++ ++ H++ V+ Y Y APE M S T
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRHYT 183
Query: 229 LKSDIYSFGVVLLELITGR 247
DI+S G + EL+ R
Sbjct: 184 SAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 52 LIGEGGFGKVYKG---RLESGQL-VAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTL 106
IGEG FG VY+G E+ ++ VA+K + +E F+ E ++ H ++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
IG T + +V E P+G L +L + ++ L + + + + L YL K
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSG 225
++RD+ + N+L+ + KL DFGL++ + D ++ +++ + APE
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFR 183
Query: 226 KLTLKSDIYSFGVVLLELI 244
+ T SD++ FGV + E++
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 8e-13
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEF-IVEVLMLSLLHHDNLVTLIGY 109
+IG G + KV RL+ + ++ A+K + E + ++ V+ N L+G
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 110 --CTSGDQRLL-VYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCK 164
C + RL V EY+ G L H+ P++ ++ + +A L YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHER 115
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG-PVGDNTHVSTRVMGTYGYCAPEYAM 223
+IYRDLK N+LLD++ + KL+D+G+ K G GD T + GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILR 169
Query: 224 SGKLTLKSDIYSFGVVLLELITGRKAMDL--SKGQGEQN 260
D ++ GV++ E++ GR D+ S +QN
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIG 108
+IG+G +G V +G+ VAIK++N E + + E+ +L LL H ++V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 109 YCTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
+R +V+E M E L+ + + L+ R L+Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYA 222
AN V +RDLK NIL + D K+ DFGLA++ T + T + T Y APE
Sbjct: 121 TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 223 MS--GKLTLKSDIYSFGVVLLELITGR 247
S K T DI+S G + E++TG+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 52 LIGEGGFGKVYKGRLESG-QLVAIKQLNHEGLQGHQEF-IVEVLMLSLLHHDNLVTLIGY 109
+IG G + KV L+ ++ A+K + E + ++ V+ N L+G
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 110 --CTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCK 164
C + RL V E++ G L H+ P++ ++ + +A L +LH +
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNFLHER 115
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYA 222
+IYRDLK N+LLD + + KL+D+G+ K + P GD T ST GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT--ST-FCGTPNYIAPEIL 168
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDL--SKGQGEQN 260
D ++ GV++ E++ GR D+ +QN
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109
IG G +G V + E+ + VAIK++ + + + + E+ +L L H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 110 CTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
+ +VYE M + L+ + + LS + RGL+Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH-S 126
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
AN V++RDLK +N+LL+ + + K+ DFGLA+ + T + T Y APE ++
Sbjct: 127 AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 225 -GKLTLKSDIYSFGVVLLELITGRK 248
+ T D++S G + EL+ GRK
Sbjct: 183 CSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 53 IGEGGFGKVYKG--RLESGQLVAIKQLNHEGLQGHQ-EFIVEVLMLSLLHHDNLVTLIGY 109
+GEG + VYKG R+ +GQLVA+K ++ + +G I E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 110 CTSGDQRLLVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+ + V+EYM + H L P +N R+ RGL Y+H +
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRL-FMFQLLRGLAYIHGQH- 123
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SG 225
+++RDLK N+L+ KL+DFGLA+ + T+ S V T Y P+ + +
Sbjct: 124 --ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGAT 179
Query: 226 KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265
+ DI+ G + +E++ G+ A EQ W+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 53 IGEGGFGKVYKG-RLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLIG- 108
IG G +G V SG+ VAIK++ H + + + E+ +L HDN++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
G VY M + +E L+ + +PL+ RGL+Y+H AN
Sbjct: 73 LRPPGADFKDVYVVMDL--MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH-SAN-- 127
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAMS- 224
VI+RDLK +N+L++ D ++ DFG+A+ P ++ + T + T Y APE +S
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVATRWYRAPELLLSL 186
Query: 225 GKLTLKSDIYSFGVVLLELITGRKAM 250
+ T D++S G + E++ GR+ +
Sbjct: 187 PEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLM-LSLLHHDNLV 104
+F + +G G G V K L+ ++L H L+ +++ L +LH N
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH--LEIKPAIRNQIIRELKVLHECNSP 59
Query: 105 TLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
++G+ + G+ + + E+M GSL+ L E + KI++ RGL Y
Sbjct: 60 YIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENI----LGKISIAVLRGLTY 114
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD---NTHVSTRVMGTYGYC 217
L + +++RD+K +NIL+++ KL DFG++ G + D N+ V TR Y
Sbjct: 115 L--REKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFVGTR-----SYM 165
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+PE T++SDI+S G+ L+E+ GR
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 61/226 (26%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQL-----NHEGLQGHQEFIVEVLMLS-LLHHDNLVT 105
+G+G +G V+K + ++VA+K++ N Q E++ L L H N+V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVK 71
Query: 106 LIG-YCTSGDQRL-LVYEYMPM--------GSLED-H----LYDLEPDQEPLSWNTRMKI 150
L+ D+ + LV+EYM LED H +Y L
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQL--------------- 116
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNT----- 204
+ L+Y+H N VI+RDLK +NILL++D KL+DFGLA+ L + +N
Sbjct: 117 ----LKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 205 --HVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 247
+V+TR Y APE + S + T D++S G +L E++ G+
Sbjct: 170 TDYVATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 44/255 (17%)
Query: 24 NGGKEKSGARSFTFRELAIATRNFRE---ANLIGEGGFGKVYKGRLE-SGQLVAIKQL-- 77
S + S A ++ E N IG G G VYK +G+L A+K +
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 78 NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP 137
NHE Q E+ +L ++H N+V + ++ E+M GSLE E
Sbjct: 110 NHEDTVRRQ-ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ 168
Query: 138 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK- 196
L+ +A G+ YLH + +++RD+K +N+L+++ N K++DFG+++
Sbjct: 169 F---LA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217
Query: 197 LGPVGDNTHVSTRVMGTYGYCAPE-------------YAMSGKLTLKSDIYSFGVVLLEL 243
L D + S +GT Y +PE YA DI+S GV +LE
Sbjct: 218 LAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEF 266
Query: 244 ITGRKAMDLSKGQGE 258
GR + + QG+
Sbjct: 267 YLGRFPFGVGR-QGD 280
|
Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 66/240 (27%), Positives = 100/240 (41%), Gaps = 47/240 (19%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG----HQEFIVEVLMLSLLHHDNLVTL 106
LIG+GG G+VY + VA+K++ E L + F+ E + + L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 107 IGYCTSGDQRLLVYEYMPM--GSLEDHLYDLEPDQEPLSWNTRMKIAVGA--------AR 156
C+ GD VY MP G L +E LS K +VGA
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL----------------GPV 200
+EY+H K V++RDLK NILL + D+G A
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT---------GRKAMD 251
+ + +++GT Y APE + + +DIY+ GV+L +++T GRK
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241
|
Length = 932 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 53 IGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFI-----VEVLMLSLLHHDNLVTL 106
IG+G FG+VY+ R ++ ++ A+K L+ + + +E +L+ +LL +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 107 IGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEYLHCK 164
+ + D L LV +YM G L HL +E R K + LE+LH K
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL-----QKEGRFSEDRAKFYIAELVLALEHLH-K 114
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
+ ++YRDLK NILLD + L DFGL+K + T + GT Y APE +
Sbjct: 115 YD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLD 170
Query: 225 GK-LTLKSDIYSFGVVLLELITG 246
K T D +S GV++ E+ G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 66/243 (27%), Positives = 99/243 (40%), Gaps = 54/243 (22%)
Query: 45 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVL----MLSLLH 99
++F++ L+G+G G+V+ RL +G+L A+K L+ + + + + VL +L+ L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLD 59
Query: 100 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--- 156
H L TL + LV +Y P G L L +P + + V AR
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGK-------CLSEEV--ARFYA 109
Query: 157 -----GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV----- 206
LEYLH ++YRDLK NILL + LSDF L+K V
Sbjct: 110 AEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 207 -------------------STRVM---GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 244
S R GT Y APE D ++ G++L E++
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
Query: 245 TGR 247
G
Sbjct: 227 YGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 71/251 (28%), Positives = 119/251 (47%), Gaps = 22/251 (8%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNL 103
F ++GEG +G V K R E+ ++VAIK+ + E + + + E+ ML L +N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH- 162
V L + LV+EY+ LE L + P+ P K+ + ++ +H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAIHW 115
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
C N +++RD+K N+L+ ++ KL DFG A+ G N + T + T Y +PE
Sbjct: 116 CHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELL 173
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-QNLVSWSR---PFLKDQKKFVHL 278
+ D++S G +L EL G+ L G+ E L + + P +Q K +
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQP---LFPGESEIDQLFTIQKVLGPLPAEQMKLFY- 229
Query: 279 VDPLLHG-RYP 288
+P HG R+P
Sbjct: 230 SNPRFHGLRFP 240
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 73/275 (26%), Positives = 124/275 (45%), Gaps = 37/275 (13%)
Query: 53 IGEGGFGKVY---------KGRLESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDN 102
+G+G FG VY + RL+ + + + +LN +E +Q +QE +LS L H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDHPA 63
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V D ++ EY L+ L +L+ + LS N + + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+ +++RDLK+ NI L N+ K+ DFG+++L + + ++T GT Y +PE
Sbjct: 124 QRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282
KSDI+S G +L E+ A + FL + V P
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------------FLSVVLRIVEGPTPS 224
Query: 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
L Y R+ LN ++ LN++ + RP +I+
Sbjct: 225 LPETYSRQ-LN---SIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHH 100
+F LI G +G VY R E+ Q A+K++N + L Q Q F VE +L+ +
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAEN 60
Query: 101 DNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
+V++ +C+ +R L V EY+ G L ++ ++ RM A L
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA---RMYFA-ETVLAL 114
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-------STR-- 209
EYLH N +++RDLK N+L+ + + KL+DFGL+K+G + T++ TR
Sbjct: 115 EYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 210 ----VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
V GT Y APE + D ++ G++L E + G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-12
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLM-LSLLHHDNLVTLIGYC 110
+G+G +G VYK +G +A+K++ L+ + +++M L +LH ++ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR---LELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 111 TSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
+ VY EYM GSL D LY E + + +I +GL++L K
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL--KEEH 122
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSG 225
+I+RD+K N+L++ + KL DFG V N ++ +G Y APE SG
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFG------VSGNLVASLAKTNIGCQSYMAPERIKSG 176
Query: 226 KL------TLKSDIYSFGVVLLELITGR 247
T++SD++S G+ +LE+ GR
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIK----QLNHEGLQGHQEFIVEVLMLSLLHH 100
+ + IGEG +GKVYK R +G+LVA+K +++ EG+ + E+ +L +L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSE 59
Query: 101 DN-LVTLIGY----CTSGDQRL-LVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
+V L+ +G L LV+EY+ + D PL T
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG--RPLPAKTIKSFMY 117
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLG--PVGDNTHVSTR 209
+G+ + H V++RDLK N+L+D K++D GL + PV TH
Sbjct: 118 QLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---- 170
Query: 210 VMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITG 246
+ T Y APE + + DI+S G + E+
Sbjct: 171 EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 43 ATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD 101
++++ N+IG G FG VY+ +++ + VAIK++ LQ Q E+L++ L+H
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHI 119
Query: 102 NLVTLIGY----CTSGDQRLL----VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 153
N++ L Y C +++ + V E++P ++ ++ + L +
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ 178
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK--LGPVGDNTHVSTRV 210
R L Y+H K + +RDLK N+L+D N KL DFG AK L +++ +R
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 211 MGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITG 246
Y APE + + T D++S G ++ E+I G
Sbjct: 236 -----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 47 FREANLIGEGGFGKV-YKGRLESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDN 102
+R+ +G G +G V +G VAIK+L + Q + E+ +L + H+N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 103 LVTLIGYCT---SGDQRLLVYEYMP-----MGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
++ L+ T S D+ Y MP +G L H E LS + +
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLSEDRIQFLVYQM 127
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
+GL+Y+H +I+RDLK N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR----- 179
Query: 215 GYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 247
Y APE ++ T DI+S G ++ E++TG+
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 52 LIGEGGFGKVY-KGRLESGQLVAIKQLNHEGLQGHQE---FIVEV-LMLSLLHHDNLVTL 106
+IG+G FGKV R G+ A+K L + + +E + E ++L + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+ ++ V +++ G L HL EP R A A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAA-EIASALGYLH---S 114
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
++YRDLK NILLD+ + L+DFGL K G +T +T GT Y APE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQP 172
Query: 227 LTLKSDIYSFGVVLLELITG 246
D + G VL E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 65/199 (32%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLV-AIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLIG 108
IG+G FGKV + R Q + A+K + + E + E +L+ ++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-GLEYLHCKANP 167
S ++ LV ++ G L HL +E +R + LE LH K N
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYTAELLCALENLH-KFN- 113
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 227
VIYRDLK NILLD + L DFGL KL D+ + GT Y APE +
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGY 170
Query: 228 TLKSDIYSFGVVLLELITG 246
T D ++ GV+L E++TG
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVL--------- 93
T + + +G G FG V R +GQ VAIK++ + F VL
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61
Query: 94 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKI 150
+L L H+N+++L S + + V E + DL PL
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGT--------DLHRLLTSRPLEKQFIQYF 113
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 210
RGL+Y+H V++RDLK +NIL++ + + K+ DFGLA++ +VSTR
Sbjct: 114 LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY 170
Query: 211 MGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 247
Y APE ++ K ++ DI+S G + E++ G+
Sbjct: 171 -----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 52 LIGEGGFGKVYKGRLES-GQLVAIKQLNHEGL--QGHQEFIV--EVLMLSLLHHDNLVTL 106
+IG+G FGKV + +S G A+K L + + + Q I+ ++L L H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKA 165
+ ++ V +Y+ G L HL EP R + A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSLN 116
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
+IYRDLK NILLD+ + L+DFGL K G + T ++ GT Y APE
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 226 KLTLKSDIYSFGVVLLELITG 246
D + G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 23/214 (10%)
Query: 53 IGEGGFGKVYKGRLE---SGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+G G FG V KG + S + VA+K L N L+ E + E ++ L + +V
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALK--DELLREANVMQQLDNPYIVR 60
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
+IG C + +LV E +G L L + ++ ++ + G++YL +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLE-ET 114
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYA 222
N ++RDL + N+LL K+SDFGL+K LG D + + G + + APE
Sbjct: 115 N--FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECM 170
Query: 223 MSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKG 255
K + KSD++SFGV++ E + G+K KG
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 61/240 (25%), Positives = 111/240 (46%), Gaps = 28/240 (11%)
Query: 53 IGEGGFGKVYKG-RLESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
+G G G VYK L + +++A+K + + ++ ++ + E+ +L ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
++ + E+M GSL+ +Y P+ +IAV +GL YL + ++
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEH------VLGRIAVAVVKGLTYLW---SLKIL 117
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 230
+RD+K +N+L++ KL DFG++ ++ +GT Y APE + +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 231 SDIYSFGVVLLELITGR-KAMDLSKGQGE-------QNLVSWSRPFLKD---QKKFVHLV 279
SD++S G+ +EL GR + K QG Q +V P L +KFVH +
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 55/217 (25%), Positives = 105/217 (48%), Gaps = 39/217 (17%)
Query: 53 IGEGGFGKV--YKGRLESGQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHHDNLVT--- 105
+G+G +G+V + R + Q V IK+LN + + + E +LS L H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYV-IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 106 -----------LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
++G+C GD +Y L++ L P+ + + W ++ +A
Sbjct: 67 SWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA--- 114
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
L+YLH K +++RDLK+ N+ L K+ D G+A++ + + +++ ++GT
Sbjct: 115 ---LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTP 166
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 251
Y +PE + KSD+++ G + E+ T + A +
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNL 103
+F + + +G G G V+K + L+ ++L H ++ + I E+ +L + +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
V G S + + E+M GSL+ L E + K+++ +GL YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
K +++RD+K +NIL+++ KL DFG++ G + D+ ++ +GT Y +PE
Sbjct: 122 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQ 175
Query: 224 SGKLTLKSDIYSFGVVLLELITGR 247
+++SDI+S G+ L+E+ GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 38 RELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVL 93
+L + +F +IG G FG+V R S Q+ A+K L+ + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 94 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMK 149
+++ + + +V L + D + L V EYMP G L + + YD+ P++ + +
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVV 152
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVST 208
+A+ A + ++H RD+K N+LLD + KL+DFG K+ G T
Sbjct: 153 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDT 202
Query: 209 RVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITG 246
V GT Y +PE S G + D +S GV L E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 70/263 (26%), Positives = 111/263 (42%), Gaps = 77/263 (29%)
Query: 53 IGEGGFGKVYK------GRLESGQLVAIKQLNHEGLQG--HQEFIVEV-LMLSLLHHDNL 103
+G G FGKV + + S + VA+K L EG ++ + E+ +++ + HH N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLK-EGATASEYKALMTELKILIHIGHHLNV 73
Query: 104 VTLIGYCTSGDQRLLV-YEYMPMGSLEDHL------------------------------ 132
V L+G CT L+V EY G+L ++L
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 133 --------------------YDLEPDQE-------PLSWNTRMKIAVGAARGLEYLHCKA 165
D+E D+E PL+ + + ARG+E+L A
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---A 190
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYA 222
+ I+RDL + NILL + K+ DFGLA+ D +V R+ + APE
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPESI 247
Query: 223 MSGKLTLKSDIYSFGVVLLELIT 245
T +SD++SFGV+L E+ +
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 52 LIGEGGFGKVYKGRLESGQ-LVAIKQLNHEGLQGHQE----FIVEVLMLSLLHHDNLVTL 106
+IG+G FGKV R ++ + A+K L + + +E ++L + H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+ D+ V +Y+ G L Y L+ ++ L R A A L YLH +
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASALGYLH---S 114
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
++YRDLK NILLD+ + L+DFGL K + N ST GT Y APE
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNGTTST-FCGTPEYLAPEVLHKQP 172
Query: 227 LTLKSDIYSFGVVLLELITG 246
D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 53 IGEGGFGKVYKGRLESGQLVA---IKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIG 108
IG G FGKV + + VA +K+L + + EF+ + +L H N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLY---DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
C LLV+EY +G L+ +L + + L ++A A G+ ++H K
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-KH 118
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS- 224
N ++ DL N L +D K+ D+G+ D + APE
Sbjct: 119 N--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 225 -GKL-----TLKSDIYSFGVVLLEL 243
G L T S++++ GV L EL
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 45 RNFREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHH 100
+ +G G +G V +G+ VAIK+L Q + E+ +L + H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 101 DNLVTLIGYCTS---GDQRLLVYEYMPMGSLEDHLYDLEPDQ-EPLSWNTRMKIAVGAAR 156
+N++ L+ TS GD+ Y MP DL+ PLS + +
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-----DLQKIMGHPLSEDKVQYLVYQMLC 128
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
GL+Y+H +I+RDLK N+ ++ D K+ DFGLA+ +V TR Y
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180
Query: 217 CAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 247
APE ++ DI+S G ++ E++TG+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 53 IGEGGFGKVYKGRLE-------SGQLVAIKQLNHEGLQGHQ---EFIVEVLMLSLLHHDN 102
+G+G F +YKG L G + + H+ F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
LV L G C D+ ++V EY+ G L+ L+ E + L W ++ +A A L YL
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 163 CKANPPVIYRDLKSANILL----DNDFNP---KLSDFGLAKLGPVGDNTHVSTRVMGTYG 215
K +++ ++ NIL+ N+ KLSD G+ V R+
Sbjct: 119 DKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 216 YCAPEY--AMSGKLTLKSDIYSFGVVLLEL 243
+ APE LT+ +D +SFG LLE+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 47 FREANLIGEGGFGKVYKG-RLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+ + +G G G V+ + + VA+K++ Q + + E+ ++ L HDN+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 106 LIGYCTSGDQRL--------------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151
+ L +V EYM E L ++ +Q PLS
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVL-EQGPLSEEHARLFM 120
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK-LGPVGDNTHVSTR 209
RGL+Y+H AN V++RDLK AN+ ++ D K+ DFGLA+ + P + +
Sbjct: 121 YQLLRGLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 210 VMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268
+ T Y +P +S T D+++ G + E++TG+ + + L+ S P
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 269 LKDQKKFVHL-VDPLL---HGRYPRRCL 292
++++ + L V P G PRR L
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPL 265
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 10/156 (6%)
Query: 89 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 148
++E ++L ++H +++ + SG +V +P S + + Y L PL + +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY-LTKRSRPLPIDQAL 160
Query: 149 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208
I GL YLH + +I+RD+K+ NI +++ + D G A+ PV +
Sbjct: 161 IIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG- 215
Query: 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 244
+ GT APE K K+DI+S G+VL E++
Sbjct: 216 -LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 46 NFREANLIGEGGFGKVYKGRLESG-QLVAIKQLNH-EGLQGHQEFIVEVLMLSLLHHDN- 102
+F +IG G FG+V +L++ ++ A+K LN E L+ + L++ DN
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 103 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGL 158
+T + Y + L LV +Y G L L E P+ + M IA+ + L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
Y+H RD+K NIL+D + + +L+DFG + L + D T S+ +GT Y +
Sbjct: 122 HYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 219 PEYAMS-----GKLTLKSDIYSFGVVLLELITG 246
PE + GK + D +S GV + E++ G
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 33/83 (39%), Positives = 49/83 (59%)
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 228
+I+RD+KSANILL ++ KL DFG +K+ + V GT Y APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 229 LKSDIYSFGVVLLELITGRKAMD 251
K+D++S GV+L EL+T ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 68/217 (31%), Positives = 96/217 (44%), Gaps = 14/217 (6%)
Query: 40 LAIATRNFREANLIGEGGFGKVYK-GRLESGQLVAIKQLNHEGLQGHQEFIVEVLML-SL 97
L T + IG+G +GKVYK + G L A+K L+ +E E +L SL
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSL 75
Query: 98 LHHDNLVTLIGYC-----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
+H N+V G G Q LV E GS+ + + L + L I
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGP--VGDNTHVSTR 209
GA GL++LH N +I+RD+K NILL + KL DFG+ A+L + NT V T
Sbjct: 136 GALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 192
Query: 210 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
A E + D++S G+ +EL G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 18/149 (12%)
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLE 159
N+V L Y S D LV ++ G L H+ + P++ W M +A L+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYCA 218
LH + ++ RDL NILLD+ + +L+ F +++ D V YCA
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELITGR 247
PE + T D +S G +L EL+TG+
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLV-AIKQLNHEGLQGHQE---FIVEVL 93
R+L + ++ +IG G FG+V R +S Q V A+K L+ + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 94 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMK 149
+++ + +V L +C D + L V EYMP G L + + YD+ P++ + +
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVV 152
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVST 208
+A+ A + +H RD+K N+LLD + KL+DFG K+ G T
Sbjct: 153 LALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDT 202
Query: 209 RVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITG 246
V GT Y +PE S G + D +S GV L E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 53 IGEGGFGKVYKG-RLESGQL-------VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 104
+G+G F K++KG R E G V +K L+ + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
G C GD+ ++V EY+ GSL+ +L + +SW ++++A A L +L K
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYA 222
+ + ++ + N+LL + + K + KL G + V + + + PE
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 223 MSGK-LTLKSDIYSFGVVLLELITG 246
+ + L+L +D +SFG L E+ +G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 35/234 (14%)
Query: 27 KEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQL--VAIKQLNHEGLQG 84
K+ S + R+ + +F +G G FG+V ++ VAIK+ +
Sbjct: 12 KKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71
Query: 85 HQEF---IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP 141
++ E +L+ ++H V L G LV E++ G L
Sbjct: 72 QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR------- 124
Query: 142 LSWNTRMKIAVGAARG------LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195
N R VG EYL + ++YRDLK N+LLD D K++DFG A
Sbjct: 125 ---NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 196 KLGPVGDNTHVSTR---VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
K+ V TR + GT Y APE ++ +D ++ G+ + E++ G
Sbjct: 179 KV--------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 45/245 (18%)
Query: 53 IGEGGFGKVYKGRLESG---QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG- 108
+G G +G VYK + + G + A+KQ+ G+ E+ +L L H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKV 66
Query: 109 YCTSGDQRL-LVYEYMPMGSLEDHLYDL-------EPDQEPLSWNTRM--KIAVGAARGL 158
+ + D+++ L+++Y E L+ + + +++P+ M + G+
Sbjct: 67 FLSHSDRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAK-----LGPVGDNTHVST 208
YLH V++RDLK ANIL+ + P K++D G A+ L P+ D
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLAD----LD 173
Query: 209 RVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267
V+ T+ Y APE + + K+ DI++ G + EL+T Q + S P
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNP 228
Query: 268 FLKDQ 272
F DQ
Sbjct: 229 FHHDQ 233
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 40/99 (40%), Positives = 59/99 (59%), Gaps = 9/99 (9%)
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK---LGPVGDNTHVSTRVMG 212
GL+Y+H AN V++RDLK N+L++ D K+ DFGLA+ P G+N T +
Sbjct: 116 CGLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVA 171
Query: 213 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAM 250
T Y APE +S + K+ D++S G +L EL+ GRK +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 46 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNH-EGLQGHQEFIV--EVLMLSLL 98
+F +IG G FG+V RL ++G + A+K+L E L+ Q V E +L+
Sbjct: 2 DFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA 58
Query: 99 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGA 154
+ +V L Y + D+ L+ EY+P G + L D ++E TR IA
Sbjct: 59 DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIA-ET 110
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-----------------L 197
++ +H K I+RD+K N+LLD + KLSDFGL L
Sbjct: 111 ILAIDSIH-KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 198 GPVGDNTHVSTR-------------------VMGTYGYCAPEYAMSGKLTLKSDIYSFGV 238
+ +GT Y APE + + D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 239 VLLELITG 246
++ E++ G
Sbjct: 228 IMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 53 IGEGGFGKVYK-GRLESGQLVAIKQLN--HEGLQGHQEFIVEVLML-SLLHHDNLVTLIG 108
IG+G +GKV+K ++G A+K L+ H+ +E E +L +L H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYG 82
Query: 109 Y-----CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
+GDQ LV E GS+ D + E + I A GL++LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH- 141
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY-- 221
I+RD+K NILL + KL DFG++ + +GT + APE
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 222 ---AMSGKLTLKSDIYSFGVVLLELITG 246
+ + D++S G+ +EL G
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLV-AIKQLNHEGL--QGHQEFIVEVLM 94
R+L + ++ +IG G FG+V R +S + V A+K L+ + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 95 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIA 151
+ + V + Y D+ L +V EYMP G L + + YD+ P++ + + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLA 154
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG----LAKLGPVGDNTHVS 207
+ A + ++H RD+K N+LLD + KL+DFG + K G V +T V
Sbjct: 155 LDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 208 TRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITG 246
GT Y +PE S G + D +S GV L E++ G
Sbjct: 205 ----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 48/181 (26%), Positives = 91/181 (50%), Gaps = 22/181 (12%)
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWN 145
E+++L ++H N+++L+ T + L ++ Y+ M ++ +L +E D E +S+
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 146 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205
+ G+++LH +I+RDLK +NI++ +D K+ DFGLA+ N
Sbjct: 129 LYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFM 178
Query: 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265
++ V+ Y Y APE + DI+S G ++ EL+ G QG ++ W+
Sbjct: 179 MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF-----QGTDHIDQWN 232
Query: 266 R 266
+
Sbjct: 233 K 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 3/155 (1%)
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 150
E+ L+ H +V S D+ LL+ EY G L + + P +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 210
L+ +H + +++RDLKSANI L KL DFG +K + V++
Sbjct: 175 FYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 211 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
GT Y APE + + K+D++S GV+L EL+T
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 36/105 (34%), Positives = 48/105 (45%), Gaps = 5/105 (4%)
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLG 198
PL + I L YLH + +I+RD+K+ NI LD N L DFG A KL
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 243
+T GT +PE K+DI+S G+VL E+
Sbjct: 237 -AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIG 108
I G FGKVY GR + + +L A+K + + + E L+L +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
S + LV EY+ G ++ L+ E ++ +K A L+YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYLHRHG--- 124
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKL 197
+I+RDLK N+L+ N+ + KL+DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLV-AIKQLNH-EGLQGHQEFIVEVLMLSLLHHD-N 102
+F +IG G FG+V +++ + + A+K LN E L+ + L++ D
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 103 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGL 158
+T + Y + L LV +Y G L L E P+ + M +A+ + L
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
Y+H RD+K N+LLD + + +L+DFG + L D T S+ +GT Y +
Sbjct: 122 HYVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 219 PEY--AMS---GKLTLKSDIYSFGVVLLELITG 246
PE AM GK + D +S GV + E++ G
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 42/233 (18%)
Query: 37 FRELAIATRNF----REANL--IGEGGFGKVYKG-RLESGQLVAIKQLNH------EGLQ 83
F + + F R NL IG G G V +GQ VAIK+L+ +
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61
Query: 84 GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL-----VYEYMPMGSLEDH----LYD 134
++E VLM L++H N++ L+ T Q+ L VY M L D +
Sbjct: 62 AYREL---VLM-KLVNHKNIIGLLNVFTP--QKSLEEFQDVYLVM---ELMDANLCQVIQ 112
Query: 135 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194
++ D E +S+ + G+++LH + +I+RDLK +NI++ +D K+ DFGL
Sbjct: 113 MDLDHERMSYLLYQMLC-----GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 164
Query: 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
A+ G + ++ V+ Y Y APE + DI+S G ++ E+I G
Sbjct: 165 ARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 45/245 (18%)
Query: 53 IGEGGFGKVYKGRLESGQL---VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIG- 108
+G G +G VYK + + G+ A+KQ+ G+ E+ +L L H N+++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 66
Query: 109 YCTSGDQRL-LVYEYMPMGSLEDHLYDL-------EPDQEPLSWNTRM--KIAVGAARGL 158
+ + D+++ L+++Y E L+ + + +++P+ M + G+
Sbjct: 67 FLSHADRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAK-----LGPVGDNTHVST 208
YLH V++RDLK ANIL+ + P K++D G A+ L P+ D
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLAD----LD 173
Query: 209 RVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267
V+ T+ Y APE + + K+ DI++ G + EL+T Q + S P
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNP 228
Query: 268 FLKDQ 272
+ DQ
Sbjct: 229 YHHDQ 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 46/176 (26%)
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE---YMPMGSLEDHLY------DLEPDQEP 141
E+L L L+H+N++ + + +L E YM + LY + P
Sbjct: 213 EILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRP 264
Query: 142 LSWNTR--MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA---- 195
L TR MK + A +EY+H K +I+RD+K NI L+ D L DFG A
Sbjct: 265 LLKQTRAIMKQLLCA---VEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 196 ------KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
G VG S ++ GYC +DI+S G++LL++++
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCE-----------ITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 215
RGL+Y+H + +I+RDLK +N+ ++ D K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 216 YCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 247
Y APE ++ DI+S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHD 101
+F +IG G FG+V ++ +GQ+ A+K LN + E F E +L ++ D
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVL--VNGD 59
Query: 102 N-LVTLIGYCTSGDQRL-LVYEYMPMGSL-------EDHLYDLEPDQEPLSWNTRMKIAV 152
+T + Y + L LV +Y G L ED L P+ + M +A+
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL----PEDMARFYLAEMVLAI 115
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
+ L Y+H RD+K N+LLD + + +L+DFG + L + D T S +G
Sbjct: 116 DSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVG 165
Query: 213 TYGYCAPEY--AM---SGKLTLKSDIYSFGVVLLELITG 246
T Y +PE AM G+ + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 30/231 (12%)
Query: 33 RSFTFRELAIATRNF----REANL--IGEGGFGKV---YKGRLESGQLVAIKQLNHE-GL 82
R F + I F R NL IG G G V Y LE VAIK+L+
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQN 63
Query: 83 QGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLE 136
Q H + E++++ ++H N++ L+ T + L ++ Y+ M ++ +L +E
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 137 PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196
D E +S+ + G+++LH +I+RDLK +NI++ +D K+ DFGLA+
Sbjct: 123 LDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
G + ++ V+ Y Y APE + DI+S G ++ E+I G
Sbjct: 175 TA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLH 99
++F +L+G G FG+V R + +G + A+K + L QE + E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISN 59
Query: 100 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEPLS--WNTRMKIAVGAA 155
+ L D LV EY P G L L Y+ + E ++ + + +A+ +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSV 118
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG-LAKLGPVGDNTHVSTRVMGTY 214
+ Y+H RD+K N+L+D + KL+DFG A+L + S +GT
Sbjct: 119 HQMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTP 167
Query: 215 GYCAPEY--AMSGKLT----LKSDIYSFGVVLLELITGR 247
Y APE M+G ++ D +S GV+ E+I GR
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 39/218 (17%)
Query: 52 LIGE----GGFGKVYKGRLESGQLVAIKQLN-----HEGLQGHQEFIVEVLMLSLLHHDN 102
LIG+ + K + + LVA+K++N E L+ Q+ E++ L H N
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQ---EIITSRQLQHPN 60
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLE 159
++ + + +V M GS ED L P+ P + IA L+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALD 115
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA--------KLGPVGDNTHVSTRVM 211
Y+H K I+R +K+++ILL D LS + + V D S + +
Sbjct: 116 YIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 212 GTYGYCAPEY---AMSGKLTLKSDIYSFGVVLLELITG 246
+ +PE + G KSDIYS G+ EL G
Sbjct: 173 P---WLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 29/206 (14%)
Query: 68 SGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122
+G LV ++ E L+ Q EV++ H N++T T+G ++ +
Sbjct: 24 TGTLVTVRITDLENCTEEHLKALQN---EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80
Query: 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 182
M GS L P E +S I GA RGL YLH I+R++K+++IL+
Sbjct: 81 MAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 183 NDFNPKLSD----FGLAKLGP----VGDNTHVSTRVMGTYGYCAPEYA---MSGKLTLKS 231
D LS + L + G V D ST V+ + +PE + G +KS
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYG-YNVKS 191
Query: 232 DIYSFGVVLLELITGRKA-MDLSKGQ 256
DIYS G+ EL TGR D+ + Q
Sbjct: 192 DIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 54/210 (25%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 45 RNFREANLIGEGGFGKV---YKGRLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLH 99
+ ++ IG G G V Y L+ VAIK+L+ + + E++++ ++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 100 HDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWNTRMKIAVGA 154
H N+++L+ T + L ++ Y+ M ++ +L +E D E +S+ +
Sbjct: 75 HKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC--- 130
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
G+++LH +I+RDLK +NI++ +D K+ DFGLA+ G + ++ V+ Y
Sbjct: 131 --GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 183
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELI 244
Y APE + DI+S G ++ E++
Sbjct: 184 -YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 53 IGEGGFGKV---YKGRLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHHDNLVTLI 107
+G G +G V Y RL Q VA+K+L+ + L + E+ +L + H+N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 108 GY---CTSGDQRLLVYEYMP-MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
TS + VY MG+ +++ + LS + RGL+Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK----LSDEHVQFLIYQLLRGLKYIHS 136
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+I+RDLK +N+ ++ D ++ DFGLA+ +V+TR Y APE +
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIML 188
Query: 224 SG-KLTLKSDIYSFGVVLLELITGR 247
+ DI+S G ++ EL+ G+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 41/120 (34%), Positives = 61/120 (50%), Gaps = 16/120 (13%)
Query: 136 EPDQE-------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 188
P QE PL+ + + ARG+E+L A+ I+RDL + NILL + K
Sbjct: 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVK 214
Query: 189 LSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ DFGLA+ D +V S R+ + APE T +SD++SFGV+L E+ +
Sbjct: 215 ICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 9/162 (5%)
Query: 89 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 148
E +L ++H +++ L G T L+ + + LY + ++ +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYKTDLYCYLAAKRNIAICDIL 185
Query: 149 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208
I R ++YLH +I+RD+K+ NI +++ + L DFG A PV N +
Sbjct: 186 AIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYY 241
Query: 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 250
GT APE DI+S G+VL E+ T ++
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 179
Y+ +++ L D E L+ + ARG+E+L A+ ++RDL + N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 180 LLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 238
LL K+ DFGLA+ + D+ +VS + APE T SD++S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 239 VLLELIT 245
+L E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 69/266 (25%), Positives = 109/266 (40%), Gaps = 57/266 (21%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH-EGLQGHQEFIVEVLMLSLLHHDN-- 102
F + IG G FG+V R +++ L A+K L + L +Q V+ L DN
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 103 LVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
+V L Y + D+ L V +Y+P G + L L +E L+ R IA +E
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIES 116
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-------------------------- 194
+H I+RD+K NIL+D D + KL+DFGL
Sbjct: 117 VH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 195 ---------AKLGPVGD-NTHVSTRVM-----GTYGYCAPEYAMSGKLTLKSDIYSFGVV 239
+L P+ R + GT Y APE + T D +S GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 240 LLELITGRKA-MDLSKGQGEQNLVSW 264
L E++ G+ + + + + +++W
Sbjct: 234 LYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 66/281 (23%), Positives = 107/281 (38%), Gaps = 86/281 (30%)
Query: 46 NFREANLIGEGGFGKVYKG------RLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLL 98
+G G FGKV + + ++ VA+K L +E ++ E+ +LS L
Sbjct: 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 95
Query: 99 -HHDNLVTLIG-------------YCTSGDQRLLVY------------------------ 120
+H N+V L+G YC GD LL +
Sbjct: 96 GNHINIVNLLGACTVGGPTLVITEYCCYGD--LLNFLRRKRDSFICPKHEDHAEAALYKN 153
Query: 121 -------------EYMPM--------------------GSLEDHLYDLE-PDQEPLSWNT 146
EYM M GS D E +++ L+ +T
Sbjct: 154 LLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDT 213
Query: 147 R--MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204
+ + A+G+ +L A+ I+RDL + NILL + K+ DFGLA+ N
Sbjct: 214 EDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270
Query: 205 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
V + APE + T +SD++S+G++L E+ +
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRVM 211
A+G+E+L A+ I+RDL + NILL + K+ DFGLA+ D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ APE T++SD++SFGV+L E+ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 3e-06
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 53 IGEGGFGKVYKGRLESGQ-LVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIG- 108
IG G FG+V+ + + Q K +++ GL+ + + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 109 YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
+ +Q+L ++ E+ G L ++ + + + I L Y H +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 168 P----VIYRDLKSANILLD-------------NDFN----PKLSDFGLAKLGPVGDNTHV 206
P V++RDLK NI L N+ N K+ DFGL+K + H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 207 STRVMGTYGYCAPEYAMSGKLTL--KSDIYSFGVVLLELITGR 247
+GT Y +PE + + KSD+++ G ++ EL +G+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 61/252 (24%), Positives = 99/252 (39%), Gaps = 60/252 (23%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDN-- 102
F + +G G FG+V R +++ L A+K L + L +Q V+ L DN
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEY 160
+V L D V +Y+P G + L + E L+ + + AV + + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL---------AKLGPVGDNTH------ 205
+H RD+K NIL+D D + KL+DFGL +K GD+
Sbjct: 123 IH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 206 ------------------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 235
++ ++GT Y APE + T D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 236 FGVVLLELITGR 247
GV+L E++ G+
Sbjct: 234 VGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 54/243 (22%)
Query: 46 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNH-EGLQGHQEFIVEVLMLSLLHH 100
+F +IG G FG+V RL ++G + A+K L + L+ Q + L+
Sbjct: 2 DFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58
Query: 101 DNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAAR 156
D + + + D+R L+ E++P G + L D ++ + +A+ A
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA---------------KLGPVG 201
L ++H RD+K N+LLD + KLSDFGL P
Sbjct: 119 QLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 202 D------------------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 243
D ++ +GT Y APE M D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 244 ITG 246
+ G
Sbjct: 230 LIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 33/113 (29%), Positives = 61/113 (53%), Gaps = 11/113 (9%)
Query: 137 PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196
D PL + ++ + A+G+++L K I+RD+ + N+LL + K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 197 LGPVGDNTHVSTRVMGT----YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ D+ +V V G + APE T++SD++S+G++L E+ +
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
++Y+H + +I+RD+K+ N+L++ + L DFG A +T + GT
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLE 242
APE T DI+S G+V+ E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 61/252 (24%), Positives = 98/252 (38%), Gaps = 60/252 (23%)
Query: 47 FREANLIGEGGFGKV-YKGRLESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDN-- 102
F + +G G FG+V ++++ L A+K L + L +Q V+ L DN
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEY 160
+V L D V +Y+P G + L +E E L+ + + +A+ + + +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL---------AKLGPVGD--------- 202
+H RD+K NIL+D D + KL+DFGL +K G
Sbjct: 123 IH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 203 --------NTHVSTRVM-------------------GTYGYCAPEYAMSGKLTLKSDIYS 235
N R+ GT Y APE + T D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 236 FGVVLLELITGR 247
GV+L E++ G+
Sbjct: 234 VGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 25/161 (15%)
Query: 46 NFREANLIGEGGFGKV-YKGRLESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLHHDN- 102
+F +IG+G FG+V + ++G++ A+K L E + Q V+ L D+
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 103 -LVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-----AVGA 154
+V+L Y + D + L + E++P G L L + E + TR + A+ A
Sbjct: 62 WVVSL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAECVLAIEA 116
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195
L ++H RD+K NIL+D + KLSDFGL+
Sbjct: 117 VHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 48/240 (20%)
Query: 46 NFREANLIGEGGFGKV-YKGRLESGQLVAIKQLNH-EGLQGHQEFIVEVLMLSLLHHDNL 103
+F +IG G FG+V + ++G + A+K L + L+ Q + L+ D+L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 104 VTLIGYCTSGDQR--LLVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAARGLE 159
+ + + D+ L+ E++P G + L D ++E + +A+ + L
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--------------- 204
++H RD+K N+LLD+ + KLSDFGL T
Sbjct: 122 FIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 205 ------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
++ +GT Y APE M D +S GV++ E++ G
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 46 NFREANLIGEGGFGKVYK------GRLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLL 98
N + +G G FGKV + G+ ++ VA+K L +E ++ E+ +LS L
Sbjct: 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL 98
Query: 99 -HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL 132
H N+V L+G CT G L++ EY G L + L
Sbjct: 99 GQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 32/109 (29%), Positives = 57/109 (52%), Gaps = 5/109 (4%)
Query: 138 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197
+ LS+ + + A G+E+L A+ ++RDL + N+L+ K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR- 287
Query: 198 GPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ D+ ++S + APE + T SD++SFG++L E+ T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 42/236 (17%)
Query: 94 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 153
M+ + H ++V L G C + ++V E++ G L+ L+ + + L+ + K+A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LF-MHRKSDVLTTPWKFKVAKQ 113
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILL-----DNDFNP--KLSDFGLAKLGPVGDNTHV 206
A L YL K +++ ++ + NILL D + P KLSD G+ P+ V
Sbjct: 114 LASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PIT----V 162
Query: 207 STR--VMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLEL-ITGRKAM-DLSKGQGEQNL 261
+R + + APE K L++ +D +SFG L E+ G + D + + E+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY 222
Query: 262 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
K+ L+ C+NY N+ FR ++ DI
Sbjct: 223 EGQCMLVTPSCKELADLM---------THCMNYDP-------NQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 16/150 (10%)
Query: 52 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT--LIGY 109
L+ G +VY + V +K +E EV +L LL L ++
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRER--EVAILQLLARKGLPVPKVLAS 61
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
S L+ E++ G D + + E + IA A L LH +
Sbjct: 62 GESDGWSYLLMEWIE-GETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVL 110
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
+ DL NIL+D+ + D+ A GP
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 20/158 (12%)
Query: 94 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 153
++S + H +L + G C G + ++V E++ G L D E + P++W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--KITVAQQ 125
Query: 154 AARGLEYLHCKANPPVIYRDLKSANIL-----LDNDFNP--KLSDFGLAKLGPVGDNTHV 206
A L YL K +++ ++ + NIL L +P KLSD G++ + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 207 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLEL 243
R+ + APE G L+ +D +SFG LLE+
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.002
Identities = 70/263 (26%), Positives = 103/263 (39%), Gaps = 55/263 (20%)
Query: 55 EGGFGKVY--KGRLESGQLV--AIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
+G FGKV K + V IK N + E +V LM + N + L
Sbjct: 26 DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMK---DNPNFIKLYYSV 78
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
T+ +L+ +Y+ G L +DL + LS KI L LH K N +I
Sbjct: 79 TTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALNDLH-KHN--II 131
Query: 171 YRDLKSANILLDNDFNPK--LSDFGLAKLGPVGDNTHVSTRVM--GTYGYCAPE------ 220
+ D+K N+L D + L D+GL K + T GT Y +PE
Sbjct: 132 HNDIKLENVLYD-RAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYFSPEKIKGHN 182
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGR--------KAMDLSKGQGEQNLVSWSRPFLKDQ 272
Y +S D ++ GV+ EL+TG+ + +DL Q PF+K+
Sbjct: 183 YDVS------FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNV 233
Query: 273 KKFVH-LVDPLLHGRYPRRCLNY 294
K + V +L R NY
Sbjct: 234 SKNANDFVQSMLKYNINYRLTNY 256
|
Length = 267 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 30/122 (24%), Positives = 50/122 (40%), Gaps = 13/122 (10%)
Query: 141 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-----------FNPKL 189
P S +I L+Y H + + +++ DLK NIL++ P
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 190 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 249
+ LG D H T ++ T Y +PE + +D++S G ++ EL TG+
Sbjct: 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344
Query: 250 MD 251
D
Sbjct: 345 YD 346
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 360 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.62 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.5 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.83 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.51 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.45 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.44 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.2 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.09 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.05 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.05 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.05 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.91 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.85 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.83 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.82 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.57 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.5 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.44 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.4 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.39 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.23 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.15 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.96 | |
| PLN02236 | 344 | choline kinase | 96.94 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.88 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.84 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.63 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.62 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.41 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.38 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.31 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.01 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.81 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.71 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.51 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-50 Score=366.39 Aligned_cols=245 Identities=25% Similarity=0.438 Sum_probs=215.7
Q ss_pred hcccccceeccCCCeEEEEEEe-cCCCEEEEEEcccC---CccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~-~~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+|+.+++||+|||+.||.+++ ..|+.||+|++.+. .....+.+.+|+++.++++||||++++.+|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6899999999999999999988 78999999999874 3345678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|.|..++|..+++ ..+.++|.+++.+++||+.||.|||+++ |+|||||..|+|++++.+|||+|||++.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999994 4688999999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. .......+||+.|.|||++.....+..+||||+|||+|.|++|++||+.. .+.+..+
T Consensus 171 ~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------------------~vkety~ 228 (592)
T KOG0575|consen 171 D--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------------------TVKETYN 228 (592)
T ss_pred c--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------------------hHHHHHH
Confidence 3 23445689999999999999999999999999999999999999999832 2222222
Q ss_pred ccccCC--CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...... +|...+.+..+||.++|+.||.+|||+++|+.
T Consensus 229 ~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 229 KIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 222222 35678889999999999999999999999995
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=347.41 Aligned_cols=259 Identities=26% Similarity=0.353 Sum_probs=211.2
Q ss_pred HhhcccccceeccCCCeEEEEEEe-cCCCEEEEEEcccCCcc-------chHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQ-------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~-~~~~~v~vK~~~~~~~~-------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
..+.|.+.+.||+|+||.|-+|.. ++|+.||+|++.+.... ....+.+|+++|++++||||++++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 568899999999999999999965 47999999999765322 2234679999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC---CceEEee
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSD 191 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~---~~v~L~D 191 (360)
..||||||++||+|.+++- .++.+.+..-+.++.|++.||.|||++| |+||||||+|||+..+ -.+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999994 4777888899999999999999999999 9999999999999665 5699999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCC---CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL---TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
||++... .........|||+.|.|||++.+... ..+.|+||+||++|-+++|.+||...-+...
T Consensus 323 FGlAK~~---g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---------- 389 (475)
T KOG0615|consen 323 FGLAKVS---GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---------- 389 (475)
T ss_pred cchhhcc---ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------
Confidence 9999853 35556677899999999999986643 3477999999999999999999974332210
Q ss_pred hhccccchhcccccc--cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCC
Q 018128 269 LKDQKKFVHLVDPLL--HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAG 337 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~ 337 (360)
-.+++..... ....-.+.+++..+||.+||..||++||++.|+| .|||-..+.
T Consensus 390 -----l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL-----------~hpW~~~~~ 444 (475)
T KOG0615|consen 390 -----LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEAL-----------NHPWFKDAP 444 (475)
T ss_pred -----HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh-----------cChhhhccc
Confidence 0001100000 0011236788999999999999999999999999 667766444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=340.03 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=211.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC-CccchHHHHHHHHHhhccCCCcccceeEEEEeCCe-eEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-RLL 118 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~-~~l 118 (360)
+.....+.+..||+|..|+||+++++ +++-+|+|.+... +....+++.+|+++++..+||+|+++|+.|.+... ..|
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 44567888999999999999999887 5889999998544 33445789999999999999999999999999884 999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|||+++|+|++++.. .+++++..+-.++.++++||.|||+ .+ |+||||||+|||++..|.|||+|||.+..
T Consensus 156 ~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred ehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHH
Confidence 9999999999999954 4789999999999999999999996 77 99999999999999999999999999986
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.... ......||..|||||.+.+..|+.++||||||++++|+++|+.||...... ...|. ..+..
T Consensus 229 lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~----~~~~~-------~Ll~~ 293 (364)
T KOG0581|consen 229 LVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP----YLDIF-------ELLCA 293 (364)
T ss_pred hhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC----CCCHH-------HHHHH
Confidence 4333 445678999999999999999999999999999999999999999754111 11111 11111
Q ss_pred cccccccCCCChh-hHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+++.. ....|.. ++.++.+||..||+.||.+||++.|+++
T Consensus 294 Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 294 IVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 1123444 8889999999999999999999999994
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-50 Score=334.24 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=211.4
Q ss_pred HhhcccccceeccCCCeEEEEEEe-cCCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEE-E-EeCCeeE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGY-C-TSGDQRL 117 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~-~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~-~-~~~~~~~ 117 (360)
.-..|+|.+.||+|.||+||.+.. .+|..+|.|.+.... ....+.+..|+.+|++++||||++++.+ + ++...++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345799999999999999999965 479999999887543 3345678899999999999999999883 3 3444489
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
||||+|+.|+|.+.|+.+++..+.+++..+|+++.|++.||..+|++= ++-|+||||||.|||++.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999999999999999999999999999999999999831 1239999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
.+. ..........||+.||+||.+.+.+|+.+|||||+||++|||+..++||...+ ++.
T Consensus 177 ~l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------------~~~------ 235 (375)
T KOG0591|consen 177 FLS--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------------LLS------ 235 (375)
T ss_pred Hhc--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------------HHH------
Confidence 743 33334456789999999999999999999999999999999999999997431 111
Q ss_pred hcccccccCCC---C-hhhHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 018128 277 HLVDPLLHGRY---P-RRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320 (360)
Q Consensus 277 ~~~~~~~~~~~---~-~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L 320 (360)
+.....++.+ | ..++.++..+|..|+..||+.||+...++..+
T Consensus 236 -L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 236 -LCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred -HHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1111222232 3 57899999999999999999999965444433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=341.97 Aligned_cols=291 Identities=57% Similarity=0.952 Sum_probs=252.6
Q ss_pred CcccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEE
Q 018128 31 GARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110 (360)
Q Consensus 31 ~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~ 110 (360)
..+.++++++..+.++|.-...||+|+||.||.+...++..||||.+.........++.+|+.++.+++|||++++++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 67889999999999999999999999999999999998899999988765443145599999999999999999999999
Q ss_pred EeCC-eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEE
Q 018128 111 TSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 189 (360)
Q Consensus 111 ~~~~-~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L 189 (360)
.+.+ ..++|+||+++|+|.+.+...... .++|....+|+.++|.||.|||....++|+|||||+.|||+|++.+.||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999763322 8899999999999999999999987778999999999999999999999
Q ss_pred eecCCccccCCCCCcceeccc-ccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh
Q 018128 190 SDFGLAKLGPVGDNTHVSTRV-MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 190 ~Dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
+|||++...... ....... .||.+|+|||....+..+.++||||||++++||++|+.+.+......+..+..|..+.
T Consensus 219 sDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999643221 1111112 7999999999999999999999999999999999999998876656666788888887
Q ss_pred hhccccchhccccccc-CCCCh-hhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 269 LKDQKKFVHLVDPLLH-GRYPR-RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
+.+. .+.+++|+.+. ..++. .....+..+..+|++.+|.+||++.|+++.|+.+...
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 7755 88999999987 66664 5666799999999999999999999999999776544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=332.37 Aligned_cols=199 Identities=33% Similarity=0.478 Sum_probs=180.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.++|.+.+.||.|+|++||.++++ ++..||||.+.+.. ....+.+..|+++|+.++||||+.+++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468999999999999999999876 58999999998773 344566889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC------CceEEeecCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND------FNPKLSDFGL 194 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~------~~v~L~Dfg~ 194 (360)
|||+||+|.+|+++ .+.+++..++.++.||+.||++||+++ |+||||||+|||++.. ..+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999954 458999999999999999999999999 9999999999999764 4589999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 252 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~ 252 (360)
++... ........+|++.|||||++...+|+-|+|+||+|+|+|++++|..||+.
T Consensus 162 AR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 99644 55556678999999999999999999999999999999999999999973
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=336.42 Aligned_cols=269 Identities=35% Similarity=0.519 Sum_probs=223.0
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEEeCC-
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGD- 114 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~- 114 (360)
..+.+......+.+.||.|+||+||.+.+.....|++|++....... .+.+.+|+.++..++||||+++++++....
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45666667777888899999999999999844449999998765433 458999999999999999999999998887
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeecC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFG 193 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg 193 (360)
..++||||+++|+|.+++... ....++...++.++.||+.|+.|||+++. |+|+||||+|||++.++ ++||+|||
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCc
Confidence 799999999999999999763 46889999999999999999999998853 89999999999999997 99999999
Q ss_pred CccccCCCCCcceecccccccccccccccc--cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
+++...... .......||..|||||++. ...++.++||||||+++|||+||..||.....
T Consensus 190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---------------- 251 (362)
T KOG0192|consen 190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---------------- 251 (362)
T ss_pred cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----------------
Confidence 998533222 2233367999999999999 66999999999999999999999999974331
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
............+...+..++..+..++.+||+.||..||++.+++..|+.+.....
T Consensus 252 ~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 252 VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 111112222233334455688899999999999999999999999999999977444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=327.34 Aligned_cols=250 Identities=28% Similarity=0.378 Sum_probs=209.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
+....|++.++||+|+||+||+++.+ +++-||+|++.+.... +.+....|..+|..++||.|++++..|.+.+.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44678999999999999999999765 6999999999876443 3467888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|++|+.||.|.-.++ +.+.+++..++.++..|+.||.|||+++ |+||||||+|||++.+|.++|+|||++..
T Consensus 102 lVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 9999999999999994 5788999999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.. .........+||+.|||||++.+..++..+|.||||+++|+|++|.+||...+. ..+......
T Consensus 175 ~~--~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~------- 239 (357)
T KOG0598|consen 175 DL--KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILK------- 239 (357)
T ss_pred cc--cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhc-------
Confidence 22 222334447899999999999999999999999999999999999999974331 111111111
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCC----CHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP----LINDIV 317 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----t~~eil 317 (360)
. .....+.-.+.+.+++++++|+.||++|. ++.+|.
T Consensus 240 ---~-k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 240 ---G-KLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred ---C-cCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 0 01123344788899999999999999995 455543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.75 Aligned_cols=272 Identities=30% Similarity=0.464 Sum_probs=234.9
Q ss_pred CCcccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEE
Q 018128 30 SGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109 (360)
Q Consensus 30 ~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~ 109 (360)
+....+....+++....++.++.||+|-||.||++..+....|++|.+... ....+.+.+|+.+++.++|++|++++++
T Consensus 191 p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 191 PQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred CCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEE
Confidence 333444477888889999999999999999999999997779999988655 3445778899999999999999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEE
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 189 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L 189 (360)
+..+..++|||||+..|+|.+|+.. ..+..+.....+.++.||++|++||++++ +|||||...||||++++.|||
T Consensus 270 ~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKI 344 (468)
T KOG0197|consen 270 CTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKI 344 (468)
T ss_pred EecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEE
Confidence 9998899999999999999999976 45788999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhh
Q 018128 190 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 190 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
+|||+++. ...+..........+..|.|||.+....++.+|||||||++||||+| |+.||....
T Consensus 345 sDFGLAr~-~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------------- 409 (468)
T KOG0197|consen 345 SDFGLARL-IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------------- 409 (468)
T ss_pred cccccccc-cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------------
Confidence 99999993 23333334444556778999999999999999999999999999999 788876332
Q ss_pred hhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
..+..+.+....+...|..+++++.+++..||+.+|++|||+..+...|+.+-.
T Consensus 410 ---n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 410 ---NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ---HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 334445555566667788999999999999999999999999999999998854
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=306.44 Aligned_cols=271 Identities=27% Similarity=0.345 Sum_probs=222.7
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe-----
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----- 112 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~----- 112 (360)
++.++.+||++.+.||.|||+-||+++.- ++..||+|++.....++.+...+|++..+.++|||+++++++...
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 45678899999999999999999999854 689999999988888888999999999999999999999876533
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....|++++|...|+|.+.++.+...+..+++.++++|+.+|+.||++||.. .+++.|+||||.||++++.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 3348999999999999999999888888999999999999999999999988 467999999999999999999999999
Q ss_pred CCccccCCCCCcce-------ecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh
Q 018128 193 GLAKLGPVGDNTHV-------STRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262 (360)
Q Consensus 193 g~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 262 (360)
|.+......-.... ......+..|+|||.+. +...+.++|||||||++|.|+.|..||+..-..+
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G----- 248 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG----- 248 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-----
Confidence 99975322211111 12345788899999886 5678899999999999999999999997432211
Q ss_pred ccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
....-.+.+..+..+-...++..+.++|+.||+.||.+||++.+++..++.++
T Consensus 249 ---------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 ---------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111111212222223458899999999999999999999999999998875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=333.81 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=211.8
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhcc-CCCcccceeEEEEeCCee
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~ 116 (360)
..-.+|..++.||.|+|++|++|+.. +++.||+|++.+.-.- ...-+..|-.+|.+| .||+|++++..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34568999999999999999999765 6999999998765332 233466788888888 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
|+|+||+++|+|.++|.. -+.+++.-.+.++.+|+.||.|||++| ||||||||+|||++.+++++|+|||.+.
T Consensus 150 YFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999954 578999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCc---------ce--ecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccc
Q 018128 197 LGPVGDNT---------HV--STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 197 ~~~~~~~~---------~~--~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 265 (360)
........ .. .....||..|.+||++.....++.+|||+||||+|+|+.|.+||...+.-
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--------- 293 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--------- 293 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---------
Confidence 65443322 11 13467999999999999999999999999999999999999999744321
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....+++. +.-.++..++....+||.++|..||.+|+|+++|.+
T Consensus 294 -------liFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 294 -------LIFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred -------HHHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11111111 111457788899999999999999999999999876
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=328.99 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=215.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC----Cc-cchHHHHHHHHHhhccC-CCcccceeEEEEeC
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE----GL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSG 113 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~----~~-~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~ 113 (360)
....++|++++.||.|.||+|+.+.+. ++..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 455789999999999999999999765 6899999977664 22 23456778999999998 99999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-CceEEeec
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDF 192 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-~~v~L~Df 192 (360)
...++||||+.+|+|.+++.+ .+++.+..+..+|+|++.||.|+|++| |+||||||+|||++.+ +++||+||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 999999999999999999953 578999999999999999999999999 9999999999999999 99999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCC-CC-cchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s-~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
|++.... .........+|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||+.... ......
T Consensus 166 G~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k--- 234 (370)
T KOG0583|consen 166 GLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK--- 234 (370)
T ss_pred ccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH---
Confidence 9998643 3444556688999999999999877 76 899999999999999999999984221 111111
Q ss_pred ccccchhcccccccCCCChhh-HHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 271 DQKKFVHLVDPLLHGRYPRRC-LNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
+..... .+|..+ +.++..+|.+||..||.+|+++.+++ .-..++.
T Consensus 235 -------i~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 235 -------IRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred -------HhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 111001 234445 88899999999999999999999999 7777766
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=320.70 Aligned_cols=255 Identities=29% Similarity=0.428 Sum_probs=206.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC--eeEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLVY 120 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~--~~~lv~ 120 (360)
..+|+.++.||+|+||+||++... +|...++|.+........+.+.+|+.+|++++||||+++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 567899999999999999999876 48999999987664444677899999999999999999999754444 689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-CCceEEeecCCccccC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGP 199 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-~~~v~L~Dfg~~~~~~ 199 (360)
||+.+|+|.+++.++. .++++..++.+.+||++||.|||++| ++||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999997633 37999999999999999999999999 999999999999999 7999999999987644
Q ss_pred C-CCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 200 V-GDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 200 ~-~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
. ...........||+.|+|||++.++ ....++|||||||++.||+||.+||.... .... ....
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~----------~~~~ 234 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAE----------ALLL 234 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHH----------HHHH
Confidence 3 1222333457799999999999853 34469999999999999999999997320 0000 0001
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
+........+|...+.+..+|+.+|++.||++|||+.++|+-
T Consensus 235 ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 235 IGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 110111114567788999999999999999999999999963
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=307.13 Aligned_cols=264 Identities=25% Similarity=0.338 Sum_probs=206.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.+|+.+..+|.|+||+||.++++ +|+-||||++-... ....+-..+|+++|++++|||++.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 36889999999999999999987 59999999885432 2233457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
||+. ++.+-++. ....++...+.+++.|++.|+.|+|+++ ++||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9977 66666655 4467999999999999999999999999 99999999999999999999999999986442
Q ss_pred CCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc--------cchhhhhc-
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS--------WSRPFLKD- 271 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--------~~~~~~~~- 271 (360)
.....+....|.+|+|||.+.+ -+|....|||++||++.||++|.+.|....+-+...... .-...+..
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 4555566778899999999987 689999999999999999999999886444321111000 00001110
Q ss_pred ----cccchhcccc-cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 ----QKKFVHLVDP-LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ----~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...+.+.-+. .+...+ +..+.-+.++++.||+.||.+|++-++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111000 111112 345568999999999999999999999986
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=341.94 Aligned_cols=278 Identities=24% Similarity=0.280 Sum_probs=226.1
Q ss_pred cccHHHHHHHhhcccccceeccCCCeEEEEEEecCC-CEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEE-E
Q 018128 34 SFTFRELAIATRNFREANLIGEGGFGKVYKGRLESG-QLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGY-C 110 (360)
Q Consensus 34 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~-~ 110 (360)
.+--..+.|...+++|.+.|.+|||+.||+|.+..+ ..||+|++-..+....+.+++|+.+++.|. |+||+.+++. .
T Consensus 26 ~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 26 YFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred CCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 344456677788999999999999999999987755 999999988777777789999999999996 9999999983 2
Q ss_pred E---e---CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 111 T---S---GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 111 ~---~---~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
. . .-.++|.||||.+|.|.+++..+... +|++.++++|+.++++|+.+||.. .+||+|||||-+|||++.+
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~ 182 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSAD 182 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCC
Confidence 1 1 12457999999999999999876533 399999999999999999999999 6889999999999999999
Q ss_pred CceEEeecCCccccCCCC-Cccee------cccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccC
Q 018128 185 FNPKLSDFGLAKLGPVGD-NTHVS------TRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSK 254 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~-~~~~~------~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~ 254 (360)
|..||||||.+.-.-... ..... -....|+.|+|||.+. +.+.++|+|||+|||+||-|+...+||+...
T Consensus 183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 999999999986322211 11000 1235789999999764 7889999999999999999999999998432
Q ss_pred ccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCC
Q 018128 255 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSR 334 (360)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~ 334 (360)
...+++........+.+++.+.+||+.||+.||++||++.++++.+-.|......-+-..
T Consensus 263 --------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 263 --------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred --------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 222333333333346899999999999999999999999999999999987666555333
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=333.18 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=216.3
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-c--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-L--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
+-|++++.||.|+.|.|-+|++. +|+.+|||++.+.. . .....+.+|+-+|+.++||||+++++++++...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56899999999999999999875 69999999997762 1 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++|.|++++. ..+++++.++..+++||+.|+.|+|..+ |+|+|+||+|+|++..+++||+|||.+..
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsL--- 161 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASL--- 161 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeec---
Confidence 9999999999994 5788999999999999999999999999 99999999999999999999999999974
Q ss_pred CCCcceecccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s-~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
......-...||.+.|.+||++++.+|. .++||||.|+|||.|++|..||+ ...+..++
T Consensus 162 e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--------------------DdNir~LL 221 (786)
T KOG0588|consen 162 EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--------------------DDNIRVLL 221 (786)
T ss_pred ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--------------------CccHHHHH
Confidence 3445556668899999999999999986 89999999999999999999998 33344444
Q ss_pred cccccCC--CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....++. +|...+.+..+||.+||..||.+|.|++||++
T Consensus 222 lKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 222 LKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 4455554 47788999999999999999999999999994
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=326.26 Aligned_cols=268 Identities=26% Similarity=0.389 Sum_probs=208.8
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCT 111 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~ 111 (360)
+.+..++|++.+.||.|+||.||.+.+. .++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 4567889999999999999999999641 356799999865432 2345688999999999 8999999999876
Q ss_pred eC-CeeEEEEEecCCCCHHHHhcccCCC----------------------------------------------------
Q 018128 112 SG-DQRLLVYEYMPMGSLEDHLYDLEPD---------------------------------------------------- 138 (360)
Q Consensus 112 ~~-~~~~lv~e~~~~~sL~~~i~~~~~~---------------------------------------------------- 138 (360)
.. ...+++|||+++|+|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4578999999999999998653210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceeccccc
Q 018128 139 ------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212 (360)
Q Consensus 139 ------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~ 212 (360)
...+++..+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++................+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 234778899999999999999999998 99999999999999999999999999875332222222223345
Q ss_pred ccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhh
Q 018128 213 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRC 291 (360)
Q Consensus 213 ~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (360)
+..|+|||.+.+..++.++||||||+++|+|++ |..||........ ... ... .......+...
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~-~~~----------~~~~~~~~~~~ 302 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQ-RLK----------DGTRMRAPENA 302 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHH-HHh----------cCCCCCCCCCC
Confidence 678999999998899999999999999999997 9999964321100 000 000 00011224456
Q ss_pred HHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 292 LNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 292 ~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 77899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=324.21 Aligned_cols=268 Identities=24% Similarity=0.310 Sum_probs=208.9
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc-hHHHHHHHHHhhccC-CCcccceeEEEEeCC-ee
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLH-HDNLVTLIGYCTSGD-QR 116 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~-~~ 116 (360)
...-.||++.+.||.|.||.||+|+.. ++..||||.+...-... ...-.+|++.|++++ ||||+++++++.+.+ .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 345689999999999999999999865 69999999987653332 234567999999998 999999999998877 89
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+ .++|.+++.. +++.+++..++.|+.||++||+++|.+| +.|||+||+|||+.....|||+|||+|+
T Consensus 86 ~fVfE~M-d~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeeHHhh-hhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccc
Confidence 9999999 5599999977 4788999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc----------chhccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ----------NLVSWS 265 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~----------~~~~~~ 265 (360)
.... ....+....|.+|+|||++. ..-|+.+.|+|++|||++|+.+.++.|.+....+.. ....|.
T Consensus 159 ev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 159 EVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 5433 23344567889999999876 677999999999999999999999888654432111 111111
Q ss_pred hhhhh---ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 266 RPFLK---DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 266 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
..+.- ..-.+.+.....+.. .-+..+.+..++|.+|+.+||.+|||+.++++.
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~-L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKD-LLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHH-hCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 10000 000011111111111 123478899999999999999999999999963
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=326.62 Aligned_cols=293 Identities=29% Similarity=0.455 Sum_probs=232.7
Q ss_pred CCCCCCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCc
Q 018128 25 GGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDN 102 (360)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~ 102 (360)
.........+.+-.+|++......+++.||+|.||+||.+++- | .||||++...... ..+.|++|+.+|++-+|.|
T Consensus 372 ~~~~~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~N 449 (678)
T KOG0193|consen 372 KISGKNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHEN 449 (678)
T ss_pred ccccccccCCccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhh
Confidence 3334455556666999999999999999999999999999876 2 3899998766543 4578999999999999999
Q ss_pred ccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe
Q 018128 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 182 (360)
Q Consensus 103 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~ 182 (360)
|+-+.+++..... .||..+|+|.+|..+++. ...++.....++|++|+++|+.|||.++ |+|+|||.+|||+.
T Consensus 450 IlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~ 522 (678)
T KOG0193|consen 450 ILLFMGACMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLH 522 (678)
T ss_pred heeeehhhcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEc
Confidence 9999999987776 999999999999999976 4477999999999999999999999999 99999999999999
Q ss_pred CCCceEEeecCCccccCCCCCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc
Q 018128 183 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259 (360)
Q Consensus 183 ~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~ 259 (360)
++++|+|+|||++.....-..........+...|+|||++. ..+|++.+||||||+++|||++|..||.... .++
T Consensus 523 ~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dq 600 (678)
T KOG0193|consen 523 EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQ 600 (678)
T ss_pred cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhh
Confidence 99999999999998544333333344456888999999986 4579999999999999999999999997211 111
Q ss_pred chhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCCCC
Q 018128 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGAR 339 (360)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~~~ 339 (360)
.+....+.++.. +. ......++.++.+|+..||..++++||.+.+|+..|+.+... .++..+.++.+
T Consensus 601 IifmVGrG~l~p--d~---------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~--~pki~RS~S~P 667 (678)
T KOG0193|consen 601 IIFMVGRGYLMP--DL---------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS--LPKINRSASEP 667 (678)
T ss_pred eEEEecccccCc--cc---------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc--ccccccCcCcc
Confidence 111111111110 00 012346788999999999999999999999999999988764 44445544444
Q ss_pred CC
Q 018128 340 GV 341 (360)
Q Consensus 340 ~~ 341 (360)
..
T Consensus 668 ~~ 669 (678)
T KOG0193|consen 668 VL 669 (678)
T ss_pred ch
Confidence 33
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=311.57 Aligned_cols=268 Identities=27% Similarity=0.358 Sum_probs=214.5
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc-hHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
..+-...+.|++.+.||.|..++||+|+.. .+..|+||++..+.... ...+.+|+..++.++||||+..+..|..++.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 445567899999999999999999999765 58999999998775444 4789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
+++||+++.+|++.+.+..+...+ +++..+..++++++.||.|||++| .+|||||+.|||++.+|.|+|+|||.+
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceee
Confidence 999999999999999998866444 999999999999999999999999 999999999999999999999999977
Q ss_pred cccCCCCC-ccee-cccccccccccccccc--cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 196 KLGPVGDN-THVS-TRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 196 ~~~~~~~~-~~~~-~~~~~~~~y~aPE~~~--~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
........ .... ....++++|+|||+++ ...|+.|+||||||++.+||.+|+.||......... ....
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tL--- 245 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTL--- 245 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHh---
Confidence 54333221 1112 5567999999999955 346999999999999999999999999744322100 0000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...................+...++++|..||+.||++|||++++++
T Consensus 246 qn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 246 QNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000000111111223355668999999999999999999999986
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=320.92 Aligned_cols=248 Identities=29% Similarity=0.365 Sum_probs=216.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEEeCCe-eEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-RLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~-~~lv~ 120 (360)
++|..++++|+|+||.+++++++ +++.+++|.+....... .....+|+.+++++.||||+.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 68999999999999999999877 58899999987765433 3467889999999999999999999988888 99999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
+||+||+|.+.+.. .++..++++.++.|+.|++.|+.|||+++ |+|||||+.|||++.++.|+|+|||++...+.
T Consensus 84 ~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999977 34678999999999999999999999998 99999999999999999999999999997544
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.. .......||+.|+.||++.+.+|+.++|||||||++|||++-+++|...+ +..++.
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------------------m~~Li~ 216 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------------------MSELIL 216 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------------------hHHHHH
Confidence 33 24455789999999999999999999999999999999999999997333 222222
Q ss_pred ccc---cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 281 PLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 281 ~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
... ....+..++.++..+|..||..+|+.||++.++|..
T Consensus 217 ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 217 KINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222 234677899999999999999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=297.86 Aligned_cols=237 Identities=27% Similarity=0.372 Sum_probs=206.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
-++|++.+.||.|+||.|.+++.+ +|..||+|++.+.... +.+...+|..+|+.+.||++++++..+.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357999999999999999999877 5899999999877543 445678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||.+||.|..+++ +-+++++..++.++.||+.||.|||+++ |++||+||+|||+|.+|.+||+|||.+....
T Consensus 123 meyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999994 4678999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
. ..-..|||+.|+|||++...+++.+.|-|+||+++|||+.|.+||...+. ....++++
T Consensus 196 ~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----------------~~iY~KI~ 254 (355)
T KOG0616|consen 196 G-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----------------IQIYEKIL 254 (355)
T ss_pred C-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----------------HHHHHHHH
Confidence 2 14457899999999999999999999999999999999999999974442 11222222
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCC
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 310 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 310 (360)
...+ .+|.-++.++.+|+.++|+.|-.+|
T Consensus 255 ~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 255 EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2222 4678889999999999999999998
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=312.03 Aligned_cols=245 Identities=27% Similarity=0.385 Sum_probs=210.3
Q ss_pred hhcccccceeccCCCeEEEEEEe-cCCCEEEEEEcccCCccchH---HHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQ---EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~---~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
..+|++.+.||+|.||.|-++.. ..|+.||||.+.+....+.+ .+.+|++++..++||||+.+|++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 57999999999999999999964 68999999999887666554 588999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||..+|.|.+|+ ...+.+++.+.+.+|+||..|+.|+|.++ ++|+|||.+|||+|.++++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999 45778999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcceecccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s-~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.. +.....||.+.|.+||++.+.+|. +..|-||||+++|.|+.|..||+..+. ..+
T Consensus 205 ~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------------------k~l 261 (668)
T KOG0611|consen 205 DK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------------------KRL 261 (668)
T ss_pred cc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------------------HHH
Confidence 33 334557899999999999999885 899999999999999999999984331 111
Q ss_pred ccccccCCC-ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+...-++.| .+.-+.+..-||+.||..||++|.|+++|..
T Consensus 262 vrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 262 VRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 111112221 2344556777999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=321.53 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=212.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
..|+..+.+|+|+.|.||.+... .++.||+|.+........+-+.+|+.+++..+|+||+.+++.|...+.+++||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 57999999999999999999654 68999999999988888889999999999999999999999998889999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
+||+|.+.+.. -.+++.++..++..+++||+|||.++ |+|+|||.+|||++.+|.|||+|||+|..+.....
T Consensus 353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999954 44999999999999999999999999 99999999999999999999999999986443332
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
......||+.|||||+.....|.++.||||||+|++||+-|.+||-... .+... ++ +.. +...
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrAl---yL-----Ia~--ng~P 487 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRAL---YL-----IAT--NGTP 487 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHHH---HH-----Hhh--cCCC
Confidence 4455779999999999999999999999999999999999999995211 11110 00 000 0111
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....+...+..|.+|+.+||+.|+++||++.|+|+
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11346678899999999999999999999999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=316.16 Aligned_cols=254 Identities=23% Similarity=0.293 Sum_probs=206.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.+..+.|++++.||+|+||.||+|+-+ +|..+|+|++.+... .+.+.++.|-.+|....+|.|++++..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 446689999999999999999999755 699999999987643 4456688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
|+||||++||++..++ .....+++..++.++.+++.||..+|+.| ++|+||||+|+|||..|.+||+|||++.
T Consensus 217 YLiMEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999 45788999999999999999999999999 9999999999999999999999999986
Q ss_pred ccCCCC----------------------Ccc----ee-------------------cccccccccccccccccCCCCcch
Q 018128 197 LGPVGD----------------------NTH----VS-------------------TRVMGTYGYCAPEYAMSGKLTLKS 231 (360)
Q Consensus 197 ~~~~~~----------------------~~~----~~-------------------~~~~~~~~y~aPE~~~~~~~s~~s 231 (360)
-..... ... .. ....||+.|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 321100 000 00 113599999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCcccccCccC-ccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCC
Q 018128 232 DIYSFGVVLLELITGRKAMDLSKGQG-EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 310 (360)
Q Consensus 232 DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 310 (360)
|.||||||+|||+.|.+||....... ...+..|...+. -+-....+.+..+||.+||. ||++|
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---------------fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---------------FPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---------------CCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 99999999999999999997544322 122222221111 11122455889999999999 99999
Q ss_pred CC---HHHHH
Q 018128 311 PL---INDIV 317 (360)
Q Consensus 311 pt---~~eil 317 (360)
.- ++||.
T Consensus 434 LG~~G~~EIK 443 (550)
T KOG0605|consen 434 LGSKGAEEIK 443 (550)
T ss_pred cCcccHHHHh
Confidence 65 55555
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=286.81 Aligned_cols=263 Identities=25% Similarity=0.340 Sum_probs=207.5
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.+|...+.||+|.||.||+|++. +|+.||+|.+......+ .....+|++.|+.++||||+.+.++|.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 58999999999999999999754 79999999987664432 3457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|++. +|...++. +...+....++.++.+++.||+|||.+. |+||||||+|+|++.+|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9955 99999976 6678999999999999999999999998 999999999999999999999999999976554
Q ss_pred CCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccC-------------ccchhccchh
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQG-------------EQNLVSWSRP 267 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~-------------~~~~~~~~~~ 267 (360)
..... ....|.+|+|||++.+. .|+...|+||.|||+.||+.+.+-|....+-+ +.++.++.
T Consensus 155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~-- 230 (318)
T KOG0659|consen 155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT-- 230 (318)
T ss_pred Ccccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc--
Confidence 43333 23678899999998864 69999999999999999999887665333211 11111110
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
.+.+...+.....+.... .-+..+.+..+|+.+|+..||.+|++++|+++.
T Consensus 231 ~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 001111111112222222 223556677999999999999999999999953
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=314.32 Aligned_cols=245 Identities=26% Similarity=0.355 Sum_probs=202.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
-++|++.+.||.|++|.||++++. +++.|++|++.... ......+.+|+.+++.++||||+++++.+.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999876 58999999986542 23345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++....
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999853 467899999999999999999999999 9999999999999999999999999987542
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. .....++..|+|||++.+..++.++|||||||++|+|++|..||...... .. ...+.
T Consensus 170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~----------~~~i~ 228 (329)
T PTZ00263 170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RI----------YEKIL 228 (329)
T ss_pred CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HH----------HHHHh
Confidence 21 12346889999999999988999999999999999999999999632210 00 00111
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
.. ...++..++..+.++|.+||+.||.+||+ +.+++.
T Consensus 229 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 229 AG--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred cC--CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 11233446677899999999999999997 677774
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=312.18 Aligned_cols=244 Identities=27% Similarity=0.326 Sum_probs=202.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|+||.||++... +++.|++|++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999876 689999999865422 23456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999954 457899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. .....++..|+|||++.+..++.++|||||||++|+|++|..||....... ...... .
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~----------~ 212 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKIL----------A 212 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH----------h
Confidence 1 123458899999999998889999999999999999999999996432110 000000 0
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
. ...++...+..+.++|.+||+.||.+||+ ++++++
T Consensus 213 ~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 213 G--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred C--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 0 11234456778999999999999999995 888873
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=304.75 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=214.1
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
....+|++.+.||.|++|.||.+....++.+++|.+..........+..|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 45678999999999999999999988789999999887766566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++... .+..+++..++.++.|++.||.+||+++ ++|+||+|+||++++++.++|+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999652 3456899999999999999999999998 999999999999999999999999998754221
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . .....
T Consensus 158 --~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~-------------~~~~~- 218 (261)
T cd05148 158 --VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---V-------------YDQIT- 218 (261)
T ss_pred --cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---H-------------HHHHH-
Confidence 111223345678999999988889999999999999999998 899996432110 0 00000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
.......+..++..+.++|.+||+.||.+|||+.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1111223456778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=311.48 Aligned_cols=266 Identities=25% Similarity=0.338 Sum_probs=206.8
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeC--CeeE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRL 117 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~~~ 117 (360)
-...|+.++.||+|+||.||+|++. +|+.||+|.+.... ........+|+.+|++++||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3467999999999999999999754 79999999987664 33345677899999999999999999998776 6899
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|+||+++ +|.-++.. .+-.|++.+++.++.||+.||.|+|+++ |+|||||..|||+|++|.+||+|||+++.
T Consensus 195 lVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence 99999977 89888854 4568999999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hcc----chhhhhc
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSW----SRPFLKD 271 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~----~~~~~~~ 271 (360)
+....... .+....|.+|+|||++.+. .|+.+.|+||.||||.||++|++.|........... ... ...++.
T Consensus 268 y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~- 345 (560)
T KOG0600|consen 268 YTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP- 345 (560)
T ss_pred ccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-
Confidence 65544332 4556789999999999865 699999999999999999999998864432111000 000 000111
Q ss_pred cccch--hccc------ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFV--HLVD------PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~--~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...+. .... ..+.. .-..++....+|+..||..||.+|.|+.++|+
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00000 0000 00000 01345677889999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=317.80 Aligned_cols=244 Identities=31% Similarity=0.434 Sum_probs=212.3
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.+|-+.+.||+|.||.||+++.+ +.+.||+|.+.+.... +...+.+|+++++.++||||+.++++|++..+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47899999999999999999876 5889999998776443 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+.| +|..++. ..+.++++.+..++.+++.||.|||+++ |.|+|+||+|||+..+|.+|++|||+++. ..
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~--m~ 151 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARA--MS 151 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhh--cc
Confidence 9966 9999994 5789999999999999999999999999 99999999999999999999999999986 34
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
..........||+.|||||++.+.+|+..+|+||+|||+||++.|++||-. ..+-+++..
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a--------------------~si~~Lv~~ 211 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA--------------------RSITQLVKS 211 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------------------HHHHHHHHH
Confidence 455666778899999999999999999999999999999999999999952 111112211
Q ss_pred cccC--CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHG--RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+.. ..|...+..+.+++...|..||..|.+..+++.
T Consensus 212 I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 212 ILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2221 235688899999999999999999999999886
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=306.92 Aligned_cols=268 Identities=29% Similarity=0.379 Sum_probs=214.4
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--------------cchHHHHHHHHHhhccCCCc
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--------------QGHQEFIVEVLMLSLLHHDN 102 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--------------~~~~~~~~e~~~l~~l~~p~ 102 (360)
.+..+.-++|++.+.||+|.||.|-+|++. +++.||+|++.+... ...+.+.+|+.+++++.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 444556689999999999999999999876 699999999876422 12357899999999999999
Q ss_pred ccceeEEEEe--CCeeEEEEEecCCCCHHHHhcccCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 018128 103 LVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 179 (360)
Q Consensus 103 i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~i~~~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NI 179 (360)
|++++++..+ .+.+|||+|||..|.+...- .... +.+.++++++++++.||.|||.+| |+||||||.|+
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNL 241 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNL 241 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhhe
Confidence 9999999865 56799999999888764332 3344 999999999999999999999999 99999999999
Q ss_pred EEeCCCceEEeecCCccccCCC---CCcceecccccccccccccccccCC----CCcchhhHHHHHHHHHHHhCCCcccc
Q 018128 180 LLDNDFNPKLSDFGLAKLGPVG---DNTHVSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAMDL 252 (360)
Q Consensus 180 lv~~~~~v~L~Dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~----~s~~sDiwslG~il~~ll~g~~pf~~ 252 (360)
|++++|.|||+|||.+...... +.........||+.|+|||...++. .+.+.||||+|++||.|+.|..||..
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 9999999999999998764222 2222233467999999999887632 35789999999999999999999963
Q ss_pred cCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCC
Q 018128 253 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 332 (360)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~ 332 (360)
... .....++++..+.....+.....+.+||.+||..||+.|.++.+|. .|||
T Consensus 322 ~~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik-----------~Hpw 374 (576)
T KOG0585|consen 322 DFE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIK-----------LHPW 374 (576)
T ss_pred chH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhe-----------ecce
Confidence 221 2223344444444444456788899999999999999999999987 6777
Q ss_pred CCCCCCCC
Q 018128 333 SRNAGARG 340 (360)
Q Consensus 333 ~~~~~~~~ 340 (360)
....+...
T Consensus 375 vt~~g~~~ 382 (576)
T KOG0585|consen 375 VTRDGDSP 382 (576)
T ss_pred eccCCCCC
Confidence 77554443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=308.78 Aligned_cols=266 Identities=26% Similarity=0.420 Sum_probs=204.7
Q ss_pred HhhcccccceeccCCCeEEEEEEecC-----------------CCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCccc
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLES-----------------GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLV 104 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~~-----------------~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~ 104 (360)
..++|++.+.||+|+||.||++.+++ +..|++|.+...... ....+.+|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 46799999999999999999997532 346999988754322 345688999999999999999
Q ss_pred ceeEEEEeCCeeEEEEEecCCCCHHHHhcccCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 018128 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169 (360)
Q Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~---------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 169 (360)
++++++.+.+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ +
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 999999999999999999999999999855221 1234778899999999999999999999 9
Q ss_pred eeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CC
Q 018128 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GR 247 (360)
Q Consensus 170 ~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~--g~ 247 (360)
+|+||||+|||++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999875433333223333445778999999988889999999999999999987 45
Q ss_pred CcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 248 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 248 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
.||....... ............ ........+..++..+.+++.+||+.||.+|||+.+|.+.|+
T Consensus 240 ~p~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQ---VIENAGEFFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHH---HHHHHHHHhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6765322111 111110111000 000111123456778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=317.77 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=208.2
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEe------cCCCEEEEEEcccCC-ccchHHHHHHHHHhhcc-CCCcccceeEEE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYC 110 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~ 110 (360)
.+.+..++|++.+.||+|+||.||.+.. ..+..|++|++.... ......+.+|+.+++.+ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3455677899999999999999999863 236689999986443 23345688899999999 899999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCC-----------------------------------------------------
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEP----------------------------------------------------- 137 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~----------------------------------------------------- 137 (360)
.+.+..++||||+++|+|.+++.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999999865221
Q ss_pred ------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 138 ------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 138 ------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
....+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 1225788899999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ....
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~----~~~~-------- 331 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY----KMIK-------- 331 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH----HHHH--------
Confidence 3222222222334567999999999999999999999999999998 888886322110 000 0000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
.......+...+.++.++|.+||+.||++||++.++++.|++.
T Consensus 332 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 --EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111112334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.58 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=210.1
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+..++|++.+.||.|++|.||++...++..+++|.+.... ...+.+.+|+.+++.++||||+++++.+.+.+..+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 45678999999999999999999998778889999876543 33567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 81 EYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred ecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999652 3456888999999999999999999998 99999999999999999999999999976432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ...
T Consensus 156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~---~~~---------- 218 (261)
T cd05072 156 NEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMS---ALQ---------- 218 (261)
T ss_pred Cce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHH---HHH----------
Confidence 211 11122335667999999988889999999999999999998 999986322110 000 000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
..........++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 219 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 219 -RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011112234667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.68 Aligned_cols=255 Identities=22% Similarity=0.233 Sum_probs=209.1
Q ss_pred hhcccccceeccCCCeEEEEEEec-C-CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-S-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
...|.+.+.||+|++|.||.+... + ++.+++|.+..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 445999999999999999999754 3 67888898766555555678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999988765445667899999999999999999999998 999999999999999999999999999865433
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
..........|+..|+|||++.+..++.++|||||||++|+|++|..||...... ... ..+...
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~----------~~~~~~ 286 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIM----------QQVLYG 286 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHH----------HHHHhC
Confidence 3323334456899999999999999999999999999999999999999632210 000 000000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++.++.++|.+||+.||.+||++.+++.
T Consensus 287 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 -KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 001224456778999999999999999999999875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.81 Aligned_cols=259 Identities=30% Similarity=0.456 Sum_probs=208.4
Q ss_pred hhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.++|.+.+.||+|++|.||++... .++.+++|.+...... ....+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 567999999999999999999753 2578999998765433 346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 117 LLVYEYMPMGSLEDHLYDLE----------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~----------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
+++|||+++++|.+++.... .....+++..+..++.|++.||.+||+++ ++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999996532 22345889999999999999999999998 999999999999999999
Q ss_pred eEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccc
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 265 (360)
++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~-- 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IE-- 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HH--
Confidence 99999999864322222222233345678999999999999999999999999999998 9999863322110 00
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
.+. .......+...+..+.+++.+||+.||.+||++.|+++.|++
T Consensus 236 -----------~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 -----------CIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----------HHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 000 011112234567889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=313.03 Aligned_cols=241 Identities=29% Similarity=0.348 Sum_probs=197.8
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
+.||+|+||.||+++.. +++.|++|++..... .....+.+|+.+++.++||||+++++.+.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999865 689999999875422 23356778999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcce
Q 018128 127 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 206 (360)
Q Consensus 127 sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~ 206 (360)
+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..... ....
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCc
Confidence 99998843 567899999999999999999999999 99999999999999999999999999864211 1122
Q ss_pred ecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCC
Q 018128 207 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 286 (360)
Q Consensus 207 ~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (360)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+.. ....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~----------~~~~~--~~~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LF----------ELILM--EEIR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HH----------HHHHc--CCCC
Confidence 233568999999999999999999999999999999999999996322110 00 00000 0113
Q ss_pred CChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 287 YPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 287 ~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
++..++.++.++|.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4556778899999999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=299.17 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=209.4
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++..++|++.+.||.|++|.||++....++.|++|.+.... ...+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 45667899999999999999999987777889999986543 34567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++... .+..+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 81 ELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred ecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999999652 2456899999999999999999999998 99999999999999999999999999876442
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. .. +
T Consensus 156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-------------~~-~ 217 (261)
T cd05068 156 DIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VL-------------QQ-V 217 (261)
T ss_pred Cccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH-------------HH-H
Confidence 2111 1111223457999999988889999999999999999999 999986322100 00 00 0
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 218 DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00111123345678899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=303.13 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=202.7
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.|++.+.||+|+||.||++... +++.||+|.+...... ....+.+|+.+++.++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4889999999999999999764 6999999988654322 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999888542 2346899999999999999999999999 999999999999999999999999998753221
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. ......++..|+|||++.+..++.++|||||||++|+|++|..||.......... .. ...+ .
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~------~~-------~~~~-~ 218 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE------EV-------DRRV-K 218 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH------HH-------HHHh-h
Confidence 1 2233468999999999999999999999999999999999999997433211000 00 0000 0
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
.....++..++.++.+||.+||+.||.+||+ +.++++
T Consensus 219 ~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111234567788999999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=303.19 Aligned_cols=264 Identities=28% Similarity=0.422 Sum_probs=210.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
...+|.+.+.||.|++|+||.+... ++..+++|.+..........+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4678999999999999999999742 2456899988765545556789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 117 LLVYEYMPMGSLEDHLYDLE---------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
+++|||+++++|.+++.... .....+++..++.++.|++.||.+||+++ ++|+||+|+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999999996532 12235899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccch
Q 018128 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~------~- 232 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------I- 232 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------H-
Confidence 9999999875332222222223335678999999998889999999999999999998 8889863321100 0
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
..+.... ....+...+.++.+++.+||+.||.+|||+.+++..|+.+...
T Consensus 233 ---------~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ---------ECITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---------HHHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0000000 0011234567799999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=306.95 Aligned_cols=268 Identities=24% Similarity=0.416 Sum_probs=210.8
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCC----EEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~----~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
...+|++.+.||+|+||.||++.+. +++ .|++|.+..... ....++.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 4578999999999999999999753 333 489999865432 3346788899999999999999999998764 56
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
+++++++++|+|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 84 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 799999999999999965 3456889999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
................+..|+|||.+.+..++.++||||||+++|+|++ |..||+...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----------------~ 220 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------I 220 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----------------H
Confidence 6543332222222334668999999999999999999999999999997 999986322110 0
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCC
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSR 334 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~ 334 (360)
............+..++..+.+++.+||+.+|.+||++.+++..|..+........+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 279 (316)
T cd05108 221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 279 (316)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchheEec
Confidence 01111111112234566789999999999999999999999999999976655444433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=308.52 Aligned_cols=244 Identities=28% Similarity=0.398 Sum_probs=196.3
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHh---hccCCCcccceeEEEEeCCeeEEE
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLML---SLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l---~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
|++.+.||+|++|.||++.+. +++.|++|++.... ....+.+.+|..++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999865 58999999986542 12234566666554 456799999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++++|..++. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998883 357999999999999999999999999 9999999999999999999999999886422
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
. .........++..|+|||.+.+..++.++|||||||++|+|++|..||....... .... +.
T Consensus 153 ~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~----------i~ 214 (324)
T cd05589 153 G--FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDS----------IV 214 (324)
T ss_pred C--CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHH----------HH
Confidence 1 1122234568999999999999899999999999999999999999996432110 0000 00
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
.. ...++..++..+.++|.+||+.||.+|| ++.++++
T Consensus 215 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 215 ND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00 1123456678899999999999999999 5777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.98 Aligned_cols=267 Identities=27% Similarity=0.405 Sum_probs=209.4
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYC 110 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~ 110 (360)
.|....++|++.+.||+|+||.||.+... ++..|++|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 44566779999999999999999998742 245799999875432 3345688899999999 899999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCC-----------------------------------------------------
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEP----------------------------------------------------- 137 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~----------------------------------------------------- 137 (360)
......++||||+++++|.+++.....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999999854210
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 138 -------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 138 -------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
...++++..++.++.||+.||.|||+++ ++||||||+||++++++.++|+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 1134788899999999999999999998 999999999999999999999999998754332222
Q ss_pred ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 205 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..........
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----------------~~~~~~~~~~ 332 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----------------KFYKMVKRGY 332 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----------------HHHHHHHccc
Confidence 22222334567999999988899999999999999999997 999996322110 0000111111
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
....+...+.++.++|.+||+.||.+|||+.++++.|+++.
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 333 QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11223345678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=312.03 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=204.6
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|++|.||++++. +++.|++|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999876 58999999987542 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999943 457899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
......++..|+|||++.+..++.++|||||||++|+|++|..||.......... .. ........
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i----~~~~~~~~ 218 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE------NL----KYWKETLQ 218 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH------HH----Hhcccccc
Confidence 2234568899999999998899999999999999999999999997433211100 00 00000000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
...........+.++.++|.+||+.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000112457789999999999999999999999963
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=300.23 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=205.9
Q ss_pred HhhcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
...+|++.+.||+|+||.||.+... .+..+++|.+..... .....+.+|+..++.++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4578999999999999999999653 356899998876532 23356888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||....
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999999965 3457899999999999999999999999 99999999999999999999999998764
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
...... .......++..|+|||.+.+..++.++|||||||++|++++ |..||....... .... .
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~-~------- 221 (266)
T cd05064 157 DKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKA-V------- 221 (266)
T ss_pred ccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHH-H-------
Confidence 221111 11112234568999999999999999999999999999775 999996432110 0000 0
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
........+..++..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 222 ---~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 ---EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00111123456778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=310.28 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=204.9
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
..++|++.+.||+|++|.||++++. ++..+++|.+..... .....+.+|+++++.++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 4679999999999999999999876 588899998875432 23457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999954 45689999999999999999999985 5 9999999999999999999999999987432
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc------------cch-
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS------------WSR- 266 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------------~~~- 266 (360)
.. ......++..|+|||++.+..++.++|||||||++|+|++|..||............. ...
T Consensus 156 ~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 156 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred cc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 21 1233468899999999998899999999999999999999999996433211000000 000
Q ss_pred -------hhh------hcccc----chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 267 -------PFL------KDQKK----FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 267 -------~~~------~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ..... ...+............++.++.+||.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00000 00000000001112246778999999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=301.50 Aligned_cols=260 Identities=33% Similarity=0.495 Sum_probs=208.6
Q ss_pred hhcccccceeccCCCeEEEEEEecC------CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLES------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~------~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
..+|++.+.||.|++|.||.+.... ...+++|.+..... .....+.+|+..++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4589999999999999999997542 25799998865432 2345688999999999999999999999988999
Q ss_pred EEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 117 LLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 999999999999999965321 1156889999999999999999999999 9999999999999999
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhc
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVS 263 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 263 (360)
+.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------ 234 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 9999999999875433332233333456788999999988889999999999999999998 999986332110
Q ss_pred cchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
....+........+..++.++.+++.+||+.||.+||++.+|++.|..+
T Consensus 235 -----------~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 -----------VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -----------HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 0000111111123456788999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=302.33 Aligned_cols=264 Identities=29% Similarity=0.444 Sum_probs=212.0
Q ss_pred HhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
..++|.+.+.||+|++|.||+++.. ++..+++|.+..........+.+|+..++.++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 3567999999999999999999743 3456888988766555566788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 117 LLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
++||||+++++|.+++..... ....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 999999999999999965321 2345899999999999999999999999 9999999999999999
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhc
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVS 263 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 263 (360)
+.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~- 235 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI- 235 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-
Confidence 9999999999875333222222233446778999999998899999999999999999998 999986432110 00
Q ss_pred cchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
. .... ......+..++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 236 --~----------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 --E----------CITQ-GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --H----------HHhC-CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0 0000 001112334567899999999999999999999999999999553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.36 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=200.3
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccc---hHHHHHHHHHhhccCCCcccceeEEEEe----CCeeEEEEEe
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLVYEY 122 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~e~~~l~~l~~p~i~~~~~~~~~----~~~~~lv~e~ 122 (360)
...++.|+++.||.+... |+.|++|.+....... .+.+.+|+.+++.++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 367999999999999885 8899999987654333 3567799999999999999999999866 3467899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
+++|+|.+++.. .+.+++...+.++.+++.||.+||+. + ++|+||+|+||+++.++.++|+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999954 45788999999999999999999985 7 889999999999999999999999998753221
Q ss_pred CCcceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
. ....++..|+|||++.+ ..++.++||||||+++|+|++|..||...... ... ..+.
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~----------~~i~ 235 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIY----------DLII 235 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHH----------HHHH
Confidence 1 12357788999999876 67899999999999999999999999743211 000 0011
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
........+..++..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 236 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 236 NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111112344577889999999999999999999999999998864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=324.52 Aligned_cols=260 Identities=22% Similarity=0.264 Sum_probs=209.7
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCC-
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD- 114 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~- 114 (360)
+.....++|++.+.||+|+||+||.++.. +++.||+|++..... .....+.+|+..+..++|+|++++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445679999999999999999999765 699999999876533 23456788999999999999999887764322
Q ss_pred -------eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 115 -------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 115 -------~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
..++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 367999999999999999765556678999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh
Q 018128 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
+|+|||++................|+..|+|||++.+..++.++||||||+++|+|++|..||..... ......
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH
Confidence 99999998764433333333445789999999999999999999999999999999999999963221 000000
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .. ......+..++.++.+++.+||+.||.+||++.+++.
T Consensus 257 ~----------~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 257 T----------LA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred H----------hc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 0 00 0111234567788999999999999999999999986
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=299.20 Aligned_cols=251 Identities=34% Similarity=0.549 Sum_probs=198.5
Q ss_pred cccceeccCCCeEEEEEEec-----CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 48 REANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 48 ~i~~~Lg~G~~g~v~~~~~~-----~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++.+.||.|+||.||.|... .+..|++|.+..... .....+.+|++.++.++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999765 367899999965433 236789999999999999999999999998888999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|++|+++||+++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999772 3567999999999999999999999998 999999999999999999999999999865333
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
..............|+|||.+.+..++.++||||||+++|||++ |..||...... .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----------------~~~~~~~ 219 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----------------EIIEKLK 219 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----------------HHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------ccccccc
Confidence 33344444567788999999998889999999999999999999 67887532110 0001111
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L 320 (360)
.......+..++..+.++|.+||..+|++||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122233556788899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=302.41 Aligned_cols=264 Identities=26% Similarity=0.354 Sum_probs=200.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||.|++|+||++... +++.|++|++..... .....+.+|+.+++.++||||+++++++.+....++|||+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999876 689999999865432 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++ +|.+++.. .+..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~- 156 (288)
T cd07871 85 LDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP- 156 (288)
T ss_pred CCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC-
Confidence 965 99998854 3456889999999999999999999999 999999999999999999999999998753221
Q ss_pred Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-cc----chhhhh---ccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW----SRPFLK---DQK 273 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~----~~~~~~---~~~ 273 (360)
........++..|+|||++.+ ..++.++||||+|+++|+|++|..||............ .. ....+. ...
T Consensus 157 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 157 -TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred -CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 112233457889999998865 56899999999999999999999999643321110000 00 000000 000
Q ss_pred cchhcccccccC----CCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 274 KFVHLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 274 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.......+.... ......+.++.++|.+||+.||.+|||++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 000111000000 01224567889999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=300.30 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=205.2
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
.+..++|++.+.||+|++|.||.+... .+..+++|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 467889999999999999999998653 256799998764322 2345688899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
...++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCE
Confidence 9999999999999999999653321 234577889999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccch
Q 018128 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~--- 232 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLR--- 232 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---
Confidence 9999999875333222222222345678999999998889999999999999999999 688885332110 000
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
.. ... .....+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus 233 ~~----------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 FV----------MEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HH----------HcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 000 001123456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.26 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=210.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||.|++|.||.++.. +++.|++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999865 689999998754322 23346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999998765555567899999999999999999999998 99999999999999999999999998875332
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.. .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ........ ..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~-------~~--- 222 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI-------EQ--- 222 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH-------hc---
Confidence 21 1122345778899999998888999999999999999999999998532211 00100000 00
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
..........++..+.+++.+||+.+|++||++.++++.+.++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00001112346678999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.05 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=206.9
Q ss_pred hhcccccceeccCCCeEEEEEEecC----CCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
..+|++.+.||+|+||.||.+.... ...+++|.+...... ....+.+|+..++.++||||+++++.+.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4679999999999999999997642 457999988654322 33567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
+||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999965 3357899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchh
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~-------------~ 220 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIK-------------A 220 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHH-------------H
Confidence 42222222222345678999999998889999999999999999998 998985322110 000 0
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
+ ........+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 221 ~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 221 V-EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred H-HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00011122345677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.10 Aligned_cols=242 Identities=27% Similarity=0.366 Sum_probs=196.4
Q ss_pred cceeccCCCeEEEEEEe----cCCCEEEEEEcccCC----ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 50 ANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++.||+|+||.||+++. ..++.|++|++.... ......+..|+.+++.++||||+++++++.+++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999975 257899999986532 1233457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++.. ...+.+..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 152 (323)
T cd05584 81 YLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH- 152 (323)
T ss_pred CCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc-
Confidence 9999999999843 456889999999999999999999999 99999999999999999999999999864221
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
.........++..|+|||++.+..++.++||||||+++|+|++|..||....... . ...+...
T Consensus 153 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~----------~~~~~~~ 215 (323)
T cd05584 153 -EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------T----------IDKILKG 215 (323)
T ss_pred -CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------H----------HHHHHcC
Confidence 1122233568999999999998889999999999999999999999996432110 0 0111111
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
....+...+..+.++|.+||+.||++|| ++.++++
T Consensus 216 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 216 --KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1123455677899999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=326.50 Aligned_cols=271 Identities=31% Similarity=0.481 Sum_probs=227.0
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYC 110 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~ 110 (360)
...++.-.+.+..+.||+|+||+||+++.. ....|+||.+...... ...+|++|++++..++||||+++++++
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 334455567778899999999999999743 3567999999876555 667899999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCCC------C----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPD------Q----EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~------~----~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
.+++..|+|+||++.|||.+|+...... + .+++..+.+.++.||+.|+.||.++. +|||||...|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence 9999999999999999999999775432 2 23889999999999999999999999 999999999999
Q ss_pred EeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCcc
Q 018128 181 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQ 259 (360)
Q Consensus 181 v~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~ 259 (360)
|.++..|||+|||+++..-..+..+......-..+|||||.+..++||.+|||||+|++|||+++ |..||.....+
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--- 712 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--- 712 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---
Confidence 99999999999999986556666666555566789999999999999999999999999999998 88888643321
Q ss_pred chhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
..++.+....+ ...|..++.++..|+..||+.+|.+||+++||-.+|........
T Consensus 713 -------------EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 -------------EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -------------HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 11222222222 35688999999999999999999999999999999998855443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=307.34 Aligned_cols=241 Identities=28% Similarity=0.358 Sum_probs=197.3
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
+.||+|+||.||++++. +++.||+|++..... .....+.+|+.+++.++||||+++++.+.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 689999999875422 23456788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcce
Q 018128 127 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 206 (360)
Q Consensus 127 sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~ 206 (360)
+|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++..... ....
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCC--cccc
Confidence 99988843 457899999999999999999999999 99999999999999999999999999864221 1122
Q ss_pred ecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCC
Q 018128 207 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 286 (360)
Q Consensus 207 ~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (360)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||....... .. ..+.. ....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~----------~~~~~--~~~~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LF----------ELILM--EDIK 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HH----------HHhcc--CCcc
Confidence 233568999999999998899999999999999999999999996322110 00 00000 0112
Q ss_pred CChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 287 YPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 287 ~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
++..++.++.++|.+||+.||.+|+ ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 3556778899999999999999997 8999885
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=293.38 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=211.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||.|++|.||.+... +++.+++|.+.... ......+.+|+++++.++|++++++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999876 79999999886432 223567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.........+++..++.++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999999765555677999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..........
T Consensus 159 ~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~----------- 221 (267)
T cd08224 159 K--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE----------- 221 (267)
T ss_pred C--CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhh-----------
Confidence 1 1112234577889999999888899999999999999999999999853321 1111100000
Q ss_pred ccccCCCCh-hhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 281 PLLHGRYPR-RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 281 ~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
.......+. .++..+.++|.+||..+|++||++.+|++.|..+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001111222 56778999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.65 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=208.4
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
+....|++.+.||.|++|.||++... .++.+++|.+.... .....+.+|+..++.++||||+++++++..+...+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 44567999999999999999999765 58899999886543 34567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++... ....+++..++.++.|++.||.+||+++ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 82 EFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999998652 2456899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... +
T Consensus 157 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~-----------~ 218 (263)
T cd05052 157 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYEL-----------L 218 (263)
T ss_pred ceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH-----------H
Confidence 2111 1111233567999999988899999999999999999998 88888632211 00000 0
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
........+..++..+.++|.+||+.+|++||++.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11111233455678899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=292.88 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=202.6
Q ss_pred hcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecC
Q 018128 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~ 124 (360)
+.|++.+.||.|+||.||++..+++..+++|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 5799999999999999999988877889999876443 334678889999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
+++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 83 NGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence 9999999864 2346899999999999999999999999 99999999999999999999999998875322111
Q ss_pred ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 205 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~---~i~~-----------~~ 218 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVE---MISR-----------GF 218 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHHC-----------CC
Confidence 11122234567999999988889999999999999999999 888986332110 000 0000 00
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
....+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 219 RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112334567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=301.17 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=201.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++.+.||+|++|.||++++. +++.+++|++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999876 588999999865432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|++++.+..+. . ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~-~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLE-E---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHH-h---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99886665444 2 3457899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhccchh-------hhhccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRP-------FLKDQK 273 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~-------~~~~~~ 273 (360)
.. .......++..|+|||++.+..++.++||||||+++|+|++|..||.......... ......+ ......
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 21 12223467889999999998889999999999999999999999996433211100 0000000 000000
Q ss_pred cchhcccccc------cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+.. ...+....+.++.+++.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 01112235678999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=300.91 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=198.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.++|++.+.||.|++|+||+++.. +++.|++|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 689999999875432 223467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+. ++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 688888754 3466899999999999999999999999 999999999999999999999999998643221
Q ss_pred CCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch----h---hhhccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR----P---FLKDQK 273 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----~---~~~~~~ 273 (360)
........++..|+|||++.+ ..++.++||||+||++|+|++|..||........ ....... + .+....
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhCCCChhhccchh
Confidence 122233557889999998875 4578999999999999999999999964321100 0000000 0 000000
Q ss_pred cchhcccccccCCC---------ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLLHGRY---------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.............. ....+..+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000000 0123457889999999999999999999984
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=307.09 Aligned_cols=238 Identities=28% Similarity=0.331 Sum_probs=193.6
Q ss_pred eccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 53 Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
||+|+||.||++++. +++.|++|++.... ......+..|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999876 58899999986532 23345677899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceec
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~ 208 (360)
.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..... ......
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccc
Confidence 999853 457899999999999999999999999 99999999999999999999999999874221 112223
Q ss_pred ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCC
Q 018128 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 288 (360)
Q Consensus 209 ~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
...|+..|+|||++.+..++.++|||||||++|+|++|..||...... ........ . ...++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~----------~--~~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ----------E--PLRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc----------C--CCCCC
Confidence 456899999999999999999999999999999999999999632210 10111110 0 11234
Q ss_pred hhhHHHHHHHHhhhcccCCCCCCC---HHHHH
Q 018128 289 RRCLNYAVAVTAMCLNEEANFRPL---INDIV 317 (360)
Q Consensus 289 ~~~~~~l~~li~~~l~~dp~~Rpt---~~eil 317 (360)
...+..+.++|.+||+.||.+||+ +.+++
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 567788999999999999999986 45555
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.90 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=208.0
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++...+|++.+.||.|++|.||++...+++.+++|.+..... ....+.+|+.+++.++||||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 566789999999999999999999988889999999875543 3467889999999999999999998874 55789999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++.+++|.+++.. ..+..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 80 EYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999865 23457899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. ........++..|+|||.+....++.++||||||+++|++++ |..||....... . ... +
T Consensus 155 ~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~---~~~-----------~ 216 (260)
T cd05067 155 NE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---V---IQN-----------L 216 (260)
T ss_pred CC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---H---HHH-----------H
Confidence 11 111122335678999999988889999999999999999998 999996332110 0 000 0
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
........+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 217 ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011112234566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=315.02 Aligned_cols=244 Identities=28% Similarity=0.441 Sum_probs=211.0
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccC-CCcccceeEEEEeCC
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGD 114 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~ 114 (360)
..+.-++|++.++||+|.||+|++++.+ +++.||||++.+... .+.+..+.|..++...+ ||.+..++..|.+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 5666789999999999999999999877 588999999988754 34566778888888775 999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
++|+||||+.||++...+ +...+++..+..++..|+.||+|||+++ |++||||.+|||+|.+|.+||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccc
Confidence 999999999999954444 5578999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
+... ..........+||+.|+|||++.+..|+.+.|-|+||++||+|+.|..||...+.
T Consensus 515 cKe~--m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------------- 573 (694)
T KOG0694|consen 515 CKEG--MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------------- 573 (694)
T ss_pred cccc--CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------------
Confidence 9852 2233456678999999999999999999999999999999999999999984432
Q ss_pred chhcccccccC--CCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 275 FVHLVDPLLHG--RYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 275 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
+++.+..+.. .||.-++.+...+++++|..||++|.-.
T Consensus 574 -ee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 -EEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -HHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2233333333 3678889999999999999999999776
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=306.97 Aligned_cols=241 Identities=28% Similarity=0.369 Sum_probs=196.3
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
+.||+|+||.||+++.. +++.|++|++..... .....+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999865 689999999865422 23345678999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcce
Q 018128 127 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 206 (360)
Q Consensus 127 sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~ 206 (360)
+|..++. ....+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++..... ....
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~ 151 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 151 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCc
Confidence 9998884 3457899999999999999999999999 99999999999999999999999998864211 1112
Q ss_pred ecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCC
Q 018128 207 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 286 (360)
Q Consensus 207 ~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (360)
.....++..|+|||++.+..++.++|||||||++|+|++|..||........ ...+... ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----------------~~~~~~~--~~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----------------FELILME--EIR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH----------------HHHHhcC--CCC
Confidence 2335688999999999988999999999999999999999999963221100 0000000 112
Q ss_pred CChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 287 YPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 287 ~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
++..++.++.++|.+||+.||.+|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3456778899999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=303.65 Aligned_cols=272 Identities=26% Similarity=0.393 Sum_probs=212.6
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec--------CCCEEEEEEcccCC-ccchHHHHHHHHHhhcc-CCCccccee
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLI 107 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~p~i~~~~ 107 (360)
.++++...+|++++.||+|+||.||.+... .+..+++|.+.... ......+.+|+.+++.+ +||||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 356677789999999999999999999642 12368999876542 22346788999999999 799999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 018128 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 175 (360)
Q Consensus 108 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~ 175 (360)
+++......++++||+++++|.+++..... ....++...+..++.|++.||.|||+++ ++|+||+
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlk 161 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLA 161 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccc
Confidence 999999999999999999999999965321 2345788899999999999999999998 9999999
Q ss_pred CCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccC
Q 018128 176 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSK 254 (360)
Q Consensus 176 p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~ 254 (360)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999875432222222222334467999999999899999999999999999998 888885322
Q ss_pred ccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 255 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
... ..... ........+..++..+.+++.+||+.+|.+||++.++++.|.++......
T Consensus 242 ~~~------~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 242 VEE------LFKLL-----------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHH------HHHHH-----------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 111 00000 00111122345667899999999999999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=302.27 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=213.1
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+=|.+.+.||+|.|+.|-++++- +|..||||++.+..... ...++.|+..++.++||||+++|++..+...+|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 457999999999999999999765 79999999998875543 357899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE-eCCCceEEeecCCccccC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL-DNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv-~~~~~v~L~Dfg~~~~~~ 199 (360)
|.-++|+|.+||-. +...+.+....++|.||+.||.|+|+.. +|||||||+||.+ -.-|.|||+|||++..+.
T Consensus 97 ELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999976 5678999999999999999999999999 9999999999877 556899999999998654
Q ss_pred CCCCcceecccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s-~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
... .-...+|...|.|||++.+..|+ ++.||||||+|+|-|++|++||...++.+. +..+
T Consensus 171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------------LTmI 231 (864)
T KOG4717|consen 171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------------LTMI 231 (864)
T ss_pred Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------------hhhh
Confidence 433 34457899999999999999987 789999999999999999999985553322 1222
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
++... ..|...+.+..+||..||..||.+|.+++||.
T Consensus 232 mDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 232 MDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred hcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 22111 34778899999999999999999999999988
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.90 Aligned_cols=266 Identities=29% Similarity=0.436 Sum_probs=211.6
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYC 110 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~ 110 (360)
.+.+...+|++.+.||+|++|.||++... ....+++|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45667789999999999999999999754 236789998875422 2335688899999999 799999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 178 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~N 178 (360)
......+++|||+.+++|.+++.... .....+++..++.++.|++.||.|||+.+ ++|+||+|+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 99999999999999999999996532 23567899999999999999999999998 9999999999
Q ss_pred EEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccC
Q 018128 179 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQG 257 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~ 257 (360)
|+++.++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999875433222222222334567999999988899999999999999999997 888885322110
Q ss_pred ccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 258 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
. ...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 243 ~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 L-----------------FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-----------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 0000111111234456778999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.90 Aligned_cols=267 Identities=27% Similarity=0.393 Sum_probs=207.9
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCT 111 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~ 111 (360)
|.+..++|++.+.||.|+||.||.+... +++.|++|++..... .....+..|+.+++.+ +||||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 4566789999999999999999999632 257899998865432 2335677899999999 7999999999875
Q ss_pred e-CCeeEEEEEecCCCCHHHHhcccCCC----------------------------------------------------
Q 018128 112 S-GDQRLLVYEYMPMGSLEDHLYDLEPD---------------------------------------------------- 138 (360)
Q Consensus 112 ~-~~~~~lv~e~~~~~sL~~~i~~~~~~---------------------------------------------------- 138 (360)
. +...+++|||+++++|.+++......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 45678999999999999998542211
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccc
Q 018128 139 -----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 213 (360)
Q Consensus 139 -----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~ 213 (360)
...+++..+..++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++................++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 136889999999999999999999998 999999999999999999999999998754322222222233456
Q ss_pred cccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhH
Q 018128 214 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCL 292 (360)
Q Consensus 214 ~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (360)
..|+|||.+.+..++.++|||||||++|+|++ |..||....... ... ... ........+...+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~----------~~~~~~~~~~~~~ 302 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRL----------KEGTRMRAPEYAT 302 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHH----------hccCCCCCCccCC
Confidence 78999999999999999999999999999997 999986322110 000 000 0011112234556
Q ss_pred HHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 293 NYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 293 ~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
.++.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=291.55 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=197.5
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
+.||.|++|.||.+... +++.+++|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999865 689999998764432 2345688999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceec
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~ 208 (360)
.+++.. .+..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999854 3456899999999999999999999998 9999999999999999999999999987432211111111
Q ss_pred ccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccccCCC
Q 018128 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY 287 (360)
Q Consensus 209 ~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (360)
....+..|+|||.+.+..++.++||||||+++|+|++ |..||....... .............
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----------------~~~~~~~~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----------------TREAIEQGVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----------------HHHHHHcCCCCCC
Confidence 1223456999999998889999999999999999997 888886322110 0000111111223
Q ss_pred ChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 288 PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 288 ~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 4456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=307.65 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=202.7
Q ss_pred HHhhcccccceeccCCCeEEEEEEecC--CCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLES--GQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~--~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
+..++|++.+.||.|+||.||+|.... +..|++|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 355689999999999999999997543 4689999886542 23345678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.
T Consensus 107 ~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 999999999999999953 467899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..... .....|+..|+|||++.+..++.++|||||||++|+|++|..||....... . ..
T Consensus 180 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~----------~~ 238 (340)
T PTZ00426 180 VVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------I----------YQ 238 (340)
T ss_pred ecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------H----------HH
Confidence 53221 123468899999999998889999999999999999999999996432110 0 00
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
.+.... ..++...+..+.++|.+||+.||.+|+ +++++++
T Consensus 239 ~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 239 KILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 011111 123455667789999999999999995 8888874
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=293.68 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=209.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++..++|++.+.||.|++|.||.+..++++.+++|.+.... ...+.+.+|+..++.++||||+++++++.+....+++|
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 46678999999999999999999988878889999887553 34567899999999999999999999999888999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++... .+..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 81 EYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 999999999999652 2356899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. .........+..|+|||.+.+..++.++|+||+|+++|+|++ |..||....... .... +.
T Consensus 156 ~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~----------~~ 218 (261)
T cd05034 156 DE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------VLEQ----------VE 218 (261)
T ss_pred hh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH----------HH
Confidence 11 111112234567999999998889999999999999999998 999985322110 0000 00
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
.......+...+.++.+++.+||+.+|.+||++.++++.|+.
T Consensus 219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 -RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001112233456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=305.19 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=203.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
+..++|++.+.||.|++|.||++.+. ++..+++|.+..... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 45689999999999999999999876 588899998765422 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999999954 45689999999999999999999974 6 999999999999999999999999998643
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc------cc-------
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS------WS------- 265 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------~~------- 265 (360)
... ......++..|+|||.+.+..++.++|||||||++|+|++|..||............. ..
T Consensus 155 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 155 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 221 1223457889999999998889999999999999999999999996433211100000 00
Q ss_pred -hh----h------hhccccchhcccccccCC---C-ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 -RP----F------LKDQKKFVHLVDPLLHGR---Y-PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 -~~----~------~~~~~~~~~~~~~~~~~~---~-~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. . .................. . ...++.++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00 0 000000000000000000 0 1135678999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=301.41 Aligned_cols=268 Identities=28% Similarity=0.409 Sum_probs=210.3
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec--------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGY 109 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~--------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~ 109 (360)
+++..++|.+.+.||+|+||.||.++.. ....+++|.+..... .....+.+|+.+++.+ +||||++++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3455678999999999999999999753 134699998875432 3345688899999999 79999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 177 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~ 177 (360)
+...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||+|+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 9999999999999999999999966332 1235889999999999999999999998 999999999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCcc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 256 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~ 256 (360)
||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999875332221111122234467999999988889999999999999999998 88888532211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
.... .+........+...+.++.++|.+||+.+|++||++.++++.|+.+.+..
T Consensus 250 ------~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ------ELFK-----------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ------HHHH-----------HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 0000 00011111234456778999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=293.23 Aligned_cols=257 Identities=29% Similarity=0.418 Sum_probs=205.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
+..++|++.+.||.|++|.||++.+.....+++|.+..... ..+.+.+|+.+++.++||||+++++.+. ....++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 45678999999999999999999877667799999875432 3467889999999999999999998875 456789999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++++++|.+++... .+..+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 81 YMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred cCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 99999999999652 2346789999999999999999999998 999999999999999999999999998754322
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
... ......++..|+|||...+..++.++||||||+++|+|++ |..||........ ... +.
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~----------~~- 217 (262)
T cd05071 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQ----------VE- 217 (262)
T ss_pred ccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHH----------Hh-
Confidence 211 1122345667999999988889999999999999999999 7888863321100 000 00
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
.......+..++..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 218 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0011122345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=311.26 Aligned_cols=250 Identities=26% Similarity=0.313 Sum_probs=204.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|++|+||++++. +++.||+|++..... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999876 689999999875422 33456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999954 367999999999999999999999998 99999999999999999999999999875433
Q ss_pred CC---------------------------CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 018128 201 GD---------------------------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 253 (360)
Q Consensus 201 ~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~ 253 (360)
.. .........++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001223356889999999999999999999999999999999999999743
Q ss_pred CccCccchhccchhhhhccccchhccc--ccccCCCChhhHHHHHHHHhhhcccCCCCCCC-HHHHHH
Q 018128 254 KGQGEQNLVSWSRPFLKDQKKFVHLVD--PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVV 318 (360)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~eil~ 318 (360)
..... ...+.. ..........++.++.++|.+||+ ||.+||+ +.++++
T Consensus 234 ~~~~~----------------~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 234 TLQET----------------YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CHHHH----------------HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 31100 000110 001111112257889999999998 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=292.62 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=206.4
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++..++|++.+.||.|++|.||.+....+..+++|.+..... ....+.+|+.+++.++|||++++++++. ....+++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 455678999999999999999999888788899999876543 3467889999999999999999999875 45688999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.. .....+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 80 EYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999999999965 22456899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ......
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~----------- 216 (260)
T cd05070 155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQV----------- 216 (260)
T ss_pred cccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHH-----------
Confidence 2211 1112234567999999988889999999999999999999 88898632211 000000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
........+...+..+.+++.+||+.+|.+|||+.++++.|++
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0011112344567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=306.50 Aligned_cols=252 Identities=23% Similarity=0.268 Sum_probs=201.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|+||+||+++.. +++.|++|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999865 689999999875432 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ....+++..++.++.|++.||.+||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999965 2357999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcceecccccccccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAM------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
.... ......++..|+|||++. ...++.++|||||||++|+|++|..||........ .......
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~--- 224 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNF--- 224 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcC---
Confidence 2222 223346889999999986 45678999999999999999999999964321100 0000000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....-......+..+.++|..||+ +|.+||++.+++.
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 -----QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -----CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0001111123467789999999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.80 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=210.0
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccC-CCcccceeEEE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYC 110 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~-~p~i~~~~~~~ 110 (360)
.+.+..++|++++.||.|+||.||.+... .+..|++|++..... ...+.+.+|+++++.+. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34455789999999999999999999753 134699999865433 23457889999999996 99999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCC-----------------------------------------------------
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEP----------------------------------------------------- 137 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~----------------------------------------------------- 137 (360)
.+....++||||+++|+|.+++.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 999999999999999999998864211
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018128 138 ---------------------------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 178 (360)
Q Consensus 138 ---------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~N 178 (360)
....+++..++.++.|++.||.|||+.+ ++|+||+|+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 1234788889999999999999999998 9999999999
Q ss_pred EEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccC
Q 018128 179 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQG 257 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~ 257 (360)
|+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 9999999999999999875433222222223345678999999988889999999999999999997 888986321110
Q ss_pred ccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 258 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
. +.. .+........+..++..+.+++.+||+.||++||++.++.+.|.++.+
T Consensus 348 ~---------~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 T---------FYN-------KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H---------HHH-------HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 000 000011112234567789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=292.76 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=203.2
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
..+|++.+.||.|++|.||++.+..+..+++|.+..... ....+.+|+.+++.++||||+++++++...+..++|||++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 356899999999999999999887777899998864432 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~- 154 (256)
T cd05059 82 ANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ- 154 (256)
T ss_pred CCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc-
Confidence 99999999965 2347899999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ . .. +...
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~---~~-----------~~~~ 217 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V---ES-----------VSAG 217 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H---HH-----------HHcC
Confidence 111111223457999999998889999999999999999999 7889863321100 0 00 0011
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L 320 (360)
.....+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11123445678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=291.85 Aligned_cols=260 Identities=28% Similarity=0.337 Sum_probs=214.4
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
....+.-+.|++++.||+|..|+||+++.. .+..+|+|++.+.... ...+...|-++|+.++||.++.+|..++.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 345566678999999999999999999877 4789999999877543 345677799999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...|++||||+||+|..+.+. +.++.+++..++.++..++.||.|||..| ||.|||||+||||.++|.|.|+||+
T Consensus 150 ~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred ceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecc
Confidence 999999999999999999977 56788999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCC-------------------------------C-c----------------------ceecccccccccccc
Q 018128 194 LAKLGPVGD-------------------------------N-T----------------------HVSTRVMGTYGYCAP 219 (360)
Q Consensus 194 ~~~~~~~~~-------------------------------~-~----------------------~~~~~~~~~~~y~aP 219 (360)
++....... . . .......||.+|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 875421100 0 0 001124588999999
Q ss_pred cccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHH
Q 018128 220 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVT 299 (360)
Q Consensus 220 E~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 299 (360)
|++.+...+.+.|-|+||+.+|||+.|.-||...+... .+.+++...+.-.-.+..+..+.+||
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----------------Tl~NIv~~~l~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----------------TLRNIVGQPLKFPEEPEVSSAAKDLI 368 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh----------------hHHHHhcCCCcCCCCCcchhHHHHHH
Confidence 99999999999999999999999999999998655321 22222222222222336678899999
Q ss_pred hhhcccCCCCCCC----HHHHHH
Q 018128 300 AMCLNEEANFRPL----INDIVV 318 (360)
Q Consensus 300 ~~~l~~dp~~Rpt----~~eil~ 318 (360)
+++|..||++|.. +.||.+
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHhccChhhhhccccchHHhhc
Confidence 9999999999998 888876
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=292.22 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=203.4
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
.+.|++.+.||.|++|+||.++..++..+++|.+.... .....+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 46799999999999999999988767779999887543 33467889999999999999999999999888899999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
.+++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|.||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999865 2346899999999999999999999999 99999999999999999999999999875432211
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ..+.. .
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~----------~~~~~-~ 217 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TV----------EKVSQ-G 217 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HH----------HHHhc-C
Confidence 11112234567999999988889999999999999999998 999986332110 00 00000 0
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
.....+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112335678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=295.97 Aligned_cols=266 Identities=26% Similarity=0.390 Sum_probs=210.4
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecC-----CCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEe-C
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLES-----GQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-G 113 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~-----~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-~ 113 (360)
.+...+|++.+.||+|+||.||.+.+.. +..+++|.+.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4567899999999999999999998664 6789999876442 2334568889999999999999999998755 5
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEE
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPD----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 189 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L 189 (360)
...+++++++++++|.+++...... +..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEE
Confidence 6788999999999999998664322 156899999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhh
Q 018128 190 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 190 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
+|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |..||....... ... .
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~ 231 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA----Y 231 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH----H
Confidence 99999875433222222222345667999999988889999999999999999998 999996432111 000 0
Q ss_pred hhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
... ......+..++.++.+++.+||+.||++|||+.++++.|..+...
T Consensus 232 ~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 232 LKD----------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHc----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 000 011112234567899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=299.00 Aligned_cols=269 Identities=25% Similarity=0.394 Sum_probs=212.4
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec--------CCCEEEEEEcccCC-ccchHHHHHHHHHhhcc-CCCcccceeEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGY 109 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~--------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~p~i~~~~~~ 109 (360)
+.+...+|++.+.||.|+||.||.++.. .+..+++|.+.... ......+.+|+..++.+ +||||+++++.
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 4577899999999999999999999641 24578999886542 23346788999999999 79999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 177 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~ 177 (360)
+......+++|||+.+++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 9999999999999999999999976322 1245788899999999999999999998 999999999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCcc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 256 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~ 256 (360)
||+++.++.++|+|||.+................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999875433222222222345567999999988889999999999999999998 77787532211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
...... ........+..++..+.+++.+||+.+|.+||++.++++.|+++.....
T Consensus 247 ------~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 247 ------ELFKLL-----------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred ------HHHHHH-----------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 100000 0001112234567889999999999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.90 Aligned_cols=261 Identities=27% Similarity=0.446 Sum_probs=208.2
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
++..++|++.+.||.|++|.||.+... .+..+++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 455789999999999999999999754 246899999865532 3345688899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
...++|||++++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCE
Confidence 9999999999999999999654321 234788999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccch
Q 018128 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+|+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..||....... ...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~--- 232 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK--- 232 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH---
Confidence 9999999875433322222233445778999999988889999999999999999998 888985322111 000
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
.. ........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 -~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 -FV----------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -HH----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00 011111234456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=295.91 Aligned_cols=264 Identities=27% Similarity=0.437 Sum_probs=206.5
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEe
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~ 112 (360)
|++...+|++.+.||+|++|.||++... .+..|++|.+..... .....+.+|+..++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4567889999999999999999998643 245799998764432 233457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
....++||||+++++|.+++...... ....+...+..++.|++.||.|||+++ ++|+||+|+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCc
Confidence 99999999999999999999653321 234567788999999999999999999 999999999999999999
Q ss_pred eEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccc
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 265 (360)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~-- 232 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK-- 232 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence 99999999875333222222222345677999999988889999999999999999998 788885322110 000
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
..... .....+...+..+.+++.+||+.||++|||+.++++.|.+.
T Consensus 233 --~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 --FVMDG----------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --HHHcC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 00000 00112334567899999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=294.80 Aligned_cols=270 Identities=30% Similarity=0.461 Sum_probs=206.6
Q ss_pred hcc-cccceeccCCCeEEEEEEe-----cCCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeC--Ce
Q 018128 45 RNF-REANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQ 115 (360)
Q Consensus 45 ~~y-~i~~~Lg~G~~g~v~~~~~-----~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~ 115 (360)
++| ++.+.||+|+||+||++.. .++..+++|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 9999999999999988642 2577899999875532 2346778899999999999999999987653 45
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+++||++++++|.+++.. ..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence 7899999999999999943 45999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 196 KLGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 196 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~ 232 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVR 232 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhh
Confidence 7543322211 11223456679999999888899999999999999999999999864332111 000000000 00111
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
.............+..++..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11222222222345567789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=302.16 Aligned_cols=250 Identities=27% Similarity=0.351 Sum_probs=210.9
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc-hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
....|+..+.||+|.||.||+|.+. .++.||+|++..+...+ .+.+.+|+.++.+++++||.+.|+.+..+..++++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 4567888999999999999999765 69999999998775543 578899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+.||++.+.+. .+..+.+..+..++++++.|+.|||.++ .+|+|||+.|||+..+|.|+|+|||.+.....
T Consensus 91 ey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999999993 4555588899999999999999999999 99999999999999999999999999976443
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.. .......||+.|||||++....|+.++||||||++.+||++|.+|+.......... .+.+-..
T Consensus 164 ~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------lIpk~~P 228 (467)
T KOG0201|consen 164 TV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------LIPKSAP 228 (467)
T ss_pred hh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------eccCCCC
Confidence 33 33366789999999999998899999999999999999999999997443311111 1111112
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+. +...++..+.+|+..||+.||+.||++.++++
T Consensus 229 P~----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PR----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred Cc----cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22 23367778999999999999999999999886
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=278.41 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=211.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
-++|++++.||+|.||.||+++.+ ++--|++|++.+... ....++.+|+++-..++||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467999999999999999999865 578899999877643 3446899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
+||...|+|...+.. ....++++...+.++.|++.|+.|+|.++ ++||||||+|+|++..|.++++|||.+....
T Consensus 101 lEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999965 34677999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.......+||..|+|||...+...+...|+|++|++.|+++.|.+||+..... .....+.
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYkrI~ 235 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYKRIR 235 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHHHHH
Confidence 33344578999999999999999999999999999999999999999732210 0111111
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..+..+|...+.+..++|.+|+..+|.+|.+..|++.
T Consensus 236 --k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 236 --KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --HccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1122346778889999999999999999999999883
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=286.49 Aligned_cols=265 Identities=23% Similarity=0.283 Sum_probs=206.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEE--eCCeeEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCT--SGDQRLLV 119 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~--~~~~~~lv 119 (360)
..|+++..|+.|.||.||.|+++ +++-||+|.+....... .-.-.+|+.+|.+.+||||+.+.++.. +-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46889999999999999999876 68999999987654221 234678999999999999999999874 45679999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++ +|..++..+. +++...+++.++.|++.|++|||.+. |+|||||++|+|++..|.+|++|||+++.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999977 9999998744 78999999999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCcc-------------chhccc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-------------NLVSWS 265 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-------------~~~~~~ 265 (360)
. ..+..+...-|.+|+|||++.+. .|+.+.|+||+|||+.+|+++.+.|......... .+..+.
T Consensus 229 s--p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 S--PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred C--CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 3 34445667789999999999865 6899999999999999999999888643321110 000000
Q ss_pred hhhhhccccchhcccccccCCCChh-hHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...........+.....++..++.. .++.-++|+..+|..||.+|.|+++.|+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000001112222222333333333 5678899999999999999999999995
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.82 Aligned_cols=252 Identities=23% Similarity=0.287 Sum_probs=199.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||.|+||+||++++. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999876 58999999986542 223355778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999853 456999999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcc------------------------------------eecccccccccccccccccCCCCcchhhHHHHHHHHHHH
Q 018128 201 GDNTH------------------------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 244 (360)
Q Consensus 201 ~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll 244 (360)
..... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11100 001235899999999999989999999999999999999
Q ss_pred hCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC---HHHHHH
Q 018128 245 TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL---INDIVV 318 (360)
Q Consensus 245 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~eil~ 318 (360)
+|..||........ ...... .. ...........+.++.++|.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~~~------~~~i~~----~~----~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQET------YRKIIN----WK----ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHH------HHHHHc----CC----CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999964321100 000000 00 000001112356788999999997 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.26 Aligned_cols=239 Identities=26% Similarity=0.332 Sum_probs=193.7
Q ss_pred cceeccCCCeEEEEEEe----cCCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 50 ANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~----~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
++.||+|+||.||+++. .+++.+++|++..... .....+..|+++++.++||||+++++++.+....|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999875 2588999999875432 23345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-- 151 (318)
T cd05582 81 RGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-- 151 (318)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--
Confidence 99999999843 456899999999999999999999999 999999999999999999999999998753222
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
........++..|+|||.+.+..++.++||||||+++|+|++|..||....... .. ..+...
T Consensus 152 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~----------~~i~~~-- 213 (318)
T cd05582 152 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TM----------TMILKA-- 213 (318)
T ss_pred CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HH----------HHHHcC--
Confidence 122233568899999999998889999999999999999999999996432110 00 000000
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 315 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~e 315 (360)
....+...+.++.++|.+||+.||.+||++.+
T Consensus 214 ~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01234456778999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=295.34 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=206.2
Q ss_pred cccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
+|++.+.||+|+||.||++... ....+++|.+..... .....+.+|+..++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5889999999999999999753 135688888765432 234578889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018128 119 VYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 178 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~N 178 (360)
++||+.+++|.+++..... ....+++..++.++.|++.||.+||+.+ ++|+||+|+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999865321 1235789999999999999999999998 9999999999
Q ss_pred EEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccC
Q 018128 179 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQG 257 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~ 257 (360)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875432222212222345678999999988889999999999999999998 999986322110
Q ss_pred ccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 258 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
. .+..........+..++.++.+++.+||+.+|.+||++.++++.|+++..
T Consensus 238 ---~--------------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---L--------------FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---H--------------HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 0 01111111222344567789999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=290.61 Aligned_cols=250 Identities=23% Similarity=0.282 Sum_probs=203.8
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
+|++.+.||.|++|.||++.+. +++.+++|.+.... ....+.+..|+.+++.++||||+++++.+.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5899999999999999999876 58999999886432 334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++++|.+++.. ..+..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 99999998854 23456899999999999999999999999 999999999999999999999999998753322
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
........++..|+|||++.+..++.++|+||||+++|+|++|..||...... ..... +. ...
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~----------~~-~~~ 216 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILK----------VC-QGS 216 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHH----------Hh-cCC
Confidence 22223356788899999999888999999999999999999999999632210 00000 00 000
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
....+..++..+.++|.+||+.||++||++.+++.+
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234566779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=297.06 Aligned_cols=259 Identities=29% Similarity=0.414 Sum_probs=205.6
Q ss_pred hhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
..+|++.+.||.|++|.||.+... .++.+++|.+...... ....+..|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 456899999999999999999753 2578999998755322 235688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 117 LLVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
+++++++.+++|.+++.... .....+++..++.++.|++.||.|||+++ ++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence 99999999999999985311 12345888999999999999999999998 9999999999999999
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhc
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVS 263 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 263 (360)
+.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~- 236 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVI- 236 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH-
Confidence 9999999999875433222222233345678999999988889999999999999999998 77888532211 000
Q ss_pred cchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
.. +........+..++.++.+++.+||+.+|.+||++.+|+..|+.
T Consensus 237 ------------~~-i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 ------------EM-IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------------HH-HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 00 00111112355678889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=292.60 Aligned_cols=268 Identities=26% Similarity=0.362 Sum_probs=208.2
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcc--cCCccchHHHHHHHHHhhccCCCcccceeEEEEe---
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--- 112 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~--~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--- 112 (360)
+......+|...+.||.|+||.|+.+.+. +|+.||+|.+. .......++..+|+++|+.++|+||+.+++++..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 34455677888999999999999999765 69999999987 4455566789999999999999999999998854
Q ss_pred --CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEe
Q 018128 113 --GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 190 (360)
Q Consensus 113 --~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~ 190 (360)
-+..|+|+|++ +.+|.+.++ +++.+++..+..++.|++.||+|+|+.+ ++||||||.|++++.+..+|++
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~ 167 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKIC 167 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEec
Confidence 45689999999 669999983 4566999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCcceecccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc---------
Q 018128 191 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN--------- 260 (360)
Q Consensus 191 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~--------- 260 (360)
|||+++...........+....|.+|.|||++. ...|+.+.||||+|||+.||++|++.|.+.+.-....
T Consensus 168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 999999754332233335566888999999876 5679999999999999999999999886444211110
Q ss_pred ----hhc----cchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 261 ----LVS----WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 261 ----~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+.. ...++...-. ......+...+ ++......+|+.+||..||.+|+|++|+|+
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp---~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLP---QIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCC---CCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 0111111100 00000001112 366778999999999999999999999996
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=308.20 Aligned_cols=251 Identities=25% Similarity=0.280 Sum_probs=197.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
..|++++.||+|+||+||++++. +++.||+|++..... .....+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999765 589999999876432 23356888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 81 DYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999999854 456899999999999999999999999 99999999999999999999999998753211
Q ss_pred CCCc---------------------------------------------ceecccccccccccccccccCCCCcchhhHH
Q 018128 201 GDNT---------------------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 235 (360)
Q Consensus 201 ~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiws 235 (360)
.... .......|+..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 0000 0011246899999999999888999999999
Q ss_pred HHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc--ccccCCCChhhHHHHHHHHhhhc--ccCCCCCC
Q 018128 236 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD--PLLHGRYPRRCLNYAVAVTAMCL--NEEANFRP 311 (360)
Q Consensus 236 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l--~~dp~~Rp 311 (360)
|||++|+|++|..||......... ..+.. ..........++.++.++|.+|+ ..+|..||
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQ----------------LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHH----------------HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence 999999999999999643311100 00000 00111112245678889998855 45555699
Q ss_pred CHHHHHH
Q 018128 312 LINDIVV 318 (360)
Q Consensus 312 t~~eil~ 318 (360)
++.+++.
T Consensus 298 ~~~~~l~ 304 (381)
T cd05626 298 GADDIKA 304 (381)
T ss_pred CHHHHhc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=300.98 Aligned_cols=251 Identities=27% Similarity=0.348 Sum_probs=199.3
Q ss_pred cccccceeccCCCeEEEEEEec----CCCEEEEEEcccCC----ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCee
Q 018128 46 NFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEG----LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~ 116 (360)
+|++.+.||+|+||+||+++.. .++.|++|++.... ....+.+..|+.+++.+ +||+|+++++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999753 57899999986432 12334677899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999853 456899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
........ ......|+..|+|||++.+. .++.++|||||||++|+|++|..||.......... ........
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~----- 225 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK----- 225 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-----
Confidence 53222221 12235689999999998765 47889999999999999999999996433211100 00000000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
....++...+..+.+++.+||+.||.+|| +++++++
T Consensus 226 -------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11123445677899999999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=289.89 Aligned_cols=253 Identities=31% Similarity=0.482 Sum_probs=207.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
+...+|++.+.||.|++|.||.+... ++.+++|.+..... ...++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 34678999999999999999999876 78899999876643 45678899999999999999999999998999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++++++|.+++... ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 81 YMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999652 2236899999999999999999999999 999999999999999999999999998754211
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. .....+..|+|||.+....++.++||||||+++|++++ |..||....... . ...+.
T Consensus 156 ~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~--------------~~~~~ 213 (256)
T cd05039 156 Q-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V--------------VPHVE 213 (256)
T ss_pred c-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---H--------------HHHHh
Confidence 1 12334567999999988889999999999999999997 998985322110 0 00000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
.......+..++..+.++|.+||..+|.+||++.++++.|.++
T Consensus 214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 214 KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0111122345678899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=300.85 Aligned_cols=264 Identities=27% Similarity=0.278 Sum_probs=220.0
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecC-CCEEEEEEcccCCcc---chHHHHHHHHHhhccC-CCcccceeEEEEeCCe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~ 115 (360)
.-....|++.+.||+|.||.||.++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+.+. ||||+.+++++++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3446789999999999999999998774 999999999876553 3468999999999998 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC----CceEEee
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND----FNPKLSD 191 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~----~~v~L~D 191 (360)
.++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.| ++|+||||+|+|+... +.++++|
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 99999999999999999663 3999999999999999999999999 9999999999999433 4799999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
||++..... .......+|++.|+|||++....++...||||+|+++|.|++|..||............ ..
T Consensus 183 FGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i------~~- 252 (382)
T KOG0032|consen 183 FGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI------LR- 252 (382)
T ss_pred CCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH------Hc-
Confidence 999987544 44556688999999999999999999999999999999999999999744322211100 00
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCCCCC
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGARG 340 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~~~~ 340 (360)
.+..+....-..++....++|.+|+..||..|+|+.++|+ |||....+...
T Consensus 253 -------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~-----------HpWi~~~~~~~ 303 (382)
T KOG0032|consen 253 -------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ-----------HPWIKSIGEAT 303 (382)
T ss_pred -------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc-----------CccccCCcccc
Confidence 0001111223456888999999999999999999999996 89988654443
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=301.81 Aligned_cols=241 Identities=28% Similarity=0.377 Sum_probs=194.9
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCC-CcccceeEEEEeCCeeEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~-p~i~~~~~~~~~~~~~~lv~ 120 (360)
+|++.+.||+|+||.||+++.. +++.||+|++.... ......+..|..++..+.| ++|+++++.+.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999866 57899999987542 2234567788888888875 46888999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998843 456899999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. ........|+..|+|||++.+..++.++||||+||++|+|++|..||....... ... .+..
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~----------~i~~ 215 (324)
T cd05587 154 G--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQ----------SIME 215 (324)
T ss_pred C--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHH----------HHHc
Confidence 1 112233568999999999999999999999999999999999999996332110 000 0000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
....++...+.++.+++.+||+.||.+|++.
T Consensus 216 --~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 --HNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1112345667789999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=302.06 Aligned_cols=236 Identities=29% Similarity=0.404 Sum_probs=191.2
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||+||+++++ +++.|++|++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 58899999986542 22345566788888766 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..... ...
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCC
Confidence 999998843 457999999999999999999999999 99999999999999999999999999864221 112
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... ........ . ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~----------~--~~ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN----------D--EV 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhc----------C--CC
Confidence 223456899999999999889999999999999999999999999743211 00001100 0 01
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
.++...+.++.++|.+||+.||.+||++
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2344567789999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=306.01 Aligned_cols=210 Identities=26% Similarity=0.348 Sum_probs=177.2
Q ss_pred ccccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-C-----Ccccc
Q 018128 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-H-----DNLVT 105 (360)
Q Consensus 33 ~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~-----p~i~~ 105 (360)
..+.+..-.+...+|++.++||+|+||.|..|.+. +++.||||++... ..-..+...|+.+|..++ | -|+++
T Consensus 174 ~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr 252 (586)
T KOG0667|consen 174 GDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVR 252 (586)
T ss_pred CceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence 33444445566669999999999999999999654 6999999998765 344567778999999986 3 39999
Q ss_pred eeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC
Q 018128 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 185 (360)
Q Consensus 106 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~ 185 (360)
++++|...+++|||+|.+ ..+|.+++.. ++-.+++...++.++.||+.||..||..+ |||+||||+|||+.+.+
T Consensus 253 m~d~F~fr~HlciVfELL-~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 253 MLDYFYFRNHLCIVFELL-STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPK 326 (586)
T ss_pred eeeccccccceeeeehhh-hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCC
Confidence 999999999999999999 6699999987 45566999999999999999999999999 99999999999996554
Q ss_pred --ceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccC
Q 018128 186 --NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 254 (360)
Q Consensus 186 --~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~ 254 (360)
.||++|||++......-. ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|...+
T Consensus 327 r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 699999999975332222 3456677999999999999999999999999999999987775444
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=291.36 Aligned_cols=261 Identities=25% Similarity=0.332 Sum_probs=210.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+|++.+.||.|++|.||++... +++.+++|.+..... .....+.+|+.+++.++||||+++++.+.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47999999999999999999864 689999998765432 23357888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.........+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998765545667999999999999999999999999 99999999999999999999999998875332
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...... ......
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-------~~~~~~- 224 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-------KIEQCD- 224 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh-------hhhcCC-
Confidence 22 1122345788899999998888999999999999999999999998632211 001000 000000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
.....+...+..+.+++.+||+.||++|||+.+|++.+.++.
T Consensus 225 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 --YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000112346778999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=293.60 Aligned_cols=258 Identities=31% Similarity=0.475 Sum_probs=204.0
Q ss_pred hcccccceeccCCCeEEEEEEe-----cCCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~-----~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
..|++.+.||+|+||+||++.. ..+..+++|.+..... .....+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5789999999999999999974 2467899998875432 233568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC
Q 018128 119 VYEYMPMGSLEDHLYDLEP-------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 185 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~ 185 (360)
+|||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 1235788999999999999999999998 99999999999999999
Q ss_pred ceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhcc
Q 018128 186 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSW 264 (360)
Q Consensus 186 ~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 264 (360)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence 999999999975433332222233345677999999988889999999999999999998 88888532210 0000
Q ss_pred chhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
.+........+..++..+.+++.+||+.||.+||++.++++.|..
T Consensus 238 -------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 -------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 000000111234567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=291.92 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=203.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCC----EEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~----~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
.+.|++.+.||.|++|+||.+... +++ .+++|.+..... ....++..|+..++.++||||+++++++. ....+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 468999999999999999999764 344 477787754322 22356777888899999999999999875 45578
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+++|++++++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||+|+||++++++.++|+|||.+..
T Consensus 85 ~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 89999999999999965 3457899999999999999999999998 99999999999999999999999999975
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..............++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----------------~ 221 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-----------------P 221 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------H
Confidence 433332222333456778999999988889999999999999999998 9999863321110 0
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
+++........+..++.++.+++.+||..||.+||++.|+++.|..+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 222 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 001111111112234567889999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=293.84 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=204.2
Q ss_pred HHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
+..++|++.+.||+|++|.||.+.+. .+..+++|.+...... ....+..|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 34678999999999999999999764 3567899987654322 2346888999999999999999999998888
Q ss_pred eeEEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC---ceE
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPK 188 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~---~v~ 188 (360)
..+++||++++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++ .++
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 99999999999999999966432 1235889999999999999999999999 99999999999998654 589
Q ss_pred EeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchh
Q 018128 189 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||....... ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~----- 231 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM----- 231 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH-----
Confidence 999999875422221111112233567999999998899999999999999999997 999986332111 00
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
..+........+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 232 ---------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 ---------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 001111112234556778999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=294.93 Aligned_cols=259 Identities=31% Similarity=0.454 Sum_probs=205.8
Q ss_pred HhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
...+|++.+.||+|+||.||.+... ++..+++|.+..........+.+|++.++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 3568899999999999999999632 3567889987765555567889999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC
Q 018128 117 LLVYEYMPMGSLEDHLYDLEP-----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF 185 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~ 185 (360)
+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence 999999999999999965331 1135889999999999999999999999 99999999999999999
Q ss_pred ceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhcc
Q 018128 186 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSW 264 (360)
Q Consensus 186 ~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~ 264 (360)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----- 234 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI----- 234 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH-----
Confidence 999999999865332222222222334678999999998899999999999999999998 88898532211100
Q ss_pred chhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
... ........+..++..+.+++.+||+.||.+||++.++++.|.
T Consensus 235 -----------~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 -----------ECI-TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----------HHH-HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 000011223456678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=301.16 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=196.2
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||.||++++. +++.||+|++..... .....+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999876 588999999875422 2234577899999888 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.... ....
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccc--cCCC
Confidence 999988843 467999999999999999999999999 9999999999999999999999999986311 1122
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCc--cchhccchhhhhccccchhcccccc
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE--QNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||+....... .....+... .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~~~~~-- 220 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ---------VILEK-- 220 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH---------HHHcC--
Confidence 22345689999999999999999999999999999999999999974332211 111111100 01111
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCC------HHHHH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPL------INDIV 317 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt------~~eil 317 (360)
....+..++..+.++|.+||+.||.+|++ +.+++
T Consensus 221 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 221 QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 11234556778999999999999999998 56666
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=306.75 Aligned_cols=261 Identities=21% Similarity=0.207 Sum_probs=197.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
...+|++.+.||.|++|.||++.+. +++.||+|... ...+.+|+.+++.++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 4468999999999999999999865 68899999643 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++ .++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 164 ~~-~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RY-KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cC-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 98 4688888843 456899999999999999999999998 999999999999999999999999998642221
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccC-c----cchhccch-------hhh
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG-E----QNLVSWSR-------PFL 269 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~-~----~~~~~~~~-------~~~ 269 (360)
. ........|+..|+|||++.+..++.++|||||||++|+|++|..||....... . ..+..... .+.
T Consensus 236 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 N-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred c-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1 112233568999999999999899999999999999999999998764322110 0 00000000 000
Q ss_pred hc-cccchhcc---------cccccCC--CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 270 KD-QKKFVHLV---------DPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 270 ~~-~~~~~~~~---------~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ........ .+..... .....+.++.++|.+||+.||.+|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 00000000 0000000 01135668999999999999999999999994
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=305.38 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=196.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+|++.+.||+|+||+||++... +++.||+|++..... .....+..|+.++..++||+|+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999765 589999999865422 23356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999953 567999999999999999999999999 99999999999999999999999999874322
Q ss_pred CCCc---------------------------------ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCC
Q 018128 201 GDNT---------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247 (360)
Q Consensus 201 ~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~ 247 (360)
.... .......|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012346899999999999999999999999999999999999
Q ss_pred CcccccCccCccchhccchhhhhccccchhcccccccCCCC--hhhHHHHHHHHhhhcc--cCCCCCCCHHHHHHH
Q 018128 248 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLN--EEANFRPLINDIVVA 319 (360)
Q Consensus 248 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~--~dp~~Rpt~~eil~~ 319 (360)
.||........ . ..+........++ ...+.++.++|.+|+. .++..||++.|+++-
T Consensus 234 ~Pf~~~~~~~~------~----------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQET------Y----------KKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHH------H----------HHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99964321100 0 0000000000111 1345678888888665 233356899999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=301.98 Aligned_cols=237 Identities=27% Similarity=0.343 Sum_probs=188.7
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHH-HHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~-~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||.||++++. +++.|++|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 588999999865422 2223344444 467888999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|...+. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~ 151 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEE 151 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCC
Confidence 99988884 3467899999999999999999999999 99999999999999999999999999864211 122
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......++..|+|||.+.+..++.++|||||||++|+|++|..||..... ...... +... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~----------i~~~--~~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDN----------ILHK--PL 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHH----------HhcC--CC
Confidence 23345688999999999988999999999999999999999999964321 000001 1110 11
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLIN 314 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 314 (360)
..+...+..+.++|.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23455677899999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=294.69 Aligned_cols=247 Identities=28% Similarity=0.414 Sum_probs=198.4
Q ss_pred eccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 53 Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
||+|+||+||++.+. +++.+++|.+...... ....+..|+.+++.++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 6899999998654322 234567899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceec
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~ 208 (360)
.+++......+..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9988665556678999999999999999999999999 99999999999999999999999999875332221 122
Q ss_pred ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCC
Q 018128 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 288 (360)
Q Consensus 209 ~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
...++..|+|||.+.+..++.++||||||+++|+|++|..||......... .. ........ ...++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~----------~~~~~~~~--~~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KE----------LKQRILND--SVTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HH----------HHHhhccc--CCCCc
Confidence 346888999999999999999999999999999999999999643221100 00 00000110 01234
Q ss_pred hhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 289 RRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 289 ~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
..++..+.+++.+||+.||.+|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 56778899999999999999999 6677774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=305.15 Aligned_cols=241 Identities=28% Similarity=0.350 Sum_probs=195.7
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
+.||+|+||.||++.+. +++.|++|++..... .....+..|+++++.++||||++++.++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999865 689999999875422 23356678999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 127 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 127 sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
+|..++. ....+++..++.++.||+.||.|||+ .+ ++|+||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~ 151 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGA 151 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCc
Confidence 9998884 34578999999999999999999997 78 99999999999999999999999999864221 111
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......++..|+|||++.+..++.++|||||||++|+|++|..||......... ..+.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~----------------~~i~~--~~~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----------------ELILM--EEI 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH----------------HHHhc--CCC
Confidence 222346899999999999989999999999999999999999999633211000 00000 011
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
.++..++.++.++|.+||+.||.+|+ ++.++++
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 23455677899999999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=303.50 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=195.9
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccC--CccchHHHHHHHHHhhccCCCcccceeEEEEeC-----CeeE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRL 117 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-----~~~~ 117 (360)
+|++.+.||.|++|.||++.+. +++.|++|.+... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999865 6899999988643 223345688999999999999999999887533 3479
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+. ++|.+++. ....+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999994 68998884 3456999999999999999999999999 99999999999999999999999999874
Q ss_pred cCCCCC-cceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-c--------cc
Q 018128 198 GPVGDN-THVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-S--------WS 265 (360)
Q Consensus 198 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~--------~~ 265 (360)
...... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||............ . ..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 322211 112233568899999998865 67899999999999999999999999643211100000 0 00
Q ss_pred hhhhhc-cccchhcccccccCC---CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 RPFLKD-QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...... .......+....... ..+..+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 000000000000000 01234567899999999999999999999994
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=308.77 Aligned_cols=253 Identities=23% Similarity=0.279 Sum_probs=202.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.+...+|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345678999999999999999999876 58999999986432 22334577899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence 999999999999999843 46889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceecccccccccccccccccC----CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
....... .......|++.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------------- 254 (370)
T cd05596 191 KMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------------- 254 (370)
T ss_pred eccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---------------
Confidence 5432211 122335689999999988643 47899999999999999999999996432110
Q ss_pred ccchhcccccccCCCC--hhhHHHHHHHHhhhcccCCCC--CCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANF--RPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~--Rpt~~eil~ 318 (360)
....+........++ ..++.++.++|.+||+.+|.+ |+++.++++
T Consensus 255 -~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 255 -TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -HHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 001111111011112 246788999999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=297.91 Aligned_cols=268 Identities=27% Similarity=0.418 Sum_probs=210.0
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec--------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGY 109 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~--------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~ 109 (360)
+.+...+|.+.+.||+|++|.||+++.. ....+++|.+..... .....+..|+.+++.+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 3455689999999999999999999742 245689998765422 3345688899999999 69999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 177 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~ 177 (360)
+.+....+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+++ ++|+||+|+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 163 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR 163 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccce
Confidence 9988899999999999999999965321 2345889999999999999999999998 999999999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCcc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 256 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~ 256 (360)
||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999975432222111122234457999999988889999999999999999999 88888532211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
. ... ... .......+..++..+.++|.+||+.+|.+||++.++++.|.++....
T Consensus 244 ~---~~~----~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 E---LFK----LLR----------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred H---HHH----HHH----------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1 000 000 00111224456778999999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=297.82 Aligned_cols=240 Identities=28% Similarity=0.411 Sum_probs=191.1
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhc-cCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~-l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||.||+++.. +++.||+|++.... .........|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 58899999886542 1223345556666654 4799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999998853 457899999999999999999999998 9999999999999999999999999987532221 2
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||....... .... +.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~----------i~~--~~~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDS----------ILN--DRP 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHH----------HHc--CCC
Confidence 2334568999999999998899999999999999999999999996432110 0000 000 011
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIV 317 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~-eil 317 (360)
.++..++.++.+++.+||+.||.+||++. +++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23455677889999999999999999975 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=302.21 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=195.3
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
...+|+..+.||.|+||.||++++. +++.|++|++..... .....+.+|+++++.++|+||+++++++.+....++||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 3467888999999999999999865 689999999865432 23456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+. ....+..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++.....
T Consensus 152 e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 152 EFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred ecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999988543 23467788899999999999999999 99999999999999999999999999875332
Q ss_pred CCCcceeccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
. ........++..|+|||.+.. ...+.++|||||||++|+|++|..||....... |......
T Consensus 221 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~----- 287 (353)
T PLN00034 221 T--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCA----- 287 (353)
T ss_pred c--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHH-----
Confidence 1 111233468899999998743 234568999999999999999999997322111 1000000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ........+..++.++.++|.+||+.||++||++.|+++
T Consensus 288 --~-~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 288 --I-CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --H-hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000111223456778999999999999999999999994
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.43 Aligned_cols=251 Identities=33% Similarity=0.491 Sum_probs=205.8
Q ss_pred ceeccCCCeEEEEEEecC----CCEEEEEEcccCCccc-hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||.|++|.||.+.... +..+++|.+....... ...+.+|+..++.++|+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 478999999999998653 7889999987664433 57888999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 126 GSLEDHLYDLEPD-----QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 126 ~sL~~~i~~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
++|.+++...... ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764222 477999999999999999999999998 99999999999999999999999999986544
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
...........++..|+|||.+....++.++||||||+++|+|++ |..||....... ... .+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------~~~------~~~ 221 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----------VLE------YLR 221 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH----------HHH------HHH
Confidence 333233344557888999999988889999999999999999999 688987432110 000 000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
. ......+..++.++.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 K-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred c-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 1112334566788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=289.44 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=207.5
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
|++..++|++.+.||+|++|.||++....+..+++|.+.... .....+.+|+.+++.++|+||+++++.+.+ ...+++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 356788999999999999999999987777889999876542 234678889999999999999999999877 778999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++++|.+++... .+..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 79 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999999652 3456888899999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.... .......++..|+|||.+....++.++|+||||+++|++++ |..||....... .... .
T Consensus 154 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~----~--------- 216 (260)
T cd05073 154 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRA----L--------- 216 (260)
T ss_pred CCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----H---------
Confidence 2211 11122334567999999988889999999999999999998 899986332110 0000 0
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
........+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 217 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 217 -ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -hCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 00011122345667899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.72 Aligned_cols=263 Identities=25% Similarity=0.376 Sum_probs=208.2
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCT 111 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~ 111 (360)
+....++|++.+.||+|++|.||.+... .+..+++|.+..... ...+.+.+|+.+++++ +||||+++++.+.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 4456678999999999999999999642 245799998865432 3345688999999999 7999999999999
Q ss_pred eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEee
Q 018128 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191 (360)
Q Consensus 112 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~D 191 (360)
..+..+++|||+.+++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~d 184 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICD 184 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECC
Confidence 999999999999999999999652 2344899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhh
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
||++................++..|+|||.+.+..++.++||||+|+++|+|++ |..||........ .
T Consensus 185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~--------- 253 (302)
T cd05055 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--F--------- 253 (302)
T ss_pred CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--H---------
Confidence 999875433222222222345678999999998889999999999999999998 9999863221100 0
Q ss_pred ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
............+...+..+.+++.+||+.+|++||++.++++.|.++
T Consensus 254 -----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 -----YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000000111112334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=290.38 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=202.4
Q ss_pred ccccceeccCCCeEEEEEEecC----CCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCe-----
Q 018128 47 FREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ----- 115 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~----- 115 (360)
|++.+.||+|+||.||.+.... +..+++|.+...... ....+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999997542 467999998754332 34578899999999999999999998765444
Q ss_pred -eEEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 116 -RLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 116 -~~lv~e~~~~~sL~~~i~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
.++++||+++++|..++.... .....+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999985532 22346899999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
|.+.................+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~-------- 226 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYD-------- 226 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--------
Confidence 99875433322222222334567999999988889999999999999999999 888885322110 000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
.... ......+..++..+.+++.+||+.||.+||++.++++.|.++
T Consensus 227 -----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 -----YLRH-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----HHHc-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 011123446677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=287.95 Aligned_cols=257 Identities=30% Similarity=0.440 Sum_probs=204.8
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++...+|++.+.||.|++|.||++....+..+++|.+.... ...+.+.+|+.+++.++|||++++++++. ....+++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 35567899999999999999999988776779999876543 33467888999999999999999998875 45678999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 80 EFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred EcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999999999652 2345889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.... ......++..|+|||...+..++.++||||||+++|+|++ |..||....... . ... +.
T Consensus 155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~~----------~~ 217 (260)
T cd05069 155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---V---LEQ----------VE 217 (260)
T ss_pred Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHH----------HH
Confidence 2211 1122335667999999988889999999999999999999 888986322110 0 000 00
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
. ......+...+..+.+++.+||+.||.+||+++++++.|+.
T Consensus 218 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 R-GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred c-CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0 01112234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=289.56 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=199.0
Q ss_pred ccccceeccCCCeEEEEEEecC-CC--EEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeC------Ce
Q 018128 47 FREANLIGEGGFGKVYKGRLES-GQ--LVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQ 115 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~~-~~--~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~------~~ 115 (360)
|.+++.||+|++|.||.+.... +. .+++|.+.... ....+.+.+|+..++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678999999999999998653 33 68999876542 23345688899999999999999999876322 24
Q ss_pred eEEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 116 RLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
.+++|||+.+++|.+++.... .....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874322 23355899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
++.................+..|+|||.+.+..++.++||||||+++|+|++ |..||...... ... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY----DYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHcC
Confidence 9876433222222223345678999999998899999999999999999999 78888632211 000 011100
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
. ....+..++..+.++|.+||+.||++|||+.++++.|+.+
T Consensus 231 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 N----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0112345667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=304.31 Aligned_cols=257 Identities=23% Similarity=0.295 Sum_probs=214.1
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccC--CccchHHHHHHHHHhhccC-CCcccceeEEEEeCCe
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~ 115 (360)
-|.|.++.|++++.||+||.+.||++...+.+.|++|.+... +.....-+.+|+..|..++ |.+|+++++|-..++.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 356778999999999999999999999887788888876543 3344567999999999995 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
+|||||+- ..+|...+.. ....++.-.++.+..|++.|+.++|+.| |||.||||.|+|+-. |.+||+|||.+
T Consensus 435 lYmvmE~G-d~DL~kiL~k---~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA 506 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKK---KKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIA 506 (677)
T ss_pred EEEEeecc-cccHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechh
Confidence 99999976 5699999965 3333443488999999999999999999 999999999998865 48999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCC-----------CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhcc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-----------LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 264 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 264 (360)
...............+||..||+||.+.... .+.++||||||||||+|+.|+.||.
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~------------- 573 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG------------- 573 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-------------
Confidence 9877777777778899999999999986432 4689999999999999999999997
Q ss_pred chhhhhccccchhcccccccCCCChhhHHH-HHHHHhhhcccCCCCCCCHHHHHH
Q 018128 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNY-AVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+......+..+.++....+|+..-... +.++++.||.+||.+||++.|+|+
T Consensus 574 --~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 574 --QIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 3333345566666666655655444333 999999999999999999999995
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=287.73 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=202.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc-----chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-----GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~-----~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
++|++.+.||.|++|.||.+... +++.+++|.+...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999765 5899999988654321 23467889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
++|++++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999854 456889999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 199 PVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 199 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... . . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~----~-------~~ 218 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----A----I-------FK 218 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----H----H-------HH
Confidence 2211111 1123456788999999998889999999999999999999999986321110 0 0 00
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........+..++..+.++|.+||..+|.+|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 219 IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 01111112334567778999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=297.74 Aligned_cols=241 Identities=27% Similarity=0.398 Sum_probs=194.7
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||.|+||+||++++. +++.|++|++.... ......+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 58899999987542 23345567788888877 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|..++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGV 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc--CCC
Confidence 999988843 457999999999999999999999999 99999999999999999999999998864211 111
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......++..|+|||++.+..++.++|||||||++|+|++|..||...... .... .+... ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~----------~i~~~--~~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQ----------SILED--EV 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHH----------HHHcC--CC
Confidence 222345889999999999999999999999999999999999999633211 0000 00000 11
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCH-----HHHHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 318 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~eil~ 318 (360)
.++..++..+.++|.+||+.||.+||++ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2344567889999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.49 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=207.4
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecC----CCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
++...+|++.+.||.|++|.||.+...+ ...+++|...... ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 3556789999999999999999997542 3478999886554 3445678899999999999999999998875 45
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+++||++++++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 81 VWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence 7899999999999999965 2346899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
....... ........++..|+|||.+....++.++||||||+++|++++ |..||........ .. ...
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~---~~~----- 222 (270)
T cd05056 155 RYLEDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IG---RIE----- 222 (270)
T ss_pred eeccccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH---HHH-----
Confidence 7543221 111222334567999999988889999999999999999886 9999964321110 00 000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
.......+..++..+.++|.+|+..+|.+|||+.++++.|+++...
T Consensus 223 ------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 223 ------NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011123456678899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=298.93 Aligned_cols=237 Identities=27% Similarity=0.358 Sum_probs=189.4
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHH-HhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~-~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|++|+||++++. +++.|++|++..... .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999876 689999999865422 12233444444 56778999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|..++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.... ....
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~--~~~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccc--cCCC
Confidence 999998843 567899999999999999999999999 9999999999999999999999999986421 1222
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......|+..|+|||++.+..++.++||||||+++|+|++|..||...... ..... +.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~----------i~~~~--~ 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDN----------ILNKP--L 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHH----------HHcCC--C
Confidence 233456899999999999999999999999999999999999999632210 00000 11111 1
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLIN 314 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 314 (360)
..+...+..+.++|.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 22345677899999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.98 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=205.9
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCC----EEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~----~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
+...+|++.+.||.|++|+||.+.+. +++ .|++|.+..... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 34678999999999999999999753 344 489998865433 234568889999999999999999998865 45
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+++++++++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred cEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCce
Confidence 6799999999999999854 3456899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
................++..|+|||...+..++.++|||||||++|+|++ |..||....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~------------ 221 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP------------ 221 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH------------
Confidence 76443222222222334667999999988889999999999999999998 888986322110 00
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
..+........+..++..+.++|.+||+.||++||++.++++.|..+....
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 222 --DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 001111111223456678999999999999999999999999998885544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=301.24 Aligned_cols=241 Identities=27% Similarity=0.360 Sum_probs=194.0
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||.||+++.. +++.|++|++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 58899999986542 22334566788888765 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|..++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GV 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cc
Confidence 999988843 457899999999999999999999999 999999999999999999999999998742221 12
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......++..|+|||++.+..++.++||||||+++|+|++|..||....... ....... .. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~----------~~--~ 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILH----------DD--V 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHc----------CC--C
Confidence 2233568899999999998899999999999999999999999997432111 0001100 00 1
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCC-------CHHHHHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRP-------LINDIVV 318 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rp-------t~~eil~ 318 (360)
.++...+.++.+++.+||+.||.+|| +++++++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 12344567899999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.64 Aligned_cols=278 Identities=26% Similarity=0.350 Sum_probs=213.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC-----eeE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRL 117 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~-----~~~ 117 (360)
.-+|+-.+++|.|+||.||.+... +++.+|||.+..+.. --.+|+++|+.+.||||+++.-+|.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 346888999999999999999765 589999998865532 2345999999999999999988774322 235
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-CceEEeecCCcc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAK 196 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-~~v~L~Dfg~~~ 196 (360)
+||||++. +|.++++.+...+.+++...++-+.+||.+||.|||..+ |+||||||+|+|+|.+ |.+||+|||.+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 99999966 999999887777899999999999999999999999998 9999999999999877 899999999999
Q ss_pred ccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCc-------------cchh
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-------------QNLV 262 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~-------------~~~~ 262 (360)
.....+.. .....+-.|+|||.+.+. .|+.+.||||.||++.||+.|++.|........ .++.
T Consensus 175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 76555544 334577789999998865 699999999999999999999999975433111 1111
Q ss_pred ccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhhhhhccCCCCCCC
Q 018128 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVSQRDSHPVSR 334 (360)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~--~L~~l~~~~~~~~~~~ 334 (360)
.+...+. .....++.......-+....+.+..+|+.++|+.+|.+|.++.|++. .++.+.......|+..
T Consensus 252 ~mn~~y~--~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~ 323 (364)
T KOG0658|consen 252 SMNPNYT--EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGR 323 (364)
T ss_pred hcCcccc--cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCC
Confidence 1111110 11111222222211245677889999999999999999999999996 5777766655555444
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.72 Aligned_cols=273 Identities=29% Similarity=0.426 Sum_probs=205.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-----CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe--CCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~~~ 116 (360)
..+|++.+.||.|+||.||.+..+ +++.|++|.+..........+.+|+.+++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 458999999999999999998742 478999999876655556678899999999999999999987643 3467
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++|+||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 899999999999999964 3356899999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCCcce-ecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
.......... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+......-.......... ......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 235 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG-QMIVYHL 235 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc-ccchHHH
Confidence 6433222111 1122334569999999888899999999999999999998776532211100000000000 0000000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
...+........+..++..+.++|.+||..+|++|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011111111122345677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=294.85 Aligned_cols=266 Identities=27% Similarity=0.432 Sum_probs=203.4
Q ss_pred HhhcccccceeccCCCeEEEEEEecC---------------CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccce
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLES---------------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTL 106 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~~---------------~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~ 106 (360)
..++|++.+.||+|+||.||++.... ...|++|.+..... .....+.+|++.++.++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45799999999999999999986532 23589998875422 234568899999999999999999
Q ss_pred eEEEEeCCeeEEEEEecCCCCHHHHhcccCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018128 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP--------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 178 (360)
Q Consensus 107 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~--------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~N 178 (360)
++++......++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|+||+|+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 9999999999999999999999999854221 1124788899999999999999999999 9999999999
Q ss_pred EEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CCCcccccCcc
Q 018128 179 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQ 256 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~--g~~pf~~~~~~ 256 (360)
|+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999875433222222223345678999999988889999999999999999998 56677532211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
. .......+.... ........+...+..+.++|.+||+.||++||++.+|++.|.
T Consensus 240 ~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 Q---VIENTGEFFRNQ-------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred H---HHHHHHHhhhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1 000000000000 001111123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=308.07 Aligned_cols=253 Identities=22% Similarity=0.265 Sum_probs=197.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+|++.+.||.|+||+||++... +++.|++|++..... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999765 689999998865422 23356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999853 467899999999999999999999999 99999999999999999999999999863211
Q ss_pred CCCc---------------------------------------------ceecccccccccccccccccCCCCcchhhHH
Q 018128 201 GDNT---------------------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 235 (360)
Q Consensus 201 ~~~~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiws 235 (360)
.... .......|+..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 0001235889999999999889999999999
Q ss_pred HHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCC---CC
Q 018128 236 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR---PL 312 (360)
Q Consensus 236 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---pt 312 (360)
|||++|+|++|..||........ ...... ... .+...-...++.++.++|.+||+ +|.+| ++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~------~~~i~~----~~~----~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHET------YRKIIN----WRE----TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHH------HHHHHc----cCC----ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999999964321100 000000 000 00000112356788999999998 67765 59
Q ss_pred HHHHHHH
Q 018128 313 INDIVVA 319 (360)
Q Consensus 313 ~~eil~~ 319 (360)
+.+++..
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.38 Aligned_cols=255 Identities=26% Similarity=0.349 Sum_probs=202.6
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
..++|++.+.||+|++|.||++... +++.+++|++..........+.+|+.+++.++||||+++++.+......++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 3568999999999999999999864 688999999876655555678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999998843 457899999999999999999999998 999999999999999999999999998754221
Q ss_pred CCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
........++..|+|||.+. ...++.++|+||+|+++|+|++|..||......... .... . ...
T Consensus 160 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~------~---~~~ 226 (267)
T cd06646 160 --IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMS------K---SNF 226 (267)
T ss_pred --ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeee------c---CCC
Confidence 11122345778899999874 345788999999999999999999998532211100 0000 0 000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
..+.. .....++..+.++|.+||+.+|++||+++++++.
T Consensus 227 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 227 QPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 00000 1122456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.74 Aligned_cols=240 Identities=27% Similarity=0.398 Sum_probs=191.9
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||.||++++. +++.|++|.+.... .........|..++... +||+|+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 58899999986542 12334566677777654 899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|..++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++..... ...
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDN 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCC
Confidence 999998843 467899999999999999999999999 99999999999999999999999999864211 112
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......|+..|+|||++.+..++.++||||||+++|+|++|..||....... ..... .. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~------~~~~~----------~~--~~~ 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE------LFESI----------RV--DTP 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHH----------Hh--CCC
Confidence 2234568999999999999999999999999999999999999996432110 00000 00 011
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIV 317 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~-eil 317 (360)
.++...+.++.++|.+||+.||++||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23344667899999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.90 Aligned_cols=252 Identities=28% Similarity=0.419 Sum_probs=202.2
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEE-EeCCeeEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVY 120 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~-~~~~~~~lv~ 120 (360)
+..++|++.+.||+|++|.||++... +..+++|.+.... ....+.+|+.+++.++|+|++++++++ ...+..++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 34578999999999999999999776 7889999876442 345688999999999999999999875 4556789999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++... ....+++..++.++.|++.||.+||+++ ++|+||+|+||++++++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999999998652 2345889999999999999999999998 99999999999999999999999999874322
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. .....+..|+|||.+.+..++.++||||||+++|+|++ |..||..... .......
T Consensus 155 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~----------- 212 (256)
T cd05082 155 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRV----------- 212 (256)
T ss_pred cC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-----------
Confidence 11 12234567999999988889999999999999999997 8888863211 0000000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00111123345678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=293.93 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=202.3
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
+|++.+.||.|+||+||++.+. +++.||+|++...... ....+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 5899999999999999999865 6899999998654322 22456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988854 23456899999999999999999999999 999999999999999999999999998753322
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. ......++..|+|||.+.+..++.++||||+|+++|+|++|..||........ .. . ....+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~----~-------~~~~~~~ 219 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--RE----E-------VERRVKE 219 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HH----H-------HHHHhhh
Confidence 1 11234678899999999988899999999999999999999999974321100 00 0 0000000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
....++..++..+.++|.+||+.||.+|| ++.++++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11123456778899999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=304.07 Aligned_cols=255 Identities=23% Similarity=0.285 Sum_probs=201.1
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
.+.+...+|++.+.||+|+||.||++++. +++.+|+|++.... ......+.+|+.+++.++||||+++++.+.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445679999999999999999999876 58899999986432 223345778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999999943 45899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccC----CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
+........ .......|+..|+|||++.+. .++.++||||+||++|+|++|..||.......
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------------- 254 (370)
T cd05621 189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------------- 254 (370)
T ss_pred ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-------------
Confidence 875432211 122345689999999998754 37889999999999999999999996432110
Q ss_pred ccccchhcccccccCCCC--hhhHHHHHHHHhhhcccCCCC--CCCHHHHHH
Q 018128 271 DQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANF--RPLINDIVV 318 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~--Rpt~~eil~ 318 (360)
....+........++ ...+..+.++|..||+.++.+ |+++.|+++
T Consensus 255 ---~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 255 ---TYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred ---HHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 001111111011111 245778899999999855543 899999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=295.06 Aligned_cols=265 Identities=25% Similarity=0.333 Sum_probs=194.5
Q ss_pred hcccccceeccCCCeEEEEEEec--CCCEEEEEEcccCCcc--chHHHHHHHHHhhcc---CCCcccceeEEEE-----e
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL---HHDNLVTLIGYCT-----S 112 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~--~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l---~~p~i~~~~~~~~-----~ 112 (360)
++|++.+.||+|+||+||++++. .++.+++|.+...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 48999999999999999999863 4688999988654322 223455677666655 6999999999875 3
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....++|||+++ ++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999995 5999998652 2345899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhccch-----
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSR----- 266 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~----- 266 (360)
|++...... .......++..|+|||.+.+..++.++||||||+++|+|++|.+||.......... ......
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 998754322 22233568899999999988899999999999999999999999997543211100 000000
Q ss_pred hhhhccccchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 267 PFLKDQKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+................. ...+..+..+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000000000000 012345677899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.71 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=206.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
..++|++.+.||.|++|.||++... +++.|++|.+........+.+.+|+.+++.++||||+++++.+......++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 3589999999999999999999864 699999999877665666778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++.. ..+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999843 46889999999999999999999998 999999999999999999999999998753222
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. .......++..|+|||.+.+..++.++|+||||+++|++++|..||......... ... ....
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~~-------------~~~~ 231 (297)
T cd06656 169 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLI-------------ATNG 231 (297)
T ss_pred c--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--eee-------------ccCC
Confidence 1 1223345788899999999888999999999999999999999999643221100 000 0000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......+...+..+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001123456677899999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.02 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=205.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
..+|++.+.||.|++|.||++... +++.+++|.+..........+.+|+.+++.+.|||++++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 469999999999999999999865 6899999998876666667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. ..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999843 45889999999999999999999999 9999999999999999999999999887532211
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ... .. ....
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~----~~---------~~~~ 233 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL----IA---------TNGT 233 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH----Hh---------cCCC
Confidence 112234578899999999888889999999999999999999999964332110 000 00 0000
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+...+..+.++|.+||..+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011123456678999999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.88 Aligned_cols=262 Identities=29% Similarity=0.438 Sum_probs=204.1
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCC--EEEEEEcccCC-ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQ--LVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~--~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~l 118 (360)
-++|++.+.||.|+||.||+|.+. ++. .+++|.+.... ......+.+|+.++..+ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 458999999999999999999865 354 45676654322 22335678899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 119 VYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
+|||+++++|.+++..... ....+++..++.++.|++.||.+||+++ ++||||+|+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999965321 2246889999999999999999999999 999999999999999999
Q ss_pred eEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccc
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 265 (360)
++|+|||++..... .........+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~ 233 (303)
T cd05088 163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY 233 (303)
T ss_pred EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HH
Confidence 99999999863211 111111234567999999988889999999999999999998 999986322110 00
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
... ........+...+..+.+++.+||+.+|++||++.++++.|..+.....
T Consensus 234 ~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 234 EKL-----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHH-----------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 000 0001111233456788999999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=285.00 Aligned_cols=248 Identities=29% Similarity=0.426 Sum_probs=200.1
Q ss_pred ceeccCCCeEEEEEEecCCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHH
Q 018128 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 129 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 129 (360)
+.||.|++|.||.+....++.+++|.+...... ....+.+|+.+++.++||||+++++++.+....++|||++++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 478999999999998766999999988765444 4567889999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecc
Q 018128 130 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 209 (360)
Q Consensus 130 ~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~ 209 (360)
+++.. ....+++..++.++.+++.+|.+||+++ ++|+||+|+||+++.++.++|+|||.+..............
T Consensus 81 ~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99865 3346889999999999999999999999 99999999999999999999999999875332111111112
Q ss_pred cccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccccCCCC
Q 018128 210 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 288 (360)
Q Consensus 210 ~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
...+..|+|||.+.+..++.++|+||||+++|+|++ |..||......... ...........+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-----------------~~~~~~~~~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-----------------ERIESGYRMPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-----------------HHHhcCCCCCCC
Confidence 233567999999988889999999999999999998 78888543211100 000011111234
Q ss_pred hhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 289 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 289 ~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
...+.++.+++.+||+.+|.+||++.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 456778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=285.76 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=203.9
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.|++.+.||+|++|.||++... +++.+++|.+.... ......+.+|+++++.++|||++++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4888999999999999999875 58999999886542 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++... .+..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999762 2467899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||.+.+..++.++|+||||+++++|++|..||....... ... .... .
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~----------~~~~-~ 216 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LIL----------KIIR-G 216 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHH----------HHHc-C
Confidence 12233457888999999998889999999999999999999999996433110 000 0000 0
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++..+.+++.+||+.+|++||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 111223356778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=308.04 Aligned_cols=251 Identities=24% Similarity=0.290 Sum_probs=198.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|++|.||++++. +++.||+|++..... .....+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999865 589999999865422 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999954 456899999999999999999999999 99999999999999999999999998753211
Q ss_pred CCCc-----------------------------------------ceecccccccccccccccccCCCCcchhhHHHHHH
Q 018128 201 GDNT-----------------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 239 (360)
Q Consensus 201 ~~~~-----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~i 239 (360)
.... .......|+..|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 0000 00112468999999999999999999999999999
Q ss_pred HHHHHhCCCcccccCccCcc-chhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC---CHHH
Q 018128 240 LLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP---LIND 315 (360)
Q Consensus 240 l~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---t~~e 315 (360)
+|+|++|..||......... ....+. ..........++..+.++|.+|+ .+|.+|+ ++.+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999999743321100 000000 00011112245677888998876 5999999 8999
Q ss_pred HHH
Q 018128 316 IVV 318 (360)
Q Consensus 316 il~ 318 (360)
++.
T Consensus 298 ll~ 300 (376)
T cd05598 298 IKA 300 (376)
T ss_pred HhC
Confidence 885
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=299.45 Aligned_cols=243 Identities=27% Similarity=0.381 Sum_probs=192.8
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||+||+++.. +++.+++|++..... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999876 588999999875422 2334577788888766 799999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|..++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~ 151 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGD 151 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCC
Confidence 99998884 3467999999999999999999999999 99999999999999999999999999864211 112
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc--chhccchhhhhccccchhcccccc
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ--NLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
......|+..|+|||++.+..++.++||||||+++|+|++|..||......... ....+... .+.. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~i~~--~ 220 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---------VILE--K 220 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH---------HHhc--C
Confidence 223456899999999999999999999999999999999999999643221111 00111000 0011 1
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
...++...+..+.++|.+||+.||.+||++
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 113455677889999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=304.07 Aligned_cols=267 Identities=26% Similarity=0.376 Sum_probs=210.8
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCcc-chHHHHHHHHHhhccC-CCcccceeEEE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLH-HDNLVTLIGYC 110 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~-~p~i~~~~~~~ 110 (360)
++.+..++|.+.+.||.|+||.||++++. .++.|++|++...... ....+.+|+.++..+. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 47778889999999999999999999753 3468999999765332 2346888999999997 99999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCC-----------------------------------------------------
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEP----------------------------------------------------- 137 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~----------------------------------------------------- 137 (360)
......++||||+++|+|.+++.....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 998999999999999999999965321
Q ss_pred -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 018128 138 -----------------------------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 176 (360)
Q Consensus 138 -----------------------------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p 176 (360)
....+++..++.++.||+.||.|||+.+ ++|+||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 1124677788999999999999999998 99999999
Q ss_pred CcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCc
Q 018128 177 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKG 255 (360)
Q Consensus 177 ~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~ 255 (360)
+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999875332222111222345678999999998889999999999999999998 8889853221
Q ss_pred cCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 256 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
... ....+........+..++.++.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 348 ~~~----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQ----------------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHH----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 100 00000011111234456788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=292.17 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=203.3
Q ss_pred hcccccceeccCCCeEEEEEEecC-C--CEEEEEEcccC-CccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLES-G--QLVAIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~~-~--~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv 119 (360)
++|++.+.||.|++|.||.+.... + ..+++|.+... .......+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999997653 3 34688877532 223345688899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 120 YEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
+||+++++|.+++..... ....+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965221 1235889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccch
Q 018128 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+|+|||++..... .........+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~- 228 (297)
T cd05089 159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LY- 228 (297)
T ss_pred EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-
Confidence 9999999863211 111111223457999999988889999999999999999997 999986322110 00
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
... ........+..++..+.+++.+||+.+|.+||++.++++.|..+....
T Consensus 229 ---------~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 229 ---------EKL-PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------HHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 000 001111223456778999999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=288.17 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=204.4
Q ss_pred hhcccccceeccCCCeEEEEEEec-C---CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-S---GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~---~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
..+|++.+.||.|+||.||.+.+. + +..+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 578999999999999999999754 2 34799998865432 234578889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
+||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999965 3356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcce-ecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccch
Q 018128 199 PVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 199 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
........ ......+..|+|||.+.+..++.++|+||||+++|++++ |..||....... ... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~---~~~------- 223 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK---AIE------- 223 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH---HHh-------
Confidence 33221111 111223467999999998889999999999999999886 999986332110 000 000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
. ......+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 224 ---~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 ---E-GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---C-CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 001122334567889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=305.56 Aligned_cols=250 Identities=23% Similarity=0.270 Sum_probs=196.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+|++++.||+|+||+||+++.. +++.|++|++..... .....+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999865 588999999875432 23456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 81 DYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999999854 356899999999999999999999999 99999999999999999999999998753210
Q ss_pred CCC---------------------------------------------cceecccccccccccccccccCCCCcchhhHH
Q 018128 201 GDN---------------------------------------------THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 235 (360)
Q Consensus 201 ~~~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiws 235 (360)
... ........|+..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 000 00011245889999999999989999999999
Q ss_pred HHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc--ccccCCCChhhHHHHHHHHhhhcccCCCCCCC-
Q 018128 236 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD--PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL- 312 (360)
Q Consensus 236 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt- 312 (360)
|||++|+|++|..||......... ..+.. ...........+.+..++|.+|+ .+|.+|++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~----------------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~ 296 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQ----------------MKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK 296 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHH----------------HHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence 999999999999999643211000 00000 00111112345677888888876 49999997
Q ss_pred --HHHHHH
Q 018128 313 --INDIVV 318 (360)
Q Consensus 313 --~~eil~ 318 (360)
+.++++
T Consensus 297 ~~~~ei~~ 304 (382)
T cd05625 297 NGADEIKA 304 (382)
T ss_pred CCHHHHhc
Confidence 877764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=305.53 Aligned_cols=269 Identities=28% Similarity=0.442 Sum_probs=222.7
Q ss_pred cHHHHHHHhhcccccceeccCCCeEEEEEEecC--C--CE-EEEEEcccCC---ccchHHHHHHHHHhhccCCCccccee
Q 018128 36 TFRELAIATRNFREANLIGEGGFGKVYKGRLES--G--QL-VAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLI 107 (360)
Q Consensus 36 ~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~--~--~~-v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~ 107 (360)
.-..|++.+.+-.+.+.||.|+||.||.++... + .. ||+|...... .....++.+|.+++++++||||++++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 345688889999999999999999999997552 2 23 8999877532 34456799999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 108 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
++......+++|||+|.||+|.+++.. ....++..+...++.+.+.||+|||+++ ++||||..+|+|++.++.+
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeE
Confidence 999999999999999999999999966 3346999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCcceec-ccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccc
Q 018128 188 KLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 265 (360)
||+|||+++... ...... ...-+..|+|||.+....+++++||||||+++||+++ |..||......
T Consensus 302 KISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------- 369 (474)
T KOG0194|consen 302 KISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------- 369 (474)
T ss_pred EeCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---------
Confidence 999999987432 222222 2345678999999999999999999999999999999 77888643311
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
.....++....+...+...+.++..++.+||..+|++||++.++.+.|+.+......
T Consensus 370 -------~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 370 -------EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -------HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111222233344455678899999999999999999999999999999999776554
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=289.84 Aligned_cols=252 Identities=33% Similarity=0.506 Sum_probs=202.0
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchH--HHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~--~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
|++++.||+|++|+||+++.. +++.+|+|++......... ....|+..++.++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 789999999999999999877 4678999999877544333 2355999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++++|.+++. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 9999999995 3577899999999999999999999999 999999999999999999999999998753 233
Q ss_pred cceecccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
........++..|+|||++. +...+.++||||||+++|+|++|..||............. .... .......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~-----~~~~~~~ 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILK-----RPLPSSS 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHH-----THHHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hccc-----ccccccc
Confidence 33444567888999999998 8889999999999999999999999997441100000000 0000 0000000
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........+.++|.+||+.||++||++.++++
T Consensus 224 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 ---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001122378999999999999999999999983
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.71 Aligned_cols=263 Identities=26% Similarity=0.351 Sum_probs=197.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeC--------
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-------- 113 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-------- 113 (360)
...+|++++.||+|+||.||++... +++.||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3568999999999999999999875 58999999885432 3345799999999999999998876432
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeec
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDF 192 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Df 192 (360)
..+++||||++ ++|.+++..+...+..+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .++|+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 24679999996 4888888665556778999999999999999999999999 99999999999998665 6999999
Q ss_pred CCccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch----h
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR----P 267 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----~ 267 (360)
|++....... ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||....... .+..... +
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence 9997543222 1223457889999998875 468999999999999999999999996433211 0000000 0
Q ss_pred h---hh-ccc-----cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 F---LK-DQK-----KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ~---~~-~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .. ... .........+...++...+.++.+||.+||+.||.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 00 000 000011111111234456778999999999999999999999995
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=291.64 Aligned_cols=265 Identities=27% Similarity=0.437 Sum_probs=205.7
Q ss_pred hhcccccceeccCCCeEEEEEEecC-----------------CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccc
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLES-----------------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVT 105 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~-----------------~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~ 105 (360)
.++|++.+.||+|+||.||++.... +..+++|.+..... ...+.+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999987542 24589998875533 33467888999999999999999
Q ss_pred eeEEEEeCCeeEEEEEecCCCCHHHHhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018128 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 178 (360)
Q Consensus 106 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~N 178 (360)
+++++..+...+++||++.+++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999965331 1236899999999999999999999999 9999999999
Q ss_pred EEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CCCcccccCcc
Q 018128 179 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQ 256 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~--g~~pf~~~~~~ 256 (360)
|+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433332233334456678999999988889999999999999999998 66777532211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
............. ........+..++.++.+++.+||+.||.+|||+.+|++.|.
T Consensus 241 ---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 0000000000000 001111123456678999999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=291.76 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=204.1
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
....++|++.+.||.|++|.||++++. +++.+++|.+..........+.+|+.+++.++||||+++++.+..+...++|
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 345688999999999999999999876 4899999998776655667788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++++|..++.+ ....+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 88 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 88 IEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred EecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999888754 3456899999999999999999999998 9999999999999999999999999876422
Q ss_pred CCCCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
. .........++..|+|||.+. ...++.++|+||||+++|+|++|..||....... .......
T Consensus 162 ~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~---- 229 (292)
T cd06644 162 K--TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK---- 229 (292)
T ss_pred c--cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhc----
Confidence 1 112223345778899999874 3457889999999999999999999986322100 0000000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...+ ....+..++.++.++|.+||+.+|++||++.++++
T Consensus 230 ---~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 230 ---SEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 00123355667899999999999999999999984
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=299.09 Aligned_cols=241 Identities=27% Similarity=0.369 Sum_probs=194.8
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
+|++.+.||+|+||.||++++. +++.|++|++..... ........|..++..+ +||+|+++++.+.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999876 578999999875422 2233456677777766 5899999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998843 456899999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.........|+..|+|||++.+..++.++|||||||++|+|++|..||....... . . ..+..
T Consensus 154 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~---~----------~~i~~ 215 (323)
T cd05616 154 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L---F----------QSIME 215 (323)
T ss_pred --CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H---H----------HHHHh
Confidence 1122234568999999999999999999999999999999999999996432110 0 0 00110
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
....++...+.++.+++.+||+.||.+|++.
T Consensus 216 --~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 --HNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0112345677889999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=293.40 Aligned_cols=265 Identities=25% Similarity=0.360 Sum_probs=199.3
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.+|++.+.||.|+||.||+++.. +++.+++|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999876 588899998865432 2234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++ +|.+++.. .+..+++..++.++.||+.||.|||+++ ++||||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 965 88888754 3456899999999999999999999999 9999999999999999999999999987532211
Q ss_pred Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-ccc----h---hhhhccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS----R---PFLKDQK 273 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~----~---~~~~~~~ 273 (360)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ ... . +......
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12223456889999998865 56889999999999999999999999644321110000 000 0 0000000
Q ss_pred cchhccccccc----CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+... .......+.++.++|.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 0011245678899999999999999999999994
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=299.01 Aligned_cols=238 Identities=26% Similarity=0.322 Sum_probs=189.2
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHH-HhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~-~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||+||+++.. +|+.+++|++..... .....+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 689999999865422 22234445544 56778999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|..++. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~ 151 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSD 151 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCC
Confidence 99998884 3567999999999999999999999999 99999999999999999999999999864211 122
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......++..|+|||++.+..++.++|||||||++|+|++|..||...... ...... .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~----------~~~~--~ 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNI----------LHKP--L 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHH----------HcCC--c
Confidence 223456899999999999999999999999999999999999999633211 000011 1000 1
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLIND 315 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~e 315 (360)
..++..+..+.+++.+||+.+|.+||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 123356678899999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=287.92 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=203.0
Q ss_pred hcccccceeccCCCeEEEEEEecC-C---CEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLES-G---QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~~-~---~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
..|++.+.||+|++|.||.+.... + ..|++|.+.... ......+..|+..++.++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 468999999999999999997652 3 369999886542 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999865 3456899999999999999999999998 9999999999999999999999999886543
Q ss_pred CCCCcceecccc---cccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 200 VGDNTHVSTRVM---GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 200 ~~~~~~~~~~~~---~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
............ .+..|+|||.+.+..++.++||||||+++|++++ |..||....... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i---------- 224 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI---------- 224 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----------
Confidence 222211111111 2347999999998899999999999999999886 999986332110 00000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
........+..++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 225 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 ----EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011122345677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=283.08 Aligned_cols=265 Identities=24% Similarity=0.337 Sum_probs=205.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCc-ccceeEEEEeCC-----
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGD----- 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~-i~~~~~~~~~~~----- 114 (360)
-..|+.++.||.|+||+||.|+.. +|+.||+|.+..... .......+|+.+++.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456888899999999999999876 689999999876643 24456788999999999999 999999998877
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 115 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 115 -~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
..++|+|+.+. +|..++......+..++...++.++.||+.||.|||+++ |+||||||+||+++..|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78999999955 999999876644467888999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccC----------ccchh
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQG----------EQNLV 262 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~----------~~~~~ 262 (360)
+++.... ..........|..|+|||++.+. .|+...||||+|||+.||+++..-|....... ..+..
T Consensus 166 lAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9985332 33335556789999999999976 79999999999999999999988886544310 00011
Q ss_pred ccchhhhhccccchhcccccccC----CCC---hhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 263 SWSRPFLKDQKKFVHLVDPLLHG----RYP---RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
.|-. .............. .+. +....+..+++.+||+.+|.+|.++..+++.
T Consensus 244 ~Wp~-----v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPG-----VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCC-----ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1100 00000000000000 001 1222478899999999999999999999964
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=291.06 Aligned_cols=266 Identities=26% Similarity=0.434 Sum_probs=203.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-----------------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccc
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-----------------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVT 105 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-----------------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~ 105 (360)
.++|++.+.||.|+||.||+++.. ++..+++|.+..... .....+.+|+..++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 568999999999999999998532 234689998875432 23457889999999999999999
Q ss_pred eeEEEEeCCeeEEEEEecCCCCHHHHhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018128 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 178 (360)
Q Consensus 106 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~N 178 (360)
+++++.+.+..+++||++++++|.+++...... ...+++..++.++.|++.||.+||+.+ ++|+||+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 999999999999999999999999999663321 234778899999999999999999999 9999999999
Q ss_pred EEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CCCcccccCcc
Q 018128 179 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQ 256 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~--g~~pf~~~~~~ 256 (360)
|+++.++.++|+|||++.................+..|++||...+..++.++||||||+++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875433222222222334578999998888889999999999999999998 67788532211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
. .......+..... .......+..++..+.+++.+||+.||.+||++.+|++.|.+
T Consensus 241 ~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q---VIENTGEFFRDQG-------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHHhhcc-------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 0000001110000 000111233466789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=287.46 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=205.3
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CC---CEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SG---QLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~---~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
...+|+..+.||+|++|.||++... ++ ..+++|.+.... ......+..|+.+++.++|||++++.+++.+.+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 4568999999999999999999865 23 378999886542 233467888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|||++++++|.+++.. ....+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 83 IITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999854 3467899999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCcce-ecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 198 GPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 198 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
......... ......+..|+|||.+.+..++.++||||||+++|+|++ |..||...... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~-------- 222 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKA-------- 222 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHH--------
Confidence 433222111 111223457999999988889999999999999999997 99998532210 00000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
+ ........+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 223 --i-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 --I-NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --H-hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00111122335677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=291.89 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=204.4
Q ss_pred HhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
..++|++.+.||.|++|.||.+... ++..+++|.+..... .....+.+|+..++.++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3578999999999999999999753 467899998875532 233568889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018128 116 RLLVYEYMPMGSLEDHLYDLE------------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 177 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~------------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~ 177 (360)
.+++||++++++|.+++.... .....+++..++.++.|++.||.+||+++ ++|+||+|+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996422 11235788999999999999999999998 999999999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCcc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 256 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~ 256 (360)
||+++.++.++|+|||.+.................+..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999874332222222222334567999999988889999999999999999997 77787532211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
. .... .. +.. ....+..++.++.+++.+||+.+|.+|||+.|+++.|++
T Consensus 240 ~------~~~~-~~---------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E------VIYY-VR---------DGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H------HHHH-Hh---------cCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 0 0000 00 000 001234567789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=303.37 Aligned_cols=260 Identities=22% Similarity=0.249 Sum_probs=203.8
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEe
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~ 112 (360)
++.+.+..++|++.+.||+|+||.||++++. +++.+++|++..... .....+.+|..+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 5667777899999999999999999999876 588999999864321 233457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....++||||+++++|.+++.. ..+++..+..++.||+.||.|||+++ ++||||||+|||++.++.++|+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999843 45899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccC----CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
|++........ .......|+..|+|||++.+. .++.++|||||||++|+|++|..||...... ......
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i 259 (371)
T cd05622 187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKI 259 (371)
T ss_pred CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence 99875432211 122345689999999998753 3789999999999999999999999743211 000000
Q ss_pred hhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCC--CCCHHHHHHH
Q 018128 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 319 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~eil~~ 319 (360)
..... .........++..+.++|.+||+.++.+ |+++.++++.
T Consensus 260 ~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 260 MNHKN--------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCCC--------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00000 0111112356778999999999844433 7889988863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=298.98 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=196.6
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCC-----
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----- 114 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~----- 114 (360)
..++|++.+.||.|+||.||++.+. .++.|++|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4589999999999999999999875 58999999986542 233456788999999999999999999886443
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 115 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 115 -~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999965 6777662 34788999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hh----------
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LV---------- 262 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~---------- 262 (360)
++..... ........++..|+|||++.+..++.++||||||+++|+|++|..||.......... ..
T Consensus 169 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred Ccccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9864221 122233567889999999999999999999999999999999999997443211000 00
Q ss_pred -----ccchhhhhccccc-----hhccccccc---CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 263 -----SWSRPFLKDQKKF-----VHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 263 -----~~~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+....... .+....... .......+..+.++|.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000000 000000000 0011234567899999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=284.28 Aligned_cols=254 Identities=28% Similarity=0.346 Sum_probs=205.8
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||.|++|.||.+... +++.+++|.+..........+.+|+.+++.++||||+++++.+.+....+++||+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 368999999999999999999875 5788999998876555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~- 154 (262)
T cd06613 82 CGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT- 154 (262)
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh-
Confidence 999999998855 3367999999999999999999999998 999999999999999999999999998753221
Q ss_pred CcceecccccccccccccccccC---CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~---~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
........++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ ... .. . ....
T Consensus 155 -~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~----~~--~---~~~~ 222 (262)
T cd06613 155 -IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL----IS--K---SNFP 222 (262)
T ss_pred -hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HH--h---ccCC
Confidence 1122234577789999998776 789999999999999999999999863221100 000 00 0 0000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........+.++.+++.+||+.+|.+|||+.+++.
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 --PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011123456778999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=284.71 Aligned_cols=250 Identities=27% Similarity=0.349 Sum_probs=205.1
Q ss_pred hhcccccceeccCCCeEEEEEEecC-CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||.|++|.||.+.... ++.+++|.+..... .+.+.+|+.+++.++||||+++++.+.+....++++|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3689999999999999999998764 88999999865532 67899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. .+..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999854 4567899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||......... .. ... ...
T Consensus 154 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---------~~----~~~--~~~ 216 (256)
T cd06612 154 --AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---------FM----IPN--KPP 216 (256)
T ss_pred --cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---------hh----hcc--CCC
Confidence 1223344778899999998888999999999999999999999999643221100 00 000 000
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++..+.++|.+||+.||.+||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111123456678999999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=289.24 Aligned_cols=272 Identities=25% Similarity=0.403 Sum_probs=204.8
Q ss_pred hhcccccceeccCCCeEEEEEEe-----cCCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeC--Ce
Q 018128 44 TRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQ 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~ 115 (360)
++.|++.+.||+|++|.||+++. .++..|++|.+.... ......+.+|+.+++.++|||++++++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 35679999999999999999973 247889999986543 23346788999999999999999999988765 56
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++||||+++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence 8899999999999999854 2346899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 196 KLGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 196 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
.......... ......++..|+|||.+.+..++.++||||||+++|+|+++..|+................... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 234 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT--VTR 234 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc--HHH
Confidence 7543322211 1223446678999999988889999999999999999999876643211100000000000000 000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
....+........+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0001111111122345678899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=320.92 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=203.4
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe-
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS- 112 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~- 112 (360)
+........+|++.+.||.|+||+||++++. .+..+++|++..... .....+..|+.+++.++||||+++++++.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3445556679999999999999999999876 578899998875433 234568889999999999999999998854
Q ss_pred -CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeCCCCCCcEEEeCC---
Q 018128 113 -GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN----PPVIYRDLKSANILLDND--- 184 (360)
Q Consensus 113 -~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~----~~i~H~di~p~NIlv~~~--- 184 (360)
...+||||||+++++|.+++.........+++..++.++.||+.||.|||+.+. .+|+|+||||+|||++.+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 456899999999999999997655556789999999999999999999998431 239999999999999642
Q ss_pred --------------CceEEeecCCccccCCCCCcceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCC
Q 018128 185 --------------FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRK 248 (360)
Q Consensus 185 --------------~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~ 248 (360)
+.++|+|||++...... .......+++.|+|||++.+ ..++.++||||||||+|+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 34899999998753222 12234568999999998864 458899999999999999999999
Q ss_pred cccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 249 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 249 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
||..... .......... . +. ......+.++.+||..||+.+|.+||++.++|.
T Consensus 242 PF~~~~~-----~~qli~~lk~-~--------p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANN-----FSQLISELKR-G--------PD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCc-----HHHHHHHHhc-C--------CC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9963221 1110000000 0 00 001234678999999999999999999999984
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=285.48 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=201.8
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc---------hHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~---------~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
+|++.+.||.|++|.||.|... +++.+++|.+....... .+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999765 58899999886543321 2457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++++||+++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999954 456889999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCC----cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 196 KLGPVGDN----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 196 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
........ ........++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~-- 222 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---------AIF-- 222 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---------HHH--
Confidence 75432111 111122347788999999998889999999999999999999999996432100 000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... ......+...+..+.++|.+||+.||.+||++.++++
T Consensus 223 -----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 -----KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 1112234567788999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=290.37 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=205.1
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||.|++|.||.+.+. +++.+++|.+........+.+.+|+..++.++|||++++++.+......++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 357999999999999999999764 6899999998766656667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|..++. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999884 346899999999999999999999999 9999999999999999999999999887533221
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||......... . ... . ...
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~----~~~--~-------~~~ 232 (296)
T cd06655 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIA--T-------NGT 232 (296)
T ss_pred c--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHH--h-------cCC
Confidence 1 122345788899999999888999999999999999999999999643311100 0 000 0 000
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++..+.++|.+||..||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 001123456678999999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=295.22 Aligned_cols=240 Identities=30% Similarity=0.448 Sum_probs=191.1
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhc-cCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~-l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||+||++++. +++.||+|++.... .........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999876 58899999986542 1223445667777765 4899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999843 456899999999999999999999999 9999999999999999999999999986422111 1
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......++..|+|||++.+..++.++||||+||++|+|++|..||....... ..... .. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----------~~~~i----~~----~~~ 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----------LFQSI----RM----DNP 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----------HHHHH----Hh----CCC
Confidence 2233568899999999998899999999999999999999999996432110 00000 00 001
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIV 317 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~-eil 317 (360)
.++...+.++.++|.+||+.||.+||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 12344667889999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=295.03 Aligned_cols=255 Identities=20% Similarity=0.213 Sum_probs=196.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|..+++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999866 58999999986532 223355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999954 3467899999999999999999999999 99999999999999999999999999865332
Q ss_pred CCCcceeccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
... .......++..|+|||++.+ ..++.++||||+||++|+|++|..||...... ...........
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~-- 225 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKE-- 225 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCC--
Confidence 221 11222458999999999863 45788999999999999999999999632210 00000000000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCC--CCCCHHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN--FRPLINDIVVA 319 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~--~Rpt~~eil~~ 319 (360)
...........+..+.++|.+||..++. .|+++.++++.
T Consensus 226 -----~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 -----HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000011123677889999998865444 37899988864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=296.17 Aligned_cols=243 Identities=28% Similarity=0.365 Sum_probs=193.6
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||+||+++.. +++.+++|++..... .....+..|..++..+ +||+|+++++.+.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 588999999876432 2334577888888887 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|..++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC--CCC
Confidence 999988843 457999999999999999999999999 99999999999999999999999999864211 122
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.................. .... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~--~~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---------ILEK--PI 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH---------HHhC--CC
Confidence 223456899999999999999999999999999999999999999643322211111111110 0000 11
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
..+...+..+.++|.+||+.||.+|+++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2345567788999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=283.59 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=196.2
Q ss_pred eeccCCCeEEEEEEec---CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCC
Q 018128 52 LIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
.||+|++|.||++... ++..+++|++..... ...+.+.+|+.+++.+.||||+++++++. .+..++|||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999998642 478899998865432 23457888999999999999999999875 45678999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcce
Q 018128 127 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 206 (360)
Q Consensus 127 sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~ 206 (360)
+|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|.||+++.++.++|+|||.+...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999843 456899999999999999999999999 99999999999999999999999999875433322211
Q ss_pred e-cccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccccccc
Q 018128 207 S-TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 284 (360)
Q Consensus 207 ~-~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (360)
. ....++..|+|||.+....++.++|+||||+++|+|++ |..||....... . ...+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~--------------~~~i~~~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V--------------TQMIESGER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H--------------HHHHHCCCC
Confidence 1 12233568999999988889999999999999999998 999996332110 0 001111111
Q ss_pred CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 285 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 285 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
...+..++.++.++|.+||+.||++||++.+|.+.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 233456778899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=281.61 Aligned_cols=247 Identities=29% Similarity=0.440 Sum_probs=197.8
Q ss_pred ceeccCCCeEEEEEEecCCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHH
Q 018128 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 129 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 129 (360)
+.||.|++|.||++...++..+++|.+...... ....+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 478999999999998878899999988655322 2346788999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecc
Q 018128 130 DHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 209 (360)
Q Consensus 130 ~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~ 209 (360)
+++.. ....+++..++.++.|++.+|.++|+++ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 99854 3356889999999999999999999998 99999999999999999999999999864322111 11112
Q ss_pred cccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccccCCCC
Q 018128 210 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 288 (360)
Q Consensus 210 ~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
..++..|+|||.+.+..++.++||||||+++|++++ |..||........ . .. .........+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~---~~-----------~~~~~~~~~~ 216 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---R---EQ-----------VEKGYRMSCP 216 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---H---HH-----------HHcCCCCCCC
Confidence 234567999999988889999999999999999998 8889863321100 0 00 0001111234
Q ss_pred hhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 289 RRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 289 ~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
..++..+.+++.+||+.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=288.37 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=193.1
Q ss_pred eccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 53 Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
||+|+||.||+++.+ +|+.|++|.+...... ....+..|+++++.++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 5899999988653222 233456799999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceec
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~ 208 (360)
.+++... ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence 9888542 3345889999999999999999999999 999999999999999999999999998753321 1223
Q ss_pred ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCC
Q 018128 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 288 (360)
Q Consensus 209 ~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
...++..|+|||++.+..++.++||||+|+++|+|++|..||........ ....... ....... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~----------~~~~~~~-~~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRR----------TLEDEVK-FEH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHH----------hhccccc-ccc
Confidence 35688899999999988899999999999999999999999963221110 0000000 0000000 011
Q ss_pred hhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 289 RRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 289 ~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..++.++.+++.+||+.||.+||++.|+++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 246778999999999999999999977664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=281.35 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=205.1
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
...++|++.+.||+|+|+.|+.+.+. +|+.+++|++.... ....+.+.+|+.+.+.++||||+++++.+......|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 45689999999999999999998654 69999999886543 3456889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe---CCCceEEeecCCc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLA 195 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~---~~~~v~L~Dfg~~ 195 (360)
|+|.+.|++|..-|-+ ..-+++..+-..++||++||.|+|.++ |+|||+||+|+++- ...-|||+|||++
T Consensus 88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999877743 256788899999999999999999999 99999999999993 3346999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
.... ......-..|++.|+|||++...+++..+|||+.|+|+|-|+.|.+||...... ...
T Consensus 161 i~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----------------rly 221 (355)
T KOG0033|consen 161 IEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----------------RLY 221 (355)
T ss_pred EEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----------------HHH
Confidence 8655 233334467999999999999999999999999999999999999999742211 001
Q ss_pred hhccccc--ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 276 VHLVDPL--LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 276 ~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
+.++... +.+++-+..+.+..+||++||..||.+|.|+.|.|
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 1111110 11112246678899999999999999999999988
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=299.03 Aligned_cols=240 Identities=26% Similarity=0.331 Sum_probs=190.0
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHH-HHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~-~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||+||++++. +++.|++|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999876 578899999865421 1222334443 456778999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCC
Confidence 999999843 456889999999999999999999999 99999999999999999999999999864221 122
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... ..... +... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~----------i~~~--~~ 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDN----------ILNK--PL 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHH----------HHhC--Cc
Confidence 233456899999999999999999999999999999999999999632211 00000 0000 11
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
..++..+..+.++|.+||+.||.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 23446678899999999999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.35 Aligned_cols=250 Identities=22% Similarity=0.278 Sum_probs=197.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|+||+||++... +++.|++|++.... ......+..|+.++..++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999876 58999999986532 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999843 467899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCc---------------------------------ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCC
Q 018128 201 GDNT---------------------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247 (360)
Q Consensus 201 ~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~ 247 (360)
.... .......|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0011246899999999999999999999999999999999999
Q ss_pred CcccccCccCccchhccchhhhhccccchhcccccccCCCC--hhhHHHHHHHHhhhcccCCCCCCC---HHHHHH
Q 018128 248 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPL---INDIVV 318 (360)
Q Consensus 248 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rpt---~~eil~ 318 (360)
.||........ . ..+........++ ...+.++.++|.+|+. ||.+|++ +.++++
T Consensus 234 ~Pf~~~~~~~~------~----------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQET------Y----------RKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHH------H----------HHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 99964322110 0 0000000000111 1356778899999774 9999985 566663
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=301.31 Aligned_cols=265 Identities=22% Similarity=0.252 Sum_probs=201.9
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec---CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
..+...+|++.+.||.|++|.||++... .++.+++|.+... ....+|+.+++.++||||+++++++......
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3445678999999999999999999643 3678999987543 2346799999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
+++||++. ++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 162 ~lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEEehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 99999984 68888883 4567999999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-ccchh-------h
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSRP-------F 268 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~-------~ 268 (360)
...............++..|+|||++.+..++.++|||||||++|+|++|..||............ ..... +
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 544333333333456899999999999999999999999999999999999999654332111000 00000 0
Q ss_pred hhc-cc----cchhcccccccCCC-------ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKD-QK----KFVHLVDPLLHGRY-------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~-~~----~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... .. ..... ....+..+ ...++.++.++|.+||+.||++||++.|++.
T Consensus 314 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 314 PQNGSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred CCccchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 00 00000 00000000 1134567889999999999999999999994
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=282.67 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=200.5
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe-CCeeEEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYE 121 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-~~~~~lv~e 121 (360)
+|++.+.||.|++|.||.+.+. +++.+++|.+..... .....+.+|+.+++.++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999866 578999999865432 334568889999999999999999988764 446789999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++++++|.+++... ....+++..++.++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999652 3456899999999999999999999999 999999999999999999999999998754321
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
........++..|+|||.+.+..++.++||||||+++++|++|..||..... ......... .
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~----------~ 217 (257)
T cd08223 156 --CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIE----------G 217 (257)
T ss_pred --CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh----------c
Confidence 1222334578899999999998999999999999999999999999863221 010000000 0
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+...+..+.+++.+||+.+|++||++.++++
T Consensus 218 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 218 -KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 001223456778999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.77 Aligned_cols=259 Identities=28% Similarity=0.426 Sum_probs=206.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CC----CEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SG----QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~----~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
...+|++.+.||.|+||.||++... ++ ..+++|....... .....+.+|+..++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 4578999999999999999999754 23 3689998765543 234578889999999999999999999876 788
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++++|++++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 84 ~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 84 QLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 999999999999999865 3456899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
...............++..|+|||.+....++.++|+||||+++|++++ |..||....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~----------- 220 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------I----------- 220 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------H-----------
Confidence 6443222222222223567999999988889999999999999999998 999986432111 0
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
...+........+..++..+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 221 PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00010111112234456778999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=288.16 Aligned_cols=272 Identities=29% Similarity=0.453 Sum_probs=209.0
Q ss_pred hhcccccceeccCCCeEEEEEEec-----CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEe--CCe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQ 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-----~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~~ 115 (360)
.+.|++.+.||+|++|.||++... .+..+++|.+...... ....+.+|+..++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 467889999999999999999743 3688999998766443 45678999999999999999999998877 557
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+++|||+++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred eEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccc
Confidence 8999999999999999965 2346999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 196 KLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 196 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
......... .......++..|+|||...+..++.++||||||+++++|++|..|+............. . ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~~~ 234 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIVTR 234 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccHHH
Confidence 865422221 11112334567999999988889999999999999999999999885432211100000 0 00000001
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
+...+........+..++..+.+++.+||+.+|.+||++.|++++|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111112222345668899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=299.78 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=197.4
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccC--CccchHHHHHHHHHhhccCCCcccceeEEEEeCC-----eeE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRL 117 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~-----~~~ 117 (360)
+|++.+.||+|+||.||++.+. +++.||+|.+... .......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4789999999999999999865 6899999988643 2233457889999999999999999999987766 789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|+||+. ++|.+++. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999995 58888773 4567999999999999999999999999 99999999999999999999999999875
Q ss_pred cCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-ccc-----hhhhh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS-----RPFLK 270 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~-----~~~~~ 270 (360)
...... .......++..|+|||.+.+. .++.++||||+||++|+|++|..||............ ... ..+..
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 432221 122234578889999998764 4789999999999999999999999644321110000 000 00000
Q ss_pred ccccchhcc-ccccc-------CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 271 DQKKFVHLV-DPLLH-------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 271 ~~~~~~~~~-~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........+ ..... .......+.++.++|.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000000 00000 0112344678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=299.81 Aligned_cols=255 Identities=29% Similarity=0.425 Sum_probs=215.1
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
+.|+|......-++-||.|+.|.||+++.. ++.||||++. +....+++.|+.++||||+.+.++|...--+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 456666666667788999999999999998 7789999763 33345888999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
||||||..|-|...+ ..+..+......+|..+|+.|+.|||.+. |+|||||.-||||+.+..|||+|||.+..
T Consensus 189 IiMEfCa~GqL~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred EeeeccccccHHHHH----hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHh
Confidence 999999999999999 45788999999999999999999999998 99999999999999999999999999875
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.... ..+-..+||-.|||||++.+.+.+.|.||||||++||||+||..||...+.. ..+--
T Consensus 262 ~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----------------AIIwG 322 (904)
T KOG4721|consen 262 LSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----------------AIIWG 322 (904)
T ss_pred hhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----------------eeEEe
Confidence 3222 2233468999999999999999999999999999999999999999632211 00111
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
.-...+....|..+++.+.-|++.||+..|.+||++.+|+.-|+...+.
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 1122344466889999999999999999999999999999999877553
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=287.02 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=200.3
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
.-|++.+.||.|++|.||.+... ++..+++|.+..........+.+|+++++.++|||++++++.+......++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34788999999999999999876 47888999887665555667888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++++|..++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++..... .
T Consensus 85 ~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~ 156 (282)
T cd06643 85 AGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 156 (282)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc--c
Confidence 99999888754 3457899999999999999999999999 99999999999999999999999999865322 1
Q ss_pred cceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 204 THVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
........++..|+|||.+. +..++.++||||+|+++|+|++|..||....... ... .... .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~----~~~~-------~ 223 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLL----KIAK-------S 223 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHH----HHhh-------c
Confidence 11223345788999999874 4457889999999999999999999986322100 000 0000 0
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.. .....+..++.++.++|.+||+.||.+||++.+++
T Consensus 224 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 224 EP--PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CC--CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 00 00112345677899999999999999999999988
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=285.82 Aligned_cols=247 Identities=27% Similarity=0.317 Sum_probs=202.5
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||.|++|.||++... +++.+++|.+.... ......+.+|+.+++.++||||+++++.+.++...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999865 58999999987553 33445788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. ..+++..++.++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999953 37899999999999999999999998 9999999999999999999999999987643321
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ... ... .
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~-------~~~----~ 213 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFL-------IPK----N 213 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHH-------hhh----c
Confidence 122334577889999999988899999999999999999999999964331100 000 000 0
Q ss_pred ccCCCChh-hHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+.. ++..+.+++.+||..+|++|||++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01111112 5677999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=295.07 Aligned_cols=241 Identities=27% Similarity=0.372 Sum_probs=194.3
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~ 120 (360)
+|+..+.||+|+||+||+++.. +++.||+|++.... ....+.+..|..+++.+. |++|+++++.+.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999865 68999999987542 223345677888888775 678888999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998843 467999999999999999999999999 99999999999999999999999999874221
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. ........|+..|+|||++.+..++.++||||+|+++|+|++|..||....... . ...+..
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~----------~~~i~~ 215 (323)
T cd05615 154 D--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------L----------FQSIME 215 (323)
T ss_pred C--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------H----------HHHHHh
Confidence 1 112233568999999999998899999999999999999999999996432110 0 000110
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
....++...+..+.+++.+||+.+|.+|++.
T Consensus 216 --~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 216 --HNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0112345567789999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=289.84 Aligned_cols=262 Identities=28% Similarity=0.426 Sum_probs=204.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCC----EEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~----~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
...+|++.+.||.|++|.||.+.+. ++. .+++|.+...... ....+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 4578899999999999999999754 343 5788887654332 233678899999999999999999988654 46
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
+++++++++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 799999999999999864 3446899999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~----~~~----- 225 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPD----LLE----- 225 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHH-----
Confidence 5433222222222345668999999988899999999999999999997 888985322111 000 111
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
.......+..++..+.+++.+||..+|++||++.++++.|..+.....
T Consensus 226 -----~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 226 -----KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -----CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 000111123456678999999999999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=295.61 Aligned_cols=267 Identities=26% Similarity=0.394 Sum_probs=204.3
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEe------cCCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCT 111 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~------~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~ 111 (360)
|....++|++.+.||.|+||.||++.+ .+++.|++|++..... .....+.+|+.++..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 445678999999999999999999963 2478899999865432 2345688899999999 6899999998875
Q ss_pred e-CCeeEEEEEecCCCCHHHHhcccCCC----------------------------------------------------
Q 018128 112 S-GDQRLLVYEYMPMGSLEDHLYDLEPD---------------------------------------------------- 138 (360)
Q Consensus 112 ~-~~~~~lv~e~~~~~sL~~~i~~~~~~---------------------------------------------------- 138 (360)
. ....+++|||+++++|.+++......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 44678999999999999998642210
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCccee
Q 018128 139 -----------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 207 (360)
Q Consensus 139 -----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~ 207 (360)
...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 124678888999999999999999999 999999999999999999999999998753222221112
Q ss_pred cccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccccCC
Q 018128 208 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 286 (360)
Q Consensus 208 ~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (360)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. . .... ......
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~---~-~~~~----------~~~~~~ 302 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF---C-RRLK----------EGTRMR 302 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HH---H-HHHh----------ccCCCC
Confidence 22334567999999988889999999999999999997 888885322110 00 0 0000 001111
Q ss_pred CChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 287 YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 287 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
.+...+..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122345678999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=283.89 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=202.0
Q ss_pred cccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc------cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
+|++.+.||.|+||.||++...+++.+++|.+..... .....+.+|+..++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 5899999999999999999887899999998865421 1234688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
+||+++++|.+++.+ ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999943 356899999999999999999999998 9999999999999999999999999887532
Q ss_pred CCC----CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 200 VGD----NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 200 ~~~----~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
... .........++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---------~~~-~~~- 222 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---------MFY-IGA- 222 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---------HHH-hhh-
Confidence 111 11112234578899999999988899999999999999999999999963221100 000 000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........+..++..+.++|.+||+.+|.+||++.++++
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 ----HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ----ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000111234456788999999999999999999999984
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=286.02 Aligned_cols=254 Identities=28% Similarity=0.362 Sum_probs=202.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
..++|++.+.||.|++|.||.+... +++.|++|.+..........+.+|+.+++.++||||+++++.+.+.+..+++||
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 3568999999999999999999765 589999999876655555678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~- 158 (267)
T cd06645 87 FCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA- 158 (267)
T ss_pred ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC-
Confidence 9999999999843 457899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.........++..|+|||.+. ...++.++|+||||+++|+|++|..||......... . .... ...
T Consensus 159 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~----~~~~-----~~~ 226 (267)
T cd06645 159 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F----LMTK-----SNF 226 (267)
T ss_pred -cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--H----hhhc-----cCC
Confidence 122223346888999999874 456889999999999999999999998532211100 0 0000 000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..+... ....++..+.++|.+||+.+|++||++.++++
T Consensus 227 ~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000 01134567899999999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.83 Aligned_cols=249 Identities=29% Similarity=0.463 Sum_probs=197.0
Q ss_pred ceeccCCCeEEEEEEec-C---CCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-S---GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~---~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|++|.||++... . +..+++|.+...... ....+.+|+.+++.+.||||+++++++. .+..+++||++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47899999999999643 2 378999998765442 4457889999999999999999999875 4567999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++.. ...+++..++.++.|++.||.+||..+ ++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999954 347899999999999999999999998 9999999999999999999999999987543322211
Q ss_pred e-ecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 206 V-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 206 ~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... +....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~--------------~~~~~ 215 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAM--------------LESGE 215 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH--------------HHcCC
Confidence 1 111223457999999998889999999999999999998 999996432110 1000 00011
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
....+..++..+.++|.+||+.+|.+||++.++++.|+.+.
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11234456678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=287.72 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=201.2
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc---hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~---~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.|++.+.||+|+||+||++... +++.+++|.+....... ...+..|+.+++.++|++++.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4788999999999999999765 68999999886543322 2456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999988652 2346899999999999999999999998 999999999999999999999999998643221
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. ......++..|+|||.+.+..++.++||||+|+++|+|++|..||........... ......
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~----------- 218 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVK----------- 218 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhh-----------
Confidence 1 11234688999999999988999999999999999999999999964321100000 000000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
.....++..++.++.+++.+||+.||++||| ++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 219 EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011234456778999999999999999999 888885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=287.89 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=203.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||.|++|.||.+... ++..+++|.+..........+..|+++++.++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999875 5899999998766555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST- 156 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc-
Confidence 999999999865 3457999999999999999999999999 999999999999999999999999987643221
Q ss_pred Ccceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 203 NTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
........++..|+|||.+. ...++.++|+||||+++|+|++|..||........ ..... .
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-------~ 222 (280)
T cd06611 157 -LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LLKIL-------K 222 (280)
T ss_pred -ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HHHHh-------c
Confidence 11223345788899999874 34578899999999999999999999964321100 00000 0
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...+ ....+..++.++.++|.+||+.+|.+||++.++++
T Consensus 223 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 223 SEPP--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCCC--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0000 01123456678999999999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=319.08 Aligned_cols=264 Identities=29% Similarity=0.452 Sum_probs=217.4
Q ss_pred hhcccccceeccCCCeEEEEEEec--CCC----EEEEEEcccC-CccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE--SGQ----LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~--~~~----~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
-.+.+..+.||+|+||.||.+... .+. .|++|.+... +..+..++.+|..+++.++||||+++++++-+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 567788899999999999999754 233 4888887654 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPD---QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
+|++||+.+|+|..|+++-+.. ...+...+++.++.||++|.+||++++ +|||||..+|+|++....||++|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999774221 456889999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
+++.....+.........-...|||||.+....++.++||||||+++||+++ |..||.......
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------------- 912 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------------- 912 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---------------
Confidence 9985444444443333334568999999999999999999999999999999 888986332111
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
.+...+... +.+.|..+++.+.+++..||+.+|++||++..|++.+..+....
T Consensus 913 -v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 913 -VLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred -HHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 111111111 34568899999999999999999999999999999999987743
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.93 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=202.7
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
...|++.+.||.|++|.||++.+.++..+++|.+.... .....+..|+++++.++||+++++++++......+++||++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 35789999999999999999987778889999886543 33457888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
.+++|.+++.. ....+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 154 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ- 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-
Confidence 99999999864 3356889999999999999999999999 9999999999999999999999999887532211
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.........+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..... ...
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----------~~~~~-------~~~ 217 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE----------VVETI-------NAG 217 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----------HHHHH-------hCC
Confidence 111112234568999999988889999999999999999998 899986322110 00000 000
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
.....+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 218 FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 011112335678999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.27 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=195.5
Q ss_pred ceeccCCCeEEEEEEec-CCC--EEEEEEcccCC-ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQ--LVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~--~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||.|++|.||.+... ++. .+++|.+.... ......+.+|+++++.+ +||||+++++++...+..+++||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999865 343 46888776432 23345788899999999 799999999999999999999999999
Q ss_pred CCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 126 GSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 126 ~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999965321 1235889999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
++.... ..........+..|+|||.+.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~---- 224 (270)
T cd05047 158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKL---- 224 (270)
T ss_pred Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHH----
Confidence 875211 1111111233567999999988889999999999999999997 999985322110 00000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
........+...+.++.+++.+||+.+|.+||++.+++..|+++.
T Consensus 225 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 -------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111123345678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=292.89 Aligned_cols=193 Identities=24% Similarity=0.358 Sum_probs=164.7
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
+...+|++.+.||.|++|.||++... .++.|++|+.... ....|+.+++.++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999876 5788999975332 2346899999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
+++ .++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 137 e~~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHY-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred Ecc-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 999 4588888854 4567999999999999999999999999 99999999999999999999999999864221
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 250 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf 250 (360)
. .......++..|+|||++.+..++.++|||||||++|+|+++..|+
T Consensus 210 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 A---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred C---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 1122345889999999999989999999999999999999865544
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=299.02 Aligned_cols=262 Identities=20% Similarity=0.205 Sum_probs=195.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+.+|.+.+.||+|++|.||++.+. .++.|++|... .....+|+.+++.++||||+++++++......++||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999876 48889999632 23456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+ .++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.++|+|||++.......
T Consensus 242 ~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 Y-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9 5688888854 3347999999999999999999999999 9999999999999999999999999987543322
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCc-cchhccchhhhhccc----cc--
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-QNLVSWSRPFLKDQK----KF-- 275 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~----~~-- 275 (360)
.........|+..|+|||++.+..++.++|||||||++|+|++|..|+........ ............... ..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 22222335689999999999999999999999999999999998765432211110 000000000000000 00
Q ss_pred -------hhccc---ccccCCC-------ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 -------VHLVD---PLLHGRY-------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 -------~~~~~---~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..... ....... ......++.+||.+||+.||.+|||+.|+|+
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00000 0000000 0123457889999999999999999999994
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=284.40 Aligned_cols=250 Identities=21% Similarity=0.319 Sum_probs=197.3
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||.|++|.||++.+. +++.+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36889999999999999999764 689999998865432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|..+ ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999988654 24688899999999999999999999 999999999999999999999999998753221
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||............. .. .....+..
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~------~~~~~~~~ 216 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL---QL------LQCIVDED 216 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH---HH------HHHHhccC
Confidence 1223467889999999998889999999999999999999999996432211100000 00 00000000
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........+.++.++|.+||+.+|.+||+++++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000112235667899999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=314.10 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=206.6
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|++|.||++.+. +++.||+|++...... ...++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999876 5899999998754222 2356888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 121 EYMPMGSLEDHLYDLEPD-------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
||+++++|.+++...... ...++...++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998653211 234567788999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCc----------------ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccC
Q 018128 194 LAKLGPVGDNT----------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 257 (360)
Q Consensus 194 ~~~~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~ 257 (360)
++......... .......|+..|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99754211100 01112458999999999999999999999999999999999999996422111
Q ss_pred ccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC-CHHHHHHHHhhhhhcc
Q 018128 258 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQR 327 (360)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~eil~~L~~l~~~~ 327 (360)
.... .....+... ......+..+.+++.+||+.||++|| +++++++.|+......
T Consensus 239 i~~~--------------~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 ISYR--------------DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hhhh--------------hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0000 000000000 01124567789999999999999995 6777778888876543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.39 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=204.2
Q ss_pred hhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.++|++.+.||.|+||.||+++.+ ..+.+++|.+...... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 478999999999999999999854 2467999988655433 346788999999999999999999999998999
Q ss_pred EEEEEecCCCCHHHHhcccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEee
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQ-----EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~D 191 (360)
++|||++++++|.+++....... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999996533211 26899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhh
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
||.+....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... +..
T Consensus 161 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----------~~~ 229 (275)
T cd05046 161 LSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----------VLN 229 (275)
T ss_pred cccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH----------HHH
Confidence 99886422211 112222345677999999888888999999999999999998 778885322110 000
Q ss_pred ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
...........+..++..+.+++.+||+.+|.+||++.+++..|.
T Consensus 230 ------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 ------RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001011111223456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=297.18 Aligned_cols=264 Identities=22% Similarity=0.282 Sum_probs=197.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeC-----
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG----- 113 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~----- 113 (360)
...++|++.+.||+|+||.||.+.+. .++.+++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34579999999999999999999865 588999999875422 2345677899999999999999999987543
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 114 -DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 114 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
...++|||++++ +|.+.+. ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 356899999965 7777663 34788999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-----------
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL----------- 261 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~----------- 261 (360)
|++..... ........++..|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 164 g~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 164 GLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99975322 1222335688999999999998999999999999999999999999964331110000
Q ss_pred -----hccchhhhhccccchhcc------cccc--cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 262 -----VSWSRPFLKDQKKFVHLV------DPLL--HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 262 -----~~~~~~~~~~~~~~~~~~------~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......+........... +... ....+......+.++|.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000000100000000000 0000 00112234567899999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=288.45 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=200.8
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||.|++|.||++.+. ++..+++|.+..... .....+.+|+++++.++||||+++++.+.+++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36999999999999999999866 588899998765422 2235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999954 3668999999999999999999997 57 999999999999999999999999988643211
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc---------
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ--------- 272 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 272 (360)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||......................
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 1223467889999999988889999999999999999999999986433211111000000000000
Q ss_pred -------ccchhccccccc---CCC-ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 -------KKFVHLVDPLLH---GRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 -------~~~~~~~~~~~~---~~~-~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+.... ... ...++.++.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000000 001 1125678999999999999999999999994
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.30 Aligned_cols=251 Identities=26% Similarity=0.353 Sum_probs=204.5
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe--CCeeEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVY 120 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~~~~lv~ 120 (360)
+|++.+.||.|++|.||++.+. +++.+++|.+..... ...+.+.+|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999765 688999998865433 234568889999999999999999987753 45678999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-----~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
||+++++|.+++.........+++..++.++.||+.||.+|| +.+ ++|+||+|+||++++++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999776555678999999999999999999999 777 999999999999999999999999998
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
........ ......++..|+|||.+.+..++.++|+||||+++++|++|..||...... .....
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-------- 221 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLASK-------- 221 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHHHH--------
Confidence 86433221 122345788999999999888999999999999999999999999743211 00000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+........+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 222 ---IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0011112334567788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=295.61 Aligned_cols=263 Identities=23% Similarity=0.294 Sum_probs=196.8
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeC------
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------ 113 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~------ 113 (360)
..++|++.+.||+|++|.||.+.+. .++.|++|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4679999999999999999999865 58899999987542 23345678899999999999999999887543
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...++||||+++ +|.+++. ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999954 7877773 34788999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-----------
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV----------- 262 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~----------- 262 (360)
++..... ........++..|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 172 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9975322 11223346788999999999999999999999999999999999999643321100000
Q ss_pred -c----cchhhhhccccc-----hhcccccc---cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 263 -S----WSRPFLKDQKKF-----VHLVDPLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 263 -~----~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ....+....... ........ ...........+.++|.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 000000000000 00000000 00111223567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=284.82 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=199.5
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||.+... +++.|++|.+..... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5899999999999999999875 589999998865432 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+. ++|.+++.... .+..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 96 68988886533 3467899999999999999999999999 999999999999999999999999998753322
Q ss_pred Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-h-hccc---hhhhhcc---c
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-L-VSWS---RPFLKDQ---K 273 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~-~~~~---~~~~~~~---~ 273 (360)
........++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......... . ..+. ...+... .
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 122223346788999998865 457899999999999999999999996432210000 0 0000 0000000 0
Q ss_pred cchhccccccc---CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........... ......++.++.++|.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0112346778899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=282.15 Aligned_cols=249 Identities=30% Similarity=0.470 Sum_probs=200.0
Q ss_pred HhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
..++|++.+.||+|++|.||.+.. .++.+++|.+.... ....+.+|+.+++.++|||++++++++... ..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 457899999999999999999875 47889999886542 345788899999999999999999988654 57999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+.+++|.+++... ....+++..++.++.|++.||.+||+.+ ++||||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 80 MSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred CCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 9999999999652 2346899999999999999999999998 999999999999999999999999998753221
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
......+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .... ...
T Consensus 154 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~-----------~~~ 212 (254)
T cd05083 154 ----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKEC-----------VEK 212 (254)
T ss_pred ----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHH-----------HhC
Confidence 111234567999999988889999999999999999997 899986332110 0000 001
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
......+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11112234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=286.01 Aligned_cols=264 Identities=24% Similarity=0.302 Sum_probs=193.1
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhcc---CCCcccceeEEEEe-----CC
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL---HHDNLVTLIGYCTS-----GD 114 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l---~~p~i~~~~~~~~~-----~~ 114 (360)
+|++.+.||+|++|+||++++. +++.|++|.+...... ......+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 6999999999999999999876 6899999988654222 223455677666655 69999999998754 34
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..+++||++. ++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999996 4898888652 2345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhccc-----hhh
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS-----RPF 268 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~-----~~~ 268 (360)
+....... ......++..|+|||++.+..++.++||||+||++|+|++|.+||.......... ..... ..+
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 87543211 1223457889999999998899999999999999999999999986432211000 00000 000
Q ss_pred hhccccchhcccccc---cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKDQKKFVHLVDPLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
............+.. .....+.++..+.++|.+||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000000 00112345677899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=279.55 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=203.9
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||.++.. +++.+++|.+.... ......+.+|+.+++.++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6999999999999999999765 58899999886553 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++... ....+++..+..++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999999652 2456899999999999999999999998 9999999999999999999999999987543222
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
. ......++..|+|||...+..++.++|+||||+++|+|++|..||...... ....... ...
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~----------~~~ 217 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV----------QGN 217 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH----------cCC
Confidence 1 223355788999999998888899999999999999999999998632211 0000000 000
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
....+..++.++.++|.+||+.+|.+||++.++++.
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 -YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 011124567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=285.16 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=200.5
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.|+..+.||.|+||+||.+.+. +++.+++|.+...... ....+.+|+.+++.++|++|+.+++.+.+++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788999999999999999765 6899999998655322 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999888652 2346999999999999999999999999 999999999999999999999999988653221
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ... ... ....
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~----~~~------~~~~- 219 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REE----VDR------RVLE- 219 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHH------hhhc-
Confidence 1 12234688999999999988899999999999999999999999963321100 000 000 0000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
....++..++..+.+++.+||+.||.+||+ +.+++.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 220 -TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 001234456778899999999999999999 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=282.60 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=203.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
...|+..+.||.|++|.||.+.+. .+..+++|.+..... .....+.+|+.+++.++||||+++++.+.+....++|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 457889999999999999999875 588999998875532 344678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++++++|.+++. ..++++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 83 YLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999984 346889999999999999999999998 999999999999999999999999998753322
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .....
T Consensus 155 ~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~~~ 215 (277)
T cd06640 155 Q--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----------------FLIPK 215 (277)
T ss_pred c--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------hhhhc
Confidence 1 1222345777899999998888999999999999999999999998633211100 00000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
......+..++..+.+++.+||+.+|.+||++.+++..
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11112345677889999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=288.71 Aligned_cols=253 Identities=27% Similarity=0.348 Sum_probs=202.3
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||.|++|.||++... +++.+++|.+...... ....+..|++.++.++||||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999876 5899999998765433 3456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++.+++|.+++.. ..+..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999864 23467999999999999999999999998 99999999999999999999999998864322
Q ss_pred CCCcc---------------------------eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 018128 201 GDNTH---------------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 253 (360)
Q Consensus 201 ~~~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~ 253 (360)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 21110 011235678899999999888999999999999999999999999633
Q ss_pred CccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC----HHHHHH
Q 018128 254 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL----INDIVV 318 (360)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt----~~eil~ 318 (360)
.... . .................+..+.++|.+||+.||++||+ +.+++.
T Consensus 236 ~~~~---------~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDE---------T-------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHH---------H-------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2110 0 00011111111111226788999999999999999999 777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=280.05 Aligned_cols=248 Identities=26% Similarity=0.381 Sum_probs=195.3
Q ss_pred eeccCCCeEEEEEEec---CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCC
Q 018128 52 LIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGS 127 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~s 127 (360)
.||.|+||.||.+... .+..+++|++...... ..+.+.+|+.+++.++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999998653 3557999988655322 2356889999999999999999999875 457899999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcce-
Q 018128 128 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV- 206 (360)
Q Consensus 128 L~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~- 206 (360)
|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999864 3457899999999999999999999998 99999999999999999999999999875433222211
Q ss_pred ecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 207 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 207 ~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
.....++..|+|||.+.+..++.++||||||+++|++++ |..||........ ...+......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----------------~~~~~~~~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-----------------MSFIEQGKRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-----------------HHHHHCCCCC
Confidence 111223567999999988889999999999999999996 9999963321110 0000011111
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
..+..++.++.++|.+||..+|++||++.+|.+.|..+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 23445678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=292.37 Aligned_cols=252 Identities=21% Similarity=0.215 Sum_probs=196.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|+||.||+++.. .++.+++|++.... ......+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999876 57889999986432 122345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999965 3456899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
.. ........|+..|+|||++. ...++.++|||||||++|+|++|..||...... ....
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~--------- 218 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYG--------- 218 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHH---------
Confidence 11 12223356899999999886 346789999999999999999999999632210 0000
Q ss_pred hhcccccccCCC---ChhhHHHHHHHHhhhcccCCCC--CCCHHHHHHH
Q 018128 276 VHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 319 (360)
Q Consensus 276 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~--Rpt~~eil~~ 319 (360)
.+........+ ...++.++.+++.+|+..++.+ |+++.++++.
T Consensus 219 -~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 -KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01110000111 2345778999999988655444 6899998854
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.21 Aligned_cols=253 Identities=28% Similarity=0.395 Sum_probs=199.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeC------
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG------ 113 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~------ 113 (360)
.+.++|++.+.||.|++|.||.+... .++.+++|.+.... .....+..|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46788999999999999999999765 58899999986553 3446788899999988 699999999998653
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...+++|||+.+++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 4678999999999999998652 2456899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
++..... .........++..|+|||.+. +..++.++||||+|+++|+|++|..||......... .
T Consensus 157 ~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~--------~ 226 (272)
T cd06637 157 VSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--------F 226 (272)
T ss_pred Cceeccc--ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH--------H
Confidence 9875322 112223356788999999886 345788999999999999999999999632211000 0
Q ss_pred hhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .............++..+.+++.+||+.+|.+|||+.++++
T Consensus 227 ~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 L--------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred H--------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 00000111112345678999999999999999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=279.94 Aligned_cols=251 Identities=33% Similarity=0.480 Sum_probs=200.9
Q ss_pred ccccceeccCCCeEEEEEEecC-----CCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 47 FREANLIGEGGFGKVYKGRLES-----GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~~-----~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
+++.+.||.|++|.||.+.... +..+++|.+...... ....+..|+..++.++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4678999999999999998763 388999998655433 4668889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999996522 122899999999999999999999998 99999999999999999999999999876443
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
...... ....++..|+|||.+.+..++.++||||+|+++++|++ |..||...... . .....
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~----~~~~~------- 217 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------E----VLEYL------- 217 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------H----HHHHH-------
Confidence 322211 12336678999999988889999999999999999998 78888632110 0 00000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L 320 (360)
........+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00011122334677899999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=288.35 Aligned_cols=264 Identities=25% Similarity=0.348 Sum_probs=199.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||.|++|.||+++.. +++.|++|.+..... .....+.+|+..++.++||||+++++++.+....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999876 588999999865432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
++ ++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 589888865 3456899999999999999999999998 9999999999999999999999999987532211
Q ss_pred Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-h--------ccchhhhhcc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-V--------SWSRPFLKDQ 272 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~--------~~~~~~~~~~ 272 (360)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... . ........ .
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 235 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS-N 235 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc-c
Confidence 12223346788999998765 4578899999999999999999999964432110000 0 00000000 0
Q ss_pred ccchhcccccccC----CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........+.... .....++.++.++|.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000000 112345678899999999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=280.47 Aligned_cols=249 Identities=30% Similarity=0.445 Sum_probs=199.4
Q ss_pred ceeccCCCeEEEEEEecC--C--CEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLES--G--QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~--~--~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||.|++|.||.+.+.. + ..+++|.+..... .....+.+|+..++.++||||+++++.+.+ ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997642 3 3689999987765 455678899999999999999999999888 889999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++..... ..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999966321 56899999999999999999999998 9999999999999999999999999987654432221
Q ss_pred e-ecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 206 V-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 206 ~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~----------~~~ 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDK----------EGE 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh----------cCC
Confidence 1 122346678999999988889999999999999999998 999985322110 0000000 001
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
....+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=280.47 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=202.8
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.+|.+... +++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++|+|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6899999999999999999765 58999999886542 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+.+++|.+++.. .....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999998864 22346889999999999999999999998 9999999999999999999999999987533221
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||.+.+..++.++|+||||+++++|++|..||...... ....... ..
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~----------~~- 216 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKII----------RG- 216 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHh----------cC-
Confidence 1222345778899999999888999999999999999999999998632210 0000000 00
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++.++.++|.+||+.+|.+||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 217 SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 011234456778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=293.69 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=194.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeC-----
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG----- 113 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~----- 113 (360)
...++|++.+.||.|+||+||.+.+. +++.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34679999999999999999999865 688999999865422 2335677899999999999999999877533
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 114 -DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 114 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
...+++++++ +++|.+++. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 779988873 356999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch-----
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR----- 266 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----- 266 (360)
|++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||....... .......
T Consensus 163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~ 235 (343)
T cd07878 163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTP 235 (343)
T ss_pred ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence 998753221 123457889999999876 568999999999999999999999996432110 0000000
Q ss_pred --hhhhcc--ccchhccccc--cc-C---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 267 --PFLKDQ--KKFVHLVDPL--LH-G---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 267 --~~~~~~--~~~~~~~~~~--~~-~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...... .......... .. . .........+.++|.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000000000 00 0 001123456789999999999999999999994
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=285.19 Aligned_cols=260 Identities=27% Similarity=0.363 Sum_probs=203.9
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEE-
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCT- 111 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~- 111 (360)
.+..++....+.|++.+.||.|++|.||++.+. +++.+++|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 456677778899999999999999999999875 58899999886553 2345678899998888 6999999999874
Q ss_pred -----eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 112 -----SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 112 -----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
..+..+++|||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 3467899999999999999996522 456889999999999999999999999 999999999999999999
Q ss_pred eEEeecCCccccCCCCCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~ 261 (360)
++|+|||++...... ........++..|+|||.+. +..++.++|+||||+++|+|++|..||.........
T Consensus 160 ~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-- 235 (282)
T cd06636 160 VKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-- 235 (282)
T ss_pred EEEeeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--
Confidence 999999998643211 11223345788899999875 346788999999999999999999999632211000
Q ss_pred hccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 262 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...............++..+.++|.+||+.||.+|||+.|+++
T Consensus 236 --------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 --------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000111112346778999999999999999999999973
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=290.79 Aligned_cols=251 Identities=21% Similarity=0.203 Sum_probs=196.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|..++..++|++|+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999876 58899999986532 122345778899999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999965 2457899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCcceeccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
... .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||....... ..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~---------- 217 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TY---------- 217 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HH----------
Confidence 221 11223568999999998875 467889999999999999999999996332110 00
Q ss_pred hhcccccccCCC---ChhhHHHHHHHHhhhcccCCCC--CCCHHHHHH
Q 018128 276 VHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANF--RPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~--Rpt~~eil~ 318 (360)
..+.....+..+ ....+.++.++|.+||..++.+ |++++++++
T Consensus 218 ~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 218 GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 000000000011 1235678999999999866544 467888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.93 Aligned_cols=264 Identities=26% Similarity=0.326 Sum_probs=205.7
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEE-
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCT- 111 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~- 111 (360)
...+.+.....+|++.+.||+|++|.||++... .++.+++|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666778899999999999999999999765 58899999876432 2235677899999998 6999999999873
Q ss_pred ----eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 112 ----SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 112 ----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
+....++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 445689999999999999988654445667899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh
Q 018128 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 262 (360)
+|+|||++....... .......++..|+|||.+. +..++.++||||+|+++|+|++|..||........ ..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LF 239 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hh
Confidence 999999987543221 1222345888999999875 34578899999999999999999999864321100 00
Q ss_pred ccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
. . . ...... ...+..++..+.++|.+||+.||++||++.|+++.
T Consensus 240 ~----~---~----~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 K----I---P----RNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred h----c---c----ccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 0 0 000000 01122345679999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=278.35 Aligned_cols=248 Identities=27% Similarity=0.365 Sum_probs=201.0
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||.+... +++.+++|.+..... .....+.+|+.+++.++|||++++++.+...+..++|||+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6899999999999999999765 688999999876532 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeecCCccccCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVG 201 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg~~~~~~~~ 201 (360)
+++++|.+++... .+..+++..++.++.+++.+|.+||+++ ++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999652 2456899999999999999999999998 99999999999998654 5799999998754322
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... .... ...
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~----------~~~- 215 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLK----------IMS- 215 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHH----------HHh-
Confidence 1 1223457889999999998888999999999999999999999986432110 0000 000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......+...+.++.+++.+||+.+|.+|||+.+++.
T Consensus 216 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 216 GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0011223446778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=273.79 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=201.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc----c----hHHHHHHHHHhhcc-CCCcccceeEEEEeC
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ----G----HQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 113 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~----~----~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~ 113 (360)
-.+|.-.+.||+|..++|-.+.++ ++..+++|++...... . .+.-..|+.+|+++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 367889999999999999888655 6888999987544221 1 23456799999998 599999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...++|++.++.|.|.+++ ++.-.+++...+.++.|++.++.|||.++ |+|+||||+|||++++-+++|+|||
T Consensus 96 sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999 45778999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAM------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
++..... ...-...+||++|+|||.+. ...|+...|+|++|+|+|.|+.|.+||.-....
T Consensus 169 Fa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm----------- 234 (411)
T KOG0599|consen 169 FACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM----------- 234 (411)
T ss_pred eeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----------
Confidence 9985443 33445688999999999875 345889999999999999999999999622110
Q ss_pred hhhccccchhcccccccCCC------ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 FLKDQKKFVHLVDPLLHGRY------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
-.+.-.+.+.| =.+.+....+||.+||+.||.+|.|++|+|.
T Consensus 235 ---------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 235 ---------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 00111111111 1356778899999999999999999999997
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=282.66 Aligned_cols=251 Identities=28% Similarity=0.446 Sum_probs=197.7
Q ss_pred ceeccCCCeEEEEEEecC-------CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 51 NLIGEGGFGKVYKGRLES-------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~-------~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+.||.|++|.||.++..+ ++.+++|.+..... .....+.+|+..++.++||||+++++++......+++||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999997642 25789998765432 3456788899999999999999999999998999999999
Q ss_pred cCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-----ceEEeecCC
Q 018128 123 MPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-----NPKLSDFGL 194 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-----~v~L~Dfg~ 194 (360)
+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999965332 2245788999999999999999999998 99999999999998877 899999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
+.................+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~----~~---- 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQ----HV---- 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHH----HH----
Confidence 875332222222223345678999999998899999999999999999998 999986322110 000 00
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
........+...+..+.++|.+||+.+|.+||++.++++.|.
T Consensus 227 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 ------TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 001111234456788999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=282.12 Aligned_cols=255 Identities=29% Similarity=0.370 Sum_probs=201.9
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCC------
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD------ 114 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~------ 114 (360)
..++|++.+.||.|++|.||++... +++.+++|++..... ....+.+|+.+++.+ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4589999999999999999999875 578999998876543 346788999999998 6999999999986544
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++||||+++++|.+++......+..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998765545678999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhh
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 269 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 269 (360)
+...... ........++..|+|||.+.. ..++.++||||||+++|+|++|..||....... .... ..
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK----IP 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH----hh
Confidence 8753221 122233457888999998753 346789999999999999999999996322110 0000 00
Q ss_pred hccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 270 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .. ......+..++..+.++|.+||..||++|||+.++++
T Consensus 232 ~-------~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 R-------NP--PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-------cC--CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 00 0011122346678999999999999999999999984
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=285.41 Aligned_cols=263 Identities=21% Similarity=0.265 Sum_probs=197.4
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||++.+. +|+.+++|.+..... .....+.+|+.+++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 6899999999999999999876 589999998865422 2234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
++ ++|.+++.. .+..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 588887754 3466999999999999999999999999 9999999999999999999999999987533221
Q ss_pred CcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch----------hhhhc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR----------PFLKD 271 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----------~~~~~ 271 (360)
.......++..|+|||.+.+. .++.++||||||+++|+|++|..|+....... ........ +....
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhhh
Confidence 122234567889999988764 47899999999999999999998864322211 00000000 00000
Q ss_pred ---cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 ---QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.................+..+.++.++|.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000001122346778999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=283.67 Aligned_cols=248 Identities=27% Similarity=0.378 Sum_probs=201.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
...|+..+.||.|++|.||.+.+. +++.+++|.+.... ......+.+|+.+++.++||||+++++.+......++|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 356888899999999999999765 58899999886543 2334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++. ...+++..++.++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 83 YLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999999883 356899999999999999999999998 999999999999999999999999998753321
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||......... . ....
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~---------------~~~~ 215 (277)
T cd06642 155 --QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--F---------------LIPK 215 (277)
T ss_pred --chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH--h---------------hhhc
Confidence 11222245778899999999888999999999999999999999998632211100 0 0000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++..+.++|.+||+.+|.+||++.++++
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0011123356678999999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=278.39 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=201.5
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-----cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-----~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
+|+..+.||.|++|+||.+... +++.|++|.+..... .....+.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 6889999999999999999876 689999998865432 2345788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
+||+++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999854 456889999999999999999999999 9999999999999999999999999887532
Q ss_pred CCCCcceecccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||........ . ...
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~---------~-------~~~ 214 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA---------V-------FKI 214 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH---------H-------HHH
Confidence 222 223455788899999987666 89999999999999999999999964321000 0 000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 215 GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000011234456788999999999999999999999984
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=278.06 Aligned_cols=252 Identities=29% Similarity=0.442 Sum_probs=192.0
Q ss_pred ceeccCCCeEEEEEEec----CCCEEEEEEcccC-CccchHHHHHHHHHhhccCCCcccceeEEEE-eCCeeEEEEEecC
Q 018128 51 NLIGEGGFGKVYKGRLE----SGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT-SGDQRLLVYEYMP 124 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~-~~~~~~lv~e~~~ 124 (360)
+.||+|+||.||.+... .+..+++|.+... .......+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2457999987543 2234467888999999999999999999764 4556789999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
+++|.+++.. .....++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999965 2344677888899999999999999998 999999999999999999999999998743221111
Q ss_pred --ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhC-CCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 205 --HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 205 --~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
.......++..|+|||.+.+..++.++||||||+++|+|++| .+||...... ....... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~~~~~-----------~ 217 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------DITVYLL-----------Q 217 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHh-----------c
Confidence 111123456689999999888899999999999999999995 5566422110 0000000 0
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
......+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00111123456789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=279.07 Aligned_cols=254 Identities=25% Similarity=0.326 Sum_probs=200.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
...++......||+|++|.||.+.+. ++..+++|.+..........+.+|+.+++.++||||+++++++...+..++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34455556679999999999999865 57889999887766556678899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-CCceEEeecCCccc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPL--SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKL 197 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-~~~v~L~Dfg~~~~ 197 (360)
|++++++|.+++.. ....+ ++..+..++.||+.||.+||+.+ ++|+||+|+||+++. ++.++|+|||.+..
T Consensus 85 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999965 22334 78889999999999999999998 999999999999976 67899999999875
Q ss_pred cCCCCCcceecccccccccccccccccC--CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
..... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||......... .+.
T Consensus 159 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~---------- 223 (268)
T cd06624 159 LAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFK---------- 223 (268)
T ss_pred cccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhh----------
Confidence 32211 122234578899999998654 3789999999999999999999998632211100 000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........+...+.++.+++.+||+.+|.+|||+.++++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 224 --VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00000111234456778999999999999999999999984
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=283.12 Aligned_cols=260 Identities=27% Similarity=0.316 Sum_probs=202.5
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeC--
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG-- 113 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~-- 113 (360)
.++....++|++.+.||.|++|.||++... +++.+++|.+.... .....+..|+.+++.+ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 444555789999999999999999999875 58899999886542 2345677899999988 799999999988643
Q ss_pred ---CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEe
Q 018128 114 ---DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 190 (360)
Q Consensus 114 ---~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~ 190 (360)
...++|+||+++++|.+++......+..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 3579999999999999998765545677999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccCCCCCcceecccccccccccccccccC-----CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccc
Q 018128 191 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 191 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 265 (360)
|||++....... .......++..|+|||.+... .++.++||||||+++|+|++|..||....... ....
T Consensus 171 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~~-- 244 (291)
T cd06639 171 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLFK-- 244 (291)
T ss_pred ecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHHH--
Confidence 999987533211 112234578889999987543 36899999999999999999999986322110 0000
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... . .......+......+.++|.+||+.+|++||++.++++
T Consensus 245 --~~~-------~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 --IPR-------N--PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --Hhc-------C--CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0 00001113345567999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=278.70 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=202.5
Q ss_pred cccccceeccCCCeEEEEEEecC--CCEEEEEEcccCCc----------cchHHHHHHHHHhhc-cCCCcccceeEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLES--GQLVAIKQLNHEGL----------QGHQEFIVEVLMLSL-LHHDNLVTLIGYCTS 112 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~~--~~~v~vK~~~~~~~----------~~~~~~~~e~~~l~~-l~~p~i~~~~~~~~~ 112 (360)
.|++.+.||.|++|.||.+.... ++.+++|.+..... .....+..|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999998764 78899998753321 123446678887764 689999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEee
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSD 191 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~D 191 (360)
.+..+++|||+++++|.+++.........+++..++.++.|++.+|.+||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999987655566789999999999999999999996 66 99999999999999999999999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~------ 222 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LA------ 222 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HH------
Confidence 99997643322 2334567888999999998889999999999999999999999986332110 00
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
...............++..+.++|.+||+.||++||++.|+..++.
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 223 ----TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000011110011245678999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=283.07 Aligned_cols=244 Identities=28% Similarity=0.386 Sum_probs=201.5
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||.|++|.||.+.+. +++.+++|.+..... .....+.+|+++++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999876 589999998865422 33456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|.||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999854 467899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. .....++..|+|||.+.+...+.++||||||+++|+|++|..||....... . ......
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------~------~~~~~~ 212 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----------I------YEKILE 212 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----------H------HHHHhc
Confidence 2 223457889999999988888999999999999999999999986332100 0 000000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
....++...+..+.++|.+||+.||.+|+ ++.++++
T Consensus 213 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 --GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 01123445678899999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=275.26 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=208.0
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||.+.+. ++..+++|.+..... .....+.+|++.++.++|||++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 6899999999999999999876 689999999876543 4456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++......+..+++..++.++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999775444678999999999999999999999998 9999999999999999999999999987543322
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||.+.+..++.++|+||+|+++++|++|..||...... ...... . ..
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~----------~-~~ 218 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKI----------L-KG 218 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHH----------h-cC
Confidence 2233346788899999998888999999999999999999999998633211 000000 0 00
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++..+.+++.+||..+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111234466788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=279.11 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=202.7
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc------chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
+|+..+.||+|++|.||.+... +++.+++|++...... ....+..|+..++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999764 6899999988654321 23568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeecCCccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKL 197 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg~~~~ 197 (360)
|+|++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999854 456899999999999999999999999 99999999999998776 599999999875
Q ss_pred cCCCCCc--ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 198 GPVGDNT--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 198 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
....... .......++..|+|||.+.+..++.++|+||+|+++++|++|..||.......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------------~~ 220 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-------------LI 220 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-------------HH
Confidence 4332111 11223457889999999988889999999999999999999999986332111000 00
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
............+...+.++.+++.+||+.+|.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111111122345567788999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=276.69 Aligned_cols=258 Identities=28% Similarity=0.367 Sum_probs=205.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||.|++|+||.+... ++..+++|++..... .....+.+|+..++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999865 588999999865432 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.... ....+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999996532 1256899999999999999999999998 9999999999999999999999999987544433
Q ss_pred Ccc--eecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 203 NTH--VSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 203 ~~~--~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
... ......++..|+|||.+... .++.++|+||||+++|+|++|..||........ .... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~----~~------~~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLT----LQ------NDP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHH----hc------CCC
Confidence 221 22334578899999998876 789999999999999999999999964332110 0000 00 000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...........++..+.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000112356788999999999999999999999984
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=296.92 Aligned_cols=243 Identities=27% Similarity=0.371 Sum_probs=206.5
Q ss_pred eeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHHH
Q 018128 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 130 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 130 (360)
+||+|.||+||.+++. +...+|||.+...+....+.+.+|+.+.+.++|.||++.++.+..+...-|+||..+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999877 467899999987777777889999999999999999999999999999999999999999999
Q ss_pred HhcccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe-CCCceEEeecCCccccCCCCCccee
Q 018128 131 HLYDLEPDQEPL--SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVS 207 (360)
Q Consensus 131 ~i~~~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~-~~~~v~L~Dfg~~~~~~~~~~~~~~ 207 (360)
++.. .-+++ .+..+-.+..||++||+|||++. |||||||=+||||+ -.|.+||.|||.+.+. ..-+-+.
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRL--AginP~T 733 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRL--AGINPCT 733 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhh--ccCCccc
Confidence 9976 66777 78888999999999999999999 99999999999995 5689999999999863 3344455
Q ss_pred cccccccccccccccccCC--CCcchhhHHHHHHHHHHHhCCCcccccCc-cCccchhccchhhhhccccchhccccccc
Q 018128 208 TRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKG-QGEQNLVSWSRPFLKDQKKFVHLVDPLLH 284 (360)
Q Consensus 208 ~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (360)
....||..|||||++..++ |..++|||||||++.||.||++||-..+. +.... +.---..+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF----------------kVGmyKvH 797 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF----------------KVGMYKVH 797 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh----------------hhcceecC
Confidence 6678999999999998765 77999999999999999999999953221 11100 01111223
Q ss_pred CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 285 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 285 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...|...+.+...+|.+|+.+||.+||+++++|+
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 3568889999999999999999999999999997
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=278.37 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=199.0
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc----------chHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ----------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~----------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
+|.+.+.||.|++|.||.+... +++.+++|.+...... ..+.+..|+..++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6889999999999999999765 5899999987542111 1235778999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++||||+++++|.+++.. ...+++..+..++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999854 357899999999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCC--CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
+................++..|+|||.+.... ++.++|+||||+++|++++|..||...... ..... .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~--~ 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFK-LG--N 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHH-hh--c
Confidence 87533222222223345788899999987654 789999999999999999999998532211 00000 00 0
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..............++..+.++|.+||+.+|++||++.++++
T Consensus 227 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 ----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000011111122346788999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=285.04 Aligned_cols=199 Identities=26% Similarity=0.370 Sum_probs=160.7
Q ss_pred cceeccCCCeEEEEEEec---CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe--CCeeEEEEEecC
Q 018128 50 ANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMP 124 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~~~~lv~e~~~ 124 (360)
++.||+|+||+||+++.. +++.+++|.+..... ...+.+|+.+++.++||||+++++++.. ....+++||++.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 568999999999999854 468899998865432 3457789999999999999999998854 456789999984
Q ss_pred CCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----eCCCceEEeecCCc
Q 018128 125 MGSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLA 195 (360)
Q Consensus 125 ~~sL~~~i~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv----~~~~~v~L~Dfg~~ 195 (360)
++|.+++.... .....+++..++.++.||+.||.|||+++ ++|+||||+|||+ +..+.++|+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888875422 12235899999999999999999999999 9999999999999 45578999999999
Q ss_pred cccCCCCCc-ceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccC
Q 018128 196 KLGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSK 254 (360)
Q Consensus 196 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~ 254 (360)
......... .......++..|+|||++.+ ..++.++||||+||++|+|++|.+||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 754332211 12233567889999999876 458999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=278.76 Aligned_cols=259 Identities=24% Similarity=0.315 Sum_probs=202.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEe--CCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~~~~lv~ 120 (360)
++|+..+.||.|++|.||++.+. +++.+++|.+..... .....+.+|+++++.++||||+++++++.+ ....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47899999999999999999875 588999998875433 334678899999999999999999998854 34689999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.........+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988665555677899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ..... ....... .
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~------~ 225 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELL-SYIVNMP------N 225 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHH-HHHhcCC------c
Confidence 11 12345677899999998889999999999999999999999999754321100 00000 0000000 0
Q ss_pred ccccCCC--ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+.+.... ....+..+.+++.+||+.+|.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0111111 1235678999999999999999999999995
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.08 Aligned_cols=266 Identities=20% Similarity=0.312 Sum_probs=190.5
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC------CCcccceeEEEE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH------HDNLVTLIGYCT 111 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~------~p~i~~~~~~~~ 111 (360)
++.+..++|++.+.||+|+||+||++.+. .++.||+|++.... ........|+.+++.++ |++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455689999999999999999999865 58899999986432 22234455666666654 456888888886
Q ss_pred eC-CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCC----
Q 018128 112 SG-DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDF---- 185 (360)
Q Consensus 112 ~~-~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~---- 185 (360)
.. ...|+||+++ +++|.+++.. ...+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 54 5688999988 7789888853 4579999999999999999999997 58 99999999999998765
Q ss_pred ------------ceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 018128 186 ------------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 253 (360)
Q Consensus 186 ------------~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~ 253 (360)
.+||+|||.+.... .......++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999875321 1223456899999999999999999999999999999999999999754
Q ss_pred CccCccchh---------ccch--------hhhhccccchhcccc-----cccCC-C-ChhhHHHHHHHHhhhcccCCCC
Q 018128 254 KGQGEQNLV---------SWSR--------PFLKDQKKFVHLVDP-----LLHGR-Y-PRRCLNYAVAVTAMCLNEEANF 309 (360)
Q Consensus 254 ~~~~~~~~~---------~~~~--------~~~~~~~~~~~~~~~-----~~~~~-~-~~~~~~~l~~li~~~l~~dp~~ 309 (360)
......... .|.. .+...........++ ..... . .......+.+||.+||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 321110000 0000 000000000000000 00000 0 0012456789999999999999
Q ss_pred CCCHHHHHH
Q 018128 310 RPLINDIVV 318 (360)
Q Consensus 310 Rpt~~eil~ 318 (360)
|||+.|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999995
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=281.04 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=195.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHH-hhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLM-LSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~-l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++.+.||.|+||.||++.+. +|+.||+|.+..... .....+..|+.. ++..+||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47999999999999999999876 599999998875532 223445556554 566789999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++ ++|.+++......+..+++..++.++.|++.||.|||++ + ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 689888866544557899999999999999999999987 8 99999999999999999999999999875322
Q ss_pred CCCcceeccccccccccccccccc----CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ... ..
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~-----------~~ 218 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQ-----------LK 218 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHH-----------HH
Confidence 1 11122457788999998864 45688999999999999999999998632110 000 00
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..............++.++.++|.+||..+|.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 219 QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000011245678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=281.11 Aligned_cols=265 Identities=24% Similarity=0.331 Sum_probs=201.3
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||++.+. +++.+++|++..... .....+.+|+.+++.++||||+++++++.+....++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 6899999999999999999875 689999999876542 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+ +++|.+++.. ....+++..++.++.||+.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 9999999865 3367999999999999999999999999 9999999999999999999999999987543322
Q ss_pred CcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hc-c------chhhhhccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VS-W------SRPFLKDQK 273 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~-~------~~~~~~~~~ 273 (360)
. .......++..|+|||.+.+. .++.++||||+|+++++|++|.+||........... .. . ..+......
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 122334678899999988654 468999999999999999999887753321110000 00 0 000000000
Q ss_pred cchhccccccc----CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....+...... .......+..+.++|.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0011245688999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=293.23 Aligned_cols=239 Identities=27% Similarity=0.328 Sum_probs=186.1
Q ss_pred eccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhcc---CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLL---HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 53 Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l---~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
||+|+||+||++++. +++.||+|++...... .......|..++... +||+|++++..+.+.+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999876 5899999998654322 222344566666554 699999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++. ....+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++..... ...
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~ 151 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT--DNK 151 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCC
Confidence 99998884 3567999999999999999999999999 99999999999999999999999999864221 122
Q ss_pred eecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccccc
Q 018128 206 VSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 284 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (360)
......|+..|+|||.+.+. .++.++|||||||++|+|++|..||...... ........ ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~----------~~~- 214 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAF----------GKV- 214 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHc----------CCC-
Confidence 23345689999999998754 4789999999999999999999999642211 00000000 000
Q ss_pred CCCC-hhhHHHHHHHHhhhcccCCCCCC----CHHHHHH
Q 018128 285 GRYP-RRCLNYAVAVTAMCLNEEANFRP----LINDIVV 318 (360)
Q Consensus 285 ~~~~-~~~~~~l~~li~~~l~~dp~~Rp----t~~eil~ 318 (360)
.++ ..++.++.++|.+||+.||.+|| ++.++++
T Consensus 215 -~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 -RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 111 23567889999999999999998 5677665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=276.84 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=191.3
Q ss_pred ceeccCCCeEEEEEEec---CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCC
Q 018128 51 NLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
+.||+|+||.||.+... .+..+++|.+...... ....+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999754 3467999988765432 3346888999999999999999999999888999999999999
Q ss_pred CHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 127 SLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 127 sL~~~i~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
+|.+++..... .....++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965332 2234667788899999999999999999 9999999999999999999999999986432222212
Q ss_pred eecccccccccccccccccC-------CCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchh
Q 018128 206 VSTRVMGTYGYCAPEYAMSG-------KLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~-------~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
......++..|+|||++.+. .++.++||||||+++|+|++ |..||......... .. .. ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~--~~---~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TY--TV---REQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HH--Hh---hcccCC
Confidence 22234567789999987632 35789999999999999996 99999643221110 00 00 000000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
..........+..+.+++.+|+ .+|++|||+.+|+..|.
T Consensus 230 ----~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 ----LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ----CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111112234567888999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=280.96 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=203.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||.|++|.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 479999999999999999999764 5889999998765555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. ..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999943 45789999999999999999999999 9999999999999999999999999876433222
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||.+.+..++.++|+||||+++|++++|..||......... ... .. ...
T Consensus 170 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~~----~~---------~~~ 232 (293)
T cd06647 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLI----AT---------NGT 232 (293)
T ss_pred --cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--eeh----hc---------CCC
Confidence 1223345778899999998888999999999999999999999999643221100 000 00 000
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+...+..+.++|.+||..+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001123345667999999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=286.24 Aligned_cols=266 Identities=20% Similarity=0.238 Sum_probs=194.3
Q ss_pred cccceeccC--CCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 48 REANLIGEG--GFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 48 ~i~~~Lg~G--~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++.++||+| ++++||++... +++.|++|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 67899999765 689999999875532 2335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++++||+.........
T Consensus 81 ~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 81 MAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred cCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999995522 345899999999999999999999999 9999999999999999999999998654321111
Q ss_pred Cc-----ceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc-chhccchh-hhh---
Q 018128 203 NT-----HVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRP-FLK--- 270 (360)
Q Consensus 203 ~~-----~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~-~~~--- 270 (360)
.. .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......... .......+ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 10 01112345677999999875 46889999999999999999999999632211000 00000000 000
Q ss_pred --------------------ccccc---hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 271 --------------------DQKKF---VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 271 --------------------~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..... ...............++..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000 0000000001123345678999999999999999999999995
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=277.10 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=188.2
Q ss_pred ceeccCCCeEEEEEEecC-------------CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 51 NLIGEGGFGKVYKGRLES-------------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~-------------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
+.||+|++|.||.+.... ...+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997431 2358889876655445567888999999999999999999999888999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc-------eEEe
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-------PKLS 190 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~-------v~L~ 190 (360)
++|||+++++|..++.. ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988854 3456899999999999999999999999 999999999999986654 8999
Q ss_pred ecCCccccCCCCCcceecccccccccccccccc-cCCCCcchhhHHHHHHHHHHH-hCCCcccccCccCccchhccchhh
Q 018128 191 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELI-TGRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 191 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
|||.+..... .....++..|+|||.+. +..++.++||||||+++|+|+ .|..||........ ..+
T Consensus 155 d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~ 221 (262)
T cd05077 155 DPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERF 221 (262)
T ss_pred CCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHH
Confidence 9998864321 11234677899999886 567899999999999999997 57778753221100 000
Q ss_pred hhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
.. ... ........++.++|.+||+.||++||++.+|++.|+
T Consensus 222 ~~----------~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 YE----------GQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Hh----------cCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 000 111233567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=277.68 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=198.9
Q ss_pred ccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCC------
Q 018128 47 FREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------ 114 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~------ 114 (360)
|++.+.||+|++|.||.+... +++.+++|++..... ...+++.+|+..++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678999999999999999743 368899998865432 33456888999999999999999999875432
Q ss_pred eeEEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
..+++++++.+++|.+++.... .....++...++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2468899999999998875322 12235789999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
|++................++..|++||...+..++.++||||||+++|+|++ |..||....... ...+ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNY----LIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHH----HHc
Confidence 99875433222222223345567999999988889999999999999999999 888886332111 0000 000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
.. ....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 231 ~~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0111234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.10 Aligned_cols=265 Identities=25% Similarity=0.305 Sum_probs=199.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++.+.||.|++|.||++... +++.|++|++..... .....+.+|+.+++.++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999876 589999998864422 223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|..++. ....+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999888877763 3456899999999999999999999998 999999999999999999999999998754332
Q ss_pred CCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc-chhc----cchh---hhhcc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVS----WSRP---FLKDQ 272 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~----~~~~---~~~~~ 272 (360)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... .... +... .....
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1223346788999998875 55789999999999999999999999643321100 0000 0000 00000
Q ss_pred ccchhcccccccCC-----CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGR-----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........+..... .....+..+.+++.+||+.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000000000 01234678999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=281.67 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=201.5
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++.+.||.|++|.||++.+. +++.|++|.+..... .....+.+|+++++.++|+||+++++++.+.+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999876 588999998865432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|++++.+..+.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 998766655552 3456899999999999999999999998 999999999999999999999999998764433
Q ss_pred CCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccc----hhh---hhcc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWS----RPF---LKDQ 272 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~----~~~---~~~~ 272 (360)
.. .......++..|+|||.+.+. .++.++||||||+++|+|++|..||........... .... ... ....
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 22 122234567889999999887 789999999999999999999999864322110000 0000 000 0000
Q ss_pred ccc-----hhcc-cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKF-----VHLV-DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~-----~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... .... .......++..++.++.++|.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000 000111233445788999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.21 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=196.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-----cchHHHHHHHHHhhccCCCcccceeEEEEe--CCee
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQR 116 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-----~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~~~ 116 (360)
-+|++.+.||+|++|.||.+... .+..+++|.+..... .....+.+|+.+++.++||||+++++.+.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 37999999999999999999765 589999998865422 123467889999999999999999998865 3577
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++++|++++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999953 456889999999999999999999998 9999999999999999999999999986
Q ss_pred ccCCCCC-cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
....... ........++..|+|||.+.+..++.++||||+|+++|+|++|..||....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----------------~~ 218 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----------------AI 218 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----------------HH
Confidence 5322111 111122457888999999998889999999999999999999999996321100 00
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...........++......+.+++ +||..+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001111111223445666778888 688899999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=283.89 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=199.8
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
..|.....||.|++|.||.+... ++..+++|.+........+.+.+|+..++.++||||+++++.+...+..++|||++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34555677999999999999865 58899999987655555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++++|.+++. ...+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~- 172 (292)
T cd06658 102 EGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV- 172 (292)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence 9999999883 346899999999999999999999998 9999999999999999999999999886432211
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||........ +. ..........
T Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---------~~----~~~~~~~~~~ 238 (292)
T cd06658 173 -PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---------MR----RIRDNLPPRV 238 (292)
T ss_pred -ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---------HH----HHHhcCCCcc
Confidence 112234578899999999888899999999999999999999999863221100 00 0000111111
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .....+..+.+++.+||..||.+|||++++++
T Consensus 239 ~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 239 K--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred c--cccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 12245667899999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=275.51 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=205.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.+|++.+.||.|++|.||++.+. +++.+++|++..... .....+.+|+..++.++|||++++++++......++++|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36899999999999999999876 599999999876644 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
+++++|.+++.. ...+++..++.++.|++.|+.+||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999954 3678999999999999999999999 98 999999999999999999999999998754322
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
.. ......++..|+|||.+.+..++.++|+|+||+++|+|++|..||....... ..... ..+...
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~----------~~~~~~ 218 (264)
T cd06623 154 LD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELM----------QAICDG 218 (264)
T ss_pred CC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHH----------HHHhcC
Confidence 21 1123457888999999998889999999999999999999999996543200 00000 000100
Q ss_pred cccCCCChh-hHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ...+.. ++..+.++|.+||+.+|++||++.++++
T Consensus 219 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 219 PP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11 112233 6788999999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=277.94 Aligned_cols=252 Identities=26% Similarity=0.360 Sum_probs=202.6
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||.|++|.||++.+. +++.+++|.+..... .....+.+|+++++.++||||+++++.+......++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46889999999999999999876 589999998876533 3445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
+++++|.+++... ...+++..++.++.|++.||.+||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999652 2678999999999999999999999 88 999999999999999999999999988643211
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ......... ..
T Consensus 155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~----------~~ 219 (265)
T cd06605 155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIV----------NE 219 (265)
T ss_pred H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHh----------cC
Confidence 1 11156788899999999889999999999999999999999999643221110 111000000 00
Q ss_pred cccCCCChh-hHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ....+.. ++..+.++|.+||..||.+|||+.+++.
T Consensus 220 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 P-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred C-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0 0011222 6778999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=280.59 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=200.2
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.+|++.+.||.|++|.||++... +++.+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 37899999999999999999876 68999999886542 22345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
+++++|..++.... ....+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999885421 23478999999999999999999996 47 999999999999999999999999998643221
Q ss_pred CCcceecccccccccccccccccC------CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~------~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ .. ..
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~----------~~ 219 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FA----------QL 219 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HH----------HH
Confidence 12224577789999988543 357899999999999999999999963221100 00 00
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..+.. ......+..++.++.++|.+||+.+|.+||++.+++.
T Consensus 220 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 220 SAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00110 0111234567888999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=275.89 Aligned_cols=255 Identities=26% Similarity=0.332 Sum_probs=189.3
Q ss_pred ceeccCCCeEEEEEEec---CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCC
Q 018128 51 NLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
+.||+|+||.||++... ....+++|.+...... ....+.+|+..++.++||||+++++.+.+....++|||+++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36899999999999644 2457888877644322 2346788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 127 SLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 127 sL~~~i~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
+|.+++...... ....++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999764322 234567888999999999999999999 9999999999999999999999999986432222111
Q ss_pred eecccccccccccccccc-------cCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchh
Q 018128 206 VSTRVMGTYGYCAPEYAM-------SGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~-------~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
......++..|+|||++. ...++.++||||||+++|+|++ |..||........ .. .... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~----~~~~--~~~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LK----QVVR--EQDIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HH----HHhh--ccCcc
Confidence 222234566799999864 2356889999999999999999 7778853221100 00 0000 00000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
......+..++..+.+++..|+ .||++||++.+|++.|.
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 ----LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ----CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111223456677788888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=274.73 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=190.0
Q ss_pred ceeccCCCeEEEEEEecC---CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCC
Q 018128 51 NLIGEGGFGKVYKGRLES---GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~---~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
+.||+|+||.||+++..+ ...+++|.+..... .....+.+|+..++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 368999999999997543 34567777654432 34467889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcce
Q 018128 127 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 206 (360)
Q Consensus 127 sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~ 206 (360)
+|.+++..........+...++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999764434456778888999999999999999998 99999999999999999999999998753222111122
Q ss_pred eccccccccccccccccc-------CCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhc
Q 018128 207 STRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 207 ~~~~~~~~~y~aPE~~~~-------~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.....++..|+|||++.. ..++.++||||||+++|+|++ |..||...... ........ ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~--~~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIK--DQQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh--hccccc
Confidence 233457788999998743 245789999999999999997 56677532211 00000110 000111
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
.+......+...+.+++..|| .+|++||++.++++.|.
T Consensus 230 ----~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 ----FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ----CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 112223346677888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=276.25 Aligned_cols=247 Identities=27% Similarity=0.352 Sum_probs=200.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.-|++.+.||.|++|.||++... ++..+++|.+..... .....+.+|+..++.++||||+++++.+..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34778899999999999999765 688999998765432 3345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++. ...+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~- 154 (277)
T cd06641 84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT- 154 (277)
T ss_pred CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc-
Confidence 99999999984 356899999999999999999999998 999999999999999999999999988653221
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .... +...
T Consensus 155 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-----------~~~~ 216 (277)
T cd06641 155 -QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-----------IPKN 216 (277)
T ss_pred -hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-----------HhcC
Confidence 111223457788999999988888999999999999999999999986322110 0000 0000
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++.++.++|.+||+.+|.+||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 217 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111223456778999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=273.21 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=206.7
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeC--CeeEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVY 120 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~~~lv~ 120 (360)
+|++.+.||+|++|.||.+... +++.+++|++..... .....+.+|+..++.++||||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999876 689999999876643 3456788999999999999999999999888 8899999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.. ...+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999954 338999999999999999999999998 99999999999999999999999999886444
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
...........++..|+|||.+.+...+.++||||||+++++|++|..||....... . .......
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~----------~~~~~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----A----------ALYKIGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----H----------HHHhccc
Confidence 332212334568889999999988889999999999999999999999997433100 0 0001111
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+...+..+.++|.+|++.+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11112344556788999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=279.48 Aligned_cols=265 Identities=26% Similarity=0.352 Sum_probs=196.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||.|++|.||++... +++.|++|.+...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 68999999999999999999876 5899999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++ +|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 99998865 3347899999999999999999999999 9999999999999999999999999986432211
Q ss_pred Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch--hcc----chhhhhcccc-
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL--VSW----SRPFLKDQKK- 274 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~--~~~----~~~~~~~~~~- 274 (360)
.......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||........... ... ....+.....
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11122345778999998875 4578999999999999999999999964331100000 000 0000000000
Q ss_pred --chhcccccccC----CCChhh--HHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 --FVHLVDPLLHG----RYPRRC--LNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 --~~~~~~~~~~~----~~~~~~--~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........... ...... ..++.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000000 000112 267889999999999999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=275.56 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=205.2
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||++... +++.+++|.+..... .....+..|+..++.++||||+++++.+.+....++|+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999765 688999999875432 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.........+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998765444577899999999999999999999999 999999999999999999999999998764332
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .. ......
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~-----------~~~~~~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------LR-----------YKVQRG 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-----------HHHhcC
Confidence 2223457889999999999889999999999999999999999996432110 00 000011
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++.++.+++.+||+.+|.+||++.++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111233467788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=275.09 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=197.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-----cchHHHHHHHHHhhccCCCcccceeEEEEe--CCee
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQR 116 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-----~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~~~ 116 (360)
.+|++.+.||+|++|.||.+.+. +++.|++|.+..... .....+.+|+.+++.+.||||+++++.+.+ ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47999999999999999999865 589999998754321 223567889999999999999999998865 3567
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
+++||++++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999854 345788999999999999999999999 9999999999999999999999999887
Q ss_pred ccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|..||...... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~-----------~~ 218 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----A-----------AI 218 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----H-----------HH
Confidence 53221111 1122345788899999998888999999999999999999999998632110 0 00
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
............+...+..+.++|.+|+. +|.+||+++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 219 FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01111111222355677788999999995 9999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=279.97 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=205.4
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
...+|++.+.||+|++|+||++... +++.+++|++..... .....+.+|+++++.++||||+++++.+......++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4578999999999999999999865 588999998765432 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||+++++|.+++.. .+.+++..+..++.+++.+|.|||+ .+ ++|+||+|+||++++++.++|+|||++....
T Consensus 83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999998843 4568999999999999999999997 57 9999999999999999999999999876421
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..||............. .... .......
T Consensus 156 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~--~~~~---~~~~~~~ 226 (284)
T cd06620 156 NS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP--MGIL---DLLQQIV 226 (284)
T ss_pred hh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh--hHHH---HHHHHHh
Confidence 11 1123467889999999988889999999999999999999999997543321100000 0000 0000000
Q ss_pred cccccCCC-ChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 280 DPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 280 ~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
... .... ...++.++.+++.+||+.||.+||++.|+++..--+
T Consensus 227 ~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 227 QEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred hcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 000 0011 123567899999999999999999999999764333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=278.77 Aligned_cols=247 Identities=26% Similarity=0.320 Sum_probs=203.4
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
+|++.+.||.|++|.||.+.+. +++.+++|.+..... .....+.+|++.++.++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 6899999999999999999876 589999999875532 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++.+++|.+++.. ...+++..++.++.|+++||.+||+++ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999954 357899999999999999999999998 999999999999999999999999998754332
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... +.. ....
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~-------~~~~ 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-------IRA-------KQET 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH-------HHH-------Hhcc
Confidence 2 2233457888999999988889999999999999999999999997443211000 000 0000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCH--HHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI--NDIV 317 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~--~eil 317 (360)
.....+...+..+.++|.+||+.||.+||++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1123445667899999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=280.94 Aligned_cols=265 Identities=25% Similarity=0.357 Sum_probs=199.2
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++.+.||.|++|.||++... +++.+++|.+...... ..+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999876 5899999988654322 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|..+.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999988887763 3445899999999999999999999998 999999999999999999999999998753222
Q ss_pred CCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc-chhccchhhhh-------cc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLK-------DQ 272 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~-------~~ 272 (360)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... ........+.. ..
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 22223457888999998875 45788999999999999999999988633211000 00000000000 00
Q ss_pred -----ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 -----KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
................+..+..+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000000012356788999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=277.94 Aligned_cols=264 Identities=24% Similarity=0.291 Sum_probs=198.1
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc-----chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-----GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~-----~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
+|++.+.||.|++|.||++... +++.|++|.+...... ....+..|++.++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 5889999999999999999865 6899999998765433 234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||++ +++|.+++.. ....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 8899999954 2237999999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccc-hh---hhhccc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWS-RP---FLKDQK 273 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~-~~---~~~~~~ 273 (360)
... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... .... .+ ......
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 322 11222345778999998864 4678999999999999999999877753322110000 0000 00 000000
Q ss_pred cchhcccccccC-----CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLLHG-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
............ ......+..+.++|.+||+.+|.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000 012345678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=273.54 Aligned_cols=250 Identities=29% Similarity=0.397 Sum_probs=201.3
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||.+... +++.+++|.+...... ....+.+|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 6999999999999999999765 6899999998766443 567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. +..+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999853 456889999999999999999999999 9999999999999999999999999987643322
Q ss_pred Ccce--ecccccccccccccccccCC---CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 203 NTHV--STRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 203 ~~~~--~~~~~~~~~y~aPE~~~~~~---~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.... .....++..|+|||.+.+.. .+.++||||||++++++++|..||....... ...+.. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-------~~~~~~-~~---- 221 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-------QIMFHV-GA---- 221 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-------HHHHHH-hc----
Confidence 2111 11245778999999988766 8899999999999999999999996322100 000000 00
Q ss_pred cccccccCCCC--hhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......+ ...+..+.++|.+||+.+|++||++.+++.
T Consensus 222 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 ----GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000111 234677889999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=282.52 Aligned_cols=256 Identities=23% Similarity=0.293 Sum_probs=200.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+|++.+.||.|++|.||++.+. .++.|++|.+..... .....+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999876 588999998865532 23456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999954 456899999999999999999999998 99999999999999999999999998763211
Q ss_pred CCCc-------------ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh
Q 018128 201 GDNT-------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 201 ~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 1100 0111234677899999998888999999999999999999999999632211 00000
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
... .... .......++.++.++|.+||+.+|++||+..++++.|+.
T Consensus 228 ~~~-----~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VIS-----DDIE----WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHh-----cccC----CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000 0000 001112467789999999999999999997666665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=282.16 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=200.2
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecC
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~ 124 (360)
-|.....||.|+||.||.+... +++.|++|.+........+.+.+|+..++.++|||++++++.+...+..++++|+++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 4455668999999999999865 689999999876555556678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
+++|.+++. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 102 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~ 171 (297)
T cd06659 102 GGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--V 171 (297)
T ss_pred CCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccc--c
Confidence 999999873 356899999999999999999999999 999999999999999999999999988643221 1
Q ss_pred ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccccc
Q 018128 205 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 284 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (360)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||........ . .. .. ..... .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~-~~------~~~~~--~ 236 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--M----KR-LR------DSPPP--K 236 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HH-Hh------ccCCC--C
Confidence 122334578899999999988899999999999999999999999863221100 0 00 00 00000 0
Q ss_pred CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 285 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 285 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
.......+..+.++|.+||+.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 237 LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 01123456678999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=270.83 Aligned_cols=249 Identities=30% Similarity=0.422 Sum_probs=203.8
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecC
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~ 124 (360)
.|++.+.||.|++|.||.+... +++.+++|++..........+.+|+..++.++||+++++.+.+......++++|+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4888999999999999999876 689999999977655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
+++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999999865 2257899999999999999999999998 99999999999999999999999999875433221
Q ss_pred ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccccc
Q 018128 205 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 284 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (360)
.....++..|+|||.+.+...+.++|+||||+++|+|++|..||........ .. ... .... ..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~---~~~--~~~~-------~~ 216 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LF---KIA--TNGP-------PG 216 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HH---HHH--hcCC-------CC
Confidence 2345578889999999888899999999999999999999999863321000 00 000 0000 00
Q ss_pred CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 285 GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 285 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...+..++..+.++|.+||+.||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0112223678999999999999999999999984
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=275.28 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=198.3
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccchHHHHHHHHHhhccC---CCcccceeEEEEeCCeeEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~---~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.|++.+.||.|++|.||.+.+. +++.+++|.+.... ......+.+|+.+++.++ |||++++++++......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5889999999999999999864 68999999886542 234456888999999886 999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ..+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998843 37899999999999999999999999 99999999999999999999999999876433
Q ss_pred CCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ......
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------------~~~~~~ 218 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------------LIPKSK 218 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------------ccccCC
Confidence 22 22233457888999998864 457899999999999999999999996432111000 000000
Q ss_pred cccccCCCCh-hhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGRYPR-RCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+ ..+. ..+.++.+++.+||+.||.+||++.+++.
T Consensus 219 ~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PP----RLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CC----CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00 1111 25678999999999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=277.46 Aligned_cols=240 Identities=26% Similarity=0.420 Sum_probs=189.4
Q ss_pred ceeccCCCeEEEEEEecC--------CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 51 NLIGEGGFGKVYKGRLES--------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+.||.|+||.||++.... ...+++|.+........+.+.+|..+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997542 234888887655444556788899999999999999999999998999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc--------eEEeecCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--------PKLSDFGL 194 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~--------v~L~Dfg~ 194 (360)
+++++|.+++.. .+..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999965 3346899999999999999999999999 999999999999987664 69999998
Q ss_pred ccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCC-CcccccCccCccchhccchhhhhcc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
+..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|. .||......... ....
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------~~~~-- 219 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYE-- 219 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-------HHHH--
Confidence 764321 122346778999999886 45789999999999999999985 555422211000 0000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
....++.....++.+++.+||+.||++|||+.++++.|+
T Consensus 220 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 ----------DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011233445567899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=272.85 Aligned_cols=238 Identities=27% Similarity=0.429 Sum_probs=187.5
Q ss_pred ceeccCCCeEEEEEEecC-C----------CEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 51 NLIGEGGFGKVYKGRLES-G----------QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~-~----------~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
+.||+|+||.||++.+.. + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 478999999999998753 3 25777876554333 5778899999999999999999999877 778999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-------ceEEeec
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-------NPKLSDF 192 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-------~v~L~Df 192 (360)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999965 2237899999999999999999999998 99999999999998887 7999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccC--CCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhh
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 269 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 269 (360)
|++..... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.......... ..
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-------~~ 219 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-------FY 219 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------HH
Confidence 99875322 2223456679999998876 78999999999999999999 567775432111000 00
Q ss_pred hccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 270 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
... ...+......+.++|.+||..+|.+||++.++++.|+
T Consensus 220 ~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQ------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcC------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0011112267899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=276.84 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=200.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
..|...+.||.|++|.||.+... +++.+++|.+..........+.+|+.+++.++|||++++++++...+..++++|++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 35666789999999999999865 68899999886655455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++++|.+++.. .++++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~-- 168 (285)
T cd06648 99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-- 168 (285)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC--
Confidence 99999999843 56899999999999999999999999 999999999999999999999999987643221
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
........++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....... ....+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~-------~~~~~~~ 235 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR-------DNLPPKL 235 (285)
T ss_pred CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-------hcCCCCC
Confidence 11222345788999999998888999999999999999999999998632210 0000000 0000000
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..+..++..+.+++.+||+.+|++||++.++++
T Consensus 236 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 --KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 112236678999999999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=294.84 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=206.8
Q ss_pred hcccccceeccCCCeEEEEEEecC-CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
+-|+|+..||.|+||.||.+..+. +-..+.|++........+.+.-|+++|..+.||+|+++++.|..++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 467888899999999999998764 6667888888777777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
.||-++..+-. -+..+.+..+.-++.|++.||.|||+++ |+|||||..|||++-+|.|+|+|||.+.. ....
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKST 183 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhH
Confidence 99999888865 4578999999999999999999999999 99999999999999999999999998864 2222
Q ss_pred cceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 204 THVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
........||+.|||||+++ ..+|+.++||||||+++.+|..+.+|-...+.. . ..+. +.+-
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------R---VllK----iaKS 250 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------R---VLLK----IAKS 250 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------H---HHHH----Hhhc
Confidence 33344578999999999875 568999999999999999999999886532211 0 0000 0000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
-.+.+ -.|...+..+.+++.+||..||+.||++.++++
T Consensus 251 ePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 00111 125677888999999999999999999999984
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=279.32 Aligned_cols=269 Identities=22% Similarity=0.285 Sum_probs=198.9
Q ss_pred cccccceeccCCCeEEEEEEec---CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeC--CeeE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRL 117 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~~~ 117 (360)
+|++.+.||.|++|.||.+... .++.|++|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5899999999999999999865 47899999987643 33346678899999999999999999999887 7899
Q ss_pred EEEEecCCCCHHHHhcccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC----CCceEEeec
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQ-EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN----DFNPKLSDF 192 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~----~~~v~L~Df 192 (360)
+|||++++ +|.+++....... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. ++.++|+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 7888775544333 37899999999999999999999999 999999999999998 899999999
Q ss_pred CCccccCCCCC-cceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-------hc
Q 018128 193 GLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-------VS 263 (360)
Q Consensus 193 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-------~~ 263 (360)
|++........ ........++..|+|||.+.+ ..++.++||||||+++++|++|..||........... ..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99875433222 111223456788999998776 4578999999999999999999999975443220000 00
Q ss_pred cchhh----------hhccccchhcccccccCCCC---------h--hhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 264 WSRPF----------LKDQKKFVHLVDPLLHGRYP---------R--RCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 264 ~~~~~----------~~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....+ ..................++ . ..+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000000000000000111 1 34567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=280.02 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=187.5
Q ss_pred cceeccCCCeEEEEEEec---CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEE--eCCeeEEEEEecC
Q 018128 50 ANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT--SGDQRLLVYEYMP 124 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~--~~~~~~lv~e~~~ 124 (360)
+..||+|+||+||+++.. .+..+++|.+.... ....+.+|+.+++.++||||+++++++. .....++++||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999864 35789999886543 2346778999999999999999999884 3567889999985
Q ss_pred CCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----eCCCceEEeecCCc
Q 018128 125 MGSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLA 195 (360)
Q Consensus 125 ~~sL~~~i~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv----~~~~~v~L~Dfg~~ 195 (360)
++|.+++.... .....+++..++.++.||+.||.|||+.+ ++|+||||+||++ +.++.++|+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 58888775321 12235889999999999999999999999 9999999999999 45678999999999
Q ss_pred cccCCCCCc-ceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh---ccchh---
Q 018128 196 KLGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV---SWSRP--- 267 (360)
Q Consensus 196 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~~~~~--- 267 (360)
......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 754332211 11223457889999999876 45789999999999999999999999644322110000 00000
Q ss_pred --------hhhccc---cchhcccccccC------------CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 --------FLKDQK---KFVHLVDPLLHG------------RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 --------~~~~~~---~~~~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+.... ............ .........+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 000000000000 011123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=276.33 Aligned_cols=239 Identities=24% Similarity=0.358 Sum_probs=186.4
Q ss_pred eeccCCCeEEEEEEec-------------------------CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccce
Q 018128 52 LIGEGGFGKVYKGRLE-------------------------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~-------------------------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~ 106 (360)
.||+|+||.||.+... ....+++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6899999999998631 123588888866544445678889999999999999999
Q ss_pred eEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-
Q 018128 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF- 185 (360)
Q Consensus 107 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~- 185 (360)
++++......++||||+++++|..++.. ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998854 3467899999999999999999999998 99999999999997643
Q ss_pred ------ceEEeecCCccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHH-hCCCcccccCccC
Q 018128 186 ------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELI-TGRKAMDLSKGQG 257 (360)
Q Consensus 186 ------~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll-~g~~pf~~~~~~~ 257 (360)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|+|+ +|..||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999987532111 12346677999998875 56899999999999999985 6888886332111
Q ss_pred ccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 258 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
.. .+... ....+......+.++|.+||+.+|.+||++.++++.|.
T Consensus 230 ~~-------~~~~~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KE-------RFYEK------------KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH-------HHHHh------------ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 00000 00112223456899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=275.72 Aligned_cols=265 Identities=24% Similarity=0.308 Sum_probs=195.8
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc-hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.++|++.+.||.|++|.||.+... +++.+++|.+....... ...+.+|+..++.++|+||+++++++.+....++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 478999999999999999999765 68899999986553322 3467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++. ++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 688777743 3356788889999999999999999998 999999999999999999999999988743221
Q ss_pred CCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccc---hh---hhhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS---RP---FLKDQKK 274 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---~~---~~~~~~~ 274 (360)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.......+.-...+. .+ .......
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 1 112233468889999988754 5788999999999999999999999643321110000000 00 0000000
Q ss_pred chhcccccccCCC---------ChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 275 FVHLVDPLLHGRY---------PRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 275 ~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
............. ....+..+.+++.+|+..||.+|||+.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 0000000000000 011256788999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=272.20 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=200.7
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||.+... ++..+++|.+..... .....+.+|+.+++.++||||+++++.+.+....++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 6899999999999999999876 588999999865422 3345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc-eEEeecCCccccCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-PKLSDFGLAKLGPVG 201 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~-v~L~Dfg~~~~~~~~ 201 (360)
+++++|.+++.. .....+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999865 23345799999999999999999999998 999999999999988864 699999988754322
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
........++..|+|||.+.+..++.++|+||||+++++|++|..||..... ..... .....
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~----------~~~~~ 217 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVL----------KICQG 217 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH----------HHhcc
Confidence 1122234578889999999888899999999999999999999999863221 11110 00000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ....+..+..+.++|.+||+.+|++|||+.+++.
T Consensus 218 ~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 218 YF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred cC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01 1123355678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=275.53 Aligned_cols=252 Identities=28% Similarity=0.372 Sum_probs=204.2
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
...+|++.+.||.|++|.||.+.+. ++..+++|++..... ....+.+|++.++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3567999999999999999999876 688999999876544 45678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++++++|.+++.... ..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999996522 47999999999999999999999998 999999999999999999999999987643322
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .. ... . ..
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~----~~~--~-------~~ 232 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LF----LIT--T-------KG 232 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHH--h-------cC
Confidence 1 122233467889999999888899999999999999999999999863221100 00 000 0 00
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......+..++..+.++|.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0001112236678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=277.16 Aligned_cols=265 Identities=25% Similarity=0.338 Sum_probs=199.3
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeC--CeeEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLV 119 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~~~lv 119 (360)
++|++.+.||.|++|.||.+... +++.+++|.+...... ....+.+|+.+++.++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57999999999999999999876 5889999988654322 223567899999999999999999998777 889999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
+|+++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 85 ~e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 499998865 2346899999999999999999999999 9999999999999999999999999887543
Q ss_pred CCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hc---------cch--
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VS---------WSR-- 266 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~---------~~~-- 266 (360)
... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||........... .. |..
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 321 122234567889999988754 468999999999999999999999964332111000 00 000
Q ss_pred hhhh-ccccchhcccccccCCCChh-hHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 267 PFLK-DQKKFVHLVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 267 ~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+.. ............+...++.. .+..+.++|.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 00001111111112223333 5778999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=271.48 Aligned_cols=242 Identities=26% Similarity=0.349 Sum_probs=197.3
Q ss_pred eccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 53 Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
||.|++|.||++... .++.+++|.+..... ...+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999876 489999999875432 2345788999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceec
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~ 208 (360)
.+++.. ...+++..+..++.||+.||.+||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999954 355899999999999999999999998 9999999999999999999999999987543322 222
Q ss_pred ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCC
Q 018128 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 288 (360)
Q Consensus 209 ~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
...++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... . ..............++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~----------~~~~~~~~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----M----------EIYNDILKGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----H----------HHHHHHhccCCCCCCC
Confidence 3457888999999988889999999999999999999999997443210 0 0011111111222345
Q ss_pred hhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 289 RRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 289 ~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
...+.++.++|.+||+.+|++||+ +.|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 556788999999999999999999 777774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=297.53 Aligned_cols=285 Identities=25% Similarity=0.377 Sum_probs=235.4
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecC----CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
++.....+|.++||.|.||.||.++.+. ...||||.+..... ++..+|..|..++-++.||||+++.++......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 3444567889999999999999998762 45799998865533 345679999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
..||.||+++|+|+.|+.. +.+.+...++..+++.|+.|++||.+.+ +|||||...||||+.+..+|+.|||++
T Consensus 705 vMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence 9999999999999999977 5566999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccc
Q 018128 196 KLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 196 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
+....+... +...--....+|.|||.+...+++.+|||||+|++|||.+. |..||.... ..
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQ 841 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQ 841 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------hH
Confidence 876444422 22222334678999999999999999999999999999776 888986322 22
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCCCCCCCCCCCCc
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDV 348 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (360)
+..+.++...+.+.|.+++..|.+|+..||+.|-.+||.+.+|+..|++++.+...-+...+.+....+...+++
T Consensus 842 dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld~~ 916 (996)
T KOG0196|consen 842 DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLDRS 916 (996)
T ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccCCC
Confidence 333344445555678899999999999999999999999999999999999988887777666555544444433
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.54 Aligned_cols=247 Identities=30% Similarity=0.432 Sum_probs=204.3
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||.+... .++.+++|.+..... .....+.+|+++++.++|||++++++++.+....++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5899999999999999999766 588999999877654 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. ...+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999854 367899999999999999999999998 9999999999999999999999999998644322
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.. .....++..|+|||...+...+.++|||++|+++|+|++|..||...... . ...... ..
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~----~~~~~~--------~~ 214 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----A----ALFRIV--------QD 214 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----H----HHHHHh--------cc
Confidence 21 23345788899999988877899999999999999999999998632210 0 000000 01
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+...+..+.+++.+||+.+|++||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111234456788999999999999999999999983
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=274.76 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=197.4
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
+|++.+.||.|++|.||+++.. +++.+++|.+..... .....+.+|++.++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5899999999999999999875 689999998865432 2335788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+. ++|.+++.. ..+..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 589888855 23467899999999999999999999998 9999999999999999999999999987533221
Q ss_pred CcceecccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh----------hhc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF----------LKD 271 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------~~~ 271 (360)
.......++..|+|||.+.+.. ++.++||||||+++|+|++|..||....... ......... ...
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhH
Confidence 1122234677899999887644 6889999999999999999999996432110 000000000 000
Q ss_pred cccchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.............. ...+..+.++.++|.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 011235567889999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=292.57 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=195.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC----CccchHHHHHHHHHhhccCCCcccceeEEEEeCCe--e
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE----GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ--R 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~----~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~--~ 116 (360)
+.-.+..+.||+|+|.+||.|.+. +|..||--.+... .....+++.+|+++|+.|+||||++++..+.+... .
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 344466779999999999999765 5777776554432 22344789999999999999999999999876655 6
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-CceEEeecCCc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLA 195 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-~~v~L~Dfg~~ 195 (360)
.+|.|.+..|+|..|..+ .+.++...++.|++||+.||.|||++ +|||+|||||.+||||+.+ |.|||+|+|++
T Consensus 119 n~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred eeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence 799999999999999955 56788889999999999999999998 7899999999999999765 89999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
+..... ......||+.|||||... ..|+...||||||++++||+|+..||...... ....+..
T Consensus 194 tl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIYKKV------- 256 (632)
T KOG0584|consen 194 TLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIYKKV------- 256 (632)
T ss_pred HHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHHHHH-------
Confidence 863322 223368999999999775 88999999999999999999999999643321 1111111
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......-+..--..++.+||.+||.. ..+||++.|+|.
T Consensus 257 ---~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 257 ---TSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---HcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 000010011122245789999999999 999999999996
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=272.12 Aligned_cols=244 Identities=27% Similarity=0.392 Sum_probs=193.3
Q ss_pred eccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 53 Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
||.|++|+||.+... +++.+++|.+..... .....+..|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999765 589999998865432 2234567899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceec
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~ 208 (360)
.+++.... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+..... .....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccc
Confidence 99986522 246899999999999999999999999 99999999999999999999999998875322 11122
Q ss_pred ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCC
Q 018128 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 288 (360)
Q Consensus 209 ~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
...++..|+|||.+.+..++.++||||+|+++|+|++|..||.......... .. ..... .....++
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-------~~~~~-~~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE------EL-------KRRTL-EMAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH------HH-------Hhccc-cccccCC
Confidence 3456778999999988889999999999999999999999996433211100 00 00000 0111234
Q ss_pred hhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 289 RRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 289 ~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
...+..+.++|.+||+.||.+|| ++.+++.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 55678899999999999999999 6666663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=281.63 Aligned_cols=264 Identities=24% Similarity=0.315 Sum_probs=198.4
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeC-----
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG----- 113 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~----- 113 (360)
...++|++.+.||+|++|.||++.+. +++.+++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35689999999999999999999865 68999999986532 23345677899999999999999999987543
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 114 -DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 114 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
...++|||++. ++|.+.+.. .++...+..++.|++.||.+||+++ ++|+||+|+||+++.++.++|+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 35799999995 588888732 2889999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc------------
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN------------ 260 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~------------ 260 (360)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...+......
T Consensus 163 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 163 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9997533221 1223457788999999999999999999999999999999999996433211000
Q ss_pred hhcc----chhhhhccc-----cchhcccccc----cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 261 LVSW----SRPFLKDQK-----KFVHLVDPLL----HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 261 ~~~~----~~~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... ...+..... ...+...... ....+...+..+.++|.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 000000000 0001110000 00112245677899999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=272.59 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=199.3
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
+|++.+.||.|++|.||++++. +++.|++|.+...... ....+.+|+.+++.++||||+++++.+.+.+..++|||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5899999999999999999876 5899999998765332 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++ +|.+++.... ....+++..++.++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~-- 153 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP-- 153 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--
Confidence 75 8988886533 2356899999999999999999999999 999999999999999999999999998743221
Q ss_pred cceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhcc-chh---hhhccccchh
Q 018128 204 THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW-SRP---FLKDQKKFVH 277 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~-~~~---~~~~~~~~~~ 277 (360)
........++..|+|||.+.+ ..++.++|||+||+++|+|++|..||.......... .... ..+ .+........
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 112223346778999998865 457899999999999999999999996443211000 0000 000 0000000000
Q ss_pred ccccccc------CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLH------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....... ....+..+..+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0112245678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=273.62 Aligned_cols=265 Identities=23% Similarity=0.289 Sum_probs=195.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccC-CCcccceeEEEEeCCe-----
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQ----- 115 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~----- 115 (360)
++|++.+.||.|++|.||++.+. +++.|++|.+..... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999865 589999998765432 22356788999999995 6999999999877665
Q ss_pred eEEEEEecCCCCHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-CCceEEeecC
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFG 193 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-~~~v~L~Dfg 193 (360)
.+++|||+++ +|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 899988653322 456899999999999999999999999 999999999999998 8899999999
Q ss_pred CccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ...... .....
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~-~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFK-LLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHH-HhCCC
Confidence 9875332211 1122345778999998865 4578999999999999999999999964321110 000000 00000
Q ss_pred c--cc---hhccc----cc----ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 K--KF---VHLVD----PL----LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~--~~---~~~~~----~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .+ ..... +. ......+..+..+.++|.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00 00000 00 000011346778999999999999999999999983
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=273.86 Aligned_cols=246 Identities=30% Similarity=0.405 Sum_probs=196.1
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
.++|++.+.||.|++|+||.+... +++.|++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 467999999999999999999865 589999998864432 2234688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
+||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99996 588777754 3456899999999999999999999999 9999999999999999999999999886532
Q ss_pred CCCCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
.. ....++..|+|||.+. ...++.++||||||+++|+|++|..||......... ... . ..
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~-~-~~--- 229 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHI-A-QN--- 229 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHH-h-cC---
Confidence 21 1235677899999874 456889999999999999999999998632211100 000 0 00
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......+..++..+.++|.+||+.+|.+||++.+++.
T Consensus 230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 230 -----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred -----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000112245677999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=274.23 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=195.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.+|+..+.||.|++|.||.+.+. +++.+++|.+..... .....+.+|+..+.++. ||||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 45677889999999999999865 589999999875432 23456788999999886 9999999999998889999999
Q ss_pred ecCCCCHHHHhccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 122 YMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 122 ~~~~~sL~~~i~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
++. +++.++.... ......+++..+..++.|++.||.|||+. + ++||||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 4666654321 12346799999999999999999999975 7 9999999999999999999999999986532
Q ss_pred CCCCcceecccccccccccccccccC---CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
... ......++..|+|||.+.+. .++.++||||+|+++|+|++|..||..... ... . .....
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~---~----~~~~~ 224 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFD---Q----LTQVV 224 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHH---H----Hhhhc
Confidence 211 11223577889999998765 688999999999999999999999963320 000 0 00000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....+......+..++..+.+||.+||+.+|.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111111222356778999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=271.10 Aligned_cols=262 Identities=24% Similarity=0.312 Sum_probs=197.2
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
|++.+.||.|++|.||.+.+. +|..|++|++...... ....+.+|+..++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 788999999999999999865 6999999998755322 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
+ ++|.+++.... ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 5 68999885522 246899999999999999999999998 9999999999999999999999999987533221
Q ss_pred cceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh-------hhccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-------LKDQKKF 275 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~ 275 (360)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ ........ +......
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhc
Confidence 111223457889999987654 578999999999999999999999964332110 00000000 0000000
Q ss_pred hhccccc------ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPL------LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....... ........++..+.++|.+||+.+|.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 000113345678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=284.39 Aligned_cols=247 Identities=28% Similarity=0.353 Sum_probs=211.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
.....|.+.+.||+|.|+.|.++.+. ++..||+|++.+.... ....+.+|+++++.++||||++++++.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34578999999999999999999865 6999999999876443 33558899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
||||+.+|.+.+++.+ ...+.+..+..++.|+..|++|||+++ |+|+|||++|||++.+-+++|+|||++..+
T Consensus 133 V~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 9999999999999954 566777999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcceecccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s-~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
. ........+|++.|.|||++.+..+. ++.|+|++|+++|.|+.|..||+... +..
T Consensus 206 ~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~--------------------lk~ 262 (596)
T KOG0586|consen 206 D---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN--------------------LKE 262 (596)
T ss_pred c---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc--------------------ccc
Confidence 4 44455668899999999999988764 89999999999999999999998433 223
Q ss_pred cccccccCC--CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+-.+.+.+. .+.-...+..++|+++|-.+|.+|++.+++-+
T Consensus 263 Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 263 LRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 333333332 34455678899999999999999999999865
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=270.64 Aligned_cols=260 Identities=21% Similarity=0.243 Sum_probs=192.0
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccC-CCcccceeEEEEeC--CeeEEEEE
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSG--DQRLLVYE 121 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~--~~~~lv~e 121 (360)
|++.+.||.|++|.||++... +++.+++|.+..... ........|+..++.+. |||++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 788999999999999999865 588999998865422 22234456888888885 99999999999877 88999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|++ ++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++. +.++|+|||.+......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 588888754 3357899999999999999999999999 999999999999999 99999999998754322
Q ss_pred CCcceecccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc-chhccc-------hhhhhcc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWS-------RPFLKDQ 272 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~-------~~~~~~~ 272 (360)
.. .....++..|+|||.+. +..++.++||||||+++|+|++|..||......... ...... .......
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 21 12234678899999764 456789999999999999999999999643321100 000000 0000000
Q ss_pred ccchhccccccc----CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. .....+... .......+..+.++|.+||+.+|++||++.++++
T Consensus 230 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RH-MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cc-ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 000000000 0012356789999999999999999999999984
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=272.79 Aligned_cols=263 Identities=17% Similarity=0.188 Sum_probs=188.2
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecC----CCEEEEEEcccCCccch-----------HHHHHHHHHhhccCCCcccc
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGLQGH-----------QEFIVEVLMLSLLHHDNLVT 105 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~~~~~-----------~~~~~e~~~l~~l~~p~i~~ 105 (360)
.+.+++|++.+.||+|+||+||++...+ +..+++|+......... .....+...+..+.|+++++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3567899999999999999999998653 45567775433321110 11223344555678999999
Q ss_pred eeEEEEeCC----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018128 106 LIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 181 (360)
Q Consensus 106 ~~~~~~~~~----~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv 181 (360)
+++...... ..+++++++ ..++.+.+.. ....++..++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill 159 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMV 159 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 998765443 346788877 4467666633 234578889999999999999999998 9999999999999
Q ss_pred eCCCceEEeecCCccccCCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCcc
Q 018128 182 DNDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 256 (360)
Q Consensus 182 ~~~~~v~L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~ 256 (360)
+.++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999998764322211 1112346899999999999999999999999999999999999999754321
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
....... ...+. ..+..... .....+..+.+++..|++.+|++||++.++++.|+
T Consensus 240 ~~~~~~~-~~~~~------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GNLIHAA-KCDFI------KRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHh-HHHHH------HHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1110000 00000 01100000 12345678999999999999999999999998763
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=281.55 Aligned_cols=268 Identities=28% Similarity=0.426 Sum_probs=221.0
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccch-HHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
+..-+...+++.||+|-||.|.+++...+..||+|.+........ .++.+|+++|.+++||||+.++++|..++.+|+|
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 445678899999999999999999999889999999987765544 7899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
+||+++|+|.+|+.++.. +.+.......++.||+.|++||.+.+ +|||||.+.|+|++.++++|++|||.++-.-
T Consensus 614 ~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999977432 22455566779999999999999999 9999999999999999999999999998666
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh--CCCcccccCccCccchhccchhhhhccccchh
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT--GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
..+..+......-..+|+|+|.+..++++.++|+|+||+++||+++ ...||..... .+..+....++.+...
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~--- 762 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGR--- 762 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCc---
Confidence 6677777777777889999999999999999999999999999876 4567753221 1111111122221111
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
......|.-++..+.+++.+||..+-.+||+++++...|...
T Consensus 763 ----~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 ----QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112234678899999999999999999999999998887654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=274.87 Aligned_cols=265 Identities=25% Similarity=0.333 Sum_probs=195.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeC--CeeEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLL 118 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~~~l 118 (360)
..+|++.+.||.|++|.||.+.+. +++.|++|.+...... ......+|+.+++.++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999875 5899999988654322 223566799999999999999999998654 56899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
|||++. ++|.+++... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999995 4898888652 367899999999999999999999999 999999999999999999999999998764
Q ss_pred CCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhccch----hh---h
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSR----PF---L 269 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~----~~---~ 269 (360)
.... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......... ...... .. .
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 3322 11222335678999998865 557899999999999999999999996433211100 000000 00 0
Q ss_pred hccccchhcc-----cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 270 KDQKKFVHLV-----DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 270 ~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......... ..... ......+..+.++|.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLK-HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchH-HhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 00000 001124667889999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=280.54 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=214.4
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec---C--CCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE---S--GQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~---~--~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
+++.-...+..+.||.|-||.||.+..- . .-.||||....+. ....+.|..|..+++.++||||+++++++.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 3444445556778999999999999632 2 3468899887643 3456789999999999999999999999965
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...+||||.++.|.|..|++. +...++...+..++.||..||.|||+.+ +|||||...||||....-|||+|||
T Consensus 463 ~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 467899999999999999976 5577999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
+++........+.. ...-..-|+|||.+.-..++.++|||.||+++||++. |..||.....
T Consensus 537 LSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------- 598 (974)
T KOG4257|consen 537 LSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------- 598 (974)
T ss_pred hhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------
Confidence 99976555544433 3445667999999999999999999999999999876 8899964331
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
.+..-.+...-+.+.|+.++..|..+..+||..+|.+||.+.++...|..+..
T Consensus 599 sDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 599 SDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11112222333445688999999999999999999999999999998887765
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=272.70 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=197.4
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
|.....||.|++|.||.+..+ +++.+++|.+..........+.+|+.+++.++|||++++++.+...+..+++|||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 334578999999999999775 6899999988655444556788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++. ...+++..++.++.|++.+|++||+.+ ++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 102 ~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~ 171 (292)
T cd06657 102 GALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP 171 (292)
T ss_pred CcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc--cc
Confidence 99999873 346899999999999999999999998 999999999999999999999999988643221 11
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ .. ... ........
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~----~~~------~~~~~~~~- 237 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK----MIR------DNLPPKLK- 237 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHH------hhCCcccC-
Confidence 22334578889999998888889999999999999999999999863221100 00 000 00000000
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..+.+++.+||+.+|.+||++.++++
T Consensus 238 -~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11245667889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=266.38 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=198.5
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-----ccchHHHHHHHHHhhccCCCcccceeEEEEeC--Cee
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQR 116 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~~ 116 (360)
.+|++.+.||+|++|.||.+.+. +++.+++|.+.... ......+.+|+.+++.++||||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999865 58999999875331 12335688899999999999999999988654 457
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++++|++++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999853 355889999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
........ .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~ 218 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------------AAI 218 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------------HHH
Confidence 53221111 1112345788899999998888899999999999999999999999632110 001
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+..........+...+..+.++|.+||+ +|..||++.+++.
T Consensus 219 ~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 FKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111111223456778889999999999 5799999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=280.19 Aligned_cols=267 Identities=22% Similarity=0.308 Sum_probs=198.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEE----eCCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCT----SGDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~----~~~~~ 116 (360)
+.+|++.+.||.|++|.||.+... +++.|++|.+..... .....+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 489999999999999999999765 599999999875422 33456778999999999999999988775 33567
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+. ++|.+++. .+..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 58988884 3556999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCc--ceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-cc-ch---hh
Q 018128 197 LGPVGDNT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW-SR---PF 268 (360)
Q Consensus 197 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~-~~---~~ 268 (360)
........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ .. .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 54332221 11123467889999998765 45889999999999999999999999643221000000 00 00 00
Q ss_pred hhc--cccchhcccc---ccc---CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKD--QKKFVHLVDP---LLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~--~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... .......... ... ....+..+.++.++|.+||+.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 0000000000 000 0112345788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.39 Aligned_cols=267 Identities=26% Similarity=0.342 Sum_probs=192.6
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCC-------
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------- 114 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~------- 114 (360)
++|++.+.||.|++|.||++... +++.|++|.+...... ......+|+.+++.++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57999999999999999999876 5899999988654322 2335678999999999999999999876543
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 115 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 115 -~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
..++|||++. ++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999995 488888754 3347899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCc--ceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhcc-c----
Q 018128 194 LAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW-S---- 265 (360)
Q Consensus 194 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~---- 265 (360)
.+......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.............. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98754332221 111223467789999988654 468899999999999999999999864332111000000 0
Q ss_pred hhhhhcccc---chhcc--cc---cccCC-CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 RPFLKDQKK---FVHLV--DP---LLHGR-YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~~~~~~~~~---~~~~~--~~---~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......... ..... .. ..... .+......+.++|.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000 00000 00 00000 01112456789999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=270.04 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=194.1
Q ss_pred eccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 53 Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
||.|++|.||+++.. +++.+++|.+..... .....+.+|+..++.++||||+++++.+......++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 499999999876543 3456788899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC-----
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN----- 203 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~----- 203 (360)
.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999954 347899999999999999999999998 99999999999999999999999998875332211
Q ss_pred -cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 204 -THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 204 -~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
........++..|+|||...+...+.++|+||||+++|+|++|..||....... .. .......
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~----------~~~~~~~ 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IF----------QNILNGK 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HH----------HHHhcCC
Confidence 112233457788999999988888999999999999999999999996432110 00 0000000
Q ss_pred ccCCCChh--hHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 018128 283 LHGRYPRR--CLNYAVAVTAMCLNEEANFRPLINDIVVAL 320 (360)
Q Consensus 283 ~~~~~~~~--~~~~l~~li~~~l~~dp~~Rpt~~eil~~L 320 (360)
...+.. .+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus 218 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 --IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred --cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 011122 377899999999999999999995444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.33 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=195.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeC-----Cee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-----~~~ 116 (360)
+++|++.+.||.|++|.||.+.+. +++.|++|.+..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999765 689999999864322 2345678899999999999999999876543 357
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++++|++. ++|.+.+. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 99999995 48888773 457999999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCc-ceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc--c
Q 018128 197 LGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD--Q 272 (360)
Q Consensus 197 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~ 272 (360)
........ .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||........ .......+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCH
Confidence 54332211 11123457888999998654 5689999999999999999999999964321100 0000000000 0
Q ss_pred ccchhccc-----------ccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 273 KKFVHLVD-----------PLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 273 ~~~~~~~~-----------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
.....+.. ..... ...+..+..+.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00000 0112346779999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=270.13 Aligned_cols=264 Identities=26% Similarity=0.333 Sum_probs=197.3
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeC--CeeEEEEE
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRLLVYE 121 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~~~lv~e 121 (360)
|++.+.||.|++|.||++... +++.+++|.+.... ......+.+|+.+++.++|||++++++++.+. ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999876 58999999987663 23345678899999999999999999999887 88999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++ +|.+++.. ....+++..++.++.||+.||.+||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9964 88888854 2357999999999999999999999998 999999999999999999999999998754333
Q ss_pred CCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhccch-hhhhccccc---
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSR-PFLKDQKKF--- 275 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~-~~~~~~~~~--- 275 (360)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......... ...... +........
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 11222346778999998764 457899999999999999999999996433211000 000000 000000000
Q ss_pred --------hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 --------VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+...+...++..+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000111123678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=269.87 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=199.6
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
|++.+.||.|++|.||.+... +++.+++|.+...... ....+..|+.+++.++||||+++++++.+.+..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 678899999999999999875 6899999988655333 3457888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++ +|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 65 88888855 3367899999999999999999999999 9999999999999999999999999987543332
Q ss_pred cceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh--ccchhhhhccccchh---
Q 018128 204 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV--SWSRPFLKDQKKFVH--- 277 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~--- 277 (360)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||............ ....+..........
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 122234577789999998776 7899999999999999999999999643321100000 000000000000000
Q ss_pred -----ccc--ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 -----LVD--PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 -----~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ...........+.++.++|.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00000112356788999999999999999999999984
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=278.84 Aligned_cols=266 Identities=22% Similarity=0.339 Sum_probs=197.4
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC--CccchHHHHHHHHHhhccCCCcccceeEEEEeC-----Ce
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQ 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-----~~ 115 (360)
..+|++.+.||.|++|+||.+.+. +++.|++|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 468999999999999999999865 6899999988653 223345677899999999999999999887543 34
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++++||+. ++|.+++. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68988884 3567999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccch-------
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWSR------- 266 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~------- 266 (360)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... .....
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7543321 22223457788999998764 4688999999999999999999999964321100000 00000
Q ss_pred hhhhc--cccchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 267 PFLKD--QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 267 ~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
.+... .............. ...+.++..+.++|.+||+.+|.+|||+.++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000 00000000000000 1123467789999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=271.73 Aligned_cols=250 Identities=29% Similarity=0.409 Sum_probs=197.5
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
..|+..+.||.|++|.||+++.. ++..+++|.+..... .....+.+|+..++.++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45889999999999999999865 588999998865432 22346888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+.+ +|.+.+.. ....+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99964 78777754 3456899999999999999999999999 99999999999999999999999998864322
Q ss_pred CCCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.....++..|+|||.+. +..++.++||||||+++|+|++|..||........ ...
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----------------~~~ 235 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LYH 235 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----------------HHH
Confidence 12235778899999874 45688999999999999999999999853211000 000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
+.............+..+.+++.+||+.+|.+||++.++++.+-.+
T Consensus 236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0000000111234567799999999999999999999999754443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=269.54 Aligned_cols=241 Identities=27% Similarity=0.366 Sum_probs=187.4
Q ss_pred eeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhc---cCCCcccceeEEEEeCCeeEEEEEecC
Q 018128 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSL---LHHDNLVTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~---l~~p~i~~~~~~~~~~~~~~lv~e~~~ 124 (360)
.||+|+||.||++... +++.+++|.+...... ......+|..+++. .+||+|+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 5899999988654322 12233444444433 469999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
+++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 9999998843 456999999999999999999999999 999999999999999999999999998643221
Q ss_pred ceecccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 205 HVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
......++..|+|||.+. +..++.++||||+|+++|+|++|..||............. . ....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--------~-------~~~~ 214 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------M-------TLTV 214 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH--------H-------hhcC
Confidence 112345889999999886 4568899999999999999999999996433211100000 0 0011
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
....+..++.++.++|.+||+.||.+|| +++++++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1223456778899999999999999999 5988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.79 Aligned_cols=273 Identities=20% Similarity=0.224 Sum_probs=189.2
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecC--CCEEEEEE--------------ccc---CCccchHHHHHHHHHhhccCCC
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLES--GQLVAIKQ--------------LNH---EGLQGHQEFIVEVLMLSLLHHD 101 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~--~~~v~vK~--------------~~~---~~~~~~~~~~~e~~~l~~l~~p 101 (360)
.....+|++.+.||+|+||+||++..+. +...+.|. +.+ ........+.+|+.+++.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3445799999999999999999986431 22222221 111 1112234578899999999999
Q ss_pred cccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 102 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
||+++++++.+.+..+++++++ .++|.+++..... .........++.++.||+.||.|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999999999999999998 4578887744211 1223446677889999999999999999 999999999999
Q ss_pred EeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCC-cccccCccCcc
Q 018128 181 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQ 259 (360)
Q Consensus 181 v~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~-pf~~~~~~~~~ 259 (360)
++.++.++|+|||++........ .......|+..|+|||++.+..++.++|||||||++|+|++|.. |+.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999975432221 12223568999999999999999999999999999999999875 44422221111
Q ss_pred chhccch-------hhhhccccchhccccccc----CCC-----ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 260 NLVSWSR-------PFLKDQKKFVHLVDPLLH----GRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 260 ~~~~~~~-------~~~~~~~~~~~~~~~~~~----~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+..... .+..........+..... ... ....+.++.++|.+||+.||.+|||+.|++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111000 000000000000000000 000 1124556788899999999999999999985
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=267.94 Aligned_cols=250 Identities=25% Similarity=0.303 Sum_probs=196.5
Q ss_pred cccccceeccCCCeEEEEEEecC-CCEEEEEEcccC---C--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHE---G--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~---~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
+|.+.+.||.|++|.||++.... +..+++|++... . ......+..|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 68999999999999999997653 444555554321 1 12334566789999999999999999999988999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
+||+++++|.+++.........+++..++.++.|++.||.+||+.+ ++|+||+|+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999999766556678999999999999999999999999 999999999999975 569999999887532
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..... ...
T Consensus 157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~----------~~~ 218 (260)
T cd08222 157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVL----------RIV 218 (260)
T ss_pred CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH----------HHH
Confidence 21 1222334577889999998888889999999999999999999999852211 00000 000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ......+..++.++.++|.+||+.+|++||++.++++
T Consensus 219 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 219 E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0 0111224567788999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=272.67 Aligned_cols=248 Identities=26% Similarity=0.371 Sum_probs=202.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv 119 (360)
.+|++.+.||.|++|.||.+... +++.+++|++..... .....+.+|+.+++.++ ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999865 699999999875422 22356788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||++++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999954 447999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCc------------------ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch
Q 018128 200 VGDNT------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261 (360)
Q Consensus 200 ~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~ 261 (360)
..... .......++..|+|||.+.+..++.++|+||||++++++++|..||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence 32211 12223456788999999988889999999999999999999999997433100
Q ss_pred hccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCH----HHHH
Q 018128 262 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI----NDIV 317 (360)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~----~eil 317 (360)
...... .....++...+..+.++|.+||+.+|.+||++ .+++
T Consensus 230 ------------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 230 ------------TFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred ------------HHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 000000 01112345567789999999999999999999 7776
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=269.25 Aligned_cols=266 Identities=23% Similarity=0.273 Sum_probs=196.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++.+.||.|++|+||++... +++.|++|.+..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999876 689999998865432 223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-CCceEEeecCCccccCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-~~~v~L~Dfg~~~~~~~ 200 (360)
|++ ++|.+++... ....+++..++.++.||+.||.+||+++ ++|+||+|+||+++. ++.++|+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 5888877441 2334688899999999999999999998 999999999999985 45799999999875332
Q ss_pred CCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hcc----chhhhhcccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSW----SRPFLKDQKK 274 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~----~~~~~~~~~~ 274 (360)
. ........++..|+|||.+.+ ..++.++||||+|+++|+|++|..||........... ... ....+.....
T Consensus 156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 2 111222346788999998765 4578999999999999999999999964322111000 000 0000000000
Q ss_pred chhcccc--cccC----CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 FVHLVDP--LLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 ~~~~~~~--~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....... .... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0000 012345677899999999999999999999995
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=268.56 Aligned_cols=260 Identities=27% Similarity=0.351 Sum_probs=214.2
Q ss_pred cccHHHHHHH-hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEE
Q 018128 34 SFTFRELAIA-TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111 (360)
Q Consensus 34 ~~~~~~~~~~-~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~ 111 (360)
.++.+.+... ..-|.+++.||.|.||.||.+.++ +|+.+++|.+..+ .+.+++..|+.+++++..|+++++|+.+-
T Consensus 21 KLd~~sL~K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF 98 (502)
T KOG0574|consen 21 KLDSSALNKPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF 98 (502)
T ss_pred ccChhhhcCChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc
Confidence 3443333333 345788999999999999999665 6999999998655 45688999999999999999999999988
Q ss_pred eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEee
Q 018128 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191 (360)
Q Consensus 112 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~D 191 (360)
....+++|||||.-|++.+.+.. .++++.+.++..+++..+.+|+|||... -+|||||..|||++.+|..||+|
T Consensus 99 K~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLAD 172 (502)
T KOG0574|consen 99 KHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLAD 172 (502)
T ss_pred cCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhh
Confidence 88899999999999999999976 5688999999999999999999999998 99999999999999999999999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
||.+-.+. +.-...+...||+.|+|||++..-.|+.++||||||++..+|..|++||....... .-|.
T Consensus 173 FGVAGQLT--DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------AIFM-- 240 (502)
T KOG0574|consen 173 FGVAGQLT--DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------AIFM-- 240 (502)
T ss_pred ccccchhh--hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------eeEe--
Confidence 99987533 33333456789999999999999999999999999999999999999996322110 0000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+.....+.+ +.|...++++.++|+.||-.+|++|.|+.++++
T Consensus 241 ---IPT~PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 241 ---IPTKPPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ---ccCCCCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 001111111 235677899999999999999999999999876
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=264.31 Aligned_cols=243 Identities=23% Similarity=0.302 Sum_probs=190.5
Q ss_pred Hhhccccccee--ccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEE
Q 018128 43 ATRNFREANLI--GEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~L--g~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~l 118 (360)
..++|++.+.+ |.|+||.||++... +++.+++|.+........ |+.....+ +|||++++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34678888877 99999999999865 588999999865432221 22222222 69999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeecCCccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKL 197 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg~~~~ 197 (360)
||||+++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 87 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999954 348999999999999999999999999 99999999999999988 999999998875
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.... ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... .....+...
T Consensus 160 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~---------- 222 (267)
T PHA03390 160 IGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR---------- 222 (267)
T ss_pred cCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh----------
Confidence 3221 12357888999999998889999999999999999999999997332211 111111100
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCC-HHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIV 317 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~eil 317 (360)
.. .....+...+..+.++|.+||+.+|.+||+ +++++
T Consensus 223 -~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 223 -QQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred -hc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 00 011223357788999999999999999996 68888
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=276.05 Aligned_cols=271 Identities=26% Similarity=0.323 Sum_probs=203.5
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCC-----eeE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-----QRL 117 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~-----~~~ 117 (360)
+|++.+.||.|++|.||++... +++.+++|.+.... ......+.+|+..++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6999999999999999999876 48999999887643 334467889999999999999999999987765 789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
++|+++. ++|.+++.. +..+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999996 588888843 458999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCc-ceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccch----hhhh
Q 018128 198 GPVGDNT-HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWSR----PFLK 270 (360)
Q Consensus 198 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~----~~~~ 270 (360)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........... ..... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 4433211 112234567889999999877 789999999999999999999999964432110000 00000 0000
Q ss_pred --ccccchhcccc------cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH--Hhhhh
Q 018128 271 --DQKKFVHLVDP------LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYLV 324 (360)
Q Consensus 271 --~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~--L~~l~ 324 (360)
........+.. .-.....+..+..+.++|.+||+.+|.+||++.+++.. +..+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000000 00001123467789999999999999999999999963 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=283.30 Aligned_cols=278 Identities=26% Similarity=0.392 Sum_probs=226.5
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec--CC--CEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEe
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE--SG--QLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~--~~--~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~ 112 (360)
....|...+.++++.||.|.||.|+.+.+. +| ..||||.+...... ....|.+|+.++-+|+|||++++|++..+
T Consensus 103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 445667788899999999999999999765 34 46899998776554 55789999999999999999999999887
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....||||.++.|+|.+.++. .....+....+..++.||+.|+.||..++ +|||||...|+++-....|||+||
T Consensus 183 -qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DF 256 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDF 256 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecc
Confidence 677899999999999999977 45677899999999999999999999999 999999999999998999999999
Q ss_pred CCccccCCCCCcceec-ccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhh
Q 018128 193 GLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
|+++.+...+..+... ...-...|||||.+....++.++|||++|+++|||++ |..||-....
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------------- 321 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------------- 321 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------
Confidence 9999766555554433 3345668999999999999999999999999999999 6678864331
Q ss_pred ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCCC
Q 018128 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGA 338 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~~ 338 (360)
..+-+.+|..-+..-+..++.++++++++||..+|.+|||+..|.+.+-....+....-...++.+
T Consensus 322 --~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~d~~e 387 (1039)
T KOG0199|consen 322 --IQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETYDSIE 387 (1039)
T ss_pred --HHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeeccccC
Confidence 222233333334455788999999999999999999999999998765555454444444443333
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=272.90 Aligned_cols=270 Identities=22% Similarity=0.272 Sum_probs=195.3
Q ss_pred ceeccC--CCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEG--GFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G--~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
..||+| ++++||.+++. +++.|++|++..... ...+.+.+|+.+++.++||||+++++++...+..++++|++.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999875 699999999875432 2346788899999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc-
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT- 204 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~- 204 (360)
++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987633 345899999999999999999999998 999999999999999999999999754321111100
Q ss_pred ce----eccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc-chh------ccchh----
Q 018128 205 HV----STRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLV------SWSRP---- 267 (360)
Q Consensus 205 ~~----~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-~~~------~~~~~---- 267 (360)
.. .....++..|+|||.+.+ ..++.++||||+||++|+|++|..||......... ... .+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 00 011224566999999876 34789999999999999999999999643211000 000 00000
Q ss_pred ----hhhc--------------cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhhhhh
Q 018128 268 ----FLKD--------------QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVS 325 (360)
Q Consensus 268 ----~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~--~L~~l~~ 325 (360)
+... ...........+.......++..+.+|+.+||+.||++|||+.++++ .+..+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000 00000011111122223457788999999999999999999999986 3444433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.11 Aligned_cols=270 Identities=27% Similarity=0.309 Sum_probs=198.6
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCC--
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-- 114 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~-- 114 (360)
+++...+|++.+.||.|++|.||++... +++.|++|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3566789999999999999999999876 588999999865432 22346778999999999999999999886654
Q ss_pred --------eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 115 --------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 115 --------~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
..++++|++++ ++.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCc
Confidence 78999999965 77777754 3457899999999999999999999998 999999999999999999
Q ss_pred eEEeecCCccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hcc
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSW 264 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~ 264 (360)
++|+|||.+........ .......++..|+|||.+.+ ..++.++||||||+++++|++|..||........... ...
T Consensus 155 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 155 IKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred EEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999999875433222 11122235677999998764 4578999999999999999999999964322110000 000
Q ss_pred c-hh---h---hhccccch-----hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 265 S-RP---F---LKDQKKFV-----HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 265 ~-~~---~---~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .+ . ........ ......... .....+..+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00 0 00000000 000000000 11234678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=265.23 Aligned_cols=242 Identities=24% Similarity=0.284 Sum_probs=186.9
Q ss_pred ceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc---hHHHHHHHHH-hhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLM-LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~---~~~~~~e~~~-l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||.|++|.||+|... +++.+++|.+....... ...+..|..+ ....+|||++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 67999999999999765 58999999986543221 1223444443 3445899999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999953 456899999999999999999999998 99999999999999999999999998864322
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||....... .......... ....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~--------~~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRRI--------NWPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhccc--------CCCC
Confidence 223457788999999988888999999999999999999999996432110 0000000000 0011
Q ss_pred CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 286 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
.....++.++.++|.+||+.+|++||++.++.+.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 1223467889999999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=299.40 Aligned_cols=283 Identities=23% Similarity=0.270 Sum_probs=222.6
Q ss_pred HHHHHhhhhhcCCCCCCCC----------CCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcc
Q 018128 10 VLIMLVLGAENGKGNGGKE----------KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLN 78 (360)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~ 78 (360)
.|++.|+.-++.=+++.-. ...+-...+++++.....|+|+++||+|+||.|.+++.+ +++.||+|++.
T Consensus 30 ~LLD~l~~L~~ec~~~~Lrr~k~i~~fl~~~kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~ln 109 (1317)
T KOG0612|consen 30 TLLDTLIALYDECDNSALRRDKNIAEFLNRYKPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILN 109 (1317)
T ss_pred HHHHHHHHHHHHhccHHHHhhhhHHHHHHHhHHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhh
Confidence 4556665555544442222 122333456777888899999999999999999999876 58999999998
Q ss_pred cC---CccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHH
Q 018128 79 HE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 155 (360)
Q Consensus 79 ~~---~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~ 155 (360)
+. ...+..-|..|-.++..-+.+=|+.++..|.++..+|+||+|++||+|..++.. -..+|+..++.++..|+
T Consensus 110 K~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiV 185 (1317)
T KOG0612|consen 110 KWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIV 185 (1317)
T ss_pred HHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHH
Confidence 74 334556788899999888899999999999999999999999999999999954 33799999999999999
Q ss_pred HHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccc----c-CCCCcc
Q 018128 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM----S-GKLTLK 230 (360)
Q Consensus 156 ~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~s~~ 230 (360)
.||..||+.| +|||||||+|||+|..|.++|+|||.|-.....+... .....|||.|.+||++. + +.|+..
T Consensus 186 lAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~e 261 (1317)
T KOG0612|consen 186 LALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRE 261 (1317)
T ss_pred HHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE-eccccCCCCccCHHHHHhhcCCccccCCc
Confidence 9999999999 9999999999999999999999999998765544443 34477999999999986 3 578999
Q ss_pred hhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCC--hhhHHHHHHHHhhhcccCCC
Q 018128 231 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEAN 308 (360)
Q Consensus 231 sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~ 308 (360)
+|-||+|+++|+|+.|..||....- .....++++..-...+| ...+.+..+||.+.+. +|+
T Consensus 262 cDwWSlGV~~YEMlyG~TPFYadsl----------------veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e 324 (1317)
T KOG0612|consen 262 CDWWSLGVFMYEMLYGETPFYADSL----------------VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DRE 324 (1317)
T ss_pred cchhhhHHHHHHHHcCCCcchHHHH----------------HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-Chh
Confidence 9999999999999999999952221 11122222221112233 4577889999998664 577
Q ss_pred CCCC---HHHHH
Q 018128 309 FRPL---INDIV 317 (360)
Q Consensus 309 ~Rpt---~~eil 317 (360)
.|.. ++++.
T Consensus 325 ~RLgrngiedik 336 (1317)
T KOG0612|consen 325 VRLGRNGIEDIK 336 (1317)
T ss_pred hhcccccHHHHH
Confidence 7777 77776
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=271.34 Aligned_cols=294 Identities=26% Similarity=0.325 Sum_probs=217.2
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccc------hHHHHHHHHHhhccCCCcccceeEEEE-
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQG------HQEFIVEVLMLSLLHHDNLVTLIGYCT- 111 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~------~~~~~~e~~~l~~l~~p~i~~~~~~~~- 111 (360)
....++|-++.+||+|+|+.||.+.+- ..+.|++|+-..+. ..+ .+...+|+.+.+.+.||.|+++|+++.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 345679999999999999999999765 57788888765442 111 134678999999999999999999985
Q ss_pred eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe---CCCceE
Q 018128 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPK 188 (360)
Q Consensus 112 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~---~~~~v~ 188 (360)
+.+..|-|+|||+|.+|+-|+. ..+-+++.+++.|+.||+.||.||... .+||+|.||||.|||+- ..|.+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred ccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 5567899999999999998884 567899999999999999999999998 68899999999999994 457899
Q ss_pred EeecCCccccCCCCCc-----ceeccccccccccccccccc----CCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc
Q 018128 189 LSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~----~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~ 259 (360)
|+|||++......... .......||.+|+|||+|.- .+.+.+.||||+|+|+|+.+.|+.||.....+-
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-- 691 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-- 691 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--
Confidence 9999999875544333 22344679999999999862 346889999999999999999999997433211
Q ss_pred chhccchhhhhccccchhccc-ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCCC
Q 018128 260 NLVSWSRPFLKDQKKFVHLVD-PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGA 338 (360)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~~ 338 (360)
++. . ...++. ..+.-+.-+..+.+...+|++||+..-++|.++.++.. ...-.|-.+++..
T Consensus 692 dIL-------q----eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~-------dpyllPh~rrs~s 753 (775)
T KOG1151|consen 692 DIL-------Q----ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC-------DPYLLPHIRRSVS 753 (775)
T ss_pred HHH-------h----hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc-------Cccccchhhhccc
Confidence 000 0 001111 11111223467788999999999999999999888763 2222233333334
Q ss_pred CCCCCCCCCcccCCCCCCCCC
Q 018128 339 RGVPTSASDVSQGSNSRRSSS 359 (360)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~ 359 (360)
.+.+.+++-..+++.++.|++
T Consensus 754 ~gs~~~a~i~~sp~~~~~s~~ 774 (775)
T KOG1151|consen 754 TGSPAGAAIASSPGASNNSSS 774 (775)
T ss_pred cCCCccccccCCCCCCccccC
Confidence 444445555555555555544
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=274.33 Aligned_cols=266 Identities=26% Similarity=0.346 Sum_probs=197.3
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC--CccchHHHHHHHHHhhcc-CCCcccceeEEEEeC--Cee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG--DQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~--~~~ 116 (360)
..++|++.+.||.|++|.||.+.+. +++.+++|.+... .......+..|+.+++.+ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4678999999999999999999876 5889999987543 223345677899999999 999999999988643 467
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++|||+++ ++|.+++.. ..+++..++.++.||+.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 599988843 37889999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCc---ceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccchh----
Q 018128 197 LGPVGDNT---HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWSRP---- 267 (360)
Q Consensus 197 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~---- 267 (360)
........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 54333221 12223457888999998764 5578999999999999999999999964322110000 000000
Q ss_pred ---hhhccccchhccccccc------CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 ---FLKDQKKFVHLVDPLLH------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+. ............. ....+.++.++.++|.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 236 DIESIK-SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHH-hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 000 0000000000000 0111236788999999999999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=270.28 Aligned_cols=265 Identities=20% Similarity=0.198 Sum_probs=192.1
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccC--CccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
|.+++.+|.| +.||.++.. +++.|++|++... .......+..|+..++.++||||+++++++.+.+..+++|||+
T Consensus 4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 3445555555 445555443 5899999998765 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+||+.+........
T Consensus 82 ~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 82 AYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence 999999999753 2346899999999999999999999999 99999999999999999999999998864322211
Q ss_pred c-----ceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc-chhc-cchh------h
Q 018128 204 T-----HVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVS-WSRP------F 268 (360)
Q Consensus 204 ~-----~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~-~~~~------~ 268 (360)
. .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......... .... .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 1 11122346678999999875 35789999999999999999999999643211100 0000 0000 0
Q ss_pred hhccccch--------hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKDQKKFV--------HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........ ..............+..++.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000000 000001111234456778999999999999999999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=276.47 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=195.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeC---------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--------- 113 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--------- 113 (360)
+++|++.+.||.|++|.||++... +++.|++|.+..........+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 579999999999999999999865 5899999998776666667788999999999999999998766443
Q ss_pred -----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-CCce
Q 018128 114 -----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNP 187 (360)
Q Consensus 114 -----~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-~~~v 187 (360)
...++++||++ ++|.+++. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999996 58988883 356899999999999999999999999 999999999999974 5578
Q ss_pred EEeecCCccccCCCCCcc-eeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccc
Q 018128 188 KLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 265 (360)
+|+|||.+.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999987533221111 1122356778999997654 56788999999999999999999999644321111000000
Q ss_pred hhhhh--ccc----cchhccc-ccccC-----CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 RPFLK--DQK----KFVHLVD-PLLHG-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~~~~~--~~~----~~~~~~~-~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+... +.. ....... ..... ......+.++.++|.+||+.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 000 0000000 00000 011245678999999999999999999999994
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.05 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=200.5
Q ss_pred cceeccCCCeEEEEEE-ecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEEEecCCCC
Q 018128 50 ANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGS 127 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~e~~~~~s 127 (360)
.+.||.|+|+.|-.+. ..+|..|+||++.+...-...++.+|++++.+.+ |+||++++++|+++...|+|||.+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4689999999999885 5689999999999887777789999999999996 9999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc---eEEeecCCccccCCCC--
Q 018128 128 LEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKLGPVGD-- 202 (360)
Q Consensus 128 L~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~---v~L~Dfg~~~~~~~~~-- 202 (360)
|...|. +...+++.++..+..+|+.||.+||.+| |.|||+||+|||....+. |||+||++........
T Consensus 163 lLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQ----KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999995 4677999999999999999999999999 999999999999966654 7999998765311111
Q ss_pred ---Ccceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 203 ---NTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 203 ---~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
..-.-...+|+..|||||++. ...|+.++|.||||+|+|-|+.|.+||-..-+.. +.|.+.-.. ...
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CGWdrGe~C-r~C 310 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CGWDRGEVC-RVC 310 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CCccCCCcc-HHH
Confidence 111122357888999999864 2358899999999999999999999996443321 112111000 001
Q ss_pred chhcccccccCC--CCh----hhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 275 FVHLVDPLLHGR--YPR----RCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 275 ~~~~~~~~~~~~--~~~----~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
...+....+.+. +|. ..+.+..++|..+|..|+.+|.++.+++
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 112223333333 232 4577888999999999999999998887
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=267.36 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=194.2
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecC-CCEEEEEEcccCCcc-chHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~ 117 (360)
.+..++|++.+.||.|++|.||.+.++. ++.+++|.+...... ....+..|+.++... .||||+++++++.+....+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3445789999999999999999998774 899999998754322 334566677666665 4999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||++ +++|.+++.. ....+++..+..++.|++.|+.|||+ .+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 91 ~v~e~~-~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 91 ICMELM-STCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred EEeecc-CcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccch
Confidence 999998 4578877755 23578999999999999999999997 57 9999999999999999999999999986
Q ss_pred ccCCCCCcceecccccccccccccccccC----CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
...... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...... . ..........
T Consensus 164 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~-~~~~~~~~~~ 235 (296)
T cd06618 164 RLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----F-EVLTKILQEE 235 (296)
T ss_pred hccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----H-HHHHHHhcCC
Confidence 532211 11223467789999998754 3788999999999999999999999632111 0 0000000000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++.++.+++.+||+.||.+||++.++++
T Consensus 236 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 236 ---------PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000111245678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=266.52 Aligned_cols=244 Identities=28% Similarity=0.386 Sum_probs=193.2
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.|...+.||.|++|+||.+... +++.+++|.+..... .....+.+|+..++.++|||++++++++.+.+..++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3777888999999999999865 588999998865432 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+. ++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 995 588887754 3456899999999999999999999999 99999999999999999999999998863211
Q ss_pred CCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.....++..|+|||.+. +..++.++||||||+++|+|++|..||.......... ....
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-------- 234 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-------- 234 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHh--------
Confidence 12345778899999874 4568899999999999999999999986332111000 0000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........++..+.+++.+||+.+|.+||++.+++.
T Consensus 235 --~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 235 --NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred --cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000112244567899999999999999999999994
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=263.23 Aligned_cols=242 Identities=28% Similarity=0.360 Sum_probs=204.9
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccch---HHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~---~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
.-.+|..+++||+|.||.|.+++.+ +++.||+|++.+...-.. ..-..|-+.|+..+||.+..+...|...+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4467889999999999999999876 699999999987754433 335568899999999999999888999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
||||..||.|.-.+ +..+.+++...+.+-..|+.||.|||+++ |+.||||.+|.|++.+|.+||+|||+|..
T Consensus 246 VMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE- 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKE- 317 (516)
T ss_pred EEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchh-
Confidence 99999999998777 34677999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
...........+||+.|+|||++....|..+.|-|.+|+++|+|++|+.||...+... ..+-+
T Consensus 318 -~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeLI 380 (516)
T KOG0690|consen 318 -EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFELI 380 (516)
T ss_pred -cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHHH
Confidence 3334445566899999999999999999999999999999999999999996322211 11111
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCC
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 311 (360)
+- -...+|...+.+...|+..+|..||.+|.
T Consensus 381 l~--ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 381 LM--EDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred Hh--hhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 11 11256888999999999999999999995
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=271.93 Aligned_cols=250 Identities=27% Similarity=0.380 Sum_probs=208.5
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
-+..+.|+.-++||+|+||.||-++.. +|+.||.|.+.+.... ......+|-.+|..++.+.|+.+-..|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 345678999999999999999999755 6999999998766443 345688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
|+|+..++||+|.-.|+++. ++.+++..+..++.+|+.||.+||+.+ ||.||+||+|||+|+.|+|+|+|+|++.
T Consensus 261 ClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred EEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEE
Confidence 99999999999999998755 368999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..... +......||.+|||||++.+..|+...|-|+|||++|+|+.|+.||........ .+
T Consensus 336 ei~~g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~e 396 (591)
T KOG0986|consen 336 EIPEG---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------RE 396 (591)
T ss_pred ecCCC---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HH
Confidence 54332 233334799999999999999999999999999999999999999963221110 00
Q ss_pred hccccc--ccCCCChhhHHHHHHHHhhhcccCCCCCCCHH
Q 018128 277 HLVDPL--LHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 314 (360)
Q Consensus 277 ~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 314 (360)
++-... ....++..++.+..++....|+.||.+|....
T Consensus 397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 110011 11246788899999999999999999996544
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=262.98 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=193.2
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhcc---CCCcccceeEEEEeCCe-----
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL---HHDNLVTLIGYCTSGDQ----- 115 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l---~~p~i~~~~~~~~~~~~----- 115 (360)
|++.+.||.|++|.||+++.. +++.+++|.+...... ....+.+|+.+++.+ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 788999999999999999876 4899999998654322 223455677766655 59999999999987776
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+++||++++ +|.+++.... ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999964 8988886522 246899999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc-ccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD-QKK 274 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 274 (360)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ............ ...
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence 75432211 122346788999999998889999999999999999999999986432111 000000000000 000
Q ss_pred c-------hhccccccc---CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 F-------VHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 ~-------~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+ ......... .......+..+.++|.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 1112345678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=263.51 Aligned_cols=241 Identities=27% Similarity=0.355 Sum_probs=187.3
Q ss_pred eeccCCCeEEEEEEec-CCCEEEEEEcccCCccc---hHHHHHHHH---HhhccCCCcccceeEEEEeCCeeEEEEEecC
Q 018128 52 LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVL---MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~---~~~~~~e~~---~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~ 124 (360)
.||.|++|.||.+... +++.|++|.+....... ......|.. .++...||+|+.+++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999765 58999999987653321 122333433 3444579999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
+++|.+++. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 999998884 3457999999999999999999999998 999999999999999999999999998643221
Q ss_pred ceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 205 HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
......++..|+|||.+.+. .++.++||||+|+++|+|++|..||............ .. ....
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------~~-~~~~ 214 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------RM-TLTM 214 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH--------------HH-hhcc
Confidence 11234688899999998744 6899999999999999999999999643221110000 00 0001
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
....+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1123445678899999999999999999 9999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=265.52 Aligned_cols=251 Identities=28% Similarity=0.372 Sum_probs=196.6
Q ss_pred cccccceeccCCCeEEEEEEe----cCCCEEEEEEcccCCc----cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCee
Q 018128 46 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~----~~~~~v~vK~~~~~~~----~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~ 116 (360)
+|++.+.||.|++|.||.++. .+|+.|++|.+..... .....+.+|+.+++.+ +||||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 589999999999999999975 3588999999865322 2335678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++|+|++++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999854 456889999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCcceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ..........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~---- 226 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILK---- 226 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhc----
Confidence 5432211 11223457888999998875 3467899999999999999999999963221110 0110000000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
....++..++..+.+++.+||+.||.+|| ++.+++.
T Consensus 227 --------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 --------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01123445677899999999999999997 6777763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.53 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=191.3
Q ss_pred hccccc-ceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEe----CCeeE
Q 018128 45 RNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS----GDQRL 117 (360)
Q Consensus 45 ~~y~i~-~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~----~~~~~ 117 (360)
..|++. ++||-|-.|.|..+.++ +++.+|+|++... ...++|+++.=.. .||||+.++++|++ ...+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 455554 48999999999999766 6999999987433 4566677765444 59999999998854 34567
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC---CceEEeecCC
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGL 194 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~---~~v~L~Dfg~ 194 (360)
+|||.++||.|++-++.. ..+.+++.++-+++.||..|+.|||+.+ |.||||||+|+|++.. ..+||+|||+
T Consensus 136 iVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 999999999999999773 3567999999999999999999999999 9999999999999644 4589999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
+.... ........+.|+.|.|||++...+|+..+|+||+|+++|-|++|.+||-....... .. .+
T Consensus 211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---sp---gM------ 275 (400)
T KOG0604|consen 211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SP---GM------ 275 (400)
T ss_pred ccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---Ch---hH------
Confidence 98532 23334457789999999999989999999999999999999999999953222100 00 00
Q ss_pred chhcccccccCC--CC----hhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 275 FVHLVDPLLHGR--YP----RRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 275 ~~~~~~~~~~~~--~~----~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
......+. || ...+....++|+.+|..+|.+|.|++++.
T Consensus 276 ----k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m 320 (400)
T KOG0604|consen 276 ----KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVM 320 (400)
T ss_pred ----HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhh
Confidence 00001111 12 25678899999999999999999999998
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=267.25 Aligned_cols=247 Identities=29% Similarity=0.400 Sum_probs=194.8
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
...|+..+.||.|++|.||++... +++.+++|.+..... .....+.+|+.+++.++|||++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 455888899999999999999875 588899998864322 2334677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+. ++|.+++.. ....+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 588877754 3456899999999999999999999998 9999999999999999999999999886532
Q ss_pred CCCCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
.. ....++..|+|||.+. ...++.++||||||+++|+|++|..||......... .
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~-------------- 224 (308)
T cd06634 167 PA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--Y-------------- 224 (308)
T ss_pred Cc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--H--------------
Confidence 21 1234678899999874 356788999999999999999999998532211000 0
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
..............++..+.++|.+||+.+|.+||++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0000000011123566789999999999999999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=266.03 Aligned_cols=255 Identities=28% Similarity=0.354 Sum_probs=198.7
Q ss_pred cccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCc----cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCee
Q 018128 46 NFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~----~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~ 116 (360)
+|++.+.||.|++|.||.++.. +++.+++|.+..... .....+.+|+.+++.+ +||+|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999998742 478899998864322 2234577899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+.+++|.+++.. ...+++..++.++.|++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999843 456899999999999999999999998 9999999999999999999999999887
Q ss_pred ccCCCCCcceecccccccccccccccccCC--CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
........ ......++..|+|||.+.+.. .+.++||||||+++|+|++|..||....... ...........
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~---- 226 (288)
T cd05583 154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILK---- 226 (288)
T ss_pred cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHc----
Confidence 53322111 112245788999999987654 7889999999999999999999986322111 00000000000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
.....+..++..+.+++.+||+.||++|||+.++.+.|+-
T Consensus 227 --------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 --------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred --------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0112344567789999999999999999998887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.34 Aligned_cols=262 Identities=31% Similarity=0.536 Sum_probs=202.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
...|+..+.||+|+||.||.++.. ++..|++|.+...... ...|++.+++++||||+++++++.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 356888899999999999999874 6899999988644322 23468889999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++. .+++.....++.|++.|+.|||....++++||||||+||+++.++..++. ++.......
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 99999999993 37889999999999999999995433339999999999999988877764 444332111
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.....++..|+|||++.+..++.++||||||+++|||++|+.||+..... ......|.+.... .......+++.
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 908 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYS-DCHLDMWIDPS 908 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcC-ccchhheeCcc
Confidence 11225678999999999999999999999999999999999999543221 2223333332222 22233344444
Q ss_pred ccCC--CChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 283 LHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 283 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
+... .+.....++.+++.+||+.||++||++.|+++.|+++..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 4332 344566678899999999999999999999999998854
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=268.83 Aligned_cols=268 Identities=24% Similarity=0.302 Sum_probs=193.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEEeC-------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSG------- 113 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~~~------- 113 (360)
.++|++.+.||.|++|.||++... +++.+++|.+....... .....+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 479999999999999999999866 58999999886543322 34567899999999999999999877443
Q ss_pred -CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 114 -DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 114 -~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
...++|++|+.+ +|...+.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 346899999854 77777754 3457999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcce---------eccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-
Q 018128 193 GLAKLGPVGDNTHV---------STRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL- 261 (360)
Q Consensus 193 g~~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~- 261 (360)
|++........... .....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99875332221111 122345778999998765 4578999999999999999999999964332110000
Q ss_pred hccchh----hhhccccchhcccccccCCC-------ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 262 VSWSRP----FLKDQKKFVHLVDPLLHGRY-------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 262 ~~~~~~----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...... ............+....... .......+.++|.+||+.||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 00000000000000000000 1123467899999999999999999999883
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=259.52 Aligned_cols=236 Identities=31% Similarity=0.394 Sum_probs=193.1
Q ss_pred eccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 53 IGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 53 Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
||.|++|.||.+... +++.+++|.+...... ....+..|+.+++.++|||++++++.+.+....+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999876 5899999998765432 345788899999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceec
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~ 208 (360)
.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999954 346899999999999999999999998 9999999999999999999999999987532221 2233
Q ss_pred ccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCC
Q 018128 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 288 (360)
Q Consensus 209 ~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
...++..|+|||...+...+.++|+|+||+++|++++|..||...... . .. ..... ....++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~----~~------~~~~~--~~~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------E----IY------EKILK--DPLRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------H----HH------HHHhc--CCCCCC
Confidence 455788899999998888899999999999999999999999633210 0 00 00000 111334
Q ss_pred hhhHHHHHHHHhhhcccCCCCCCCHHH
Q 018128 289 RRCLNYAVAVTAMCLNEEANFRPLIND 315 (360)
Q Consensus 289 ~~~~~~l~~li~~~l~~dp~~Rpt~~e 315 (360)
...+..+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 455788999999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=271.05 Aligned_cols=266 Identities=24% Similarity=0.287 Sum_probs=195.8
Q ss_pred hhccc-ccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--------------hHHHHHHHHHhhccCCCccccee
Q 018128 44 TRNFR-EANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--------------HQEFIVEVLMLSLLHHDNLVTLI 107 (360)
Q Consensus 44 ~~~y~-i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--------------~~~~~~e~~~l~~l~~p~i~~~~ 107 (360)
.++|. +.+.||.|++|+||++.+. .++.|++|.+....... ...+.+|+.+++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 45676 4578999999999999866 58999999886543221 12467899999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 108 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
+++...+..+++||++. ++|.+++. ....+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999996 59999884 3456899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCC------------CcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccC
Q 018128 188 KLSDFGLAKLGPVGD------------NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSK 254 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~ 254 (360)
+|+|||.+....... .........++..|+|||.+.+. .++.++||||||+++|+|++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987543111 01111223457789999988764 46899999999999999999999996443
Q ss_pred ccCccc-hhccchhh----hhcccc------chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 255 GQGEQN-LVSWSRPF----LKDQKK------FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 255 ~~~~~~-~~~~~~~~----~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...... ........ +..... .......... ......+..+.++|.+||+.+|++||++.+++.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 211000 00000000 000000 0000000000 011244677899999999999999999999994
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=264.12 Aligned_cols=262 Identities=26% Similarity=0.341 Sum_probs=197.9
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
|++.+.||.|++|.||.+... +++.+++|.+.... ......+..|+..++.++|||++++++++.+....++|+|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 678899999999999999876 59999999987653 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
+ ++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 6 599999965 2257999999999999999999999998 99999999999999999999999999875432221
Q ss_pred cceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhccc----hhhhhc------
Q 018128 204 THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKD------ 271 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~----~~~~~~------ 271 (360)
.......+..|+|||.+.+. .++.++||||||+++++|++|..||.......... ..... ...+..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 22223456789999998766 78999999999999999999999996433211000 00000 000000
Q ss_pred -cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 -QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.............. ..+..+..+.++|.+||..||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000000 11233678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=269.74 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=197.1
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe-CCee
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQR 116 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-~~~~ 116 (360)
...+++|++.+.||.|++|.||++... +++.+++|.+..... .....+..|+.+++.++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999866 689999998764322 234678889999999999999999998865 5678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++++|++ +++|.+++. ...+++..+..++.|++.||.+||+++ ++|+||+|.||+++.++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 568988883 356888999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhc--------cch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS--------WSR 266 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~--------~~~ 266 (360)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......... ... +..
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43221 122346778999998765 568999999999999999999999996433211000 000 000
Q ss_pred hhhhccccchhccccc-ccCCC-----ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 267 PFLKDQKKFVHLVDPL-LHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... .. ........ ..... .+.++..+.++|.+||+.+|++||++.+++.
T Consensus 232 ~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 232 TICS-EN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hccc-hh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00 00000000 00011 1235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=264.02 Aligned_cols=263 Identities=26% Similarity=0.301 Sum_probs=195.3
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEEEec
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
|++.+.||.|++|+||.|... +++.+++|.+..... .......+|+..++.++ |||++++++++.+.+..++|||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 788999999999999999876 588999998865432 22334567889999998 999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
+++|.+++... .+..+++..++.++.|++.+|.+||+++ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 77998888552 2357899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceecccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccchh----hhhccccchh
Q 018128 204 THVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWSRP----FLKDQKKFVH 277 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~----~~~~~~~~~~ 277 (360)
......++..|+|||.+. +..++.++|+||||+++++|++|..||........... ...... .+........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 122345678899999875 45578999999999999999999999964432111000 000000 0000000000
Q ss_pred ccccccc-------CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLH-------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....... .......+..+.++|.+||+.+|++|||++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0011123577999999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=273.54 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=195.9
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCe----
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ---- 115 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~---- 115 (360)
..++|++.+.||.|++|.||.++.. +++.|++|++.... ......+.+|+.+++.++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999876 58899999886542 2234567789999999999999999887765544
Q ss_pred --eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 116 --RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 116 --~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
.++|+|++ +++|.+++. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 669999884 357999999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhccc----hh
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RP 267 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~----~~ 267 (360)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......... ..... ..
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 98754322 122356778999998765 467899999999999999999999996433211000 00000 00
Q ss_pred hhhc-----cccchhcccccccCCC---ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 FLKD-----QKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+... ...............+ ....+..+.++|.+||+.+|.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000 0000000000000011 1234678999999999999999999999983
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=304.49 Aligned_cols=252 Identities=28% Similarity=0.356 Sum_probs=205.7
Q ss_pred hhcccccceeccCCCeEEEEEEe-cCCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~-~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.-+|.-+..+|.|.||.||.+.+ ++|.-.|+|.+..... .....+.+|..++..++|||+++.+++=.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 45888899999999999999965 4699999997765433 33457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|||++|+|.+++ ..++..++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++|||.+.....
T Consensus 1314 EyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999 35666778888889999999999999999 99999999999999999999999999986444
Q ss_pred CCCc--ceecccccccccccccccccCC---CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 201 GDNT--HVSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 201 ~~~~--~~~~~~~~~~~y~aPE~~~~~~---~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
.... ..-....||+.|||||++.+.. -.-++|||||||++.||+||+.||...+. ++.-
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~aI------------ 1450 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EWAI------------ 1450 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hhHH------------
Confidence 3211 1223457999999999998643 45789999999999999999999963321 1110
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.-.+...-..++|...+.+-.++|.+||..||..|+++.|+++
T Consensus 1451 My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1451 MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 0111112223457778999999999999999999999998885
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=278.43 Aligned_cols=273 Identities=27% Similarity=0.366 Sum_probs=206.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCC------ee
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QR 116 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~------~~ 116 (360)
..|...+.||+||||.||.++++ +|+.||+|.+.... ....+....|++++++++||||++.+++=++.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 56788899999999999999965 69999999987753 345678899999999999999999988754433 45
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe--CCCc--eEEeec
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--NDFN--PKLSDF 192 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~--~~~~--v~L~Df 192 (360)
.+|||||.+|+|...+.+-. +...+++.+++.++.++..|+.+||++| |+||||||.||++- .+|+ .||+||
T Consensus 93 vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred eEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecc
Confidence 79999999999999997644 5567999999999999999999999999 99999999999983 3344 699999
Q ss_pred CCccccCCCCCcceecccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhcc---chhh
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW---SRPF 268 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~---~~~~ 268 (360)
|+++... .........||..|++||.+. ...|+...|.||||+++|+++||..||..-.+........| .++.
T Consensus 169 G~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 169 GAARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 9998533 333667788999999999998 48899999999999999999999999965443321100111 0000
Q ss_pred ----------hhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC--CHHHHHHHHhhhhhc
Q 018128 269 ----------LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP--LINDIVVALDYLVSQ 326 (360)
Q Consensus 269 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp--t~~eil~~L~~l~~~ 326 (360)
.+....+...+.. .-...+.....+...+..+|..+|++|. ...+....++.|...
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred CceeEeeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 0000011111100 1112233444566677789999999999 777777766666543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=270.98 Aligned_cols=264 Identities=25% Similarity=0.329 Sum_probs=196.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCC---
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--- 114 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~--- 114 (360)
...+++|++.+.||.|++|.||.+... ++..|++|++..... .....+.+|+.+++.++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 335789999999999999999999765 689999998864322 22346788999999999999999999886543
Q ss_pred ---eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEee
Q 018128 115 ---QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191 (360)
Q Consensus 115 ---~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~D 191 (360)
..++||+++ +++|.+++. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 358999998 779988883 356899999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc-chhcc----c
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSW----S 265 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~----~ 265 (360)
||.+...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||......... ..... .
T Consensus 162 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 162 FGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred cccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9998753221 122346788999998875 45789999999999999999999999643321000 00000 0
Q ss_pred hhhhhc-----cccchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 RPFLKD-----QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..+... .......+...... .....++..+.++|.+||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000000000000 112345667899999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=269.89 Aligned_cols=268 Identities=22% Similarity=0.318 Sum_probs=196.7
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeC-
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG- 113 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~- 113 (360)
.++....++|++.+.||+|++|.||.+... +++.|++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 345556789999999999999999999764 68999999886542 22345677899999999999999999887543
Q ss_pred -----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 114 -----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 114 -----~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
...+++++++ +++|.+++. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888877 779988873 346899999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccc-
Q 018128 189 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWS- 265 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~- 265 (360)
|+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... ....
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999875322 1223456788999998766 5688999999999999999999999954322110000 0000
Q ss_pred --h-hhhh---cc--ccchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 266 --R-PFLK---DQ--KKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 266 --~-~~~~---~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
. .... .. ............. ......+..+.++|.+||+.||.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0000 00 0000000000000 0011245678999999999999999999999953
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=277.49 Aligned_cols=246 Identities=30% Similarity=0.431 Sum_probs=203.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
.+.|.-++.||.|.||.||.+++. +.+.|+||.+.-.+. ..++.+..|+..|++++|||++.+.+.|..+...++|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 357888999999999999999865 688999999976543 4567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||| -|+-.|++.- ..+++-+.++..|+.+.+.||.|||+.+ .+|||||..|||+++.|.|||+|||.+....
T Consensus 105 MEYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 9999 5588888865 5588999999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
. .....||+.|||||++. .+.|+-+.||||||++-.+|.-.++|+...+...... . +.
T Consensus 178 P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY------H-------IA 238 (948)
T KOG0577|consen 178 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------H-------IA 238 (948)
T ss_pred c------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH------H-------HH
Confidence 2 33467999999999875 6789999999999999999999999875332211100 0 00
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+.-.+.+. ....++.+.+|+..||+.-|.+|||..+++.
T Consensus 239 QNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 239 QNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 00111111 4577889999999999999999999988764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=267.51 Aligned_cols=265 Identities=21% Similarity=0.252 Sum_probs=191.3
Q ss_pred cccccceeccCCCeEEEEEEec-C--CCEEEEEEcccCCc--cchHHHHHHHHHhhcc-CCCcccceeEEEEe----CCe
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-S--GQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS----GDQ 115 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~--~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~----~~~ 115 (360)
+|++.+.||.|++|.||.++.. . +..+++|.+..... .....+.+|+.+++.+ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5899999999999999999865 3 77899998764321 2245678899999998 59999999986532 245
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+++++++. ++|.+++. ....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688899884 68988884 4567999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCc--ceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch---------hc
Q 018128 196 KLGPVGDNT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL---------VS 263 (360)
Q Consensus 196 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~---------~~ 263 (360)
......... .......++..|+|||.+.+ ..++.++||||+|+++|+|++|.+||........... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 754322111 11123457889999998765 5689999999999999999999999964331100000 00
Q ss_pred cchhhhhc-cccchhccccccc---CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 264 WSRPFLKD-QKKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 264 ~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........ ............. .......+..+.+++.+||+.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 0000000000000 0011234678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.14 Aligned_cols=252 Identities=27% Similarity=0.351 Sum_probs=187.2
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEe-------
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------- 112 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~------- 112 (360)
.=...|+.+++||+||||.||+++++ +|+.||||++.... ......+.+|++.+.+++||||++++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567899999999999999999988 79999999998764 2344678999999999999999987532100
Q ss_pred --------------------------------------------------------------------------------
Q 018128 113 -------------------------------------------------------------------------------- 112 (360)
Q Consensus 113 -------------------------------------------------------------------------------- 112 (360)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeeEEEEEecCCCCHHHHhcccCCCCCCC-CHHHHHHHHHHHHHHHH
Q 018128 113 ------------------------G--------DQRLLVYEYMPMGSLEDHLYDLEPDQEPL-SWNTRMKIAVGAARGLE 159 (360)
Q Consensus 113 ------------------------~--------~~~~lv~e~~~~~sL~~~i~~~~~~~~~l-~~~~~~~i~~qi~~al~ 159 (360)
+ ..+||=||||+..++.+++.+ +... .....|.+|++|++||.
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHH
Confidence 0 134788999988777777743 2222 57889999999999999
Q ss_pred HHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC----C------------CCCcceecccccccccccccccc
Q 018128 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP----V------------GDNTHVSTRVMGTYGYCAPEYAM 223 (360)
Q Consensus 160 ~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~----~------------~~~~~~~~~~~~~~~y~aPE~~~ 223 (360)
|+|++| ++||||||.|||+++++.|||+|||+++... . .......+...||..|.|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999999 9999999999999999999999999997511 0 00111223467999999999998
Q ss_pred cC---CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCC--CChhhHHHHHHH
Q 018128 224 SG---KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR--YPRRCLNYAVAV 298 (360)
Q Consensus 224 ~~---~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 298 (360)
+. .|+.|.|+||||++++||+. ||.... +....+..+.+..+... +....-..-..+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---------------ERa~iL~~LR~g~iP~~~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---------------ERASILTNLRKGSIPEPADFFDPEHPEEASL 850 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchH---------------HHHHHHHhcccCCCCCCcccccccchHHHHH
Confidence 54 49999999999999999976 454221 11111111211111111 111222334679
Q ss_pred HhhhcccCCCCCCCHHHHHH
Q 018128 299 TAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 299 i~~~l~~dp~~Rpt~~eil~ 318 (360)
|..|++.||.+|||+.|+|.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999984
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=268.34 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=193.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeC------C
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------D 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~------~ 114 (360)
..+|.+.+.||.|++|.||.+.+. +++.+++|.+...... ....+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 579999999999999999999865 6899999988654222 234578899999999999999999988654 2
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++|++++. .+|.++. +..+++..++.++.|++.||.+||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4589999985 4776655 246899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hcc---ch-hh
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSW---SR-PF 268 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~---~~-~~ 268 (360)
+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... ... .. .+
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8753221 112346778999998875 4688999999999999999999999974321110000 000 00 00
Q ss_pred hhc--cccchhc---ccccccCC---CChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH--Hhhh
Q 018128 269 LKD--QKKFVHL---VDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA--LDYL 323 (360)
Q Consensus 269 ~~~--~~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~--L~~l 323 (360)
... ....... ........ ..+..+..+.++|.+||+.||.+||++.+++.. ++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 0000000 00000000 012345678999999999999999999999952 4444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=257.62 Aligned_cols=275 Identities=24% Similarity=0.327 Sum_probs=208.0
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhcc--CCCcccceeEEEEeC-
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL--HHDNLVTLIGYCTSG- 113 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l--~~p~i~~~~~~~~~~- 113 (360)
.-.-+-..++.++.+.+|+|.||.||.+++. |+.||||++...+ +...++|.++++.. +|+||+.+++.-..+
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 3444556789999999999999999999999 8999999997553 45677888888864 899999998775332
Q ss_pred ---CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeCCCCCCcEEEeCCC
Q 018128 114 ---DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-----KANPPVIYRDLKSANILLDNDF 185 (360)
Q Consensus 114 ---~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-----~~~~~i~H~di~p~NIlv~~~~ 185 (360)
..+++|.+|.+.|+|.||+. ...++....++++..++.||.+||. +|.|.|.|||||.+||||..+|
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 35789999999999999994 4779999999999999999999995 5678899999999999999999
Q ss_pred ceEEeecCCccccCCCCC--cceecccccccccccccccccCC----C--CcchhhHHHHHHHHHHHhC----------C
Q 018128 186 NPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSGK----L--TLKSDIYSFGVVLLELITG----------R 247 (360)
Q Consensus 186 ~v~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~----~--s~~sDiwslG~il~~ll~g----------~ 247 (360)
.+.|+|+|++........ ....+...||.+|||||++.+.. + -..+||||||.++||++.. +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 999999999976433321 22334567999999999987532 1 2578999999999999862 3
Q ss_pred CcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 248 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 248 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
.||......+ ..+.++ ++..-..++....-...........+.++++.||..||.-|-|+-.+.+.|.++...
T Consensus 434 ~Pyyd~Vp~D-Ps~eeM-----rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 434 LPYYDVVPSD-PSFEEM-----RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCcccCCCCC-CCHHHH-----hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 4553222111 011111 001111111111111122456777899999999999999999999999999999753
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=250.26 Aligned_cols=248 Identities=28% Similarity=0.410 Sum_probs=194.1
Q ss_pred cccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc-chHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEEEecC
Q 018128 48 REANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 48 ~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~e~~~ 124 (360)
+.+..||.|..|+||.++.. +|.-.|||.+...+.. +.+++...+.++...+ +|+|++++++|..+...++-||.+
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 34567999999999999876 5899999999876543 3456777777666554 999999999999999999999987
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
...+..++.+ ..+++++..+-++...++.||.||..+.+ |+|||+||+|||+|+.|++||+|||.+-+... .
T Consensus 174 s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---S 245 (391)
T KOG0983|consen 174 STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD---S 245 (391)
T ss_pred HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec---c
Confidence 4456666655 34679999999999999999999997653 99999999999999999999999999875332 2
Q ss_pred ceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 205 HVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
.......|-+.|||||.+. ...|+.++||||||++++||+||..||.....+-+ .. .+.+. -..+
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~l---------tkvln-~ePP 313 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VL---------TKVLN-EEPP 313 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HH---------HHHHh-cCCC
Confidence 3334456778899999886 45688999999999999999999999986543211 00 00011 1112
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+.. ...++..+.+++..||+.|+++||.+.++++
T Consensus 314 ~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 314 LLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2222 2237888999999999999999999999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=254.52 Aligned_cols=274 Identities=23% Similarity=0.255 Sum_probs=200.7
Q ss_pred HhhcccccceeccCCCeEEEEEEec---C--CCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEe-CC
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE---S--GQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GD 114 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~---~--~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-~~ 114 (360)
....|+++..||+|.||.||+|... + .+.+|+|.+.... ........+|+.+++.++|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3468999999999999999999543 2 2378999886552 2233567889999999999999999988866 77
Q ss_pred eeEEEEEecCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC----CceEE
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND----FNPKL 189 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~----~~v~L 189 (360)
..+++++|.+. +|.+.|+-++. ..+.++...++.+++||+.|+.|||++= |+||||||.||||..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 88999999977 99998866443 3457999999999999999999999997 9999999999999877 89999
Q ss_pred eecCCccccCCCCCc-ceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccc----hhc
Q 018128 190 SDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN----LVS 263 (360)
Q Consensus 190 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~----~~~ 263 (360)
+|+|+++.+...-.. .......-|.+|+|||++.+. .||++.|||++|||+.||++..+.|.......... ...
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999975543332 233445678999999998865 69999999999999999999888775433221111 000
Q ss_pred -------------cchhhhhccccchhcccccccCCC-C----------hhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 264 -------------WSRPFLKDQKKFVHLVDPLLHGRY-P----------RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 264 -------------~~~~~~~~~~~~~~~~~~~~~~~~-~----------~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
..++.+.........+.......+ + ..-+..-.+|+.+||+.||-+|.|+++.++-
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 000111111111000000000000 0 0112337789999999999999999999974
Q ss_pred H
Q 018128 320 L 320 (360)
Q Consensus 320 L 320 (360)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 3
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=271.61 Aligned_cols=266 Identities=26% Similarity=0.393 Sum_probs=223.6
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecC-CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
++|+.--...++...||.|.||.||.+.++. .--|+||.+. ++....++|..|..+++.++|||+++++++|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 7788888888899999999999999998874 4568888764 4456678999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
|||.||+..|+|.+|+... +...++...+++++.||..|+.||..++ ++||||...|.||.++..||+.|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999773 3456888899999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
...-+. .....-.....-|.|||-+....++.++|||+||++|||+.| |-.||...+ -...
T Consensus 414 lMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqV 475 (1157)
T KOG4278|consen 414 LMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQV 475 (1157)
T ss_pred hhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHH
Confidence 743322 222233345667999999999999999999999999999998 666875332 1122
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
-.++....+..-|..|+..+.+|++.||+++|.+||++.|+-+.++.+....
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 2334444455567899999999999999999999999999999999886543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=271.49 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=200.9
Q ss_pred cccc--cceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 46 NFRE--ANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 46 ~y~i--~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
-|+| .++||.|-||+||-+++. +|+.||||++.+-.. ....++++|+.+|+.+.||+|+.+...+++.+..++||
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 4444 469999999999999765 799999999976533 45578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC---CceEEeecCCccc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLAKL 197 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~---~~v~L~Dfg~~~~ 197 (360)
|.+ +|+..+.|-. ...+++++..-+.++.||+.||+|||.++ |+|+||||+|||+... ..+||+|||.++.
T Consensus 643 EKl-~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 643 EKL-HGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred hhh-cchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceee
Confidence 999 5677777755 46788999999999999999999999999 9999999999999543 5799999999985
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
. ..........||+.|+|||++.++.|+..-|+||.|+|+|--+.|..||+.+.+-.+ +++. . .|+....
T Consensus 717 I---gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-QIQN-A-aFMyPp~---- 786 (888)
T KOG4236|consen 717 I---GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-QIQN-A-AFMYPPN---- 786 (888)
T ss_pred c---chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-Hhhc-c-ccccCCC----
Confidence 3 344445567899999999999999999999999999999999999999974332111 0000 0 0000000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.=.+.+.+..+||..+|+..-++|-++...+
T Consensus 787 ---------PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 ---------PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---------chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1125667789999999999999999987654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=261.64 Aligned_cols=276 Identities=19% Similarity=0.256 Sum_probs=205.5
Q ss_pred CCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC--CC----
Q 018128 29 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH--HD---- 101 (360)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--~p---- 101 (360)
+..-.++-+........+|++...||+|+||.|..+.+. .+..||+|++..-. .-.+..+-|+++++.+. .|
T Consensus 73 dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 73 DDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred CCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCce
Confidence 333444666666777899999999999999999999755 47899999886543 33456677999999983 22
Q ss_pred cccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018128 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 181 (360)
Q Consensus 102 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv 181 (360)
-++++.+||+...+.|||+|.+ |.++.+++.+ ++-.+++...++.+..|+++++++||+.+ ++|.||||+|||+
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILf 225 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILF 225 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEE
Confidence 3566778899999999999988 6699999965 34567999999999999999999999999 9999999999998
Q ss_pred eC--------------------CCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHH
Q 018128 182 DN--------------------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 241 (360)
Q Consensus 182 ~~--------------------~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~ 241 (360)
.+ +..|+++|||.++.... .......|..|.|||++.+..|+.++||||+||||+
T Consensus 226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred eccceEEEeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 31 22379999999985221 124567899999999999999999999999999999
Q ss_pred HHHhCCCcccccCccCc-----cchhccchhhhhcc--------ccc-----------------hhcccccccCCCChhh
Q 018128 242 ELITGRKAMDLSKGQGE-----QNLVSWSRPFLKDQ--------KKF-----------------VHLVDPLLHGRYPRRC 291 (360)
Q Consensus 242 ~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~--------~~~-----------------~~~~~~~~~~~~~~~~ 291 (360)
|+.+|...|..-...+. ..+......+.... ..+ .+.++..+ ......
T Consensus 301 ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~--~~~d~e 378 (415)
T KOG0671|consen 301 ELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM--LQDDLE 378 (415)
T ss_pred EeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh--ccCcHH
Confidence 99999988865442110 00000000111100 000 00000000 112355
Q ss_pred HHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 292 LNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 292 ~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...|++|+.+||..||.+|+|+.|++.
T Consensus 379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 379 HVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HhHHHHHHHHHHccCccccccHHHHhc
Confidence 667999999999999999999999985
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=250.08 Aligned_cols=219 Identities=24% Similarity=0.216 Sum_probs=175.8
Q ss_pred CCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHHHHhcc
Q 018128 56 GGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD 134 (360)
Q Consensus 56 G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~ 134 (360)
|.++.||++++. +++.+++|.+.... ....|...+....||||+++++++.+.+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999876 68999999986543 223344445555799999999999999999999999999999999854
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceeccccccc
Q 018128 135 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214 (360)
Q Consensus 135 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~ 214 (360)
...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++++|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 345899999999999999999999998 999999999999999999999999987543221 11233566
Q ss_pred ccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHH
Q 018128 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 294 (360)
Q Consensus 215 ~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (360)
.|+|||...+..++.++|+||+|+++|+|++|..|+....... ........+..++..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCcccCCHH
Confidence 7999999988888999999999999999999998875321100 000011234456678
Q ss_pred HHHHHhhhcccCCCCCCCH
Q 018128 295 AVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 295 l~~li~~~l~~dp~~Rpt~ 313 (360)
+.++|.+||+.||.+||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 8999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=280.05 Aligned_cols=146 Identities=32% Similarity=0.410 Sum_probs=131.0
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
-++|++.+.||+|+||+||++.+. .++.||+|++...... ....+..|+.+++.++||||++++..+......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999876 6899999998654322 235678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||..+ |+|+||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999954 356889999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=268.02 Aligned_cols=238 Identities=24% Similarity=0.300 Sum_probs=195.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
...|++...+|.|+|+.|-.+.+. +++.+++|++.... .+..+|..++... +||||++.++.+.+....++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 568899999999999999888765 68899999997662 2223355444444 69999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE-eCCCceEEeecCCccccCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL-DNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv-~~~~~v~L~Dfg~~~~~~~ 200 (360)
.+.++-+.+-+.. .+.....+.+|+.+|+.|+.|||.+| ++||||||+|||+ ++.++++|+|||.+.....
T Consensus 397 ~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999888777733 23333777889999999999999999 9999999999999 6889999999999986444
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. ....+-|..|.|||+.....++.++|+||||++||+|++|..||...... .++..
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ei~~ 524 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------IEIHT 524 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------HHHHH
Confidence 3 33346788899999999999999999999999999999999999743321 23333
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
....+.+....++...+|+.+||+.||.+||++.+++
T Consensus 525 ~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 525 RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 3444445577889999999999999999999999998
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=268.11 Aligned_cols=246 Identities=25% Similarity=0.323 Sum_probs=207.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCC-EEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQ-LVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~-~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.+.-.+++++..||-|+||.|=+++.+..+ -+|+|++.+... .+.+.+..|-.++...+.|.|+++|..|.+....
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 344578888999999999999999877533 388888776543 4456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
|++||-|-||.|...+. ..+.+++...+.++..+++|+.|||+++ |+.|||||+|.+++.+|-+||.|||++.
T Consensus 496 YmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred hhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHH
Confidence 99999999999999994 5778999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
...... ..-..+||+.|.|||++.+...+.+.|.|+||+++|||++|.+||...+.....+
T Consensus 569 ki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn---------------- 629 (732)
T KOG0614|consen 569 KIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN---------------- 629 (732)
T ss_pred HhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH----------------
Confidence 644333 3344789999999999999999999999999999999999999998655432222
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 312 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt 312 (360)
.++...-...+|...+....+||++++..+|.+|..
T Consensus 630 ~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 630 LILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred HHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 111112222457778888999999999999999966
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=271.54 Aligned_cols=269 Identities=27% Similarity=0.403 Sum_probs=223.6
Q ss_pred cHHHHHHH-hhcccccceeccCCCeEEEEEEe-cC----CCEEEEEEcccC-CccchHHHHHHHHHhhccCCCcccceeE
Q 018128 36 TFRELAIA-TRNFREANLIGEGGFGKVYKGRL-ES----GQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIG 108 (360)
Q Consensus 36 ~~~~~~~~-~~~y~i~~~Lg~G~~g~v~~~~~-~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~p~i~~~~~ 108 (360)
+...+.+. ....+..++||.|+||+||.+.+ .. +.+|++|++... ..+...++.+|+..+..+.|||++++++
T Consensus 686 n~~~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLg 765 (1177)
T KOG1025|consen 686 NLALLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLG 765 (1177)
T ss_pred hhhheeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhh
Confidence 33334443 35667788999999999999954 22 457899987654 4455678999999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 109 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
++.... .-||.++++.|+|.++++. +..++..+..+.|+.||++|++|||.++ ++||||..+||||..-..||
T Consensus 766 vc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvk 838 (1177)
T KOG1025|consen 766 VCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVK 838 (1177)
T ss_pred hcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEE
Confidence 987655 7799999999999999987 5578999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchh
Q 018128 189 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
++|||++......+..+......-..-|+|=|.+....++.++||||||+++||++| |..|++.....
T Consensus 839 itdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----------- 907 (1177)
T KOG1025|consen 839 ITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----------- 907 (1177)
T ss_pred EEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------
Confidence 999999998777776666665666778999999999999999999999999999998 88898744422
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
.+.+++...-+...|+.++.++..++.+||..|+..||+++++...+........
T Consensus 908 ------eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 908 ------EIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred ------HhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 2223333333345588999999999999999999999999999999998855443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=251.42 Aligned_cols=270 Identities=30% Similarity=0.423 Sum_probs=202.5
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhc--cCCCcccceeEEEEeCC----eeE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTSGD----QRL 117 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~--l~~p~i~~~~~~~~~~~----~~~ 117 (360)
-...++.+++|+|+||.||+|... ++.||||++.... .+.+.+|..+++. ++|+||++++.+-+... ..+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 567778899999999999999988 6999999987443 4566777777765 47999999998865444 778
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCcEEEeCCCceEEee
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------NPPVIYRDLKSANILLDNDFNPKLSD 191 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------~~~i~H~di~p~NIlv~~~~~v~L~D 191 (360)
+|++|.+.|+|.+|+. ...+++.....++..++.||+|||+-. +++|+|||||.+||||.++++..|+|
T Consensus 285 LVt~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999994 467999999999999999999999742 46799999999999999999999999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCC-C-----CcchhhHHHHHHHHHHHhCCCcccc-cCccCccchhcc
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-L-----TLKSDIYSFGVVLLELITGRKAMDL-SKGQGEQNLVSW 264 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-----s~~sDiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~ 264 (360)
||++..+.............||.+|||||++.+.. + -.+.||||+|.++|||++....+.. ...+-...+...
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99999877666555555578999999999987542 1 2578999999999999986543321 000000000000
Q ss_pred ---------chhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 265 ---------SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 265 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
.+...-..+.-..+.+.... -....-+.+.+..||..||+-|.|+.=+-+++.++..-
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 00000011111111111111 13456788999999999999999999999999988543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=241.72 Aligned_cols=237 Identities=32% Similarity=0.417 Sum_probs=191.7
Q ss_pred CCeEEEEEEec-CCCEEEEEEcccCCccc-hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHHHHhcc
Q 018128 57 GFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD 134 (360)
Q Consensus 57 ~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~ 134 (360)
++|.||.+... +++.+++|++....... ...+.+|+..++.++|+|++++++.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57999999876 48999999987765544 67899999999999999999999999999999999999999899999854
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceeccccccc
Q 018128 135 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214 (360)
Q Consensus 135 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~ 214 (360)
...+++..++.++.+++.++.+||+.+ ++|+||+|.||++++++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 223899999999999999999999998 9999999999999999999999999998643322 223355778
Q ss_pred ccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCC-CChhhHH
Q 018128 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR-YPRRCLN 293 (360)
Q Consensus 215 ~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 293 (360)
.|+|||.+.+..++.++|||++|++++++++|..||...... ..... .......... ....++.
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~-------------~~~~~~~~~~~~~~~~~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFK-------------KIGKPKPPFPPPEWKISP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHH-------------HHhccCCCCccccccCCH
Confidence 899999998888899999999999999999999998642110 00000 0000000000 0111667
Q ss_pred HHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 294 YAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 294 ~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+.+++.+||..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 8999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=222.47 Aligned_cols=264 Identities=22% Similarity=0.276 Sum_probs=200.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.+|.-.+.||.|.||+||.++.. +++-|++|.+..++. .......+|+-+++.++|.||++++++...+..+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35777889999999999999866 588999998876543 345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
+|+. +|..+... -++.++.+.++.++.|++.+|.++|+++ +.|+|+||+|.+++.+|.+||.|||+++.+ .
T Consensus 82 ~cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglaraf--g 152 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAF--G 152 (292)
T ss_pred HhhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhc--C
Confidence 9955 88888865 5688999999999999999999999999 999999999999999999999999999863 3
Q ss_pred CCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh----hhccccch
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF----LKDQKKFV 276 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~ 276 (360)
-...+.....-|..|.||.++.+. -|+...|+||.|||+.|+.....|.-..... ..++....+.. ...-..+.
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccc
Confidence 455566666789999999999875 4889999999999999999855554322211 11111100000 00000011
Q ss_pred hcccccccC---------CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPLLHG---------RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
++.+-.... +.-++....-++++.+.|.-+|.+|.++++.++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111110 112344455678899999999999999998874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=265.41 Aligned_cols=259 Identities=29% Similarity=0.405 Sum_probs=210.9
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEE---
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCT--- 111 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~--- 111 (360)
+..+....+.|++.+++|.|.+|.||.++.. +++..++|+..... ...+++..|+++++.. .|||+..+++++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3344445678999999999999999999765 68999999887664 3346788899999887 5999999999984
Q ss_pred --eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEE
Q 018128 112 --SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 189 (360)
Q Consensus 112 --~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L 189 (360)
.++.+++|||+|.+|+..|+++... +.++.|..+..|++.++.|+.+||.+. ++|+|||=.|||++.++.|||
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 4678999999999999999998866 889999999999999999999999998 999999999999999999999
Q ss_pred eecCCccccCCCCCcceeccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhcc
Q 018128 190 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 264 (360)
Q Consensus 190 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 264 (360)
+|||.+... ...........|++.|||||++.- ..|+..+|+||||++..||..|.+|+.........
T Consensus 165 vDFGvSaQl--dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL----- 237 (953)
T KOG0587|consen 165 VDFGVSAQL--DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL----- 237 (953)
T ss_pred eeeeeeeee--ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-----
Confidence 999998753 334444556789999999999863 35778999999999999999999998532211100
Q ss_pred chhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+.-..++.....-+......+.++|..||..|.++||+..++++
T Consensus 238 ----------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 ----------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00011111222235677888999999999999999999999885
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=269.99 Aligned_cols=268 Identities=26% Similarity=0.405 Sum_probs=216.9
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec----C----CCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE----S----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIG 108 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~----~----~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~ 108 (360)
.+++...+..+.+.||.|+||.|+.+... . ...||+|.+..... .+...+..|+++++.+ .||||+.+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 68888888899999999999999999643 1 34689998765433 4567899999999998 5999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHhcccC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 018128 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLE---P-------DQ--EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 176 (360)
Q Consensus 109 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~---~-------~~--~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p 176 (360)
++......++|+||+..|+|.+++...+ . .. ..++...++.++.||+.|+.||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997754 0 01 23889999999999999999999998 99999999
Q ss_pred CcEEEeCCCceEEeecCCccccCCCCCcceeccc-ccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccC
Q 018128 177 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV-MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSK 254 (360)
Q Consensus 177 ~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~ 254 (360)
+|||++.+..+|++|||+++.............. .-...|+|||.+....++.++||||+|+++|||++ |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999854444433322211 13456999999999999999999999999999999 777885311
Q ss_pred ccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 255 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
. ...+.+.+....+...|..++.++.++++.||+.+|++||++.++.+.++....
T Consensus 527 ~----------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 P----------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred c----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 0 011111233333445577889999999999999999999999999999999643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=251.37 Aligned_cols=245 Identities=28% Similarity=0.363 Sum_probs=200.8
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc---hHHHHHHHHHhhcc-CCCcccceeEEEEeCCe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~---~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~ 115 (360)
.+-...|..+.+||+|+||.|.+++.+ +.+.||||++.++..-+ .+--+.|-++|... +-|.+++++..|.+-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 566678999999999999999999766 58899999987764322 22234466666655 46788999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
+|+||||+.||+|--.|++ -+++.+..+..++..|+.||-+||++| |+.||||.+|||++.+|.|||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999888844 566788888999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
.. ..-........+||+.|+|||++...+|+.+.|-||+|+++|||+.|++||+..+.....
T Consensus 498 KE--ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------------- 559 (683)
T KOG0696|consen 498 KE--NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------- 559 (683)
T ss_pred cc--cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------
Confidence 85 223334455678999999999999999999999999999999999999999854422111
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 312 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt 312 (360)
..+.+. .-.||..++.+...+++..|..+|.+|..
T Consensus 560 ~aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 560 QAIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 111111 11467888999999999999999999953
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=244.11 Aligned_cols=258 Identities=25% Similarity=0.321 Sum_probs=195.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
..+.+-+..||.|+||+|+.-.++ .|+..|||.+..... .+..++..|.+....- ++|||+++|+..-.+..++|-|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 345556778999999999998766 699999999987765 4446677787765554 6999999999998889999999
Q ss_pred EecCCCCHHHHhcc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 121 EYMPMGSLEDHLYD-LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 121 e~~~~~sL~~~i~~-~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|.+ ..+|..+... +...+..+++..+-.+....+.||.||...-. |+|||+||+|||++..|.|||+|||.+-...
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH
Confidence 998 4477665432 33456789999999999999999999997633 9999999999999999999999999986422
Q ss_pred CCCCcceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.....+...|-..|+|||.+.. ..++.+|||||||+++||+.||..|+...+.. +..-.....
T Consensus 220 ---~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv------------feql~~Vv~ 284 (361)
T KOG1006|consen 220 ---DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV------------FEQLCQVVI 284 (361)
T ss_pred ---HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH------------HHHHHHHHc
Confidence 2222333456667999998863 35899999999999999999999998643321 000000000
Q ss_pred cccccccC-CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 278 LVDPLLHG-RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 278 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
--.+.+.. .-...++..+..+|.-||..|.+.||.+.++++.
T Consensus 285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 00011111 1123578889999999999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=256.36 Aligned_cols=206 Identities=26% Similarity=0.334 Sum_probs=176.3
Q ss_pred HHhhcccccceeccCCCeEEEEEE-ecCCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~-~~~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
..+.-|..++.||-|+||.|++++ .++...||+|.+.+.+.- +...++.|-.+|..-.++-|+++|.-|.+++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 335678889999999999999995 566889999999877543 3345788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||+|++||++-.++.+ .+-|++..++.++..+.+|+.+.|..| ++||||||+|||||.+|.+||+|||+|+-
T Consensus 706 FVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 99999999999998854 577999999999999999999999999 99999999999999999999999999973
Q ss_pred cCCCCCcce----------------------------------------ecccccccccccccccccCCCCcchhhHHHH
Q 018128 198 GPVGDNTHV----------------------------------------STRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 237 (360)
Q Consensus 198 ~~~~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG 237 (360)
+.-....+. .....||..|+|||++....++..+|.||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 211110000 0113589999999999999999999999999
Q ss_pred HHHHHHHhCCCcccccC
Q 018128 238 VVLLELITGRKAMDLSK 254 (360)
Q Consensus 238 ~il~~ll~g~~pf~~~~ 254 (360)
+|||+|+.|+.||-...
T Consensus 859 vil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADT 875 (1034)
T ss_pred HHHHHHhhCCCCccCCC
Confidence 99999999999996433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=238.47 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=206.0
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCC
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD 114 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~ 114 (360)
+.+.-+.|.++++||+|.|++|.+++++ +.+-|++|++.++- .++..-+..|-..+.+. +||.++.++..|.+++
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 3445578999999999999999999876 58889999887653 23344566677777765 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
.+++|.||.+||+|--.+ +.+++++++-++.+...|..||.|||+.| |+.+|||.+|+|++.+|.+||+|+|.
T Consensus 325 rlffvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred eEEEEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccch
Confidence 999999999999997666 35788999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccC-ccchhccchhhhhccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG-EQNLVSWSRPFLKDQK 273 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 273 (360)
+.. ...........+||+.|.|||++.+..|....|-|+||+++++|+.|+.||+....+. +.+-.++....
T Consensus 398 cke--~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv----- 470 (593)
T KOG0695|consen 398 CKE--GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV----- 470 (593)
T ss_pred hhc--CCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-----
Confidence 985 3344555667899999999999999999999999999999999999999998655332 22222222211
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 312 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt 312 (360)
++... .+.|...+.....+++..|+.||.+|..
T Consensus 471 ----ilekq--iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 471 ----ILEKQ--IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----Hhhhc--ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 11111 2345566666778889999999999853
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=254.61 Aligned_cols=213 Identities=24% Similarity=0.274 Sum_probs=181.6
Q ss_pred CcccccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCC------Ccc
Q 018128 31 GARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH------DNL 103 (360)
Q Consensus 31 ~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~------p~i 103 (360)
.-.+++|.-.++..++|.+....|+|-|++|..|.+. .|+.||||++..+... ...-..|+++|+.|+. -|+
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHH
Confidence 4467889999999999999999999999999999876 4889999999877533 3455679999999962 389
Q ss_pred cceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC
Q 018128 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 183 (360)
Q Consensus 104 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~ 183 (360)
++++..|...+++|||||.+ ..+|.+.+..+. .+-.+....+..++.|+..||..|...| |+|.||||+||||++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEecc
Confidence 99999999999999999998 669999998877 5667888999999999999999999999 999999999999988
Q ss_pred CC-ceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 018128 184 DF-NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 253 (360)
Q Consensus 184 ~~-~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~ 253 (360)
.. .+||||||.+..... ... +...-+-.|.|||++.+.+|+...|+||+||+||||.||+..|...
T Consensus 572 ~k~iLKLCDfGSA~~~~e---nei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASE---NEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred CcceeeeccCcccccccc---ccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 75 579999999874221 111 1222445699999999999999999999999999999999988543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-31 Score=238.96 Aligned_cols=140 Identities=21% Similarity=0.302 Sum_probs=115.9
Q ss_pred HHHHHHHh-hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-----C---Ccccce
Q 018128 37 FRELAIAT-RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----H---DNLVTL 106 (360)
Q Consensus 37 ~~~~~~~~-~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----~---p~i~~~ 106 (360)
+.-+.+.. +||-+.++||+|.|++||++.+- ..+.||+|+..... .-.+....|+++|++++ + .+|+++
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 34445555 89999999999999999999765 67889999876542 23456788999999884 2 378999
Q ss_pred eEEEEe----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe
Q 018128 107 IGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 182 (360)
Q Consensus 107 ~~~~~~----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~ 182 (360)
++.|.. ..++|||+|++ |.+|..+|.. ..-+.++...+++|++||+.||.|||...+ |+|.||||+|||+.
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLC 222 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeee
Confidence 999864 66899999999 7799999976 335679999999999999999999998754 99999999999984
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=259.91 Aligned_cols=270 Identities=20% Similarity=0.235 Sum_probs=172.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-C----CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEE------EE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-S----GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY------CT 111 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~----~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~------~~ 111 (360)
..++|++.+.||+|+||.||++.+. + +..|++|.+..... .+...++ .++...+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5679999999999999999999865 4 68999998754321 1111111 1111112222111111 24
Q ss_pred eCCeeEEEEEecCCCCHHHHhcccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 018128 112 SGDQRLLVYEYMPMGSLEDHLYDLEP----------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 175 (360)
Q Consensus 112 ~~~~~~lv~e~~~~~sL~~~i~~~~~----------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~ 175 (360)
.....++|+||+.+++|.+++..... .+.......+..++.||+.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56678999999999999999854210 0111224456789999999999999998 9999999
Q ss_pred CCcEEEeC-CCceEEeecCCccccCCCCCcceecccccccccccccccccC----------------------CCCcchh
Q 018128 176 SANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG----------------------KLTLKSD 232 (360)
Q Consensus 176 p~NIlv~~-~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~s~~sD 232 (360)
|+|||++. ++.+||+|||++....... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5789999999997532222 2223345678899999965422 2345679
Q ss_pred hHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc---cccchhcccccccC------CCChhhHHHHHHHHhhhc
Q 018128 233 IYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD---QKKFVHLVDPLLHG------RYPRRCLNYAVAVTAMCL 303 (360)
Q Consensus 233 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l 303 (360)
||||||++|+|+++..+++... ..+...+... ...+.....+.... ...........+||.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999776643211 0000000000 00000111110000 001112234568999999
Q ss_pred ccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCCC
Q 018128 304 NEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGA 338 (360)
Q Consensus 304 ~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~~ 338 (360)
+.||++|||+.+++ .|||-...+.
T Consensus 435 ~~dP~kR~ta~e~L-----------~Hpff~~~~~ 458 (566)
T PLN03225 435 RFKGRQRISAKAAL-----------AHPYFDREGL 458 (566)
T ss_pred cCCcccCCCHHHHh-----------CCcCcCCCCc
Confidence 99999999999999 5666665444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-33 Score=262.88 Aligned_cols=247 Identities=29% Similarity=0.366 Sum_probs=188.2
Q ss_pred ccccceeccCCCe-EEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEecC
Q 018128 47 FREANLIGEGGFG-KVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 47 y~i~~~Lg~G~~g-~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~~~ 124 (360)
|.-.+.+|.|+.| .||.+..+ |+.||||.+-... .....+|+..|+.- +||||+++++.-.+....||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4445678899987 46778877 8899999875432 34678899999988 5999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC---C--CceEEeecCCccccC
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---D--FNPKLSDFGLAKLGP 199 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~---~--~~v~L~Dfg~~~~~~ 199 (360)
.++|.++++..............+.++.|++.||++||+.+ |+||||||+||||+. + .+++|.|||++....
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 66999999773111122222556889999999999999999 999999999999965 3 468999999999765
Q ss_pred CCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhC-CCcccccCccCccchhccchhhhhccccchh
Q 018128 200 VGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 200 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
...... ......|+.+|+|||++.+...+.+.||||+||++|+.++| .+||...-... .+.+.....+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceee
Confidence 554432 23457799999999999988888999999999999999986 89996322110 011111111111
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+ .....+ +..+||.+|++++|..||++.+|+.
T Consensus 735 L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 L-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 111122 7899999999999999999999983
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=227.09 Aligned_cols=250 Identities=21% Similarity=0.335 Sum_probs=186.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEE-EEeCCeeEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGY-CTSGDQRLLVY 120 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~-~~~~~~~~lv~ 120 (360)
.+.|.|.+.||.|.||.+-+++++ +.+.+++|.+..+. ....++.+|...--.+ .|.||+..|++ |...+...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 578999999999999999999877 58899999988774 3456778887765555 48999998875 57777888999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe--CCCceEEeecCCcccc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--NDFNPKLSDFGLAKLG 198 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~--~~~~v~L~Dfg~~~~~ 198 (360)
|+++.|+|...+. ...+.+...+.++.|+++||.|+|+++ +||||||.+||||- +..+|||+|||..+..
T Consensus 102 E~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999884 367899999999999999999999999 99999999999993 3348999999998753
Q ss_pred CCCCCcceecccccccccccccccccC-----CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
+..- ........|.+||..... ...+.+|+|+||+++|.++||..||... ......+..|.
T Consensus 174 g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~-------- 239 (378)
T KOG1345|consen 174 GTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWE-------- 239 (378)
T ss_pred Ccee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHH--------
Confidence 3221 123355679999976432 3568999999999999999999999722 22222222221
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.+.....+.+...+ ..++..+..+.++-|.+++++|-...++.
T Consensus 240 ~w~~rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 240 QWLKRKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred HHhcccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 11111122221111 23566678899999999999994444433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=236.26 Aligned_cols=271 Identities=24% Similarity=0.331 Sum_probs=216.0
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccC-CccchHHHHHHHHHhhccCCCcccceeEE
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~p~i~~~~~~ 109 (360)
++++.+...|++...++.+|.||.||.+.+. +.+.+.+|.+... ..-+...+..|-.++....|||++.+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4577788889999999999999999999433 2345667765433 22344568889889988999999999988
Q ss_pred E-EeCCeeEEEEEecCCCCHHHHhcccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 110 C-TSGDQRLLVYEYMPMGSLEDHLYDLEP----DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 110 ~-~~~~~~~lv~e~~~~~sL~~~i~~~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
. ++.+..++++.+..-|+|..|+...+. ..+.+...+...++.|++.|+.+||+.+ ++|.||...|.++++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 6 556778899999999999999985432 2345778888999999999999999999 9999999999999999
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhc
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVS 263 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~ 263 (360)
.+|||+|=.+++..-..+.........++..||+||.+.+..|+.++|+||||+++|||+| |+.|+...++.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 9999999988875444444433333446678999999999999999999999999999998 888886433211
Q ss_pred cchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
...|+.+. .+...|.+++++|+.++.-||...|++||+++++..-|..+..+.
T Consensus 507 -m~~ylkdG----------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 507 -MEHYLKDG----------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -HHHHHhcc----------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 11233322 223346789999999999999999999999999999999886554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-33 Score=233.08 Aligned_cols=268 Identities=26% Similarity=0.372 Sum_probs=194.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEe--------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-------- 112 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-------- 112 (360)
.+.|+-...+|+|.||.||+|+.+ .|+.|++|++..+. ..-.....+|+++|..+.|+|++.+++++..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 456788889999999999999876 47888888765432 2223567789999999999999998887643
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....|+||.+|+. +|..++.+ ...+++...+..++.+++.||.|+|... |+|||+|+.|+|++.+|.++|+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 3457999999976 88888854 4478999999999999999999999998 999999999999999999999999
Q ss_pred CCccccCCCCCcc--eeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-------
Q 018128 193 GLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV------- 262 (360)
Q Consensus 193 g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~------- 262 (360)
|+++.+....... ......-|..|++||.+.+ ..++++.|||..|||+.+|+++.+-+.....+......
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 9997543333221 1234456899999998875 57899999999999999999998877543321111000
Q ss_pred -ccchhhhhccccchhcc-cccccCCC--------ChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 263 -SWSRPFLKDQKKFVHLV-DPLLHGRY--------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 263 -~~~~~~~~~~~~~~~~~-~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...++....-.-+..+- .+.-.+.+ +-.-.++..+|+.+++..||.+|+++.+++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00001000000011110 00111110 1112456789999999999999999998874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=246.89 Aligned_cols=266 Identities=20% Similarity=0.240 Sum_probs=177.7
Q ss_pred HhhcccccceeccCCCeEEEEEEe-----------------cCCCEEEEEEcccCCccchHH--------------HHHH
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRL-----------------ESGQLVAIKQLNHEGLQGHQE--------------FIVE 91 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~-----------------~~~~~v~vK~~~~~~~~~~~~--------------~~~e 91 (360)
..++|++.+.||+|+||+||.+.. ..++.|++|.+.........+ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999853 235679999986543222222 2336
Q ss_pred HHHhhccCCCcc-----cceeEEEEe--------CCeeEEEEEecCCCCHHHHhcccCC--------------------C
Q 018128 92 VLMLSLLHHDNL-----VTLIGYCTS--------GDQRLLVYEYMPMGSLEDHLYDLEP--------------------D 138 (360)
Q Consensus 92 ~~~l~~l~~p~i-----~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~i~~~~~--------------------~ 138 (360)
+.++..++|.++ +++++++.. ....++||||+.+++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666666655443 455555532 3467899999999999999864211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceeccccccccccc
Q 018128 139 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218 (360)
Q Consensus 139 ~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 218 (360)
...+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++........ ........++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123467788999999999999999998 99999999999999999999999999864322111 11112234788999
Q ss_pred ccccccCCC----------------------CcchhhHHHHHHHHHHHhCCC-cccccCccCccchhccchhhhhccccc
Q 018128 219 PEYAMSGKL----------------------TLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 219 PE~~~~~~~----------------------s~~sDiwslG~il~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
||.+..... ..+.|+||+||++++|++|.. ||........ ... .+..+...+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~----~~~~~~~~~ 453 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELR----QYDNDLNRW 453 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHh----hccchHHHH
Confidence 998753221 134699999999999999875 6642211100 000 000000001
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCC---CCCCCHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEA---NFRPLINDIV 317 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rpt~~eil 317 (360)
.........-......+....+++.+||..+| .+|+|+.|+|
T Consensus 454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 11111111111233557789999999999766 6899999999
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=217.76 Aligned_cols=211 Identities=25% Similarity=0.338 Sum_probs=175.9
Q ss_pred cHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEEEe
Q 018128 36 TFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS 112 (360)
Q Consensus 36 ~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~ 112 (360)
....+++..+....+..||+|++|.|-..++. +|.-.|+|.+...-. +..++..+|+.+.... .||.++.+|+....
T Consensus 37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 34456777788888999999999999888765 799999999876533 3345677788876665 69999999999989
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....++.||.+ ..+|..+...-...++.+++..+-+++..+++||.+||++-. ++|||+||.|||++.+|+||++||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEccc
Confidence 99999999998 558988887777789999999999999999999999998743 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccc----cCCCCcchhhHHHHHHHHHHHhCCCcccc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM----SGKLTLKSDIYSFGVVLLELITGRKAMDL 252 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~s~~sDiwslG~il~~ll~g~~pf~~ 252 (360)
|.+-.+...- ..+...|-..|+|||.+. ...|+.++||||||+++.||.+++.||+.
T Consensus 194 GIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 194 GISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 9987543222 122244667799999876 34689999999999999999999999973
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=215.23 Aligned_cols=210 Identities=38% Similarity=0.560 Sum_probs=181.9
Q ss_pred eccCCCeEEEEEEecC-CCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHHH
Q 018128 53 IGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 130 (360)
Q Consensus 53 Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~ 130 (360)
||.|.+|.||.+.... ++.+++|++...... ....+.+|+..++.+.|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998764 899999998766433 34678999999999999999999999999899999999999899999
Q ss_pred HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-CCceEEeecCCccccCCCCCcceecc
Q 018128 131 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTR 209 (360)
Q Consensus 131 ~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-~~~v~L~Dfg~~~~~~~~~~~~~~~~ 209 (360)
++... ...++...++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+||+.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99552 146899999999999999999999998 999999999999999 89999999999875433221 2233
Q ss_pred cccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCC
Q 018128 210 VMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 288 (360)
Q Consensus 210 ~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
..+...|++||..... ..+.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577889999998877 788999999999999999
Q ss_pred hhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 289 RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 289 ~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
..+.+++.+|++.||.+||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=215.69 Aligned_cols=274 Identities=17% Similarity=0.291 Sum_probs=203.9
Q ss_pred CCCcccccHHHHHHH---hhcccccceeccCCCeEEEEEEe-cCCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcc
Q 018128 29 KSGARSFTFRELAIA---TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNL 103 (360)
Q Consensus 29 ~~~~~~~~~~~~~~~---~~~y~i~~~Lg~G~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i 103 (360)
......+.++...+. .++|++.+.+|+|.++.||.+.. .+++.+++|++.+- ..+.+.+|+++|+.+. +|||
T Consensus 19 ~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NI 95 (338)
T KOG0668|consen 19 ERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNI 95 (338)
T ss_pred cCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCe
Confidence 444556677665554 47899999999999999999964 46888999988643 3467899999999997 9999
Q ss_pred cceeEEEEeC--CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018128 104 VTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 181 (360)
Q Consensus 104 ~~~~~~~~~~--~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv 181 (360)
++++++..+. ....+|+|+.++.+...+. +.++.-.+..++.+++.||.|+|++| |.|||+||.|+++
T Consensus 96 i~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmI 165 (338)
T KOG0668|consen 96 IKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMI 165 (338)
T ss_pred eehhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeee
Confidence 9999998664 3467999999998887776 55788899999999999999999999 9999999999999
Q ss_pred eCC-CceEEeecCCccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc
Q 018128 182 DND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259 (360)
Q Consensus 182 ~~~-~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~ 259 (360)
+.. ..++|+|||++..+........ ...+..|-.||++-. ..++.+-|+|||||++..|+..+.||-.......+
T Consensus 166 dh~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ 242 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 242 (338)
T ss_pred chhhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH
Confidence 866 4699999999997765544332 335556889998875 45889999999999999999999999544332111
Q ss_pred -----------chhccchhhh-hccccchhccccc--------ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 260 -----------NLVSWSRPFL-KDQKKFVHLVDPL--------LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 260 -----------~~~~~~~~~~-~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+..+...+- .-......++... ....-..-...+..+++.++|..|-++|+|+.|...
T Consensus 243 LVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 243 LVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111110 0011111111111 111111123578899999999999999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=239.35 Aligned_cols=196 Identities=24% Similarity=0.324 Sum_probs=168.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--------hHHHHHHHHHhhccC---CCcccceeEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--------HQEFIVEVLMLSLLH---HDNLVTLIGYCTS 112 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--------~~~~~~e~~~l~~l~---~p~i~~~~~~~~~ 112 (360)
..|+..+.||.|+||.|+++.++ +...|++|.+.+...-. .-.+-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46999999999999999999877 46789999887764321 123556999999987 9999999999999
Q ss_pred CCeeEEEEEec-CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEee
Q 018128 113 GDQRLLVYEYM-PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191 (360)
Q Consensus 113 ~~~~~lv~e~~-~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~D 191 (360)
++..|+++|.. ++.+|.++|+ ....+++.++..++.|++.|+++||+++ |+|||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999976 5779999994 4778999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCccc
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMD 251 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~ 251 (360)
||.+.... ........||..|.|||++.+.+| ...-|||++|+++|.++....||-
T Consensus 714 fgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99986532 222334579999999999998776 578899999999999999888874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-31 Score=223.63 Aligned_cols=265 Identities=25% Similarity=0.348 Sum_probs=192.1
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccC--CccchHHHHHHHHHhhccCCCcccceeEEEEeC-----CeeE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQRL 117 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-----~~~~ 117 (360)
+.+-.+.||.|+||.||.+.+. +|+.+++|++..- .....+.+.+|+++|..++|.|++..+++..-. ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4566789999999999999865 7999999987543 334457899999999999999999888775432 2356
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
++.|.+ ..+|...| .+.+.++..-++-++.||+.||+|||+.+ |.||||||.|.|++.+-.+||+|||+++.
T Consensus 134 V~TELm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 777776 45777666 56788999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-cc-chhhhhcccc
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW-SRPFLKDQKK 274 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~ 274 (360)
....+...+ ....-|..|+|||++++. .|+.+.||||.|||+.||+..+..|...+.....+.. +. ..+-+++.+.
T Consensus 206 ee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 444433333 234568889999999975 6899999999999999999888777533321111110 00 0000000000
Q ss_pred ch-----hccccccc---------CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 275 FV-----HLVDPLLH---------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 275 ~~-----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
.. .++....+ ..-+..-..+...+...++..||++|.+..+.+.-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 00 00000000 01123445677788899999999999999988764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=218.27 Aligned_cols=262 Identities=24% Similarity=0.288 Sum_probs=196.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC--CccchHHHHHHHHHhhccCCCcccceeEEEEeC------
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------ 113 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~------ 113 (360)
...||.-++.+|.|+- .|..+.+. .+++|++|.+..+ ......+..+|+..+..++|+||++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3568888999999998 67777655 5899999988665 234456788999999999999999999998533
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...|+|||++ ..+|.+.+. -.++=..+..++.|++.|+++||+.+ |+||||||+||++..+..+|+.|||
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccch
Confidence 3468999999 558988884 34566788899999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccC------------c---
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG------------E--- 258 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~------------~--- 258 (360)
++... ...-..+....+..|.|||++-+..+....||||+||++.+|++|..-|.....-. .
T Consensus 164 ~ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 164 LARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 99742 22234455667888999999999889999999999999999999998885222100 0
Q ss_pred -cchhccchhhhhccc------cchhcccccccCC--CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 259 -QNLVSWSRPFLKDQK------KFVHLVDPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 259 -~~~~~~~~~~~~~~~------~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.++..-.+.+..... -.+...|..+... .++.......+++.+||-.||++|.+++++|.
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 001111111211110 0111112222211 22344667889999999999999999999994
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=209.70 Aligned_cols=199 Identities=37% Similarity=0.468 Sum_probs=171.9
Q ss_pred ccccceeccCCCeEEEEEEecC-CCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecC
Q 018128 47 FREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~ 124 (360)
|++.+.||.|++|.||.+.... ++.+++|.+...... ..+.+.+|+..++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999998764 899999999876554 56788999999999999999999999999899999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
+++|.+++.... ..+++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999996522 11889999999999999999999998 999999999999999999999999998764433211
Q ss_pred ceeccccccccccccccc-ccCCCCcchhhHHHHHHHHHHHhCCCcccc
Q 018128 205 HVSTRVMGTYGYCAPEYA-MSGKLTLKSDIYSFGVVLLELITGRKAMDL 252 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~-~~~~~s~~sDiwslG~il~~ll~g~~pf~~ 252 (360)
......+...|++||.+ ....++.++|+|+||+++++|++|..||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334567789999998 666778899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=234.62 Aligned_cols=251 Identities=27% Similarity=0.350 Sum_probs=205.0
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|+..+.+|.|.||.||++++. +++..++|++......+..-+..|+-+++..+||||+.+++-+...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 578999999999999999999876 6999999999988778888889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
|.+|+|++..+ -.+.+++.++...++..+.+++|||+++ =+|||||=.||++++.|.|++.|||.+-.++.
T Consensus 94 cgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred cCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 99999988663 4788999999999999999999999998 99999999999999999999999998865332
Q ss_pred Ccceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh--ccccchh
Q 018128 203 NTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK--DQKKFVH 277 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 277 (360)
.........|++.|+|||+.. ...|...+|||++|++..++.-.++|.... ..+..-++. ..-....
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl--------hpmr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL--------HPMRALFLMTKSGFQPPT 236 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc--------chHHHHHHhhccCCCCCc
Confidence 223344578999999999764 567899999999999999998877664211 111111111 0001111
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+.| .......+.+|++.+|..+|.+||+++.+|.
T Consensus 237 lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccC-------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 2345667999999999999999999988764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=214.99 Aligned_cols=264 Identities=25% Similarity=0.332 Sum_probs=197.3
Q ss_pred HhhcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~ 117 (360)
....|++.+++|.|.|++||.+.+. .++.|++|.+... ....++.+|+++|..+. +.||+++.+.+...+...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 3468999999999999999999643 3678999988655 34567999999999995 899999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-CceEEeecCCcc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAK 196 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-~~v~L~Dfg~~~ 196 (360)
+|+||+++.+..++.. .++...+..++++++.||.++|.+| |+||||||.|++.+.. +.-.|+|||++.
T Consensus 112 ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999883 3678899999999999999999999 9999999999999654 678999999987
Q ss_pred ccCCCC------------------------------------------CcceecccccccccccccccccC-CCCcchhh
Q 018128 197 LGPVGD------------------------------------------NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDI 233 (360)
Q Consensus 197 ~~~~~~------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDi 233 (360)
...... .........||++|.|||++... ..+++.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 210000 00001124599999999999865 46899999
Q ss_pred HHHHHHHHHHHhCCCcccccCccCcc--chh-------------------ccc-hh---hhhccccchhc-cccc-----
Q 018128 234 YSFGVVLLELITGRKAMDLSKGQGEQ--NLV-------------------SWS-RP---FLKDQKKFVHL-VDPL----- 282 (360)
Q Consensus 234 wslG~il~~ll~g~~pf~~~~~~~~~--~~~-------------------~~~-~~---~~~~~~~~~~~-~~~~----- 282 (360)
||.|+|++.++++..||-....+... .+. -|- .+ .......++.+ ....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999999544332110 000 000 00 00000011111 0111
Q ss_pred ---ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 ---LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........+..+.+++.+|+..||.+|.|+++.|+
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 111123445668999999999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=191.58 Aligned_cols=169 Identities=24% Similarity=0.199 Sum_probs=126.2
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
|+|.+++.. .+..+++..++.++.|++.||.|||+++ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999964 3567999999999999999999999886 999999999999999 99887533211
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
..++..|+|||++.+..++.++|||||||++|+|++|..||....... .... ........ . .+. ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~----~~~~~~~~---~-~~~-~~ 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILE----ILLNGMPA---D-DPR-DR 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHH----HHHHHhcc---C-Ccc-cc
Confidence 257899999999999999999999999999999999999996332110 0000 00000000 0 000 00
Q ss_pred CCChhhHH--HHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 286 RYPRRCLN--YAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 286 ~~~~~~~~--~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
..+..... .+.++|.+||+.+|.+||++.++++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11223333 69999999999999999999999998877644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-25 Score=200.47 Aligned_cols=263 Identities=23% Similarity=0.235 Sum_probs=200.4
Q ss_pred cccccceeccCCCeEEEEEEecC--CCEEEEEEcccCCccchHHHHHHHHHhhccC----CCcccceeEEE-EeCCeeEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLES--GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH----HDNLVTLIGYC-TSGDQRLL 118 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~----~p~i~~~~~~~-~~~~~~~l 118 (360)
+|++.+.||.|+||.||.+.... ...+|+|............+..|..++..+. .+++..++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999998764 3578888876654343337777888888876 36899999888 57778899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-----CceEEeecC
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-----FNPKLSDFG 193 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-----~~v~L~Dfg 193 (360)
||+.+ |.+|.++..... .+.++...+..++.|++.+|+++|+.| ++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 889999886643 688999999999999999999999999 9999999999999754 469999999
Q ss_pred Ccc--ccCCCCCcc-----e-ecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccc
Q 018128 194 LAK--LGPVGDNTH-----V-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 194 ~~~--~~~~~~~~~-----~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 265 (360)
+++ .+....... . .....||..|+++.++.+...+.+.|+||++.++.+++.|..||.......... .
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~--~-- 248 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS--K-- 248 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH--H--
Confidence 998 322222110 1 123459999999999999999999999999999999999999995433221110 0
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
+.. ..............+.++.++...+-..+..++|....+...|.......
T Consensus 249 --~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 --FEK-------DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred --HHH-------HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 00000000022334566777777777799999999999999988876654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-25 Score=190.46 Aligned_cols=274 Identities=19% Similarity=0.203 Sum_probs=214.6
Q ss_pred cHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeC
Q 018128 36 TFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSG 113 (360)
Q Consensus 36 ~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~ 113 (360)
+...-.+.+-.|++++.||+|.||.++.++.- ++++||||.-... .+.-++..|+..++.|. +++|..++-+....
T Consensus 19 s~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 19 SSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred CCCCceEecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 33455678999999999999999999999754 7999999965433 34567888999999985 89999999888888
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-----CceE
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-----FNPK 188 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-----~~v~ 188 (360)
-+-.+|++.+ |-+|.|+..- .+++|+...+..++.|++.-++++|.++ +|.|||||+|+||... ..|.
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~Ih 169 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIH 169 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEE
Confidence 8888999998 7788887765 6789999999999999999999999999 9999999999999644 3489
Q ss_pred EeecCCccccCCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc
Q 018128 189 LSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 263 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 263 (360)
++|||++..+...... .......||.+||+-..+.+...+.+.|+=|||-++++++-|..||....+.......+
T Consensus 170 iiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 170 IIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred EEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 9999999876554432 33355779999999999999999999999999999999999999997665543322221
Q ss_pred cchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
.+..-.+ ...+.. .-..++.++..-+.-.-..+-.+-|+.+-+...+..+....+
T Consensus 250 KIGe~Kr-~T~i~~---------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 250 KIGETKR-STPIEV---------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred Hhccccc-cCCHHH---------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 1110000 000111 123467778887777888888999999998888777765433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=235.19 Aligned_cols=195 Identities=15% Similarity=0.202 Sum_probs=133.8
Q ss_pred cCC-CcccceeEEE-------EeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 018128 98 LHH-DNLVTLIGYC-------TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169 (360)
Q Consensus 98 l~~-p~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 169 (360)
++| +||..+++++ ......++++|+. +++|.+++.. ....+++..++.++.||+.||.|||+++ |
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 344 4666666665 2234566778877 6699999954 3456999999999999999999999999 9
Q ss_pred eeCCCCCCcEEEeCCCceEEeec-------------------CCccccCCCCCc--------------ceeccccccccc
Q 018128 170 IYRDLKSANILLDNDFNPKLSDF-------------------GLAKLGPVGDNT--------------HVSTRVMGTYGY 216 (360)
Q Consensus 170 ~H~di~p~NIlv~~~~~v~L~Df-------------------g~~~~~~~~~~~--------------~~~~~~~~~~~y 216 (360)
+||||||+|||++..+.++++|| |+++........ .......++..|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999976555555555 444321100000 000113467889
Q ss_pred ccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHH
Q 018128 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAV 296 (360)
Q Consensus 217 ~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 296 (360)
+|||++.+..++.++|||||||++|||++|..|+..... .... .. .....+ ... .......
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~----~~------~~~~~~----~~~-~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSS----LR------HRVLPP----QIL-LNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHH----HH------HhhcCh----hhh-hcCHHHH
Confidence 999999999999999999999999999998887642110 0000 00 000000 000 1123456
Q ss_pred HHHhhhcccCCCCCCCHHHHHH
Q 018128 297 AVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 297 ~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+++.+||+.+|.+||++.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7889999999999999999975
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=226.42 Aligned_cols=261 Identities=21% Similarity=0.187 Sum_probs=191.4
Q ss_pred cccccHHHHHHHhh-cccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc----cchHHHHHHHHHhhccCCCcccce
Q 018128 32 ARSFTFRELAIATR-NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHHDNLVTL 106 (360)
Q Consensus 32 ~~~~~~~~~~~~~~-~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~----~~~~~~~~e~~~l~~l~~p~i~~~ 106 (360)
.+...++.+..--. .|...+.||.+.|=+|..+++.+|. |++|++-+.+. ....+...|++ ...+++||++++
T Consensus 9 sQi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPf 86 (1431)
T KOG1240|consen 9 SQISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPF 86 (1431)
T ss_pred cccchHHHHhhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccch
Confidence 34444444443322 7888999999999999999999887 99999876642 22333444444 455689999999
Q ss_pred eEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 107 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
..+...+...|+|-+|..+ +|.|-+ ...+-+...+.++++.||+.||..+|..| |+|||||.+|||++.-+-
T Consensus 87 qk~~~t~kAAylvRqyvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW 158 (1431)
T KOG1240|consen 87 QKVLVTDKAAYLVRQYVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNW 158 (1431)
T ss_pred HHHHHhhHHHHHHHHHHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeech
Confidence 8887778888899999855 888877 44566788899999999999999999999 999999999999999999
Q ss_pred eEEeecCCccc-----cCCCCCcceecccccccccccccccccC----------C-CCcchhhHHHHHHHHHHHh-CCCc
Q 018128 187 PKLSDFGLAKL-----GPVGDNTHVSTRVMGTYGYCAPEYAMSG----------K-LTLKSDIYSFGVVLLELIT-GRKA 249 (360)
Q Consensus 187 v~L~Dfg~~~~-----~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~-~s~~sDiwslG~il~~ll~-g~~p 249 (360)
+.|+||..-+. -+..+....+.......+|.|||.+... + .+++.||||+||++.||++ |.+|
T Consensus 159 ~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl 238 (1431)
T KOG1240|consen 159 LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL 238 (1431)
T ss_pred hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence 99999986542 1122222333344566789999987541 2 5789999999999999998 6888
Q ss_pred ccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 250 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 250 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
|+.++- ..+...- ....+..+.. -....++++|..|++.||.+|.++++.|+.
T Consensus 239 F~LSQL------~aYr~~~---~~~~e~~Le~--------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 239 FTLSQL------LAYRSGN---ADDPEQLLEK--------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccHHHH------HhHhccC---ccCHHHHHHh--------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 875542 1111110 0011111111 112257899999999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=178.98 Aligned_cols=272 Identities=21% Similarity=0.210 Sum_probs=211.8
Q ss_pred HHHhhcccccceeccCCCeEEEEEEe-cCCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~l 118 (360)
.+..++|++++.||.|+||.+|++.. .+|..||+|+-.... ...++..|..++..++ ..+|..+..+..+...-.+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 45678999999999999999999964 579999999865442 2346777888888886 5788888888888888899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC---CCceEEeecCCc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLA 195 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~---~~~v~L~Dfg~~ 195 (360)
||+.+ |-+|.++.+- ..+.++...++.++-|++.-++|+|.++ ++||||||+|+|+.- ...+.|+|||++
T Consensus 89 VMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccch
Confidence 99998 7799988865 4578999999999999999999999999 999999999999954 357999999999
Q ss_pred cccCCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh
Q 018128 196 KLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 196 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
..+...... .......||..|.+-..+.+...+.+.|+-|+|.++.++--|..||....+....+..+.+....-
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 875544332 223446799999998888888889999999999999999999999986655544433332221111
Q ss_pred ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCC
Q 018128 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 331 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~ 331 (360)
...++ ..-..+|.++.-.+..|-...-++-|+..-+.+.+.-+.....+..
T Consensus 242 -s~~ie---------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~ 292 (341)
T KOG1163|consen 242 -STPIE---------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQY 292 (341)
T ss_pred -CCCHH---------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccC
Confidence 00000 1123567788888888999999999999888888777766555443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=192.12 Aligned_cols=170 Identities=18% Similarity=0.134 Sum_probs=129.9
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec--CCCEEEEEEcccCC-----ccchHHHHHHHHHhhccCCCcccceeEEE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~--~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~~p~i~~~~~~~ 110 (360)
+...+...+|++.+.||+|+||+||++.+. +++.+++|.+.... ......+.+|+++++.++|+|++..+..
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 345667889999999999999999999765 47778999865331 1224568899999999999999853322
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCcEEEeCCCceEE
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL-KSANILLDNDFNPKL 189 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di-~p~NIlv~~~~~v~L 189 (360)
....++||||+++++|.. +. ... ...++.+++.+|.+||+++ |+|||| ||+|||++.++.++|
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence 245799999999999963 21 111 1467899999999999999 999999 999999999999999
Q ss_pred eecCCccccCCCCCccee------ccccccccccccccccc
Q 018128 190 SDFGLAKLGPVGDNTHVS------TRVMGTYGYCAPEYAMS 224 (360)
Q Consensus 190 ~Dfg~~~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~ 224 (360)
+|||++............ ....++..|.+||.+..
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999865433211110 23456778999998763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-25 Score=212.39 Aligned_cols=254 Identities=20% Similarity=0.235 Sum_probs=187.8
Q ss_pred cccceeccCCCeEEEEEEec-CCCEEEEEEccc---C--Cccch-HHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 48 REANLIGEGGFGKVYKGRLE-SGQLVAIKQLNH---E--GLQGH-QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 48 ~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~---~--~~~~~-~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.....+|.|++|.|+.+... ..+.+..|.+.. . ..... ..+..|+.+-..+.|||++.....+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 57789999999988777543 333344443321 1 11111 12556777777889999988776665555555559
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|||++ +|..++. ....+...++..++.|++.|++|+|..| +.|+|+|++|++++.+|.+|++|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999994 3458999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCCc--ceecccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 201 GDNT--HVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 201 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~s-~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.... ......+|...|+|||+..+..|+ ...||||.|++++.|.+|+.||.............. ......
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-------~~~~~~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-------YSDQRN 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-------cccccc
Confidence 5554 555667899999999999998887 578999999999999999999975554332210000 000000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... .......++...+.+|.+||++||.+|.|+++|++
T Consensus 546 ~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 00123356778889999999999999999999984
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=176.74 Aligned_cols=173 Identities=13% Similarity=0.132 Sum_probs=134.4
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHH---------HHHHHHHhhccCCCcccceeEEEEe
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQE---------FIVEVLMLSLLHHDNLVTLIGYCTS 112 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~---------~~~e~~~l~~l~~p~i~~~~~~~~~ 112 (360)
+..++|++.++||.|++|.||++.. ++..+|+|++.......... +.+|+..+.+++||+|..+..++.+
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999866 47789999997654333322 5788889999999999999888653
Q ss_pred C--------CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 113 G--------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 113 ~--------~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
. ...+++|||++|.+|.++.. +++ ....+++.+|..+|..| ++|||++|.||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 3 35789999999999988741 222 34669999999999999 9999999999999998
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~ 245 (360)
| ++|+|||............ ..+....+..++|+|+||+++..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHHH
Confidence 8 9999999886431111110 02334456678999999999886654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-21 Score=177.53 Aligned_cols=262 Identities=33% Similarity=0.437 Sum_probs=197.5
Q ss_pred ccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCC-cccceeEEEEeCCeeEEEEEe
Q 018128 47 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHD-NLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p-~i~~~~~~~~~~~~~~lv~e~ 122 (360)
|++.+.||.|+|+.||.+... ..+++|.+...... ....+.+|...+..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 788999999999999999877 78899988765443 356788999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeecCCccccCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVG 201 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg~~~~~~~~ 201 (360)
+.++++.+++...... ..+.......++.|++.++.++|..+ ++|+|+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777442211 37999999999999999999999999 99999999999999988 7999999998743333
Q ss_pred CCcc----eeccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 202 DNTH----VSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 202 ~~~~----~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
.... ......++..|++||.+.+ ...+...|+|++|++++++++|..||...... ................
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTP 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCc
Confidence 3221 3456779999999999987 57889999999999999999999997543321 0000000000000000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002223678899999999999999999987764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=177.44 Aligned_cols=235 Identities=22% Similarity=0.314 Sum_probs=151.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccC----------CCcccceeEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH----------HDNLVTLIGYC 110 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~----------~p~i~~~~~~~ 110 (360)
..+..++.||.|+++.||.+.+. +++++++|++..... ...+.+++|......+. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 45677889999999999999876 599999998865542 23455666665554432 11233333332
Q ss_pred E---------eC---C-----eeEEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 018128 111 T---------SG---D-----QRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170 (360)
Q Consensus 111 ~---------~~---~-----~~~lv~e~~~~~sL~~~i~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 170 (360)
. .. . ..+++|+.+ .++|.+++..... ....+.....+.+..|++..+++||..| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 11 1 235778877 6688887644221 2223444555667799999999999999 99
Q ss_pred eCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceeccccccccccccccccc--------CCCCcchhhHHHHHHHHH
Q 018128 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--------GKLTLKSDIYSFGVVLLE 242 (360)
Q Consensus 171 H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~s~~sDiwslG~il~~ 242 (360)
|+||+|+|++++.+|.+.|+||+.....+. .... ...+..|.|||.... ..++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999988864221 1111 334577999997643 257889999999999999
Q ss_pred HHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCC
Q 018128 243 LITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 310 (360)
Q Consensus 243 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 310 (360)
|.++..||+.......... ...... +.++.+..||..+|+.||++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999985533221111 111223 788899999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=195.78 Aligned_cols=204 Identities=21% Similarity=0.229 Sum_probs=167.5
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccch---HHHHHHHHHhhccCCCcccceeEEEE
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHDNLVTLIGYCT 111 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~e~~~l~~l~~p~i~~~~~~~~ 111 (360)
-...++++.+..|.|-+.+|.|+||+||.|...+|+.||+|+-.....-+. .+++..++ . .--+.|+.+...+.
T Consensus 688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~--~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-P--QMLPSIMHISSAHV 764 (974)
T ss_pred CccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-h--hhhcchHHHHHHHc
Confidence 344677888999999999999999999999888799999998766644322 23333333 1 11345777777777
Q ss_pred eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-------C
Q 018128 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-------D 184 (360)
Q Consensus 112 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-------~ 184 (360)
-.+..++|++|.+.|||.+++. ..+.+++..+..++.|++..|..||..+ ||||||||+|+++.. .
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred cCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcc
Confidence 7788889999999999999995 6788999999999999999999999999 999999999999942 2
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 248 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~ 248 (360)
-.++|+|||.+.-.............+++..+--+|...|.+|+...|.|.|+.+++-|+.|..
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 3489999999875444444445555778999999999999999999999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=170.88 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=195.5
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
-++..+..+|.....|..|.++++ |..+++|++....... ...+.+|.-.|+.+.||||+.+++.+.....+.++..
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 345566778899999999999998 7778888876554332 2468889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEe--ecCCccccC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS--DFGLAKLGP 199 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~--Dfg~~~~~~ 199 (360)
|++.|+|.+.++. ..+--++..++..++.+++.++.|||+.. +-|.---|+...++++++.+.+|. |--++.+
T Consensus 268 ~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee--
Confidence 9999999999965 34445677888999999999999999985 223344588899999999876553 3222211
Q ss_pred CCCCcceecccccccccccccccccCCCC---cchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLT---LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s---~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
. .-..-.+.|++||.++..+-+ .++|+|||++++|||.|...||...... ..-.
T Consensus 343 --e-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm----------------ecgm 399 (448)
T KOG0195|consen 343 --E-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM----------------ECGM 399 (448)
T ss_pred --c-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch----------------hhhh
Confidence 1 112245679999999876543 6899999999999999999999643321 1112
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
++..+.++-..|+..+..+.+++.-|.+.||.+||.+..|+-.|++++
T Consensus 400 kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 400 KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 233334555678889999999999999999999999999999998864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=161.99 Aligned_cols=139 Identities=18% Similarity=0.120 Sum_probs=108.8
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc--c------------------------hHHHHHHHHHhhccCCCc
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--G------------------------HQEFIVEVLMLSLLHHDN 102 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~~p~ 102 (360)
+...||+|++|.||.|...+|+.||+|++...... . ......|+..++.+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 35789999999999998878999999998654211 1 012345999999998777
Q ss_pred ccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCcEEE
Q 018128 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL-HCKANPPVIYRDLKSANILL 181 (360)
Q Consensus 103 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~i~H~di~p~NIlv 181 (360)
+.....+.. ...++||||++++++..... ....++...+..++.|++.+|.++ |+.+ ++|+||||+||++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 644433322 22389999998877655432 245789999999999999999999 7888 9999999999999
Q ss_pred eCCCceEEeecCCccc
Q 018128 182 DNDFNPKLSDFGLAKL 197 (360)
Q Consensus 182 ~~~~~v~L~Dfg~~~~ 197 (360)
+ ++.++|+|||++..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-20 Score=155.80 Aligned_cols=140 Identities=19% Similarity=0.131 Sum_probs=110.7
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccCCccc--------------------------hHHHHHHHHHhhccCCCc
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--------------------------HQEFIVEVLMLSLLHHDN 102 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~~p~ 102 (360)
+.+.||+|++|+||++.+.+|+.||+|++....... ......|...+..+.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467899999999999987789999999987652110 112357889999999988
Q ss_pred ccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEE
Q 018128 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILL 181 (360)
Q Consensus 103 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv 181 (360)
+.....+... ..++||||++++++..... ....++...+..++.|++.++.++|. .| ++|+||||+||++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 7555444333 2489999998875543321 23457888999999999999999999 88 9999999999999
Q ss_pred eCCCceEEeecCCcccc
Q 018128 182 DNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 182 ~~~~~v~L~Dfg~~~~~ 198 (360)
+ ++.++|+|||++...
T Consensus 152 ~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 152 H-DGKPYIIDVSQAVEL 167 (190)
T ss_pred E-CCCEEEEEcccceec
Confidence 9 789999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=150.86 Aligned_cols=186 Identities=20% Similarity=0.143 Sum_probs=137.8
Q ss_pred cccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc----chHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEEEe
Q 018128 48 REANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ----GHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 48 ~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~----~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
-+...|++|+||+|+.+.. .+.+++.+.+.....- ....+.+|+++|+++. ++++++++++ +..+++|+|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4678999999999998776 5788887777654331 1225788999999995 5889998886 457899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCcEEEeCCCceEEeecCCccccCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL-KSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di-~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
+.|.+|.+... . ....++.|++.+|.++|++| ++|+|| +|+||+++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPP----R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhh----h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99988865431 1 11357889999999999999 999999 799999999999999999999854332
Q ss_pred CCc---ce--------ecccccccccccccccccC-CCC-cchhhHHHHHHHHHHHhCCCcccc
Q 018128 202 DNT---HV--------STRVMGTYGYCAPEYAMSG-KLT-LKSDIYSFGVVLLELITGRKAMDL 252 (360)
Q Consensus 202 ~~~---~~--------~~~~~~~~~y~aPE~~~~~-~~s-~~sDiwslG~il~~ll~g~~pf~~ 252 (360)
... .. ......++.|+.|+...-. ..+ ...+-++.|+.+|.++|+..++..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 210 00 0112245667777644322 233 567888999999999999887653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-21 Score=182.18 Aligned_cols=225 Identities=27% Similarity=0.345 Sum_probs=182.1
Q ss_pred eeccCCCeEEEEEEe----cCCCEEEEEEcccCCcc--chHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEEEecC
Q 018128 52 LIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~----~~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~e~~~ 124 (360)
++|.|.+|.|++++. +.+..+++|+..+.... .......|..++...+ ||.+++++..+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999999852 34788999987665322 1124455777777776 9999999999999999999999999
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
+++|...+ .....+.+..+..+...++-++..+|+.+ ++|+|+|++||+++.+|.+++.|||+.+..-....
T Consensus 81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99988877 34667888999999999999999999999 99999999999999999999999999875222111
Q ss_pred ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccccc
Q 018128 205 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH 284 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (360)
.+|+..|+|||++. ......|.||+|+++++|++|..||.. .....++. ..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~--~~ 203 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILK--AE 203 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhh--hc
Confidence 18999999999998 557899999999999999999999973 01111111 11
Q ss_pred CCCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 285 GRYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 285 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
..+|........+++..++..+|.+|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 23578889999999999999999999765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-20 Score=161.46 Aligned_cols=203 Identities=23% Similarity=0.206 Sum_probs=145.4
Q ss_pred CCCcccceeEEEEe---------------------------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHH
Q 018128 99 HHDNLVTLIGYCTS---------------------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151 (360)
Q Consensus 99 ~~p~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~ 151 (360)
+||||+.++.+|.+ ....|+||...+. +|..++. ....+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence 59999998776532 3357899998844 9999994 3556667777899
Q ss_pred HHHHHHHHHHHhCCCCCeeeCCCCCCcEEE--eCCC--ceEEeecCCccccCCCCCc----ceecccccccccccccccc
Q 018128 152 VGAARGLEYLHCKANPPVIYRDLKSANILL--DNDF--NPKLSDFGLAKLGPVGDNT----HVSTRVMGTYGYCAPEYAM 223 (360)
Q Consensus 152 ~qi~~al~~LH~~~~~~i~H~di~p~NIlv--~~~~--~v~L~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~ 223 (360)
.|+++|+.+||++| +.|+|+|.+|||+ ++++ .+.+.|||+|-......-. .-....-|+...+|||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999999 4443 5789999998642221111 1112234778899999987
Q ss_pred cCC------CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHH
Q 018128 224 SGK------LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVA 297 (360)
Q Consensus 224 ~~~------~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 297 (360)
..+ .-.++|.|+.|.+.||++....||.... +..+. .....+.--+ ..+..++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG---em~L~---------~r~Yqe~qLP----alp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG---EMLLD---------TRTYQESQLP----ALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc---hheec---------hhhhhhhhCC----CCcccCChHHHH
Confidence 432 1268999999999999999999996422 11100 1111111111 235678888999
Q ss_pred HHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 298 VTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 298 li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
++...|+.||.+|++..-....|.-....
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~LsLw~ 517 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLNLSLWR 517 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHHHHHhc
Confidence 99999999999999988776666554443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=169.25 Aligned_cols=219 Identities=27% Similarity=0.386 Sum_probs=166.6
Q ss_pred hhccCCCcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-eeCC
Q 018128 95 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV-IYRD 173 (360)
Q Consensus 95 l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i-~H~d 173 (360)
|+.+.|.|+.++++.+.+....++|.++|..|+|.+.+.. ....+++.....++++|+.|+.|+|..- + .||.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4567899999999999999999999999999999999976 5677999999999999999999999765 5 9999
Q ss_pred CCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccC-------CCCcchhhHHHHHHHHHHHhC
Q 018128 174 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-------KLTLKSDIYSFGVVLLELITG 246 (360)
Q Consensus 174 i~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~s~~sDiwslG~il~~ll~g 246 (360)
++..|.+++..-.+||+|||+.................-...|.|||.+.+. ..+.++||||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998764332222222233356679999988753 257889999999999999999
Q ss_pred CCcccccCccCcc-chhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 247 RKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 247 ~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
..||+........ .+... +.. .......+.+.. ......++..++.+||..+|.+||++..+...++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~----~~~--~~~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR----VKK--GGSNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHH----HHh--cCCCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999764433221 11111 110 011111111110 01444579999999999999999999999999988865
Q ss_pred cc
Q 018128 326 QR 327 (360)
Q Consensus 326 ~~ 327 (360)
..
T Consensus 227 ~~ 228 (484)
T KOG1023|consen 227 GG 228 (484)
T ss_pred cc
Confidence 43
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.2e-19 Score=148.45 Aligned_cols=137 Identities=19% Similarity=0.225 Sum_probs=106.8
Q ss_pred ccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhcc-----CCCcccceeEEEEeCC---eeE-
Q 018128 47 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-----HHDNLVTLIGYCTSGD---QRL- 117 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-----~~p~i~~~~~~~~~~~---~~~- 117 (360)
+.-.+.||+|+++.||. +......++|++..........+.+|+.+++.+ .||||++++++++++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467999999999995 443333479988765555567899999999999 5799999999998874 323
Q ss_pred EEEEe--cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeCCCCCCcEEEeC----CCceEEe
Q 018128 118 LVYEY--MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL-EYLHCKANPPVIYRDLKSANILLDN----DFNPKLS 190 (360)
Q Consensus 118 lv~e~--~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~~i~H~di~p~NIlv~~----~~~v~L~ 190 (360)
+|+|| +.+++|.+++.+ ..+++. ..++.+++.++ .|||+++ |+|+||||+||+++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 457899999943 346555 35678888777 9999999 999999999999974 3379999
Q ss_pred ecCCc
Q 018128 191 DFGLA 195 (360)
Q Consensus 191 Dfg~~ 195 (360)
|++.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-18 Score=144.46 Aligned_cols=134 Identities=22% Similarity=0.296 Sum_probs=112.2
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccc--------hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~--------~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.+.||+|++|.||.+.. .+..+++|+........ ...+.+|+.++..+.|+++.....++.+....+++||
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 36799999999999987 47789999765433211 2356789999999999998877777777788899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
|++|++|.+++... .. ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+.
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence 99999999998431 11 77889999999999999999 99999999999999 7889999999886
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-17 Score=145.40 Aligned_cols=143 Identities=17% Similarity=0.098 Sum_probs=110.5
Q ss_pred hhcccccceeccCCCeEEEEEE--ecCCCEEEEEEcccCCcc------------------------chHHHHHHHHHhhc
Q 018128 44 TRNFREANLIGEGGFGKVYKGR--LESGQLVAIKQLNHEGLQ------------------------GHQEFIVEVLMLSL 97 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~--~~~~~~v~vK~~~~~~~~------------------------~~~~~~~e~~~l~~ 97 (360)
+.-|++.+.||.|++|.||.|. ..+|+.|++|++...... ....+..|+..++.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4459999999999999999998 457999999988654211 01235679999999
Q ss_pred cCCC--cccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 018128 98 LHHD--NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 175 (360)
Q Consensus 98 l~~p--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~ 175 (360)
+.+. .+.+++.+ ...++|||++++.+|..... ....+....+..++.|++.++.+||+.|. ++|+||+
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik 176 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS 176 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence 8753 33444432 23589999999888766542 23445666778999999999999997753 9999999
Q ss_pred CCcEEEeCCCceEEeecCCccc
Q 018128 176 SANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 176 p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
|+||+++ ++.++|+|||.+..
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhc
Confidence 9999999 88999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-17 Score=137.82 Aligned_cols=142 Identities=20% Similarity=0.097 Sum_probs=110.8
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc----------------------chHHHHHHHHHhh
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ----------------------GHQEFIVEVLMLS 96 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~----------------------~~~~~~~e~~~l~ 96 (360)
++...+..|.+.+.||.|++|.||.+...+|+.+++|++...... .......|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444445569999999999999999998878999999987543210 0112566888888
Q ss_pred ccCCCc--ccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 018128 97 LLHHDN--LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 174 (360)
Q Consensus 97 ~l~~p~--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di 174 (360)
.+.+++ +...+. ....+++|||+++++|...... .....++.+++.++.++|..+ ++|+||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 887764 444433 2455899999999998765421 235678899999999999998 999999
Q ss_pred CCCcEEEeCCCceEEeecCCccc
Q 018128 175 KSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 175 ~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|.||+++.++.++|+|||.+..
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CcccEEEcCCCcEEEEECCcccc
Confidence 99999999999999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.4e-17 Score=137.43 Aligned_cols=130 Identities=25% Similarity=0.337 Sum_probs=105.4
Q ss_pred eeccCCCeEEEEEEecCCCEEEEEEcccCCcc--------chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 52 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~--------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
.||+|++|.||.+... +..+++|........ ....+.+|++++..+.++++.....++...+..+++||++
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4799999999999854 788999986543211 1245678999999998887665555555667778999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|++|.+++.. ... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998743 111 78999999999999999 99999999999999 78999999998863
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.9e-18 Score=166.17 Aligned_cols=212 Identities=26% Similarity=0.352 Sum_probs=145.8
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
......|..++.+.-|+||.||+++++ ..+++++| ++++...- ++ ++....+|.++
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil----Rn---ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL----RN---ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh----hc---cccccCCccee---------------
Confidence 344678999999999999999999887 47888884 43332111 11 22222344433
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|+=...+. .-+.++... +.+++|||+.+ |+|+|+||+|.+|+.-|.+|++|||+.+...
T Consensus 136 ------gDc~tllk----~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ------GDCATLLK----NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ------chhhhhcc----cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence 22223331 223444333 77899999998 9999999999999999999999999887522
Q ss_pred CCCCcce-------------ecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch
Q 018128 200 VGDNTHV-------------STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 200 ~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 266 (360)
....... ....++|+.|.|||++....|....|-|++|+|+|+++.|..||...-.+.. ..
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg 268 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FG 268 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hh
Confidence 2111111 1235899999999999999999999999999999999999999975422211 11
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 311 (360)
.+..+...+.+- -...+.+..++|.++|+.+|..|-
T Consensus 269 ~visd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 269 QVISDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 111111111111 124566789999999999999994
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.6e-18 Score=155.17 Aligned_cols=124 Identities=31% Similarity=0.420 Sum_probs=107.0
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
.+||.|++|...+|.+++...+ .....+....+.++.|++.++.| ++ .+|+|++|.||+...+..++|+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 4689999999999999996533 45667888899999999999999 77 99999999999999999999999999
Q ss_pred ccccCCCC----CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh
Q 018128 195 AKLGPVGD----NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245 (360)
Q Consensus 195 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~ 245 (360)
........ .........++..|++||.+.+..|+.+.|||+||+++++++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87543333 1223445779999999999999999999999999999999988
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=153.70 Aligned_cols=137 Identities=24% Similarity=0.290 Sum_probs=111.0
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--------cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
...|...+.||+|++|+||++..... .+++|+...... ...+.+.+|+++++.++|+++.....+..+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44567789999999999999987633 344443222111 112457889999999999999888777777777
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999883 34678999999999999999 9999999999999 5778999999998
Q ss_pred cc
Q 018128 196 KL 197 (360)
Q Consensus 196 ~~ 197 (360)
..
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 74
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-15 Score=130.87 Aligned_cols=135 Identities=24% Similarity=0.236 Sum_probs=103.6
Q ss_pred cceec-cCCCeEEEEEEecCCCEEEEEEcccCCc-------------cchHHHHHHHHHhhccCCCcc--cceeEEEEeC
Q 018128 50 ANLIG-EGGFGKVYKGRLESGQLVAIKQLNHEGL-------------QGHQEFIVEVLMLSLLHHDNL--VTLIGYCTSG 113 (360)
Q Consensus 50 ~~~Lg-~G~~g~v~~~~~~~~~~v~vK~~~~~~~-------------~~~~~~~~e~~~l~~l~~p~i--~~~~~~~~~~ 113 (360)
...|| .|+.|+||.++.. +..+++|.+..... .....+.+|+.++..+.|+++ +..+.+....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45676 7888889988876 77899998753211 123467889999999988775 6666654332
Q ss_pred C----eeEEEEEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 114 D----QRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 114 ~----~~~lv~e~~~~-~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
. ..++|+|++++ .+|.+++.. ..+++. .+.+|+.+|.+||+.| |+|+||+|.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 2 23599999987 689888843 345543 3678999999999999 99999999999999989999
Q ss_pred EeecCCccc
Q 018128 189 LSDFGLAKL 197 (360)
Q Consensus 189 L~Dfg~~~~ 197 (360)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.9e-17 Score=160.99 Aligned_cols=258 Identities=24% Similarity=0.277 Sum_probs=197.2
Q ss_pred HhhcccccceeccCCCeEEEEEEec--CCCEEEEEEcccCC--ccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~--~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~ 117 (360)
....|++.+.||+|+++.|-++... ....++.|.+.... ......+..|..+-+.+. |+|++.+++...+.+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5678999999999999999988653 34556666665543 222344555777777776 999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCcEEEeCCC-ceEEeecCCc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKANPPVIYRDLKSANILLDNDF-NPKLSDFGLA 195 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg~~ 195 (360)
++.++..++++.+.+.. ......+....-.++.|+..++.|+| ..+ +.|+||+|+|.+++..+ ..++.|||++
T Consensus 98 ~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence 99999999999888831 13335677778889999999999999 888 99999999999999999 9999999999
Q ss_pred cccCC-CCCcceeccccc-ccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 196 KLGPV-GDNTHVSTRVMG-TYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 196 ~~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
..+.. ..........+| +..|.|||...+. ...+..|+||.|+++..+++|..|++........ ...|... .
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~----~ 247 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN----K 247 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc----c
Confidence 87766 555555566778 9999999998874 5568899999999999999999999755533311 1111110 0
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ...............+++.+++..+|..|.+.+++-.
T Consensus 248 ~--------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 G--------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 0001112344556778889999999999999988763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-15 Score=126.24 Aligned_cols=135 Identities=21% Similarity=0.175 Sum_probs=96.9
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccCCccc--hHH----------------------HHHHHHHhhccCCC--c
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--HQE----------------------FIVEVLMLSLLHHD--N 102 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~~p--~ 102 (360)
+.+.||+|++|+||.+...+++.|++|++....... ... ...|...+..+.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467899999999999988789999999876542211 111 13455555555433 2
Q ss_pred ccceeEEEEeCCeeEEEEEecCCCCHHH-HhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEE
Q 018128 103 LVTLIGYCTSGDQRLLVYEYMPMGSLED-HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANIL 180 (360)
Q Consensus 103 i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIl 180 (360)
+.+++.. ...+++||+++++++.. .+.... . ......++.+++.++.++|. .+ ++|+||+|+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4444433 24589999998854321 111100 0 16678899999999999999 88 999999999999
Q ss_pred EeCCCceEEeecCCccc
Q 018128 181 LDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 181 v~~~~~v~L~Dfg~~~~ 197 (360)
++ ++.++|+|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 88999999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.4e-15 Score=119.82 Aligned_cols=134 Identities=22% Similarity=0.165 Sum_probs=111.9
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCC--CcccceeEEEEeCCeeEEEEEecCCC
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~--p~i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
+.+.|+.|.++.||.+.... ..+++|....... ...+..|...++.+++ +++++++.+....+..+++||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56789999999999999864 7899998865533 4678889999999975 58889888888778899999999886
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 127 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 127 sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++..+ +......++.+++.++..+|.....+++|+|++|.||+++..+.++++||+.+.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 66433 556667889999999999998633339999999999999998999999999886
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.6e-16 Score=134.69 Aligned_cols=202 Identities=26% Similarity=0.320 Sum_probs=143.7
Q ss_pred HHhhccCCCcccceeEEEEe-----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 018128 93 LMLSLLHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167 (360)
Q Consensus 93 ~~l~~l~~p~i~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ 167 (360)
..+-++-|.|+++++.|+.+ .....++.||+..|++..++++.+..+..+......+|+-||+.||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 34445568999999998754 3457899999999999999999888899999999999999999999999998 78
Q ss_pred CeeeCCCCCCcEEEeCCCceEEeecCCccccC---CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHH
Q 018128 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGP---VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 244 (360)
Q Consensus 168 ~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll 244 (360)
+++|+++..+.|++..+|-++++- +...... ............+.++|.+||.-.-...+-++|||++|+...+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999999998888742 1111000 011111223345788999999766666778999999999999998
Q ss_pred hCCCcccccCc--cCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 245 TGRKAMDLSKG--QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 245 ~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+..--..+.. ..+.+.. ..+.-+-+.+ -+.+|.+|++..|..||++.+++.
T Consensus 277 ilEiq~tnseS~~~~ee~ia----------~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA----------NVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhh----------hheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 87542110000 0000000 0000111111 235788999999999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.6e-13 Score=129.66 Aligned_cols=166 Identities=16% Similarity=0.159 Sum_probs=128.3
Q ss_pred ecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHH
Q 018128 66 LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN 145 (360)
Q Consensus 66 ~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~ 145 (360)
..++.++.++..............+-++.++.++||||+++++.++.+...|+|.|.+ ..|..++.+ +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------hHHH
Confidence 3457788888776554455567888999999999999999999999999999999987 367777744 3378
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccC
Q 018128 146 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225 (360)
Q Consensus 146 ~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (360)
.+..-+.||+.||.+||+.++ ++|++|....|+|+..|..+|++|..+........ ......-...|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 888899999999999985543 99999999999999999999999998764222111 12222334456667644322
Q ss_pred CCCcchhhHHHHHHHHHHHhC
Q 018128 226 KLTLKSDIYSFGVVLLELITG 246 (360)
Q Consensus 226 ~~s~~sDiwslG~il~~ll~g 246 (360)
. -..|.|.|||++++++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.5e-14 Score=131.36 Aligned_cols=257 Identities=25% Similarity=0.267 Sum_probs=189.1
Q ss_pred HHHhhcccccceecc--CCCeEEEEEEe--c-CCCEEEEEEcccC--CccchHHHHHHHHHhhccC-CCcccceeEEEEe
Q 018128 41 AIATRNFREANLIGE--GGFGKVYKGRL--E-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTS 112 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~--G~~g~v~~~~~--~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~ 112 (360)
......+.+.+.+|. |.+|.+|.+.. . ++..+++|.-... .......-.+|+...+.++ |++.++.+..+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 344567788899999 99999999976 3 5778888873332 2233445556777666664 8899998889999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeCCCCCCcEEEeCC-Cce
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIYRDLKSANILLDND-FNP 187 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~~i~H~di~p~NIlv~~~-~~v 187 (360)
.+..++-.|.+ +.+|..++.. ...-++...++..+.+... ||..+|..+ ++|-|++|.||+...+ ...
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred CCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccccee
Confidence 99999999999 5789898865 3345888899999999999 999999998 9999999999999988 789
Q ss_pred EEeecCCccccCCCCCcc---eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhcc
Q 018128 188 KLSDFGLAKLGPVGDNTH---VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 264 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 264 (360)
+++||++........-.. ......+...|++||.. +..++..+|+|++|.++.+..++.++....-
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~---------- 331 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK---------- 331 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC----------
Confidence 999999988655444222 22234678889999966 4566899999999999999988876543211
Q ss_pred chhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
...+.++-...+..++-..-...+...+..|+..+|..|++.+.+. .+.-|
T Consensus 332 -------~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i 382 (524)
T KOG0601|consen 332 -------NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVI 382 (524)
T ss_pred -------CCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh-ccccc
Confidence 0111111111222223333455566689999999999999988765 44444
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.3e-12 Score=112.18 Aligned_cols=267 Identities=17% Similarity=0.164 Sum_probs=169.3
Q ss_pred cccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEE------EEe-CCeeEEEE
Q 018128 48 REANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY------CTS-GDQRLLVY 120 (360)
Q Consensus 48 ~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~------~~~-~~~~~lv~ 120 (360)
..++.||+|+.+.+|..-.- ...+.|++..+......+...|+ -+.-.||-+-.-+.| .-+ .....+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45788999999999875322 22478888776544333322222 222246643321111 112 22367889
Q ss_pred EecCCCCHHHHhcc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 121 EYMPMGSLEDHLYD---LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 121 e~~~~~sL~~~i~~---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+.+.+..=-..+.+ .+.+-.-..+..++...++++.+...||..| .+-||++++|+||++++.|.|.|-+....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 98866432222322 1223344779999999999999999999999 99999999999999999999999776653
Q ss_pred cCCCCCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhC-CCcccccCccC------ccchhccc
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQG------EQNLVSWS 265 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g-~~pf~~~~~~~------~~~~~~~~ 265 (360)
. ..........+...|.+||... +...+..+|.|.||+++++++.| .+||....... +..+....
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2 3334444567889999999755 44567899999999999999886 89996443221 11111111
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhccc--CCCCCCCHHHHHHHHhhhhhcc
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNE--EANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
..+..+. . .-...+.. ...-.-.+..+..+..+|+.. ++.-|||++-|+..|..+..+.
T Consensus 244 f~ya~~~-~-~g~~p~P~-~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 244 FAYASDQ-R-RGLKPPPR-SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeechhc-c-CCCCCCCC-CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 1111110 0 00000000 000123455677777788774 4679999999999999887644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.5e-13 Score=124.36 Aligned_cols=139 Identities=22% Similarity=0.165 Sum_probs=96.2
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccch----------------------------------------HHHH
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH----------------------------------------QEFI 89 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~----------------------------------------~~~~ 89 (360)
.+.||.|++|+||.|+..+|+.||||+......... -.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999998999999998754311100 0133
Q ss_pred HHHHHhhccC-----CCcccceeEEE-EeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 018128 90 VEVLMLSLLH-----HDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-GLEYLH 162 (360)
Q Consensus 90 ~e~~~l~~l~-----~p~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~-al~~LH 162 (360)
+|...+..+. ++++ .+-.++ ......++||||++|.+|.++.... ..... ...++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHH
Confidence 4555555542 3332 222222 2334578999999999998876431 11122 2345555555 478889
Q ss_pred hCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 163 ~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
..| ++|+|++|.||+++.++.++++|||++...
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 888 999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-11 Score=113.70 Aligned_cols=216 Identities=18% Similarity=0.172 Sum_probs=157.5
Q ss_pred CeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEE----eCCeeEEEEEecCC-CCHHHH
Q 018128 58 FGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT----SGDQRLLVYEYMPM-GSLEDH 131 (360)
Q Consensus 58 ~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~----~~~~~~lv~e~~~~-~sL~~~ 131 (360)
..+.|++... +|..|++|+++............-+++++++.|+|++++.+++. .+..+++|++|.++ .+|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4578888655 79999999996665555556677889999999999999998875 35567899999875 467665
Q ss_pred hccc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 132 LYDL-----------EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 132 i~~~-----------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
.-.- ...+.+.++..+|.++.|+..||.++|+.| +.-.-|.+.+|+++++-+++|..+|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5331 224557889999999999999999999999 99999999999999999999999888765332
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
... |.+.+ -.+-|.=.||.+++.|.||..--.. ....... .
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~-----~d~~~~s---------~------ 486 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNR-----TDSTQSS---------H------ 486 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhccccccc-----ccchHHH---------H------
Confidence 220 10111 2467999999999999998532100 0000000 0
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
.......++.+++++|.-....++++ -++++++.+
T Consensus 487 ---~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 ---LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 00123567888888888888888887 578887764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.7e-12 Score=105.95 Aligned_cols=130 Identities=18% Similarity=0.087 Sum_probs=95.9
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcc-cceeEEEEeCCeeEEEEEecCCCCH
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i-~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
.+.|+.|..+.||.++.. ++.+++|+...... .......|+.+++.+...++ .+++... ....++|||++++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467889999999999876 78899998765432 22346778888888864443 4455443 3345799999999776
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
.+.- .....++.+++.+|..||..+ ...++|||++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5320 111346789999999999886 11249999999999999 6689999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.8e-11 Score=100.22 Aligned_cols=135 Identities=15% Similarity=0.064 Sum_probs=97.3
Q ss_pred cceeccCCCeEEEEEEecC-------CCEEEEEEcccCCc----------------------cchHHH----HHHHHHhh
Q 018128 50 ANLIGEGGFGKVYKGRLES-------GQLVAIKQLNHEGL----------------------QGHQEF----IVEVLMLS 96 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~-------~~~v~vK~~~~~~~----------------------~~~~~~----~~e~~~l~ 96 (360)
...||.|..+.||.+...+ +..+|+|++..... .....+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999997542 57899997642100 011223 37999999
Q ss_pred ccCC--CcccceeEEEEeCCeeEEEEEecCCCCHHH-HhcccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeC
Q 018128 97 LLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSLED-HLYDLEPDQEPLSWNTRMKIAVGAARGLEYL-HCKANPPVIYR 172 (360)
Q Consensus 97 ~l~~--p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~i~~~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~~i~H~ 172 (360)
++.. -+++.++.+ ...++|||++.+..+.. .+ ....++......+..+++.++..+ |+.+ ++||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8853 355666654 56779999996543321 12 122345566778889999999998 8888 9999
Q ss_pred CCCCCcEEEeCCCceEEeecCCccc
Q 018128 173 DLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 173 di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
||++.||+++ ++.+.|+||+.+..
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCcee
Confidence 9999999997 46899999998874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.6e-11 Score=96.75 Aligned_cols=143 Identities=20% Similarity=0.239 Sum_probs=108.7
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc--------chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~--------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
...++-+|+.+.|+.+... |+.+++|.-...... ...+..+|.+++.++.--+|.-..-++.+....+++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5778999999999998887 888888854433222 2345777999988886556666566677777888999
Q ss_pred EecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC---ceEEeecCCcc
Q 018128 121 EYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAK 196 (360)
Q Consensus 121 e~~~~-~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~---~v~L~Dfg~~~ 196 (360)
||+++ .++.+++.... ...........++..|-+.|..||..+ ++||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 48888886633 222233334789999999999999998 99999999999996554 35899999987
Q ss_pred c
Q 018128 197 L 197 (360)
Q Consensus 197 ~ 197 (360)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.6e-12 Score=122.99 Aligned_cols=144 Identities=17% Similarity=0.153 Sum_probs=95.4
Q ss_pred hhcccccceeccCCCeEEEEEEecC-CCEEEEEEcccCCcc---------------------------------c-hH--
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQ---------------------------------G-HQ-- 86 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~---------------------------------~-~~-- 86 (360)
...|.. +.||.|++|+||.|+..+ |+.||||+..+.-.. + ..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 446776 899999999999999876 999999998654110 0 01
Q ss_pred ----HHHHHHHHhhccC----CCcccceeEEEEe-CCeeEEEEEecCCCCHHHHhc--ccCCCCCCCCHHHHHHHHHHHH
Q 018128 87 ----EFIVEVLMLSLLH----HDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAA 155 (360)
Q Consensus 87 ----~~~~e~~~l~~l~----~p~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~i~--~~~~~~~~l~~~~~~~i~~qi~ 155 (360)
.+.+|...+.++. +...+.+-.++.+ ....++||||++|+++.++-. ........+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1333444444442 3333443344332 456679999999999987431 1110111244444444555553
Q ss_pred HHHHHHHhCCCCCeeeCCCCCCcEEEeCCC----ceEEeecCCcccc
Q 018128 156 RGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDFGLAKLG 198 (360)
Q Consensus 156 ~al~~LH~~~~~~i~H~di~p~NIlv~~~~----~v~L~Dfg~~~~~ 198 (360)
..| ++|+|++|.||+++.+| .++++|||++...
T Consensus 278 -------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 -------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 477 99999999999999887 9999999998754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.1e-10 Score=94.34 Aligned_cols=131 Identities=24% Similarity=0.305 Sum_probs=102.0
Q ss_pred ceeccCCCeEEEEEEecCCCEEEEEEcccCCccc--------hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~--------~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
..+.+|+-+.++.+... |.++++|.=.+..... ..+-.+|..++..+.--+|.-..-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999665 5557888544433221 23466799998888765666656566677778899999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
++|-.|.+++... ...++..+-..+..||..| |+||||.++||.+..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998999898542 1467888888899999999 99999999999998875 99999999873
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-10 Score=100.71 Aligned_cols=142 Identities=20% Similarity=0.237 Sum_probs=108.5
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCc-cchHHHHHHHHHhhccCC--CcccceeEEEEeCC---eeEEEEEec
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGD---QRLLVYEYM 123 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~--p~i~~~~~~~~~~~---~~~lv~e~~ 123 (360)
.+.|+.|..+.+|++...+|+.+++|....... .....+..|+++++.+.+ ..+.+++.+..... ..++|||++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 367899999999999877678999998765432 234578889999999865 34677777765532 568999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-------------------------------------- 165 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------- 165 (360)
+|.++.+.+. ...++......++.+++.+|..||+..
T Consensus 83 ~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9988766552 135677777778888888888888521
Q ss_pred ---------------CCCeeeCCCCCCcEEEeC--CCceEEeecCCcc
Q 018128 166 ---------------NPPVIYRDLKSANILLDN--DFNPKLSDFGLAK 196 (360)
Q Consensus 166 ---------------~~~i~H~di~p~NIlv~~--~~~v~L~Dfg~~~ 196 (360)
...++|||+++.||+++. ++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 124899999999999988 5668999999886
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.4e-10 Score=95.29 Aligned_cols=147 Identities=19% Similarity=0.118 Sum_probs=109.4
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc----------------------cchHHHHHHH
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL----------------------QGHQEFIVEV 92 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~----------------------~~~~~~~~e~ 92 (360)
+-...+...+.=+.++..||-|.-+.||.+....|.++++|.-..-.. .......+|.
T Consensus 81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf 160 (304)
T COG0478 81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF 160 (304)
T ss_pred HHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence 334444455556788999999999999999999999999996432111 0123467899
Q ss_pred HHhhccCCC--cccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 018128 93 LMLSLLHHD--NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170 (360)
Q Consensus 93 ~~l~~l~~p--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 170 (360)
++|..+... .+++.+++ +...+|||+++|..|...- +.......++..|+.-+..+-..| ++
T Consensus 161 ~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iV 224 (304)
T COG0478 161 EALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IV 224 (304)
T ss_pred HHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---cc
Confidence 999998644 67777755 6778999999886553322 133444556666777677777788 99
Q ss_pred eCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 171 YRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 171 H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
|||+++-||+++++|.+.++||-.+..
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCccccc
Confidence 999999999999999999999987763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.5e-11 Score=111.01 Aligned_cols=246 Identities=20% Similarity=0.193 Sum_probs=172.3
Q ss_pred HhhcccccceeccCCCeEEEEEEe--cCCCEEEEEEcccCCccchHHH--HHHHHHhhccC-CCcccceeEEEEeCCeeE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRL--ESGQLVAIKQLNHEGLQGHQEF--IVEVLMLSLLH-HDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~--~~~~~v~vK~~~~~~~~~~~~~--~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~ 117 (360)
-..+|..+..||.|.++.|+.+.. .++..|++|.....-.....++ ..|+.+...+. |.+++.....+...+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 346888999999999999998753 3577899998766544433332 33555555553 777777666666666777
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-CceEEeecCCcc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAK 196 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-~~v~L~Dfg~~~ 196 (360)
+=.|||+++++...+ .....+.+...+.+..|++.++.++|+.. ++|+|++|.||++..+ +..+++||++..
T Consensus 343 ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 889999998887766 24566788889999999999999999999 9999999999999776 677899999986
Q ss_pred ccCCCCCcceecccccccccc--cccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYC--APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
....... .......+. +++......+..+.|+++||..+.+..++..--.. ...
T Consensus 416 ~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------------------~~~ 471 (524)
T KOG0601|consen 416 RLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------------------GVQ 471 (524)
T ss_pred ccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcc-------------------ccc
Confidence 4221111 112233344 45555567788999999999999999997642110 000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
+..+... .. ...+.....+..+.+.++..++..||.+.++....+
T Consensus 472 ~~~i~~~-~~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 472 SLTIRSG-DT-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ceeeecc-cc-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0011000 00 012233467788889999999999999988765443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.2e-09 Score=92.83 Aligned_cols=140 Identities=18% Similarity=0.132 Sum_probs=98.1
Q ss_pred ceeccCCCeEEEEEEecCCCEEEEEEcccCCcc-----------chHHHHHHHHHhhccCCCcc--cceeEEEEe-----
Q 018128 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-----------GHQEFIVEVLMLSLLHHDNL--VTLIGYCTS----- 112 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~-----------~~~~~~~e~~~l~~l~~p~i--~~~~~~~~~----- 112 (360)
+.+-......|+.+..+ |+.|.+|........ ......+|...+..+..-+| +.+..+.+.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34443333446666554 788999977443311 11136788888887743333 344444433
Q ss_pred CCeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-------C
Q 018128 113 GDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-------D 184 (360)
Q Consensus 113 ~~~~~lv~e~~~~~-sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-------~ 184 (360)
....++|+|++++. +|.+++.... ....+......++.+++..+..||..| ++|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23568999999875 8999885422 234567778899999999999999999 999999999999975 4
Q ss_pred CceEEeecCCcc
Q 018128 185 FNPKLSDFGLAK 196 (360)
Q Consensus 185 ~~v~L~Dfg~~~ 196 (360)
..+.|+||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 679999999885
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.6e-11 Score=118.05 Aligned_cols=252 Identities=21% Similarity=0.176 Sum_probs=172.1
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEccc---CCccchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNH---EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~---~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
.+..-+.+.+.+.+..|.++.++.++-. .|.-...|+... -...+...+..+-..+-...+|.++....-+.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 4567788899999999999999998643 343333333221 111222233333333322344555544433445567
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++++++..+++|...+++ -+..+.......+..+..++++||... +.|+|++|.|.+...++..+++||+..
T Consensus 879 ~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred cchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccc
Confidence 7899999999999998855 335666677778888999999999987 999999999999999999999999733
Q ss_pred cccCCC----C-------------------------CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhC
Q 018128 196 KLGPVG----D-------------------------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246 (360)
Q Consensus 196 ~~~~~~----~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g 246 (360)
...... . .........+++.|.+||...+......+|.|++|+++++.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 211110 0 00112234688999999999999999999999999999999999
Q ss_pred CCcccccCccCccchhccchhhhhccccchhcccccccC-CCChhhHHHHHHHHhhhcccCCCCCCCHH
Q 018128 247 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG-RYPRRCLNYAVAVTAMCLNEEANFRPLIN 314 (360)
Q Consensus 247 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 314 (360)
..||+....+... +.+.+..... ..+...+.+..+++.+.+..+|.+|..+.
T Consensus 1032 ~pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999744332211 1111111110 12445667788999999999999998776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.3e-09 Score=88.22 Aligned_cols=124 Identities=23% Similarity=0.179 Sum_probs=81.5
Q ss_pred EEEEEEecCCCEEEEEEcccCCc-------------c-------------chHHHHHHHHHhhccCCC--cccceeEEEE
Q 018128 60 KVYKGRLESGQLVAIKQLNHEGL-------------Q-------------GHQEFIVEVLMLSLLHHD--NLVTLIGYCT 111 (360)
Q Consensus 60 ~v~~~~~~~~~~v~vK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~~p--~i~~~~~~~~ 111 (360)
.||.|...+|..+|+|+...... . ......+|++.|..+..- ++++++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999888899999998743210 0 012366799999999755 466666542
Q ss_pred eCCeeEEEEEecC--CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 112 SGDQRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY-LHCKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 112 ~~~~~~lv~e~~~--~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
...+||||++ |..+..+... .++......++.+++..+.. +|..| ++|||+++.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 4469999998 6555544422 11134456677788774444 67888 9999999999999988 999
Q ss_pred EeecCCccc
Q 018128 189 LSDFGLAKL 197 (360)
Q Consensus 189 L~Dfg~~~~ 197 (360)
++|||.+..
T Consensus 147 iIDf~qav~ 155 (188)
T PF01163_consen 147 IIDFGQAVD 155 (188)
T ss_dssp E--GTTEEE
T ss_pred EEecCccee
Confidence 999998874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.3e-10 Score=106.07 Aligned_cols=149 Identities=20% Similarity=0.279 Sum_probs=104.7
Q ss_pred HHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCccee-------cccccccccccccccccC
Q 018128 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-------TRVMGTYGYCAPEYAMSG 225 (360)
Q Consensus 153 qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~ 225 (360)
+++.|+.++|..-+ +||++|.|++|.++..+..||+.|+.+............ ........|.|||.+.+.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44488999997643 999999999999999999999999988643221111111 112345679999999998
Q ss_pred CCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcc
Q 018128 226 KLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLN 304 (360)
Q Consensus 226 ~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 304 (360)
..+.++|+||+|+.+|.+.. |..-+...+.... .......+......++...+.++.+=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--------------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcch--------------hhhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 88999999999999999984 4444432211110 11111112222223456788899999999999
Q ss_pred cCCCCCCCHHHHH
Q 018128 305 EEANFRPLINDIV 317 (360)
Q Consensus 305 ~dp~~Rpt~~eil 317 (360)
.++..||++.+++
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999877765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.1e-07 Score=79.66 Aligned_cols=136 Identities=17% Similarity=0.157 Sum_probs=100.1
Q ss_pred ccCCCeEEEEEEecCCCEEEEEEcccCC------ccchHHHHHHHHHhhccCCC--cccceeEEEE-e----CCeeEEEE
Q 018128 54 GEGGFGKVYKGRLESGQLVAIKQLNHEG------LQGHQEFIVEVLMLSLLHHD--NLVTLIGYCT-S----GDQRLLVY 120 (360)
Q Consensus 54 g~G~~g~v~~~~~~~~~~v~vK~~~~~~------~~~~~~~~~e~~~l~~l~~p--~i~~~~~~~~-~----~~~~~lv~ 120 (360)
++||-+.|+....+ |+.+-+|.-...- .-....+.+|+..++.+..- .++++. ++. . ....+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 56888889998777 4478888765211 12456788999999988522 245544 222 1 22357999
Q ss_pred EecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc--eEEeecCCcc
Q 018128 121 EYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSDFGLAK 196 (360)
Q Consensus 121 e~~~~-~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~--v~L~Dfg~~~ 196 (360)
|.+++ .+|.+++.+. .-.+.+......++.+++.+|..||+.| +.|+|+.+.||+++.++. |.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97743 5888887441 1235677888899999999999999999 999999999999986677 9999998765
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.7e-08 Score=80.66 Aligned_cols=138 Identities=14% Similarity=0.111 Sum_probs=93.1
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHH---------HHHHHHhhcc---CCCcccceeEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEF---------IVEVLMLSLL---HHDNLVTLIGY 109 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~---------~~e~~~l~~l---~~p~i~~~~~~ 109 (360)
+..++|++.+++-......|.+.+.+ |+.+++|............+ .+.+..+..+ ..-....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45789999999999888888888777 78899998766543322221 2233333333 22222232222
Q ss_pred E-----EeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 110 C-----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 110 ~-----~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
. ......+++|||++|..|.++.. +++ .+...+.+++..+|+.| +.|||.+|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 2 22234568999999987765431 222 24566778899999999 9999999999999865
Q ss_pred CceEEeecCCcc
Q 018128 185 FNPKLSDFGLAK 196 (360)
Q Consensus 185 ~~v~L~Dfg~~~ 196 (360)
+ ++++||+...
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 4 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=6e-08 Score=82.59 Aligned_cols=122 Identities=24% Similarity=0.205 Sum_probs=89.3
Q ss_pred CCEEEEEEcccCCc-------cchHHHHHHHHHhhccCCC--cccceeEEEEeCC----eeEEEEEecCCC-CHHHHhcc
Q 018128 69 GQLVAIKQLNHEGL-------QGHQEFIVEVLMLSLLHHD--NLVTLIGYCTSGD----QRLLVYEYMPMG-SLEDHLYD 134 (360)
Q Consensus 69 ~~~v~vK~~~~~~~-------~~~~~~~~e~~~l~~l~~p--~i~~~~~~~~~~~----~~~lv~e~~~~~-sL~~~i~~ 134 (360)
++.+.+|.....-. -......+|...+..+..- .++.++.+.+... ..++|+|.+++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 56677775432211 1234677788877777432 2445555554422 357999999874 79998854
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC---ceEEeecCCccc
Q 018128 135 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAKL 197 (360)
Q Consensus 135 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~---~v~L~Dfg~~~~ 197 (360)
. ...+......++.+++..+..||..| ++|+|+++.|||++.++ .+.|+||+-+..
T Consensus 112 ~----~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 112 W----EQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred h----cccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 2 22666778899999999999999999 99999999999998887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.8e-07 Score=89.36 Aligned_cols=140 Identities=19% Similarity=0.170 Sum_probs=92.1
Q ss_pred ceeccCCCeEEEEEEecCCCEEEEEEcccCCccc----------------------------------------hHHHHH
Q 018128 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG----------------------------------------HQEFIV 90 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~----------------------------------------~~~~~~ 90 (360)
+.|+.++-|+||.|+..+|+.||||+..+.-... +-.+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6889999999999999999999999876531110 001334
Q ss_pred HHHHhhccC-----CCcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 018128 91 EVLMLSLLH-----HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165 (360)
Q Consensus 91 e~~~l~~l~-----~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ 165 (360)
|...+.++. .|++.-..-+.+-.....++|||++|..+.+.... ....++...+...+.++. +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 555555442 33332222233344566799999999888887432 123444333333222221 23333356
Q ss_pred CCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 166 ~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
+.|+|.+|.||+++.+|++.+.|||.....
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999999999999999999998753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.6e-07 Score=76.25 Aligned_cols=139 Identities=14% Similarity=0.113 Sum_probs=85.2
Q ss_pred ceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCC--cccceeEEEEeCCeeEEEEEecCCCC-
Q 018128 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD--NLVTLIGYCTSGDQRLLVYEYMPMGS- 127 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p--~i~~~~~~~~~~~~~~lv~e~~~~~s- 127 (360)
+.++.|..+.||.. .+..+++|...... ....+.+|.++++.+..- .+.+++.+..+.+...++|++++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 67899999999973 25568899876532 345678899999888532 25777888777788889999998863
Q ss_pred HHHHh---------------------cccCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHhC-CCCCeeeCCC
Q 018128 128 LEDHL---------------------YDLEPDQEPLSWNTRMKIAV----------GAAR-GLEYLHCK-ANPPVIYRDL 174 (360)
Q Consensus 128 L~~~i---------------------~~~~~~~~~l~~~~~~~i~~----------qi~~-al~~LH~~-~~~~i~H~di 174 (360)
+.... +........++.. ...+.. .+.. ...+|... ..+.++|||+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100011111100 000000 0001 01111111 1234899999
Q ss_pred CCCcEEEeCCCceEEeecCCcc
Q 018128 175 KSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 175 ~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.6e-07 Score=75.57 Aligned_cols=150 Identities=19% Similarity=0.134 Sum_probs=100.8
Q ss_pred cHHHHHHHhhcccccce---eccCCCeEEEEEEecCCCEEEEEEcccCCcc-------------------c-----hHHH
Q 018128 36 TFRELAIATRNFREANL---IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-------------------G-----HQEF 88 (360)
Q Consensus 36 ~~~~~~~~~~~y~i~~~---Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~-------------------~-----~~~~ 88 (360)
+.+.+.-...+..+... |+.|..+.||.|...++..+|+|++...... . ..-.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34455555566666665 4568888999999888999999987543111 0 0114
Q ss_pred HHHHHHhhccC--CCcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 018128 89 IVEVLMLSLLH--HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KA 165 (360)
Q Consensus 89 ~~e~~~l~~l~--~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ 165 (360)
..|+..|+++. +=.+++.+.+.. -.+|||++... ..-.-. -+...+...+...+..+++..+..|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~--g~pAP~--LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDD--GLPAPR--LKDVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCC--CCCCCC--cccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 46888888774 334555555543 34999998442 100000 012223333677788888888888887 66
Q ss_pred CCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 166 ~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||+||+.-|||+. ++.+.++|++.+..
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccc
Confidence 99999999999999 88999999998864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.5e-06 Score=73.84 Aligned_cols=144 Identities=21% Similarity=0.247 Sum_probs=83.1
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCC--cccceeEEE---EeCCeeEEEEEecC
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD--NLVTLIGYC---TSGDQRLLVYEYMP 124 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p--~i~~~~~~~---~~~~~~~lv~e~~~ 124 (360)
++.|+.|..+.||.+...+ ..+++|..... .....+..|..+++.+... .+.+++... ......+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4688999999999999886 69999987554 3456777888888887422 355666543 23335689999999
Q ss_pred CCCHHH----------------Hhc---ccCCCCCCCCHHH------HHHH---------------HHHHHH-HHHHHHh
Q 018128 125 MGSLED----------------HLY---DLEPDQEPLSWNT------RMKI---------------AVGAAR-GLEYLHC 163 (360)
Q Consensus 125 ~~sL~~----------------~i~---~~~~~~~~l~~~~------~~~i---------------~~qi~~-al~~LH~ 163 (360)
+.++.. .+. ............. .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887776 111 1100111111000 0000 111222 2333332
Q ss_pred ----CCCCCeeeCCCCCCcEEEe-CCCceEEeecCCcc
Q 018128 164 ----KANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK 196 (360)
Q Consensus 164 ----~~~~~i~H~di~p~NIlv~-~~~~v~L~Dfg~~~ 196 (360)
.....++|||+.|.||+++ +++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1123399999999999999 66667899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.1e-06 Score=72.73 Aligned_cols=141 Identities=18% Similarity=0.115 Sum_probs=85.2
Q ss_pred eeccCCC-eEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEEEecCCCCHH
Q 018128 52 LIGEGGF-GKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLE 129 (360)
Q Consensus 52 ~Lg~G~~-g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 129 (360)
.|..|.. +.||.+... +..+++|+..... ...+..|+++++.+. +--+.+++.+....+..++||++++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4455555 788998765 4789999876543 345677888888774 344667777777666789999999987776
Q ss_pred HHhc-------------------ccCCCCCCCCHH--HHHHH-----------------------HHHHHHHHHHHH-hC
Q 018128 130 DHLY-------------------DLEPDQEPLSWN--TRMKI-----------------------AVGAARGLEYLH-CK 164 (360)
Q Consensus 130 ~~i~-------------------~~~~~~~~l~~~--~~~~i-----------------------~~qi~~al~~LH-~~ 164 (360)
.... ........+... ..... ..++...|.... ..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 100001111100 00000 111111111111 01
Q ss_pred CCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 165 ~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
..+.++|||+.|.||++++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12349999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.44 E-value=9.2e-06 Score=68.22 Aligned_cols=134 Identities=22% Similarity=0.236 Sum_probs=94.5
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccCC----------------ccchHHHHHHHHHhhccC------CCcccce
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEG----------------LQGHQEFIVEVLMLSLLH------HDNLVTL 106 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~----------------~~~~~~~~~e~~~l~~l~------~p~i~~~ 106 (360)
-...||+|+.-.||. +.++...+||+..... .....+..+|+..+..+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999998887 5556678899887665 122345556666555554 7789999
Q ss_pred eEEEEeCCeeEEEEEecCC------CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 107 IGYCTSGDQRLLVYEYMPM------GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 107 ~~~~~~~~~~~lv~e~~~~------~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
+++.+++....+|+|.+.. -||.+++. ...+++ ...+.+.++ ..+|-+.+ |+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEE
Confidence 9999999999999997632 36888883 345665 445555554 66777777 999999999999
Q ss_pred EeCC--C--ceEEee-cCCcc
Q 018128 181 LDND--F--NPKLSD-FGLAK 196 (360)
Q Consensus 181 v~~~--~--~v~L~D-fg~~~ 196 (360)
+... + .+.|+| ||...
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EEecCCCceEEEEEeCCCCcc
Confidence 9433 2 466666 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.5e-05 Score=64.41 Aligned_cols=130 Identities=19% Similarity=0.204 Sum_probs=94.2
Q ss_pred cccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCccc-ceeEEEEeCCeeEEEEEecC
Q 018128 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV-TLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~-~~~~~~~~~~~~~lv~e~~~ 124 (360)
..++.+.|++|..|.||++.+. +..+++|+-..+. ....+..|.++|..+.--++- +++.+.. .++.|||++
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~ 95 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID 95 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence 4456789999999999999988 5688888765553 346778899998888755443 3444432 336699998
Q ss_pred CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC-CCcEEEeCCCceEEeecCCcc
Q 018128 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK-SANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 125 ~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~-p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
|-.|.++... . + .+-+..++++-..|-..| |-|+.|. |...++.+++.+.|+||..++
T Consensus 96 G~~L~~~~~~-----~--~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 96 GRPLGKLEIG-----G--D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred Ccchhhhhhc-----c--c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 8888776621 1 1 345566777777777788 9999997 555556566699999999887
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=76.72 Aligned_cols=138 Identities=22% Similarity=0.189 Sum_probs=88.3
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccc-------------------------------------hHHHHHHH
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG-------------------------------------HQEFIVEV 92 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~-------------------------------------~~~~~~e~ 92 (360)
-+.|+....|+|+.|+.++|+.||||+-.+.-... +-.+..|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36899999999999999999999999865431100 00133344
Q ss_pred HHhhcc----CCCc------ccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 018128 93 LMLSLL----HHDN------LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162 (360)
Q Consensus 93 ~~l~~l----~~p~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 162 (360)
+...++ .|-+ |++++. +-.....++|||++|..+.+.-.- ....++...+..-+.+.. +..+-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~--~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAY--LEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHH--HHHHH
Confidence 433333 2333 333332 223566799999999877654322 234456554444333332 23334
Q ss_pred hCCCCCeeeCCCCCCcEEEeC----CCceEEeecCCccc
Q 018128 163 CKANPPVIYRDLKSANILLDN----DFNPKLSDFGLAKL 197 (360)
Q Consensus 163 ~~~~~~i~H~di~p~NIlv~~----~~~v~L~Dfg~~~~ 197 (360)
..| ++|+|=+|.||+++. ++.+.+.|||+...
T Consensus 319 ~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 319 KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred hcC---CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 456 999999999999983 56799999999874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.4e-05 Score=79.28 Aligned_cols=78 Identities=17% Similarity=0.265 Sum_probs=57.0
Q ss_pred cceeccCCCeEEEEEEecCC---CEEEEEEcccCCc-cchHHHHHHHHHhhccC-CCcc--cceeEEEEeC---CeeEEE
Q 018128 50 ANLIGEGGFGKVYKGRLESG---QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLH-HDNL--VTLIGYCTSG---DQRLLV 119 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~---~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~-~p~i--~~~~~~~~~~---~~~~lv 119 (360)
.+.++.|..+.+|++....+ ..+++|+...... .....+.+|+.+++.+. |+++ .+++.++.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57788899999999876643 4788887654322 23457889999999985 6654 6777776654 457899
Q ss_pred EEecCCCC
Q 018128 120 YEYMPMGS 127 (360)
Q Consensus 120 ~e~~~~~s 127 (360)
||+++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.1e-06 Score=74.04 Aligned_cols=144 Identities=16% Similarity=0.070 Sum_probs=102.9
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc----------------------chHHHHHHHHH
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ----------------------GHQEFIVEVLM 94 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~----------------------~~~~~~~e~~~ 94 (360)
.+++.--+.-+.+++.||-|.-+.+|.+-+.+|++.++|....-.+. ..-...+|+..
T Consensus 84 lktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 84 LKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred HHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 33444444568899999999999999999999999999965332111 01124567777
Q ss_pred hhccCC--CcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 018128 95 LSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172 (360)
Q Consensus 95 l~~l~~--p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~ 172 (360)
++.+.. --+++.+ +.+..++||+.+++.+|.+.-+- . ....+...+...|..|..+| ++||
T Consensus 164 mkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v-------~---d~~~ly~~lm~~Iv~la~~G---lIHg 226 (465)
T KOG2268|consen 164 MKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV-------E---DPPTLYDDLMGLIVRLANHG---LIHG 226 (465)
T ss_pred HHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeec-------C---ChHHHHHHHHHHHHHHHHcC---ceec
Confidence 777742 1244444 34678899999988887554311 1 12345566666688888888 9999
Q ss_pred CCCCCcEEEeCCCceEEeecCCccc
Q 018128 173 DLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 173 di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
|++-=||++++++.++++||-.+..
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ccchheeEEecCCCEEEeechHhhc
Confidence 9999999999999999999987654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00022 Score=59.56 Aligned_cols=104 Identities=29% Similarity=0.321 Sum_probs=80.5
Q ss_pred HHHHHHhhccCC-CcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 018128 89 IVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167 (360)
Q Consensus 89 ~~e~~~l~~l~~-p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~ 167 (360)
.+|.-+++.+++ ++++++++.+ ..+++.|+...+++....... ..-...++....+++.+++..+.+|+..-.+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888875 6999999998 345899999766553210000 1223468999999999999999999986545
Q ss_pred CeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 168 ~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
.+.-+|++++|+-++++++++++|.+.+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 599999999999999999999999987753
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00032 Score=65.39 Aligned_cols=76 Identities=20% Similarity=0.193 Sum_probs=54.2
Q ss_pred cceeccCCCeEEEEEEecCC-CEEEEEEcccC------C-ccchHHHHHHHHHhhccC---CCcccceeEEEEeCCeeEE
Q 018128 50 ANLIGEGGFGKVYKGRLESG-QLVAIKQLNHE------G-LQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~-~~v~vK~~~~~------~-~~~~~~~~~e~~~l~~l~---~p~i~~~~~~~~~~~~~~l 118 (360)
.+.||.|..+.||.+...+| +.++||.-... . ....++...|.+.|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46789999999999998766 58999985421 1 123456777888888763 2356777766 4466789
Q ss_pred EEEecCCCC
Q 018128 119 VYEYMPMGS 127 (360)
Q Consensus 119 v~e~~~~~s 127 (360)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00017 Score=65.05 Aligned_cols=80 Identities=16% Similarity=0.105 Sum_probs=58.0
Q ss_pred cccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCC---CcccceeEEEEe---CCeeEEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH---DNLVTLIGYCTS---GDQRLLV 119 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~---p~i~~~~~~~~~---~~~~~lv 119 (360)
.-.-.+.|+.|..+.||.....++ .+++|... . ......+..|...++.+.- -.+.++++++.+ .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMAR-S-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEec-c-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 444467899999999999977655 47777742 2 1233578889999988852 367888877654 3568999
Q ss_pred EEecCCCCH
Q 018128 120 YEYMPMGSL 128 (360)
Q Consensus 120 ~e~~~~~sL 128 (360)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999988654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.8e-05 Score=67.09 Aligned_cols=140 Identities=14% Similarity=0.025 Sum_probs=77.9
Q ss_pred eeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcc-cceeEEEEeCCeeEEEEEecCCCCHHH
Q 018128 52 LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMGSLED 130 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i-~~~~~~~~~~~~~~lv~e~~~~~sL~~ 130 (360)
.+..|-.+.+|.+... ++.+++|........-......|..+++.+..-++ .+++... . .++|+++++|.++..
T Consensus 3 ~~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHP-GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEeC-CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 4556778899988744 67899997654322211235678888888853323 3444332 2 368999998866432
Q ss_pred H-----------------hcccCCCCCCCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCCeeeCCCCCCc
Q 018128 131 H-----------------LYDLEPDQEPLSWN-TRMKIAVGA---------ARGLEYLHCK-----ANPPVIYRDLKSAN 178 (360)
Q Consensus 131 ~-----------------i~~~~~~~~~l~~~-~~~~i~~qi---------~~al~~LH~~-----~~~~i~H~di~p~N 178 (360)
. ++.......+++.. .+..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111111122211 111111111 1111212111 01239999999999
Q ss_pred EEEeCCCceEEeecCCccc
Q 018128 179 ILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~ 197 (360)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.05 E-value=7.5e-05 Score=64.99 Aligned_cols=74 Identities=14% Similarity=0.154 Sum_probs=46.1
Q ss_pred cceeccCCCe-EEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCC---cccceeEEEEeC---CeeEEEEEe
Q 018128 50 ANLIGEGGFG-KVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD---NLVTLIGYCTSG---DQRLLVYEY 122 (360)
Q Consensus 50 ~~~Lg~G~~g-~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p---~i~~~~~~~~~~---~~~~lv~e~ 122 (360)
++.++.|+.. .||.+ +..+++|..... .....+..|.+.++.+... -+..++...... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 4567777665 58876 235788875432 2345788899999877521 244444433322 234789999
Q ss_pred cCCCCHH
Q 018128 123 MPMGSLE 129 (360)
Q Consensus 123 ~~~~sL~ 129 (360)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9887663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.9e-05 Score=78.07 Aligned_cols=195 Identities=21% Similarity=0.182 Sum_probs=133.6
Q ss_pred HHHHHHHhhccCCCcccceeEEEEeCCeeE----EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 018128 88 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRL----LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163 (360)
Q Consensus 88 ~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~----lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~ 163 (360)
..-|+..+....|+|+..++.|........ +..+++...++...++ +-..++...++.+..++++++.++|.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 344667777788999999998875543332 4456777777777773 46678999999999999999999998
Q ss_pred CCCCCeeeCCCCCC---cEEEeCCCceEEe--ecCCccccCCCCCcceecccccccccccccccccCCCC--cchhhHHH
Q 018128 164 KANPPVIYRDLKSA---NILLDNDFNPKLS--DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT--LKSDIYSF 236 (360)
Q Consensus 164 ~~~~~i~H~di~p~---NIlv~~~~~v~L~--Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s--~~sDiwsl 236 (360)
.. +.|.-+... +.-++.++.+..+ ||+....+....... ....+..+.+||.......+ ...|+|++
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 86 666655554 4445666677766 888877543322222 22345557778776655544 45799999
Q ss_pred HHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHH
Q 018128 237 GVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316 (360)
Q Consensus 237 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ei 316 (360)
|.....+..|..+-.... ....++ +......+.++..+|+..++++|+++.++
T Consensus 379 gll~~~~~~~~~i~~~~~-------------------~~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-------------------VPVSLL--------DVLSTSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCccccccc-------------------chhhhh--------ccccchhhhhhhhhhcchhhhhccchhhh
Confidence 999999988765432111 001111 11112257788899999999999999999
Q ss_pred HHH
Q 018128 317 VVA 319 (360)
Q Consensus 317 l~~ 319 (360)
+..
T Consensus 432 l~~ 434 (1351)
T KOG1035|consen 432 LTH 434 (1351)
T ss_pred hhc
Confidence 964
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00017 Score=62.74 Aligned_cols=74 Identities=18% Similarity=0.156 Sum_probs=48.2
Q ss_pred cceeccCCCeEEEEEEecC--CCEEEEEEcccCCccchHHHHHHHHHhhccCCCc-ccceeEEEEeCCeeEEEEEecCCC
Q 018128 50 ANLIGEGGFGKVYKGRLES--GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~-i~~~~~~~~~~~~~~lv~e~~~~~ 126 (360)
.+.|..|-...+|++...+ ++.|++|+.... .........|+.+++.+...+ .++++.... ..++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~-~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK-TELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC-ccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 4567778888999998764 678999977543 222223456888888875333 344443332 24899999887
Q ss_pred CH
Q 018128 127 SL 128 (360)
Q Consensus 127 sL 128 (360)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 65
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.5e-07 Score=84.09 Aligned_cols=188 Identities=18% Similarity=0.107 Sum_probs=129.2
Q ss_pred hcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCc-ccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~-i~~~~~~~~~~~~~~lv~e~~ 123 (360)
+-|....-+++++++++++.+.-..+....+.+... ....-++++|.+++||| .+..++-++.++...+.++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 334445566888888888765443333334444333 56677999999999999 555555556667778999998
Q ss_pred CCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 124 PMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 124 ~~~-sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
..+ +....+. .....+.+-+...+++.-+.+++++|+.- =+|+| ||+..+ +.++.+||+....+....
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 665 2222111 12223444455566777778899999775 58887 666555 678999999887543332
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 251 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~ 251 (360)
......+++.++|||+.....+...-|.|++|.--.++.-|.+|-.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3445678999999999999999999999999987777777777654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0002 Score=64.60 Aligned_cols=143 Identities=18% Similarity=0.134 Sum_probs=82.1
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCc--ccceeE------EEEeCCeeEEEEE
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIG------YCTSGDQRLLVYE 121 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~--i~~~~~------~~~~~~~~~lv~e 121 (360)
.+.+..|....+|.+...+ ..+++|+... .....+..|+.+++.+..-+ +.+++. +....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987664 4799998764 23455667777777764222 344432 2233456789999
Q ss_pred ecCCCCHHH----Hh----------cc----cCCCC---CCCCHHHH----------HHHHHHHHHHHHHHHhC----CC
Q 018128 122 YMPMGSLED----HL----------YD----LEPDQ---EPLSWNTR----------MKIAVGAARGLEYLHCK----AN 166 (360)
Q Consensus 122 ~~~~~sL~~----~i----------~~----~~~~~---~~l~~~~~----------~~i~~qi~~al~~LH~~----~~ 166 (360)
+++|.++.. .. +. +.... ....+... ......+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865421 00 00 01000 00000000 00111122334444431 11
Q ss_pred CCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 167 ~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 239999999999999998777899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0011 Score=60.13 Aligned_cols=160 Identities=18% Similarity=0.180 Sum_probs=87.8
Q ss_pred cccHHHHHHHhhcccc-----cceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCc--ccce
Q 018128 34 SFTFRELAIATRNFRE-----ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTL 106 (360)
Q Consensus 34 ~~~~~~~~~~~~~y~i-----~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~--i~~~ 106 (360)
..+.+.+.-.-.+|.+ .+.++.|....+|.++..++ .+++|+..... ....+..|..++..+...+ +.++
T Consensus 6 ~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~ 82 (307)
T TIGR00938 6 SVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKP 82 (307)
T ss_pred cCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3445555555556655 45666777789999876644 68889875431 2344556667666663211 3333
Q ss_pred eEE------EEeCCeeEEEEEecCCCCHH-----------HH---hcc----cCCCCC---CCC-HHHHH----------
Q 018128 107 IGY------CTSGDQRLLVYEYMPMGSLE-----------DH---LYD----LEPDQE---PLS-WNTRM---------- 148 (360)
Q Consensus 107 ~~~------~~~~~~~~lv~e~~~~~sL~-----------~~---i~~----~~~~~~---~l~-~~~~~---------- 148 (360)
+.. ....+..++++++++|..+. .. ++. +..... ..+ +....
T Consensus 83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l 162 (307)
T TIGR00938 83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQL 162 (307)
T ss_pred ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhccccc
Confidence 321 12345678999999875431 00 011 100000 000 00000
Q ss_pred --HHHHHHHHHHHHHHh----CCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 149 --KIAVGAARGLEYLHC----KANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 149 --~i~~qi~~al~~LH~----~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
.....+...+.++.. .-...++|+|+++.||++++++.+.++||+.+.
T Consensus 163 ~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 163 EAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001122334444432 112339999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00083 Score=61.28 Aligned_cols=89 Identities=9% Similarity=0.014 Sum_probs=51.5
Q ss_pred ccHHHHHHHhhcccc-----cceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCC--ccccee
Q 018128 35 FTFRELAIATRNFRE-----ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD--NLVTLI 107 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i-----~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p--~i~~~~ 107 (360)
++..++.-.-.+|.+ .+.+..|....+|.+...+| .+++|++.. ...+.+..|+..++.+... .+.+++
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 444555444456655 34566677788999987655 689998762 1223344455555544211 133333
Q ss_pred E------EEEeCCeeEEEEEecCCCC
Q 018128 108 G------YCTSGDQRLLVYEYMPMGS 127 (360)
Q Consensus 108 ~------~~~~~~~~~lv~e~~~~~s 127 (360)
. +....+..++++++++|..
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~ 108 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKW 108 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCC
Confidence 2 2233566789999998864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00042 Score=57.94 Aligned_cols=125 Identities=26% Similarity=0.407 Sum_probs=88.6
Q ss_pred hcccccceeccCCC-eEEEEEEecCCCEEEEEEccc---CCc------------------cchHHHHHHHHHhhccC---
Q 018128 45 RNFREANLIGEGGF-GKVYKGRLESGQLVAIKQLNH---EGL------------------QGHQEFIVEVLMLSLLH--- 99 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~-g~v~~~~~~~~~~v~vK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 99 (360)
..++.++.||.|.. |.||+++.. |+.||+|++.. ... .....+..|.+++.+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 89999999999999 999999998 77999999321 111 01124677888877774
Q ss_pred CCcc--cceeEEEEeC------------------CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHH
Q 018128 100 HDNL--VTLIGYCTSG------------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159 (360)
Q Consensus 100 ~p~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~ 159 (360)
+.+. +++++|..-. ....||.|+.+... .+ ...-+.+|++-+.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHHHHHHH
Confidence 4455 8888887322 01246677664422 11 2335667788888
Q ss_pred HHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 160 ~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+|..| |+-+|+++.|.. .=+|+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 999999 999999999976 4478899864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.002 Score=58.90 Aligned_cols=79 Identities=14% Similarity=0.103 Sum_probs=50.4
Q ss_pred eeccCCCeEEEEEEecCC-CEEEEEEcccC------C-ccchHHHHHHHHHhhccC--CC-cccceeEEEEeCCeeEEEE
Q 018128 52 LIGEGGFGKVYKGRLESG-QLVAIKQLNHE------G-LQGHQEFIVEVLMLSLLH--HD-NLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~~~-~~v~vK~~~~~------~-~~~~~~~~~e~~~l~~l~--~p-~i~~~~~~~~~~~~~~lv~ 120 (360)
.+|.|-...||.+....+ +.++||.-..- + .-...+...|.+.|+... .| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 468888999999987654 68999964311 1 223456667888887663 45 45555533 556667999
Q ss_pred EecCC-CCHHHHh
Q 018128 121 EYMPM-GSLEDHL 132 (360)
Q Consensus 121 e~~~~-~sL~~~i 132 (360)
|+++. ..|.+.+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 98843 3343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0017 Score=58.59 Aligned_cols=139 Identities=19% Similarity=0.218 Sum_probs=88.3
Q ss_pred cccceeccCCCeEEEEEEecCCCEEEEEEccc--CCccchHHHHHHHHHhhccCC--CcccceeEEEEeCC--eeEEEEE
Q 018128 48 REANLIGEGGFGKVYKGRLESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGD--QRLLVYE 121 (360)
Q Consensus 48 ~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~--~~~~~~~~~~~e~~~l~~l~~--p~i~~~~~~~~~~~--~~~lv~e 121 (360)
.+.+....|.-..+|..... ++.++++ ... ..........+|+..++.+.- --+...+..+.++. ..++||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 34444444444455555544 8889999 332 233445667788888887742 23444566665555 6799999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHH-HHHHHHHHHHHhCC-----------------------------------
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKA----------------------------------- 165 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~-~qi~~al~~LH~~~----------------------------------- 165 (360)
+++|..+.+.... .... .+.+ ..++..|..||+..
T Consensus 106 ~veGe~~~~~~~~-----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 106 WVEGEVVWSALPP-----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EecceeccCcCCc-----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 9988544332211 0111 1222 36666666677521
Q ss_pred --------------------CCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 166 --------------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 166 --------------------~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
.+.++|||+++.|+++++++.+-+.||+.+..
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 13599999999999999998899999999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0012 Score=58.91 Aligned_cols=76 Identities=20% Similarity=0.299 Sum_probs=48.3
Q ss_pred ccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC---CCcccceeEEEEeCCeeEEEEEec
Q 018128 47 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
-+-.+.++.|..+.+|.+. .+++.+.+|.-.. .....+..|..-|+.+. .-.+++++.+....+..++++|++
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678889999999988 4488899998662 22356777888877773 446788898888878889999999
Q ss_pred CCC
Q 018128 124 PMG 126 (360)
Q Consensus 124 ~~~ 126 (360)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0014 Score=59.27 Aligned_cols=74 Identities=20% Similarity=0.202 Sum_probs=47.9
Q ss_pred ceeccCCCeEEEEEEecC-------CCEEEEEEcccCCccchHHHHHHHHHhhccCCCc-ccceeEEEEeCCeeEEEEEe
Q 018128 51 NLIGEGGFGKVYKGRLES-------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~-i~~~~~~~~~~~~~~lv~e~ 122 (360)
+.|..|-...+|.+...+ ++.+++|+..... .......+|+++++.+...+ ..+++..+.. .+|+++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667778999987654 5789999865542 33345677888888775322 3445544432 368898
Q ss_pred cCCCCHH
Q 018128 123 MPMGSLE 129 (360)
Q Consensus 123 ~~~~sL~ 129 (360)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 8876653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0034 Score=58.52 Aligned_cols=74 Identities=16% Similarity=0.112 Sum_probs=51.4
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccCCc-------cchHHHHHHHHHhhccC--C-CcccceeEEEEeCCeeEE
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL-------QGHQEFIVEVLMLSLLH--H-DNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~-------~~~~~~~~e~~~l~~l~--~-p~i~~~~~~~~~~~~~~l 118 (360)
..+.||.|....||++... +..++||.-..... -...+...|...|+.+. . ..+++++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3667899999999999875 56799997542111 13345566677777664 2 37777887766 55678
Q ss_pred EEEecCC
Q 018128 119 VYEYMPM 125 (360)
Q Consensus 119 v~e~~~~ 125 (360)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999966
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0016 Score=59.01 Aligned_cols=140 Identities=19% Similarity=0.147 Sum_probs=93.4
Q ss_pred cccceeccCCCeEEEEEEecCCCEEEEEEcccC-----Ccc-----------------ch----HHHHHHHHHhhccCCC
Q 018128 48 REANLIGEGGFGKVYKGRLESGQLVAIKQLNHE-----GLQ-----------------GH----QEFIVEVLMLSLLHHD 101 (360)
Q Consensus 48 ~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~-----~~~-----------------~~----~~~~~e~~~l~~l~~p 101 (360)
.+...|..|.-+.||.|...+|..+|||++.-. +.. .. --...|...|++++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 344578889999999999888999999986321 000 01 1245688888888766
Q ss_pred cccceeEEEEeCCeeEEEEEecCCCCH-HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 102 NLVTLIGYCTSGDQRLLVYEYMPMGSL-EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 102 ~i~~~~~~~~~~~~~~lv~e~~~~~sL-~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
+|.-..-+.. ....+||+++....- .-.+ ....++...+..+-.+++.-+..|-+... +||.||.--|+|
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~L 297 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLL 297 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhhe
Confidence 6543332222 234599999843211 0111 34456666777777888777777766543 999999999998
Q ss_pred EeCCCceEEeecCCccc
Q 018128 181 LDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 181 v~~~~~v~L~Dfg~~~~ 197 (360)
+.+ |.+.++|-+.+..
T Consensus 298 yhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 298 YHD-GKLYIIDVSQSVE 313 (520)
T ss_pred EEC-CEEEEEEcccccc
Confidence 865 4888999887753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00093 Score=56.27 Aligned_cols=119 Identities=15% Similarity=0.085 Sum_probs=74.1
Q ss_pred CCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHHHHhccc
Q 018128 56 GGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL 135 (360)
Q Consensus 56 G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~ 135 (360)
++.++.-.++.+-|..+.-|+...+..-....+++++.++.++. +|+++..- +.....++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------- 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------
Confidence 44555555554444444444444443324456788888888775 46666522 34456799999844110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 136 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 136 ~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
... .++..=+.+|..+|+. ++..+|||..|+||+.+..|.+||.|-++..
T Consensus 142 ------~~~----N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll 191 (308)
T PF07387_consen 142 ------NFS----NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL 191 (308)
T ss_pred ------chh----HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh
Confidence 000 1111224567788855 3349999999999999999999999988654
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.013 Score=54.50 Aligned_cols=74 Identities=18% Similarity=0.151 Sum_probs=50.6
Q ss_pred cceeccCCCeEEEEEEecC-CCEEEEEEcccC-----C-ccchHHHHHHHHHhhccC--CC-cccceeEEEEeCCeeEEE
Q 018128 50 ANLIGEGGFGKVYKGRLES-GQLVAIKQLNHE-----G-LQGHQEFIVEVLMLSLLH--HD-NLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~-----~-~~~~~~~~~e~~~l~~l~--~p-~i~~~~~~~~~~~~~~lv 119 (360)
.+.||.|-...||.+...+ ++.++||.-..- + .-..++...|.+.|+... .| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5678999999999998753 568999964221 1 233467777888888764 45 45555543 45666789
Q ss_pred EEecCC
Q 018128 120 YEYMPM 125 (360)
Q Consensus 120 ~e~~~~ 125 (360)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998843
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.17 E-value=3.9e-05 Score=80.08 Aligned_cols=159 Identities=14% Similarity=0.012 Sum_probs=113.9
Q ss_pred HHHHHhhccCCCcccceeEEEE--eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 018128 90 VEVLMLSLLHHDNLVTLIGYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-- 165 (360)
Q Consensus 90 ~e~~~l~~l~~p~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-- 165 (360)
.|...++...|+++...+.-.. +....+.+++++.+|.+.+.+..--.+.+.+.+..+.....+.+....-+|...
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444444556777665444332 233457889999999999998664334445555555555555477777777654
Q ss_pred CCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh
Q 018128 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245 (360)
Q Consensus 166 ~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~ 245 (360)
++-.+|.++++-|.++..+.+|+++++|+.+.... .........+++-|+.|++.....++.++|+|..|+-+|....
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 33489999999999999999999999999883211 1122233456778999999999999999999999999999988
Q ss_pred CCCcc
Q 018128 246 GRKAM 250 (360)
Q Consensus 246 g~~pf 250 (360)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 88776
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0067 Score=54.06 Aligned_cols=30 Identities=33% Similarity=0.483 Sum_probs=25.4
Q ss_pred CeeeCCCCCCcEEEeCCCc-eEEeecCCccc
Q 018128 168 PVIYRDLKSANILLDNDFN-PKLSDFGLAKL 197 (360)
Q Consensus 168 ~i~H~di~p~NIlv~~~~~-v~L~Dfg~~~~ 197 (360)
.++|||++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997565 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.015 Score=52.74 Aligned_cols=28 Identities=25% Similarity=0.277 Sum_probs=24.9
Q ss_pred CeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 168 PVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 168 ~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 3999999999999988 678999999775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.02 Score=52.75 Aligned_cols=142 Identities=15% Similarity=0.175 Sum_probs=78.7
Q ss_pred cceeccCCCeEEEEEEecC-----CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcc-cceeEEEEeCCeeEEEEEec
Q 018128 50 ANLIGEGGFGKVYKGRLES-----GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i-~~~~~~~~~~~~~~lv~e~~ 123 (360)
.+.|..|-...+|++...+ ++.+++|+...... ..-.-..|..+++.+..-++ .++++.+... .|.+|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3455557778999986432 46899998765432 22223668888887753333 3455554332 578888
Q ss_pred CCCCHHHH-----------------hcccCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHHH---hC
Q 018128 124 PMGSLEDH-----------------LYDLEPDQE--PLSWNTRMKIAVGA-----------------ARGLEYLH---CK 164 (360)
Q Consensus 124 ~~~sL~~~-----------------i~~~~~~~~--~l~~~~~~~i~~qi-----------------~~al~~LH---~~ 164 (360)
++.+|... +++...... ......+..++.++ ...+..|. ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 76555311 111110111 11123333333222 11111121 11
Q ss_pred -C-CCCeeeCCCCCCcEEEeC-CCceEEeecCCcc
Q 018128 165 -A-NPPVIYRDLKSANILLDN-DFNPKLSDFGLAK 196 (360)
Q Consensus 165 -~-~~~i~H~di~p~NIlv~~-~~~v~L~Dfg~~~ 196 (360)
. ...++|+|+++.||++++ ++.+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 224999999999999986 4679999998875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.018 Score=52.29 Aligned_cols=29 Identities=17% Similarity=0.206 Sum_probs=27.0
Q ss_pred CeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 168 PVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 168 ~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||+|+.+.|+++++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 49999999999999999999999999886
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0068 Score=51.67 Aligned_cols=29 Identities=38% Similarity=0.455 Sum_probs=21.1
Q ss_pred CeeeCCCCCCcEEE-eCCCceEEeecCCcc
Q 018128 168 PVIYRDLKSANILL-DNDFNPKLSDFGLAK 196 (360)
Q Consensus 168 ~i~H~di~p~NIlv-~~~~~v~L~Dfg~~~ 196 (360)
.++|+|+.+.||++ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 49999999999999 888999999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.073 Score=56.23 Aligned_cols=161 Identities=20% Similarity=0.223 Sum_probs=87.5
Q ss_pred ccccHHHH-HHHhhccccc---ceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhcc-------CCC
Q 018128 33 RSFTFREL-AIATRNFREA---NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-------HHD 101 (360)
Q Consensus 33 ~~~~~~~~-~~~~~~y~i~---~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-------~~p 101 (360)
..++..++ .+..+.|-+. +.|+ |..-.+|++...+++.+++|+.+... .......|...+..+ ..|
T Consensus 9 p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP 85 (1013)
T PRK06148 9 PEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVP 85 (1013)
T ss_pred CCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcC
Confidence 33555554 4556777664 4554 55688899988888899999987653 223334444455433 233
Q ss_pred ccccee-----EEEEe-CC--eeEEEEEecCCCCHHHHhc---------------------ccCC--CCCCCCH------
Q 018128 102 NLVTLI-----GYCTS-GD--QRLLVYEYMPMGSLEDHLY---------------------DLEP--DQEPLSW------ 144 (360)
Q Consensus 102 ~i~~~~-----~~~~~-~~--~~~lv~e~~~~~sL~~~i~---------------------~~~~--~~~~l~~------ 144 (360)
.+++.. ..... +. ..+-+++|++|..+.+... .+.. ....+.|
T Consensus 86 ~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~ 165 (1013)
T PRK06148 86 RLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAG 165 (1013)
T ss_pred eeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccch
Confidence 333321 11111 11 4567899999877654110 0110 0011111
Q ss_pred -----------HHHHHHHHHHHHHHH-----HHHhCCCCCeeeCCCCCCcEEEeCCC--ceE-EeecCCccc
Q 018128 145 -----------NTRMKIAVGAARGLE-----YLHCKANPPVIYRDLKSANILLDNDF--NPK-LSDFGLAKL 197 (360)
Q Consensus 145 -----------~~~~~i~~qi~~al~-----~LH~~~~~~i~H~di~p~NIlv~~~~--~v~-L~Dfg~~~~ 197 (360)
...+.++.+++.... .+... ...++|+|+++.||+++.++ .+. |+|||-+..
T Consensus 166 ~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 166 RARDRLHFIDDPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred hhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 111222333333222 12211 12299999999999998775 565 999998763
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.022 Score=52.20 Aligned_cols=142 Identities=17% Similarity=0.196 Sum_probs=76.3
Q ss_pred cceeccCCCeEEEEEEecC----CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcc-cceeEEEEeCCeeEEEEEecC
Q 018128 50 ANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMP 124 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i-~~~~~~~~~~~~~~lv~e~~~ 124 (360)
.+.|..|=...+|.+...+ +..|++|+..... ...-.-.+|..+++.+..-++ .+++.++. +. +|.+|++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~ 93 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-DYVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFIN 93 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-CeEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeehhhc
Confidence 3455557778889886542 3479999876542 222233568888887754333 34554442 22 5788886
Q ss_pred CCCHHH-----------H------hcccCCCCC--CCCHHHHHHHHHHH-------------------------HHHHHH
Q 018128 125 MGSLED-----------H------LYDLEPDQE--PLSWNTRMKIAVGA-------------------------ARGLEY 160 (360)
Q Consensus 125 ~~sL~~-----------~------i~~~~~~~~--~l~~~~~~~i~~qi-------------------------~~al~~ 160 (360)
+.+|.. . ++....... .-.+..+..++.++ +..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 655421 0 111110111 11122222222221 111222
Q ss_pred HH-hCC-CCCeeeCCCCCCcEEEeC-CCceEEeecCCcc
Q 018128 161 LH-CKA-NPPVIYRDLKSANILLDN-DFNPKLSDFGLAK 196 (360)
Q Consensus 161 LH-~~~-~~~i~H~di~p~NIlv~~-~~~v~L~Dfg~~~ 196 (360)
+. ..+ ...++|+|+.+.||++++ ++.++++||..+.
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 22 111 123899999999999975 4789999998875
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.11 Score=47.55 Aligned_cols=95 Identities=16% Similarity=0.076 Sum_probs=55.6
Q ss_pred cccccHHHHHHHhhccccc---c-eeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCc--ccc
Q 018128 32 ARSFTFRELAIATRNFREA---N-LIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVT 105 (360)
Q Consensus 32 ~~~~~~~~~~~~~~~y~i~---~-~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~--i~~ 105 (360)
-..++...+.-+-..+-+. + ..-.+....||.+...++..+++|+.... .....++..|+..+..+.... ++.
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3445555555555544332 1 12224567799998888889999988533 234566777888777663211 222
Q ss_pred ee---E--EEEeCCeeEEEEEecCCCC
Q 018128 106 LI---G--YCTSGDQRLLVYEYMPMGS 127 (360)
Q Consensus 106 ~~---~--~~~~~~~~~lv~e~~~~~s 127 (360)
.. + +...+...+.++++++|..
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 11 1 1233456788999987653
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.051 Score=46.38 Aligned_cols=77 Identities=25% Similarity=0.329 Sum_probs=53.7
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhcc---CCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL---HHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l---~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
..+.+..|.....|.+.+. ..++.+|.-.. .....+..|+.-|..+ +.-.+.+++.+..+..+.|+|++|++-
T Consensus 20 er~~v~gG~inea~~v~dg-~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~ 95 (286)
T COG3001 20 EREEVSGGDINEAWRLRDG-TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT 95 (286)
T ss_pred cccccCCccccceeEeecC-CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence 3445666666777776665 56788886432 2334566666666655 446788889888999999999999987
Q ss_pred CCHH
Q 018128 126 GSLE 129 (360)
Q Consensus 126 ~sL~ 129 (360)
+.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 6554
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.066 Score=48.84 Aligned_cols=137 Identities=22% Similarity=0.335 Sum_probs=80.6
Q ss_pred CCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCc------ccce----eEEEEeCCeeEEEEEecCCC
Q 018128 57 GFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN------LVTL----IGYCTSGDQRLLVYEYMPMG 126 (360)
Q Consensus 57 ~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~------i~~~----~~~~~~~~~~~lv~e~~~~~ 126 (360)
....+|.+...+|+. ++|+.... ....++..|+..+..+.-.+ +... +.........+-++++++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 556789998886766 99988766 45567788888888773111 1111 11122223778899999887
Q ss_pred CHHH-------------------HhcccC----CCCCCCCHH-------------HHHHHHHHHHHHHHHHHhCC-----
Q 018128 127 SLED-------------------HLYDLE----PDQEPLSWN-------------TRMKIAVGAARGLEYLHCKA----- 165 (360)
Q Consensus 127 sL~~-------------------~i~~~~----~~~~~l~~~-------------~~~~i~~qi~~al~~LH~~~----- 165 (360)
.+.. ....+. .......+. .-.....++...+..+...-
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 6652 001111 000011111 00112334444444444321
Q ss_pred CCC--eeeCCCCCCcEEEeCCCc-eEEeecCCcc
Q 018128 166 NPP--VIYRDLKSANILLDNDFN-PKLSDFGLAK 196 (360)
Q Consensus 166 ~~~--i~H~di~p~NIlv~~~~~-v~L~Dfg~~~ 196 (360)
..+ +||+|+.|.||+++.+.. +-++||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 112 899999999999999885 8899999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.067 Score=48.80 Aligned_cols=104 Identities=19% Similarity=0.179 Sum_probs=66.1
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..|++|++. |+++ ..+ ......++..++++.+..+.-+..+- ++-|+|+...||+++ +|+|.|+||-+
T Consensus 300 y~yl~~kdh-gt~i-s~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPI-SII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Ccee-eee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 446777764 4343 323 22456778888888887777776542 389999999999999 99999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHH
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 238 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~ 238 (360)
++.. ...... .....-.|-.+.|.. +.+-|||-+--
T Consensus 368 sRl~--~~q~~i-----sy~rldhp~lF~G~d-d~QFeIYrlMr 403 (488)
T COG5072 368 SRLS--YSQGII-----SYNRLDHPDLFNGVD-DYQFEIYRLMR 403 (488)
T ss_pred eecc--cCCcee-----eccccCchhhhcCcc-ceeeeHHHHHH
Confidence 9841 122211 112233444444332 56667776533
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.035 Score=52.78 Aligned_cols=51 Identities=25% Similarity=0.347 Sum_probs=39.7
Q ss_pred cchHHHHHHHHHhhccCCCcccceeEEEEe-CCeeEEEEEecCCCCHHHHhcc
Q 018128 83 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYD 134 (360)
Q Consensus 83 ~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~i~~ 134 (360)
....++.....+++.+.|+|....+.+... ..+..+|+|++ +.+|.+....
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 345678889999999999999998877643 34467899998 6699888844
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.18 Score=47.10 Aligned_cols=75 Identities=17% Similarity=0.179 Sum_probs=42.4
Q ss_pred cceeccCCCeEEEEEEecCC--CE-----EEEEEcccCCccchHHHHHHHHHhhccCCC-cccceeEEEEeCCeeEEEEE
Q 018128 50 ANLIGEGGFGKVYKGRLESG--QL-----VAIKQLNHEGLQGHQEFIVEVLMLSLLHHD-NLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~--~~-----v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p-~i~~~~~~~~~~~~~~lv~e 121 (360)
.+.|..|=...+|.+...++ .. |+++..... ....-.-..|+.+++.+..- .-.++++.+.. +++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 44555577788999865432 22 444443221 11112335588888888543 34455555532 58899
Q ss_pred ecCCCCHH
Q 018128 122 YMPMGSLE 129 (360)
Q Consensus 122 ~~~~~sL~ 129 (360)
|++|-+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99876553
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.093 Score=45.94 Aligned_cols=81 Identities=17% Similarity=0.094 Sum_probs=54.2
Q ss_pred cccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec-CCC
Q 018128 48 REANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM-PMG 126 (360)
Q Consensus 48 ~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~-~~~ 126 (360)
+....+..|..+.|+.++..+|.+.++|+........ .+. .....|+..+-.+.++++..-. ....+++|.+ ++.
T Consensus 5 ~~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E~-~g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~ 80 (253)
T PF04655_consen 5 TPDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HEA-RGEAALRWWNGRGAVRLLAADP--ERGALLLERLDPGR 80 (253)
T ss_pred ccCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hhh-hHHhHhheeCCCCceeeecccc--ccchhhhhhccCCC
Confidence 3445567788999999999899999999875442111 111 1224577777777888887643 3556889988 445
Q ss_pred CHHHHh
Q 018128 127 SLEDHL 132 (360)
Q Consensus 127 sL~~~i 132 (360)
+|.+..
T Consensus 81 ~L~~~~ 86 (253)
T PF04655_consen 81 SLASLP 86 (253)
T ss_pred chhhcc
Confidence 665544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 360 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-63 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-44 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-26 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-26 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-26 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-26 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-26 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-26 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-26 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-26 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-26 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-26 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-26 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-26 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-26 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-26 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-25 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-25 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-24 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-24 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-24 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-21 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-21 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-18 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 7e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 511 bits (1318), Expect = 0.0
Identities = 122/310 (39%), Positives = 172/310 (55%), Gaps = 4/310 (1%)
Query: 21 GKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHE 80
+ + +L AT NF LIG G FGKVYKG L G VA+K+ E
Sbjct: 15 ALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE 74
Query: 81 GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE 140
QG +EF E+ LS H +LV+LIG+C ++ +L+Y+YM G+L+ HLY +
Sbjct: 75 SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM 134
Query: 141 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200
+SW R++I +GAARGL YLH +I+RD+KS NILLD +F PK++DFG++K G
Sbjct: 135 SMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 260
D TH+ST V GT GY PEY + G+LT KSD+YSFGVVL E++ R A+ S + N
Sbjct: 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
Query: 261 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320
L W+ + +VDP L + L CL + RP + D++ L
Sbjct: 252 LAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
Query: 321 DYLVSQRDSH 330
+Y + ++S
Sbjct: 311 EYALRLQESV 320
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 506 bits (1306), Expect = 0.0
Identities = 121/306 (39%), Positives = 170/306 (55%), Gaps = 19/306 (6%)
Query: 30 SGARSFTFRELAIATRNFRE------ANLIGEGGFGKVYKGRLESGQLVAIKQL----NH 79
+ SF+F EL T NF E N +GEGGFG VYKG + VA+K+L +
Sbjct: 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDI 68
Query: 80 EGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 139
+ Q+F E+ +++ H+NLV L+G+ + GD LVY YMP GSL D L L+
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GT 127
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
PLSW+ R KIA GAA G+ +LH I+RD+KSANILLD F K+SDFGLA+
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
T +++R++GT Y APE + G++T KSDIYSFGVVLLE+ITG A+D + Q
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQ 241
Query: 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319
L+ ++K +D + + +V + CL+E+ N RP I +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 320 LDYLVS 325
L + +
Sbjct: 301 LQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 494 bits (1273), Expect = e-177
Identities = 131/293 (44%), Positives = 184/293 (62%), Gaps = 5/293 (1%)
Query: 32 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQ-EFIV 90
+ F+ REL +A+ NF N++G GGFGKVYKGRL G LVA+K+L E QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 150
EV M+S+ H NL+ L G+C + +RLLVY YM GS+ L + Q PL W R +I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 210
A+G+ARGL YLH +P +I+RD+K+ANILLD +F + DFGLAKL D THV+T V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAV 195
Query: 211 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ--NLVSWSRPF 268
GT G+ APEY +GK + K+D++ +GV+LLELITG++A DL++ + L+ W +
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321
LK+ KK LVD L G Y + + V +C RP ++++V L+
Sbjct: 256 LKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 1e-95
Identities = 80/327 (24%), Positives = 126/327 (38%), Gaps = 28/327 (8%)
Query: 23 GNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL 82
G+ S L + + + G FG V+K +L + VA+K +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK 60
Query: 83 QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPD 138
Q + EV L + H+N++ IG G L+ + GSL D L
Sbjct: 61 QS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----- 114
Query: 139 QEPLSWNTRMKIAVGAARGLEYLH-------CKANPPVIYRDLKSANILLDNDFNPKLSD 191
+SWN IA ARGL YLH P + +RD+KS N+LL N+ ++D
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITG 246
FGLA G + + +GT Y APE L+ D+Y+ G+VL EL +
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 247 RKAMDLSKGQGEQNLVS--WSRPFLKDQKKFV--HLVDPLLHGRYPRRCLNYAVAVTAM- 301
A D + P L+D ++ V P+L + + + T
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 302 CLNEEANFRPLINDIVVALDYLVSQRD 328
C + +A R + + + +
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQRLTN 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 5e-77
Identities = 78/333 (23%), Positives = 130/333 (39%), Gaps = 47/333 (14%)
Query: 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI--VEV 92
E ++ N + LIG G +G VYKG L+ + VA+K + Q FI +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFS---FANRQNFINEKNI 58
Query: 93 LMLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 147
+ L+ HDN+ I + LLV EY P GSL +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 148 MKIAVGAARGLEYLH------CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----- 196
++A RGL YLH P + +RDL S N+L+ ND +SDFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 197 -LGPVGDNTHVSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELITGRK 248
L G+ + + +GT Y APE + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 249 AMDLSKGQGEQNL----VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM--- 301
+ + E + + P +D + V ++P ++AV ++
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLV--SREKQRPKFPEAWKENSLAVRSLKET 291
Query: 302 ---CLNEEANFRPLINDIVVALDYLVSQRDSHP 331
C +++A R + L+ + +
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 4e-74
Identities = 86/303 (28%), Positives = 127/303 (41%), Gaps = 42/303 (13%)
Query: 37 FRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH--QEFIVEVLM 94
+ +L I + IG G FG V++ G VA+K L + EF+ EV +
Sbjct: 36 WCDLNIKEK-------IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 95 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
+ L H N+V +G T +V EY+ GSL L+ +E L R+ +A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDV 146
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
A+G+ YLH + NPP+++R+LKS N+L+D + K+ DFGL++L S GT
Sbjct: 147 AKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTP 203
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR------KAMDLSKGQGEQNLVSWSRPF 268
+ APE KSD+YSFGV+L EL T + + G + R
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK----RLE 259
Query: 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328
+ PR A+ C E RP I+ L L+
Sbjct: 260 I------------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
Query: 329 SHP 331
P
Sbjct: 302 PPP 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 3e-70
Identities = 68/197 (34%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG V K + + VAIKQ+ E + + FIVE+ LS ++H N+V L G C
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ LV EY GSL + L+ EP + M + ++G+ YLH +I+R
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 173 DLKSANILLDNDFN-PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 231
DLK N+LL K+ DFG A D T G+ + APE + K
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 232 DIYSFGVVLLELITGRK 248
D++S+G++L E+IT RK
Sbjct: 185 DVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 7e-70
Identities = 88/309 (28%), Positives = 138/309 (44%), Gaps = 56/309 (18%)
Query: 38 RELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGH-------QEFI 89
R +A IG+GGFG V+KGRL +VAIK L +G QEF
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 90 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 149
EV ++S L+H N+V L G + +V E++P G L L D P+ W+ +++
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLR 126
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-----DFNPKLSDFGLAKLGPVGDNT 204
+ + A G+EY+ + NPP+++RDL+S NI L + K++DFGL++ +
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSV 180
Query: 205 HVSTRVMGTYGYCAPE--YAMSGKLTLKSDIYSFGVVLLELITGRK--------AMDLSK 254
H + ++G + + APE A T K+D YSF ++L ++TG +
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240
Query: 255 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 314
E+ L RP + P C V +C + + RP +
Sbjct: 241 MIREEGL----RPTI------------------PEDCPPRLRNVIELCWSGDPKKRPHFS 278
Query: 315 DIVVALDYL 323
IV L L
Sbjct: 279 YIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-68
Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 55/299 (18%)
Query: 37 FRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH--QEFIVEVLM 94
F++L T+ + E G+++KGR G + +K L ++F E
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 95 LSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
L + H N++ ++G C S + +MP GSL + L++ + + +K A+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFAL 118
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
ARG+ +LH P + L S ++++D D ++S + + S M
Sbjct: 119 DMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMY 170
Query: 213 TYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGR------KAMDLSKGQGEQNLV 262
+ APE A+ K +D++SF V+L EL+T M++ + L
Sbjct: 171 APAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL- 228
Query: 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321
RP + P + + +C+NE+ RP + IV L+
Sbjct: 229 ---RPTI------------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-67
Identities = 81/303 (26%), Positives = 124/303 (40%), Gaps = 57/303 (18%)
Query: 37 FRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH----QEFIVEV 92
F EL + IG GGFGKVY+ G VA+K H+ + + E
Sbjct: 6 FAELTLEEI-------IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 93 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
+ ++L H N++ L G C LV E+ G L L + + + + AV
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAV 112
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--------KLSDFGLAKLGPVGDNT 204
ARG+ YLH +A P+I+RDLKS+NIL+ K++DFGLA+ T
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRT 169
Query: 205 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR------KAMDLSKGQGE 258
+ G Y + APE + + SD++S+GV+L EL+TG + ++ G
Sbjct: 170 TKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 259 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318
L + P C + C N + + RP +I+
Sbjct: 229 NKL----ALPI------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266
Query: 319 ALD 321
L
Sbjct: 267 QLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-64
Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 34/291 (11%)
Query: 53 IGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
+G+G FG+ K E+G+++ +K+L + + F+ EV ++ L H N++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
+ + EY+ G+L + ++ W+ R+ A A G+ YLH +I+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 172 RDLKSANILLDNDFNPKLSDFGLAKL------------GPVGDNTHVSTRVMGTYGYCAP 219
RDL S N L+ + N ++DFGLA+L + V+G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279
E K D++SFG+VL E+I A + + + F + + F+
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADP--------DYLPRTMDFGLNVRGFLDR- 242
Query: 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 330
P C +T C + + RP + L+ L H
Sbjct: 243 -YC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 7e-64
Identities = 76/230 (33%), Positives = 105/230 (45%), Gaps = 14/230 (6%)
Query: 23 GNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL 82
G + I IG G FG VYKG+ G VA+K LN
Sbjct: 2 KKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAP 59
Query: 83 QGH--QEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE 140
Q F EV +L H N++ +GY T Q +V ++ SL HL+ E
Sbjct: 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASET--- 115
Query: 141 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200
+ IA ARG++YLH K +I+RDLKS NI L D K+ DFGLA
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172
Query: 201 GDNTHVSTRVMGTYGYCAPE---YAMSGKLTLKSDIYSFGVVLLELITGR 247
+H ++ G+ + APE S + +SD+Y+FG+VL EL+TG+
Sbjct: 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-62
Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 23/233 (9%)
Query: 29 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH--Q 86
K+ S +E I LIG+G FG+VY GR G+ VAI+ ++ E +
Sbjct: 17 KASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLK 74
Query: 87 EFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNT 146
F EV+ H+N+V +G C S ++ +L + D + L N
Sbjct: 75 AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNK 131
Query: 147 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL---GPVGDN 203
+IA +G+ YLH K ++++DLKS N+ DN ++DFGL + G
Sbjct: 132 TRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRR 187
Query: 204 THVSTRVMGTYGYCAPEYAMSGKL---------TLKSDIYSFGVVLLELITGR 247
G + APE + SD+++ G + EL
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-62
Identities = 68/310 (21%), Positives = 120/310 (38%), Gaps = 32/310 (10%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLH 99
+ + IG+G +G+V+ G+ G+ VA+K + E+ L+
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMR 89
Query: 100 HDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 155
H+N++ I G Q L+ +Y GSL D+L L + +K+A +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSV 144
Query: 156 RGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--VST 208
GL +LH + P + +RDLKS NIL+ + ++D GLA N
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 209 RVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG-QGEQNL 261
+GT Y PE + + +D+YSFG++L E+ + + + Q +
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 262 VSWSRPFLKDQKKFVHLVD---PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318
+ S P +D ++ V + + CL + C R +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 319 ALDYLVSQRD 328
L + +D
Sbjct: 325 TLAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-61
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLHHD 101
R+ +G+G +G+V++G + G+ VA+K + + + + E+ +L H+
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHE 62
Query: 102 NLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
N++ I + Q L+ Y MGSL D+L L + ++I + A G
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASG 117
Query: 158 LEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV--STRV 210
L +LH + P + +RDLKS NIL+ + ++D GLA + N +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 211 MGTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLELITG 246
+GT Y APE + DI++FG+VL E+
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-59
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI--VEVLMLSLLHHDNLVTLIG 108
IG+G FG+V++G+ G+ VA+K + + + + E+ +L H+N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 109 YCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-- 162
+ Q LV +Y GSL D+L ++ ++ +K+A+ A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 163 ---CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYC 217
+ P + +RDLKS NIL+ + ++D GLA +T +GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 218 APEYAMSGKL-------TLKSDIYSFGVVLLELITG 246
APE + + ++DIY+ G+V E+
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-45
Identities = 63/297 (21%), Positives = 114/297 (38%), Gaps = 39/297 (13%)
Query: 38 RELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLS 96
+ I +++ +GEGGF V L G A+K++ Q +E E M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 97 LLHHDNLVTLIGYC----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
L +H N++ L+ YC + + L+ + G+L + + L+ L+ + + + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM- 211
G RGLE +H +RDLK NILL ++ P L D G + +
Sbjct: 142 GICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 212 ------GTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
T Y APE + + + ++D++S G VL ++ G D+ +G+
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255
Query: 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
L Q + R+ + + + + RP I +
Sbjct: 256 VA-------LAVQNQL----SIPQSPRHSSALWQ----LLNSMMTVDPHQRPHIPLL 297
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-44
Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 37/293 (12%)
Query: 53 IGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 107
+G+G FG V R + +G++VA+K+L H + ++F E+ +L L HDN+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 108 GYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
G C S +R L+ EY+P GSL D+L +E + ++ +G+EYL K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPE 220
I+RDL + NIL++N+ K+ DFGL K+ P + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280
K ++ SD++SFGVVL EL T + + + + + Q HL++
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI--GNDKQ--GQMIVFHLIE 274
Query: 281 PLLHGR---YPRRCLN--YAVAVTAM--CLNEEANFRPLINDIVVALDYLVSQ 326
L + P C + Y + M C N N RP D+ + +D + Q
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMI----MTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-44
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 45 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 101
R + IG G F VYKG E+ VA +L L Q F E ML L H
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85
Query: 102 NLVTLIGYCTS---GDQRLLVY-EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
N+V S G + +++ E M G+L+ +L + + +G
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKG 141
Query: 158 LEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
L++LH + PP+I+RDLK NI + + K+ D GLA L + V+GT +
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEF 196
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
APE K D+Y+FG+ +LE+ T
Sbjct: 197 MAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-44
Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 22/205 (10%)
Query: 53 IGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 107
+G+G FG V R + +G++VA+K+L H + ++F E+ +L L HDN+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 108 GYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
G C S +R L+ EY+P GSL D+L +E + ++ +G+EYL K
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPE 220
I+RDL + NIL++N+ K+ DFGL K+ P G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 221 YAMSGKLTLKSDIYSFGVVLLELIT 245
K ++ SD++SFGVVL EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-44
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 53 IGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 107
+G+G FG V R +G LVA+KQL H G ++F E+ +L LH D +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 108 GYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
G ++ LV EY+P G L D L L + + + +G+EYL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRR 147
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPE 220
++RDL + NIL++++ + K++DFGLAKL P+ + +V G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 221 YAMSGKLTLKSDIYSFGVVLLELIT 245
+ +SD++SFGVVL EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 53 IGEGGFGKVYKGRLESGQL-VAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
IG G FG+V+ GRL + VA+K +F+ E +L H N+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
T +V E + G L + L T +++ AA G+EYL K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY--CAPEYAMSGKLT 228
+RDL + N L+ K+SDFG+++ D + ++ + APE G+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 229 LKSDIYSFGVVLLELIT 245
+SD++SFG++L E +
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 76/301 (25%), Positives = 130/301 (43%), Gaps = 41/301 (13%)
Query: 45 RNFREANLIGEGGFGKVYKGRLE-----SGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLL 98
R + +GEG FGKV R + +G+ VA+K L G + E+ +L L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 99 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
+H+N+V G CT L+ E++P GSL+++L ++ ++ ++K AV +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICK 137
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG- 215
G++YL + ++RDL + N+L++++ K+ DFGL K +
Sbjct: 138 GMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRD 190
Query: 216 ----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLK 270
+ APE M K + SD++SFGV L EL+T L
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS----DSSPMALFLKMIGPTH-- 244
Query: 271 DQKKFVHLVDPLLHGR---YPRRCLN--YAVAVTAM--CLNEEANFRPLINDIVVALDYL 323
Q LV+ L G+ P C + Y + M C + + R +++ + L
Sbjct: 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQL----MRKCWEFQPSNRTSFQNLIEGFEAL 300
Query: 324 V 324
+
Sbjct: 301 L 301
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG V G+ + VA+K + EG EF E + L H LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+V EY+ G L ++L + L + +++ G+ +L I+R
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHR 128
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 229
DL + N L+D D K+SDFG+ + V D+ + +GT + APE K +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 230 KSDIYSFGVVLLELIT-GRK 248
KSD+++FG+++ E+ + G+
Sbjct: 185 KSDVWAFGILMWEVFSLGKM 204
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 83/294 (28%), Positives = 127/294 (43%), Gaps = 35/294 (11%)
Query: 53 IGEGGFGKVYKGRLE-----SGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FGKV + +G++VA+K L G Q + E+ +L L+H++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 107 IGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
G C LV EY+P+GSL D+L + + + A G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAP 219
I+RDL + N+LLDND K+ DFGLAK P G + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAP 206
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278
E K SD++SFGV L EL+T + E + Q + L
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI----AQ--GQMTVLRL 260
Query: 279 VDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329
+ L G P +C + C EA+FRP +++ L + +
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 3e-42
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
IG G FG V+ G + VAIK + EG ++FI E ++ L H LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
LV E+M G L D+L + + T + + + G+ YL VI+R
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 229
DL + N L+ + K+SDFG+ + V D+ + T GT + +PE + +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 230 KSDIYSFGVVLLELIT-GRK 248
KSD++SFGV++ E+ + G+
Sbjct: 185 KSDVWSFGVLMWEVFSEGKI 204
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 67/279 (24%), Positives = 111/279 (39%), Gaps = 31/279 (11%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHD 101
NFR IG G F +VY+ L G VA+K++ L + I E+ +L L+H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
N++ ++ +V E G L + + + + T K V LE++
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H + V++RD+K AN+ + KL D GL + T + ++GT Y +PE
Sbjct: 153 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 207
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281
KSDI+S G +L E+ + PF D+ L
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNLYSLCKK 249
Query: 282 LLHGRYPRRCLNY----AVAVTAMCLNEEANFRPLINDI 316
+ YP ++ + MC+N + RP + +
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-41
Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG V G+ VAIK + EG EFI E ++ L H+ LV L G CT
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
++ EYM G L ++L ++ +++ +EYL K ++R
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ---FLHR 144
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 229
DL + N L+++ K+SDFGL++ V D+ + T +G+ + PE M K +
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 230 KSDIYSFGVVLLELIT 245
KSDI++FGV++ E+ +
Sbjct: 201 KSDIWAFGVLMWEIYS 216
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 14/196 (7%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
+G G FG+V+ G VA+K L +G F+ E ++ L H LV L T
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172
+ ++ EYM GSL D L P L+ N + +A A G+ ++ + I+R
Sbjct: 79 QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLTL 229
DL++ANIL+ + + K++DFGLA+L + DN + T G + APE G T+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 230 KSDIYSFGVVLLELIT 245
KSD++SFG++L E++T
Sbjct: 190 KSDVWSFGILLTEIVT 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-41
Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 10/197 (5%)
Query: 51 NLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109
+ +G G +G+VY+G + VA+K L E +EF+ E ++ + H NLV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
CT ++ E+M G+L D+L + + +S + +A + +EYL K
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---F 339
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG-TYGYCAPEYAMSGKLT 228
I+R+L + N L+ + K++DFGL++L + +T+ + + APE K +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 229 LKSDIYSFGVVLLELIT 245
+KSD+++FGV+L E+ T
Sbjct: 398 IKSDVWAFGVLLWEIAT 414
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-41
Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
+G+G FG+V+ G VAIK L G + F+ E ++ L H+ LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
+ + +V EYM GSL D L + L + +A A G+ Y+ +
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 230
+RDL++ANIL+ + K++DFGLA+L + T + APE A+ G+ T+K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 231 SDIYSFGVVLLELIT 245
SD++SFG++L EL T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 53 IGEGGFGKVYKGRLESG-----QLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 106
+G G FG VYKG VAIK+L + ++E + E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HC 163
+G C L+ + MP G L D++ + ++ + + V A+G+ YL
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
++RDL + N+L+ + K++DFGLAKL + + + + A E +
Sbjct: 139 ------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 224 SGKLTLKSDIYSFGVVLLELIT-GRK 248
T +SD++S+GV + EL+T G K
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 62/197 (31%), Positives = 106/197 (53%), Gaps = 14/197 (7%)
Query: 53 IGEGGFGKVYKGRLESGQL-VAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
+G G +G+VY+G + L VA+K L E +EF+ E ++ + H NLV L+G CT
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
++ E+M G+L D+L + + +S + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 172 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKLT 228
RDL + N L+ + K++DFGL++L + +T+ + G + APE K +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFS 190
Query: 229 LKSDIYSFGVVLLELIT 245
+KSD+++FGV+L E+ T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
+G+G FG+V+ G VAIK L G + F+ E ++ L H+ LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
+ + +V EYM GSL D L + L + +A A G+ Y+ +
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 385
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK 230
+RDL++ANIL+ + K++DFGLA+L + T + APE A+ G+ T+K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 231 SDIYSFGVVLLELIT 245
SD++SFG++L EL T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
+G G FG+V+ VA+K + G + F+ E ++ L HD LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
T + ++ E+M GSL D L + + + A G+ ++ + I
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSGKL 227
+RDL++ANIL+ K++DFGLA++ + DN + T G + APE G
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFGSF 362
Query: 228 TLKSDIYSFGVVLLELIT 245
T+KSD++SFG++L+E++T
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 69/282 (24%), Positives = 115/282 (40%), Gaps = 32/282 (11%)
Query: 45 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 101
++ IG G +G+ K R G+++ K+L++ + Q + EV +L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 102 NLVTLIG-YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
N+V + L +V EY G L + +++ L +++ L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 160 YLHCKANPP--VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
H +++ V++RDLK AN+ LD N KL DFGLA++ + +T + +GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYM 183
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277
+PE KSDI+S G +L EL PF
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM------------------PPF--TAFSQKE 223
Query: 278 LVDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDI 316
L + G++ R Y + LN + RP + +I
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-40
Identities = 66/220 (30%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FGKV+ + LVA+K L L ++F E +L+ L H+++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------PLSWNTRMKIAVGA 154
G C GD ++V+EYM G L L PD L + + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 155 ARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV- 210
A G+ YL H ++RDL + N L+ + K+ DFG+++ D V
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 211 -----MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
M PE M K T +SD++SFGV+L E+ T
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 62/275 (22%), Positives = 98/275 (35%), Gaps = 34/275 (12%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN--HEGLQGHQEFIVEV-LMLSLLHHD 101
+F+ + +G G +G+V+K R E G+L A+K+ G + + EV + H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
V L G L E SL+ H L L +L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHL 173
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H + +++ D+K ANI L KL DFGL +G + G Y APE
Sbjct: 174 HSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE- 226
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281
+ G +D++S G+ +LE+ + G+G Q L Q
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNMELP--HGGEGWQQLR---------QGY------- 268
Query: 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
L + + +V M L + R +
Sbjct: 269 -LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 53/290 (18%)
Query: 45 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL 103
+F+E LIG GGFG+V+K + G+ IK++ + + +E V L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66
Query: 104 VTLIGY---------------CTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 147
V G S + L + E+ G+LE + E L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLA 124
Query: 148 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 207
+++ +G++Y+H K +I RDLK +NI L + K+ DFGL N
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178
Query: 208 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 266
TR GT Y +PE S + D+Y+ G++L EL+ A + SK
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------------ 226
Query: 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
L G + L+++ RP ++I
Sbjct: 227 -----------FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FGKV+ + LVA+K L Q+F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE-----------PLSWNTRMKIAVGAA 155
G CT G L+V+EYM G L L PD + PL + +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 156 RGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV-- 210
G+ YL H ++RDL + N L+ K+ DFG+++ D V R
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 211 ----MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
M PE + K T +SD++SFGVVL E+ T
Sbjct: 223 PIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 66/245 (26%), Positives = 106/245 (43%), Gaps = 24/245 (9%)
Query: 25 GGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQ 83
GG F + + + R ++ EGGF VY+ + + SG+ A+K+L +
Sbjct: 8 GGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE 67
Query: 84 GHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQR-------LLVYEYMPMGSLEDHLYDL 135
++ I EV M L H N+V + G + L+ + G L + L +
Sbjct: 68 KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 136 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195
E + PLS +T +KI R ++++H + PP+I+RDLK N+LL N KL DFG A
Sbjct: 128 E-SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
Query: 196 ---KLGPVGDNTHVSTRVM-------GTYGYCAPE--YAMSGK-LTLKSDIYSFGVVLLE 242
P + ++ T Y PE S + K DI++ G +L
Sbjct: 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 243 LITGR 247
L +
Sbjct: 246 LCFRQ 250
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 102
+G G FG+V++ + ++G A+K++ E + E E++ + L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--VE---ELVACAGLSSPR 111
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V L G G + E + GSL + + E + + A GLEYLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA----LYYLGQALEGLEYLH 167
Query: 163 CKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LGPVGDNTHVSTR--VMGTYGYCA 218
+ +++ D+K+ N+LL +D + L DFG A L P G + T + GT + A
Sbjct: 168 TRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELITGR 247
PE M K DI+S ++L ++ G
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 53 IGEGGFGKVYKGRLESGQL-----VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 106
+G G FG V+KG V IK + + G Q Q +L + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+G C G LV +Y+P+GSL DH+ + L + V A+G+ YL
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
+++R+L + N+LL + +++DFG+A L P D + + + A E GK
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 227 LTLKSDIYSFGVVLLELIT-GRK 248
T +SD++S+GV + EL+T G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 24/239 (10%)
Query: 24 NGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ 83
+ G + F+ +++ R + IG GG KV++ E Q+ AIK +N E
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 66
Query: 84 GH--QEFIVEVLMLSLL--HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 139
+ E+ L+ L H D ++ L Y + +V E L L +
Sbjct: 67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK----KK 121
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
+ + R + +H +++ DLK AN L+ + KL DFG+A
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQ 177
Query: 200 VGDNTHVSTRVMGTYGYCAPE-----------YAMSGKLTLKSDIYSFGVVLLELITGR 247
+ V +GT Y PE K++ KSD++S G +L + G+
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 20/207 (9%)
Query: 53 IGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVT 105
IG G FG+VYKG L + VAIK L G Q +F+ E ++ H N++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
L G + +++ EYM G+L+ L + + + S + + G A G++YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYLANMN 167
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYA 222
++RDL + NIL++++ K+SDFGL+++ + D+ + G + APE
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 223 MSGKLTLKSDIYSFGVVLLELIT-GRK 248
K T SD++SFG+V+ E++T G +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-39
Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 53 IGEGGFGKVYKGRLESGQL----VAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVT 105
+G+G FG V +G ++ VA+K L + L + +FI EV + L H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
L G +V E P+GSL D L Q T + AV A G+ YL K
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYA 222
I+RDL + N+LL K+ DFGL + P D+ +V + +CAPE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 223 MSGKLTLKSDIYSFGVVLLELIT-GRK 248
+ + SD + FGV L E+ T G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-39
Identities = 65/277 (23%), Positives = 113/277 (40%), Gaps = 33/277 (11%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLLHHDN 102
+ IGEG FGK + E G+ IK++N + +E EV +L+ + H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V +V +Y G L + + + + V L+++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVH 142
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+ +++RD+KS NI L D +L DFG+A++ + ++ +GT Y +PE
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEIC 197
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282
+ KSDI++ G VL EL T + F + +LV +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK------------------HAF--EAGSMKNLVLKI 237
Query: 283 LHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDI 316
+ G +P L+Y ++ + RP +N I
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-39
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 53 IGEGGFGKVYKGRLESG----QLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTL 106
IG G G+V GRL VAIK L G Q +F+ E ++ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
G T G ++V EYM GSL+ L + + + G G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAM 223
++RDL + N+L+D++ K+SDFGL+++ + D+ + G + APE
Sbjct: 172 --YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 224 SGKLTLKSDIYSFGVVLLELIT-GRK 248
+ SD++SFGVV+ E++ G +
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-39
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVT 105
+G+G FG VY+G E VAIK +N ++ EF+ E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHL------YDLEPDQEPLSWNTRMKIAVGAARGLE 159
L+G + G L++ E M G L+ +L P P S + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV------MGT 213
YL+ ++RDL + N ++ DF K+ DFG+ + D + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 214 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+PE G T SD++SFGVVL E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
++G+G +G VY GR L + +AIK++ + Q E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 111 TSGDQRLLVYEYMPMGSLED---HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
+ + E +P GSL + D E +I GL+YLH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI----LEGLKYLHDNQ-- 142
Query: 168 PVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
+++RD+K N+L++ K+SDFG +K + + GT Y APE G
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 227 L--TLKSDIYSFGVVLLELITGR 247
+DI+S G ++E+ TG+
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 53 IGEGGFGKVYKGRL----ESGQLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTL 106
+G G FG+V GRL + VAIK L G Q +F+ E ++ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
G T ++V EYM GSL+ L + + + + G A G++YL
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAM 223
++RDL + NIL++++ K+SDFGL ++ + D+ + G + +PE
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 224 SGKLTLKSDIYSFGVVLLELIT-GRK 248
K T SD++S+G+VL E+++ G +
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 22/198 (11%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
IG+G FG V G G VA+K + ++ Q F+ E +++ L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 113 GDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
L +V EYM GSL D+L + L + +K ++ +EYL ++
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 172 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAMSGKL 227
RDL + N+L+ D K+SDFGL K +T + ++ APE K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKKF 363
Query: 228 TLKSDIYSFGVVLLELIT 245
+ KSD++SFG++L E+ +
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 53 IGEGGFGKVYKGRLESG-----QLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTL 106
+G G FG VYKG VAIK+L + ++E + E +++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+G C L+ + MP G L D++ + ++ + + V A+G+ YL +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
+++RDL + N+L+ + K++DFGLAKL + + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 227 LTLKSDIYSFGVVLLELIT-GRK 248
T +SD++S+GV + EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 48/277 (17%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 102
+F E ++G+G FG+V K R + AIK++ H + + EV++L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 103 LVTLIG-YCTSGDQRL------------LVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRM 148
+V + + + EY G+L D ++ Q W
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 149 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL----------- 197
+I L Y+H + +I+RDLK NI +D N K+ DFGLAK
Sbjct: 124 QIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 198 --GPVGDNTHVSTRVMGTYGYCAPE-YAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLS 253
G + ++++ + GT Y A E +G K D+YS G++ E+I M+
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
Query: 254 K-----GQGEQNLVSW-SRPFLKDQKKFVHL---VDP 281
+K +KK + L DP
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDP 272
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 53 IGEGGFGKVYKGRLESGQ---LVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTLI 107
+G G FG V +G + VAIK L +G + E + E ++ L + +V LI
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCK 164
G C + +LV E G L L +E + + ++ + G++YL +
Sbjct: 77 GVCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 218
++RDL + N+LL N K+SDFGL+K D+ + + + A
Sbjct: 132 -----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 248
PE K + +SD++S+GV + E ++ G+K
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
IG+G FG V G G VA+K + Q F+ E +++ L H NLV L+G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIK-NDAT-AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 111 TSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
L +V EYM GSL D+L + L + +K ++ +EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 138
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAMSG 225
++RDL + N+L+ D K+SDFGL K +T + ++ APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 189
Query: 226 KLTLKSDIYSFGVVLLELIT-GRK 248
K + KSD++SFG++L E+ + GR
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRV 213
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 59/295 (20%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNL 103
++ +IG G V + VAIK++N E Q + ++ E+ +S HH N+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN-TRMKIAV---GAARGLE 159
V+ D+ LV + + GS+ D + + E S IA GLE
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGY 216
YLH I+RD+K+ NILL D + +++DFG+ A L GD T R +GT +
Sbjct: 136 YLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 217 CAPEYAMSGKL-TLKSDIYSFGVVLLELITGR---------KAMDL----------SKGQ 256
APE + K+DI+SFG+ +EL TG K + L + Q
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311
++ L + + F +K + ++CL ++ RP
Sbjct: 253 DKEMLKKYGKSF----RKMI-----------------------SLCLQKDPEKRP 280
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-38
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 53 IGEGGFGKVYKGRLESGQL---VAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLI 107
+G G FG V KG + ++ VA+K L +E E + E ++ L + +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL---HCK 164
G C + +LV E +G L +L + +++ + G++YL +
Sbjct: 85 GICE-AESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNF- 138
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCA 218
++RDL + N+LL K+SDFGL+K +N + + + A
Sbjct: 139 -----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYA 188
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 248
PE K + KSD++SFGV++ E + G+K
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-38
Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 55/280 (19%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHDNLV 104
F + IG+G FG+V+KG + ++VAIK ++ E + ++ E+ +LS +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYL 161
G + ++ EY+ GS D L + P E +IA +GL+YL
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDET-------QIATILREILKGLDYL 135
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H + I+RD+K+AN+LL KL+DFG+A G + D +GT + APE
Sbjct: 136 HSEK---KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGEQNLVS-WSRPFLKD 271
K+DI+S G+ +EL G K + L L +S+P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL--- 247
Query: 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311
K+FV CLN+E +FRP
Sbjct: 248 -KEFV-----------------------EACLNKEPSFRP 263
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-38
Identities = 67/222 (30%), Positives = 99/222 (44%), Gaps = 42/222 (18%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLV 104
+GE FGKVYKG L E Q VAIK L + +EF E ++ + L H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------PLSWNTRMKIAV 152
L+G T +++ Y G L + L P + L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 153 GAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 208
A G+EYL H +++DL + N+L+ + N K+SD GL + D +
Sbjct: 136 QIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 209 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
R M APE M GK ++ SDI+S+GVVL E+ +
Sbjct: 190 SLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-38
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+G G FG+VY+G++ S VA+K L Q +F++E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE---PLSWNTRMKIAVGAARGLEYL- 161
IG R ++ E M G L+ L + P L+ + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 162 --HCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
H I+RD+ + N LL K+ DFG+A+ M +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
PE M G T K+D +SFGV+L E+ +
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 51 NLIGEGGFGKVYKGRLESG---QLVAIKQLNHE-GLQGHQEFIVEV-LMLSLLHHDNLVT 105
++IGEG FG+V K R++ AIK++ H++F E+ ++ L HH N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMKIAVG 153
L+G C L EY P G+L D L LS + A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST----- 208
ARG++YL K I+RDL + NIL+ ++ K++DFGL++ + T
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 209 -RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
R M A E T SD++S+GV+L E+++
Sbjct: 205 VRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-38
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 34/215 (15%)
Query: 53 IGEGGFGKVYKGRL----ESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTL 106
+GEG FG V +G L + VA+K + + + +EF+ E + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 107 IGYCTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEP--LSWNTRMKIAVGAARGLE 159
+G C + +++ +M G L +L + P + T +K V A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 160 YL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV------ 210
YL + ++RDL + N +L +D ++DFGL+K GD
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 211 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ A E T KSD+++FGV + E+ T
Sbjct: 216 I------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 24/218 (11%)
Query: 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGH--QEFIVEVLMLSLL--HH 100
R + IG GG KV++ E Q+ AIK +N E + E+ L+ L H
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
D ++ L Y + +V E L L ++ + R +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 123
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
+H +++ DLK AN L+ + KL DFG+A + V +GT Y PE
Sbjct: 124 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 221 -----------YAMSGKLTLKSDIYSFGVVLLELITGR 247
K++ KSD++S G +L + G+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 45/219 (20%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIV-----------------EVLML 95
+ +G F K+ + + A+K+ L+ ++F E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 96 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 155
+ + ++ +T G T+ D+ ++YEYM S+ + + +++
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 156 R----GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
+ Y+H + N + +RD+K +NIL+D + KLSDFG ++ + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG-SR 211
Query: 212 GTYGYCAPEYAMSGKLT---LKSDIYSFGVVLLELITGR 247
GTY + PE S + + K DI+S G+ L +
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 53 IGEGGFGKVYKGRLESGQL----VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLI 107
+GEG FG+VY+G + + VA+K + L ++F+ E +++ L H ++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
G + ++ E P G L +L + L T + ++ + + YL
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEY 221
++RD+ NIL+ + KL DFGL++ + D + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 222 AMSGKLTLKSDIYSFGVVLLELIT-GRK 248
+ T SD++ F V + E+++ G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 48 REANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDN 102
+IG+G FG VY G ++ AIK L+ +Q + F+ E L++ L+H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 103 LVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
++ LIG + ++ YM G L + + + + + + ARG+EYL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYL 140
Query: 162 ---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG------ 212
++RDL + N +LD F K++DFGLA+ + D + S +
Sbjct: 141 AEQKF------VHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPV 192
Query: 213 --TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
T A E + + T KSD++SFGV+L EL+T
Sbjct: 193 KWT----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 35/216 (16%)
Query: 53 IGEGGFGKVYKGRL----ESGQLVAIKQL--NHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106
+G+G FG V + +L S VA+K L + +EF+ E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 107 IGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEP--LSWNTRMKIAVGAARGL 158
+G + +++ +M G L L + P L T ++ V A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 159 EYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV----- 210
EYL + I+RDL + N +L D ++DFGL++ GD
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 211 -MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ A E T+ SD+++FGV + E++T
Sbjct: 205 WL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 53 IGEGGFGKVYKGRL--------ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 104
+G+G F K++KG V +K L+ + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL--- 161
G C GD+ +LV E++ GSL+ +L ++ ++ ++++A A + +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 162 HCKANPPVIYRDLKSANILLDNDFNP--------KLSDFGLAKLGPVGDNTHVSTRVMGT 213
I+ ++ + NILL + + KLSD G++ V + R+
Sbjct: 133 TL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERIPWV 184
Query: 214 YGYCAPEYAMSGKL-TLKSDIYSFGVVLLELIT-GRK 248
PE + K L +D +SFG L E+ + G K
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 53 IGEGGFGKVYKGRLESG----QLVAIKQLNHEGLQGHQ--EFIVEVLMLSLLHHDNLVTL 106
IGEG FG V++G S VAIK +F+ E L + H ++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
IG T + ++ E +G L L + L + + A + L YL K
Sbjct: 82 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESKR- 136
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPE 220
++RD+ + N+L+ ++ KL DFGL++ + D+T+ + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 221 YAMSGKLTLKSDIYSFGVVLLELIT-GRK 248
+ T SD++ FGV + E++ G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-37
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+G G FG+VY+G++ S VA+K L Q +F++E L++S +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE---PLSWNTRMKIAVGAARGLEYL- 161
IG R ++ E M G L+ L + P L+ + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 162 --HCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
H I+RD+ + N LL K+ DFG+A+ M +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
PE M G T K+D +SFGV+L E+ +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 51 NLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHD 101
+G G FGKV + ++ VA+K L + + E+ +M L H+
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK-STAHADEKEALMSELKIMSHLGQHE 110
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL----------YDLEPDQEPLSWNTRMKIA 151
N+V L+G CT G L++ EY G L + L S + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST--- 208
A+G+ +L K I+RD+ + N+LL N K+ DFGLA+ N V
Sbjct: 171 SQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 209 ---RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ M APE T++SD++S+G++L E+ +
Sbjct: 228 LPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 7e-37
Identities = 55/238 (23%), Positives = 91/238 (38%), Gaps = 24/238 (10%)
Query: 25 GGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL-- 82
G + A S +++ R + IG GG KV++ E Q+ AIK +N E
Sbjct: 36 GTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 95
Query: 83 QGHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE 140
Q + E+ L+ L D ++ L Y + +V E L L ++
Sbjct: 96 QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK----KKK 150
Query: 141 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200
+ R + +H +++ DLK AN L+ + KL DFG+A
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 206
Query: 201 GDNTHVSTRVMGTYGYCAPE-----------YAMSGKLTLKSDIYSFGVVLLELITGR 247
+ V +G Y PE K++ KSD++S G +L + G+
Sbjct: 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-37
Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 42/260 (16%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 102
IGEG G V R SG+ VA+K ++ Q + EV+++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLE 159
+V + G++ ++ E++ G+L D + E +IA + L
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEE-------QIATVCEAVLQALA 155
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGY 216
YLH + VI+RD+KS +ILL D KLSDFG A++ + V R ++GT +
Sbjct: 156 YLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI-----SKDVPKRKSLVGTPYW 207
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGE---QNLVSW 264
APE + DI+S G++++E++ G +AM + +N
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267
Query: 265 SRPFLKDQKKFVHL---VDP 281
S + F+ DP
Sbjct: 268 SPVL----RDFLERMLVRDP 283
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-37
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 53 IGEGGFGKVYKGRL--------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHD 101
+GEG FG+V + VA+K L + + + + E+ +M + H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMK 149
N++ L+G CT ++ EY G+L ++L +E +++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 208
ARG+EYL + I+RDL + N+L+ + K++DFGLA+ D +T
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 209 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ M APE T +SD++SFGV++ E+ T
Sbjct: 219 GRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 76/260 (29%), Positives = 117/260 (45%), Gaps = 42/260 (16%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 102
+ + IG+G G VY + +GQ VAI+Q+N + + I E+L++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLE 159
+V + GD+ +V EY+ GSL D + E +IA + LE
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEG-------QIAAVCRECLQALE 130
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGY 216
+LH VI+RD+KS NILL D + KL+DFG A++ P +T V GT +
Sbjct: 131 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYW 182
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGE---QNLVSW 264
APE K DI+S G++ +E+I G +A+ L G QN
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 265 SRPFLKDQKKFVHL---VDP 281
S F + F++ +D
Sbjct: 243 SAIF----RDFLNRCLEMDV 258
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 51 NLIGEGGFGKVYKGRL----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVT 105
+IG G FG VY G L A+K LN + +F+ E +++ H N+++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 106 LIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL--- 161
L+G C + L+V YM G L + + + + + + + A+G++YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLASK 147
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG------TYG 215
++RDL + N +LD F K++DFGLA+ + V +
Sbjct: 148 KF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-- 199
Query: 216 YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
A E + K T KSD++SFGV+L EL+T
Sbjct: 200 --ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNL 103
+G G FGKV + ++ VA+K L L + + E+ ++ L +H N+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHL--------------YDLEPDQEPLSWNTRMK 149
V L+G CT G L++ EY G L + L +E D+ L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 208
+ A+G+ +L K I+RDL + NILL + K+ DFGLA+ N V
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 209 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ M APE + T +SD++S+G+ L EL +
Sbjct: 207 ARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 44/227 (19%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLV 104
+GEG FGKV K VA+K L E ++ + E +L ++H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHL--------------------YDLEPDQEPLSW 144
L G C+ LL+ EY GSL L PD+ L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 145 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204
+ A ++G++YL +++RDL + NIL+ K+SDFGL++ D+
Sbjct: 150 GDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 205 HVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ + M A E T +SD++SFGV+L E++T
Sbjct: 207 VKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 53 IGEGGFGKVYKGRL--------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHD 101
+GEG FG+V + VA+K L + + + + E+ +M + H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMK 149
N++ L+G CT ++ EY G+L ++L +E +++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 208
ARG+EYL + I+RDL + N+L+ + K++DFGLA+ D +T
Sbjct: 208 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 209 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ M APE T +SD++SFGV++ E+ T
Sbjct: 265 GRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 53 IGEGGFGKVYKGRLESGQ---LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIG 108
+G G FG V +G + VAIK L +E + E ++ L + +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 168
C + +LV E G L L + +E + + ++ + G++YL K
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFL--VGKREE-IPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 169 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAMSG 225
++R+L + N+LL N K+SDFGL+K D+ + + + APE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFR 514
Query: 226 KLTLKSDIYSFGVVLLELIT-GRK 248
K + +SD++S+GV + E ++ G+K
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK 538
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 62/298 (20%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNL 103
+F +G GGFG V++ + AIK++ + +E ++ EV L+ L H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 104 VTLIGY---------CTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151
V ++ +Y + +L+D + +E + + I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIF 124
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL----------GPVG 201
+ A +E+LH K +++RDLK +NI D K+ DFGL
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261
T +GT Y +PE + K DI+S G++L EL+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------------- 225
Query: 262 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDI 316
PF ++ L D + + ++P + L+ RP +I
Sbjct: 226 -----PFSTQMERVRTLTD-VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-36
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTL 106
+G GG VY VAIK + + +E + EV S L H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
I D LV EY+ +L +++ PLS +T + G+++ H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH-DMR 131
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSG 225
+++RD+K NIL+D++ K+ DFG+AK + + + T V+GT Y +PE A
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 226 KLTLKSDIYSFGVVLLELITGR 247
+DIYS G+VL E++ G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 26/212 (12%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+ +G+G FGKVYK + E+G L A K + + + +++IVE+ +L+ H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLH 162
L+G + ++ E+ P G+++ + L T +I V L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAI---MLELDRGL---TEPQIQVVCRQMLEALNFLH 134
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAP 219
K +I+RDLK+ N+L+ + + +L+DFG++ N + +GT + AP
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAP 186
Query: 220 EYAMSGKLT-----LKSDIYSFGVVLLELITG 246
E M + K+DI+S G+ L+E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 51 NLIGEGGFGKVYKGRL----ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVT 105
+IG G FG VY G L A+K LN + +F+ E +++ H N+++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 106 LIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL--- 161
L+G C + L+V YM G L + + + + + + + A+G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKFLASK 211
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG------TYG 215
++RDL + N +LD F K++DFGLA+ + V +
Sbjct: 212 KF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-- 263
Query: 216 YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
A E + K T KSD++SFGV+L EL+T
Sbjct: 264 --ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 102
F +GEG +G VYK E+GQ+VAIKQ+ E QE I E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLE 159
+V G +V EY GS+ D + L L T +IA +GLE
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNK--TL---TEDEIATILQSTLKGLE 139
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGD--NTHVSTRVMGTYGY 216
YLH I+RD+K+ NILL+ + + KL+DFG+ +L NT + GT +
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFW 191
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
APE +DI+S G+ +E+ G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-35
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 15/206 (7%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHD 101
+F +G+G FG VY R +S ++A+K L L+ + EV + S L H
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
N++ L GY + L+ EY P+G++ L L E + A L Y
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----ATYITELANALSYC 125
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H K VI+RD+K N+LL + K++DFG + P + GT Y PE
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLPPEM 178
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGR 247
K D++S GV+ E + G+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 53 IGEGGFGKVYKGRL--------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHD 101
+GEG FG+V VA+K L + + I E+ +M + H
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHK 135
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMK 149
N++ L+G CT ++ EY G+L ++L +E LS +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST- 208
A ARG+EYL K I+RDL + N+L+ D K++DFGLA+ D +T
Sbjct: 196 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 209 -----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ M APE T +SD++SFGV+L E+ T
Sbjct: 253 GRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 53 IGEGGFGKVYKGRLESG----QLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLI 107
IGEG FG V++G S VAIK + ++F+ E L + H ++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
G T + ++ E +G L L + L + + A + L YL K
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESKR-- 511
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYA 222
++RD+ + N+L+ ++ KL DFGL++ + D+T+ G + APE
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKLPIKWMAPESI 564
Query: 223 MSGKLTLKSDIYSFGVVLLELIT 245
+ T SD++ FGV + E++
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILM 587
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNL 103
+G G FG+V + + + VA+K L EG H+ + E+ +++ + HH N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNV 93
Query: 104 VTLIGYCTSGDQ-RLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTRMKI 150
V L+G CT +++ E+ G+L +L + ++ L+ +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-- 208
+ A+G+E+L + I+RDL + NILL K+ DFGLA+ +
Sbjct: 154 SFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 209 ----RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
+ M APE T++SD++SFGV+L E+ +
Sbjct: 211 RLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 48/229 (20%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVT 105
IGEG FG+V++ R E +VA+K L E +F E +++ + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE--------------------PLSWN 145
L+G C G L++EYM G L + L + P PLS
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 146 TRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
++ IA A G+ YL ++RDL + N L+ + K++DFGL++ D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 203 NTHVSTRV------MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
M PE + T +SD++++GVVL E+ +
Sbjct: 229 YYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-35
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 23/212 (10%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY 109
++G+G V++GR ++G L AIK N+ + + E +L L+H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 110 CTSGDQRL--LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
R L+ E+ P GSL L + L + + + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 168 PVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--- 220
+++R++K NI+ D KL+DFG A+ + D+ + GT Y P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYE 188
Query: 221 -----YAMSGKLTLKSDIYSFGVVLLELITGR 247
K D++S GV TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-35
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 44/227 (19%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHEG--LQGHQEFIVEV-LMLSLLHHDNL 103
+G G FGKV VA+K L E + + E+ +M L H+N+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENI 111
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHL-------------------YDLEPDQEPLSW 144
V L+G CT L++EY G L ++L + E D L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 145 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204
+ A A+G+E+L K+ ++RDL + N+L+ + K+ DFGLA+ N
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 205 HVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 245
V + M APE G T+KSD++S+G++L E+ +
Sbjct: 229 VVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-34
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 27/218 (12%)
Query: 47 FREANLIGEG--GFGKVYKGR-LESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHD 101
+ +IG+G V R +G+ V ++++N E E+ + L +H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD--QEPLSWNTRMKIAV---GAAR 156
N+V + ++ +V +M GS +D + D E IA G +
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IAYILQGVLK 139
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG-LAKLGPVGD--NTHVSTRVM-- 211
L+Y+H ++R +K+++IL+ D LS + G
Sbjct: 140 ALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 212 GTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 247
+ +PE KSDIYS G+ EL G
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-34
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY 109
++G+G V++GR ++G L AIK N+ + + E +L L+H N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 110 --CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
T+ ++L+ E+ P GSL L + + L + + + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 168 PVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--- 220
+++R++K NI+ D KL+DFG A+ + D+ + GT Y P+
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYE 188
Query: 221 -----YAMSGKLTLKSDIYSFGVVLLELITGR 247
K D++S GV TG
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 81/295 (27%), Positives = 117/295 (39%), Gaps = 71/295 (24%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLS-LLHHDNLV 104
F L+G G +G+VYKGR +++GQL AIK ++ G +E E+ ML HH N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 105 TLIG-----YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAA 155
T G D +L LV E+ GS+ D L L IA
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGN-TL---KEEWIAYICREIL 139
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMG 212
RGL +LH VI+RD+K N+LL + KL DFG++ R +G
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIG 191
Query: 213 TYGYCAPEYAMSGKLT-----LKSDIYSFGVVLLELITGR---------KAMDLSKGQGE 258
T + APE + KSD++S G+ +E+ G +A+ L
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251
Query: 259 QNLVS--WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311
L S WS+ F + F+ CL + + RP
Sbjct: 252 PRLKSKKWSKKF----QSFI-----------------------ESCLVKNHSQRP 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-34
Identities = 49/228 (21%), Positives = 77/228 (33%), Gaps = 33/228 (14%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHE--GLQGHQEFIVEV-LMLSLLH 99
T F E IG G FG V+K G + AIK+ G Q + EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 100 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
H ++V D L+ EY GSL D + + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNP-------------------KLSDFGLAKLGPV 200
Y+H + +++ D+K +NI + P K+ D G
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---R 183
Query: 201 GDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
+ V G + A E K+DI++ + ++
Sbjct: 184 ISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-34
Identities = 63/206 (30%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLI--- 107
+G GGFG V + ++G+ VAIKQ E ++E E+ ++ L+H N+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 108 ---GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
D LL EY G L +L E + L + + L YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 165 ANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
+I+RDLK NI+L K+ D G AK + + V GT Y APE
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GTLQYLAPEL 194
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGR 247
K T+ D +SFG + E ITG
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 35/228 (15%), Positives = 73/228 (32%), Gaps = 21/228 (9%)
Query: 38 RELAIATRNFREANLIGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQGHQEFIVE 91
E + ++ +L+GEG F +VY+ ++ Q +K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKI 150
+ L + + +LV E G+L + + ++ + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-----------KLSDFGLAKLGP 199
A+ +E +H +I+ D+K N +L N F L D G +
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+ + T T G+ E + + D + + ++ G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 82/290 (28%), Positives = 119/290 (41%), Gaps = 66/290 (22%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLH 99
+ F + IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 100 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAAR 156
H N + G LV EY GS D LE ++PL ++IA GA +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD---LLEVHKKPL---QEVEIAAVTHGALQ 165
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYG 215
GL YLH +I+RD+K+ NILL KL DFG + + P N+ +GT
Sbjct: 166 GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS-----FVGTPY 215
Query: 216 YCAPEYAMSGKLT---LKSDIYSFGVVLLELITGR---------KAMDLSKGQGEQNLVS 263
+ APE ++ K D++S G+ +EL + A+ L S
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 275
Query: 264 --WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311
WS F + FV CL + RP
Sbjct: 276 GHWSEYF----RNFV-----------------------DSCLQKIPQDRP 298
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 52 LIGEGGFGKVYKG---RLESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLV 104
++G GG +V+ R + VA+K L L F + E + L+H +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 105 TL--IGYCTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
+ G L Y EY+ +L D ++ + P++ +++ A + L
Sbjct: 76 AVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALN 130
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGY 216
+ H + +I+RD+K ANI++ K+ DFG+A+ + D+ + T+ V+GT Y
Sbjct: 131 FSH-QNG--IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQY 185
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+PE A + +SD+YS G VL E++TG
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 30/248 (12%), Positives = 67/248 (27%), Gaps = 53/248 (21%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL-------------------- 82
R ++G+ + E+G+ +
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 83 --------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM----GSLED 130
+ H FI ++ ++ + + Y M + +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 131 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 190
L + L + R+++ + R L LH +++ L+ +I+LD L+
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLT 248
Query: 191 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVV 239
F G + G+ PE +T D ++ G+V
Sbjct: 249 GFEHLV--RDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 240 LLELITGR 247
+ +
Sbjct: 303 IYWIWCAD 310
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 47 FREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLV 104
F + + +G G G V+K SG ++A K ++ E + I+ E+ +L + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLEYLHC 163
G S + + E+M GSL+ L E L K+++ +GL YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 149
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYA 222
K +++RD+K +NIL+++ KL DFG++ +L ++ ++ V GT Y +PE
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV-GTRSYMSPERL 202
Query: 223 MSGKLTLKSDIYSFGVVLLELITGR 247
+++SDI+S G+ L+E+ GR
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 54/202 (26%), Positives = 78/202 (38%), Gaps = 16/202 (7%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTL 106
L+G GG G VY+ ++VA+K + E L F E L ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
+ Q + + L L Q PL+ + I L+ H A
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH-AAG 154
Query: 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSG 225
+RD+K NIL+ D L DFG+A D +GT Y APE
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 226 KLTLKSDIYSFGVVLLELITGR 247
T ++DIY+ VL E +TG
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 7e-33
Identities = 27/238 (11%), Positives = 55/238 (23%), Gaps = 42/238 (17%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLH 99
R + + G V+ R +E + A+K E + L
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 100 HDNLVTLIGYC--------------------------TSGDQRLLVYEYMP--MGSLEDH 131
++ + LL+ + L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 132 LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191
L + + + R L K +++ N+ + D L D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGD 237
Query: 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 247
VG S+ Y E+ + T + + G+ + +
Sbjct: 238 VSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-33
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 17/217 (7%)
Query: 40 LAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLML 95
+ + + +G G +G V K R + SGQ++A+K++ Q+ ++ ++ M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM- 60
Query: 96 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 155
+ VT G + E M SL+ + + + + KIAV
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTY 214
+ LE+LH K + VI+RD+K +N+L++ K+ DFG+ L + G
Sbjct: 120 KALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCK 173
Query: 215 GYCAPE----YAMSGKLTLKSDIYSFGVVLLELITGR 247
Y APE ++KSDI+S G+ ++EL R
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 9e-33
Identities = 51/204 (25%), Positives = 80/204 (39%), Gaps = 25/204 (12%)
Query: 52 LIGEGGFGKVYKGR--LESGQLVAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLVTLIG 108
I GG G +Y +G+ V +K L H G Q + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 109 YCTSGDQRL-----LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
+ D+ +V EY+ SL+ + L + + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLH- 199
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+ ++Y DLK NI+L + KL D G + + GT G+ APE
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINS----FGYLYGTPGFQAPEIVR 250
Query: 224 SGKLTLKSDIYSFGVVLLELITGR 247
T+ +DIY+ G L L
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDL 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 42 IATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLMLSL 97
+ ++ IG G +G V K SGQ++A+K++ + Q+ ++ +V+M
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM-RS 77
Query: 98 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
+V G + E M + + Y + + KI + +
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGY 216
L +L +I+RD+K +NILLD N KL DFG+ +L ++ TR G Y
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPY 191
Query: 217 CAPE----YAMSGKLTLKSDIYSFGVVLLELITGR 247
APE A ++SD++S G+ L EL TGR
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 19/208 (9%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLH 99
+F +G+G FG VY R ++ ++A+K QL EG++ E+ + S L
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHLR 72
Query: 100 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
H N++ + Y + L+ E+ P G L L E S A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS----ATFMEELADALH 128
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
Y H + VI+RD+K N+L+ K++DFG + P GT Y P
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPP 181
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGR 247
E K D++ GV+ E + G
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 46/368 (12%), Positives = 95/368 (25%), Gaps = 78/368 (21%)
Query: 38 RELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQL------------------- 77
EL R ++G+ + E+G+ +
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 78 ---------NHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLLVYEYM--P 124
N + + H FI ++ ++ + R +Y M
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 125 MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184
+ + + L + L + R+++ + R L LH +++ L+ +I+LD
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 247
Query: 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY----------AMSGKLTLKSDIY 234
L+ F G S G+ PE +T D +
Sbjct: 248 GGVFLTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 235 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG--RYPRRCL 292
+ G+ + + P D + + + P+
Sbjct: 302 TLGLAIYWIWCAD------------------LPNTDDAA--LGGSEWIFRSCKNIPQ--- 338
Query: 293 NYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGS 352
A+ L R L + +Y + + G PT
Sbjct: 339 -PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSG 397
Query: 353 NSRRSSSA 360
S+ +
Sbjct: 398 TSQPDEAG 405
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 45 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHH 100
R + +G+GGF K ++ ++ ++ A K + L ++ +E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
++V G+ D +V E SL + + EP + G +Y
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQY 156
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 219
LH VI+RDLK N+ L+ D K+ DFGLA +V+ GT Y AP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 210
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGR 247
E + + D++S G ++ L+ G+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 45 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHH 100
R + +G+GGF K ++ ++ ++ A K + L ++ +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
++V G+ D +V E SL + + EP + G +Y
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQIVLGCQY 130
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 219
LH VI+RDLK N+ L+ D K+ DFGLA +V+ GT Y AP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAP 184
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGR 247
E + + D++S G ++ L+ G+
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 23/238 (9%)
Query: 21 GKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH 79
G +++G + + + +G G G+V+K R ++G ++A+KQ+
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 80 EGLQGHQEFIV---EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE 136
G + + I+ +V++ +V G + + E M + +
Sbjct: 61 SGNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG 119
Query: 137 PDQEP-LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL- 194
P E L K+ V + L YL K VI+RD+K +NILLD KL DFG+
Sbjct: 120 PIPERILG-----KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 195 AKLGPVGDNTHVSTRVMGTYGYCAPE-----YAMSGKLTLKSDIYSFGVVLLELITGR 247
+L + R G Y APE +++D++S G+ L+EL TG+
Sbjct: 173 GRL----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-31
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLHHD 101
+F+ NL+G+G F VY+ + +G VAIK ++ + + Q EV + L H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE-PDQEPLSWNTRMKIAVGAARGLEY 160
+++ L Y + LV E G + +L + P E + + +I G+ Y
Sbjct: 72 SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLY 127
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
LH +++RDL +N+LL + N K++DFGLA + H T + GT Y +PE
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPE 182
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGR 247
A L+SD++S G + L+ GR
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 101
F + ++G GGFG+V+ ++ +G+L A K+LN + L+ + + +VE +L+ +H
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 102 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLE 159
+V+L Y L LV M G + H+Y+++ D R GLE
Sbjct: 246 FIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLE 303
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
+LH + +IYRDLK N+LLD+D N ++SD GLA G GT G+ AP
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAP 358
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGR 247
E + + D ++ GV L E+I R
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 20/211 (9%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLV 104
+F +++G G G + + + VA+K++ E +E V++L H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE--VQLLR-ESDEHPNVI 81
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
+ + E +L++++ + L + + GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL 137
Query: 165 ANPPVIYRDLKSANILLDN-----DFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCA 218
+++RDLK NIL+ +SDFGL K L + + V GT G+ A
Sbjct: 138 N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 219 PEY---AMSGKLTLKSDIYSFGVVLLELITG 246
PE T DI+S G V +I+
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 20/210 (9%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 101
FR+ ++G+GGFG+V ++ +G++ A K+L + ++ + + E +L ++
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 102 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQ--EPLSWNTRMKI-AVGAARG 157
+V+L Y L LV M G L+ H+Y + E R A G
Sbjct: 245 FVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-----RAVFYAAEICCG 298
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
LE LH + ++YRDLK NILLD+ + ++SD GLA P G RV GT GY
Sbjct: 299 LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYM 352
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGR 247
APE + + T D ++ G +L E+I G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY 109
+GEG +G+V + + VA+K ++ + E I E+ + +L+H+N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYL 161
G+ + L EY G L D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H + +RD+K N+LLD N K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 222 AMSGKL--TLKSDIYSFGVVLLELITGR 247
+ + D++S G+VL ++ G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 101
+F +IG GGFG+VY R ++G++ A+K L+ + ++ Q + E +MLSL+
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 102 N---LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAAR 156
+ +V + Y +L + + M G L HL E M+ A
Sbjct: 250 DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIIL 303
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
GLE++H + V+YRDLK ANILLD + ++SD GLA H V GT+GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHGY 356
Query: 217 CAPEYAMSGKLTLKS-DIYSFGVVLLELITGR 247
APE G S D +S G +L +L+ G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 49/271 (18%), Positives = 89/271 (32%), Gaps = 73/271 (26%)
Query: 45 RNFREANLIGEGGFGKVYKGR-LESGQLVAIK----------------------QLNHEG 81
+F +G GGFG V++ + AIK +L H G
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 82 -LQGHQEFIVEVLM--------------------------------LSLLHHDNLVTLIG 108
++ ++ + + + +G
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 109 YCTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
++ +Y + +L+D + ++ + I + A +E+LH K
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-EHGVCLHIFIQIAEAVEFLHSKG 184
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAK----------LGPVGDNTHVSTRVMGTYG 215
+++RDLK +NI D K+ DFGL + T +GT
Sbjct: 185 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 216 YCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
Y +PE + K DI+S G++L EL+
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 43/244 (17%)
Query: 53 IGEGGFGKVYKGR---LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109
+G G +G VYK + + + A+KQ+ G+ E+ +L L H N+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 110 CTS-GDQRL-LVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAA---------- 155
S D+++ L+++Y +H DL S + + +
Sbjct: 87 FLSHADRKVWLLFDYA------EH--DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKL--GPVGDNTHVSTR 209
G+ YLH V++RDLK ANIL+ + K++D G A+L P+ +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 210 VMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268
V+ T+ Y APE + + T DI++ G + EL+T Q + S P+
Sbjct: 196 VV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSNPY 249
Query: 269 LKDQ 272
DQ
Sbjct: 250 HHDQ 253
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGY 109
+GEG +G+V + + VA+K ++ + E I E+ + +L+H+N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYL 161
G+ + L EY G L D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYL 121
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H + +RD+K N+LLD N K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 222 AMSGKL--TLKSDIYSFGVVLLELITGR 247
+ + D++S G+VL ++ G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV----EVLMLSLLHHDNLVTL 106
L+GEG +GKV + E+ A+K L + L+ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 107 --IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-------- 156
+ Y + +V EY G E + D P++ R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQ--AHGYFCQLID 120
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
GLEYLH + ++++D+K N+LL K+S G+A+ G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 217 CAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 247
PE A K DI+S GV L + TG
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 51/223 (22%), Positives = 85/223 (38%), Gaps = 35/223 (15%)
Query: 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGY 109
++G G G V G+ VA+K++ + ++E+ L+ H N++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAARGLEYLHCKAN 166
T+ + E +L+D + E L A G+ +LH
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK- 135
Query: 167 PPVIYRDLKSANILLDN-------------DFNPKLSDFGLAKL---GPVGDNTHVSTRV 210
+I+RDLK NIL+ + +SDFGL K G T+++
Sbjct: 136 --IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 211 MGTYGYCAPE-------YAMSGKLTLKSDIYSFGVVLLELITG 246
GT G+ APE +LT DI+S G V +++
Sbjct: 194 -GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 109
IG+G F KV R + +G+ VAIK ++ L + EV ++ +L+H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYL 161
+ L+ EY G + D+L + RMK AR ++Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVA----------HGRMKEKE--ARSKFRQIVSAVQYC 130
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H K +++RDLK+ N+LLD D N K++DFG + + G Y APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAPE- 183
Query: 222 AMSGKL--TLKSDIYSFGVVLLELITGR 247
GK + D++S GV+L L++G
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 13/208 (6%)
Query: 45 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHH 100
+F+ ++GEG F V R + + AIK L + + E ++S L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLE 159
V L ++ Y G L ++ + E TR A + +A LE
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA--LE 144
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YLH K +I+RDLK NILL+ D + +++DFG AK+ + +GT Y +P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGR 247
E SD+++ G ++ +L+ G
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-27
Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 44 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHD 101
++ + +IG G FG VY+ +L +SG+LVAIK++ LQ + F E+ ++ L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQ-DKRFKNRELQIMRKLDHC 107
Query: 102 NLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 155
N+V L + S ++ LV +Y+P ++ ++ L
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LGPVGDNTH-VSTRVMG 212
R L Y+H + +RD+K N+LLD D KL DFG AK L N + +R
Sbjct: 167 RSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 220
Query: 213 TYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
Y Y APE T D++S G VL EL+ G+
Sbjct: 221 -Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHH 100
F++ +G G + VYKG +G VA+K++ + +G I E+ ++ L H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKH 62
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPM---GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
+N+V L + ++ LV+E+M ++ P L N +G
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP--RGLELNLVKYFQWQLLQG 120
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYG 215
L + H +++RDLK N+L++ KL DFGLA+ PV + V+ T
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173
Query: 216 YCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
Y AP+ M + + DI+S G +L E+ITG+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 109
+G G +G+V R + AIK + + + EV +L LL H N++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
LV E G L D + + + I G+ YLH +
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKHN---I 157
Query: 170 IYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 226
++RDLK N+LL++ D K+ DFGL+ + + + R+ GT Y APE + K
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERL-GTAYYIAPE-VLRKK 213
Query: 227 LTLKSDIYSFGVVLLELITGR 247
K D++S GV+L L+ G
Sbjct: 214 YDEKCDVWSIGVILFILLAGY 234
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 109
IGEG +G V+K R ++GQ+VAIK+ + I E+ ML L H NLV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169
+ LV+EY L++L+ Q + + I + + + H
Sbjct: 71 FRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 170 IYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAMSGK 226
I+RD+K NIL+ KL DFG A+L GP V+TR Y +PE
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE------ 172
Query: 227 LTLKS-------DIYSFGVVLLELITGR 247
L + D+++ G V EL++G
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLLHH 100
+ IGEG +G VYK + G+ A+K++ L+ E I E+ +L L H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELKH 59
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
N+V L + + +LV+E++ L+ L + L T + G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAY 115
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCA 218
H + V++RDLK N+L++ + K++DFGLA+ PV TH ++ T Y A
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRA 168
Query: 219 PEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
P+ M K + DI+S G + E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 37/214 (17%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--------EVLMLSLLHHDNL 103
+G G FG V+ E + V +K + E + E+ +LS + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR------- 156
+ ++ + LV E G L+ L+ + + R+ + A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAF------IDRHPRLDEPL--ASYIFRQLV 140
Query: 157 -GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 215
+ YL K +I+RD+K NI++ DF KL DFG A G + GT
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIE 194
Query: 216 YCAPEYAMSGKLTL--KSDIYSFGVVLLELITGR 247
YCAPE + G + +++S GV L L+
Sbjct: 195 YCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+G G FGKV G +G VA+K ++ + G + E+ L L H +++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIK 75
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------G 157
L ++ +V EY+ G L D++ + R++ AR
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYI----------CKHGRVEEME--ARRLFQQILSA 123
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
++Y H V++RDLK N+LLD N K++DFGL+ + G+ S G+ Y
Sbjct: 124 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 177
Query: 218 APEYAMSGKL--TLKSDIYSFGVVLLELITGR 247
APE +SG+L + DI+S GV+L L+ G
Sbjct: 178 APE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-26
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEFIVEVLMLSLLHH 100
+ + IGEG +G V+K + E+ ++VA+K++ + EG+ + E+ +L L H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKH 60
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
N+V L S + LV+E+ L+ + L +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGF 116
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCA 218
H + V++RDLK N+L++ + KL++FGLA+ PV + V+ T Y
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169
Query: 219 PEYAMSGKL-TLKSDIYSFGVVLLELITGRKAM 250
P+ KL + D++S G + EL + +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDN 102
+ L+GEG +G V K R ++G++VAIK+ + I E+ +L L H+N
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
LV L+ C + LV+E++ L DLE L + K G+ + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAP 219
+I+RD+K NIL+ KL DFG A+ P V+TR Y AP
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAP 193
Query: 220 E-------YAMSGKLTLKSDIYSFGVVLLELITGR 247
E Y + D+++ G ++ E+ G
Sbjct: 194 ELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 44 TRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG---HQEFIVEVLML 95
T F + ++G+G FG+V + +GQ A+K ++ ++ + + EV +L
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 96 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 155
L H N++ L + LV E G L D + + E + ++ +
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSG- 138
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMG 212
+ Y+H +++RDLK N+LL++ D N ++ DFGL+ + + +G
Sbjct: 139 --ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIG 190
Query: 213 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
T Y APE + G K D++S GV+L L++G
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEF-------IVEVLMLSLL 98
+++ +GEG +G VYK + G++VA+K++ + E I E+ +L L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLD-----AEDEGIPSTAIREISLLKEL 76
Query: 99 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
HH N+V+LI S LV+E+M L+ L + + L + RG+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGV 132
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGY 216
+ H +++RDLK N+L+++D KL+DFGLA+ PV TH V+ T Y
Sbjct: 133 AHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWY 185
Query: 217 CAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
AP+ M K + DI+S G + E+ITG+
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIK-----QLNHEGLQGHQEFI-VEVLMLSLLHHD--N 102
L+G GGFG VY G + VAIK +++ G + + +EV++L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 103 LVTLIGYCTSGDQRLLVYEY-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
++ L+ + D +L+ E P+ L D + + QE L+ R + +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---R-SFFWQVLEAVRHC 165
Query: 162 HCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
H V++RD+K NIL+D N KL DFG L +T + GT Y PE
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYSPPE 218
Query: 221 YAMSGKL--TLKSDIYSFGVVLLELITGR 247
+ + + ++S G++L +++ G
Sbjct: 219 W-IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 45 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-----FIVEVLMLSLL 98
+ + + + +GEG F VYK R + Q+VAIK++ ++ + E+ +L L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 99 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGA 154
H N++ L+ LV+++M DL + + L+ + +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMET--------DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRVM 211
+GLEYLH +++RDLK N+LLD + KL+DFGLAK P TH V TR
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-- 176
Query: 212 GTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
Y APE ++ + D+++ G +L EL+
Sbjct: 177 ---WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 28/214 (13%)
Query: 51 NLIGEGGFGKVYKGR-LESGQLVAIKQLN-------------HEGLQGHQEFIVEVLMLS 96
+G G +G+V + AIK + + H+E E+ +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 97 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
L H N++ L LV E+ G L + + + E + N MK +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-MKQILSG-- 158
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 213
+ YLH +++RD+K NILL+N N K+ DFGL+ + +GT
Sbjct: 159 -ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGT 211
Query: 214 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
Y APE + K K D++S GV++ L+ G
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 38 RELAIATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIV 90
RE F E ++G+G FG+V K + + Q A+K +N + +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 150
EV +L L H N++ L +V E G L D + + E + +K
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQ 129
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVS 207
+ Y+H +++RDLK NILL++ D + K+ DFGL+ NT +
Sbjct: 130 VFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK 181
Query: 208 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
R+ GT Y APE + G K D++S GV+L L++G
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYCT 111
IG G FG V++ +L VAIK++ LQ + F E+ ++ ++ H N+V L +
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKV----LQ-DKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 112 SGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
S + LV EY+P ++ ++ + R L Y+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SI 160
Query: 166 NPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYA 222
+ +RD+K N+LLD KL DFG AK L N + +R Y Y APE
Sbjct: 161 G--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELI 213
Query: 223 MSGKL-TLKSDIYSFGVVLLELITGR 247
T DI+S G V+ EL+ G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 56/244 (22%), Positives = 86/244 (35%), Gaps = 53/244 (21%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTL 106
IG+G +G V ++ + AIK ++ + + EV ++ LHH N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG------------- 153
LV E G L D L D +K +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 154 ----------------AAR-------GLEYLHCKANPPVIYRDLKSANILL--DNDFNPK 188
+ L YLH + + +RD+K N L + F K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 189 LSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPE--YAMSGKLTLKSDIYSFGVVLLEL 243
L DFGL+K G+ ++T+ GT + APE + K D +S GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 244 ITGR 247
+ G
Sbjct: 270 LMGA 273
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 30/214 (14%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF----IVEVLMLSLLHH 100
+ + + +GEG + VYKG+ + LVA+K++ E +G I EV +L L H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKH 59
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAAR 156
N+VTL + LV+EY+ DL + ++ + R
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK--------DLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTY 214
GL Y H + V++RDLK N+L++ KL+DFGLA+ P + V+ T
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TL 164
Query: 215 GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
Y P+ + + + D++ G + E+ TGR
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 62/202 (30%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHDNLVTLIGYC 110
+G G FG V+ SG IK +N + Q E I E+ +L L H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN---TRMKIAVGAARGLEYLHCKANP 167
+V E G L + + + + LS MK + A L Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQH-- 144
Query: 168 PVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
V+++DLK NIL + K+ DFGLA+L + H + GT Y APE
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAA-GTALYMAPE-VFK 199
Query: 225 GKLTLKSDIYSFGVVLLELITG 246
+T K DI+S GVV+ L+TG
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 66/242 (27%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 23 GNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEG 81
G G A + F+ + G+G FG V G+ +G VAIK++
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---- 56
Query: 82 LQGHQEF----IVEVLMLSLLHHDNLVTLIGYCTSGDQR-------LLVYEYMPMGSLED 130
+Q F + + L++LHH N+V L Y + +R +V EY+P +L
Sbjct: 57 IQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114
Query: 131 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLD-NDFNPK 188
+ Q R + LH N V +RD+K N+L++ D K
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK 172
Query: 189 LSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELIT 245
L DFG AK L P N + +R Y Y APE + T DI+S G + E++
Sbjct: 173 LCDFGSAKKLSPSEPNVAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 246 GR 247
G
Sbjct: 228 GE 229
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 33/210 (15%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV---EVLMLSLLHHDNLVTLI 107
+G G FGKV G+ +G VA+K LN + ++ E+ L L H +++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLE 159
++ +V EY+ G L D++ N R+ +R G++
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI----------CKNGRLDEKE--SRRLFQQILSGVD 130
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
Y H V++RDLK N+LLD N K++DFGL+ + G+ S G+ Y AP
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAP 184
Query: 220 EYAMSGKL--TLKSDIYSFGVVLLELITGR 247
E +SG+L + DI+S GV+L L+ G
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 101
+F IG+G FGKV + ++ ++ A+K +N + E E+ ++ L H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 102 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLE 159
LV L Y ++ + +V + + G L HL +E ++ I + A L+
Sbjct: 76 FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET---VKLFICELVMA--LD 129
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YL + +I+RD+K NILLD + ++DF +A + P T + GT Y AP
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 220 EYAMSGKLTLKS---DIYSFGVVLLELITGR 247
E S K S D +S GV EL+ GR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 52 LIGEGGFGKVY----KGRLESGQLVAIKQLNHEGLQGHQEFIVEVLM----LSLLHHDNL 103
++G+G FGKV+ ++ QL A+K L L+ V M L ++H +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVEVNHPFI 88
Query: 104 VTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK-----IAVGAARG 157
V L Y + +L L+ +++ G L L E +K +A+
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLAELALA---- 138
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 216
L++LH +IYRDLK NILLD + + KL+DFGL+K + GT Y
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEY 192
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
APE T +D +SFGV++ E++TG
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 46/227 (20%), Positives = 95/227 (41%), Gaps = 28/227 (12%)
Query: 33 RSFTFRELAIATRNFRE----ANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE 87
+ + + + + + + +G G FG V++ +G++ K +N
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT 94
Query: 88 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL------EDHLYDLEPDQEP 141
E+ +++ LHH L+ L + +L+ E++ G L ED+ E +
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS-EAEVIN 153
Query: 142 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGP 199
M+ A GL+++H + +++ D+K NI+ + K+ DFGLA
Sbjct: 154 Y-----MRQACE---GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK-- 200
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
+ + V T + APE + +D+++ GV+ L++G
Sbjct: 201 LNPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)
Query: 35 FTFRELAIATRNFRE------ANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE 87
F R + ++G G FG+V+K +G +A K + G++ +E
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 88 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL------EDHLYDLEPDQEP 141
E+ +++ L H NL+ L S + +LV EY+ G L E + E D
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-ELDTIL 191
Query: 142 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGP 199
MK G+ ++H +++ DLK NIL N K+ DFGLA+
Sbjct: 192 F-----MKQICE---GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR-- 238
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
+ GT + APE ++ +D++S GV+ L++G
Sbjct: 239 YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 38/212 (17%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIK-----QLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+GEG FGKV ++ Q VA+K L + E E+ L LL H +++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIK 73
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------G 157
L T+ ++V EY G L D++ RM R
Sbjct: 74 LYDVITTPTDIVMVIEYAG-GELFDYI----------VEKKRMTEDE--GRRFFQQIICA 120
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
+EY H +++RDLK N+LLD++ N K++DFGL+ + G+ S G+ Y
Sbjct: 121 IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 174
Query: 218 APEYAMSGKL--TLKSDIYSFGVVLLELITGR 247
APE ++GKL + D++S G+VL ++ GR
Sbjct: 175 APE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 68/208 (32%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 101
F L+G+G FGKV + +G+ A+K L E + E + E +L H
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 102 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLE 159
L L Y RL V EY G L HL E R + L+
Sbjct: 209 FLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALD 262
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YLH + N V+YRDLK N++LD D + K++DFGL K G + D + T GT Y AP
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAP 318
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELITGR 247
E D + GVV+ E++ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-24
Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 44/229 (19%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-------------------- 90
IG+G +G V A+K L+ + L F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 91 ------EVLMLSLLHHDNLVTLIG-YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPL 142
E+ +L L H N+V L+ + L +V+E + G + + P +PL
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPL 134
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
S + +G+EYLH + +I+RD+K +N+L+ D + K++DFG++ G
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGS 190
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTL----KSDIYSFGVVLLELITGR 247
+ +S V GT + APE ++S + D+++ GV L + G+
Sbjct: 191 DALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-24
Identities = 50/192 (26%), Positives = 78/192 (40%), Gaps = 15/192 (7%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
IG G +G+V + A K++ ++ F E+ ++ L H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171
LV E G L + + +E + MK + A + Y H V +
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLSA---VAYCHKLN---VAH 129
Query: 172 RDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 228
RDLK N L D KL DFGLA + T+V GT Y +P+ + G
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQ-VLEGLYG 185
Query: 229 LKSDIYSFGVVL 240
+ D +S GV++
Sbjct: 186 PECDEWSAGVMM 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 23/197 (11%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
++G G F +V+ + +G+L A+K + E+ +L + H+N+VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
S LV + + G L D + + E D + ++ + A ++YLH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLSA---VKYLHENG- 126
Query: 167 PPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+++RDLK N+L + + ++DFGL+K + N +ST GT GY APE
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTAC-GTPGYVAPEVLA 180
Query: 224 SGKLTLKSDIYSFGVVL 240
+ D +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVIT 197
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-24
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 39/221 (17%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEF-------IVEVLMLSL 97
+R +GEG +G+VYK + + VAIK++ E E I EV +L
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE-----HEEEGVPGTAIREVSLLKE 89
Query: 98 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGA 154
L H N++ L + L++EY DL+ +S
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN--------DLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAKL--GPVGDNTHVS 207
G+ + H + ++RDLK N+LL K+ DFGLA+ P+ TH
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH-- 196
Query: 208 TRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
++ T Y PE + + + DI+S + E++
Sbjct: 197 -EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-24
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLH----H 100
L+G+GGFG V+ G L VAIK + L +EV +L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 101 DNLVTLIGYCTSGDQRLLVYEY-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
++ L+ + + + +LV E +P L D++ + P E S R ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---R-CFFGQVVAAIQ 153
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
+ H + V++RD+K NIL+D KL DFG L + + GT Y
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFD-GTRVYSP 206
Query: 219 PEYAMSGKL--TLKSDIYSFGVVLLELITGR 247
PE+ +S L + ++S G++L +++ G
Sbjct: 207 PEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 55/242 (22%), Positives = 101/242 (41%), Gaps = 35/242 (14%)
Query: 29 KSGARSFTFRELAIATRNFREANL---------IGEGGFGKVYKGR-LESGQLVAIKQLN 78
S + F F +L + ++ L +G G G+V ++ + VAI+ ++
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169
Query: 79 HEGLQGHQEFIV--------EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED 130
E+ +L L+H ++ + + + D +V E M G L D
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFD 228
Query: 131 HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNP 187
+ + +E ++ ++YLH +I+RDLK N+LL + D
Sbjct: 229 KVVGNKRLKEATCKLYFYQM----LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI 281
Query: 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAMSGKLTLKSDIYSFGVVLLELI 244
K++DFG +K+ +G+ + + T GT Y APE + D +S GV+L +
Sbjct: 282 KITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 245 TG 246
+G
Sbjct: 339 SG 340
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-24
Identities = 66/249 (26%), Positives = 98/249 (39%), Gaps = 49/249 (19%)
Query: 17 GAENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL----ESGQLV 72
G+ N G EK F L ++G+GG+GKV++ R +G++
Sbjct: 1 GSSETSVNRGPEKIRPECFEL--LR----------VLGKGGYGKVFQVRKVTGANTGKIF 48
Query: 73 AIKQLNHEGLQGHQEFIVEVLM----LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGS 127
A+K L + + + L + H +V LI Y +L L+ EY+ G
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGE 107
Query: 128 LEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSANI 179
L L E A L +LH K +IYRDLK NI
Sbjct: 108 LFMQLEREGIFMEDT------------ACFYLAEISMALGHLHQKG---IIYRDLKPENI 152
Query: 180 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGV 238
+L++ + KL+DFGL K T GT Y APE M D +S G
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHDGTV---THTFCGTIEYMAPEILMRSGHNRAVDWWSLGA 209
Query: 239 VLLELITGR 247
++ +++TG
Sbjct: 210 LMYDMLTGA 218
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 24/234 (10%)
Query: 28 EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQ 86
+ + +E+ + +F +IG G F +V ++ ++GQ+ A+K +N +
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG 103
Query: 87 E---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPL 142
E F E +L + L + + L LV EY G L L ++ P
Sbjct: 104 EVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPA 161
Query: 143 SWNTRMKIA--VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200
R +A V A ++ +H ++RD+K NILLD + +L+DFG
Sbjct: 162 EM-ARFYLAEIVMA---IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214
Query: 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY-------SFGVVLLELITGR 247
V GT Y +PE + + Y + GV E+ G+
Sbjct: 215 DGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-24
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQ--LNHEGLQGHQEF----IVEV---LML 95
+ IG G +G VYK R SG VA+K + + G G + EV L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG-GGGGGLPISTVREVALLRRL 68
Query: 96 SLLHHDNLVTLI----GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 150
H N+V L+ T + ++ LV+E++ L +L L T +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAP--PPGLPAETIKDL 125
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 210
RGL++LH +++RDLK NIL+ + KL+DFGLA+ ++ V
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTPVV 180
Query: 211 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+ T Y APE + D++S G + E+ +
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 53/211 (25%), Positives = 80/211 (37%), Gaps = 37/211 (17%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIG 108
IG G FG R + +LVA+K + V E++ L H N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKE 83
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--------GLEY 160
+ ++ EY G L + + + R AR G+ Y
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICN----------AGRFSEDE--ARFFFQQLLSGVSY 131
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
H + +RDLK N LLD P K+ DFG +K + + V GT Y A
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIA 185
Query: 219 PEYAMSGKL--TLKSDIYSFGVVLLELITGR 247
PE + + +D++S GV L ++ G
Sbjct: 186 PE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 41/226 (18%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQL----NHEGLQGHQEF----IVEVLMLS 96
+ + IG+G FG+V+K R ++GQ VA+K++ EG F + E+ +L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG------FPITALREIKILQ 71
Query: 97 LLHHDNLVTLIGYCTSGDQRL--------LVYEYMPMGSLEDHLYDL----EPDQEPLSW 144
LL H+N+V LI C + LV+++ +H DL +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EH--DLAGLLSNVLVKFTL 123
Query: 145 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGD 202
+ ++ GL Y+H +++RD+K+AN+L+ D KL+DFGLA+
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
+ T + T Y PE + + D++ G ++ E+ T
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 25/198 (12%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGY 109
+G+G FG+V K + + Q A+K +N + + EV +L L H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
+V E G L D + E D + +K + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFSG---ITYMHKHN 141
Query: 166 NPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+++RDLK NILL + D + K+ DFGL+ NT + R+ GT Y APE
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAYYIAPE-V 194
Query: 223 MSGKLTLKSDIYSFGVVL 240
+ G K D++S GV+L
Sbjct: 195 LRGTYDEKCDVWSAGVIL 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 24/225 (10%)
Query: 33 RSFTFRELAIATRNFRE----ANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE 87
+ + + + I + + +G G FG V++ +G A K + +
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 200
Query: 88 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 147
E+ +S+L H LV L ++ +++YE+M G L + + D + +S
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMS---- 253
Query: 148 MKIAVGAAR----GLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVG 201
AV R GL ++H ++ DLK NI+ + KL DFGL +
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LD 308
Query: 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
V GT + APE A + +D++S GV+ L++G
Sbjct: 309 PKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-23
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 22/232 (9%)
Query: 28 EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQ 86
E + + +++ + +F +IG G FG+V +L + ++ A+K LN +
Sbjct: 57 EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA 116
Query: 87 E---FIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPL 142
E F E +L + TL Y D L LV +Y G L L E D+ P
Sbjct: 117 ETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPE 174
Query: 143 SWNTRMKIA--VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200
R +A V A ++ +H ++RD+K NIL+D + + +L+DFG
Sbjct: 175 EM-ARFYLAEMVIA---IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227
Query: 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS-----DIYSFGVVLLELITGR 247
S V GT Y +PE + + D +S GV + E++ G
Sbjct: 228 DGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 24/231 (10%)
Query: 26 GKEKSGARSFTFRELAIATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIK----- 75
G ++A F + +IG+G F V + E+GQ A+K
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 76 QLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL 135
+ ++ E + +L H ++V L+ +S +V+E+M L +
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 136 EPDQEPLSWN---TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKL 189
S M+ + A L Y H +I+RD+K +LL +N KL
Sbjct: 121 ADAGFVYSEAVASHYMRQILEA---LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKL 174
Query: 190 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 240
FG+A +G++ V+ +GT + APE D++ GV+L
Sbjct: 175 GGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 18/207 (8%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIV-EVLMLSLLHHD 101
F +G G FG+V + ESG A+K L+ + + E + E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEY 160
LV L +V EY+ G + HL + EP R A + EY
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---ARFYAAQIVLT--FEY 156
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
LH +IYRDLK N+L+D +++DFG AK V T + GT APE
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LCGTPEALAPE 208
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGR 247
+S D ++ GV++ E+ G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 9e-23
Identities = 67/209 (32%), Positives = 90/209 (43%), Gaps = 19/209 (9%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHD 101
+F L+G+G FGKV R +G+ A+K L E + E + E +L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 102 NLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLE 159
L L Y RL V EY G L HL E R + LE
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGAEIVSALE 119
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCA 218
YLH + V+YRD+K N++LD D + K++DFGL K G T + GT Y A
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELITGR 247
PE D + GVV+ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 9e-23
Identities = 52/211 (24%), Positives = 82/211 (38%), Gaps = 28/211 (13%)
Query: 44 TRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIVEVLMLS 96
+ F + +G+G F V + +G A K +N + L Q+ E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 97 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
L H N+V L LV++ + G L + + E E A +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQ 112
Query: 157 ----GLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTR 209
+ Y H +++R+LK N+LL KL+DFGLA V D+
Sbjct: 113 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGF 167
Query: 210 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 240
GT GY +PE + DI++ GV+L
Sbjct: 168 A-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 52 LIGEGGFGKVY----KGRLESGQLVAIKQLNHEGLQGHQEFIVEVLM-----LSLLHHDN 102
++G G +GKV+ ++G+L A+K L + + +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 103 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEY 160
LVTL Y + +L L+ +Y+ G L HL E E ++ + + A LE+
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE---VQIYVGEIVLA--LEH 174
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
LH +IYRD+K NILLD++ + L+DFGL+K + GT Y AP+
Sbjct: 175 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPD 230
Query: 221 YAMSGKL--TLKSDIYSFGVVLLELITGR 247
G D +S GV++ EL+TG
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 56/234 (23%), Positives = 88/234 (37%), Gaps = 24/234 (10%)
Query: 17 GAENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIK 75
G GG++ F + N+ +G+G F V + +G A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 76 QLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY 133
+N + L Q+ E + L H N+V L LV++ + G L + +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 134 DLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIYRDLKSANILL---DNDFN 186
E E A + + Y H +++R+LK N+LL
Sbjct: 121 AREFYSE--------ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 169
Query: 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 240
KL+DFGLA V D+ GT GY +PE + DI++ GV+L
Sbjct: 170 VKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-22
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 45/226 (19%)
Query: 43 ATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLN--------HEGLQGHQEFI 89
+T F E ++G G V + + + A+K ++ E +Q +E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 90 ---VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQE 140
V++L + H N++ L + LV++ M G L D L E +
Sbjct: 71 LKEVDILR-KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS--EKETR 127
Query: 141 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200
+ M+ + + LH +++RDLK NILLD+D N KL+DFG + +
Sbjct: 128 KI-----MRALLEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--L 174
Query: 201 GDNTHVSTRVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVL 240
+ GT Y APE + D++S GV++
Sbjct: 175 DPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-22
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 29/217 (13%)
Query: 37 FRELAIATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVE 91
++L + F + IG G + + + A+K ++ +E +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IE 67
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTR 147
+ +L H N++TL G +V E M G L D + E + +
Sbjct: 68 I-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV----- 121
Query: 148 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDN 203
+ +EYLH + V++RDLK +NIL N + ++ DFG AK +N
Sbjct: 122 LFTITKT---VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AEN 174
Query: 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 240
+ T T + APE DI+S GV+L
Sbjct: 175 GLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 43 ATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVL---- 93
A + F + ++IG G V + +G A+K + + E + EV
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 94 -----MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPL 142
+ + H +++TLI S LV++ M G L D L E + +
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS--EKETRSI 205
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
M+ + A + +LH +++RDLK NILLD++ +LSDFG + +
Sbjct: 206 -----MRSLLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEP 252
Query: 203 NTHVSTRVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVL 240
+ GT GY APE + D+++ GV+L
Sbjct: 253 GEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 6e-22
Identities = 54/266 (20%), Positives = 97/266 (36%), Gaps = 78/266 (29%)
Query: 53 IGEGGFGKVYKGRL------ESGQLVAIKQLNHE-GLQGHQEFIVEV-LMLSLLHHDNLV 104
+G G FG+V + + + VA+K L H+ + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 105 TLIG--------------YCTSGDQRLLVY------------------------------ 120
L+G +C G+ L Y
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 121 ---------------------EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
E + +E+ + ++ L+ + + A+G+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
+L + I+RDL + NILL K+ DFGLA+ + + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 220 EYAMSGKLTLKSDIYSFGVVLLELIT 245
E T++SD++SFGV+L E+ +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLM------LSLL 98
+F ++G+G FGKV + +L A+K L + + + VE M
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPG 399
Query: 99 HHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
L L C RL V EY+ G L H+ + +EP A A G
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH---AVFYAA-EIAIG 454
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 216
L +L K +IYRDLK N++LD++ + K++DFG+ K T T+ GT Y
Sbjct: 455 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDY 508
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
APE D ++FGV+L E++ G+
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 7e-22
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 38 RELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQE---FIVEVL 93
R+L + ++ +IG G FG+V R + ++ A+K L+ + + F E
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 94 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKI 150
+++ + +V L Y D+ L +V EYMP G L + + YD+ R
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW------ARFYT 174
Query: 151 A-VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 209
A V A L+ +H I+RD+K N+LLD + KL+DFG T
Sbjct: 175 AEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 210 VMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGR 247
V GT Y +PE S G + D +S GV L E++ G
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-22
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVE--VLMLSLLH 99
+F ++G+G FGKV+ ++ Q AIK L + + + +VE VL L+
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-E 76
Query: 100 HDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARG 157
H L + + L V EY+ G L H+ R A G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILG 130
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 216
L++LH K ++YRDLK NILLD D + K++DFG+ K +GD T GT Y
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDY 184
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
APE + K D +SFGV+L E++ G+
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 9e-22
Identities = 64/225 (28%), Positives = 96/225 (42%), Gaps = 43/225 (19%)
Query: 46 NFREANLIGEGGFGKVYKGR--LESGQLVAIKQL----NHEGLQGHQEF----IVEV--- 92
+ IGEG +GKV+K R G+ VA+K++ EG I EV
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVL 65
Query: 93 LMLSLLHHDNLVTLI----GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEP--DQEPLSWN 145
L H N+V L T + +L LV+E++ D DL D+ P
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQ--DLTTYLDKVPEPGV 117
Query: 146 TRMKIAVGAA---RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
I RGL++LH V++RDLK NIL+ + KL+DFGLA+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSF 172
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+++ V+ T Y APE + D++S G + E+ +
Sbjct: 173 QMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 55/248 (22%), Positives = 96/248 (38%), Gaps = 58/248 (23%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV-EVLMLSLLHHD 101
++ + +G G FG V + +ESG+ A+K++ LQ + E+ ++ +L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQ-DPRYKNRELDIMKVLDHV 60
Query: 102 NLVTLIGYCTSGDQRL--------------------------------------LVYEYM 123
N++ L+ Y + ++ EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD- 182
P +L L + N R + ++H + +RD+K N+L++
Sbjct: 121 PD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LG--ICHRDIKPQNLLVNS 176
Query: 183 NDFNPKLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVV 239
D KL DFG AK L P + + +R + Y APE + T D++S G V
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDLWSIGCV 231
Query: 240 LLELITGR 247
ELI G+
Sbjct: 232 FGELILGK 239
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+G G F V K R +G A K + +E EV +L + H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYL 161
L + +L+ E + G L D L E E + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 162 HCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
H K + + DLK NI+L + P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITG 246
APE L L++D++S GV+ L++G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 52 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVEVLMLSLLHHDNLVTLI 107
+G G FG+V+ R +G+ A+K L E + ++ E LMLS++ H ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 108 GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAARGLEYLHCKA 165
Q++ ++ +Y+ G L L + P+ + A V A LEYLH K
Sbjct: 73 -GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---AKFYAAEVCLA--LEYLHSKD 126
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
+IYRDLK NILLD + + K++DFG AK V D T+ T + GT Y APE +
Sbjct: 127 ---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCGTPDYIAPEVVSTK 178
Query: 226 KLTLKSDIYSFGVVLLELITGR 247
D +SFG+++ E++ G
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGY 200
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 23/205 (11%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLN--HEGLQGHQEFIVEV-LMLSLLHHDNLVTLIG 108
+G G F V + +GQ A K L G E + E+ ++ ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCK 164
+ + +L+ EY G + L E +S + + G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC--LPELAEMVS----ENDVIRLIKQILEGVYYLHQN 150
Query: 165 ANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
+++ DLK NILL + + K+ DFG+++ +G + + GT Y APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEI 204
Query: 222 AMSGKLTLKSDIYSFGVVLLELITG 246
+T +D+++ G++ L+T
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 71/238 (29%), Positives = 104/238 (43%), Gaps = 34/238 (14%)
Query: 19 ENGKGNGGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQL 77
NG G + G +F F + ++G+G FGKV R+ E+G L A+K L
Sbjct: 9 GNGIGVNSSNRLGIDNFEF--IR----------VLGKGSFGKVMLARVKETGDLYAVKVL 56
Query: 78 NHEGLQGHQEF---IVE--VLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDH 131
+ + + + E +L L+ +H L L C RL V E++ G L H
Sbjct: 57 KKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFH 114
Query: 132 LYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 190
+ E R + A L +LH K +IYRDLK N+LLD++ + KL+
Sbjct: 115 IQKSRRFDEA-----RARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLA 166
Query: 191 DFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
DFG+ K G T T GT Y APE D ++ GV+L E++ G
Sbjct: 167 DFGMCKEGICNGVT---TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 38/209 (18%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIV--------EVLMLSLLHHDNL 103
+G G G+V ++ + VAIK ++ E+ +L L+H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPLSWNTRMKIAVGAARG 157
+ + + + D +V E M G L D L E + + A
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK--EATCKLY-----FYQMLLA--- 126
Query: 158 LEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
++YLH +I+RDLK N+LL + D K++DFG +K+ +G+ + + T GT
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTP 180
Query: 215 GYCAPE---YAMSGKLTLKSDIYSFGVVL 240
Y APE + D +S GV+L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGY 109
++GEG +V L + Q A+K + + EV ++ H N++ LI +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR-----MKIAVGAARGLEYLHCK 164
D+ LV+E M GS+ H+ + +N ++ A L++LH K
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHI------HKRRHFNELEASVVVQDVASA---LDFLHNK 130
Query: 165 ANPPVIYRDLKSANILL---DNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM----GTYGY 216
+ +RDLK NIL + K+ DF L + GD + +ST + G+ Y
Sbjct: 131 G---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 217 CAPE-----YAMSGKLTLKSDIYSFGVVL 240
APE + + D++S GV+L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 65/205 (31%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 52 LIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVE--VLMLSLLHHDNLVT 105
+IG+G FGKV R A+K L + + +E + E VL+ ++ H LV
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVG 103
Query: 106 LIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHC 163
L + +L V +Y+ G L HL EP R + A A L YLH
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHS 157
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYA 222
++YRDLK NILLD+ + L+DFGL K ++T T GT Y APE
Sbjct: 158 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVL 211
Query: 223 MSGKLTLKSDIYSFGVVLLELITGR 247
D + G VL E++ G
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVE--VLMLSLLH 99
+F ++G+G FGKV + +L A+K L + + + +VE VL L
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-K 79
Query: 100 HDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARG 157
L L C RL V EY+ G L H+ + +EP A A G
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIG 133
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGY 216
L +L K +IYRDLK N++LD++ + K++DFG+ K T T+ GT Y
Sbjct: 134 LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDY 187
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
APE D ++FGV+L E++ G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+G G F V K R +G A K + +E EV +L + H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYL 161
L + +L+ E + G L D L E E + A + G+ YL
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSFIKQILDGVNYL 131
Query: 162 HCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
H K + + DLK NI+L + P KL DFGLA + D GT +
Sbjct: 132 HTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFV 185
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITG 246
APE L L++D++S GV+ L++G
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-21
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+G G F V K R +G+ A K + +E EV +L + H N++T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYL 161
L + +L+ E + G L D L + E E A + G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQFLKQILDGVHYL 124
Query: 162 HCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
H K + + DLK NI+L + P KL DFG+A + GT +
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPEFV 178
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITG 246
APE L L++D++S GV+ L++G
Sbjct: 179 APEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 53/213 (24%), Positives = 85/213 (39%), Gaps = 27/213 (12%)
Query: 42 IATRNFREA----NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIVEVLM 94
I F E +G+G F V + + +GQ A +N + L HQ+ E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 95 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKI 150
LL H N+V L + L+++ + G L + + E D ++
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQ 118
Query: 151 AVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVS 207
+ A + + H V++R+LK N+LL KL+DFGLA V
Sbjct: 119 ILEA---VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAW 170
Query: 208 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 240
GT GY +PE D+++ GV+L
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 32/231 (13%)
Query: 25 GGKEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQ 83
G + G + F L +IG G + KV RL ++ ++ A+K + E +
Sbjct: 1 GAMDPLGLQDFDL--LR----------VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN 48
Query: 84 GHQEF---IVE--VLMLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEP 137
++ E V + +H LV L C + RL V EY+ G L H+
Sbjct: 49 DDEDIDWVQTEKHVFEQAS-NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK 106
Query: 138 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197
E R A + L YLH + +IYRDLK N+LLD++ + KL+D+G+ K
Sbjct: 107 LPEEH---ARFYSAE-ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159
Query: 198 GPVGDNTHVSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
G +T T GT Y APE D ++ GV++ E++ GR
Sbjct: 160 GLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-21
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 25/197 (12%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGYC 110
+GEG F K +S Q A+K ++ Q+ E+ + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 166
LV E + G L + + E + + M+ V A + ++H
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHMHDVG- 126
Query: 167 PPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
V++RDLK N+L +++ K+ DFG A+L P DN + T T Y APE
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHYAAPELLN 182
Query: 224 SGKLTLKSDIYSFGVVL 240
D++S GV+L
Sbjct: 183 QNGYDESCDLWSLGVIL 199
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 24/197 (12%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
+G G VY+ + + + A+K L + E+ +L L H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKAN 166
+ + LV E + G L D + + E + A A + + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSE--------RDAADAVKQILEAVAYLHENG- 168
Query: 167 PPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+++RDLK N+L D K++DFGL+K+ V + T GT GYCAPE
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILR 223
Query: 224 SGKLTLKSDIYSFGVVL 240
+ D++S G++
Sbjct: 224 GCAYGPEVDMWSVGIIT 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 36/206 (17%), Positives = 82/206 (39%), Gaps = 31/206 (15%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111
+G G FG V++ S + K + +G E+ +L++ H N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 112 SGDQRLLVYEYMPMGSLEDHLYDL-----EPDQEPLSWNTRMKIAVGAAR----GLEYLH 162
S ++ ++++E++ + + + E + V L++LH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNERE------------IVSYVHQVCEALQFLH 119
Query: 163 CKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
+ + D++ NI+ + K+ +FG A+ + + Y APE
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPE 173
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITG 246
++ +D++S G ++ L++G
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 29/209 (13%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLN------HEGLQGHQEFIVEVLMLSLLHHDNLVT 105
+G G F V K R +G A K + ++ EV +L + H N++T
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYL 161
L + +L+ E + G L D L + E E + A + G+ YL
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVYYL 130
Query: 162 HCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
H + + DLK NI+L + P K+ DFGLA + GT +
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF-GTPEFV 184
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITG 246
APE L L++D++S GV+ L++G
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEF---IVE--VLMLSLLH 99
+F +IG G + KV RL ++ ++ A++ + E + ++ E V + +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-N 111
Query: 100 HDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
H LV L C + RL V EY+ G L H+ E R A + L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH---ARFYSAE-ISLAL 166
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYC 217
YLH + +IYRDLK N+LLD++ + KL+D+G+ K G +T T GT Y
Sbjct: 167 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYI 220
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGR 247
APE D ++ GV++ E++ GR
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 100
+ ++ IG G G V + VAIK+L+ + + E++++ ++H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 101 DNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVG 153
N+++L+ T LV E M +L + Q L +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA--------NLCQVIQMELDHERMSYLLYQ 172
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVM 211
G+++LH A +I+RDLK +NI++ +D K+ DFGLA+ +V TR
Sbjct: 173 MLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 228
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
Y APE + DI+S G ++ E++ +
Sbjct: 229 ----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 41/228 (17%)
Query: 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIV-----------EV 92
+ I G +G V G G VAIK++ + G I+ E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 93 LMLSLLHHDNLVTLIGYCTSGDQRL-----LVYEYMPMGSLEDHLYDLE----PDQEPLS 143
+L+ HH N++ L ++ LV E M DL + +S
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR--------TDLAQVIHDQRIVIS 132
Query: 144 WNTRMK-IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
++ GL LH +A V++RDL NILL ++ + + DF LA+
Sbjct: 133 -PQHIQYFMYHILLGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 203 NT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 247
N +V+ R Y APE M T D++S G V+ E+ +
Sbjct: 189 NKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 49/230 (21%), Positives = 83/230 (36%), Gaps = 38/230 (16%)
Query: 30 SGARSFTFRELAIATRNFRE-----ANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQ 83
S F+ + ++G G GKV + +GQ A+K L
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68
Query: 84 GHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQR----LLVYEYMPMGSLEDHLYDLEPD 138
EV ++V ++ + L++ E M G L + +
Sbjct: 69 RQ-----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE---- 119
Query: 139 QEPLSWNTR-----MKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLS 190
+ ++ R M+ A +++LH + +RD+K N+L + D KL+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTA---IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 191 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 240
DFG AK + T T Y APE K D++S GV++
Sbjct: 174 DFGFAK---ETTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 100
+ ++ IG G G V + VAIK+L+ + + E++++ ++H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 101 DNLVTLIGYCTSGDQRL------LVYEYMP--------MGSLEDH----LYDLEPDQEPL 142
N++ L+ T +V E M M + LY +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM------- 136
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
G+++LH A +I+RDLK +NI++ +D K+ DFGLA
Sbjct: 137 ------------LCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAG 178
Query: 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+ + T + T Y APE + DI+S G ++ E+I G
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 44/212 (20%), Positives = 90/212 (42%), Gaps = 38/212 (17%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLML-SLLHHDNLVTLIGYC 110
+G G + +V++ + + + V +K L ++ E+ +L +L N++TL
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIV 100
Query: 111 TSGDQR--LLVYEYMPMGSLEDHLYDLEPDQ------EPLSWNTRMKIAVGAARGLEYLH 162
R LV+E++ + L E L + L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 163 CKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAP 219
+++RD+K N+++D++ +L D+GLA+ G N V++R + P
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 220 EYAMSGKLTLKS-DIYSFGVVLLELITGRKAM 250
E + ++ S D++S G +L +I ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 28/200 (14%), Positives = 56/200 (28%), Gaps = 42/200 (21%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLI 107
G + ++ + VA+ ++ +G+ QE + L LS + + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 167
+ L+V E++ GSL++ S ++ A + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 227
V + + + D G L
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVLA--------------YPATMPDA------- 179
Query: 228 TLKSDIYSFGVVLLELITGR 247
+ DI G L L+ R
Sbjct: 180 NPQDDIRGIGASLYALLVNR 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 32/202 (15%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIG-Y 109
+G G GKV + + + A+K L + EV L ++V ++ Y
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 124
Query: 110 CTSGDQR---LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR-----MKIAVGAARGLEYL 161
R L+V E + G L + D + ++ R MK A ++YL
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASEIMKSIGEA---IQYL 177
Query: 162 HCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
H + +RD+K N+L + KL+DFG AK + ++T T Y A
Sbjct: 178 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPYYVA 231
Query: 219 PEYAMSGKLTLKSDIYSFGVVL 240
PE K D++S GV++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 48/228 (21%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN---HEGLQGHQEFIVEVLMLSLLH 99
+ + IGEG +G V + VAIK+++ H+ Q + E+ +L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRFR 83
Query: 100 HDNLVTLIGYCTSGDQRL-----LVYEYMP--------MGSL-EDH----LYDLEPDQEP 141
H+N++ + + +V + M L DH LY +
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------ 137
Query: 142 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPV 200
RGL+Y+H AN V++RDLK +N+LL+ + K+ DFGLA+ P
Sbjct: 138 -------------LRGLKYIH-SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 201 GDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
D+T T + T Y APE ++ K T DI+S G +L E+++ R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 100
+R+ +G G +G V +G VAIK+L + + E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 101 DNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
+N++ L+ T + LV +M L L + L + +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHE-KLGEDRIQFLVYQM 137
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
+GL Y+H A +I+RDLK N+ ++ D K+ DFGLA+ +V TR
Sbjct: 138 LKGLRYIH-AAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW---- 190
Query: 215 GYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 247
Y APE ++ + T DI+S G ++ E+ITG+
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 49/226 (21%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 100
+ + +G G +G V SG+ VAIK+L+ + + E+L+L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 101 DNLVTLIGYCTSGDQRL------LVYEYMP--------MGSLEDH----LYDLEPDQEPL 142
+N++ L+ T LV +M + E+ +Y +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML------ 136
Query: 143 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202
+GL+Y+H A V++RDLK N+ ++ D K+ DFGLA+
Sbjct: 137 -------------KGLKYIH-SAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 247
+V TR Y APE +S DI+S G ++ E++TG+
Sbjct: 181 TGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 53/235 (22%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 102
+ + +G GG G V+ + + VAIK++ Q + + E+ ++ L HDN
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 103 LVTLIGYCTSGDQRL--------------LVYEYMP--------MGSL-EDH----LYDL 135
+V + +L +V EYM G L E+H +Y L
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 136 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGL 194
RGL+Y+H AN V++RDLK AN+ ++ D K+ DFGL
Sbjct: 130 -------------------LRGLKYIH-SAN--VLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 195 AK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
A+ + P + + + T Y +P +S T D+++ G + E++TG+
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-17
Identities = 53/233 (22%), Positives = 96/233 (41%), Gaps = 51/233 (21%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN-HEGLQGHQEFIVEVLMLSLLHHD 101
+ +F+ +L+GEG +G V +G++VAIK++ + + E+ +L H+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 102 NLVTLIGYCTSGDQRL-----LVYEYMP--------MGSL-EDH----LYDLEPDQEPLS 143
N++T+ ++ E M L +DH +Y
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT-------- 121
Query: 144 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA----KLGP 199
R ++ LH +N VI+RDLK +N+L++++ + K+ DFGLA +
Sbjct: 122 -----------LRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 200 VGDNTHVSTRVMGTY----GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
M + Y APE ++ + D++S G +L EL R
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLHH 100
++ + +G G +G V ++G VA+K+L+ + + + E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 101 DNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
+N++ L+ T LV M L ++ Q L+ + +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQ-KLTDDHVQFLIYQI 141
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
RGL+Y+H A+ +I+RDLK +N+ ++ D K+ DFGLA+ +V+TR
Sbjct: 142 LRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW---- 194
Query: 215 GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
Y APE ++ DI+S G ++ EL+TGR
Sbjct: 195 -YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 55/264 (20%), Positives = 95/264 (35%), Gaps = 74/264 (28%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN----HEGLQGHQEFIVEVLMLSLL 98
+ +LIG G +G V + ++VAIK++ + + E+ +L+ L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC--KRILREIAILNRL 109
Query: 99 HHDNLVTLIGYCTSGDQRL-----LVYEYMPM---------GSL-EDH----LYDLEPDQ 139
+HD++V ++ D +V E L E H LY+L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNL---- 165
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
G++Y+H A +++RDLK AN L++ D + K+ DFGLA+
Sbjct: 166 ---------------LVGVKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
Query: 200 VGDNTHVSTRVMGTYG-------------------------YCAPEYAMSGKL-TLKSDI 233
+N + + Y APE + + T D+
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267
Query: 234 YSFGVVLLELITGRKAMDLSKGQG 257
+S G + EL+ K
Sbjct: 268 WSIGCIFAELLNMIKENVAYHADR 291
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 70/309 (22%), Positives = 110/309 (35%), Gaps = 85/309 (27%)
Query: 27 KEKSGARSFTFRELA--IATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EG 81
SG + F+ + N+ +LIG G +G VY + + VAIK++N E
Sbjct: 6 HHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED 65
Query: 82 LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL-----LVYEYM----------PMG 126
L + + E+ +L+ L D ++ L D +V E P+
Sbjct: 66 LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF 125
Query: 127 SLEDH----LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 182
E+H LY+L L G ++H ++ +I+RDLK AN LL+
Sbjct: 126 LTEEHIKTILYNL------L-------------LGENFIH-ESG--IIHRDLKPANCLLN 163
Query: 183 NDFNPKLSDFGLAKLGPVGDNT-------------------------HVSTRVMGTYGYC 217
D + K+ DFGLA+ +T HV TR Y
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYR 218
Query: 218 APEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLS--------KGQGEQNLVSWSRPF 268
APE + + T DI+S G + EL+ ++ G L
Sbjct: 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSK 278
Query: 269 LKDQKKFVH 277
+K
Sbjct: 279 KVHEKSNRD 287
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 23/215 (10%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNL 103
+++ IGEG FG +++G L + Q VAIK + E LL +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGI 68
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
+ + G +LV + + SLED L DL + S T A ++ +H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGP-SLED-LLDLCGRK--FSVKTVAMAAKQMLARVQSIHE 124
Query: 164 KANPPVIYRDLKSANILLDNDFNPK-----LSDFGLAKL-GPVGDNTHVSTR----VMGT 213
K+ ++YRD+K N L+ + + DFG+ K H+ R + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 214 YGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 247
Y G+ + + D+ + G V + + G
Sbjct: 182 ARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNL 103
NFR IG G FG++ G+ L + + VAIK + + +E L D +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGI 67
Query: 104 VTLIGYCTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+ + G +V E +G SLED L+DL S T + IA+ +EY+H
Sbjct: 68 PQVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRT--FSLKTVLMIAIQLISRMEYVH 122
Query: 163 CKANPPVIYRDLKSANILLDNDFNPK-----LSDFGLAKL-GPVGDNTHVSTR----VMG 212
K +IYRD+K N L+ N + DF LAK H+ R + G
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 213 TYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 247
T Y GK + + D+ + G + + + G
Sbjct: 180 TARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 39 ELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL 97
EL + R +R IG G FG +Y G + +G+ VAIK + H + +E + +
Sbjct: 4 ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKM 60
Query: 98 LHH-DNLVTLIGYCTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAA 155
+ + T+ GD ++V E +G SLED L++ + S T + +A
Sbjct: 61 MQGGVGIPTIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRK--FSLKTVLLLADQMI 115
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPK---LSDFGLAKL-GPVGDNTHVSTR-- 209
+EY+H K I+RD+K N L+ + DFGLAK + H+ R
Sbjct: 116 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 210 --VMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 247
+ GT Y A G + + D+ S G VL+ G
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNL 103
FR IG G FG++Y G +++ + VAIK N + H + + E + +L +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGI 65
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
+ + GD +LV + + SLED L++ LS T + +A +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGP-SLED-LFNFCS--RKLSLKTVLMLADQMINRVEFVHS 121
Query: 164 KANPPVIYRDLKSANILLDNDFNPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTYG 215
K+ ++RD+K N L+ + DFGLAK + H+ R + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 216 YCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 247
Y A G + + D+ S G VL+ + G
Sbjct: 179 Y-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 44/221 (19%), Positives = 92/221 (41%), Gaps = 39/221 (17%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLH---------- 99
+G G F V+ + + + VA+K + + + E+ +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 100 -HDNLVTLIGY----CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAV 152
++++ L+ + +G ++V+E +G +L L + + + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFE--VLGE---NLLALIKKYEHRGIPLIYVKQISK 138
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLD------NDFNPKLSDFGLAKLGPVGDNTHV 206
GL+Y+H + +I+ D+K N+L++ N K++D G A +
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 207 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
TR Y +PE + +DI+S ++ ELITG
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 2e-13
Identities = 53/308 (17%), Positives = 88/308 (28%), Gaps = 62/308 (20%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQ------ 86
F + T + IGEG FG+V++ + VAIK + EG
Sbjct: 9 GPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 87 --EFIVEVLMLSLLH---------HDNLVTLIGY--CTSGDQRLLVYEYMPMGS------ 127
E + E+++ L + + L LL+ + S
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 128 ----------------LEDHLYDLE-PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
E DLE + S T I L
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FE 184
Query: 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP--EYAMSGKLT 228
+RDL N+LL KL K + + + G +Y +S
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLER 233
Query: 229 LKSDIYSFGVVLLELITGRKAM--DLSKGQGEQNLVSWSRPFLKDQKKFVH-LVDPLLHG 285
++ + +L TG D+ + ++N W ++H L D +L
Sbjct: 234 DGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ 293
Query: 286 RYPRRCLN 293
+ N
Sbjct: 294 MTFKTKCN 301
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLH-HD-----NL 103
+IG+G FG+V K + Q VA+K + N + H++ E+ +L L D N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 104 VTLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGA 154
+ ++ C + +E L +LY+L + + S K A
Sbjct: 162 IHMLENFTFRNHIC-------MTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMG 212
+ L+ LH +I+ DLK NILL K+ DFG + T++ +R
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-- 264
Query: 213 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
Y APE + + + D++S G +L EL+TG
Sbjct: 265 ---YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 61/243 (25%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNH--EGLQGHQEFIVEVLMLSLLH- 99
R + +G+G +G V+K +G++VA+K++ + Q E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 100 HDNLVTLIGYCTSGDQR--LLVYEYMP--------MGSLED-H----LYDLEPDQEPLSW 144
H+N+V L+ + + R LV++YM LE H +Y L
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL--------- 118
Query: 145 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA--------- 195
+ ++YLH +++RD+K +NILL+ + + K++DFGL+
Sbjct: 119 ----------IKVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 196 ------KLGPVGDNTHVSTRVMGTY----GYCAPEYAMSGKL-TLKSDIYSFGVVLLELI 244
+ +N ++ Y Y APE + T D++S G +L E++
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 245 TGR 247
G+
Sbjct: 226 CGK 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 61/216 (28%), Positives = 92/216 (42%), Gaps = 39/216 (18%)
Query: 51 NLIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLL-HHD-----N 102
+LIG+G FG+V K + VAIK + N + + +EV +L L+ HD
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY 117
Query: 103 LVTLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVG 153
+V L + C LV+E L +LYDL + +S N K A
Sbjct: 118 IVHLKRHFMFRNHLC-------LVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVM 211
L +L +I+ DLK NILL N K+ DFG + ++ +R
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
Y +PE + L D++S G +L+E+ TG
Sbjct: 224 ----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 36/159 (22%), Positives = 58/159 (36%), Gaps = 31/159 (19%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIG-Y 109
+G G GKV + + + A+K L + EV L ++V ++ Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 80
Query: 110 CTSGDQRLLVY---EYMPMGSLED------HLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
R + E + G L E + + MK A ++Y
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKSIGEA---IQY 132
Query: 161 LHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAK 196
LH + +RD+K N+L + KL+DFG AK
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 31/175 (17%), Positives = 63/175 (36%), Gaps = 30/175 (17%)
Query: 45 RNFREANLIGEGGFGKVYKGR---------LESGQLVAIK------QLNHEGL----QGH 85
R ++ + G +Y+ Q ++K +L +E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 86 QEFIVEVLMLSLLHHDNLVTLIGY-CTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLS 143
+ + L + T +G+ R LV +G SL+ D+ P LS
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQS-ALDVSPKH-VLS 157
Query: 144 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK--LSDFGLAK 196
+ +++A LE+LH ++ ++ + NI +D + + L+ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 45/236 (19%), Positives = 85/236 (36%), Gaps = 45/236 (19%)
Query: 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIK-------------QLNHEG----LQGHQE 87
++ IG+GGFG +Y + S + V L E E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 88 FIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM----GSLEDHLYDLEPDQEPLS 143
I + + L + + G Y +M M L+ +Y+ + S
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQK-IYEANAKR--FS 150
Query: 144 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK--LSDFGLAKL-GPV 200
T +++++ LEY+H ++ D+K++N+LL+ + L D+GLA P
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 201 GDNTHVSTR----VMGTYGYCAPEYA-----MSGKLTLKSDIYSFGVVLLELITGR 247
G + + GT E+ + + D+ G +++ +TG
Sbjct: 208 GVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 33/170 (19%), Positives = 62/170 (36%), Gaps = 23/170 (13%)
Query: 45 RNFREANLIGEGGFGKVYKG-RLESGQLVAIK----------QLNHEG-----LQGHQEF 88
+ IG GGFG +Y + A L E + ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDC 95
Query: 89 IVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 148
I + + L + + G + + Y +M M L L + +T +
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRS-YRFMVMERLGIDLQKISGQNGTFKKSTVL 154
Query: 149 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK--LSDFGLAK 196
++ + LEY+H ++ D+K+AN+LL + L+D+GL+
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 48/258 (18%), Positives = 81/258 (31%), Gaps = 75/258 (29%)
Query: 53 IGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH--------HDNL 103
+G G F V+ ++ + VA+K + + + E+ +L + + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 104 VTLIGYCT----SGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
V L+ +G +V+E +G L + PL KI +GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQQVLQGL 159
Query: 159 EYLHCKANPPVIYRDLKSANILL------------------------------------- 181
+YLH K +I+ D+K NILL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 182 ------------DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 229
K++D G A + TR Y + E +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272
Query: 230 KSDIYSFGVVLLELITGR 247
+DI+S + EL TG
Sbjct: 273 PADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 2e-08
Identities = 52/307 (16%), Positives = 91/307 (29%), Gaps = 80/307 (26%)
Query: 33 RSFTFRELAIATRNFREANLI---GEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFI 89
R + +L A R A + G G GK VA+ +Q +F
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGSGK---------TWVALDVCLSYKVQCKMDF- 182
Query: 90 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL---SWNT 146
++ L+L C S + L + L+ LY ++P+ S N
Sbjct: 183 -KIFWLNL----------KNCNSPETVLEM--------LQKLLYQIDPNWTSRSDHSSNI 223
Query: 147 RMKIAVGAARGLEYLHCKANPP--VIYRDLKSANILLDNDFNPK---L---SDFGLAKLG 198
+++I A L K ++ ++++A N FN L +
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW--NAFNLSCKILLTTRFKQVTDFL 281
Query: 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 258
TH+S + E LL + DL + E
Sbjct: 282 SAATTTHISL-DHHSMTLTPDE-------VKS---------LLLKYLDCRPQDLPR---E 321
Query: 259 QNLVSWSRPFL-----KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLN--EEANFRP 311
+ P + + + D H + L + LN E A +R
Sbjct: 322 VLTTN---PRRLSIIAESIRDGLATWDNWKHVNCDK--LTTII---ESSLNVLEPAEYRK 373
Query: 312 LINDIVV 318
+ + + V
Sbjct: 374 MFDRLSV 380
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 67/238 (28%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLLHHD-----NLV 104
+G+G FG+V + +++ + A+K + N + + +E +L + +D N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY--TRSAKIEADILKKIQNDDINNNNIV 99
Query: 105 TLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAA 155
G C L++E L LY++ + +
Sbjct: 100 KYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNP-------------------------KLS 190
+ L YL K + + + DLK NILLD+ + KL
Sbjct: 148 KALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 191 DFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
DFG A D + ++TR Y APE ++ + SD++SFG VL EL TG
Sbjct: 205 DFGCA--TFKSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 48/235 (20%), Positives = 79/235 (33%), Gaps = 65/235 (27%)
Query: 52 LIGEGGFGKVYKG--RLESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLL-HHD-----N 102
+GEG FGKV + VA+K + N + +E+ +L + D
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY--REAARLEINVLKKIKEKDKENKFL 83
Query: 103 LVTLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVG 153
V + + C + +E L + ++ E + +P +A
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-------------------KLSDFGL 194
L +LH + + + DLK NIL N +++DFG
Sbjct: 132 LCHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 195 AKLGPVGDNTH---VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
A H V+TR Y PE + D++S G +L E G
Sbjct: 189 ATFD---HEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 55/234 (23%), Positives = 86/234 (36%), Gaps = 63/234 (26%)
Query: 52 LIGEGGFGKVYKG--RLESGQLVAIKQL-NHEGLQGHQEFIVEVLMLSLL-HHD-----N 102
+GEG FGKV + G+ VA+K + N + + E+ +L L D
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY--CEAARSEIQVLEHLNTTDPNSTFR 78
Query: 103 LVTLIGY-------CTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVG 153
V ++ + C +V+E L YD E P + K+A
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-------------------KLSDFGL 194
+ + +LH + + DLK NIL K+ DFG
Sbjct: 127 ICKSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 195 AKLGPVGDN--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 246
A ++ T VSTR Y APE ++ + D++S G +L+E G
Sbjct: 184 ATY--DDEHHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 360 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.76 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.58 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.41 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.1 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.95 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.43 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.39 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.28 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.02 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.46 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.43 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.0 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.08 | |
| 3eps_A | 578 | Isocitrate dehydrogenase kinase/phosphatase; ATP-b | 83.24 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=398.14 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=218.6
Q ss_pred hhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
..+|.+.+.||+|+||+||+|++. ++..||+|++........+++.+|++++++++||||+++++++.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 468999999999999999999753 47789999998766556678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 118 LVYEYMPMGSLEDHLYDLE---------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~---------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
+||||+++|+|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997632 23457999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchh
Q 018128 189 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
|+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||...... ... ..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~---~~ 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVI---EC 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH---HH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HH
Confidence 999999986444333334444568999999999999999999999999999999998 89999643211 000 00
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
+........|..++.++.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 243 -----------i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 -----------ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -----------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 001111234667888999999999999999999999999999998654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=398.95 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=221.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+|++++.||+|+||+||+|++. +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999876 69999999987542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||++||+|.+++.+ .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999964 467999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
..........+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~---------- 248 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIK---------- 248 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc----------
Confidence 44444455678999999999999999999999999999999999999999643211 11111111
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCCCCCC
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAGARGV 341 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~~~~~ 341 (360)
. ...++..++.++.+||.+||+.||.+|||++|++..- .| -.|||=++.++...
T Consensus 249 ~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~-~i----~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 249 L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG-PL----KAHPFFESVTWENL 302 (311)
T ss_dssp T--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH-HH----HTSGGGTTCCCTTG
T ss_pred C--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCH-HH----HCCCCcCCCCHHHh
Confidence 0 1134556778899999999999999999999875321 11 14677666655443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=405.92 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=204.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++++.||+|+||+||+|++. +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999876 699999999976543 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
||++|+|.+++.. ..+..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 104 y~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-- 176 (350)
T 4b9d_A 104 YCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-- 176 (350)
T ss_dssp CCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC--
T ss_pred CCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec--
Confidence 9999999999965 23556899999999999999999999999 9999999999999999999999999998532
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........ .
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~----------~ 240 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIIS----------G 240 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH----------T
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHc----------C
Confidence 1222234467999999999999999999999999999999999999999743211 11111111 0
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ....+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 241 S-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 01234567888999999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=397.94 Aligned_cols=263 Identities=30% Similarity=0.452 Sum_probs=212.5
Q ss_pred hhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
..+|.+.+.||+|+||+||+|+.. +++.||||++........+++.+|+++++.++||||+++++++.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 467888999999999999999753 47889999998766566678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 118 LVYEYMPMGSLEDHLYDLEP-----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
|||||+++|+|.+++..... ...++++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999976432 2346999999999999999999999999 999999999999999999
Q ss_pred eEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccc
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 265 (360)
+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||....... . .
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~---~ 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---A---I 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---H---H
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---H---H
Confidence 99999999986544444444455679999999999999999999999999999999999 899996432110 0 0
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
.. +....+...|..++.++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 271 ~~-----------i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DC-----------ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HH-----------HHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH-----------HHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 00 001112234667888999999999999999999999999999999654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=399.84 Aligned_cols=257 Identities=24% Similarity=0.329 Sum_probs=215.8
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
..|++.+.||+|+||+||+|++. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+.+||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999876 69999999998776666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++|+|.+++.. .++++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++..... .
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC--C
Confidence 99999999954 56999999999999999999999999 99999999999999999999999999986432 2
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..... ... .
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~---~~i~~-------~~~--~ 288 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM---KMIRD-------NLP--P 288 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHHHH-------SSC--C
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH---HHHHc-------CCC--C
Confidence 223345689999999999999999999999999999999999999996332110 00 00000 000 0
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCC
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAG 337 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~ 337 (360)
.......++.++.+||.+||+.||.+|||+.|++ .|||-.++.
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l-----------~Hp~~~~~~ 331 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL-----------KHPFLAKAG 331 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------TCGGGGGCC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------cCHhhcCCC
Confidence 1122346788999999999999999999999998 567766543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-55 Score=394.12 Aligned_cols=264 Identities=21% Similarity=0.247 Sum_probs=215.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
..|++.+.||+|+||+||+|++. +|+.||+|++...... .+|+.+++.++||||+++++++.+.+.+||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56889999999999999999876 6999999999765322 46999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeecCCccccCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg~~~~~~~~~ 202 (360)
++|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+| .+||+|||++.......
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999964 457999999999999999999999999 99999999999999987 59999999998654332
Q ss_pred Ccc---eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 203 NTH---VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 203 ~~~---~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~------ 273 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL------CLKIASEPP------ 273 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC------HHHHHHSCC------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHcCCC------
Confidence 221 22345799999999999999999999999999999999999999964332111 011111000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc--CCCCCCCC
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR--DSHPVSRN 335 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~--~~~~~~~~ 335 (360)
.....++.++.++.++|.+||+.||.+|||+.|+++.|....... -.|||...
T Consensus 274 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 274 ---PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp ---GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred ---CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 001235677889999999999999999999999999998887654 46788653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=388.55 Aligned_cols=261 Identities=30% Similarity=0.440 Sum_probs=215.7
Q ss_pred HhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
...++++.+.||+|+||+||+|+.. +++.||||.+..... ...+++.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 3467888999999999999999752 467899999865432 345689999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 183 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~ 183 (360)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECC
Confidence 9999999999999999965321 1346899999999999999999999999 999999999999999
Q ss_pred CCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchh
Q 018128 184 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLV 262 (360)
Q Consensus 184 ~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 262 (360)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||...... ...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~ 257 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVV 257 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHH
Confidence 99999999999986544444444455679999999999999999999999999999999998 89999643211 111
Q ss_pred ccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
..+........|..++.++.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 258 --------------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 --------------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --------------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01111112234667889999999999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=389.03 Aligned_cols=267 Identities=28% Similarity=0.452 Sum_probs=210.5
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
..|++..+++++.+.||+|+||+||+|++.. .||||++..... ...+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 3466778899999999999999999998753 589999865432 334678999999999999999999998754 56
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+|||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCc
Confidence 8999999999999999965 4467999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceeccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
................||+.|+|||++.+ .+++.++|||||||++|||+||..||........ .. ......
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~----~~~~~~ 253 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--II----FMVGRG 253 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HHHHTT
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HH----HHHhcC
Confidence 86544333344455689999999999863 4689999999999999999999999964321100 00 000000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
...+ .....+..++..+.+|+.+||+.||.+|||+.||++.|+.|+.
T Consensus 254 -----~~~p-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 254 -----YASP-DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp -----CCCC-CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred -----CCCC-CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0000 0112345678899999999999999999999999999998854
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=401.46 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=215.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
+.|++.+.||+|+||+||+|++. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999876 69999999998776667778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
+||+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++..... .
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~ 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--E 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS--S
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC--C
Confidence 99999999954 56999999999999999999999999 99999999999999999999999999986432 2
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|..||....... .. .... ....+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~---~~i~-------~~~~~-- 365 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM---KMIR-------DNLPP-- 365 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH---HHHH-------HSCCC--
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH---HHHH-------cCCCC--
Confidence 223345689999999999999999999999999999999999999996322110 00 0000 00000
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCCC
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNAG 337 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~~ 337 (360)
.......++.++.+||.+||+.||.+|||+.|++ .|||-.++.
T Consensus 366 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell-----------~Hp~~~~~~ 408 (423)
T 4fie_A 366 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL-----------KHPFLAKAG 408 (423)
T ss_dssp CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHT-----------TCGGGGGCC
T ss_pred CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHh-----------cCHHhcCCC
Confidence 1122345678899999999999999999999998 567766543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=381.48 Aligned_cols=245 Identities=26% Similarity=0.340 Sum_probs=194.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|+||+||+|++. +++.||+|++.+... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999875 699999999876532 33467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+ +|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6799999854 467999999999999999999999999 99999999999999999999999999975332
Q ss_pred CCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||..... .........
T Consensus 165 ---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~--------- 226 (275)
T 3hyh_A 165 ---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISN--------- 226 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH---------
T ss_pred ---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHc---------
Confidence 222334679999999999998876 5899999999999999999999963221 111111111
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ...++..++.++.+||.+||+.||++|||+.|+++
T Consensus 227 -~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 227 -G--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -T--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -C--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 01234567788999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=385.89 Aligned_cols=246 Identities=27% Similarity=0.329 Sum_probs=199.4
Q ss_pred hcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
++|++++.||+|+||+||+|+.. .++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 68999999999999999999753 478999999876532 233468889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
||||++||+|.+++.+ .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999964 467999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.. ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 177 ~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~-------- 240 (304)
T 3ubd_A 177 ID--HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILK-------- 240 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH--------
T ss_pred cC--CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHc--------
Confidence 22 222334467999999999999999999999999999999999999999743211 10111111
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCH-----HHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIV 317 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~eil 317 (360)
. ...++..++.++.+||.+||+.||.+|||+ +|++
T Consensus 241 --~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil 280 (304)
T 3ubd_A 241 --A--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK 280 (304)
T ss_dssp --C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHH
T ss_pred --C--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHH
Confidence 0 113455678889999999999999999985 5666
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=375.96 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=198.5
Q ss_pred hcc-cccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe----CCee
Q 018128 45 RNF-REANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQR 116 (360)
Q Consensus 45 ~~y-~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~----~~~~ 116 (360)
++| ++.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 78889999999999999876 589999999875532 234578999999999999999999999865 3457
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-CCceEEeecCCc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLA 195 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-~~~v~L~Dfg~~ 195 (360)
||||||+++|+|.+++.+ ...+++..++.++.||+.||.|||+++ ++|+||||||+|||++. ++.+||+|||++
T Consensus 105 ~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999999964 467999999999999999999999873 45999999999999975 789999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ......
T Consensus 180 ~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~-------- 241 (290)
T 3fpq_A 180 TLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRR-------- 241 (290)
T ss_dssp GGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHH--------
T ss_pred EeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHH--------
Confidence 75322 12234679999999998865 6999999999999999999999999632211 000000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
+........++...+.++.+||.+||+.||.+|||+.|++
T Consensus 242 --i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 242 --VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp --HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred --HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0000111112334556799999999999999999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=387.52 Aligned_cols=273 Identities=25% Similarity=0.366 Sum_probs=224.0
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEecC------CCEEEEEEcccCCc-cchHHHHHHHHHhhccCC-Ccccce
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLES------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHH-DNLVTL 106 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~------~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~-p~i~~~ 106 (360)
+..+.|++..++|++++.||+|+||+||+|.+.. ++.||+|.+..... .....+.+|+.+++.++| |||+++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3456788999999999999999999999997542 35799999876533 234578899999999965 999999
Q ss_pred eEEEEe-CCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 018128 107 IGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 173 (360)
Q Consensus 107 ~~~~~~-~~~~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~d 173 (360)
++++.+ .+.+++|||||++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 999865 4568999999999999999975321 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccc
Q 018128 174 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 252 (360)
Q Consensus 174 i~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~ 252 (360)
|||+|||+++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986544444444555678999999999999999999999999999999998 8999964
Q ss_pred cCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 253 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
..... .+...+....+...|..++.++.+++.+||+.||.+|||+.||++.|+.+...
T Consensus 291 ~~~~~----------------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 32110 01111111122344667788999999999999999999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=370.37 Aligned_cols=277 Identities=24% Similarity=0.303 Sum_probs=203.3
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC----eeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~----~~~lv 119 (360)
.++|.+.+.||+|+||+||+|++. |+.||||++...... ......|+..+..++||||+++++++.+.+ ..++|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 467999999999999999999885 899999998654321 223345666677889999999999997654 57999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-----NPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
|||+++|+|.+++.. .++++..+..++.|++.||.|||++. .++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999954 56899999999999999999999871 12399999999999999999999999999
Q ss_pred ccccCCCCCcc--eecccccccccccccccccC------CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch
Q 018128 195 AKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 195 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+.......... ......||+.|+|||++.+. .++.++|||||||++|||+||..||........ ....+..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-p~~~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-PYYDLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-TTTTTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc-cchhccc
Confidence 97644333221 12335799999999998754 467899999999999999999988754332111 0000000
Q ss_pred hhhhccccchhcccccccCCC-----ChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 267 PFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
.................+... +...+..+.+|+.+||+.||.+|||+.||++.|++|..+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 000000000011111222222 23466789999999999999999999999999999976543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=364.02 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=188.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCC--------
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-------- 114 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~-------- 114 (360)
.+|++.+.||+|+||+||+|++. +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999876 6999999998765432 3457889999999999999999999986544
Q ss_pred ----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEe
Q 018128 115 ----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 190 (360)
Q Consensus 115 ----~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~ 190 (360)
.+|+||||+++|+|.+++.... .....++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999996532 2233566778999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCcc----------eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc
Q 018128 191 DFGLAKLGPVGDNTH----------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 260 (360)
Q Consensus 191 Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~ 260 (360)
|||+++......... .....+||+.|+|||++.+..++.++|||||||++|+|++ ||.....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----- 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----- 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----
Confidence 999998644322211 1223579999999999999999999999999999999996 6642110
Q ss_pred hhccchhhhhccccchhcccccccCCCC---hhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 261 LVSWSRPFLKDQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ..+.. .....++ ......+.+||.+||+.||.+|||+.|+++
T Consensus 233 ~~----------~~~~~----~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RV----------RTLTD----VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH----------HHHHH----HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----------HHHHH----HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 00000 0111222 233456788999999999999999999984
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=366.43 Aligned_cols=266 Identities=22% Similarity=0.293 Sum_probs=200.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe------CCe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQ 115 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~------~~~ 115 (360)
++|++++.||+|+||+||+|++. +|+.||||++..... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999876 699999999975532 234568899999999999999999998754 367
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
+||||||++ |+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 134 ~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 68999994 4678999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC--CcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-ccc----hh
Q 018128 196 KLGPVGD--NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS----RP 267 (360)
Q Consensus 196 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~----~~ 267 (360)
....... ........+||+.|+|||++.+. .++.++||||+||++|+|++|.+||............ ... ..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8543322 12233456899999999998875 5699999999999999999999999643321100000 000 00
Q ss_pred hhhc--cccchhc---ccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 FLKD--QKKFVHL---VDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ~~~~--~~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... ....... ....... ...+..+.++.+||.+||+.||.+|||+.|+|+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0000000 0000000 011245678999999999999999999999984
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=359.20 Aligned_cols=263 Identities=20% Similarity=0.254 Sum_probs=198.3
Q ss_pred HhhcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~ 117 (360)
..++|++.+.||+|+||+||+|+++ .++.||+|.+... .....+.+|+++++.+ +||||+++++++.+.+..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3578999999999999999999753 4678999988654 3345788899999988 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-CceEEeecCCcc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAK 196 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-~~v~L~Dfg~~~ 196 (360)
+||||+++++|.+++ +.+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+++
T Consensus 97 lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999998 24899999999999999999999999 9999999999999877 799999999997
Q ss_pred ccCCCCCc--------------------------ceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCc
Q 018128 197 LGPVGDNT--------------------------HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKA 249 (360)
Q Consensus 197 ~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~p 249 (360)
........ ......+||+.|+|||++.+. .++.++||||+||++|+|++|..|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 54332211 112235799999999999875 489999999999999999999999
Q ss_pred ccccCccCcc--chh---------ccch------------------hhhhcccc----chh----cccccccCCCChhhH
Q 018128 250 MDLSKGQGEQ--NLV---------SWSR------------------PFLKDQKK----FVH----LVDPLLHGRYPRRCL 292 (360)
Q Consensus 250 f~~~~~~~~~--~~~---------~~~~------------------~~~~~~~~----~~~----~~~~~~~~~~~~~~~ 292 (360)
|......... .+. .+.. ........ ... ..............+
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9543321100 000 0000 00000000 000 000000011123456
Q ss_pred HHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 293 NYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 293 ~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.++.+||.+||+.||.+|||++|++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHh
Confidence 7889999999999999999999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=350.92 Aligned_cols=288 Identities=42% Similarity=0.703 Sum_probs=240.9
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
++..++....++|++.+.||+|+||+||+++..+++.|++|++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33444445668999999999999999999998889999999988776666778999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999999765444557999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
+................++..|+|||++.+..++.++||||||+++|+|++|..||.............|...... ...
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 264 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQ 264 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-ccc
Confidence 9764433333333445689999999999988999999999999999999999999976554444333333322211 233
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
....+++......+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 4445555555667788999999999999999999999999999999998654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=352.72 Aligned_cols=302 Identities=43% Similarity=0.710 Sum_probs=246.4
Q ss_pred CCCCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccc
Q 018128 27 KEKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVT 105 (360)
Q Consensus 27 ~~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~ 105 (360)
......+.++..++.+..++|++.+.||+|+||.||+++..+++.||+|++...... ....+.+|+.+++.++||||++
T Consensus 12 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp ---CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred cccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 335557889999999999999999999999999999998878999999998765432 2347889999999999999999
Q ss_pred eeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCeeeCCCCCCcEEEe
Q 018128 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK---ANPPVIYRDLKSANILLD 182 (360)
Q Consensus 106 ~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~~~~i~H~di~p~NIlv~ 182 (360)
+++++.+....++||||+++++|.+++.........+++..++.++.|++.||.|||++ + ++|+||||+||+++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLD 168 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEEC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEEC
Confidence 99999999999999999999999999988666677799999999999999999999999 7 99999999999999
Q ss_pred CCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCcc--Cccc
Q 018128 183 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ--GEQN 260 (360)
Q Consensus 183 ~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~--~~~~ 260 (360)
.++.++|+|||++....... ........++..|+|||++.+..++.++||||||+++|+|++|..||+..... ....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp TTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 99999999999998643322 22334456899999999999888999999999999999999999999633211 1222
Q ss_pred hhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCC
Q 018128 261 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 333 (360)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~ 333 (360)
...+...... ........+......++...+..+.+++.+||+.||.+|||+.++++.|+..........|.
T Consensus 248 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 319 (326)
T 3uim_A 248 LLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQ 319 (326)
T ss_dssp HHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC---
T ss_pred HHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhh
Confidence 2333333222 33445555666666778889999999999999999999999999999998765554444443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=379.05 Aligned_cols=251 Identities=21% Similarity=0.260 Sum_probs=210.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
++|++.+.||+|+||+||++.+. +|+.||+|++........+.+.+|+.+|+.++||||+++++++.+...+|+||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999876 69999999998776666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC--CceEEeecCCccccCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND--FNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~--~~v~L~Dfg~~~~~~~~ 201 (360)
+||+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 237 ~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999854 4467999999999999999999999999 9999999999999754 88999999999865432
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........ .
T Consensus 311 ---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~~~--------~ 373 (573)
T 3uto_A 311 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCD--------W 373 (573)
T ss_dssp ---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTTC--------C
T ss_pred ---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHhCC--------C
Confidence 223345799999999999999999999999999999999999999964332110 00000000 0
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++.++.+||.+||+.||.+|||+.|+++
T Consensus 374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111122356778999999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=373.61 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=202.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHH---HHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFI---VEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~---~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
++|++++.||+|+||+||+|++. +|+.||+|++.+... ....... .++.+++.++||||+++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999876 699999999865422 2222333 3466777789999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
|||||++||+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++..
T Consensus 269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999964 467999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcceecccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..... ....+||+.|+|||++. +..++.++|+|||||++|+|++|..||........... ......
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~------ 408 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLT------ 408 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHH------
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcC------
Confidence 43222 23468999999999997 45799999999999999999999999964332111100 000000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
....++..++.++.+||.+||+.||.+|++ ++||++
T Consensus 409 ------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 ------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111345677889999999999999999998 677774
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=340.40 Aligned_cols=264 Identities=25% Similarity=0.371 Sum_probs=217.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||+|+||+||++.+. +++.|++|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 578999999999999999999876 5899999998766666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999976 3567999999999999999999999999 9999999999999999999999999997643322
Q ss_pred Ccc------------eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh
Q 018128 203 NTH------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 203 ~~~------------~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||............. .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~----- 236 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-V----- 236 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-H-----
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-h-----
Confidence 211 1114568999999999999999999999999999999999999986433221111000 0
Q ss_pred ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
.. ......+..++..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 237 -----~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 237 -----RG----FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp -----HH----HHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----hc----cccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 01111244566779999999999999999999999999999976543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=337.22 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=210.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||+|+||+||++.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 478999999999999999999865 6999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++++|.+++.. ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999954 46899999999999999999999999 9999999999999999999999999987643222
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||++.+..++.++||||||+++|+|++|..||........ ...... ...
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~---------~~~ 233 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIAT---------NGT 233 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH---------HCS
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh---------CCC
Confidence 223445789999999999999999999999999999999999999963321100 000000 001
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++..+.++|.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111234567788999999999999999999999984
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=343.01 Aligned_cols=280 Identities=29% Similarity=0.394 Sum_probs=211.0
Q ss_pred CCcccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCccccee
Q 018128 30 SGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLI 107 (360)
Q Consensus 30 ~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~ 107 (360)
.-+..+....+.+...+|++.+.||+|+||+||+++.. ++.|++|++...... ..+.+.+|+.+++.++||||++++
T Consensus 22 ~~~~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 100 (309)
T 3p86_A 22 YFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100 (309)
T ss_dssp ----------CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eeccCCCcccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 34456677777888899999999999999999999875 889999998765433 335688999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 108 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
+++.+....++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++++||||||+||+++.++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~ 178 (309)
T 3p86_A 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTV 178 (309)
T ss_dssp EEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCE
T ss_pred EEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcE
Confidence 99999999999999999999999996421 1124899999999999999999999873 459999999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh
Q 018128 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
+|+|||++..... .........++..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 179 kL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--------- 247 (309)
T 3p86_A 179 KVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--------- 247 (309)
T ss_dssp EECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---------
T ss_pred EECCCCCCccccc--cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---------
Confidence 9999999874222 22223345689999999999999999999999999999999999999964321100
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCC
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 330 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~ 330 (360)
.............+..++..+.++|.+||+.||.+|||+.++++.|+.+......+
T Consensus 248 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 248 -------VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -------HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 00000111122345677888999999999999999999999999999997765433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=344.77 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=217.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec--------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEEEe
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTS 112 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~--------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~ 112 (360)
..++|++.+.||+|+||+||++++. .+..|++|++..... .....+.+|+.+++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578999999999999999999752 345799999876532 2346788999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
.+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999976432 1346899999999999999999999999 999999999999
Q ss_pred EeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCcc
Q 018128 181 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQ 259 (360)
Q Consensus 181 v~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~ 259 (360)
++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999986544333333344557788999999999999999999999999999999 999996432111
Q ss_pred chhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
. ...+........+..++.++.++|.+||+.||.+||++.|+++.|+.+....
T Consensus 314 -~--------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 -L--------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -H--------------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -H--------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 0011111122345567889999999999999999999999999999987643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=337.44 Aligned_cols=275 Identities=24% Similarity=0.363 Sum_probs=218.5
Q ss_pred CCCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCccccee
Q 018128 28 EKSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLI 107 (360)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~ 107 (360)
..++.....+..+.+..++|++.+.||+|+||+||.++..++..|++|++.... .....+.+|+.+++.++||||++++
T Consensus 7 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~ 85 (283)
T 3gen_A 7 NAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 85 (283)
T ss_dssp ---------CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCccccCCCCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEE
Confidence 344444555567778899999999999999999999998888899999987654 3356788999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCce
Q 018128 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 187 (360)
Q Consensus 108 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v 187 (360)
+++.+....++|||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~ 159 (283)
T 3gen_A 86 GVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVV 159 (283)
T ss_dssp EEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCE
T ss_pred EEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCE
Confidence 999999999999999999999999965 2456999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccch
Q 018128 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+|+|||++...... .........++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 160 kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-------- 230 (283)
T 3gen_A 160 KVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------- 230 (283)
T ss_dssp EECSTTGGGGBCCH-HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--------
T ss_pred EEcccccccccccc-ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--------
Confidence 99999999753221 1122223446778999999998899999999999999999998 9999964321100
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
...+........+...+..+.++|.+||+.||.+|||+.++++.|..+..++
T Consensus 231 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 231 ---------AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp ---------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---------HHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 0001111112234456778999999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=339.51 Aligned_cols=266 Identities=27% Similarity=0.402 Sum_probs=214.7
Q ss_pred HHhhcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
+..++|++.+.||+|+||+||.+++. .+..|++|++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 44678999999999999999999874 34569999987653 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999965 4467999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcccc
Q 018128 197 LGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 197 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------- 262 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----------------- 262 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----------------
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----------------
Confidence 64433222 12223345778999999998999999999999999999999 999996332110
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCC
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 330 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~ 330 (360)
....+........+..++..+.++|.+||+.||.+|||+.++++.|+.+.......
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 263 VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 00111111222345567889999999999999999999999999999997654433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=337.99 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=205.8
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.++|++.+.||+|+||+||++.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 699999999865533 233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
|+++++|.+++. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999984 4567999999999999999999999999 999999999999999999999999999764433
Q ss_pred CCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
..........++..|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+ ..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~--------------~~ 223 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW--------------KE 223 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH--------------HT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH--------------hc
Confidence 33333445679999999999987765 7899999999999999999999974332110 00000 00
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........++..+.++|.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 01111112456778899999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=339.71 Aligned_cols=278 Identities=26% Similarity=0.316 Sum_probs=214.1
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC----e
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----Q 115 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~----~ 115 (360)
+.+..++|++.+.||+|+||+||+++.. ++.||+|++.... ........|+.+++.++||||+++++++.+.. .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3355689999999999999999999877 8999999986543 23345566888999999999999999997744 3
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeCCCCCCcEEEeCCC
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK----------ANPPVIYRDLKSANILLDNDF 185 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------~~~~i~H~di~p~NIlv~~~~ 185 (360)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. + ++|+||||+|||++.++
T Consensus 97 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTC
T ss_pred EEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCC
Confidence 6999999999999999954 4599999999999999999999998 8 99999999999999999
Q ss_pred ceEEeecCCccccCCCCCcceeccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc
Q 018128 186 NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 260 (360)
Q Consensus 186 ~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~ 260 (360)
.+||+|||++................++..|+|||++.+ ..++.++||||||+++|+|++|..||..........
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999999999976554444333444678999999999886 355678999999999999999999997544332221
Q ss_pred hhccchhhhhccccchhcccccccCCC-----ChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 261 LVSWSRPFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
........................... ....+..+.++|.+||+.||.+|||+.++++.|++|....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111000000000000001111111111 2245677999999999999999999999999999997643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=330.95 Aligned_cols=262 Identities=25% Similarity=0.366 Sum_probs=217.2
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
+.+..++|++.+.||+|+||.||++.+.+++.|++|++.... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 345568999999999999999999998888899999987654 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred EEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccc
Confidence 999999999999965 4457999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.. .........++..|+|||++.+..++.++||||||+++|+|++ |..||....... .. ..
T Consensus 158 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~-----------~~ 219 (269)
T 4hcu_A 158 DD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VV-----------ED 219 (269)
T ss_dssp CH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH-----------HH
T ss_pred cc-ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HH-----------HH
Confidence 21 1122233456778999999998999999999999999999999 999996432110 00 00
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
+........+...+..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 220 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 001111223445678899999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=338.98 Aligned_cols=248 Identities=27% Similarity=0.369 Sum_probs=207.7
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
.-++|++.+.||+|+||.||++++. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4578999999999999999999874 799999999876532 3345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999955 356999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCcceecccccccccccccccccCCCC-cchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s-~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
... ......+++.|+|||++.+..++ .++|||||||++|+|++|..||...... ........
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-------- 228 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLR-------- 228 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH--------
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh--------
Confidence 322 23446799999999999888765 8999999999999999999999743211 11101110
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ....+...+.++.++|.+||+.||.+|||+.|+++
T Consensus 229 --~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 229 --G--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --C--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --C--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 11234456788999999999999999999999984
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=330.30 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=216.0
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++..++|++.+.||+|++|.||+++..++..|++|++.... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 34578999999999999999999998888889999987654 34567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.. .+..+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 83 EYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp ECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999999966 3456999999999999999999999999 99999999999999999999999999976433
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......... .. .
T Consensus 157 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~-----------~ 218 (268)
T 3sxs_A 157 DQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LK-----------V 218 (268)
T ss_dssp TC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HH-----------H
T ss_pred hh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HH-----------H
Confidence 22 222233446678999999998899999999999999999999 99999643321100 00 0
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
........+...+..+.+++.+||+.||.+|||+.++++.|+.+..+.
T Consensus 219 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 219 SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred HcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 001111223445678999999999999999999999999999996643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=337.87 Aligned_cols=269 Identities=26% Similarity=0.380 Sum_probs=220.5
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYC 110 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~ 110 (360)
.++.+..++|++.+.||+|+||.||++.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 345566789999999999999999999752 357899999875432 3346788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 170 (360)
.+.+..++|||++++++|.+++..... ....+++..++.++.||+.||.|||+++ ++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 999999999999999999999976442 1234899999999999999999999999 99
Q ss_pred eCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCc
Q 018128 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKA 249 (360)
Q Consensus 171 H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~p 249 (360)
|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986544443333344567788999999999899999999999999999999 9999
Q ss_pred ccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 250 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 250 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
|........ ...+........+..++..+.++|.+||+.||.+||++.++++.|+++..+
T Consensus 253 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 253 YPGIPPERL-----------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp STTCCGGGH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHHH-----------------HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 964332110 011111112233456788899999999999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=344.43 Aligned_cols=275 Identities=28% Similarity=0.400 Sum_probs=223.8
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec--------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGY 109 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~--------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~ 109 (360)
+++..++|++.+.||+|+||+||++++. .+..||+|++..... .....+.+|+.+++.+ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 4566789999999999999999999752 235799999876533 2346788999999999 89999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 177 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~ 177 (360)
+.+.+..++|||++++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence 9999999999999999999999976432 1346999999999999999999999999 999999999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCcc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 256 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~ 256 (360)
|||++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986544443344444567889999999999999999999999999999999 99999633211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCC
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSR 334 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~ 334 (360)
. ....+........+..++.++.++|.+||+.||.+|||+.++++.|+.+...........
T Consensus 301 ~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 301 E-----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp H-----------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred H-----------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 0 011111111223345677889999999999999999999999999999987665544433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=343.58 Aligned_cols=268 Identities=27% Similarity=0.414 Sum_probs=207.1
Q ss_pred HHhhcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
+...+|++.+.||+|+||.||.++.. .+..|++|.+..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34568999999999999999999865 477899999875532 3345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+++++|.+++.. .+..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 999999999999999965 4467999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcccc
Q 018128 197 LGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 197 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----------------- 258 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----------------- 258 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----------------
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence 64332211 11122234678999999999999999999999999999998 999996332110
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCC
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 332 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~ 332 (360)
....+........+..++..+.++|.+||+.||.+||++.++++.|+.+.........
T Consensus 259 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~~~ 316 (373)
T 2qol_A 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKI 316 (373)
T ss_dssp HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGGGS
T ss_pred HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcccccc
Confidence 0011111112233456778899999999999999999999999999999876554433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=334.91 Aligned_cols=280 Identities=29% Similarity=0.432 Sum_probs=214.9
Q ss_pred HHHhhcccccceeccCCCeEEEEEEe-----cCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe--C
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--G 113 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~ 113 (360)
.+..++|++.+.||+|+||+||+++. .+++.||+|++..........+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34578999999999999999999983 2588999999987665666788999999999999999999999854 4
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCc
Confidence 568999999999999999976 3456999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||................... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~ 238 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IV 238 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH-HH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch-hH
Confidence 99864332221 22233456778999999999999999999999999999999999886432110000000000000 00
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
......+........+..++.++.++|.+||+.||.+|||+.|+++.|+.+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0111111112222345677889999999999999999999999999999997654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=336.30 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=206.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCE----EEEEEcccC-CccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQL----VAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~----v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
.++|++.+.||+|+||+||++.+. +++. +++|.+... .......+.+|+.+++.++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 689999999999999999999865 3443 577776543 3345678999999999999999999999998754 78
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
++++++.+++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 89999999999999976 4567999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..............++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~~ 229 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------IS 229 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HH
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------HH
Confidence 544443333344556788999999999999999999999999999999 999997433211 11
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
..+........+..++.++.++|.+||+.||.+||++.|+++.|+++....
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 111111222345567788999999999999999999999999999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=338.44 Aligned_cols=277 Identities=22% Similarity=0.357 Sum_probs=202.2
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecC-C---CEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLES-G---QLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~-~---~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~ 111 (360)
+++.+..++|++.+.||+|+||+||.+++.. + ..|++|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 4455667899999999999999999998663 3 379999987652 334567899999999999999999999997
Q ss_pred eCCee------EEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC
Q 018128 112 SGDQR------LLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 183 (360)
Q Consensus 112 ~~~~~------~lv~e~~~~~sL~~~i~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~ 183 (360)
..... ++||||+++++|.+++.... .....+++..++.++.||+.||.|||+++ ++|+||||+||+++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence 76655 89999999999999996533 22336999999999999999999999999 999999999999999
Q ss_pred CCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchh
Q 018128 184 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLV 262 (360)
Q Consensus 184 ~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~ 262 (360)
++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--- 249 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY--- 249 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---
Confidence 99999999999976444333333334456778999999999999999999999999999999 89999743321100
Q ss_pred ccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCC
Q 018128 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSR 334 (360)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~ 334 (360)
... ........+..++.++.++|.+||+.||.+|||+.++++.|+++.......+.+.
T Consensus 250 ---~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 250 ---NYL-----------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp ---HHH-----------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred ---HHH-----------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 000 0011122345677889999999999999999999999999999987554444333
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=323.95 Aligned_cols=286 Identities=42% Similarity=0.630 Sum_probs=230.8
Q ss_pred CcccccHHHHHHHhhccccc------ceeccCCCeEEEEEEecCCCEEEEEEcccCC----ccchHHHHHHHHHhhccCC
Q 018128 31 GARSFTFRELAIATRNFREA------NLIGEGGFGKVYKGRLESGQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHH 100 (360)
Q Consensus 31 ~~~~~~~~~~~~~~~~y~i~------~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~~ 100 (360)
....++..++.....+|... +.||+|++|.||.+... ++.+++|++.... ....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45778999999999888777 99999999999999874 8899999886532 2234678899999999999
Q ss_pred CcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 101 p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
|||+++++++.+.+..++|||++++++|.+++.... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 999999999999999999999999999999996533 3456999999999999999999999999 999999999999
Q ss_pred EeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc
Q 018128 181 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 260 (360)
Q Consensus 181 v~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~ 260 (360)
++.++.++|+|||++................++..|+|||.+.+ .++.++||||||+++|+|++|..||....... .
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~ 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--L 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--B
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--H
Confidence 99999999999999986544433334445678999999998765 57899999999999999999999997543221 1
Q ss_pred hhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 261 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
...+..........+...++..+ ...+...+..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111111111222333333322 23466788999999999999999999999999999999853
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=334.63 Aligned_cols=252 Identities=25% Similarity=0.291 Sum_probs=206.8
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc------chHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
..++|++.+.||+|+||+||++.+. +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3578999999999999999999876 5999999998765332 34678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC----ceEEee
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSD 191 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~----~v~L~D 191 (360)
.++||||+++++|.+++. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .++|+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999994 3567999999999999999999999999 99999999999998776 799999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .......
T Consensus 163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~------~~~i~~~ 233 (361)
T 2yab_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANITAV 233 (361)
T ss_dssp CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTT
T ss_pred cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc
Confidence 99998643322 22345699999999999999999999999999999999999999964321110 0000000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ....+....+..+.+||.+||+.||.+|||+.|+++
T Consensus 234 ~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SYD--------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC--------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 000112345678999999999999999999999984
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=347.70 Aligned_cols=267 Identities=27% Similarity=0.384 Sum_probs=218.3
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
...+.+..++|++.+.||+|+||.||.+++. +++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 3456777899999999999999999999876 689999999875422 22346788999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++|||++++++|.+++.. .+..+++..++.++.|++.||.|||+++ ++||||+|+|||++.++.++|+|||+
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCC
Confidence 99999999999999999965 3456899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
+................++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---------------- 323 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---------------- 323 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH----------------
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------
Confidence 875322211111122235678999999998899999999999999999998 999996432110
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
....+........+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 324 -~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 324 -TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0011111112234556788899999999999999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=342.03 Aligned_cols=275 Identities=25% Similarity=0.375 Sum_probs=222.2
Q ss_pred ccccHHHHHHHhhcccccceeccCCCeEEEEEEe------cCCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCccc
Q 018128 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLV 104 (360)
Q Consensus 33 ~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~------~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~ 104 (360)
.-+....+++..++|++.+.||+|+||.||++++ .+++.||+|++..... .....+.+|+.+++.+ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3456678888999999999999999999999973 2468899999976533 2345788999999999 799999
Q ss_pred ceeEEEEeCCe-eEEEEEecCCCCHHHHhcccCCC---------------------------------------------
Q 018128 105 TLIGYCTSGDQ-RLLVYEYMPMGSLEDHLYDLEPD--------------------------------------------- 138 (360)
Q Consensus 105 ~~~~~~~~~~~-~~lv~e~~~~~sL~~~i~~~~~~--------------------------------------------- 138 (360)
++++++.+.+. .++||||+++++|.+++......
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999877554 89999999999999999764321
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 139 -----------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 139 -----------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
...+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999999 999999999999999999999999999865444
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
..........++..|+|||++.+..++.++||||||+++|+|++ |..||........ ....+.
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~~~~ 310 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----------------FCRRLK 310 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----------------HHHHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----------------HHHHHH
Confidence 44444455668889999999999999999999999999999998 9999964321110 000111
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
.......+..++.++.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 311 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1112233456778899999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=339.33 Aligned_cols=270 Identities=26% Similarity=0.400 Sum_probs=217.7
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYC 110 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~ 110 (360)
..+.+..++|++.+.||+|+||.||++++. +++.|++|++..... .....+.+|+.+++.++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445566789999999999999999999874 347899999876533 2346788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPD--------------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 170 (360)
.+.+..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ ++
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999999764321 267999999999999999999999999 99
Q ss_pred eCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCc
Q 018128 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKA 249 (360)
Q Consensus 171 H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~p 249 (360)
|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999875433332233344567889999999998899999999999999999999 9999
Q ss_pred ccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 250 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 250 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
|....... ..... .. ......+..++..+.++|.+||+.||.+||++.++++.|+++....
T Consensus 277 ~~~~~~~~------~~~~~----------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 277 YYGMAHEE------VIYYV----------RD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTSCHHH------HHHHH----------HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCCChHH------HHHHH----------hC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 96332110 00000 00 0111234567788999999999999999999999999999986543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=334.35 Aligned_cols=248 Identities=28% Similarity=0.359 Sum_probs=208.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC---CccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
-++|++.+.||+|+||+||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 478999999999999999999876 6999999998654 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.++|+|||++....
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999854 457899999999999999999999999 9999999999999999999999999997522
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
. ........+|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 157 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~--------- 219 (337)
T 1o6l_A 157 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM--------- 219 (337)
T ss_dssp C--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH---------
T ss_pred c--CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHc---------
Confidence 2 222234467899999999999999999999999999999999999999633211 00000110
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
. ...++..++.++.++|.+||+.||.+|| ++.|+++
T Consensus 220 -~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 220 -E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -C--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 0 1134556788999999999999999999 8999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=339.04 Aligned_cols=257 Identities=21% Similarity=0.239 Sum_probs=208.1
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-----ccchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-----LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-----~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
...++|++.+.||+|+||+||++.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45689999999999999999999875 68999999985431 2245778999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc---eEEeec
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDF 192 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~---v~L~Df 192 (360)
.++||||+++++|.+++......+..+++..++.++.||+.||.|||+++ ++|+||||+|||++.++. ++|+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999888665445567999999999999999999999999 999999999999987654 999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
|++...... ........+++.|+|||++.+..++.++|||||||++|+|++|..||...... .........
T Consensus 178 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~i~~~~ 248 (351)
T 3c0i_A 178 GVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-------LFEGIIKGK 248 (351)
T ss_dssp TTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-------HHHHHHHTC
T ss_pred cceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-------HHHHHHcCC
Confidence 999764332 22233457899999999999999999999999999999999999999642210 000000000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ..+ .....++.++.++|.+||+.||.+|||+.++++
T Consensus 249 ~~----~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK----MNP----RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC----CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC----CCc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000 001245678999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=333.19 Aligned_cols=273 Identities=26% Similarity=0.399 Sum_probs=222.4
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEe------cCCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGY 109 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~------~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~ 109 (360)
..+++..++|++.+.||+|+||.||.++. .+++.|++|++..... ...+.+.+|+.+++.+ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 34566778999999999999999999974 2467899999875533 3446788999999999 89999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEP--------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 175 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~ 175 (360)
+.+.+..++|||++++++|.+++..... ....+++..++.++.||+.||.+||+++ ++|+|||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 9999999999999999999999976432 1235899999999999999999999999 9999999
Q ss_pred CCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccC
Q 018128 176 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSK 254 (360)
Q Consensus 176 p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~ 254 (360)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999986554443333444557788999999999999999999999999999998 999996432
Q ss_pred ccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 255 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
.... .............+..++..+.++|.+||+.||.+|||+.++++.|+++......
T Consensus 253 ~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 253 VDSK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp SSHH----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred chhH----------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 1110 0001111111223456678899999999999999999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=336.30 Aligned_cols=261 Identities=27% Similarity=0.433 Sum_probs=209.8
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCE----EEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQL----VAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~----v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
.++|++.+.||+|+||+||++.+. +++. +++|.+.... ......+.+|+.+++.++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 578999999999999999999865 3443 7888775442 233456778999999999999999999986 55688
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999965 3457899999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..............++..|+|||++.+..++.++||||||+++|+|++ |..||........ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----------------~ 227 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-----------------P 227 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-----------------H
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-----------------H
Confidence 655444444455667889999999998999999999999999999999 9999974331111 0
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
..+........+..++.++.++|.+||+.||.+||++.++++.|..+.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 228 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279 (325)
T ss_dssp HHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred HHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 1111111122344456678899999999999999999999999999976543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=333.48 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=207.7
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCC----EEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~----~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
...+|++.+.||+|+||+||++++. +++ .|++|.+.... ......+.+|+.+++.++||||+++++++.+.. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 3678999999999999999999864 344 35888775432 344567899999999999999999999998754 7
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
+++++++.+++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++.
T Consensus 92 ~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 889999999999999976 4567999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------------~ 228 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------I 228 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------H
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----------------H
Confidence 6554444444444556889999999999999999999999999999999 999997433211 1
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
...+........+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111111222234556778899999999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.53 Aligned_cols=269 Identities=27% Similarity=0.398 Sum_probs=216.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
.+..++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 344689999999999999999999842 46789999986542 23345688899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC---ce
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NP 187 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~---~v 187 (360)
...++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceE
Confidence 999999999999999999977542 2356999999999999999999999999 99999999999998555 49
Q ss_pred EEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccch
Q 018128 188 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--------- 294 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------- 294 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence 9999999874322222222333457889999999999999999999999999999998 999996432110
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
....+........+..++..+.+++.+||+.||.+||++.++++.|+.+......
T Consensus 295 --------~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 295 --------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp --------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred --------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 0011111111223456778899999999999999999999999999999775543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=327.06 Aligned_cols=265 Identities=24% Similarity=0.320 Sum_probs=210.6
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
..++|++.+.||+|+||.||++++. .++.|++|.+...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4679999999999999999999865 6899999998654332 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 89 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999965 357999999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.... ........++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...... ..
T Consensus 162 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~------~~ 228 (294)
T 4eqm_A 162 SETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQ------DS 228 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHS------SC
T ss_pred cccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhh------cc
Confidence 3221 1222335689999999999999999999999999999999999999964321100 000000 00
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCC-CHHHHHHHHhhhhhccC
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQRD 328 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~eil~~L~~l~~~~~ 328 (360)
.+......+..++..+.++|.+||+.||.+|| +++++++.|..+.....
T Consensus 229 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 229 -VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp -CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred -CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 00001112345678899999999999999998 99999999998865443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=336.37 Aligned_cols=269 Identities=25% Similarity=0.396 Sum_probs=216.8
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEe------cCCCEEEEEEcccCC-ccchHHHHHHHHHhhcc-CCCcccceeEEE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYC 110 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~------~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~ 110 (360)
++++..++|++.+.||+|+||.||.+.+ ..+..|++|++.... ......+.+|+.+++.+ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4667789999999999999999999985 235689999987542 23456789999999999 899999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPD-------------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~-------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H 171 (360)
.+.+..++|||++++++|.+++...... ...+++..++.++.||+.||.|||+++ ++|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999999999999999999999763321 134899999999999999999999999 999
Q ss_pred CCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcc
Q 018128 172 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAM 250 (360)
Q Consensus 172 ~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf 250 (360)
+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999976544433334444567888999999999999999999999999999998 99999
Q ss_pred cccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 251 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
....... .....+........+..++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 276 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 6432111 00011111122233456778899999999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=330.28 Aligned_cols=251 Identities=18% Similarity=0.235 Sum_probs=206.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||+|+||+||++.+. +++.+++|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999876 58899999987543 3446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC--CCceEEeecCCccccCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~--~~~v~L~Dfg~~~~~~~ 200 (360)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++. ++.++|+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999954 3457999999999999999999999999 999999999999987 78999999999986433
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|..||....... ............
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~----- 222 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTF----- 222 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCCC-----
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCCCCC-----
Confidence 22 2334568999999999998889999999999999999999999996432110 000111100000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......++.++.++|.+||+.||.+|||+.|+++
T Consensus 223 ---~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 ---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00001245778999999999999999999999997
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=325.33 Aligned_cols=261 Identities=24% Similarity=0.297 Sum_probs=214.6
Q ss_pred ccccHHHHHHHhh----------cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCC
Q 018128 33 RSFTFRELAIATR----------NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD 101 (360)
Q Consensus 33 ~~~~~~~~~~~~~----------~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p 101 (360)
..++..++..+.. .|+..+.||+|+||.||+++.. +|+.||+|++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 4467777766654 3888899999999999999876 6999999999877666677899999999999999
Q ss_pred cccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018128 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 181 (360)
Q Consensus 102 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv 181 (360)
||+++++++...+..++||||+++++|.+++. ...+++..++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999984 356999999999999999999999999 9999999999999
Q ss_pred eCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch
Q 018128 182 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 261 (360)
Q Consensus 182 ~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~ 261 (360)
+.++.++|+|||++...... ........++..|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---- 248 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---- 248 (321)
T ss_dssp CTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred CCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 99999999999998764322 222334578999999999999999999999999999999999999996432110
Q ss_pred hccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 262 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..... .....+. ......++..+.++|.+||+.||.+|||+.++++
T Consensus 249 --~~~~~-------~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 249 --AMKRL-------RDSPPPK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp --HHHHH-------HHSSCCC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHH-------hcCCCCC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0000000 0123356778999999999999999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=334.13 Aligned_cols=277 Identities=29% Similarity=0.420 Sum_probs=217.6
Q ss_pred hhcccccceeccCCCeEEEEEEe-----cCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEE--eCCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT--SGDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~--~~~~~ 116 (360)
.++|++.+.||+|+||.||+++. ..++.|++|++..........+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 57999999999999999999983 358899999998776666677999999999999999999999886 45678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+++++|.+++... ...+++..++.++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999652 346999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
......... ......++..|+|||++.+..++.++||||||+++|+|++|..||........... ..... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~-~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERD-VPALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-----CCHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccc-cccHHHH
Confidence 654333222 22335578889999999998999999999999999999999999864322100000 00000 0000111
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
...+........+..++..+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 12222223334466788899999999999999999999999999999966543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=323.91 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=216.0
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+..++|++.+.||+|++|.||.+.+.+++.|++|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 345689999999999999999999988888999999876543 3467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 83 EFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 99999999999965 3457899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
. .........++..|+|||++.+..++.++||||||+++|+|++ |..||....... .... +
T Consensus 157 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~----------i- 218 (267)
T 3t9t_A 157 D-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVED----------I- 218 (267)
T ss_dssp H-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH----------H-
T ss_pred c-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHH----------H-
Confidence 1 1112223456778999999998899999999999999999999 899996432110 0000 0
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
........+...+..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 219 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 219 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00111123445677899999999999999999999999999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=334.76 Aligned_cols=270 Identities=24% Similarity=0.332 Sum_probs=214.7
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe----
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS---- 112 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~---- 112 (360)
+.+.+..++|++.+.||+|++|.||+++.. +++.||+|++..........+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 334566889999999999999999999874 699999999877665666788999999999999999999999862
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....++|||++++++|.+++......+..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEec
Confidence 34778999999999999999876666788999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcc-------eecccccccccccccccccCC---CCcchhhHHHHHHHHHHHhCCCcccccCccCccchh
Q 018128 193 GLAKLGPVGDNTH-------VSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 262 (360)
Q Consensus 193 g~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 262 (360)
|++.......... ......++..|+|||++.+.. ++.++||||||+++|+|++|..||.........
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--- 255 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--- 255 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC---
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch---
Confidence 9887532111110 011234688999999987544 689999999999999999999999632211100
Q ss_pred ccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 263 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
.............+..++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 256 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 256 ------------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ------------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ------------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000000111112234567889999999999999999999999999999854
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=330.08 Aligned_cols=275 Identities=25% Similarity=0.397 Sum_probs=214.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEe-----cCCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeC--
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-- 113 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~-----~~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-- 113 (360)
...++|++.+.||+|++|.||+++. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3467899999999999999999983 358899999987543 23457789999999999999999999999776
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...++|||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred ceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccc
Confidence 668999999999999999965 3456999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
++......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+................. ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~ 249 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ--MTV 249 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG--GHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc--cCH
Confidence 99865443322 223345678889999999999999999999999999999999998753221100000000000 001
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
...............+..++..+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1111112222233345677889999999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=327.47 Aligned_cols=266 Identities=20% Similarity=0.228 Sum_probs=213.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+++|++.+.||+|+||+||++++. +++.||+|++..... ...+..|+.+++.+ +||||+++++++.+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 4679999999999999999999864 689999999865532 34678899999999 8999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc-----eEEeecCCc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-----PKLSDFGLA 195 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~-----v~L~Dfg~~ 195 (360)
|++ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++. ++|+|||++
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 8999999976 2567999999999999999999999999 999999999999998887 999999999
Q ss_pred cccCCCCCcc-----eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh
Q 018128 196 KLGPVGDNTH-----VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 196 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
.......... ......|+..|+|||++.+..++.++||||||+++|+|++|..||............. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~~ 234 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ---KIGD 234 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHH---HHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHH---HHHh
Confidence 8643332221 1234678999999999999999999999999999999999999997543221111111 0000
Q ss_pred ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
... ...... ....++ ++.+++.+||+.||.+||++.+|++.|+.+....+
T Consensus 235 ~~~---~~~~~~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 235 TKR---ATPIEV----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHH---HSCHHH----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hhc---cCCHHH----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 000 000000 012245 89999999999999999999999999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=327.86 Aligned_cols=266 Identities=25% Similarity=0.400 Sum_probs=221.8
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
+.+++..++|++.+.||+|++|+||.+.+. ++..|++|.+... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 456677899999999999999999999876 4889999998754 34457788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++|||++++++|.+++... ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999762 3456999999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
...... ........++..|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 160 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----------------~ 221 (288)
T 3kfa_A 160 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------V 221 (288)
T ss_dssp TSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------H
T ss_pred eccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------H
Confidence 643322 223333456778999999998999999999999999999999 999986432111 1
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 222 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111112222345567788999999999999999999999999999887643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=334.37 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=202.4
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc--chHHHHHHHHHhhccCC--CcccceeEEEEeCCeeE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHH--DNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~--p~i~~~~~~~~~~~~~~ 117 (360)
+.+++|++.+.||+|+||.||++.+.+++.||+|++...... ....+.+|+.+++.++| |||+++++++.+....+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 457899999999999999999999888999999998755332 33678899999999976 99999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|||+ .+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.++|+|||++..
T Consensus 86 lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99995 57899999965 467999999999999999999999999 99999999999997 57899999999986
Q ss_pred cCCCCCcceeccccccccccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 266 (360)
..............|+..|+|||++.+ ..++.++||||||+++|+|++|..||......
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------- 226 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------- 226 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----------
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----------
Confidence 544333333445679999999999865 67889999999999999999999999632110
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........+......++...+.++.++|.+||+.||.+|||+.++++
T Consensus 227 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 227 -----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp -----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 11122222333333445556678999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=326.01 Aligned_cols=268 Identities=25% Similarity=0.304 Sum_probs=203.9
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
...++|++.+.||+|+||+||++++.+++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 345899999999999999999999888999999998754322 246788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++ +|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 98 ~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999975 88888865 4466999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-ccc----hhhhhccc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS----RPFLKDQK 273 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~----~~~~~~~~ 273 (360)
. .........++..|+|||++.+ ..++.++||||||+++|+|++|..||............ ... ...+....
T Consensus 171 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 171 I--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp S--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred C--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 2 2222334568999999999876 56899999999999999999999999754332211000 000 00000000
Q ss_pred cchhcc-------cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLV-------DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...... .........+.++.++.+||.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 000000112345678999999999999999999999993
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=325.86 Aligned_cols=264 Identities=24% Similarity=0.357 Sum_probs=204.0
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecC----CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEe
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~ 112 (360)
.++++..++|++.+.||+|+||.||.+.+.. +..|++|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 3445677899999999999999999998642 45799998865432 33467889999999999999999999984
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
++..++|||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcc
Confidence 5678999999999999999965 3457999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
|++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||........ . ..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~---~~---- 229 (281)
T 1mp8_A 161 GLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I---GR---- 229 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H---HH----
T ss_pred ccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---H---HH----
Confidence 99975432221 12223446778999999998899999999999999999997 9999964322110 0 00
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
+ ........+..++..+.++|.+||+.||.+|||+.++++.|+++...
T Consensus 230 ------i-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 230 ------I-ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ------H-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------H-HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 00111224556788899999999999999999999999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=331.62 Aligned_cols=245 Identities=25% Similarity=0.322 Sum_probs=204.2
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|+||+||++.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 68999999999999999999874 68999999986432 223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 89 E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 7799998854 456999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
. ......+|++.|+|||++.+..+ +.++||||||+++|+|++|..||.......... .+.
T Consensus 161 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i~ 221 (336)
T 3h4j_B 161 G---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KVN 221 (336)
T ss_dssp S---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CCC
T ss_pred C---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HHH
Confidence 2 22334568999999999988776 689999999999999999999997432211100 000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .....+..++.++.++|.+||+.||.+|||+.|+++
T Consensus 222 ~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 S--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp S--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred c--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 011234567788999999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=329.72 Aligned_cols=270 Identities=25% Similarity=0.401 Sum_probs=218.5
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec--------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGY 109 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~--------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~ 109 (360)
+.+..++|++.+.||+|+||.||++++. ++..|++|++..... .....+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3456799999999999999999999863 467899999876532 3346788999999999 89999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 177 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~ 177 (360)
+.+.+..++|||++++++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 99999999999999999999999764321 235899999999999999999999999 999999999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCcc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 256 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~ 256 (360)
||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999986544433333344557788999999998889999999999999999999 99999643211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
. ... .+........+..++..+.++|.+||+.||.+|||+.++++.|+.+......
T Consensus 267 ~------~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 E------LFK-----------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp H------HHH-----------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred H------HHH-----------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 0 000 0001111223456778899999999999999999999999999999875443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=320.40 Aligned_cols=255 Identities=31% Similarity=0.449 Sum_probs=200.6
Q ss_pred HhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc----cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~----~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
..++|++.+.||+|++|.||++.+. ++.+++|++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3578999999999999999999976 88999999865432 224678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC--------CCceEEe
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--------DFNPKLS 190 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~--------~~~v~L~ 190 (360)
|||++++++|.+++ .+..+++..++.++.|++.||.+||+++..+++|+||+|+||+++. ++.++|+
T Consensus 84 v~e~~~~~~L~~~~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHH-----TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 99999999999999 3467999999999999999999999987444789999999999985 6789999
Q ss_pred ecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh
Q 018128 191 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 191 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
|||++....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------------- 221 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------------- 221 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-------------
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------------
Confidence 999997533221 223468999999999999999999999999999999999999996432110
Q ss_pred ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
..............+..++..+.++|.+||+.||.+|||+.|+++.|+.|
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 222 ---VAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---HHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00011111122234556778899999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=326.93 Aligned_cols=252 Identities=24% Similarity=0.299 Sum_probs=206.7
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc------chHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
..++|++.+.||+|+||.||.+.+. +++.|++|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4578999999999999999999876 5899999998754322 35678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC----ceEEee
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSD 191 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~----~v~L~D 191 (360)
.++|||++++++|.+++. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++ .++|+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999999994 3567999999999999999999999999 99999999999998877 799999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||........ .......
T Consensus 162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~ 232 (326)
T 2y0a_A 162 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAV 232 (326)
T ss_dssp CTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHT
T ss_pred CCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHhc
Confidence 99998643222 22345689999999999989999999999999999999999999964321100 0000000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ...........+..+.++|.+||+.||.+|||+.++++
T Consensus 233 ~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 N--------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C--------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C--------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000112345678999999999999999999999995
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=336.65 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=202.5
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~ 115 (360)
.+.-++|++.+.||+|+||+||++++. +++.||+|++.... ......+..|..+++.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 345689999999999999999999876 58999999987542 23445678899999987 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 99 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccce
Confidence 9999999999999999954 466999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
.... .........+|++.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 172 ~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~----- 238 (353)
T 3txo_A 172 KEGI--CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN----- 238 (353)
T ss_dssp BCSC--C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-----
T ss_pred eecc--cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHc-----
Confidence 7422 2222334467999999999999989999999999999999999999999643211 00111111
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCH------HHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~------~eil~ 318 (360)
. ...++..++..+.++|.+||+.||.+||++ .++++
T Consensus 239 -----~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 -----D--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----C--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1 112455677889999999999999999998 77765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=335.99 Aligned_cols=279 Identities=25% Similarity=0.311 Sum_probs=203.6
Q ss_pred CCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccce
Q 018128 29 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTL 106 (360)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~ 106 (360)
......+....+++...+|++.+.||+|+||.||++++. +++.|++|++..........+.+|+.+++.+. ||||+++
T Consensus 12 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~ 91 (337)
T 3ll6_A 12 GRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91 (337)
T ss_dssp ---CCSSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCE
T ss_pred cchHHHhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhc
Confidence 344445555667778889999999999999999999875 68999999987666566678899999999996 9999999
Q ss_pred eEEEE--------eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018128 107 IGYCT--------SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 178 (360)
Q Consensus 107 ~~~~~--------~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~N 178 (360)
++++. .....+++||+++ ++|.+++.... ....+++..++.++.||+.||.|||+++ ++++|+||||+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~N 168 (337)
T 3ll6_A 92 CSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVEN 168 (337)
T ss_dssp EEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGG
T ss_pred cccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCccc
Confidence 99984 3445789999995 69999886543 3456999999999999999999999773 349999999999
Q ss_pred EEEeCCCceEEeecCCccccCCCCCcc----------eeccccccccccccccc---ccCCCCcchhhHHHHHHHHHHHh
Q 018128 179 ILLDNDFNPKLSDFGLAKLGPVGDNTH----------VSTRVMGTYGYCAPEYA---MSGKLTLKSDIYSFGVVLLELIT 245 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~s~~sDiwslG~il~~ll~ 245 (360)
||++.++.++|+|||++.......... ......++..|+|||++ .+..++.++||||||+++|+|++
T Consensus 169 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~ 248 (337)
T 3ll6_A 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248 (337)
T ss_dssp CEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHH
T ss_pred EEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHh
Confidence 999999999999999998643322211 11134588999999998 56778999999999999999999
Q ss_pred CCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 246 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 246 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
|..||....... ..............+..+.++|.+||+.||.+|||+.|+++.|..+..
T Consensus 249 g~~p~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 249 RQHPFEDGAKLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp SSCCC--------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcchhHHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999996322110 001111111122334558899999999999999999999999999977
Q ss_pred ccCCC
Q 018128 326 QRDSH 330 (360)
Q Consensus 326 ~~~~~ 330 (360)
.....
T Consensus 309 ~~~~~ 313 (337)
T 3ll6_A 309 ARNVN 313 (337)
T ss_dssp HTTCC
T ss_pred ccCCC
Confidence 55433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=323.21 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=198.7
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--------------------------chHHHHHHHHHh
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--------------------------GHQEFIVEVLML 95 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--------------------------~~~~~~~e~~~l 95 (360)
..++|++.+.||+|+||.||++++. +++.||+|++...... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3579999999999999999999875 5899999998654321 135688999999
Q ss_pred hccCCCcccceeEEEEe--CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 018128 96 SLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 173 (360)
Q Consensus 96 ~~l~~p~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~d 173 (360)
+.++||||+++++++.+ ....++|||++++++|.+++ ....+++..++.++.||+.||.|||+++ ++|+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 99999999999999986 56889999999999998765 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCC---CCcchhhHHHHHHHHHHHhCCCcc
Q 018128 174 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAM 250 (360)
Q Consensus 174 i~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~s~~sDiwslG~il~~ll~g~~pf 250 (360)
|||+||+++.++.++|+|||++...... ........++..|+|||++.+.. .+.++||||||+++|+|++|..||
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999764322 22234457899999999998655 478899999999999999999999
Q ss_pred cccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 251 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...... ....... ...........++..+.++|.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~------~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDERIM------CLHSKIK----------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCSSHH------HHHHHHH----------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccHH------HHHHHHh----------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 632210 0000000 001111112356778999999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=333.45 Aligned_cols=255 Identities=21% Similarity=0.233 Sum_probs=207.1
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.....++|++.+.||+|+||.||++.+. +++.|++|++..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3445689999999999999999999876 589999999876543 2345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC---ceEEeecC
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFG 193 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~---~v~L~Dfg 193 (360)
++|||++++++|.+++. ....+++..++.++.||+.||.|||+++ ++|+||||+|||++.++ .++|+|||
T Consensus 104 ~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecC
Confidence 99999999999999984 3567999999999999999999999999 99999999999997654 59999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||...... ...........
T Consensus 177 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~~ 247 (362)
T 2bdw_A 177 LAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAY 247 (362)
T ss_dssp TCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC
T ss_pred cceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC
Confidence 997543222 223457899999999999989999999999999999999999999643211 00000000000
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++.++.++|.+||+.||.+||++.++++
T Consensus 248 --------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 248 --------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp --------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000112356778999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=322.23 Aligned_cols=272 Identities=21% Similarity=0.276 Sum_probs=211.8
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCC--eeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~--~~~l 118 (360)
..++|++.+.||+|+||+||++++. +++.||+|++.... ......+.+|+.+++.++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3578999999999999999999876 58999999987543 234567889999999999999999999987665 7799
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----eCCCceEEeecCC
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGL 194 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv----~~~~~v~L~Dfg~ 194 (360)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ ++|+||||+||++ +.++.++|+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999997633 2334999999999999999999999999 9999999999999 7777899999999
Q ss_pred ccccCCCCCcceecccccccccccccccc--------cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAM--------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+....... ......++..|+|||++. +..++.++|||||||++|+|++|..||......... .....
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~ 237 (319)
T 4euu_A 163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMY 237 (319)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHH
T ss_pred ceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHH
Confidence 98643322 223356899999999886 567899999999999999999999999643321111 00000
Q ss_pred hhhhcc-----ccchhcc--------cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 267 PFLKDQ-----KKFVHLV--------DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 267 ~~~~~~-----~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
...... ....... ........+..++..+.++|.+||+.||.+|||+.|+++-....
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 000000 0000000 00111235678899999999999999999999999999976554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=332.44 Aligned_cols=252 Identities=19% Similarity=0.239 Sum_probs=208.0
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||+|+||.||++.+. +++.+++|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999876 6899999998776555566789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC--CCceEEeecCCccccCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~--~~~v~L~Dfg~~~~~~~ 200 (360)
+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+|||++. .+.++|+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999854 3457999999999999999999999999 999999999999974 46799999999986433
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.. ......++..|+|||++.+..++.++|||||||++|+|++|..||....... ........ .
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~i~~~--------~ 266 (387)
T 1kob_A 204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRC--------D 266 (387)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHC--------C
T ss_pred Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------HHHHHHhC--------C
Confidence 22 2233468999999999999999999999999999999999999997432110 00000000 0
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........++.++.++|.+||+.||.+|||+.++++
T Consensus 267 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 267 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00111123456788999999999999999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=324.84 Aligned_cols=275 Identities=23% Similarity=0.291 Sum_probs=209.2
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
.....++|++.+.||+|++|.||.+... +++.|++|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 3345578999999999999999999864 689999999875432 334578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++|||++++++|.+++.........+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 99999999999999999765556678999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
...... ........++..|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 184 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~------- 250 (310)
T 2wqm_A 184 RFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI------- 250 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHH-------
T ss_pred eeecCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHh-------
Confidence 753221 12223346889999999999999999999999999999999999999633211 00000000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCC
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 333 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~ 333 (360)
.. ..........++.++.++|.+||+.||.+|||+.++++.|+++.+....++..
T Consensus 251 ~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~~ 305 (310)
T 2wqm_A 251 EQ---CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305 (310)
T ss_dssp HT---TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-----
T ss_pred hc---ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhhh
Confidence 00 00001112456778999999999999999999999999999998877666543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=319.57 Aligned_cols=270 Identities=18% Similarity=0.193 Sum_probs=215.9
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~l 118 (360)
.+..++|++.+.||+|++|.||++.+. +++.|++|++.... ....+.+|+..++.+ +|++++++++++.+....++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 345689999999999999999999864 69999999886543 334678899999998 79999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc-----eEEeecC
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-----PKLSDFG 193 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~-----v~L~Dfg 193 (360)
|||++ +++|.+++.. .+..+++..++.++.||+.||.|||+++ ++||||||+||+++.++. ++|+|||
T Consensus 84 v~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99999 9999999976 3456999999999999999999999999 999999999999987765 9999999
Q ss_pred CccccCCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh
Q 018128 194 LAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 194 ~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.............. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~---~ 233 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER---I 233 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH---H
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH---H
Confidence 99865433222 123445689999999999999999999999999999999999999975432211111100 0
Q ss_pred hhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
..... . .........++.++.+++.+||+.||.+||++.+|++.|+++......
T Consensus 234 ~~~~~---~----~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 234 GEKKQ---S----TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHH---H----SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred Hhhcc---C----ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 00000 0 000001234677899999999999999999999999999999776543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=323.68 Aligned_cols=265 Identities=26% Similarity=0.422 Sum_probs=216.5
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
.++++..++|++.+.||+|++|.||.+...++..|++|.+.... ...+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 45677789999999999999999999998888899999987553 34578899999999999999999999986 45689
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|||++++++|.+++... .+..+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 999999999999999541 1236999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..... ........++..|+|||++.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 159 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~-------- 223 (279)
T 1qpc_A 159 IEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNL-------- 223 (279)
T ss_dssp CSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHH--------
T ss_pred ccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHH--------
Confidence 43322 122233456778999999998889999999999999999999 899986432110 00000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
........+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 224 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 224 ---ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---hcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 001112234567788999999999999999999999999999987643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.44 Aligned_cols=274 Identities=24% Similarity=0.366 Sum_probs=209.0
Q ss_pred cccHHHHHHHhhcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCccccee
Q 018128 34 SFTFRELAIATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLI 107 (360)
Q Consensus 34 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~ 107 (360)
.....++.+..++|++.+.||+|+||.||.+... .++.|++|.+..... .....+.+|+.+++.++||||++++
T Consensus 23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 23 QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp -CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeee
Confidence 3445566677899999999999999999999754 345899999875533 2345688999999999999999999
Q ss_pred EEEEeCC-----eeEEEEEecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 108 GYCTSGD-----QRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 108 ~~~~~~~-----~~~lv~e~~~~~sL~~~i~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
+++.+.. ..++|||++++++|.+++.... .....+++..++.++.||+.||.|||+++ ++|+||+|+||+
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIl 179 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCM 179 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEE
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEE
Confidence 9987654 3599999999999999985422 34567999999999999999999999998 999999999999
Q ss_pred EeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCcc
Q 018128 181 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQ 259 (360)
Q Consensus 181 v~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~ 259 (360)
++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~- 258 (313)
T 3brb_A 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM- 258 (313)
T ss_dssp ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-
Confidence 99999999999999976443333333334557788999999999999999999999999999999 8889864322110
Q ss_pred chhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
.... ........+..++..+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 259 -----~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 259 -----YDYL-----------LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -----HHHH-----------HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----HHHH-----------HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0000 001112334567788999999999999999999999999999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=336.01 Aligned_cols=260 Identities=26% Similarity=0.394 Sum_probs=206.9
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~ 115 (360)
.+..++|++.+.||+|+||+||+++.. +++.||+|++.+... .....+..|..++..+ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 344579999999999999999999876 588999999876532 2335678899998877 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++||||+++++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 128 ~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeeccee
Confidence 9999999999999999964 457999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
.... .........+||+.|+|||++.+..++.++|||||||++|+|++|..||............. .... .
T Consensus 201 ~~~~--~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~--~~~~-----~ 271 (396)
T 4dc2_A 201 KEGL--RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--EDYL-----F 271 (396)
T ss_dssp BCCC--CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC--HHHH-----H
T ss_pred eecc--cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh--HHHH-----H
Confidence 7422 22233445679999999999999999999999999999999999999996433211110000 0000 0
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCH------HHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~------~eil~ 318 (360)
..+.. ....++..++.++.+||.+||+.||.+||++ .|+++
T Consensus 272 ~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 272 QVILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HHHHH--CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred HHHhc--cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 00111 1113456678889999999999999999996 56654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=324.02 Aligned_cols=267 Identities=30% Similarity=0.470 Sum_probs=201.2
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
..+++..++|++.+.||+|+||+||+++... .+++|++..... ...+.+.+|+.+++.++||||++++++. ....
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 3456678999999999999999999998653 599998865533 3346788999999999999999999965 5567
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++|||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA 167 (289)
T ss_dssp CEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred cEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceec
Confidence 8999999999999999965 4567999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
................++..|+|||++. +..++.++||||||+++|+|++|..||....... ... ......
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~----~~~~~~ 241 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QII----EMVGRG 241 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHH----HHHHHT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHH----HHhccc
Confidence 7544333333334466899999999986 6678899999999999999999999996432111 000 000000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
. .. .........++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus 242 ~-----~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 S-----LS-PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp S-----CC-CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred c-----cC-cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 00 00112234677889999999999999999999999999999854
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=339.90 Aligned_cols=256 Identities=21% Similarity=0.208 Sum_probs=206.5
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.....++|++.+.||+|+||+||++.+. +++.+++|++...... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 3455789999999999999999999865 6899999998765432 345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe---CCCceEEeecC
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFG 193 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~---~~~~v~L~Dfg 193 (360)
++|||++++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++|+|||
T Consensus 86 ~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 999999999999999964 466999999999999999999999999 99999999999997 45789999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
++...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||....... ..........
T Consensus 159 ~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~ 230 (444)
T 3soa_A 159 LAIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------LYQQIKAGAY 230 (444)
T ss_dssp SCBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCC
T ss_pred eeEEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhCCC
Confidence 99754322 222334679999999999999999999999999999999999999996332110 0000000000
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++.++.++|.+||+.||.+|||+.|+++
T Consensus 231 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 --------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0001112356778999999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=327.27 Aligned_cols=268 Identities=21% Similarity=0.241 Sum_probs=212.2
Q ss_pred CCCcccccHHHHHHHhhccccc-ceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccC-CCcc
Q 018128 29 KSGARSFTFRELAIATRNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH-HDNL 103 (360)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~y~i~-~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~-~p~i 103 (360)
+.+...+.+...+...++|.+. +.||+|+||+||++.+. +++.||+|++..... .....+.+|+.+++.+. ||||
T Consensus 12 ~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i 91 (327)
T 3lm5_A 12 DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91 (327)
T ss_dssp ----CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB
T ss_pred cccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE
Confidence 4455667777888899999998 89999999999999876 599999999875432 33567889999999985 7999
Q ss_pred cceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC
Q 018128 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 183 (360)
Q Consensus 104 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~ 183 (360)
+++++++.+....++||||+++++|.+++.. .....+++..++.++.||+.||.+||+++ ++||||+|+||+++.
T Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~ 166 (327)
T 3lm5_A 92 INLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSS 166 (327)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESC
T ss_pred EEEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEec
Confidence 9999999999999999999999999999854 23567999999999999999999999999 999999999999987
Q ss_pred ---CCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc
Q 018128 184 ---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 260 (360)
Q Consensus 184 ---~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~ 260 (360)
++.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 167 ~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-- 241 (327)
T 3lm5_A 167 IYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-- 241 (327)
T ss_dssp BTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--
T ss_pred CCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--
Confidence 7899999999998543221 22335689999999999999999999999999999999999999964321110
Q ss_pred hhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 261 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...... ............++..+.++|.+||+.||.+|||+.++++
T Consensus 242 ----~~~i~~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 242 ----YLNISQ--------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ----HHHHHH--------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----HHHHHh--------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 000000 0001111223456778999999999999999999999984
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=329.52 Aligned_cols=275 Identities=25% Similarity=0.401 Sum_probs=222.2
Q ss_pred CcccccHHHHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcc
Q 018128 31 GARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNL 103 (360)
Q Consensus 31 ~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i 103 (360)
....+...++++..++|++.+.||+|++|.||.+.+. .++.|++|.+..... .....+.+|+.+++.++||||
T Consensus 11 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 90 (322)
T 1p4o_A 11 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90 (322)
T ss_dssp CCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB
T ss_pred cccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 4455666788889999999999999999999999754 367899999875432 334568899999999999999
Q ss_pred cceeEEEEeCCeeEEEEEecCCCCHHHHhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018128 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 177 (360)
Q Consensus 104 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~ 177 (360)
+++++++.+.+..++|||++++++|.+++.... .....+++..++.++.||+.||.+||+++ ++||||||+
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~ 167 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAAR 167 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGG
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccc
Confidence 999999999999999999999999999996532 11256789999999999999999999999 999999999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCcc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 256 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~ 256 (360)
||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 99999999999999999875433222222333456788999999999999999999999999999999 88898633211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
. ..... .. ......+..++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus 248 ~------~~~~~----------~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 Q------VLRFV----------ME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp H------HHHHH----------HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H------HHHHH----------Hc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0 00000 00 00112345677889999999999999999999999999998744
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=319.52 Aligned_cols=264 Identities=20% Similarity=0.268 Sum_probs=203.2
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++.+.||+|+||+||++++. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 58999999999999999999876 5899999998755432 33678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++++ +|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~- 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI- 153 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS-
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC-
Confidence 9965 67666654 4577999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCcceecccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh-------hhccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-------LKDQK 273 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~ 273 (360)
.........++..|+|||++.+.. ++.++||||||+++|+|++|..||........ ......... +....
T Consensus 154 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 154 -PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp -CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGG
T ss_pred -ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhc
Confidence 223334456899999999988765 79999999999999999998888643221110 000000000 00000
Q ss_pred cc------hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KF------VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. .............+.++..+.++|.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 0000000111223467788999999999999999999999983
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=329.21 Aligned_cols=250 Identities=27% Similarity=0.357 Sum_probs=199.0
Q ss_pred HHhhcccccceeccCCCeEEEEEEe----cCCCEEEEEEcccCCc----cchHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~----~~~~~v~vK~~~~~~~----~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
+..++|++.+.||+|+||.||+++. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 4468999999999999999999986 3689999999876532 2345678899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred CEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence 999999999999999999954 456899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
++..... .........|+..|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 167 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~--- 235 (327)
T 3a62_A 167 LCKESIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK--- 235 (327)
T ss_dssp CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH---
T ss_pred ccccccc--CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh---
Confidence 9874221 122233457899999999999999999999999999999999999999643211 00001111
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
. ...++..++.++.++|.+||+.||.+|| ++.++++
T Consensus 236 -------~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 236 -------C--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -------T--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -------C--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 1123556778899999999999999999 7788875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=318.37 Aligned_cols=257 Identities=32% Similarity=0.543 Sum_probs=207.7
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc-------hHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-------HQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-------~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
+..++|++.+.||+|+||+||++++. +++.|++|++....... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34689999999999999999999875 68999999986543322 15788999999999999999999998665
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc-----eE
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-----PK 188 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~-----v~ 188 (360)
. ++|||++++++|.+++.. ....+++..++.++.|++.||.|||+++ .+++|+||||+||+++.++. ++
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred C--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEE
Confidence 5 699999999999998865 4567999999999999999999999873 45999999999999987776 99
Q ss_pred EeecCCccccCCCCCcceecccccccccccccccc--cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch
Q 018128 189 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 266 (360)
|+|||++..... ......++..|+|||++. ...++.++||||||+++|+|++|..||........ ..
T Consensus 170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~-- 238 (287)
T 4f0f_A 170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KF-- 238 (287)
T ss_dssp ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HH--
T ss_pred eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HH--
Confidence 999999874222 233456899999999984 55678999999999999999999999964322110 00
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
.............+..++..+.++|.+||+.||.+|||+.++++.|++|
T Consensus 239 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 239 --------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --------HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --------HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0111111222234567788999999999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=324.80 Aligned_cols=268 Identities=28% Similarity=0.415 Sum_probs=207.2
Q ss_pred CCcccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEE
Q 018128 30 SGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGY 109 (360)
Q Consensus 30 ~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~ 109 (360)
+++..+....+.+..++|++.+.||+|++|+||+++.. ++.|++|++.... ..+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (278)
T 1byg_A 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGV 82 (278)
T ss_dssp ---------CCBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred cchhhhhhccccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34445555556677899999999999999999999876 8899999987543 45678899999999999999999998
Q ss_pred EEeC-CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 110 CTSG-DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 110 ~~~~-~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
+.+. ...++|||++++++|.+++.... ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 157 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAK 157 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEE
Confidence 7544 57899999999999999996521 223789999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchh
Q 018128 189 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
|+|||++...... .....++..|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 158 l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~------ 223 (278)
T 1byg_A 158 VSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V------ 223 (278)
T ss_dssp ECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H------
T ss_pred Eeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H------
Confidence 9999998743221 122356788999999998999999999999999999998 999996432110 0
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
...+........+..++..+.++|.+||+.||.+||++.++++.|+.+....
T Consensus 224 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 224 --------VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp --------HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------HHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 0001111122345567888999999999999999999999999999997654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=340.71 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=213.3
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC-eeE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD-QRL 117 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~-~~~ 117 (360)
.+.+..++|++.+.||+|+||.||++... ++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.. ..+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 34566789999999999999999999887 7899999987653 4567899999999999999999999987655 789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+++ ++||||+|+|||++.++.+||+|||++..
T Consensus 264 iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 999999999999999763 2334799999999999999999999999 99999999999999999999999999874
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
.... .....++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 339 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~-------------- 396 (450)
T 1k9a_A 339 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV-------------- 396 (450)
T ss_dssp CC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH--------------
T ss_pred cccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH--------------
Confidence 3211 122356788999999999999999999999999999998 999996432111 00
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
..+....+...+..++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 397 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 397 PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 00111112234567888999999999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=332.05 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=207.6
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
+..++|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999876 58999999986542 234567889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..
T Consensus 92 lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp EEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeee
Confidence 99999999999999953 567999999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCCCcceeccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
.... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||............. ...
T Consensus 165 ~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~----- 233 (384)
T 4fr4_A 165 LPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFE----- 233 (384)
T ss_dssp CCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHH-----
T ss_pred ccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHh-----
Confidence 4322 22344679999999999874 458999999999999999999999997433221111110 000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC-HHHHHH
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVV 318 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~eil~ 318 (360)
.....++..++..+.++|.+||+.||.+||+ ++++++
T Consensus 234 -------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 -------TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111345567888999999999999999999 666654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=326.96 Aligned_cols=275 Identities=24% Similarity=0.373 Sum_probs=221.3
Q ss_pred cccHHHHHHHhhcccccceeccCCCeEEEEEEe------cCCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccc
Q 018128 34 SFTFRELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVT 105 (360)
Q Consensus 34 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~------~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~ 105 (360)
.+....+.+..++|++.+.||+|+||+||++++ .+++.|++|++..... .....+.+|+.+++.+ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 355667788899999999999999999999974 2468899999876533 2345788999999999 6999999
Q ss_pred eeEEEEeCC-eeEEEEEecCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 018128 106 LIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 172 (360)
Q Consensus 106 ~~~~~~~~~-~~~lv~e~~~~~sL~~~i~~~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~ 172 (360)
+++++...+ ..++|||++++++|.+++...... ...+++..++.++.|++.||.|||+++ ++|+
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999987654 489999999999999999764321 223889999999999999999999999 9999
Q ss_pred CCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCccc
Q 018128 173 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 251 (360)
Q Consensus 173 di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~ 251 (360)
||+|+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986544443334445567889999999999999999999999999999998 999996
Q ss_pred ccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 252 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
....... .. ..+........+..++..+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus 253 ~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 253 GVKIDEE--FC--------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp TCCCSHH--HH--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchhHH--HH--------------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 4321100 00 000001111234456778999999999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=326.14 Aligned_cols=267 Identities=28% Similarity=0.407 Sum_probs=209.9
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecC-----CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLES-----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~-----~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
++...+|++.+.||+|+||+||++.... +..|++|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4456789999999999999999997642 24699999875432 23456889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++|||++++++|.+++.. ....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred CcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCc
Confidence 99999999999999999965 4467999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcc
Q 018128 195 AKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 195 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
+......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~------- 260 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VM------- 260 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH-------
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HH-------
Confidence 9764332211 11222345778999999999999999999999999999999 999996332110 00
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCC
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 330 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~ 330 (360)
..+........+..++..+.++|.+||+.||.+||++.++++.|+++.......
T Consensus 261 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 261 ----KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp ----HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred ----HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 000011112234567788999999999999999999999999999998754443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.70 Aligned_cols=263 Identities=29% Similarity=0.434 Sum_probs=210.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCE--EEEEEcccC-CccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQL--VAIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~--v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~l 118 (360)
.++|++.+.||+|++|.||++++. ++.. +++|.+... .......+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 479999999999999999999865 4654 488987643 223456788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 119 VYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~------------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
|||++++++|.+++.... .....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999997633 23457999999999999999999999999 999999999999999999
Q ss_pred eEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccc
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~ 265 (360)
++|+|||++.... .........++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 181 ~kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY 251 (327)
T ss_dssp EEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH
T ss_pred EEEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HH
Confidence 9999999987321 1122233456788999999998889999999999999999998 999996432110 00
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
..+........+..++..+.++|.+||+.||.+|||+.++++.|+.+......
T Consensus 252 -----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 252 -----------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp -----------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -----------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 00011112233456778899999999999999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.42 Aligned_cols=252 Identities=28% Similarity=0.414 Sum_probs=205.8
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhcc-CCCcccceeEEEEeC
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSG 113 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~ 113 (360)
...+..++|++.+.||+|+||+||++++. +++.||+|++.... ......+..|..+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 45567789999999999999999999876 58999999987542 23445678899988876 899999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.+|.++|+|||
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence 999999999999999999954 356999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
++...... .......+|++.|+|||++.+..++.++|+||||+++|+|++|..||....... .......
T Consensus 164 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~--- 232 (345)
T 1xjd_A 164 MCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRM--- 232 (345)
T ss_dssp TCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH---
T ss_pred hhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHh---
Confidence 99753221 222345679999999999999999999999999999999999999996432110 0000000
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHH-HHH
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIV 317 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~-eil 317 (360)
....++..++.++.++|.+||+.||.+||++. +++
T Consensus 233 ---------~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 233 ---------DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---------CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---------CCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01123456778899999999999999999997 665
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=325.50 Aligned_cols=245 Identities=28% Similarity=0.404 Sum_probs=207.4
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
-++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 478999999999999999999876 69999999986542 23456788899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.+|.++|+|||++....
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999954 457999999999999999999999999 9999999999999999999999999997533
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
. ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...... .. ...+.
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~----------~~~i~ 216 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KT----------YEKIL 216 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HH----------HHHHH
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HH----------HHHHH
Confidence 2 123457899999999999999999999999999999999999999643211 00 01111
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
.. ...++..++.++.++|.+||+.||.+|| +++++++
T Consensus 217 ~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 217 NA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred hC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11 1134556778899999999999999999 8899884
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=318.03 Aligned_cols=268 Identities=25% Similarity=0.346 Sum_probs=216.8
Q ss_pred HHhhcccccc-eeccCCCeEEEEEEec---CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 42 IATRNFREAN-LIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 42 ~~~~~y~i~~-~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
+..++|.+.+ .||+|++|.||.+... .+..|++|++..... ...+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 3457888887 9999999999999753 578899999876532 3456788999999999999999999999 55678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++|||++++++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp EEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccccee
Confidence 999999999999999964 4567999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcccc
Q 018128 197 LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 197 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~------------ 223 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM------------ 223 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH------------
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HH------------
Confidence 654333221 1223446788999999998889999999999999999998 999996432111 00
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCC
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 333 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~ 333 (360)
..+........+..++..+.++|.+||+.||.+||++.++++.|..+........+.
T Consensus 224 --~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 224 --AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp --HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred --HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 000111122345677889999999999999999999999999999997755544433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.90 Aligned_cols=268 Identities=28% Similarity=0.414 Sum_probs=215.8
Q ss_pred cccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 34 SFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 34 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
.++...+++..++|++.+.||+|+||.||++.+..+..||+|++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 173 ~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 173 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp SSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 344566778889999999999999999999998877889999987654 345688999999999999999999999876
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...++|||++++++|.+++... .+..+++..++.++.||+.||.|||+++ ++||||+|+|||++.++.+||+|||
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCc
Confidence 6789999999999999999642 2356899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
++....... ........++..|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 326 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~----------- 390 (452)
T 1fmk_A 326 LARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V----------- 390 (452)
T ss_dssp TTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H-----------
T ss_pred cceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---H-----------
Confidence 997543221 112223446778999999998999999999999999999999 999996332110 0
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
...+....+...+..++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 391 ---~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 391 ---LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 000111112234567788999999999999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=320.74 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=201.4
Q ss_pred hcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||+|+||+||++++.+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 58999999999999999999988899999999865532 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++ +|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc-
Confidence 965 99998865 3467999999999999999999999999 999999999999999999999999998754321
Q ss_pred Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhccc----hhhhhccccch
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKDQKKFV 276 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~----~~~~~~~~~~~ 276 (360)
........++..|+|||++.+ ..++.++||||||+++|+|++|..||.......... ..... ...+.......
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 122233467999999999875 458999999999999999999999996433211000 00000 00000000000
Q ss_pred hc------ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HL------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ..+.........++.++.++|.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0000001122356788999999999999999999999984
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=325.54 Aligned_cols=275 Identities=29% Similarity=0.442 Sum_probs=215.6
Q ss_pred hhcc-cccceeccCCCeEEEEEEec-----CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEe--CC
Q 018128 44 TRNF-REANLIGEGGFGKVYKGRLE-----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GD 114 (360)
Q Consensus 44 ~~~y-~i~~~Lg~G~~g~v~~~~~~-----~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~ 114 (360)
.++| ++.+.||+|+||+||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+ ..
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3455 99999999999999988542 588999999876532 334678899999999999999999999987 46
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++|||++++++|.+++.. ..+++..++.++.||+.||.+||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred eEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence 78999999999999999954 45999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 195 AKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 195 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
+......... .......++..|+|||++.+..++.++||||||+++|+|++|..||........ ....+...... ..
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~-~~ 258 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMT-VL 258 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHH-HH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchh-HH
Confidence 9865443322 223345578889999999998999999999999999999999999863321100 00000000000 11
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
.....+........+..++..+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 1222222233334566788899999999999999999999999999999976544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.94 Aligned_cols=266 Identities=24% Similarity=0.390 Sum_probs=218.8
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
+....+++...+|++.+.||+|+||+||++..+.+..||+|.+.... ...+.+.+|+.+++.++||||+++++++. .+
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 34566788899999999999999999999998888899999987653 45678999999999999999999999986 66
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++|||++++++|.+++... ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred ccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 789999999999999999642 1236889999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
+...... .........++..|+|||++....++.++||||||+++|+|++ |..||....... . .
T Consensus 331 a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~---~-------- 395 (454)
T 1qcf_A 331 ARVIEDN-EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V---I-------- 395 (454)
T ss_dssp GGGBCCH-HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H---H--------
T ss_pred ceEcCCC-ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---H---H--------
Confidence 9754321 1111222345778999999998899999999999999999999 999996322110 0 0
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
..+........+..++..+.++|.+||+.||.+|||+.+|++.|+.+..
T Consensus 396 ---~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 396 ---RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0001111223355678899999999999999999999999999999854
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=337.67 Aligned_cols=262 Identities=20% Similarity=0.228 Sum_probs=209.5
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEe
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~ 112 (360)
++.+.+..++|++.+.||+|+||+||+++.. +++.||+|++..... .....+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455566789999999999999999999876 488999999865321 223348889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999965 3467999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
|++....... .......+||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...
T Consensus 220 Gla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~ 292 (437)
T 4aw2_A 220 GSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGK 292 (437)
T ss_dssp TTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH
T ss_pred hhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHh
Confidence 9997543322 22233467999999999987 56789999999999999999999999974321110 000
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCC--CCCHHHHHH
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVV 318 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rpt~~eil~ 318 (360)
...... . .........++.++.+||.+||+.+|++ ||+++|+++
T Consensus 293 i~~~~~---~----~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 293 IMNHKE---R----FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHTHHH---H----CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhccc---c----ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000000 0 0000112346788999999999988888 999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=319.34 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=200.5
Q ss_pred HhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhc--cCCCcccceeEEEEe----CCee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYCTS----GDQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~--l~~p~i~~~~~~~~~----~~~~ 116 (360)
..++|++.+.||+|+||+||+++.. ++.||+|++... ....+..|.+++.. ++||||+++++++.+ ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 4689999999999999999999884 899999998654 23445556666665 789999999998644 3457
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--------CKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
++||||+++++|.+++. ...+++..++.++.|++.||.||| +.+ ++||||||+|||++.++.++
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 89999999999999993 457999999999999999999999 888 99999999999999999999
Q ss_pred EeecCCccccCCCCCcc--eecccccccccccccccccC------CCCcchhhHHHHHHHHHHHhC----------CCcc
Q 018128 189 LSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITG----------RKAM 250 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~s~~sDiwslG~il~~ll~g----------~~pf 250 (360)
|+|||++.......... ......++..|+|||++.+. .++.++||||||+++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999987543322221 12334789999999999876 456799999999999999999 6666
Q ss_pred cccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 251 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
......... ..... .... .............+...+..+.+++.+||+.||.+|||+.++++.|++|
T Consensus 234 ~~~~~~~~~-~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPS-FEDMR-KVVC----VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCC-HHHHH-HHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcc-hhhhh-HHHh----ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 432211110 00000 0000 0000000111112345788999999999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.51 Aligned_cols=277 Identities=26% Similarity=0.403 Sum_probs=215.1
Q ss_pred ccccHHHH-HHHhhcccccceeccCCCeEEEEEEe------cCCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCccc
Q 018128 33 RSFTFREL-AIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLV 104 (360)
Q Consensus 33 ~~~~~~~~-~~~~~~y~i~~~Lg~G~~g~v~~~~~------~~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~ 104 (360)
.+.+..++ .+..++|++.+.||+|++|.||+++. .+++.|++|.+..... .....+.+|+.+++.++||||+
T Consensus 17 ~sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 17 KTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96 (327)
T ss_dssp EEECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCC
Confidence 33333333 46689999999999999999999973 2477899999865432 3345788899999999999999
Q ss_pred ceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018128 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD---QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 181 (360)
Q Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv 181 (360)
++++++.+....++|||++++++|.+++...... ...+++..++.++.||+.||.|||+++ ++|+||+|+||++
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli 173 (327)
T 2yfx_A 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLL 173 (327)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred eEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEE
Confidence 9999999999999999999999999999764322 245899999999999999999999999 9999999999999
Q ss_pred eCC---CceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccC
Q 018128 182 DND---FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQG 257 (360)
Q Consensus 182 ~~~---~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~ 257 (360)
+.+ ..++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 174 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 253 (327)
T 2yfx_A 174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253 (327)
T ss_dssp SCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH
Confidence 844 4699999999875433333333334557889999999998899999999999999999998 889986432110
Q ss_pred ccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 258 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
.. ..+........+..++..+.++|.+||+.||.+||++.++++.|..+......
T Consensus 254 ---~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 254 ---VL--------------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp ---HH--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ---HH--------------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 00 00000111123456778899999999999999999999999999999765543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=329.88 Aligned_cols=254 Identities=21% Similarity=0.248 Sum_probs=197.3
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
...++|++.+.||+|+||+||++++. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 34679999999999999999999876 69999999987653 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc--eEEeecCCcccc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSDFGLAKLG 198 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~--v~L~Dfg~~~~~ 198 (360)
||+++++|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++.++. ++|+|||++...
T Consensus 96 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 96 EYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999854 456999999999999999999999999 999999999999987765 999999998732
Q ss_pred CCCCCcceecccccccccccccccccCCCCcc-hhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK-SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~-sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
. .........+++.|+|||++.+..++.+ +|||||||++|+|++|..||........ ..... ..
T Consensus 169 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~----------~~ 233 (361)
T 3uc3_A 169 V---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTI----------QR 233 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHH----------HH
T ss_pred c---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHH----------HH
Confidence 2 2222234568999999999988877655 8999999999999999999974332111 11000 01
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+............++..+.+||.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11111111112246778999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.70 Aligned_cols=272 Identities=19% Similarity=0.227 Sum_probs=205.6
Q ss_pred HHhhcccccceeccC--CCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 42 IATRNFREANLIGEG--GFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G--~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
...++|++.+.||+| ++|+||++++. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 356799999999999 99999999876 699999999876532 2345688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||.+.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999999762 3456999999999999999999999999 9999999999999999999999999876
Q ss_pred ccCCCCC-----cceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccchh-
Q 018128 197 LGPVGDN-----THVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWSRP- 267 (360)
Q Consensus 197 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~- 267 (360)
....... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||........... .....+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 4222111 111223468889999999987 6789999999999999999999999964332211000 000000
Q ss_pred hhhcc----c-------------cchhc---------ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 FLKDQ----K-------------KFVHL---------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ~~~~~----~-------------~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..... . ..... ........++..++..+.+||.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000 0 00000 0000011134456788999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=344.48 Aligned_cols=265 Identities=25% Similarity=0.406 Sum_probs=220.6
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEecC-CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
+..+++...+|++.+.||+|+||.||++.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 34566778899999999999999999998774 8899999987553 346789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccc
Confidence 99999999999999999762 3456899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
...... .........++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 366 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----------------- 427 (495)
T 1opk_A 366 RLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------- 427 (495)
T ss_dssp ECCTTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------
T ss_pred eeccCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence 864322 1122223445678999999998899999999999999999999 999996432110
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
....+....+...+..++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 428 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 428 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 011111122223456778899999999999999999999999999998854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=325.85 Aligned_cols=278 Identities=29% Similarity=0.453 Sum_probs=216.6
Q ss_pred HHHhhcccccceeccCCCeEEEEEEe-----cCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC-
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD- 114 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~- 114 (360)
.+..++|++.+.||+|++|.||+++. .+++.|++|++..........+.+|+.+++.++||||+++++++...+
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 34468899999999999999999983 358899999998766556678999999999999999999999986543
Q ss_pred -eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 115 -QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 115 -~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
..++|||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred CceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCc
Confidence 68999999999999999976 3456999999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch-hhhhc
Q 018128 194 LAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR-PFLKD 271 (360)
Q Consensus 194 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~ 271 (360)
++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||................ ...
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-- 268 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-- 268 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH--
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh--
Confidence 99865433322 11233456778999999998889999999999999999999999886321100000000000 000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
...+...+........+..++..+.++|.+||+.||.+|||+.++++.|+++...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0001111111112234566788999999999999999999999999999998654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=327.80 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=206.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++.+.||+|+||.||++++. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999876 69999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999965 356999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... ..... +..
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~----------i~~ 252 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEK----------IVS 252 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH----------HHH
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHH----------HHc
Confidence 2 22356899999999999999999999999999999999999999643211 00001 111
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
. ...++..++.++.++|.+||+.||.+||+ +.++++
T Consensus 253 ~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 253 G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1 11345567888999999999999999998 888875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=314.21 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=209.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeC--CeeE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG--DQRL 117 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~--~~~~ 117 (360)
+..++|++.+.||+|++|+||++++. ++.+++|++..... .....+.+|+.+++.++||||+++++++.+. ...+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 34579999999999999999999986 88999999876543 3345788999999999999999999999876 7789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|||++++++|.+++.. ..+..+++..++.++.|++.||.|||++ +.+++|+||+|+||+++.++.++|+||++...
T Consensus 86 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999999965 2234699999999999999999999986 34599999999999999999999999888753
Q ss_pred cCCCCCcceecccccccccccccccccCCCCc---chhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL---KSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~---~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
... ....++..|+|||++.+..++. ++||||||+++|+|++|..||....... .
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~ 219 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----------------I 219 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----------------H
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----------------H
Confidence 211 2245788999999998765544 8999999999999999999996332110 0
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
.............+..++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011111112223455678889999999999999999999999999999854
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=318.37 Aligned_cols=264 Identities=28% Similarity=0.405 Sum_probs=207.8
Q ss_pred HhhcccccceeccCCCeEEEEEEecC----CCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEE-EeCCee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~-~~~~~~ 116 (360)
...+|++.+.||+|+||+||++.... ...+++|.+.... ......+.+|+.+++.++||||+++++++ ..+...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 35689999999999999999998542 3368999887543 23446788999999999999999999985 456678
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++|||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccc
Confidence 999999999999999965 4567899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCc--ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccc
Q 018128 197 LGPVGDNT--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 197 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
........ .......++..|+|||.+.+..++.++||||||+++|+|++ |.+||........ . ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~---~~~~---- 246 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---T---VYLL---- 246 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---H---HHHH----
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---H---HHHh----
Confidence 54332211 12233456788999999999999999999999999999999 5556643221110 0 0000
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
.......+..++..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 247 -------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 247 -------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred -------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0011122445677899999999999999999999999999999775443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=314.56 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=207.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
..++|++.+.||+|++|.||.+.+. +++.|++|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3578999999999999999999876 689999999865432 34467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999884 3567999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
...........++..|+|||.+.+..+ +.++||||||+++|+|++|..||........ ....+ .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~---------- 222 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----K---------- 222 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH----H----------
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh----h----------
Confidence 332233344668999999999987665 7899999999999999999999974332110 00000 0
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...........++..+.++|.+||+.||.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000011112356778999999999999999999999983
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=315.67 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=186.1
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
.++|++.+.||+|++|.||.+++. +++.|++|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 368999999999999999999874 699999999865421 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999965 3467999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ...
T Consensus 164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------~~~ 225 (278)
T 3cok_A 164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------------KVV 225 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CC
T ss_pred CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------------HHh
Confidence 221 12233568899999999998889999999999999999999999997433211100 000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
. .....+..++.++.++|.+||+.||.+|||+.+++
T Consensus 226 ~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 226 L--ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp S--SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred h--cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 0 00123445677899999999999999999999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=320.58 Aligned_cols=267 Identities=25% Similarity=0.377 Sum_probs=211.0
Q ss_pred ccHHHHHHHhhcccccc-eeccCCCeEEEEEEe--c-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeE
Q 018128 35 FTFRELAIATRNFREAN-LIGEGGFGKVYKGRL--E-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIG 108 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~-~Lg~G~~g~v~~~~~--~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~ 108 (360)
+...++.+..++|++.+ .||+|+||+||.+.. . .++.|++|++...... ..+.+.+|+.+++.++||||+++++
T Consensus 6 i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp -----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 33445556678999999 999999999999954 2 4788999998765322 2467889999999999999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 109 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
++ ..+..++|||++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~k 157 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAK 157 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEE
Confidence 98 56778999999999999999965 456999999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccch
Q 018128 189 LSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 266 (360)
|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------- 228 (291)
T 1xbb_A 158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------- 228 (291)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------
T ss_pred EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---------
Confidence 99999998654333221 1222345688999999998889999999999999999999 999996432111
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
....+........+..++..+.++|.+||+.||.+||++.++++.|+.+...
T Consensus 229 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 229 --------VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0001111112234556788999999999999999999999999999998664
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=323.88 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=199.4
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc---hHHHHHHHHHhhccCCCcccceeEEEEeCCe----
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ---- 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~---~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~---- 115 (360)
.++|++.+.||+|+||.||++++. +++.||+|++....... ...+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 579999999999999999999874 68999999997653332 3468899999999999999999999876543
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999964 456999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 196 KLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 196 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
......... .......++..|+|||++.+..++.++||||||+++|+|++|..||....... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC
Confidence 754332222 22233568999999999999999999999999999999999999996432110 00000000000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH-HHHhhhhhc
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV-VALDYLVSQ 326 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil-~~L~~l~~~ 326 (360)
. .......++.++.++|.+||+.||.+||+..+++ +.+.++...
T Consensus 238 ~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 238 P--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp C--------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred C--------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0 0001234677899999999999999999666555 456666443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=326.27 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=203.0
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~l 118 (360)
-++|++.+.||+|+||.||++++. +++.||+|++...... ....+.+|..+++.+ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 468999999999999999999876 5899999998765332 335678899999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++...
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999954 356999999999999999999999999 999999999999999999999999999742
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.. ........+|++.|+|||++.+..++.++|||||||++|+|++|..||............. .... ...+
T Consensus 161 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~-----~~~i 231 (345)
T 3a8x_A 161 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--EDYL-----FQVI 231 (345)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C--HHHH-----HHHH
T ss_pred cC--CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc--HHHH-----HHHH
Confidence 21 2222344679999999999999999999999999999999999999996433211110000 0000 0001
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
... ...++..++..+.++|.+||+.||.+||++
T Consensus 232 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 232 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111 113456678889999999999999999996
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=334.04 Aligned_cols=257 Identities=22% Similarity=0.268 Sum_probs=208.7
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEe
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~ 112 (360)
+..+.+..++|++.+.||+|+||+||++++. +++.||+|++.... ......+.+|..+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556689999999999999999999876 58999999986532 2233457889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999954 46899999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCC----CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
|++....... .......+|++.|+|||++.+.. ++.++||||||+++|+|++|..||....... .
T Consensus 213 G~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~---- 281 (410)
T 3v8s_A 213 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------T---- 281 (410)
T ss_dssp TTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H----
T ss_pred ceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------H----
Confidence 9997643322 12233567999999999998655 7899999999999999999999996432110 0
Q ss_pred hhccccchhcccccccCCC--ChhhHHHHHHHHhhhcccCCCC--CCCHHHHHH
Q 018128 269 LKDQKKFVHLVDPLLHGRY--PRRCLNYAVAVTAMCLNEEANF--RPLINDIVV 318 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~--Rpt~~eil~ 318 (360)
...++.......+ ...++.++.+||.+||+.+|.+ ||+++||++
T Consensus 282 ------~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 282 ------YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ------HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ------HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0111111000111 2256788999999999999988 999999996
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.35 Aligned_cols=270 Identities=26% Similarity=0.374 Sum_probs=218.2
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecC------CCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLES------GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGY 109 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~------~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~ 109 (360)
..+++..++|++.+.||+|+||.||.+.+.. ...|++|.+..... .....+.+|+.+++.+ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3567778999999999999999999998642 24799999876532 3346788999999999 89999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcE
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEP----------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 179 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NI 179 (360)
+.+.+..++|||++++++|.+++..... ....+++..++.++.||+.||.|||+++ ++|+||+|+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence 9999999999999999999999965321 1456899999999999999999999999 99999999999
Q ss_pred EEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCc
Q 018128 180 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGE 258 (360)
Q Consensus 180 lv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~ 258 (360)
+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999999975443333333344556788999999999999999999999999999998 8899964321110
Q ss_pred cchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 259 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
.............+...+..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 276 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 ----------------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 0011111111223445677899999999999999999999999999988653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=328.04 Aligned_cols=251 Identities=26% Similarity=0.351 Sum_probs=206.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~ 115 (360)
.+.-++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 345689999999999999999999877 48899999987542 23456788899999887 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.++|+|||++
T Consensus 96 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999999964 356999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
..... ........+|++.|+|||++.+..++.++|+||||+++|+|++|..||...... .....
T Consensus 169 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~-------- 232 (353)
T 2i0e_A 169 KENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQS-------- 232 (353)
T ss_dssp BCCCC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH--------
T ss_pred ccccc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHH--------
Confidence 75221 222234467999999999999999999999999999999999999999643211 00111
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
+... ...++..++.++.++|.+||+.||.+||+ +.++++
T Consensus 233 --i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 233 --IMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --HHHC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --HHhC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 11345667889999999999999999995 577764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.67 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=206.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
.++|++.+.||+|+||.||++++. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 478999999999999999999876 699999999865422 2346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++++|.+++. ..+.+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999994 4567999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
... .....+|++.|+|||++.+..+ +.++||||||+++|+|++|..||...... ... ..+
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~----------~~i 228 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLF----------KKI 228 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHH----------HHH
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHH----------HHH
Confidence 322 2334579999999999988765 68999999999999999999999743211 000 011
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..... ..+..++.++.++|.+||+.||.+|||+.++++
T Consensus 229 ~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 229 CDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11111 224456778999999999999999999999996
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=318.75 Aligned_cols=282 Identities=23% Similarity=0.295 Sum_probs=208.7
Q ss_pred cccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhcc--CCCcccceeEE
Q 018128 32 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL--HHDNLVTLIGY 109 (360)
Q Consensus 32 ~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l--~~p~i~~~~~~ 109 (360)
...++........++|++.+.||+|+||.||+++.. ++.||+|++.... ......|.+++... +||||++++++
T Consensus 24 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 24 GSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp CSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CCCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 334556667777899999999999999999999887 8999999985432 33445555555554 89999999999
Q ss_pred EEeC----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeeCCCCCC
Q 018128 110 CTSG----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK--------ANPPVIYRDLKSA 177 (360)
Q Consensus 110 ~~~~----~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~~~i~H~di~p~ 177 (360)
+.+. ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ + ++|+||||+
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~ 171 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSK 171 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGG
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchH
Confidence 9877 788999999999999999954 4699999999999999999999988 7 999999999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcc--eecccccccccccccccccCCCCcc------hhhHHHHHHHHHHHhCCCc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSGKLTLK------SDIYSFGVVLLELITGRKA 249 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~------sDiwslG~il~~ll~g~~p 249 (360)
||+++.++.++|+|||++.......... ......++..|+|||++.+...+.. +||||||+++|+|++|..|
T Consensus 172 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~ 251 (337)
T 3mdy_A 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251 (337)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred HEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCc
Confidence 9999999999999999997543322221 1124568999999999987766654 9999999999999999555
Q ss_pred ccccCccCccchhc-cchhhhhccccchhcccccccCCC-----ChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 250 MDLSKGQGEQNLVS-WSRPFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 250 f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
+............. ......... ............. ...++..+.++|.+||+.||.+|||+.++++.|+++
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 252 GGIVEEYQLPYHDLVPSDPSYEDM--REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHH--HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccccccHhhhcCCCCchhhh--HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 43211100000000 000000000 0000011111112 237788999999999999999999999999999999
Q ss_pred hhcc
Q 018128 324 VSQR 327 (360)
Q Consensus 324 ~~~~ 327 (360)
....
T Consensus 330 ~~~~ 333 (337)
T 3mdy_A 330 SESQ 333 (337)
T ss_dssp HHTT
T ss_pred Hhhc
Confidence 7754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=320.40 Aligned_cols=252 Identities=25% Similarity=0.283 Sum_probs=206.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc------chHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
..++|++.+.||+|+||.||++.+. +++.|++|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4678999999999999999999876 5899999998765322 35678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC----ceEEee
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSD 191 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~----~v~L~D 191 (360)
.++|||++++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999953 467899999999999999999999999 99999999999998887 799999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..||....... ........
T Consensus 163 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~ 233 (321)
T 2a2a_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITSV 233 (321)
T ss_dssp CTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTT
T ss_pred CccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhc
Confidence 99997643322 2234568999999999999999999999999999999999999996432110 00000000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ..........+..+.++|.+||+.||.+|||+.|+++
T Consensus 234 ~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SY--------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC--------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc--------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000012345678999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=318.92 Aligned_cols=256 Identities=30% Similarity=0.407 Sum_probs=202.7
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
.++|++.+.||+|+||+||+++.. ++.|++|.+... ...+.+.+|+.+++.++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 578999999999999999999886 788999998644 34567889999999999999999999876 4478999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeeeCCCCCCcEEEeCCCc-eEEeecCCccccC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC---KANPPVIYRDLKSANILLDNDFN-PKLSDFGLAKLGP 199 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~~~~i~H~di~p~NIlv~~~~~-v~L~Dfg~~~~~~ 199 (360)
++++|.+++.... ....+++..++.++.|++.||.|||+ ++ ++|+||||+||+++.++. ++|+|||++....
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999996522 22357899999999999999999999 66 999999999999998886 7999999986432
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. .....++..|+|||++.+..++.++||||||+++|+|++|..||........ ..... .
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~-----------~ 217 (307)
T 2eva_A 158 TH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWA-----------V 217 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHH-----------H
T ss_pred cc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHH-----------H
Confidence 21 2234589999999999999999999999999999999999999964321110 00000 0
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
........+..++..+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus 218 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 218 HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp HTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred hcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0011112344567789999999999999999999999999999976543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=321.15 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=205.9
Q ss_pred HhhcccccceeccCCCeEEEEEEecC-C-------CEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLES-G-------QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~~-~-------~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
..++|++.+.||+|+||+||++.+.. + ..|++|++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 46799999999999999999997652 3 479999987766666778999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc--------
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN-------- 186 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~-------- 186 (360)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999975 3345999999999999999999999999 999999999999988876
Q ss_pred eEEeecCCccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCC-cccccCccCccchhcc
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSW 264 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~-pf~~~~~~~~~~~~~~ 264 (360)
++|+|||++..... .....++..|+|||++.+ ..++.++||||||+++|+|++|.. ||.........
T Consensus 160 ~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~----- 228 (289)
T 4fvq_A 160 IKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL----- 228 (289)
T ss_dssp EEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----
T ss_pred eeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-----
Confidence 99999999864321 122347788999999987 778999999999999999999654 44321110000
Q ss_pred chhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCC
Q 018128 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 331 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~ 331 (360)
.... .....+...+.++.++|.+||+.||.+|||+.++++.|+.+.......+
T Consensus 229 --~~~~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 229 --QFYE------------DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp --HHHH------------TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred --HHhh------------ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 0000 0111233345568899999999999999999999999999976544443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.49 Aligned_cols=253 Identities=26% Similarity=0.297 Sum_probs=201.1
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.++|++.+.||+|+||+||+++.. +++.+++|.+..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 478999999999999999999875 589999999876532 345788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---eCCCceEEeecCCcccc
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv---~~~~~v~L~Dfg~~~~~ 198 (360)
++++++|.+++......+..+++..++.++.||+.||.+||+++ ++|+||+|+||++ +.++.++|+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999765445678999999999999999999999999 9999999999999 44578999999999753
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.. ........++..|+|||++. ..++.++||||||+++|+|++|..||............ ..
T Consensus 178 ~~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~------~~-------- 239 (285)
T 3is5_A 178 KS---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------TY-------- 239 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH--------
T ss_pred CC---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh------cc--------
Confidence 32 22233456899999999875 56899999999999999999999999643211100000 00
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...... ......+..+.++|.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 240 KEPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCcccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 001225677899999999999999999999983
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=331.41 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=201.5
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--cchHHHHHHHHHhhccC--CCcccceeEEEEeCCeeE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~--~p~i~~~~~~~~~~~~~~ 117 (360)
+.+++|++.+.||+|+||+||++.+..++.||+|++..... .....+.+|+.+++.++ ||||+++++++...+..+
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34567999999999999999999988899999999876533 33467889999999996 599999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||| +.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++..
T Consensus 133 lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp EEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred EEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 9999 558899999965 357899999999999999999999999 99999999999995 58999999999986
Q ss_pred cCCCCCcceeccccccccccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 266 (360)
..............|++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------- 273 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------- 273 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----------
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----------
Confidence 543333333445679999999999865 36889999999999999999999999632110
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......+++......++...+.++.++|.+||+.||.+|||+.|+++
T Consensus 274 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 274 -----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 01111222222223344455678999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=315.14 Aligned_cols=260 Identities=22% Similarity=0.365 Sum_probs=208.1
Q ss_pred HHhhcccccceeccCCCeEEEEEEecC----CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
+..++|++.+.||+|++|+||.+.... +..|++|.+..... .....+.+|+.+++.++||||+++++++.+ +..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 456899999999999999999997542 34699999876532 345678899999999999999999999865 456
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++|||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 899999999999999966 3456899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||........ .
T Consensus 162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~------------- 224 (281)
T 3cc6_A 162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---I------------- 224 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---H-------------
T ss_pred ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---H-------------
Confidence 5433221 12233456788999999998899999999999999999998 9999963322110 0
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
..+........+..++..+.++|.+||+.||.+||++.++++.|+.+...
T Consensus 225 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 225 -GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 00000111123445678899999999999999999999999999988653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=320.52 Aligned_cols=269 Identities=22% Similarity=0.333 Sum_probs=191.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.++|++.+.||+|+||+||++.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999876 589999999875532 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 122 YMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|++ ++|.+++.... .....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 59999986532 22356999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-cc----chhhhhccc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW----SRPFLKDQK 273 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~----~~~~~~~~~ 273 (360)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++|..||............ .. ....+....
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 22 222334568999999999876 46899999999999999999999999644321110000 00 000000000
Q ss_pred cchhc-----------ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHL-----------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..... +...+.......++.++.++|.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 0000011112245678999999999999999999999983
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=322.60 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=198.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCC-------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------- 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~------- 114 (360)
.++|++.+.||+|+||.||++++. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 478999999999999999999876 699999999875543 34567899999999999999999999885543
Q ss_pred --------------------------------------------------eeEEEEEecCCCCHHHHhcccCCCCCCCCH
Q 018128 115 --------------------------------------------------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSW 144 (360)
Q Consensus 115 --------------------------------------------------~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~ 144 (360)
..++|||++++++|.+++.... .....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3799999999999999997643 2344567
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc----------ceeccccccc
Q 018128 145 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT----------HVSTRVMGTY 214 (360)
Q Consensus 145 ~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~----------~~~~~~~~~~ 214 (360)
..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++......... .......++.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 789999999999999999999 999999999999999999999999999865443221 1223356899
Q ss_pred ccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHH
Q 018128 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY 294 (360)
Q Consensus 215 ~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (360)
.|+|||++.+..++.++||||||+++|+|++|..|+..... . ...... ..........+..
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~------------~------~~~~~~-~~~~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR------------I------ITDVRN-LKFPLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH------------H------HHHHHT-TCCCHHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH------------H------HHHhhc-cCCCcccccCChh
Confidence 99999999999999999999999999999998776531100 0 000000 0000112345567
Q ss_pred HHHHHhhhcccCCCCCCCHHHHHH
Q 018128 295 AVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 295 l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+.++|.+||+.||.+|||+.|+++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 899999999999999999999984
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=315.74 Aligned_cols=264 Identities=27% Similarity=0.352 Sum_probs=209.6
Q ss_pred cccccceeccCCCeEEEEEEec-C---CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCee-EEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-S---GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR-LLV 119 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~---~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~-~lv 119 (360)
.|++.+.||+|+||+||++.+. + +..+++|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5677899999999999999753 2 33799998875432 3346788999999999999999999999766655 999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||++.+++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999965 4567899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCC--cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 200 VGDN--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 200 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.... ........++..|+|||.+.+..++.++||||||+++|+|++|..|+....... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~----------------~~~~ 239 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF----------------DLTH 239 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG----------------GHHH
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH----------------HHHH
Confidence 3221 122233567889999999999999999999999999999999665543211110 0011
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCC
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 331 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~ 331 (360)
.+........+..++..+.+++.+||+.||.+|||+.++++.|+++........
T Consensus 240 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 240 FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 111111122345667889999999999999999999999999999988665444
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=320.23 Aligned_cols=250 Identities=22% Similarity=0.242 Sum_probs=197.7
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhcc-CCCcccceeEEEEeCC
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD 114 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~ 114 (360)
...+..++|++.+.||+|+||+||++++. +++.||+|++...... .......|+..+..+ +||||+++++++.+..
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34456689999999999999999999876 6999999987654322 233445555555554 8999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++|||++ +++|.+++.. .+..+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.++|+|||+
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTT
T ss_pred EEEEEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcccee
Confidence 999999999 6799999876 3467999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
+...... .......|+..|+|||++.+ .++.++||||||+++|+|++|..|+.....
T Consensus 204 a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------------- 260 (311)
T 3p1a_A 204 LVELGTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------------- 260 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------------
T ss_pred eeecccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------------
Confidence 8754322 22334568999999998876 789999999999999999999766532110
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...+........++..++.++.++|.+||+.||.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 261 WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01111111111123456788999999999999999999999993
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=314.62 Aligned_cols=247 Identities=21% Similarity=0.241 Sum_probs=206.0
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
..++|++.+.||+|+||.||++.+. ++..+++|.+........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4678999999999999999999876 478999999987666667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---eCCCceEEeecCCcccc
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv---~~~~~v~L~Dfg~~~~~ 198 (360)
++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998854 456899999999999999999999999 9999999999999 77889999999999754
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.... ......++..|+|||++.+. ++.++||||||+++|+|++|..||........ ......
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-------- 221 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV------MLKIRE-------- 221 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH--------
T ss_pred cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh--------
Confidence 3322 23345689999999988654 89999999999999999999999964321100 000000
Q ss_pred ccccccCCCC----hhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ..+ ..++..+.++|.+||+.||.+|||+.++++
T Consensus 222 --~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 222 --GTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --CCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 111 145678999999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=324.64 Aligned_cols=266 Identities=21% Similarity=0.261 Sum_probs=194.4
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.....++|++.+.||+|+||+||++.+. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3445689999999999999999999865 6899999998755332 234677899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe-----CCCceEEee
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-----NDFNPKLSD 191 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~-----~~~~v~L~D 191 (360)
++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+|||++ ..+.++|+|
T Consensus 109 ~lv~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 109 HLIFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEEEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EEEEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECc
Confidence 999999964 99999954 456999999999999999999999999 99999999999995 445599999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh---
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP--- 267 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--- 267 (360)
||++...... ........++..|+|||++.+. .++.++|||||||++|+|++|..||........ .......
T Consensus 181 fg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~ 256 (329)
T 3gbz_A 181 FGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGL 256 (329)
T ss_dssp TTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCC
T ss_pred CCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCC
Confidence 9999754322 2223334678999999999864 589999999999999999999999964332110 0000000
Q ss_pred ----h---hhccccchh----cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 268 ----F---LKDQKKFVH----LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 268 ----~---~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
. ......+.. .....+....+..++.++.+||.+||+.||.+|||+.|++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0 000000000 0000000011223567899999999999999999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.01 Aligned_cols=262 Identities=24% Similarity=0.211 Sum_probs=204.0
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC-----CccchHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE-----GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~-----~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
+....++|++.+.||+|+||+||++.+. +++.|++|++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4567899999999999999999999875 6889999998654 234456789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPD------------------------------------QEPLSWNTRMKIAVGAARG 157 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~a 157 (360)
+..++||||+++++|.+++..+... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999999632211 2234678889999999999
Q ss_pred HHHHHhCCCCCeeeCCCCCCcEEEeCCC--ceEEeecCCccccCCCCC--cceeccccccccccccccccc--CCCCcch
Q 018128 158 LEYLHCKANPPVIYRDLKSANILLDNDF--NPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMS--GKLTLKS 231 (360)
Q Consensus 158 l~~LH~~~~~~i~H~di~p~NIlv~~~~--~v~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~s~~s 231 (360)
|.|||+++ ++|+||+|+||+++.++ .++|+|||++........ ........++..|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 899999999975432221 122344568999999999875 6789999
Q ss_pred hhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC
Q 018128 232 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311 (360)
Q Consensus 232 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 311 (360)
||||||+++|+|++|..||....... ........... ........++..+.++|.+||+.||.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLC--------FENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC--------TTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcccc--------cCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999996433111 00011110000 00011224677899999999999999999
Q ss_pred CHHHHHH
Q 018128 312 LINDIVV 318 (360)
Q Consensus 312 t~~eil~ 318 (360)
++.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=315.21 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=208.8
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe--------
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-------- 112 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-------- 112 (360)
....+|++.+.||+|++|.||++.+. +++.|++|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 45789999999999999999999876 69999999986543 456789999999999999999998754
Q ss_pred --------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 113 --------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 113 --------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
....++||||+++++|.+++... ....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 44578999999999999999752 2467999999999999999999999999 9999999999999999
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhcc
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 264 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 264 (360)
+.++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++|..|+....
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------- 225 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------- 225 (284)
T ss_dssp TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------
T ss_pred CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------
Confidence 999999999987643322 2233468999999999999999999999999999999999998874211
Q ss_pred chhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
... ..+ .....+..++..+.++|.+||+.||.+|||+.|+++.|..+...
T Consensus 226 --~~~------~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 226 --KFF------TDL----RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --HHH------HHH----HTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --HHH------HHh----hcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 000 001 11122345667789999999999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=324.53 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=191.7
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
...++|++.+.||+|+||+||++++. +++.|++|++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34578999999999999999999876 58899999987543 3456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC---CCceEEeecCCccc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKL 197 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~---~~~v~L~Dfg~~~~ 197 (360)
||+++++|.+++. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++. ++.++|+|||++..
T Consensus 128 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999994 3566999999999999999999999999 999999999999975 78999999999875
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
... ........++..|+|||++.+..++.++|||||||++|+|++|..||........ .........
T Consensus 201 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~----- 267 (349)
T 2w4o_A 201 VEH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCE----- 267 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTC-----
T ss_pred cCc---ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCC-----
Confidence 322 1222345689999999999999999999999999999999999999963321100 000000000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........++.++.++|.+||+.||++|||+.++++
T Consensus 268 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 268 ---YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111122456778999999999999999999999984
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=327.68 Aligned_cols=273 Identities=17% Similarity=0.174 Sum_probs=208.1
Q ss_pred HHhhcccccceeccCCCeEEEEEEecC------CCEEEEEEcccCCccc-----------hHHHHHHHHHhhccCCCccc
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLES------GQLVAIKQLNHEGLQG-----------HQEFIVEVLMLSLLHHDNLV 104 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~------~~~v~vK~~~~~~~~~-----------~~~~~~e~~~l~~l~~p~i~ 104 (360)
+..++|++.+.||+|+||.||++.+.. ++.||+|++....... ......|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 345699999999999999999998753 4789999986553211 11234466667778899999
Q ss_pred ceeEEEEeC----CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 105 TLIGYCTSG----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 105 ~~~~~~~~~----~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
++++++.+. ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil 184 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL 184 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence 999998664 4579999999 9999999976 4467999999999999999999999999 999999999999
Q ss_pred Ee--CCCceEEeecCCccccCCCCCcc-----eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 018128 181 LD--NDFNPKLSDFGLAKLGPVGDNTH-----VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 253 (360)
Q Consensus 181 v~--~~~~v~L~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~ 253 (360)
++ .++.++|+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 88999999999997543322111 112345899999999999999999999999999999999999999743
Q ss_pred CccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 254 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
.... .......... ......+++..+. ...++.++.+++..||+.||.+||++.++++.|+.+....+
T Consensus 265 ~~~~--~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 265 LKDP--KYVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp TTCH--HHHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCH--HHHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 2211 1110000000 1112222222211 13457789999999999999999999999999999977543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=321.84 Aligned_cols=259 Identities=21% Similarity=0.263 Sum_probs=187.7
Q ss_pred hccccc---ceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEE
Q 018128 45 RNFREA---NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 45 ~~y~i~---~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv 119 (360)
++|++. +.||+|+||+||++.+. +++.||+|++... ......+|+.+++.+. ||||+++++++.+....++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 567765 78999999999999876 6899999998643 3456788999999997 99999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC---ceEEeecCCcc
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPKLSDFGLAK 196 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~---~v~L~Dfg~~~ 196 (360)
||++++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 85 MELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp ECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999999999965 467999999999999999999999999 99999999999998766 79999999997
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc-chhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~ 275 (360)
..... ........++..|+|||++.+..++.++||||||+++|+|++|..||......... .......
T Consensus 158 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--------- 226 (325)
T 3kn6_A 158 LKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK--------- 226 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH---------
T ss_pred ecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH---------
Confidence 53322 22233456799999999999999999999999999999999999999754321110 0000000
Q ss_pred hhcccccc--cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCCCCC
Q 018128 276 VHLVDPLL--HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVSRNA 336 (360)
Q Consensus 276 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~~~~ 336 (360)
.+..... .......++.++.++|.+||+.||.+|||+.+++ .|+|-.+.
T Consensus 227 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell-----------~h~w~~~~ 277 (325)
T 3kn6_A 227 -KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR-----------YNEWLQDG 277 (325)
T ss_dssp -HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST-----------TCGGGCTT
T ss_pred -HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh-----------cChhhccC
Confidence 0000000 0001134678899999999999999999999987 56776644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=319.62 Aligned_cols=265 Identities=22% Similarity=0.235 Sum_probs=203.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc---hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~---~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
.-++|++.+.||+|++|.||.+.+. +++.|++|++....... ...+.+|+.+++.++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3579999999999999999999876 68899999987653322 3678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
|||++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999964 356999999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.... ........++..|+|||++.+..++.++||||||+++|+|++|..||...... . ........
T Consensus 185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~~~~~------ 250 (309)
T 2h34_A 185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------V-MGAHINQA------ 250 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------H-HHHHHHSC------
T ss_pred cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------H-HHHHhccC------
Confidence 3222 12223456889999999999999999999999999999999999999643211 0 00000000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCC-CHHHHHHHHhhhhhccCCC
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQRDSH 330 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~eil~~L~~l~~~~~~~ 330 (360)
. ......+..++..+.++|.+||+.||++|| +++++++.|+++.......
T Consensus 251 ~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 251 I--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp C--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred C--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 0 000122445677899999999999999999 9999999999986655443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.48 Aligned_cols=267 Identities=21% Similarity=0.255 Sum_probs=207.3
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEE-EeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~-~~~~~~~lv~ 120 (360)
..++|++.+.||+|++|+||++++. +++.||+|++..... ...+..|+.+++.++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4689999999999999999999864 689999998655432 24578899999999887766665554 7778889999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---eCCCceEEeecCCccc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKL 197 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv---~~~~~v~L~Dfg~~~~ 197 (360)
|++ +++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+||++ +.++.++|+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 8899999965 3467999999999999999999999999 9999999999999 7889999999999986
Q ss_pred cCCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccc-hhhhhc
Q 018128 198 GPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS-RPFLKD 271 (360)
Q Consensus 198 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 271 (360)
....... .......++..|+|||++.+..++.++||||||+++|+|++|..||............... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 236 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-
Confidence 5443321 1223457899999999999999999999999999999999999999754433222111100 00000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
.... .....++.++.++|.+||+.||.+|||+.++++.|+++....+.
T Consensus 237 ------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 237 ------TPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ------SCHH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ------chhh----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0000 01134567899999999999999999999999999999776543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=325.96 Aligned_cols=277 Identities=16% Similarity=0.151 Sum_probs=205.7
Q ss_pred HHhhcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCcc-----------chHHHHHHHHHhhccCCCcccce
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGLQ-----------GHQEFIVEVLMLSLLHHDNLVTL 106 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~~-----------~~~~~~~e~~~l~~l~~p~i~~~ 106 (360)
+..++|++.+.||+|+||.||++.+. .+..+++|++...... ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 34579999999999999999999875 5788999998765321 11235678888999999999999
Q ss_pred eEEEEe----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe
Q 018128 107 IGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 182 (360)
Q Consensus 107 ~~~~~~----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~ 182 (360)
++++.+ ....++|||++ +++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEc
Confidence 999987 67889999999 9999999964 337999999999999999999999999 99999999999998
Q ss_pred CCC--ceEEeecCCccccCCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCc
Q 018128 183 NDF--NPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 255 (360)
Q Consensus 183 ~~~--~v~L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~ 255 (360)
.++ .++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 877 9999999999764322111 111345789999999999999999999999999999999999999963221
Q ss_pred cCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCCCC
Q 018128 256 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 333 (360)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~~~ 333 (360)
... ........... ......... .....++.++.++|.+||+.||.+||++.++++.|+.+....+...++
T Consensus 266 ~~~-~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~~ 336 (345)
T 2v62_A 266 DPV-AVQTAKTNLLD---ELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFS 336 (345)
T ss_dssp CHH-HHHHHHHHHHH---TTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCCC
T ss_pred ccH-HHHHHHHhhcc---cccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCcc
Confidence 110 00000000000 000000000 001256678999999999999999999999999999986544444443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=318.25 Aligned_cols=258 Identities=25% Similarity=0.338 Sum_probs=205.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEE--eCCeeEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCT--SGDQRLL 118 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~--~~~~~~l 118 (360)
.++|++.+.||+|++|.||.+... +++.|++|.+..... ...+.+.+|+.+++.++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999876 689999999876533 23456889999999999999999999874 4678899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
||||+++++|.+++.........+++..++.++.|++.||.+||+.+ +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999775555667999999999999999999999875 2349999999999999999999999999987
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..... ........++..|+|||++.+..++.++||||||+++|+|++|..||...... ........
T Consensus 165 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~------ 230 (279)
T 2w5a_A 165 ILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIRE------ 230 (279)
T ss_dssp HC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH------
T ss_pred eeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHHhh------
Confidence 54322 11222346889999999999989999999999999999999999999743211 00000000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L 320 (360)
......+..++.++.++|.+||+.||.+||++.++++.+
T Consensus 231 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 231 -----GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp -----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred -----cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 011123456778899999999999999999999999644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=313.31 Aligned_cols=246 Identities=21% Similarity=0.258 Sum_probs=201.7
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~l 118 (360)
..++|++.+.||+|++|+||++.+. +++.|++|++..... .....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3578999999999999999999876 699999999876432 3446788899999998 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC--------------
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-------------- 184 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-------------- 184 (360)
|||++++++|.+++.........+++..++.++.||+.||.|||+++ ++|+||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999764444477999999999999999999999999 9999999999999844
Q ss_pred -----CceEEeecCCccccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCc
Q 018128 185 -----FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 258 (360)
Q Consensus 185 -----~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~ 258 (360)
..++|+|||.+...... ....++..|+|||++.+. .++.++||||||+++|+|++|.+|+.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 47999999998764322 123488999999998865 667899999999999999999877642110
Q ss_pred cchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 259 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
...+.. ......+..++..+.++|.+||+.||.+|||+.+++
T Consensus 237 ----------------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 237 ----------------WHEIRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp ----------------HHHHHT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ----------------HHHHHc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 000000 111123456778899999999999999999999998
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=323.10 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=207.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
..++|++.+.||+|+||.||.+.+. +++.+++|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3579999999999999999999876 588999999865432 334678889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 119 v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 119 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999999854 457999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.... .......++..|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus 192 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~-------- 255 (335)
T 2owb_A 192 EYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKK-------- 255 (335)
T ss_dssp CSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH--------
T ss_pred ccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhc--------
Confidence 3222 22334568999999999999999999999999999999999999996432110 0000000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ....+..++..+.++|.+||+.||.+||++.++++
T Consensus 256 --~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 256 --N--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --C--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 01234456778999999999999999999999996
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=339.60 Aligned_cols=250 Identities=28% Similarity=0.357 Sum_probs=198.9
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC---CccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
+..++|++.+.||+|+||.||++++. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999875 6899999998654 2233456778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.++|+|||++.
T Consensus 225 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 99999999999999954 4579999999999999999999998 88 9999999999999999999999999987
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
... ..........|+..|+|||++.+..++.++|||||||++|+|++|..||....... .......
T Consensus 298 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~------ 363 (446)
T 4ejn_A 298 EGI--KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILM------ 363 (446)
T ss_dssp TTC--C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH------
T ss_pred ecc--CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHHh------
Confidence 422 22223344679999999999999999999999999999999999999996432110 0000000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
. ...++..++.++.++|.+||+.||.+|| ++.|+++
T Consensus 364 ----~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 364 ----E--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----C--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 1124556778899999999999999999 9999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=314.53 Aligned_cols=249 Identities=27% Similarity=0.347 Sum_probs=207.8
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
..+|++.+.||+|++|.||.+.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999865 689999999876543 345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++++++|.+++. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999993 467999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. .......++..|+|||++.+..++.++||||||+++|+|++|..||........ .... ..
T Consensus 173 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~-----------~~ 233 (303)
T 3a7i_A 173 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------LFLI-----------PK 233 (303)
T ss_dssp B--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHH-----------HH
T ss_pred c--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------HHHh-----------hc
Confidence 2 222345688999999999999999999999999999999999999964321100 0000 00
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~ 319 (360)
......+..++..+.++|.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 234 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11112344567789999999999999999999999873
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=322.60 Aligned_cols=242 Identities=23% Similarity=0.317 Sum_probs=203.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--------chHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
..++|++.+.||+|+||+||++.+. +++.|++|++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3579999999999999999999865 6899999998765321 234577899999999999999999999999
Q ss_pred CeeEEEEEecCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 114 DQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 114 ~~~~lv~e~~~~~-sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
...++|||++.++ +|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999998666 99999953 557999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
|++....... ......++..|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 9998643322 2233568999999999988776 88999999999999999999999632110
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... ...+..++.++.++|.+||+.||.+|||+.++++
T Consensus 237 -------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 -------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp -------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0123346778999999999999999999999996
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=332.19 Aligned_cols=261 Identities=21% Similarity=0.213 Sum_probs=207.6
Q ss_pred HHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEe
Q 018128 37 FRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112 (360)
Q Consensus 37 ~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~ 112 (360)
.+++.+..++|++.+.||+|+||+||+++.. +++.||+|++.+... .....+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4455566789999999999999999999876 699999999865321 233457889999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
.+..|+||||+++++|.+++... +..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999652 357999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceecccccccccccccccc-------cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 265 (360)
|++........ ......+||+.|+|||++. ...++.++|||||||++|+|++|..||........ .
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~ 279 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------Y 279 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------H
Confidence 99976433222 2223457999999999987 35689999999999999999999999964321110 0
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCC---CCHHHHHH
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR---PLINDIVV 318 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---pt~~eil~ 318 (360)
....... ... .....+..++.++.++|.+||+ +|.+| |+++|+++
T Consensus 280 ~~i~~~~---~~~----~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 280 GKIVHYK---EHL----SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHTHH---HHC----CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHhcc---cCc----CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0000000 000 0011124567889999999999 99998 58999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=310.69 Aligned_cols=267 Identities=21% Similarity=0.254 Sum_probs=211.0
Q ss_pred hhcccccceeccCCCeEEEEEEe-cCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEE-EeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC-TSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~-~~~~~~~lv~e 121 (360)
.++|++.+.||+|++|.||++++ .+++.||+|++..... ...+.+|+.+++.++|++++..+.++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57999999999999999999987 4699999999865532 35688999999999988766655544 67778899999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---eCCCceEEeecCCcccc
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv---~~~~~v~L~Dfg~~~~~ 198 (360)
++ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+||++ +.++.++|+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 8899999965 3467999999999999999999999999 9999999999999 47889999999999864
Q ss_pred CCCCCcc-----eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 199 PVGDNTH-----VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 199 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
....... ......++..|+|||++.+..++.++||||||+++|+|++|..||...................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---- 234 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK---- 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH----
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc----
Confidence 4433211 1234568999999999999999999999999999999999999997543322211111000000
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
. ....+ .....++..+.++|.+||+.||.+|||+.++++.|+++....+.
T Consensus 235 -~-~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 235 -M-STPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -H-HSCHH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -c-CCchH----HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 00000 01234567899999999999999999999999999999776554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=325.23 Aligned_cols=264 Identities=26% Similarity=0.360 Sum_probs=196.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc-hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||+|+||+||++++. +++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999876 68999999986543221 12345799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
++ ++|.+++.. .+..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~-- 152 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI-- 152 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC--
Confidence 96 599999876 4567999999999999999999999999 99999999999999999999999999875322
Q ss_pred Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-cc--------chhhhhcc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW--------SRPFLKDQ 272 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~--------~~~~~~~~ 272 (360)
.........++..|+|||++.+ ..++.++||||||+++|+|++|..||............ .. ...... .
T Consensus 153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~ 231 (324)
T 3mtl_A 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS-N 231 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-C
T ss_pred CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc-c
Confidence 2222334567999999999876 56899999999999999999999999754321100000 00 000000 0
Q ss_pred ccchhcccccccC----CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........+.... .....++.++.+||.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000000000 012346678999999999999999999999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=317.87 Aligned_cols=273 Identities=25% Similarity=0.327 Sum_probs=215.0
Q ss_pred ccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhc--cCCCcccceeEEE
Q 018128 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL--LHHDNLVTLIGYC 110 (360)
Q Consensus 33 ~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~--l~~p~i~~~~~~~ 110 (360)
...+........++|++.+.||+|++|.||+++.. ++.||+|++... ....+..|.++++. ++||||+++++++
T Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 35666777888999999999999999999999885 899999998643 34567778888877 6899999999999
Q ss_pred EeCC----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCc
Q 018128 111 TSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--------CKANPPVIYRDLKSAN 178 (360)
Q Consensus 111 ~~~~----~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--------~~~~~~i~H~di~p~N 178 (360)
.... ..++|||++++++|.+++.. ..+++..++.++.|++.||.||| +.+ ++|+||||+|
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~N 177 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKN 177 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGG
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHH
Confidence 8776 78999999999999999954 46899999999999999999999 788 9999999999
Q ss_pred EEEeCCCceEEeecCCccccCCCCCcc--eecccccccccccccccccC------CCCcchhhHHHHHHHHHHHhC----
Q 018128 179 ILLDNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITG---- 246 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~s~~sDiwslG~il~~ll~g---- 246 (360)
|+++.++.++|+|||++.......... ......++..|+|||++.+. .++.++||||||+++|+|++|
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 999999999999999997644333221 22345689999999998765 334789999999999999999
Q ss_pred ------CCcccccCccCccchhccchhhhhccccchhcccccccCCC-----ChhhHHHHHHHHhhhcccCCCCCCCHHH
Q 018128 247 ------RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLIND 315 (360)
Q Consensus 247 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~e 315 (360)
..||........ ....+.. ........... ....+..+.+++.+||+.||.+|||+.+
T Consensus 258 ~~~~~~~~p~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 326 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDP-SVEEMRK----------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326 (342)
T ss_dssp TBCCCCCCTTTTTSCSSC-CHHHHHH----------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CcccccccCccccCcCcc-cHHHHHH----------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence 556643221110 0000000 01111111111 2367788999999999999999999999
Q ss_pred HHHHHhhhhhccC
Q 018128 316 IVVALDYLVSQRD 328 (360)
Q Consensus 316 il~~L~~l~~~~~ 328 (360)
+++.|+++..+..
T Consensus 327 i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 327 IKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhc
Confidence 9999999977653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=327.04 Aligned_cols=250 Identities=23% Similarity=0.296 Sum_probs=199.6
Q ss_pred cccc--cceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 46 NFRE--ANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 46 ~y~i--~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.|++ .+.||+|+||.||++... +++.|++|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 4444 568999999999999875 6999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE--eCCCceEEeecCCccccCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL--DNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv--~~~~~v~L~Dfg~~~~~~~ 200 (360)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+|||+ +.++.++|+|||++.....
T Consensus 168 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 168 VDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp CTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999998865 3456999999999999999999999999 9999999999999 4567899999999986433
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.. ......++..|+|||++.+..++.++|||||||++|+|++|..||....... ...........
T Consensus 242 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~~------ 306 (373)
T 2x4f_A 242 RE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACRWD------ 306 (373)
T ss_dssp TC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCC------
T ss_pred cc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccCC------
Confidence 22 2233468999999999998899999999999999999999999996433111 00011110000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........++.++.+||.+||+.||.+|||+.|+++
T Consensus 307 --~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 307 --LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000112356778999999999999999999999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=317.00 Aligned_cols=265 Identities=23% Similarity=0.291 Sum_probs=199.2
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++.+.||+|++|+||++++. +++.|++|++...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999876 5899999988655332 23567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++++++|.+++. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 154 (311)
T 4agu_A 83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG- 154 (311)
T ss_dssp CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC-
Confidence 999989988874 3567999999999999999999999999 99999999999999999999999999976332
Q ss_pred CCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc-c-------chhhhhcc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-W-------SRPFLKDQ 272 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~-------~~~~~~~~ 272 (360)
.........++..|+|||++.+ ..++.++||||||+++|+|++|..||............. . ........
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 155 -PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred -cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 2222334568899999999876 678999999999999999999999996543221110000 0 00000000
Q ss_pred ccchhcccccccC--C---CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHG--R---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~--~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........+.... . ..+.++..+.++|.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000000 0 01346778999999999999999999999993
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=346.38 Aligned_cols=268 Identities=28% Similarity=0.412 Sum_probs=219.5
Q ss_pred cccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 34 SFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 34 ~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
.+....+++..++|++.+.||+|+||.||++.+..+..||+|++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 256 ~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 256 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp SSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 344567788899999999999999999999998877889999987654 345688999999999999999999999866
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
...++||||+++++|.+++... .+..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTT
T ss_pred ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccc
Confidence 6789999999999999999642 2356899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
++...... .........++..|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 409 ~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~----------- 473 (535)
T 2h8h_A 409 LARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V----------- 473 (535)
T ss_dssp STTTCCCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---H-----------
T ss_pred cceecCCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H-----------
Confidence 99753321 1111222346678999999998899999999999999999999 899996332110 0
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
...+....+...+..++..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus 474 ---~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 474 ---LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 000111112234557788999999999999999999999999999988543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=329.01 Aligned_cols=246 Identities=26% Similarity=0.311 Sum_probs=196.2
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHH-hhccCCCcccceeEEEEeCCee
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLM-LSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~-l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
+..++|++.+.||+|+||+||++++. +++.||+|++.+.... ....+..|..+ ++.++||||+++++++.+.+..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34578999999999999999999876 5889999998765432 23445666666 5678999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.++|+|||++.
T Consensus 115 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 999999999999999954 457899999999999999999999999 9999999999999999999999999997
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
.... ........+|++.|+|||++.+..++.++|+|||||++|+|++|..||...... .....
T Consensus 188 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~--------- 250 (373)
T 2r5t_A 188 ENIE--HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDN--------- 250 (373)
T ss_dssp GGBC--CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHH---------
T ss_pred cccc--CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHH---------
Confidence 5222 122334467999999999999999999999999999999999999999633211 11111
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 314 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ 314 (360)
++.. ...++..++..+.++|.+||+.||.+||++.
T Consensus 251 -i~~~--~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 251 -ILNK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp -HHHS--CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred -HHhc--ccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 1111 1123456778899999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=327.54 Aligned_cols=276 Identities=20% Similarity=0.271 Sum_probs=214.8
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCC--eeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD--QRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~--~~~l 118 (360)
..++|++.+.||+|+||+||++++. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.. ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3578999999999999999999876 599999999875432 34567789999999999999999999998755 6799
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----eCCCceEEeecCC
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGL 194 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv----~~~~~v~L~Dfg~ 194 (360)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ ++||||||+|||+ +.++.++|+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999996533 2234999999999999999999999999 9999999999999 6777899999999
Q ss_pred ccccCCCCCcceeccccccccccccccccc--------CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+...... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ....
T Consensus 163 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~ 237 (396)
T 4eut_A 163 ARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMY 237 (396)
T ss_dssp CEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHH
T ss_pred ceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHH
Confidence 9754322 22234568999999998865 567889999999999999999999996433221110 0000
Q ss_pred hhhhcc-c----cchhcc--------cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 267 PFLKDQ-K----KFVHLV--------DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 267 ~~~~~~-~----~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
...... . ...... ........+..++..+.+++.+||+.||++||++.++++.++.+....
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 000000 0 000000 001112345788899999999999999999999999999999987754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=318.27 Aligned_cols=265 Identities=23% Similarity=0.270 Sum_probs=200.7
Q ss_pred hhccccc-ceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEE
Q 018128 44 TRNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 44 ~~~y~i~-~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.++|++. +.||+|+||+||++.+. +++.||+|++..........+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4789985 78999999999999865 6999999999876656677899999999885 7999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc---eEEeecCCccc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKL 197 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~---v~L~Dfg~~~~ 197 (360)
|++++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.++. ++|+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999965 356899999999999999999999999 999999999999988765 99999999875
Q ss_pred cCCCCC-----cceeccccccccccccccccc-----CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh
Q 018128 198 GPVGDN-----THVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 198 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
...... ........++..|+|||++.+ ..++.++||||||+++|+|++|..||.................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 332211 111223458999999999875 5578999999999999999999999975432221000000000
Q ss_pred hhhccccchhcccccccCCCC----hhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 FLKDQKKFVHLVDPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ......+..... .++ ..++..+.++|.+||+.||.+|||+.|+++
T Consensus 244 ~~~-~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQ-NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHH-HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHH-HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000 000000000000 111 235678999999999999999999999994
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=314.22 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=203.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
..++|++.+.||+|++|+||++.+. +++.|++|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999876 57899999986542 2234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
|||++++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999999965 356899999999999999999999998 999999999999999999999999988542
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.. .......++..|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~--------- 220 (279)
T 3fdn_A 160 PS----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRIS--------- 220 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH---------
T ss_pred Cc----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHH---------
Confidence 21 12234568999999999999999999999999999999999999996332110 000000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....++..++..+.++|.+||+.||.+|||+.|+++
T Consensus 221 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 221 ---RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ---HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0111234557788999999999999999999999996
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=315.55 Aligned_cols=268 Identities=24% Similarity=0.287 Sum_probs=198.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-----cchHHHHHHHHHhhccC---CCcccceeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-----QGHQEFIVEVLMLSLLH---HDNLVTLIGYCT 111 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-----~~~~~~~~e~~~l~~l~---~p~i~~~~~~~~ 111 (360)
.+..++|++.+.||+|+||+||++++. +++.||+|++..... .......+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 456789999999999999999999875 689999999864321 12345667777777664 999999999997
Q ss_pred eCC-----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 112 SGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 112 ~~~-----~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
+.. ..++|||++. ++|.+++... ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGT 158 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSC
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCC
Confidence 755 5789999996 5999999662 2345999999999999999999999999 999999999999999999
Q ss_pred eEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccc
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWS 265 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~ 265 (360)
++|+|||++..... ........++..|+|||++.+..++.++|||||||++|+|++|..||........... ....
T Consensus 159 ~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 159 VKLADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp EEECSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEeeCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999975332 2223445689999999999999999999999999999999999999964332111000 0000
Q ss_pred hh----hhhccccchh-ccccccc---CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 266 RP----FLKDQKKFVH-LVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 266 ~~----~~~~~~~~~~-~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.. .+........ ....... ....+.++..+.++|.+||+.||.+|||+.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 00 0000000000 0000000 001235678899999999999999999999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=325.27 Aligned_cols=264 Identities=27% Similarity=0.392 Sum_probs=201.2
Q ss_pred hcccccceeccCCCeEEEEEEec--C--CCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEE-eCCeeEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE--S--GQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCT-SGDQRLL 118 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~--~--~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~-~~~~~~l 118 (360)
.+|++.+.||+|+||+||++... + +..+++|.+.... ......+.+|+.+++.++||||+++++++. .+...++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 45788999999999999999753 2 2468999886542 234567899999999999999999999864 4567899
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||++...
T Consensus 169 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999965 4566899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCcc--eecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 199 PVGDNTH--VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 199 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |.+||........ .. ....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~---~~~~----- 311 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV---YLLQ----- 311 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HH---HHHT-----
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HH---HHHc-----
Confidence 3222111 1223456778999999999999999999999999999999 6777754322110 00 0000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCCC
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 331 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~~ 331 (360)
......+..++..+.+++.+||+.||.+|||+.++++.|+.+........
T Consensus 312 ------~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 312 ------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 01112245577889999999999999999999999999999987655433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=312.56 Aligned_cols=251 Identities=22% Similarity=0.245 Sum_probs=204.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.++|++.+.||+|++|.||.+.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 579999999999999999999876 589999999865533 23467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc---eEEeecCCccc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDFGLAKL 197 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~---v~L~Dfg~~~~ 197 (360)
|++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++. ++|+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998854 456999999999999999999999999 999999999999976655 99999999975
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
..... ......++..|+|||++.+..++.++||||||+++|+|++|..||....... ..........
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~---- 224 (284)
T 3kk8_A 158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQIKAGAY---- 224 (284)
T ss_dssp CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC----
T ss_pred cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHHHHhccc----
Confidence 43222 2233568999999999999999999999999999999999999996432110 0000000000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++.++.++|.+||+.||.+|||+.|+++
T Consensus 225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 ----DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001112356778999999999999999999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=316.65 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=204.7
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
...++|++.+.||+|++|+||++++. +++.|++|++..........+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 35689999999999999999999876 69999999998665555567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---eCCCceEEeecCCccc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKL 197 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv---~~~~~v~L~Dfg~~~~ 197 (360)
|++++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||++ +.++.++|+|||++..
T Consensus 86 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999854 356899999999999999999999999 9999999999999 7788999999999874
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
... .......++..|+|||++.+..++.++||||||+++|+|++|..||....... .........
T Consensus 159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~----- 223 (304)
T 2jam_A 159 EQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEKIKEGY----- 223 (304)
T ss_dssp CCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHCC-----
T ss_pred cCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCC-----
Confidence 321 12233458899999999999999999999999999999999999996432110 000000000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........++..+.++|.+||+.||.+|||+.++++
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 224 ---YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111223456788999999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=322.62 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=201.8
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
..++|++.+.||+|+||.||++.+. +++.||+|++...... ..+|++++..+ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4678999999999999999999876 5899999998765432 34577778777 7999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC----CceEEeecCCcc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND----FNPKLSDFGLAK 196 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~----~~v~L~Dfg~~~ 196 (360)
||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||+.++ +.++|+|||++.
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999954 467999999999999999999999999 9999999999998443 359999999998
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
...... .......++..|+|||++.+..++.++||||||+++|+|++|..||............ ......
T Consensus 169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~~i~~~----- 238 (342)
T 2qr7_A 169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---ARIGSG----- 238 (342)
T ss_dssp ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH---HHHHHC-----
T ss_pred cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH---HHHccC-----
Confidence 643322 2233457899999999998888999999999999999999999999743221111111 000000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+...++.++.++|.+||+.||.+||++.++++
T Consensus 239 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 239 ---KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111223467788999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.25 Aligned_cols=263 Identities=17% Similarity=0.201 Sum_probs=213.2
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEE------ecCCCEEEEEEcccCCccchHHHHHHHHHhhccC---CCcccceeE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIG 108 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~------~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---~p~i~~~~~ 108 (360)
.++.+..++|++.+.||+|+||+||+|. ...++.||+|++.... ...+..|..+++.++ |+||+.+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 4455667899999999999999999994 3468899999987543 345666777777665 999999999
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC----
Q 018128 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---- 183 (360)
Q Consensus 109 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~---- 183 (360)
++...+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 99999999999999999999999976433 3567999999999999999999999999 999999999999988
Q ss_pred -------CCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCcc
Q 018128 184 -------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 256 (360)
Q Consensus 184 -------~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~ 256 (360)
++.++|+|||++................||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997544334444455677999999999999999999999999999999999999998532211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCC-CCHHHHHHHHhhhhhccC
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR-PLINDIVVALDYLVSQRD 328 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-pt~~eil~~L~~l~~~~~ 328 (360)
.. .. ...+. .+ .....+.+++..||+.+|.+| |++.++.+.|+.+.....
T Consensus 292 ~~---------------~~----~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 292 EC---------------KP----EGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp EE---------------EE----CSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ce---------------ee----chhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 00 00 00010 11 235678899999999999999 788889999988876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=319.09 Aligned_cols=256 Identities=23% Similarity=0.279 Sum_probs=193.8
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
++..++|++.+.||+|+||+||++++. +++.||+|++....... ...+.++...++.++||||+++++++.+.+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 456789999999999999999999875 68999999987653222 233445555678889999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
+|||+++ ++|.+++......+..+++..++.++.|++.||.|||++ + ++|+||||+||+++.++.++|+|||++.
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 9999996 499888876555678899999999999999999999998 8 9999999999999999999999999987
Q ss_pred ccCCCCCcceeccccccccccccccc----ccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYA----MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
..... .......++..|+|||++ .+..++.++||||||+++|+|++|..||....... ..
T Consensus 159 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~--------- 222 (290)
T 3fme_A 159 YLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF----QQ--------- 222 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH----HH---------
T ss_pred ccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH----HH---------
Confidence 53322 222334688999999996 56678999999999999999999999996322110 00
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
................++.++.++|.+||+.||.+|||+.|+++
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 --LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00011111111123356778999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=312.89 Aligned_cols=252 Identities=23% Similarity=0.271 Sum_probs=202.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC----ccchHHHHHHHHHhhccCCCcccceeEEE--EeCCe
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG----LQGHQEFIVEVLMLSLLHHDNLVTLIGYC--TSGDQ 115 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l~~p~i~~~~~~~--~~~~~ 115 (360)
..++|++.+.||+|+||.||.+.+. +++.+++|++.... ......+.+|+.+++.++||||+++++++ .+...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3479999999999999999999875 58999999986542 23456789999999999999999999998 44567
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++|||+++++ |.+++... ....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999765 77777653 3567999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCC--CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
................++..|+|||++.+.. .+.++||||||+++|+|++|..||...... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~--- 227 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIGK--- 227 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH---
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHhc---
Confidence 8654433344444567899999999987644 478999999999999999999999743211 00000000
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ....+..++..+.++|.+||+.||.+|||+.++++
T Consensus 228 -------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 228 -------G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp -------C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 01234466788999999999999999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.15 Aligned_cols=213 Identities=24% Similarity=0.323 Sum_probs=184.5
Q ss_pred CCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-----CCc
Q 018128 29 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----HDN 102 (360)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----~p~ 102 (360)
+.....++.+.+.+..++|++.+.||+|+||+||++++. +++.||+|++... .........|+.+++.+. |||
T Consensus 19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 455667778888888999999999999999999999875 6899999998643 233456777999998886 999
Q ss_pred ccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe
Q 018128 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 182 (360)
Q Consensus 103 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~ 182 (360)
|+++++++...+..++|||++ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 999999999999999999999 88999999762 3346999999999999999999999999 99999999999997
Q ss_pred C-------------------------CCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHH
Q 018128 183 N-------------------------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 237 (360)
Q Consensus 183 ~-------------------------~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG 237 (360)
. ++.++|+|||++...... .....++..|+|||++.+..++.++||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 5 788999999999753221 2345689999999999999999999999999
Q ss_pred HHHHHHHhCCCccccc
Q 018128 238 VVLLELITGRKAMDLS 253 (360)
Q Consensus 238 ~il~~ll~g~~pf~~~ 253 (360)
|++|+|++|..||...
T Consensus 247 ~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 247 CVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHCCCCCCCC
Confidence 9999999999999643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=313.90 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=207.4
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
..++|++.+.||+|+||.||.+.+. +++.+++|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3578999999999999999999876 588999999865432 234568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
|||++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 93 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999998854 457999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.... .......++..|+|||++.+..++.++||||||+++|+|++|..||....... ... .+
T Consensus 166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~----------~~ 227 (294)
T 2rku_A 166 EYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYL----------RI 227 (294)
T ss_dssp CSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH----------HH
T ss_pred ccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH----------HH
Confidence 3222 22334568999999999999889999999999999999999999996432110 000 00
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ....+..++..+.++|.+||+.||.+|||+.++++
T Consensus 228 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 228 KKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 11234566778999999999999999999999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=310.15 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=207.2
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc------chHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
..++|++.+.||+|++|.||.+.+. +++.|++|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4678999999999999999999876 6899999988654322 35678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC----ceEEee
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSD 191 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~----~v~L~D 191 (360)
.++|||++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++ .++|+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999954 457899999999999999999999999 99999999999998776 799999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
||.+....... ......++..|+|||++.+..++.++||||||+++|+|++|..||........ .......
T Consensus 156 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~ 226 (283)
T 3bhy_A 156 FGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET------LTNISAV 226 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTT
T ss_pred cccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH------HHHhHhc
Confidence 99997543222 22335688999999999989999999999999999999999999964321100 0000000
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhhhhh
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVS 325 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~--~L~~l~~ 325 (360)
. ...........+..+.++|.+||+.||.+||++.++++ .+..+..
T Consensus 227 ~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 227 N--------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp C--------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred c--------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0 00000112345678999999999999999999999997 4555543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=312.61 Aligned_cols=246 Identities=23% Similarity=0.343 Sum_probs=206.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
.++|++.+.||+|++|.||.+++. +++.|++|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 478999999999999999999876 58899999986542 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999965 356899999999999999999999999 9999999999999999999999999986533
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
.. ......++..|+|||++.+..++.++||||||+++|+|++|..||........ .. .+.
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~----------~~~ 225 (284)
T 2vgo_A 166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HR----------RIV 225 (284)
T ss_dssp SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH----------HHH
T ss_pred cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HH----------HHh
Confidence 21 12335689999999999999999999999999999999999999964321100 00 000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ....++..++..+.++|.+||+.||.+||++.++++
T Consensus 226 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 226 N--VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp T--TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c--cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 011234567788999999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=312.30 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=199.2
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.+..++|++.+.||+|++|.||.+++. +++.|++|++.... ......+.+|+..++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 345679999999999999999999876 69999999986542 23356788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++|||++++++|.+++.. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 159 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN 159 (276)
T ss_dssp EEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred EEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccc
Confidence 999999999999999965 356899999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
..... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... ........
T Consensus 160 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~----- 225 (276)
T 2h6d_A 160 MMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIRG----- 225 (276)
T ss_dssp CCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-----
T ss_pred ccCCC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhc-----
Confidence 54322 22233568899999999987765 68999999999999999999999642211 00000000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ....+..++..+.++|.+||+.||.+|||+.++++
T Consensus 226 -----~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 226 -----G--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -----C--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----C--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0 01124456778999999999999999999999997
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=323.35 Aligned_cols=267 Identities=16% Similarity=0.167 Sum_probs=208.5
Q ss_pred hhcccccceeccCCCeEEEEEEecC---------CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccc---------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLES---------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT--------- 105 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~--------- 105 (360)
+++|++.+.||+|+||.||++++.. ++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 5799999999999999999998763 789999998654 46788999999999999887
Q ss_pred ------eeEEEEe-CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018128 106 ------LIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 178 (360)
Q Consensus 106 ------~~~~~~~-~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~N 178 (360)
+++++.. ....++|||++ +++|.+++... ....+++..++.++.||+.||.|||+++ ++|+||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 5667765 77889999999 99999999752 2467999999999999999999999999 9999999999
Q ss_pred EEEeCCC--ceEEeecCCccccCCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCccc
Q 018128 179 ILLDNDF--NPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 251 (360)
Q Consensus 179 Ilv~~~~--~v~L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~ 251 (360)
|+++.++ .++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999754322211 11233478999999999999999999999999999999999999997
Q ss_pred ccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 252 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
...... .........+..... ..... ......++..+.++|.+||+.||.+|||+.++++.|+++.....
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDKPG---PFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHSCC---CEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCH-HHHHHHHHhccCChh---hhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 543111 111111111111000 00000 00112456889999999999999999999999999999977655
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=320.66 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=205.2
Q ss_pred CCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--cchHHHHHHHHHhhccC--CCccc
Q 018128 29 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH--HDNLV 104 (360)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~--~p~i~ 104 (360)
....+.+.+..+.+.+++|++.+.||+|+||.||++.+.+++.|++|++..... .....+.+|+.+++.++ ||||+
T Consensus 12 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp --------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred cCCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceE
Confidence 455666777777888999999999999999999999988899999999875533 33467889999999997 59999
Q ss_pred ceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
++++++.+....++||| +.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||++++
T Consensus 92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~- 162 (313)
T 3cek_A 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD- 162 (313)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-
T ss_pred EEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-
Confidence 99999999999999999 558899999965 457899999999999999999999999 999999999999965
Q ss_pred CceEEeecCCccccCCCCCcceeccccccccccccccccc-----------CCCCcchhhHHHHHHHHHHHhCCCccccc
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGRKAMDLS 253 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~s~~sDiwslG~il~~ll~g~~pf~~~ 253 (360)
+.++|+|||++................++..|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 8999999999986443333333344568999999999875 46889999999999999999999999632
Q ss_pred CccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 254 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ........+......++...+..+.++|.+||+.||.+||++.++++
T Consensus 243 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 243 INQ---------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CSH---------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH---------------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 211 01111222222233344555778999999999999999999999995
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.68 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=210.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
.++|++.+.||+|+||+||++++. +|+.||+|++..... .....+..|+.+++.++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999876 699999999865422 3346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++++|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.++|+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999776555678999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~--------- 407 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLE--------- 407 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHH---------
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhh---------
Confidence 222 122335799999999999999999999999999999999999999974332111 0111111110
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCH-----HHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~eil~ 318 (360)
. ...++..++.++.++|.+||+.||.+||++ .++++
T Consensus 408 -~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 -Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0 113456778899999999999999999975 56663
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=313.80 Aligned_cols=262 Identities=29% Similarity=0.409 Sum_probs=201.6
Q ss_pred HHhhcccccceeccCCCeEEEEEEec--CCC--EEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE--SGQ--LVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~--~~~--~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
+..++|++.+.||+|++|+||.+++. +++ .|++|++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 34689999999999999999999753 233 68999887542 233467889999999999999999999987665
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
.++|+|++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 95 -~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred -ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccc
Confidence 8899999999999999965 2356899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcc
Q 018128 195 AKLGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 195 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
+.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~-------- 233 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------I-------- 233 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H--------
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------H--------
Confidence 98654333222 2233456778999999998889999999999999999999 999996432110 0
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
...+.........+..++..+.++|.+||+.||.+|||+.++++.|.++.+.
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 234 --LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp --HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --HHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0011111111123456778899999999999999999999999999998654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=318.27 Aligned_cols=266 Identities=24% Similarity=0.290 Sum_probs=197.6
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc-----hHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-----HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-----~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
...++|++.+.||+|+||.||.+.+. +++.|++|++....... ...+.+|+.+++.++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34689999999999999999999876 58999999987543221 2467889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++|||++++ +|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999975 89888854 4457899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhh----hh
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF----LK 270 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----~~ 270 (360)
..... .........++..|+|||++.+. .++.++||||||+++|+|++|.+||........ ........ ..
T Consensus 160 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGS--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEE 235 (346)
T ss_dssp STTTS--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTT
T ss_pred eeccC--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChh
Confidence 75432 22223345689999999998754 589999999999999999999999864432110 00000000 00
Q ss_pred ccccchhcccccccCC--------CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 271 DQKKFVHLVDPLLHGR--------YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........+...... ....++.++.++|.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000000000000000 11345688999999999999999999999995
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=312.67 Aligned_cols=252 Identities=27% Similarity=0.347 Sum_probs=202.2
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
...++|++.+.||.|++|.||.+.+. +++.|++|.+.... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 44689999999999999999999876 58999999987643 3467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++++++|.+++.. ....+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999964 3567999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. ........++..|+|||++.+..++.++||||||+++|+|++|..||........ ..... ..
T Consensus 178 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-------~~-- 240 (314)
T 3com_A 178 T--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIP-------TN-- 240 (314)
T ss_dssp T--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH-------HS--
T ss_pred h--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHh-------cC--
Confidence 2 2222345688999999999999999999999999999999999999963321100 00000 00
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+..++..+.++|.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 241 PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00011224456788999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.14 Aligned_cols=270 Identities=27% Similarity=0.391 Sum_probs=198.7
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHH--HHHHhhccCCCcccceeEEEEe-----CC
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIV--EVLMLSLLHHDNLVTLIGYCTS-----GD 114 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~--e~~~l~~l~~p~i~~~~~~~~~-----~~ 114 (360)
+..++|++.+.||+|+||.||+++.. ++.||+|++.... ...+.. ++..+..++||||+++++.+.. ..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred cChHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 44689999999999999999999774 8999999986442 233333 4444555899999999976532 23
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeCCCCCCcEEEeCCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK---------ANPPVIYRDLKSANILLDNDF 185 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------~~~~i~H~di~p~NIlv~~~~ 185 (360)
..++||||+++++|.+++.. ...++..++.++.||+.||.|||+. + ++||||||+|||++.++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTS
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCC
Confidence 56899999999999999954 4458899999999999999999998 8 99999999999999999
Q ss_pred ceEEeecCCccccCCCCC------cceeccccccccccccccccc-------CCCCcchhhHHHHHHHHHHHhCCCcccc
Q 018128 186 NPKLSDFGLAKLGPVGDN------THVSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELITGRKAMDL 252 (360)
Q Consensus 186 ~v~L~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~s~~sDiwslG~il~~ll~g~~pf~~ 252 (360)
.++|+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999999976433221 122234568999999999886 4567899999999999999999887754
Q ss_pred cCccCccchhc----cchhhhhccccchhcccccccCCC------ChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 253 SKGQGEQNLVS----WSRPFLKDQKKFVHLVDPLLHGRY------PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 253 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
........... ...+..... ............+ ...++..+.++|.+||+.||.+|||+.|+++.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDM--QVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHH--HHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHH--HhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 33222111000 000000000 0000001111111 23467789999999999999999999999999999
Q ss_pred hhh
Q 018128 323 LVS 325 (360)
Q Consensus 323 l~~ 325 (360)
+..
T Consensus 316 ll~ 318 (336)
T 3g2f_A 316 LMM 318 (336)
T ss_dssp HHH
T ss_pred HHH
Confidence 964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=319.22 Aligned_cols=246 Identities=29% Similarity=0.385 Sum_probs=201.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
.++|++.+.||+|+||+||++++. +++.|++|++...... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 467999999999999999999864 6899999998755332 235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+. |+|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99996 588888865 3467999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
. .....++..|+|||++. +..++.++||||||+++|+|++|..||....... .......
T Consensus 206 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~------ 267 (348)
T 1u5q_A 206 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ------ 267 (348)
T ss_dssp S------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH------
T ss_pred C------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHh------
Confidence 2 12356899999999984 5678999999999999999999999986332110 0000000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+..++..+.++|.+||+.||.+|||+.++++
T Consensus 268 ----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 268 ----NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ----SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00001113356778999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=308.82 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=200.1
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
|.....||+|++|.||++.+. +++.|++|.+........+.+.+|+.+++.++||||+++++++.+.+..++|||++++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 333449999999999999865 5889999999876666667899999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-CCceEEeecCCccccCCCCCc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNT 204 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-~~~v~L~Dfg~~~~~~~~~~~ 204 (360)
++|.+++.... ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++. ++.++|+|||++...... .
T Consensus 104 ~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~ 177 (295)
T 2clq_A 104 GSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--N 177 (295)
T ss_dssp EEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC--C
Confidence 99999997632 2345779999999999999999999999 999999999999987 889999999999754322 1
Q ss_pred ceecccccccccccccccccCC--CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 205 HVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~--~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||++.+.. ++.++||||||+++|+|++|..||........ . ... .....
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~----~~~-------~~~~~ 242 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----A----MFK-------VGMFK 242 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----H----HHH-------HHHHC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----H----HHh-------hcccc
Confidence 2223456899999999987654 78999999999999999999999963221100 0 000 00001
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+..++.++.++|.+||+.||++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112345567788999999999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=319.89 Aligned_cols=266 Identities=27% Similarity=0.363 Sum_probs=202.6
Q ss_pred CCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccce
Q 018128 29 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTL 106 (360)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~ 106 (360)
......+...++....++|++.+.||.|++|.||++++. +++.|++|++.... .....+.+|+.+++.+ +||||+++
T Consensus 8 ~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~ 86 (326)
T 2x7f_A 8 ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATY 86 (326)
T ss_dssp --------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred CCcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeee
Confidence 344455566666677899999999999999999999875 68999999987553 3456788999999998 79999999
Q ss_pred eEEEEe------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 107 IGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 107 ~~~~~~------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
++++.. ....++|||++++++|.+++... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+
T Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl 161 (326)
T 2x7f_A 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVL 161 (326)
T ss_dssp EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEE
T ss_pred eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEE
Confidence 999976 56789999999999999999762 2457999999999999999999999999 999999999999
Q ss_pred EeCCCceEEeecCCccccCCCCCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCc
Q 018128 181 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 255 (360)
Q Consensus 181 v~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~ 255 (360)
++.++.++|+|||++..... .........++..|+|||++. +..++.++||||||+++|+|++|..||.....
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 162 LTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp ECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EcCCCCEEEeeCcCceecCc--CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 99999999999999875322 112223456899999999987 56788999999999999999999999963321
Q ss_pred cCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 256 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ...... .......+..++..+.++|.+||+.||.+||++.++++
T Consensus 240 ~~~------~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 MRA------LFLIPR----------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHH------HHHHHH----------SCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH------HHHhhc----------CccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 100 000000 00001113356778999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=338.34 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=207.0
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.+..++|++.+.||+|+||.||++++. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356789999999999999999999876 69999999986543 23457789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---eCCCceEEeecC
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFG 193 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv---~~~~~v~L~Dfg 193 (360)
++|||++.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||++ +.++.++|+|||
T Consensus 102 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 999999999999998853 567999999999999999999999999 9999999999999 567889999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
++....... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||....... ..........
T Consensus 175 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~ 244 (484)
T 3nyv_A 175 LSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVEKGKY 244 (484)
T ss_dssp HHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC
T ss_pred eeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCC
Confidence 987543322 2233568999999999876 68999999999999999999999997432110 0000000000
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++..+.++|.+||+.||.+|||+.++++
T Consensus 245 --------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 --------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0000112356788999999999999999999999995
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=315.09 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=201.7
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
..++|++.+.||+|++|.||.+.+. +++.+++|++..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4689999999999999999999876 589999999987766677889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++++++|.+++.. ....+++..++.++.||+.||.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~-- 168 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-- 168 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHH--
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccc--
Confidence 9999999999865 3466999999999999999999999999 9999999999999999999999999865311
Q ss_pred CCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..........++..|+|||++. +..++.++||||||+++|+|++|..||....... ........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~----- 237 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS----- 237 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-----
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhcc-----
Confidence 1111122346889999999883 6678999999999999999999999997432110 00000000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+..++..+.++|.+||+.||.+|||+.++++
T Consensus 238 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 238 ----DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00011124566788999999999999999999999983
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=323.11 Aligned_cols=268 Identities=24% Similarity=0.358 Sum_probs=192.7
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC--CccchHHHHHHHHHhhccC-CCcccceeEEEEeCC--e
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGD--Q 115 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~--~ 115 (360)
...++|++.+.||+|+||.||++.+. +++.||+|++... .......+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45689999999999999999999875 6999999998654 2234456788999999997 999999999997544 6
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999996 599999954 57899999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC-------------------Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCc
Q 018128 196 KLGPVGD-------------------NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKG 255 (360)
Q Consensus 196 ~~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~ 255 (360)
....... .........+|..|+|||++.+ ..++.++|||||||++|+|++|.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 7543211 1112234579999999999886 6789999999999999999999999964432
Q ss_pred cCccchh-c----------------cchhhhhccccchhccccccc------------CCCChhhHHHHHHHHhhhcccC
Q 018128 256 QGEQNLV-S----------------WSRPFLKDQKKFVHLVDPLLH------------GRYPRRCLNYAVAVTAMCLNEE 306 (360)
Q Consensus 256 ~~~~~~~-~----------------~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~d 306 (360)
....... . +...+................ ......++.++.+||.+||+.|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 1100000 0 000000000000000000000 0011245678999999999999
Q ss_pred CCCCCCHHHHHH
Q 018128 307 ANFRPLINDIVV 318 (360)
Q Consensus 307 p~~Rpt~~eil~ 318 (360)
|.+|||+.|+++
T Consensus 317 P~~R~t~~e~l~ 328 (388)
T 3oz6_A 317 PNKRISANDALK 328 (388)
T ss_dssp GGGSCCHHHHTT
T ss_pred cccCCCHHHHhC
Confidence 999999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=318.81 Aligned_cols=267 Identities=23% Similarity=0.389 Sum_probs=202.1
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
.-++|++.+.||+|++|.||++++. +++.|++|++....... ...+.+|+.+++.++||||+++++++.+....++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3579999999999999999999876 58999999886553332 34577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||++++++|.++.. ....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 103 FEFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999988888763 3467999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh--------ccchhhhh
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV--------SWSRPFLK 270 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~--------~~~~~~~~ 270 (360)
. .........++..|+|||++.+. .++.++||||||+++|+|++|..||............ ......+.
T Consensus 176 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 176 A--PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred C--CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 2 22223345689999999998865 7899999999999999999999999654321110000 00000000
Q ss_pred ccccchhcccccccC-----CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 271 DQKKFVHLVDPLLHG-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........+.... ...+.++..+.++|.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011111111111111 112356788999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=332.28 Aligned_cols=251 Identities=24% Similarity=0.299 Sum_probs=202.9
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
..++|++.+.||+|+||+||++.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999876 69999999986432 23457789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe---CCCceEEeecCCcc
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAK 196 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~---~~~~v~L~Dfg~~~ 196 (360)
||++.+++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998854 356999999999999999999999999 99999999999995 45679999999997
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..... .......+++.|+|||++.+ .++.++|||||||++|+|++|..||....... .........
T Consensus 173 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~---- 238 (486)
T 3mwu_A 173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGK---- 238 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC----
T ss_pred ECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC----
Confidence 54322 22334569999999999875 58999999999999999999999996432110 000000000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........++.++.++|.+||+.||.+|||+.++++
T Consensus 239 ----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 239 ----YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ----CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000112356778999999999999999999999996
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.94 Aligned_cols=263 Identities=25% Similarity=0.349 Sum_probs=208.6
Q ss_pred HHHhhcccccc-eeccCCCeEEEEEEec---CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 41 AIATRNFREAN-LIGEGGFGKVYKGRLE---SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~-~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
.+...++.+.+ .||+|+||.||++... .+..||+|++.... ....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 33445556666 8999999999999754 46679999987653 2356789999999999999999999999876 56
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 410 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp EEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred eEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 8999999999999999964 4567999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccc
Q 018128 196 KLGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 196 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~------------ 548 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V------------ 548 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---H------------
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H------------
Confidence 8643322211 1122335678999999999999999999999999999998 999997433211 0
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
...+....+...+..++.++.++|.+||+.||.+||++.++++.|+.+....
T Consensus 549 --~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 549 --MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp --HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0111111222345678889999999999999999999999999999986543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=321.85 Aligned_cols=251 Identities=21% Similarity=0.218 Sum_probs=191.0
Q ss_pred hccccc-ceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhh-ccCCCcccceeEEEEe----CCeeE
Q 018128 45 RNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLS-LLHHDNLVTLIGYCTS----GDQRL 117 (360)
Q Consensus 45 ~~y~i~-~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~-~l~~p~i~~~~~~~~~----~~~~~ 117 (360)
++|.+. +.||.|+||+||++.+. +++.||+|++.. ...+.+|+.++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 79999999999999876 689999999853 245677888774 4589999999999875 56789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC---CCceEEeecCC
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGL 194 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~---~~~v~L~Dfg~ 194 (360)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999652 2356999999999999999999999999 999999999999987 78899999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
+...... .......++..|+|||++.+..++.++|||||||++|+|++|..||........... ..........
T Consensus 211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~i~~~~~- 284 (400)
T 1nxk_A 211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQY- 284 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--HHHHHHHTCC-
T ss_pred ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--HHHHHHcCcc-
Confidence 9753321 222345689999999999999999999999999999999999999974432211000 0000000000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++.++.+||.+||+.||.+|||+.++++
T Consensus 285 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 -------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000111356778999999999999999999999996
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=330.49 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=195.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC--CccchHHHHHHHHHhhccCCCcccceeEEEEeC------C
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE--GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------D 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~--~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~------~ 114 (360)
.++|++.+.||+|+||+||++.+. +++.||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999866 5899999998754 223346788999999999999999999999654 4
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++||||+++ +|.+.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999965 6777772 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-------------
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL------------- 261 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~------------- 261 (360)
+..... ........++..|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 211 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 975332 2223446789999999999999999999999999999999999999964332110000
Q ss_pred ---hccchhhhhcccc-----chhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 262 ---VSWSRPFLKDQKK-----FVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 262 ---~~~~~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......+...... +.......... ......+.++.+||.+||+.||.+|||+.|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 00000000000 001123678999999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=334.40 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=209.9
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
+..++|++.+.||+|+||.||++++. +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34578999999999999999999876 69999999986542 234466889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.++|+|||++..
T Consensus 261 lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999999652 2345999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||......... ........
T Consensus 336 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~-------- 402 (576)
T 2acx_A 336 VPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVK-------- 402 (576)
T ss_dssp CCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHH--------
T ss_pred cccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhh--------
Confidence 43222 223357999999999999989999999999999999999999999743321110 00000000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
.....++..++.++.+||.+||+.||.+|| ++.|+++
T Consensus 403 ----~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 403 ----EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011234556788999999999999999999 7888885
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.45 Aligned_cols=252 Identities=24% Similarity=0.301 Sum_probs=200.0
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
...++|++.+.||+|+||+||++++. ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999876 68999999987653 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC---CceEEeecCCc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGLA 195 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~---~~v~L~Dfg~~ 195 (360)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.. +.++|+|||++
T Consensus 114 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 114 VMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999998854 356999999999999999999999999 9999999999999764 45999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
...... .......+++.|+|||++. ..++.++||||+||++|+|++|..||....... ..........
T Consensus 187 ~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~-- 254 (494)
T 3lij_A 187 AVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVEKGKY-- 254 (494)
T ss_dssp EECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC--
T ss_pred eECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC--
Confidence 764332 2233456999999999876 568999999999999999999999996432211 0000000000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++..+.++|.+||+.||.+|||+.++++
T Consensus 255 ------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 ------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000111345678999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=326.98 Aligned_cols=265 Identities=22% Similarity=0.266 Sum_probs=210.1
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCC-CcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~-p~i~~~~~~~~~~~~~~lv~e 121 (360)
.++|++.+.||+|+||.||++++. +++.||+|++..... ...+..|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 579999999999999999999864 699999998765432 2457889999999976 566666677788888999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE---eCCCceEEeecCCcccc
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv---~~~~~v~L~Dfg~~~~~ 198 (360)
++ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.++|+|||++...
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 8899999965 3467999999999999999999999999 9999999999999 58889999999999865
Q ss_pred CCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 199 PVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 199 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
...... .......++..|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----- 231 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----- 231 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-----
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-----
Confidence 443322 1223567899999999999999999999999999999999999999754332211111110000
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
....... .....++.++.++|.+||+.||.+||++.+|++.|+.+....
T Consensus 232 ~~~~~~~-----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 232 KVATSIE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHSCHH-----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccccHH-----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0000000 011345678999999999999999999999999999986644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=332.62 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=201.2
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-------------cchHHHHHHHHHhhccCCCccccee
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-------------QGHQEFIVEVLMLSLLHHDNLVTLI 107 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-------------~~~~~~~~e~~~l~~l~~p~i~~~~ 107 (360)
...++|++.+.||+|+||+||++.+. +++.||+|++..... .....+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35689999999999999999999876 588999999875432 2346788999999999999999999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC--
Q 018128 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-- 185 (360)
Q Consensus 108 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-- 185 (360)
+++.+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999999854 456999999999999999999999999 99999999999998776
Q ss_pred -ceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhcc
Q 018128 186 -NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 264 (360)
Q Consensus 186 -~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 264 (360)
.++|+|||++...... .......+++.|+|||++. ..++.++||||+|+++|+|++|..||....... .
T Consensus 186 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~ 255 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------I 255 (504)
T ss_dssp SSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred ccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------H
Confidence 6999999999864332 2233456899999999886 468999999999999999999999997433211 0
Q ss_pred chhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......... ........++.++.++|.+||+.||.+|||+.|+++
T Consensus 256 ~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKKVEKGKYY--------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHCCCC--------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCC--------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000 000001245678999999999999999999999984
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=329.77 Aligned_cols=195 Identities=26% Similarity=0.372 Sum_probs=154.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEe-----CCe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-----GDQ 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-----~~~ 115 (360)
.++|++.+.||+|+||+||++.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999876 68999999986542 2344678899999999999999999999843 356
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.|+|||++ +++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 569999984 3567999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc-------------------------ceeccccccccccccccc-ccCCCCcchhhHHHHHHHHHHHhC
Q 018128 196 KLGPVGDNT-------------------------HVSTRVMGTYGYCAPEYA-MSGKLTLKSDIYSFGVVLLELITG 246 (360)
Q Consensus 196 ~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~s~~sDiwslG~il~~ll~g 246 (360)
......... .......+|..|+|||++ .+..++.++|||||||++|+|++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 864322211 122335679999999976 566799999999999999999994
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=317.43 Aligned_cols=270 Identities=25% Similarity=0.340 Sum_probs=190.1
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
..+.+..++|++.+.||+|++|.||.+.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 446677899999999999999999999865 689999998865432 334668889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEee
Q 018128 116 RLLVYEYMPMGSLEDHLYDLE----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~D 191 (360)
.++|||++++++|.+++.... .....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEe
Confidence 999999999999999986432 13456999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCC---cceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh
Q 018128 192 FGLAKLGPVGDN---THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 267 (360)
Q Consensus 192 fg~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 267 (360)
||++........ ........++..|+|||++.+ ..++.++||||||+++|+|++|..||.......... .
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~ 238 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------L 238 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------H
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------H
Confidence 998875433221 112233568899999999875 568999999999999999999999997433211100 0
Q ss_pred hhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ..................++..+.++|.+||+.||.+||++.++++
T Consensus 239 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQ--NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHT--SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Hhc--cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 0000001111111223456778999999999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=322.16 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=205.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
..++|++.+.||+|+||+||++.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3578999999999999999999876 689999999876532 33467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++....
T Consensus 111 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999965 35689999999999999999999986 8 9999999999999999999999999986421
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc----------------
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS---------------- 263 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---------------- 263 (360)
. .......++..|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 184 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 184 D----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp H----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred c----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 1 12233568999999999999999999999999999999999999996433211100000
Q ss_pred ---cchhhh---hcccc----chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 264 ---WSRPFL---KDQKK----FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 264 ---~~~~~~---~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....+. ..... ...+............++.++.+||.+||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000 00000 00011111111112346778999999999999999999999996
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=321.90 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=201.0
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe------
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------ 112 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~------ 112 (360)
++...++|++.+.||+|+||+||+|.+. +++.||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4566789999999999999999999865 699999998865432 22369999999999999999999843
Q ss_pred --------------------------------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 018128 113 --------------------------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160 (360)
Q Consensus 113 --------------------------------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~ 160 (360)
....++||||++ ++|.+.+..+...+..+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334789999997 58888887665567889999999999999999999
Q ss_pred HHhCCCCCeeeCCCCCCcEEEe-CCCceEEeecCCccccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHH
Q 018128 161 LHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGV 238 (360)
Q Consensus 161 LH~~~~~~i~H~di~p~NIlv~-~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~ 238 (360)
||+++ ++||||||+||+++ .++.++|+|||++....... ......++..|+|||++.+. .++.++||||+||
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99999 99999999999998 68899999999998543322 22335678899999998765 5899999999999
Q ss_pred HHHHHHhCCCcccccCccCccchhccch--------hhhhcccc-----chhcccccccCCCChhhHHHHHHHHhhhccc
Q 018128 239 VLLELITGRKAMDLSKGQGEQNLVSWSR--------PFLKDQKK-----FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNE 305 (360)
Q Consensus 239 il~~ll~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 305 (360)
++|+|++|..||........ ...... .+...... ............++...+.++.+||.+||+.
T Consensus 231 il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999999974332110 000000 00000000 0001111111123556778899999999999
Q ss_pred CCCCCCCHHHHHH
Q 018128 306 EANFRPLINDIVV 318 (360)
Q Consensus 306 dp~~Rpt~~eil~ 318 (360)
||.+|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999995
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=323.61 Aligned_cols=254 Identities=21% Similarity=0.265 Sum_probs=193.3
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--------cchHHHHHHHHHhhccCCCcccceeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--------QGHQEFIVEVLMLSLLHHDNLVTLIGYCT 111 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l~~p~i~~~~~~~~ 111 (360)
....++|++.+.||+|+||+||++.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345789999999999999999999876 589999999865421 12234788999999999999999999975
Q ss_pred eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC---ceE
Q 018128 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF---NPK 188 (360)
Q Consensus 112 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~---~v~ 188 (360)
....++||||+++++|.+++. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++ .++
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred -cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence 456899999999999999884 4567999999999999999999999999 99999999999997544 599
Q ss_pred EeecCCccccCCCCCcceeccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccc
Q 018128 189 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 265 (360)
|+|||++..... ........++..|+|||++.+ ..++.++||||||+++|+|++|..||........ ...
T Consensus 283 l~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~-- 355 (419)
T 3i6u_A 283 ITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD-- 355 (419)
T ss_dssp ECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH--
T ss_pred EeecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH--
Confidence 999999985432 222334678999999999863 5688999999999999999999999964322111 000
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........ ........++..+.++|.+||+.||.+|||+.|+++
T Consensus 356 -~i~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 -QITSGKYN--------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHHTTCCC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHhcCCCC--------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000000 000001245678999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=326.25 Aligned_cols=200 Identities=29% Similarity=0.359 Sum_probs=167.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeC-----Ce
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQ 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-----~~ 115 (360)
.++|++.+.||+|+||.||++.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 579999999999999999999876 58899999987542 23446788999999999999999999998766 57
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.|+|||+++ ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999985 59999994 3567999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCc--------------------ceeccccccccccccccc-ccCCCCcchhhHHHHHHHHHHHhCCCccc
Q 018128 196 KLGPVGDNT--------------------HVSTRVMGTYGYCAPEYA-MSGKLTLKSDIYSFGVVLLELITGRKAMD 251 (360)
Q Consensus 196 ~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~s~~sDiwslG~il~~ll~g~~pf~ 251 (360)
......... .......+|..|+|||++ ....++.++|||||||++|+|++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 864332211 122456789999999986 56679999999999999999999766654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.07 Aligned_cols=255 Identities=23% Similarity=0.298 Sum_probs=203.7
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--------chHHHHHHHHHhhcc-CCCcccceeEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--------GHQEFIVEVLMLSLL-HHDNLVTLIGY 109 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--------~~~~~~~e~~~l~~l-~~p~i~~~~~~ 109 (360)
.....++|++.+.||.|++|.||++.+. +|+.||+|++...... ....+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3444578999999999999999999876 6999999998655321 134577899999999 79999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEE
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 189 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L 189 (360)
+......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.| ++|+||+|+||+++.++.++|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999964 457999999999999999999999999 999999999999999999999
Q ss_pred eecCCccccCCCCCcceeccccccccccccccccc------CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc
Q 018128 190 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 263 (360)
Q Consensus 190 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 263 (360)
+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------ 312 (365)
T 2y7j_A 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------ 312 (365)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------
T ss_pred EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------
Confidence 9999987643322 2234678999999998863 358899999999999999999999996422110
Q ss_pred cchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
............ ........+..+.++|.+||+.||.+|||+.++++
T Consensus 313 ~~~~i~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 MLRMIMEGQYQF--------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHTCCCC--------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhCCCCC--------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000000000 00001234567999999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=307.11 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=198.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe----CCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~----~~~~ 116 (360)
+..|++.+.||+|+||+||++.+. ++..|++|.+..... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 456999999999999999999875 588999998875432 334678899999999999999999998865 4568
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe-CCCceEEeecCCc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLA 195 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~-~~~~v~L~Dfg~~ 195 (360)
++|||++++++|.+++.. ...+++..++.++.||+.||.|||+.+ .+++|+||+|+||+++ .++.++|+|||++
T Consensus 105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999999954 356899999999999999999999874 3499999999999997 7889999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
...... ......++..|+|||++.+ .++.++||||||+++|+|++|..||....... ...
T Consensus 180 ~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~---------- 239 (290)
T 1t4h_A 180 TLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIY---------- 239 (290)
T ss_dssp GGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHH----------
T ss_pred cccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHH----------
Confidence 643221 2233568999999998764 58999999999999999999999996422110 000
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
............+...+.++.++|.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 240 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000011111123344567999999999999999999999983
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=318.97 Aligned_cols=274 Identities=23% Similarity=0.228 Sum_probs=202.0
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc-----------chHHHHHHHHHhhccCCCcc
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ-----------GHQEFIVEVLMLSLLHHDNL 103 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~-----------~~~~~~~e~~~l~~l~~p~i 103 (360)
..+.++....++|++.+.||+|+||.||.+.+..++.||+|++...... ....+.+|+.+++.++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3467788889999999999999999999999888999999988654221 12678899999999999999
Q ss_pred cceeEEEEe-----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCc
Q 018128 104 VTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 178 (360)
Q Consensus 104 ~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~N 178 (360)
+++++++.. ....++|||+++ ++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999999844 336799999996 588888864 4567999999999999999999999999 9999999999
Q ss_pred EEEeCCCceEEeecCCccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccC
Q 018128 179 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 257 (360)
Q Consensus 179 Ilv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~ 257 (360)
|+++.++.++|+|||++..... ........++..|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999974222 222334568889999999876 678999999999999999999999997433211
Q ss_pred ccch-hccch-hhhh-----ccccchhcccccc-------cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 258 EQNL-VSWSR-PFLK-----DQKKFVHLVDPLL-------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 258 ~~~~-~~~~~-~~~~-----~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... ..... +... ............. ........+..+.++|.+||+.||.+|||+.|+++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000 00000 0000 0000000000000 00123355678999999999999999999999994
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=317.23 Aligned_cols=262 Identities=20% Similarity=0.245 Sum_probs=204.5
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccc-----------------hHHHHHHHHHhhccCCCcccce
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG-----------------HQEFIVEVLMLSLLHHDNLVTL 106 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~-----------------~~~~~~e~~~l~~l~~p~i~~~ 106 (360)
.++|++.+.||+|++|.||++.. +++.|++|++....... ...+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999999998 79999999986542221 1788999999999999999999
Q ss_pred eEEEEeCCeeEEEEEecCCCCHHHHhccc----CCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEE
Q 018128 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILL 181 (360)
Q Consensus 107 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~----~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv 181 (360)
++++.+.+..++|||++++++|.+++... ......+++..++.++.|++.||.+||+ .+ ++|+||+|+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 99999999999999999999999983211 1225789999999999999999999998 88 9999999999999
Q ss_pred eCCCceEEeecCCccccCCCCCcceecccccccccccccccccC-CCCc-chhhHHHHHHHHHHHhCCCcccccCccCcc
Q 018128 182 DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTL-KSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259 (360)
Q Consensus 182 ~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~-~sDiwslG~il~~ll~g~~pf~~~~~~~~~ 259 (360)
+.++.++|+|||++...... ......++..|+|||++.+. .++. ++||||||+++|+|++|..||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence 99999999999999764322 33446789999999999877 6666 9999999999999999999997543210
Q ss_pred chhccchhhhhccccch-------hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 260 NLVSWSRPFLKDQKKFV-------HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 260 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ........... ..............++..+.++|.+||+.||.+|||+.|+++
T Consensus 260 ~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ELF---NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH---HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH---HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000000000 000000000112456788999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=319.26 Aligned_cols=276 Identities=23% Similarity=0.311 Sum_probs=208.3
Q ss_pred CCCcccccHHHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccce
Q 018128 29 KSGARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTL 106 (360)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~ 106 (360)
.+........++.+..++|++.+.||+|++|.||.++... .+++|++..... .....+.+|+.+++.++||||+++
T Consensus 17 ~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 17 KASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp -----CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred cccccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEE
Confidence 3444555667788889999999999999999999998763 489998865432 233567789999999999999999
Q ss_pred eEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 107 IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 107 ~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
++++.+....++|||++++++|.+++.. .+..+++..++.++.||+.||.+||+++ ++|+||+|+||+++ ++.
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~ 167 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGK 167 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---C
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCC
Confidence 9999999999999999999999999954 3457999999999999999999999999 99999999999998 679
Q ss_pred eEEeecCCccccCCCC---Ccceeccccccccccccccccc---------CCCCcchhhHHHHHHHHHHHhCCCcccccC
Q 018128 187 PKLSDFGLAKLGPVGD---NTHVSTRVMGTYGYCAPEYAMS---------GKLTLKSDIYSFGVVLLELITGRKAMDLSK 254 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~s~~sDiwslG~il~~ll~g~~pf~~~~ 254 (360)
++|+|||++....... .........++..|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999976532211 1122233458899999999874 357899999999999999999999996432
Q ss_pred ccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCC
Q 018128 255 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329 (360)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~ 329 (360)
.... ...... ..........++..+.++|.+||+.||.+|||+.++++.|+.+......
T Consensus 248 ~~~~------~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 248 AEAI------IWQMGT----------GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHHH------HHHHHT----------TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HHHH------HHHhcc----------CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1100 000000 0000011224556789999999999999999999999999999765433
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.88 Aligned_cols=267 Identities=25% Similarity=0.331 Sum_probs=200.7
Q ss_pred HhhcccccceeccCCCeEEEEEEec--CCCEEEEEEcccCCc--cchHHHHHHHHHhhcc---CCCcccceeEEEE----
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL---HHDNLVTLIGYCT---- 111 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~--~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l---~~p~i~~~~~~~~---- 111 (360)
..++|++.+.||+|++|.||++++. +++.|++|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4589999999999999999999873 588999998865422 2233566677777666 8999999999986
Q ss_pred -eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEe
Q 018128 112 -SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 190 (360)
Q Consensus 112 -~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~ 190 (360)
.....++|||+++ ++|.+++... ....+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 5999999763 2345999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhcc-----
Q 018128 191 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----- 264 (360)
Q Consensus 191 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~----- 264 (360)
|||++.... .........++..|+|||++.+..++.++||||||+++|+|++|..||.......... ....
T Consensus 163 Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCccccccc---CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999987532 1222334568999999999999899999999999999999999999997443211000 0000
Q ss_pred chhhhhccccchhccc---ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 265 SRPFLKDQKKFVHLVD---PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...+............ ......+...++..+.++|.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000000000 00001123456788999999999999999999999983
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=308.35 Aligned_cols=258 Identities=17% Similarity=0.263 Sum_probs=201.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEe--CCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTS--GDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~--~~~~~lv 119 (360)
.++|++.+.||+|+||+||++.+. +++.||+|++... ....+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 478999999999999999999864 6899999998643 3567889999999997 9999999999987 6678999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeecCCcccc
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLG 198 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg~~~~~ 198 (360)
||++++++|.+++. .+++..++.++.||+.||.|||+++ ++||||||+|||++.++ .++|+|||++...
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999883 3889999999999999999999999 99999999999999776 8999999999754
Q ss_pred CCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch--------hhh
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR--------PFL 269 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--------~~~ 269 (360)
.... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......... ...... .+.
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHH
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHH
Confidence 3322 2234568889999999886 67899999999999999999999999533221100 000000 000
Q ss_pred hc-----c--------ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 270 KD-----Q--------KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 270 ~~-----~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. . ...............+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0 0000011111222233446889999999999999999999999994
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=325.69 Aligned_cols=243 Identities=15% Similarity=0.178 Sum_probs=190.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC---CccchHHHHHHHH---HhhccCCCccccee-------EE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVL---MLSLLHHDNLVTLI-------GY 109 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~---~l~~l~~p~i~~~~-------~~ 109 (360)
.++|++.+.||+|+||+||++++. +++.||+|++... .....+.+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999864 6999999998743 2334567889995 45555799999988 77
Q ss_pred EEeCCe-----------------eEEEEEecCCCCHHHHhcccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 018128 110 CTSGDQ-----------------RLLVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 169 (360)
Q Consensus 110 ~~~~~~-----------------~~lv~e~~~~~sL~~~i~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i 169 (360)
+.+.+. .+++|||+ +|+|.+++.... .....+++..++.++.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 679999996521 11223445888899999999999999999 9
Q ss_pred eeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccC-----------CCCcchhhHHHHH
Q 018128 170 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----------KLTLKSDIYSFGV 238 (360)
Q Consensus 170 ~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~s~~sDiwslG~ 238 (360)
+||||||+|||++.++.+||+|||++..... ......| ..|+|||++.+. .++.++||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999975221 2334557 999999999877 8999999999999
Q ss_pred HHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 239 VLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 239 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
++|+|++|..||......... ..+. .....++.++.++|.+||+.||.+|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~----------------~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS----------------EWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS----------------GGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch----------------hhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999643321110 0000 011345678999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=311.65 Aligned_cols=268 Identities=25% Similarity=0.335 Sum_probs=199.8
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEe--------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTS-------- 112 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-------- 112 (360)
.++|++.+.||+|+||+||++++. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999875 6999999998655332 24577899999999999999999999876
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....++|||++++ +|.+.+.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999965 78777754 3467999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCc--ceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc-c----
Q 018128 193 GLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-W---- 264 (360)
Q Consensus 193 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~---- 264 (360)
|++......... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||............. .
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999764432221 22234568999999998876 568999999999999999999999997543211100000 0
Q ss_pred chhh---hhccccchhcccc-cccCCCCh-----hhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 265 SRPF---LKDQKKFVHLVDP-LLHGRYPR-----RCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 265 ~~~~---~~~~~~~~~~~~~-~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... ............. ........ ..+..+.+||.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 0000000000000 00000000 12456889999999999999999999993
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.55 Aligned_cols=273 Identities=22% Similarity=0.241 Sum_probs=196.0
Q ss_pred cHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC
Q 018128 36 TFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD 114 (360)
Q Consensus 36 ~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~ 114 (360)
........-++|++.+.||+|+||+||++++. +++.||+|++.... .......+++..++.++||||+++++++....
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp SSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 44566777899999999999999999999875 68999999886543 33456677888888899999999999986543
Q ss_pred e-------eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeCCCCCCcEEEeC-C
Q 018128 115 Q-------RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--CKANPPVIYRDLKSANILLDN-D 184 (360)
Q Consensus 115 ~-------~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~~~~i~H~di~p~NIlv~~-~ 184 (360)
. .++||||+++ +|.+.+.........+++..++.++.|++.||.||| +.+ ++|+||||+|||++. +
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCC
Confidence 3 7899999965 776666554456778999999999999999999999 888 999999999999997 8
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 263 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 263 (360)
+.++|+|||++....... ......++..|+|||++.+. .++.++||||||+++|+|++|..||......... ..
T Consensus 169 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~ 243 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HE 243 (360)
T ss_dssp TEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH
T ss_pred CcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HH
Confidence 999999999998543322 22345689999999998754 4899999999999999999999999754321110 00
Q ss_pred cchh-------hhhc----cccch-----hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 264 WSRP-------FLKD----QKKFV-----HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 264 ~~~~-------~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... .+.. ..... ...............+.++.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 0000 00000 000000011123346789999999999999999999999994
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=307.33 Aligned_cols=253 Identities=24% Similarity=0.255 Sum_probs=204.1
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---------cchHHHHHHHHHhhccC-CCcccceeEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---------QGHQEFIVEVLMLSLLH-HDNLVTLIGYC 110 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---------~~~~~~~~e~~~l~~l~-~p~i~~~~~~~ 110 (360)
...++|++.+.||+|++|.||.+.+. +++.|++|++..... ...+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34689999999999999999999876 589999999865531 12345778999999995 99999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEe
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 190 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~ 190 (360)
.+....++|||++++++|.+++.. ...+++..++.++.||+.||.+||+++ ++|+||+|+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999964 457999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccCCCCCcceecccccccccccccccc------cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhcc
Q 018128 191 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM------SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 264 (360)
Q Consensus 191 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 264 (360)
|||++....... ......++..|+|||++. ...++.++||||||+++|+|++|..||....... .
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~ 237 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------M 237 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------H
Confidence 999997543222 223456889999999885 4568899999999999999999999996332110 0
Q ss_pred chhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........ ..........++..+.++|.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCC--------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00000000 00011112456788999999999999999999999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=311.51 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=197.4
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--------cchHHHHHHHHHhhccCCCcccceeEEEEe
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~ 112 (360)
...++|++.+.||+|+||.||++.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34679999999999999999999876 589999999865432 122357889999999999999999999876
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc---eEE
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKL 189 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~---v~L 189 (360)
.. .++|||++++++|.+++. ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++. ++|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence 55 899999999999999884 4567999999999999999999999999 999999999999987654 999
Q ss_pred eecCCccccCCCCCcceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch
Q 018128 190 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 190 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 266 (360)
+|||++...... .......++..|+|||++. ...++.++||||||+++|+|++|..||........ ...
T Consensus 159 ~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~--- 230 (322)
T 2ycf_A 159 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD--- 230 (322)
T ss_dssp CCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH---
T ss_pred ccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH---
Confidence 999999754321 1223346889999999874 56788999999999999999999999964332111 000
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........ ........++..+.++|.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITSGKYN--------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTCCC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCccc--------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000000 000011245678999999999999999999999984
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.03 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=193.0
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCC------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------ 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~------ 114 (360)
.++|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999865 589999999875422 33456889999999999999999999997654
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++|||++++ +|.+++. ..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999964 8888883 34899999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhc----------
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS---------- 263 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~---------- 263 (360)
+..... ........++..|+|||++.+..++.++|||||||++|+|++|..||.......... ...
T Consensus 174 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 975322 122234568999999999999999999999999999999999999996543211000 000
Q ss_pred -----cchhhhhccc-----cchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 264 -----WSRPFLKDQK-----KFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 264 -----~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....+..... ............ ......+..+.+||.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000000 000000000000 011234778999999999999999999999996
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=314.34 Aligned_cols=264 Identities=17% Similarity=0.224 Sum_probs=199.5
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-----------CCcccceeEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----------HDNLVTLIGYC 110 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----------~p~i~~~~~~~ 110 (360)
..++|++.+.||+|+||+||++++. +++.||+|++.... .....+.+|+.+++.++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3579999999999999999999875 68999999986442 33456788999888876 79999999998
Q ss_pred EeCC----eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeC--
Q 018128 111 TSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDN-- 183 (360)
Q Consensus 111 ~~~~----~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~-- 183 (360)
.... ..+++||++ +++|.+++.... ...+++..++.++.||+.||.|||++ + ++|+||||+|||++.
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence 7654 788999999 889999997633 45699999999999999999999998 9 999999999999953
Q ss_pred ----CCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCcc
Q 018128 184 ----DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259 (360)
Q Consensus 184 ----~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~ 259 (360)
.+.++|+|||++..... ......++..|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 34799999999975432 123346899999999999999999999999999999999999999754422111
Q ss_pred chhccch---------------------hhhhccccchhcccc---------cccCCCChhhHHHHHHHHhhhcccCCCC
Q 018128 260 NLVSWSR---------------------PFLKDQKKFVHLVDP---------LLHGRYPRRCLNYAVAVTAMCLNEEANF 309 (360)
Q Consensus 260 ~~~~~~~---------------------~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~ 309 (360)
....... .++........+... .....++...+..+.+||.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 0000000 000000000000000 0011345678899999999999999999
Q ss_pred CCCHHHHHH
Q 018128 310 RPLINDIVV 318 (360)
Q Consensus 310 Rpt~~eil~ 318 (360)
|||+.|+++
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=339.58 Aligned_cols=251 Identities=26% Similarity=0.361 Sum_probs=207.4
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~ 115 (360)
.+..++|++.+.||+|+||+||++++. +++.||+|++.... ......+..|..++..+ +||+|++++.++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345578999999999999999999876 58899999987542 23446678899999887 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence 9999999999999999965 356999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
..... .........||+.|+|||++.+..++.++||||||+++|+|++|..||...... .. .
T Consensus 490 ~~~~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~----------~ 551 (674)
T 3pfq_A 490 KENIW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------EL----------F 551 (674)
T ss_dssp EECCC--TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH----------H
T ss_pred ecccc--CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HH----------H
Confidence 75322 222334567999999999999999999999999999999999999999743211 00 1
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCH-----HHHHH
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 318 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~-----~eil~ 318 (360)
..+... ...++..++.++.+||.+||+.||.+||++ +||++
T Consensus 552 ~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 552 QSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111111 123466788899999999999999999998 77764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=318.27 Aligned_cols=253 Identities=28% Similarity=0.367 Sum_probs=203.5
Q ss_pred hhcccccceeccCCCeEEEEEEe----cCCCEEEEEEcccCC----ccchHHHHHHHHHhhcc-CCCcccceeEEEEeCC
Q 018128 44 TRNFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEG----LQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGD 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~----~~~~~v~vK~~~~~~----~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~ 114 (360)
.++|++.+.||+|+||+||+++. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47999999999999999999987 368999999986542 22345677799999999 6999999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+|||++.++.++|+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999965 356999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
+....... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .........
T Consensus 206 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~-- 280 (355)
T 1vzo_A 206 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK-- 280 (355)
T ss_dssp EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHH--
T ss_pred CeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhc--
Confidence 87543222 122233568999999999985 35789999999999999999999999743322111 111111100
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
....++..++..+.++|.+||+.||.+|| ++.++++
T Consensus 281 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 281 ----------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp ----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 01134556778899999999999999999 9999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=339.78 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=201.6
Q ss_pred ceeccCCCeEEEEEEec---CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||.||++.+. .++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999543 467899999875432 335689999999999999999999999864 568899999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCc-
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT- 204 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~- 204 (360)
++|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999954 567999999999999999999999999 999999999999999999999999999765433322
Q ss_pred ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 205 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGE 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCC
Confidence 22233446788999999999999999999999999999998 999996433111 111111112
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
....+..++.++.++|.+||+.||++||++.+|++.|+.+...
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2234567888999999999999999999999999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.28 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=195.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCC------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------ 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~------ 114 (360)
.++|++.+.||+|+||.||.+.+. +|+.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999875 699999999865432 23456889999999999999999999997653
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..++|||++ +++|.+++.. ..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.++|+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999954 56999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhcc----chhh
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPF 268 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~----~~~~ 268 (360)
+...... .....++..|+|||++.+ ..++.++||||+||++|+|++|..||.......... .... ...+
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9863321 233568899999999887 679999999999999999999999997443211000 0000 0000
Q ss_pred hhc-----cccchhccccccc---CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKD-----QKKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~-----~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... .......+..... .......+..+.+||.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 0000000000000 0122356788999999999999999999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=315.88 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=197.1
Q ss_pred HhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC------ee
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------QR 116 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~------~~ 116 (360)
...+|++.+.||+|+||+||++++..+..+++|++..... ...+|+.+++.++||||+++++++.... ..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4568999999999999999999987666688888754422 2236999999999999999999985433 37
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe-CCCceEEeecCCc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLA 195 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~-~~~~v~L~Dfg~~ 195 (360)
++||||+++ ++.+.+..+......+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.++|+|||++
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 899999966 555555443345678999999999999999999999999 99999999999999 7899999999999
Q ss_pred cccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh-------
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP------- 267 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------- 267 (360)
....... ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ .......
T Consensus 190 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 190 KILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSRE 264 (394)
T ss_dssp EECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred ccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 7643322 22335678999999998764 589999999999999999999999975432110 0000000
Q ss_pred hhh-cc-----ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 268 FLK-DQ-----KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 268 ~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+. .. ..........+...++...+.++.+||.+||+.||.+|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000 00 0000000001111133456788999999999999999999999995
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.39 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=201.0
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeC-----Cee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-----~~~ 116 (360)
+++|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 579999999999999999999876 688999999875432 2336788999999999999999999998654 368
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++|||+++ ++|.+++.. ..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999996 599999854 56999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcc-eeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-cc----chhhh
Q 018128 197 LGPVGDNTH-VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SW----SRPFL 269 (360)
Q Consensus 197 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~----~~~~~ 269 (360)
......... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||............ .. .....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 643222111 1234578999999998664 55899999999999999999999999644322111000 00 00000
Q ss_pred hc------cccchhcccc--cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 270 KD------QKKFVHLVDP--LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 270 ~~------~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. .......... .........++.++.+||.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000000000 0000112345678999999999999999999999994
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=316.53 Aligned_cols=266 Identities=19% Similarity=0.215 Sum_probs=203.7
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC--------CCcccceeEEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH--------HDNLVTLIGYCT 111 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--------~p~i~~~~~~~~ 111 (360)
.+..++|++.+.||+|+||+||++++. +++.||+|++... ......+.+|+.+++.++ ||||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 344689999999999999999999865 5889999998644 233467888999999885 788999999987
Q ss_pred ----eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCC-
Q 018128 112 ----SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDF- 185 (360)
Q Consensus 112 ----~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~- 185 (360)
+....++|||++ +++|.+++.. .....+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccch
Confidence 556789999999 6677777755 2346799999999999999999999998 8 99999999999998775
Q ss_pred ------------------------------------------------ceEEeecCCccccCCCCCcceecccccccccc
Q 018128 186 ------------------------------------------------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217 (360)
Q Consensus 186 ------------------------------------------------~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 217 (360)
.++|+|||++...... .....++..|+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~ 260 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCccc
Confidence 7999999999754321 23356899999
Q ss_pred cccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh---------------------hhhccccch
Q 018128 218 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP---------------------FLKDQKKFV 276 (360)
Q Consensus 218 aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~ 276 (360)
|||++.+..++.++|||||||++|+|++|..||................. ++.......
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99999999999999999999999999999999975443321111000000 000000000
Q ss_pred hccccc---------ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 277 HLVDPL---------LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 277 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+.... .....+...+..+.+||.+||+.||.+|||+.|+++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000000 001235677889999999999999999999999983
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=303.45 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=203.1
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
....++|++.+.||+|++|.||++++. +++.|++|++.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344679999999999999999999876 68999999986543 234578899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC---CceEEeecCC
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDFGL 194 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~---~~v~L~Dfg~ 194 (360)
+|||++++++|.+++.. ...+++..++.++.||+.||.+||+++ ++|+||+|+||+++.+ +.++|+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999998854 356899999999999999999999999 9999999999999654 4699999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
+....... ......++..|+|||++.+ .++.++||||||+++|+|++|..||....... ..........
T Consensus 171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~- 239 (287)
T 2wei_A 171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKY- 239 (287)
T ss_dssp GGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-
T ss_pred ceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC-
Confidence 87543222 1223457889999998875 48999999999999999999999996432110 0000000000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++.++.++|.+||+.||.+|||+.++++
T Consensus 240 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 240 -------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -------CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0000011345778999999999999999999999997
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=308.40 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=195.4
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEE-----------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCT----------- 111 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~----------- 111 (360)
.++|++.+.||+|++|.||++.+. +++.|++|++..........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 579999999999999999999876 48999999987766566678899999999999999999999873
Q ss_pred ---eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe-CCCce
Q 018128 112 ---SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNP 187 (360)
Q Consensus 112 ---~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~-~~~~v 187 (360)
+....++|||+++ ++|.+++. ...+++..++.++.|++.||.+||+++ ++|+||+|+||+++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 59999993 467999999999999999999999999 99999999999997 56799
Q ss_pred EEeecCCccccCCCCC-cceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccc
Q 018128 188 KLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 265 (360)
+|+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||...............
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999985432211 112233456888999998865 67899999999999999999999999754321110000000
Q ss_pred hhh--hhccccchh----ccccccc------CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 RPF--LKDQKKFVH----LVDPLLH------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~~~--~~~~~~~~~----~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+. ......... ....... ......++..+.++|.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 000000000 0000000 0012356788999999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=316.76 Aligned_cols=254 Identities=11% Similarity=0.005 Sum_probs=183.1
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhcc--CCCccccee-------EEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLL--HHDNLVTLI-------GYC 110 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l--~~p~i~~~~-------~~~ 110 (360)
..+|++.+.||+|+||+||++++. +++.||+|++..... .....+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 356999999999999999999876 689999999987643 2334567775544444 699987754 454
Q ss_pred EeC-----------------CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 018128 111 TSG-----------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR------MKIAVGAARGLEYLHCKANP 167 (360)
Q Consensus 111 ~~~-----------------~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~------~~i~~qi~~al~~LH~~~~~ 167 (360)
... ...++||||++ ++|.+++... +..+++... +.++.||+.||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 433 33799999997 7999999763 223444444 677799999999999999
Q ss_pred CeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHh
Q 018128 168 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELIT 245 (360)
Q Consensus 168 ~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~ 245 (360)
|+||||||+|||++.++.+||+|||++..... ......++..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999985321 1113446699999999987 779999999999999999999
Q ss_pred CCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 246 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 246 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
|..||.............. .................++..+.++|.+||+.||.+|||+.++++
T Consensus 289 g~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccchhhh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999975432211111000 000000111111122466788999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=317.54 Aligned_cols=201 Identities=25% Similarity=0.318 Sum_probs=172.0
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhcc------CCCcccceeEEEEeCC
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL------HHDNLVTLIGYCTSGD 114 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l------~~p~i~~~~~~~~~~~ 114 (360)
....+|++.+.||+|+||+||++.+. +++.||+|++.... .....+.+|+.+++.+ +|+||+++++++....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 34578999999999999999999876 58999999986542 3335667787777776 5789999999999999
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc--eEEeec
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSDF 192 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~--v~L~Df 192 (360)
..++|||++. ++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. ++|+||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999995 6999999762 3356999999999999999999999999 999999999999999887 999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccC
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 254 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~ 254 (360)
|++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 247 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999753221 223568899999999999999999999999999999999999996543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=311.12 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=196.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCee----
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR---- 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~---- 116 (360)
.++|++.+.||+|+||+||++.+. +++.||+|++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 479999999999999999999876 6899999998765332 246788999999999999999999999877655
Q ss_pred --EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 117 --LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 117 --~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
++|||++. ++|.+++ +..+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 5888887 234999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhcc----chhh
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPF 268 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~----~~~~ 268 (360)
+..... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.......... .... ...+
T Consensus 191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 975322 1233567999999999887 788999999999999999999999997433211000 0000 0000
Q ss_pred hhc-----cccchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKD-----QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... .............. .....++..+.+||.+||+.||.+|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000 00000000000000 012345788999999999999999999999994
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=335.77 Aligned_cols=263 Identities=23% Similarity=0.346 Sum_probs=209.5
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeC
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG 113 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~ 113 (360)
.+.+..++|++.+.||+|+||.||.+.+. .+..+++|.+..... ...+.+.+|+.+++.++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 44556688999999999999999999764 245799998865432 33467889999999999999999999985 4
Q ss_pred CeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecC
Q 018128 114 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 193 (360)
Q Consensus 114 ~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg 193 (360)
+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.++|+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 568999999999999999965 3456899999999999999999999999 9999999999999999999999999
Q ss_pred CccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcc
Q 018128 194 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||....... . ....
T Consensus 537 ~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~---~~~i---- 605 (656)
T 2j0j_A 537 LSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V---IGRI---- 605 (656)
T ss_dssp CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHH----
T ss_pred CCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHH----
Confidence 9976432221 12223456778999999998899999999999999999997 999996432110 0 0000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
........+..++..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 606 -------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 606 -------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00111234556788999999999999999999999999999998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=300.93 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=194.4
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe---------
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--------- 112 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--------- 112 (360)
..++|++.+.||+|++|.||.+++. +++.|++|++... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3578999999999999999999875 6999999998543 2344678899999999999999999998755
Q ss_pred ----CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 113 ----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 113 ----~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
....++|||++++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||+|+||+++.++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 3567899999999999999975 3456888999999999999999999999 99999999999999999999
Q ss_pred EeecCCccccCCCCC------------cceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCc
Q 018128 189 LSDFGLAKLGPVGDN------------THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKG 255 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~ 255 (360)
|+|||++........ ........++..|+|||++.+. .++.++||||||+++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 999999875432110 1122345688999999998864 68999999999999999998 4431110
Q ss_pred cCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 256 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
......... .........++...+..+.++|.+||+.||.+|||+.++++
T Consensus 234 -----~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 -----RVNILKKLR--------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -----HHHHHHHHH--------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----HHHHHHhcc--------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 000000000 00111122344566778999999999999999999999994
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=317.17 Aligned_cols=267 Identities=27% Similarity=0.328 Sum_probs=199.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeC------Cee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------DQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~------~~~ 116 (360)
..+|++.+.||+|+||.||++++. +++.||+|++.... ....+|+++++.++||||+++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 347999999999999999999876 59999999986542 2234699999999999999999987432 236
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-CceEEeecCCc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLA 195 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-~~v~L~Dfg~~ 195 (360)
++||||+++ +|.+.+..+......+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999965 777777655456778999999999999999999999999 9999999999999965 56899999999
Q ss_pred cccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchh-------
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP------- 267 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------- 267 (360)
........ .....++..|+|||++.+. .++.++|||||||++|+|++|..||....... .+......
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHH
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 86433221 2335689999999998764 78999999999999999999999997533211 11110000
Q ss_pred -hhhccccchhccccc-----ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhhh
Q 018128 268 -FLKDQKKFVHLVDPL-----LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYL 323 (360)
Q Consensus 268 -~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~--~L~~l 323 (360)
+............+. +...++...+.++.+||.+||+.||.+|||+.|+++ .+..+
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 000000000000000 001133456788999999999999999999999986 34444
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=305.57 Aligned_cols=266 Identities=19% Similarity=0.271 Sum_probs=203.4
Q ss_pred HHHhhcccccceeccCCCeEEEEEEe-c-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCC------cccceeEEEEe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRL-E-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD------NLVTLIGYCTS 112 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~-~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p------~i~~~~~~~~~ 112 (360)
.+..++|++.+.||+|+||+||++.+ . +++.||+|++.... .....+.+|+.+++.++|+ +++++++++.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 34568999999999999999999986 3 58899999986442 3346788899999888654 59999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC---------
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--------- 183 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~--------- 183 (360)
.+..++|||++ +++|.+++... ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC-
T ss_pred CCcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCC
Confidence 99999999999 88999999662 2346899999999999999999999999 999999999999987
Q ss_pred ----------CCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCccccc
Q 018128 184 ----------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 253 (360)
Q Consensus 184 ----------~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~ 253 (360)
++.++|+|||++..... ......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 66799999999975322 123356899999999999999999999999999999999999999754
Q ss_pred CccCccchhc-----cchhhhhccc--------------------cchhccccc-ccCCCChhhHHHHHHHHhhhcccCC
Q 018128 254 KGQGEQNLVS-----WSRPFLKDQK--------------------KFVHLVDPL-LHGRYPRRCLNYAVAVTAMCLNEEA 307 (360)
Q Consensus 254 ~~~~~~~~~~-----~~~~~~~~~~--------------------~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp 307 (360)
.......... ....+..... .......+. .........+..+.++|.+||+.||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 3211100000 0000000000 000000000 0011234667889999999999999
Q ss_pred CCCCCHHHHHH
Q 018128 308 NFRPLINDIVV 318 (360)
Q Consensus 308 ~~Rpt~~eil~ 318 (360)
.+|||+.|+++
T Consensus 318 ~~Rpt~~ell~ 328 (339)
T 1z57_A 318 AKRITLREALK 328 (339)
T ss_dssp TTSCCHHHHTT
T ss_pred ccccCHHHHhc
Confidence 99999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.69 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=184.0
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeC------C
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG------D 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~------~ 114 (360)
.++|++.+.||+|+||.||++.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 479999999999999999999865 68999999986542 23446788999999999999999999998654 5
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..+++++++ +++|.+++. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999998 779988883 367999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hccc----hhh
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSWS----RPF 268 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~----~~~ 268 (360)
+..... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||........... .... ...
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 975322 1233568999999999886 6789999999999999999999999964432110000 0000 000
Q ss_pred hhcc--ccchhccccc---ccCC---CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKDQ--KKFVHLVDPL---LHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~~--~~~~~~~~~~---~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... ......+... .... .....+..+.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000 0000000000 0000 11234678999999999999999999999995
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=305.68 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=183.5
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHH-HhhccCCCcccceeEEEEeCCeeE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVL-MLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~-~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
.+..++|++.+.||+|+||.||++.+. +++.|++|++..... .....+..|+. +++.++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 345689999999999999999999875 689999999876532 22334555555 777789999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 118 LVYEYMPMGSLEDHLYDLE-PDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
+|||++++ +|.+++.... .....+++..++.++.|++.||.+||+. + ++|+||+|+||+++.++.++|+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999965 8888775321 2356799999999999999999999998 9 999999999999999999999999999
Q ss_pred cccCCCCCcceeccccccccccccccc----ccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYA----MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
...... .......++..|+|||++ .+..++.++||||||+++|+|++|..||......... ..
T Consensus 174 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~--------- 240 (327)
T 3aln_A 174 GQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-LT--------- 240 (327)
T ss_dssp CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------C---------
T ss_pred eecccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-HH---------
Confidence 753221 122334688999999998 4567899999999999999999999999643211000 00
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.......+.+.......++..+.++|.+||+.||.+||++.++++
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 --QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000011111122356778999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.04 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=199.3
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeC-----Ce
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQ 115 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-----~~ 115 (360)
..++|++.+.||+|++|.||++.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3579999999999999999999876 689999999865432 2345678899999999999999999987654 67
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++|||++. ++|.+++.. ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999996 599999854 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcc--------eeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-ccc
Q 018128 196 KLGPVGDNTH--------VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWS 265 (360)
Q Consensus 196 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~ 265 (360)
.......... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||............ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 8643322111 1123468999999998764 77899999999999999999999999744321100000 000
Q ss_pred h-----hhhh--ccccchhcccccc---c---CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 R-----PFLK--DQKKFVHLVDPLL---H---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ~-----~~~~--~~~~~~~~~~~~~---~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .... ............. . ......++.++.++|.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0000 0000000000000 0 0012356778999999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=305.35 Aligned_cols=260 Identities=23% Similarity=0.337 Sum_probs=196.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCCe-----
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ----- 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~----- 115 (360)
.++|++.+.||.|+||.||.+.+. +|+.|++|++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 478999999999999999999875 6999999998764322 24568899999999999999999999977654
Q ss_pred -eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 116 -RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 116 -~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
.++|||+++ ++|.+++. ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 58887772 35999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhcc----chhh
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW----SRPF 268 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~----~~~~ 268 (360)
+...... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||.......... .... ...+
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8753221 223467899999999876 678999999999999999999999997443211000 0000 0000
Q ss_pred hhcc-----ccchhccccccc---CCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKDQ-----KKFVHLVDPLLH---GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~~-----~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... ............ ......++..+.++|.+||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000000000000 1123466889999999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=313.77 Aligned_cols=270 Identities=21% Similarity=0.263 Sum_probs=184.9
Q ss_pred Hhhcccc-cceeccCCCeEEEEEEec---CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe--CCee
Q 018128 43 ATRNFRE-ANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQR 116 (360)
Q Consensus 43 ~~~~y~i-~~~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~~~ 116 (360)
..+.|++ +++||+|+||+||+++.. +++.||+|++..... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 4566887 568999999999999865 478999999875532 3568889999999999999999999954 6789
Q ss_pred EEEEEecCCCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----eCCCce
Q 018128 117 LLVYEYMPMGSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNP 187 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv----~~~~~v 187 (360)
++||||+. ++|.+++.... .....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence 99999995 58888875422 12235999999999999999999999999 9999999999999 667899
Q ss_pred EEeecCCccccCCCCC-cceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch---h
Q 018128 188 KLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL---V 262 (360)
Q Consensus 188 ~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~---~ 262 (360)
+|+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||........... .
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 9999999976433211 122334578999999999887 4589999999999999999999999964432110000 0
Q ss_pred ccchhhhhc-----cccch---------hcccccccC------------CCChhhHHHHHHHHhhhcccCCCCCCCHHHH
Q 018128 263 SWSRPFLKD-----QKKFV---------HLVDPLLHG------------RYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316 (360)
Q Consensus 263 ~~~~~~~~~-----~~~~~---------~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~ei 316 (360)
......... ...+. ......... ......+..+.+||.+||+.||.+|||+.|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 000000000 00000 000000000 0011125678899999999999999999999
Q ss_pred HH
Q 018128 317 VV 318 (360)
Q Consensus 317 l~ 318 (360)
++
T Consensus 332 L~ 333 (405)
T 3rgf_A 332 MQ 333 (405)
T ss_dssp HT
T ss_pred hc
Confidence 96
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=303.54 Aligned_cols=254 Identities=20% Similarity=0.225 Sum_probs=176.1
Q ss_pred HHhhcccccc-eeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe----CCe
Q 018128 42 IATRNFREAN-LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQ 115 (360)
Q Consensus 42 ~~~~~y~i~~-~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~----~~~ 115 (360)
...++|++.+ .||+|+||+||++.+. +++.||+|++... .....+....++.++||||+++++++.. ...
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 3567899965 6999999999999876 6999999998543 2222333334566789999999999876 445
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC---CceEEeec
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND---FNPKLSDF 192 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~---~~v~L~Df 192 (360)
.++||||+++++|.+++... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++.+ +.++|+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 89999999999999999752 2357999999999999999999999999 9999999999999764 45999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
|++..... .......++..|+|||++.+..++.++||||||+++|+|++|..||............ ....
T Consensus 176 g~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~---- 245 (336)
T 3fhr_A 176 GFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRI---- 245 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhh----
Confidence 99975332 1223356789999999998888999999999999999999999999643322110000 0000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..............++.++.++|.+||+.||.+|||+.|+++
T Consensus 246 ----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 246 ----RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000111112356788999999999999999999999996
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=295.56 Aligned_cols=245 Identities=16% Similarity=0.103 Sum_probs=190.9
Q ss_pred cHHHHH-HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc---hHHHHHHHHHhhccCCCcccceeEEE
Q 018128 36 TFRELA-IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDNLVTLIGYC 110 (360)
Q Consensus 36 ~~~~~~-~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~---~~~~~~e~~~l~~l~~p~i~~~~~~~ 110 (360)
...... +..++|++.+.||+|+||.||++++. +++.|++|++....... ...+.+|+..++.++||||+++++++
T Consensus 21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 333444 56689999999999999999999876 48999999997664332 36788999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEe
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 190 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~ 190 (360)
.+.+..|+||||+++++|.+++.. . .....+..++.||+.||.|||+++ ++|+||||+||+++.++.++|+
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEEC
T ss_pred EECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEE
Confidence 999999999999999999999932 2 355678889999999999999999 9999999999999999999997
Q ss_pred ecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh
Q 018128 191 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 191 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
+++ |++ +++.++||||||+++|+|++|..||............ ......
T Consensus 172 ~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--~~~~~~ 220 (286)
T 3uqc_A 172 YPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--ERDTAG 220 (286)
T ss_dssp SCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--CBCTTS
T ss_pred ecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--HHHhcc
Confidence 443 223 3688999999999999999999999754332111000 000000
Q ss_pred ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccCCC
Q 018128 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 330 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~~~ 330 (360)
... ........++..+.++|.+||+.||.+| |+.|+++.|+++.......
T Consensus 221 -~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~ 270 (286)
T 3uqc_A 221 -QPI--------EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRT 270 (286)
T ss_dssp -CBC--------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred -CCC--------ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence 000 0001123567789999999999999999 9999999999997765433
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=307.09 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=201.5
Q ss_pred cccccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc------chHHHHHHHHHhhccC--CCc
Q 018128 32 ARSFTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLH--HDN 102 (360)
Q Consensus 32 ~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~--~p~ 102 (360)
.+..+........++|++.+.||+|+||.||.+.+. +++.|++|++...... ....+.+|+.+++.++ |||
T Consensus 30 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~ 109 (320)
T 3a99_A 30 TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109 (320)
T ss_dssp ----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred hccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence 344455667777899999999999999999999865 6899999998765332 2245677999999986 599
Q ss_pred ccceeEEEEeCCeeEEEEEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE
Q 018128 103 LVTLIGYCTSGDQRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 181 (360)
Q Consensus 103 i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv 181 (360)
|+++++++.+.+..++|+|++.+ ++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||++
T Consensus 110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 182 (320)
T 3a99_A 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILI 182 (320)
T ss_dssp BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEE
Confidence 99999999999999999999975 899999954 457899999999999999999999999 9999999999999
Q ss_pred e-CCCceEEeecCCccccCCCCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCcc
Q 018128 182 D-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259 (360)
Q Consensus 182 ~-~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~ 259 (360)
+ +++.++|+|||++...... ......++..|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 183 ~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---- 254 (320)
T 3a99_A 183 DLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---- 254 (320)
T ss_dssp ETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred eCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----
Confidence 9 7889999999999764321 2233568999999999887665 6889999999999999999999963210
Q ss_pred chhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.... ...++..++..+.++|.+||+.||.+|||+.++++
T Consensus 255 --------~~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 --------IIRG------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --------HHHC------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------hhcc------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00123456778999999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=303.66 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=192.5
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc------chHHHHHHHHHhhcc----CCCcccce
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLL----HHDNLVTL 106 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l----~~p~i~~~ 106 (360)
++.....++|++.+.||+|+||.||.+++. +++.|++|++...... ....+.+|+.+++.+ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 456777899999999999999999999875 6899999998765432 223455688888888 89999999
Q ss_pred eEEEEeCCeeEEEEEe-cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe-CC
Q 018128 107 IGYCTSGDQRLLVYEY-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-ND 184 (360)
Q Consensus 107 ~~~~~~~~~~~lv~e~-~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~-~~ 184 (360)
++++.+.+..++|+|+ +.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .+
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 9999999999999999 788999999965 356999999999999999999999999 99999999999999 88
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhc
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 263 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 263 (360)
+.++|+|||++...... ......++..|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 177 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------- 244 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------- 244 (312)
T ss_dssp TEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred CeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------
Confidence 99999999998764322 1233568899999999887665 4589999999999999999999963210
Q ss_pred cchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ....++..++..+.++|.+||+.||++|||+.|+++
T Consensus 245 ----~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ----ILE------------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----HHH------------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----Hhh------------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 011234566778999999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=304.52 Aligned_cols=267 Identities=17% Similarity=0.222 Sum_probs=201.2
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEec-CC-CEEEEEEcccCCccchHHHHHHHHHhhccCCCc------ccceeEEEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLE-SG-QLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN------LVTLIGYCT 111 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~-~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~------i~~~~~~~~ 111 (360)
.....++|++.+.||+|+||+||++.+. ++ +.||+|++... ......+.+|+.+++.++|++ ++.+++++.
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3445689999999999999999999875 34 68999998644 233466788999998886554 889999999
Q ss_pred eCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEE----------
Q 018128 112 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---------- 181 (360)
Q Consensus 112 ~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv---------- 181 (360)
.....++|||++ +++|.+++.. .....+++..++.++.||+.||.|||+++ ++|+||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred eCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence 999999999999 6678787765 23357999999999999999999999998 9999999999999
Q ss_pred ---------eCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccc
Q 018128 182 ---------DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 252 (360)
Q Consensus 182 ---------~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~ 252 (360)
+.++.++|+|||++...... .....++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999999753221 2335689999999999999999999999999999999999999974
Q ss_pred cCccCccchh-c----cchhhhhcccc--------------------chhcccc-cccCCCChhhHHHHHHHHhhhcccC
Q 018128 253 SKGQGEQNLV-S----WSRPFLKDQKK--------------------FVHLVDP-LLHGRYPRRCLNYAVAVTAMCLNEE 306 (360)
Q Consensus 253 ~~~~~~~~~~-~----~~~~~~~~~~~--------------------~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~d 306 (360)
.......... . ....+...... ......+ ..........+..+.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 4321100000 0 00000000000 0000000 0000122355778999999999999
Q ss_pred CCCCCCHHHHHH
Q 018128 307 ANFRPLINDIVV 318 (360)
Q Consensus 307 p~~Rpt~~eil~ 318 (360)
|.+|||+.|+++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999983
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=314.13 Aligned_cols=254 Identities=22% Similarity=0.250 Sum_probs=190.8
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~l 118 (360)
+.+...+|++.+.||+|+||+|+.....+++.||+|++...... ...+|+.+++.+ +||||+++++++.+....++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 44556789999999999999987666667999999998654332 356799999998 79999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC---CC--ceEEeecC
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DF--NPKLSDFG 193 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~---~~--~v~L~Dfg 193 (360)
|||++. ++|.+++.. ......+..++.++.||+.||.|||+++ |+||||||+|||++. ++ .++|+|||
T Consensus 96 v~E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG 168 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFG 168 (432)
T ss_dssp EEECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred EEECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence 999995 599999965 3334555667899999999999999999 999999999999953 22 57899999
Q ss_pred CccccCCCCCc-ceecccccccccccccccc---cCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhh
Q 018128 194 LAKLGPVGDNT-HVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 268 (360)
Q Consensus 194 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~---~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~ 268 (360)
++......... .......|+..|+|||++. ...++.++|||||||++|+|++ |..||......... ..
T Consensus 169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~ 241 (432)
T 3p23_A 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------IL 241 (432)
T ss_dssp EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HH
T ss_pred ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HH
Confidence 99764332211 2233467999999999987 4567889999999999999999 89998532211000 00
Q ss_pred hhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ... ..........+..+.++|.+||+.||.+|||+.++++
T Consensus 242 ~~-~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LG-ACS-------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TT-CCC-------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hc-cCC-------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 000 0001112355677899999999999999999999983
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=309.58 Aligned_cols=255 Identities=21% Similarity=0.264 Sum_probs=188.6
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.+.|.+.+.||+|+||+||.+...+|+.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+....++|||+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 3567778999999999998876667999999988643 235678899999876 899999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC-------------Cc
Q 018128 123 MPMGSLEDHLYDLEPDQEP---LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-------------FN 186 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~---l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~-------------~~ 186 (360)
++ ++|.+++......... ..+..++.++.||+.||.|||+++ ++||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 5999999653322111 133456789999999999999999 9999999999999754 37
Q ss_pred eEEeecCCccccCCCCCcc--eeccccccccccccccccc-------CCCCcchhhHHHHHHHHHHHh-CCCcccccCcc
Q 018128 187 PKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 256 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~ 256 (360)
++|+|||++.......... ......|+..|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998654332211 1234568999999999875 568999999999999999999 99999632211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. . ......... +.........++.++.++|.+||+.||.+|||+.++++
T Consensus 247 ~-~-------~i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 E-S-------NIIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H-H-------HHHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-H-------HHhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 0 011100000 00111124567889999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=307.40 Aligned_cols=208 Identities=26% Similarity=0.320 Sum_probs=174.2
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CC-----ccccee
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HD-----NLVTLI 107 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p-----~i~~~~ 107 (360)
+.+.......++|++.+.||+|+||+||++.+. +++.||+|++.... .....+..|+.+++.++ |+ +|++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 445555666789999999999999999999876 58899999986442 33456777888888774 44 499999
Q ss_pred EEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeeCCCCCCcEEEe--C
Q 018128 108 GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC--KANPPVIYRDLKSANILLD--N 183 (360)
Q Consensus 108 ~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~~~~i~H~di~p~NIlv~--~ 183 (360)
+++...+..++|||+++ ++|.+++... ....+++..++.++.|++.||.|||. .+ |+||||||+|||++ .
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPK 196 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTT
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCC
Confidence 99999999999999995 5999999762 23569999999999999999999994 56 99999999999995 4
Q ss_pred CCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccC
Q 018128 184 DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 254 (360)
Q Consensus 184 ~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~ 254 (360)
++.++|+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 197 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999764321 233568899999999999999999999999999999999999997543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.84 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=183.3
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc--hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~--~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
..-++|++.+.||.|++|.||++.+. +++.|++|++....... ...+.++..+++.++||||+++++++.+.+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34578999999999999999999876 68999999987654322 2234445556778899999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
|||++ ++.+..+... ....+++..++.++.|++.||.|||++ + ++|+||+|+||+++.++.++|+|||++..
T Consensus 102 v~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999 5566666543 246799999999999999999999985 8 99999999999999999999999999875
Q ss_pred cCCCCCcceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
.... .......++..|+|||++. +..++.++||||||+++|+|++|..||...... ...........
T Consensus 175 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~ 246 (318)
T 2dyl_A 175 LVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE 246 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC
T ss_pred ccCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC
Confidence 3222 2223356889999999984 456889999999999999999999999642211 00000111100
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.+.. .....++.++.++|.+||+.||.+||++.++++
T Consensus 247 -------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 -------PPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -------CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------CCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 112246778999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=320.40 Aligned_cols=270 Identities=27% Similarity=0.319 Sum_probs=206.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC-ccchHHHHHHHHHhhccCCCcccceeEEEEe------CCe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQ 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~------~~~ 115 (360)
.++|++.+.||.|+||+||++.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 379999999999999999999875 68999999987542 2334678899999999999999999998755 667
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc---eEEeec
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN---PKLSDF 192 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~---v~L~Df 192 (360)
.++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++. ++|+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 799999999999999997643 3346899999999999999999999999 999999999999987765 899999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh--
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-- 270 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 270 (360)
|++...... .......++..|+|||++.+..++.++||||||+++|+|++|..||...... ..|......
T Consensus 169 G~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~ 240 (676)
T 3qa8_A 169 GYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKS 240 (676)
T ss_dssp CCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC---
T ss_pred ccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhccc
Confidence 999854322 2233457899999999999999999999999999999999999999643211 000000000
Q ss_pred -----------ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHH-----HHHHHhhhhhcc
Q 018128 271 -----------DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND-----IVVALDYLVSQR 327 (360)
Q Consensus 271 -----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~e-----il~~L~~l~~~~ 327 (360)
....... ...........++..+.++|.+||+.||.+|||+.+ +.+.++.+....
T Consensus 241 ~~~~~~~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp ---CCSCCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred chhhhhhhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000000 001112245678999999999999999999999988 667777776654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=302.66 Aligned_cols=242 Identities=17% Similarity=0.181 Sum_probs=181.5
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHHHHHHHhhccCC-Ccc---------cc-----
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHH-DNL---------VT----- 105 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~-p~i---------~~----- 105 (360)
.+|+..+.||+|+||+||++.+. +|+.||+|++..... ...+.+.+|+.+++.++| ++. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 46889999999999999999865 699999999874332 235678899999998876 211 11
Q ss_pred -------eeEEEEe-----CCeeEEEEEecCCCCHHHHhccc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 018128 106 -------LIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDL---EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170 (360)
Q Consensus 106 -------~~~~~~~-----~~~~~lv~e~~~~~sL~~~i~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 170 (360)
+..++.. ....+++|+.+ +++|.+++... ...+..+++..++.++.||+.||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 22356777766 67999988532 234566888899999999999999999999 99
Q ss_pred eCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceeccccccccccccccc----------ccCCCCcchhhHHHHHHH
Q 018128 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----------MSGKLTLKSDIYSFGVVL 240 (360)
Q Consensus 171 H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~s~~sDiwslG~il 240 (360)
||||||+|||++.++.+||+|||++..... ......| ..|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999875322 1334567 999999998 555688999999999999
Q ss_pred HHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 241 LELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 241 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
|+|++|..||........ ... .+.. ...++..+.++|.+||+.||.+||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~----------------~~~----~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG----------------SEW----IFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC----------------SGG----GGSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh----------------HHH----HHhh--cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999964332111 000 0110 1245578999999999999999999776643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=318.43 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=195.4
Q ss_pred HHHhhcccccceeccCCCeEEEEEEec--CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCe--
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLE--SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ-- 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~-- 115 (360)
.+..++|++.+.||+|+||+||++.+. +++.|++|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 345689999999999999999999875 589999999865432 334568899999999999999999999987665
Q ss_pred ---eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 116 ---RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 116 ---~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
.|+||||+++++|.+++. ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.+ .++|+||
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp CEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEec
Confidence 799999999999988762 27999999999999999999999999 9999999999999885 9999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
|++...... ....|++.|+|||++.+.. +.++||||||+++|+|++|..||........
T Consensus 226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------- 284 (681)
T 2pzi_A 226 GAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------- 284 (681)
T ss_dssp TTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------
T ss_pred ccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------
Confidence 999864322 3456899999999987654 8999999999999999999988863211000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC-HHHHHHHHhhhh
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVVALDYLV 324 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~eil~~L~~l~ 324 (360)
.........+..+.++|.+||+.||.+||+ ++++.+.|..+.
T Consensus 285 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 ----------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000011234567899999999999999995 666666666654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=282.89 Aligned_cols=224 Identities=21% Similarity=0.296 Sum_probs=178.9
Q ss_pred hccccc-ceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHh-hccCCCcccceeEEEEe----CCeeE
Q 018128 45 RNFREA-NLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLML-SLLHHDNLVTLIGYCTS----GDQRL 117 (360)
Q Consensus 45 ~~y~i~-~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l-~~l~~p~i~~~~~~~~~----~~~~~ 117 (360)
++|.+. +.||+|++|.||.+.+. +++.||+|++.. .....+|+.++ +..+||||+++++++.+ ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567776 88999999999999875 689999999853 35667788887 55689999999999877 67789
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC---CCceEEeecCC
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGL 194 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~---~~~v~L~Dfg~ 194 (360)
+||||+++++|.+++.. .....+++..++.++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999976 23457999999999999999999999999 999999999999987 78899999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
+.... +..++.++||||||+++|+|++|..||...........
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~------------- 209 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG------------- 209 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------------
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------------
Confidence 86421 34568899999999999999999999964332110000
Q ss_pred chhcccccccC--CCC----hhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 FVHLVDPLLHG--RYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 ~~~~~~~~~~~--~~~----~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........ ..+ ..++.++.++|.+||+.||.+|||+.|+++
T Consensus 210 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 ---MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ---SCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000 111 346778999999999999999999999995
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=288.10 Aligned_cols=243 Identities=19% Similarity=0.182 Sum_probs=185.1
Q ss_pred HHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--------cchHHHHHHHHHhhccC---------CCccc
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--------QGHQEFIVEVLMLSLLH---------HDNLV 104 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--------~~~~~~~~e~~~l~~l~---------~p~i~ 104 (360)
+..++|++.+.||+|+||+||++++ +++.||+|++..... .....+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 4468999999999999999999988 589999999876532 22367888998888875 77777
Q ss_pred ceeEEE-----------------Ee-------------CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHH
Q 018128 105 TLIGYC-----------------TS-------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154 (360)
Q Consensus 105 ~~~~~~-----------------~~-------------~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi 154 (360)
++.+++ .+ ....++||||+++|++.+.+. ...+++..++.++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHH
Confidence 766653 22 678999999999997777662 2568999999999999
Q ss_pred HHHHHHHH-hCCCCCeeeCCCCCCcEEEeCCC--------------------ceEEeecCCccccCCCCCcceecccccc
Q 018128 155 ARGLEYLH-CKANPPVIYRDLKSANILLDNDF--------------------NPKLSDFGLAKLGPVGDNTHVSTRVMGT 213 (360)
Q Consensus 155 ~~al~~LH-~~~~~~i~H~di~p~NIlv~~~~--------------------~v~L~Dfg~~~~~~~~~~~~~~~~~~~~ 213 (360)
+.||.||| +++ |+||||||+|||++.++ .+||+|||++..... ....|+
T Consensus 171 ~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt 240 (336)
T 2vuw_A 171 TASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFC 240 (336)
T ss_dssp HHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECC
T ss_pred HHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEe
Confidence 99999999 899 99999999999999887 899999999985432 124689
Q ss_pred cccccccccccCCCCcchhhHHHHHH-HHHHHhCCCcccccCccCccchhccchhhhhccccchhc-ccccccCCCChhh
Q 018128 214 YGYCAPEYAMSGKLTLKSDIYSFGVV-LLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL-VDPLLHGRYPRRC 291 (360)
Q Consensus 214 ~~y~aPE~~~~~~~s~~sDiwslG~i-l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 291 (360)
..|+|||++.+.. +.++||||+|++ .++++.|..||.... |...... ...... ............+
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLHYLTD--KMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHHHHHH--HHHHTCCCSSCCCSHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hhhHHHH--hhhhhhccCcccchhhhhhc
Confidence 9999999998776 999999998777 677888999985210 0000000 000000 0000011123468
Q ss_pred HHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 292 LNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 292 ~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
+.++.+||.+||+.| |+.|++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 889999999999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-31 Score=256.59 Aligned_cols=183 Identities=18% Similarity=0.121 Sum_probs=128.1
Q ss_pred cCCCeEEEEEEec-CCCEEEEEEcccCCc----------cchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEEEEEe
Q 018128 55 EGGFGKVYKGRLE-SGQLVAIKQLNHEGL----------QGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 55 ~G~~g~v~~~~~~-~~~~v~vK~~~~~~~----------~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.|+.|....++.. .|+.+++|++..... ...+++.+|+++|+++ .|+||++++++++++...||||||
T Consensus 244 ~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEy 323 (569)
T 4azs_A 244 AGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEK 323 (569)
T ss_dssp --------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEEC
T ss_pred cCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEec
Confidence 3444444444322 478899999865421 1234688999999999 699999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
++|++|.+++.. ++.+++. .++.||+.||.|+|++| |+||||||+|||++.+|.+||+|||+++....
T Consensus 324 v~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~-- 391 (569)
T 4azs_A 324 LPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ-- 391 (569)
T ss_dssp CCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred CCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC--
Confidence 999999999954 5567654 47899999999999999 99999999999999999999999999975332
Q ss_pred CcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 250 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf 250 (360)
........+||+.|+|||++.+. +..++|+|++|++++.+.++..++
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 22223446799999999998764 577899999999988876665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=222.79 Aligned_cols=187 Identities=19% Similarity=0.213 Sum_probs=142.9
Q ss_pred cccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccc--------hHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQG--------HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~--------~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
.+...+.||+|+||+||++... ++.+++|......... .+.+.+|+++++.++||||+++..++.+.+..+
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp -----------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred cCCCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 3345679999999999999544 7888998765433221 234789999999999999996666666777889
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+++++|.+++.. ++.++.|++.+|.|||+++ |+||||||+|||++. .++|+|||++..
T Consensus 416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 99999999999999943 4689999999999999999 999999999999998 999999999986
Q ss_pred cCCCCCcc-----eeccccccccccccccccc--CCCCcchhhHHHHHHHHHHHhCCCcc
Q 018128 198 GPVGDNTH-----VSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAM 250 (360)
Q Consensus 198 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~s~~sDiwslG~il~~ll~g~~pf 250 (360)
........ ......||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 53322111 1234678999999999986 56788899999988888877766655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.8e-24 Score=189.22 Aligned_cols=151 Identities=13% Similarity=0.035 Sum_probs=119.1
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc------------------chHHHHHHHHHhhccCC
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ------------------GHQEFIVEVLMLSLLHH 100 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~------------------~~~~~~~e~~~l~~l~~ 100 (360)
.+...+..|++++.||.|++|.||++.+.+|+.||+|.+...... ....+.+|+.+++.++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 333445667777999999999999998877999999998643221 2356889999999998
Q ss_pred CcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEE
Q 018128 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 180 (360)
Q Consensus 101 p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIl 180 (360)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.+||+.+ ++|+||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 4 555554433 55699999999999988 411 234579999999999999999 999999999999
Q ss_pred EeCCCceEEeecCCccccCCCCCcceecccccccccccccccc
Q 018128 181 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223 (360)
Q Consensus 181 v~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (360)
++ ++.++|+|||++.. +..+.|||.+.
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99 99999999999863 34478888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=159.28 Aligned_cols=137 Identities=17% Similarity=0.085 Sum_probs=107.3
Q ss_pred hcccccceeccCCCeEEEEEEe-cCCCE--EEEEEcccCCcc------------------------chHHHHHHHHHhhc
Q 018128 45 RNFREANLIGEGGFGKVYKGRL-ESGQL--VAIKQLNHEGLQ------------------------GHQEFIVEVLMLSL 97 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~-~~~~~--v~vK~~~~~~~~------------------------~~~~~~~e~~~l~~ 97 (360)
.-|++.+.||+|++|.||.+.. .+|+. ||+|++...... ....+.+|+.+++.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3478999999999999999987 57888 999987543111 01257889999999
Q ss_pred cCCCcc--cceeEEEEeCCeeEEEEEecCC-C----CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCe
Q 018128 98 LHHDNL--VTLIGYCTSGDQRLLVYEYMPM-G----SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKANPPV 169 (360)
Q Consensus 98 l~~p~i--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~~i 169 (360)
+.|+++ +.++.. ...++||||+.+ | +|.++... .++..+..++.|++.+|.+|| +.+ +
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 987754 334432 356899999942 3 77776532 234567889999999999999 998 9
Q ss_pred eeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 170 IYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 170 ~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||||+|||++. .++|+|||++..
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred EeCCCCHHHEEEcC--cEEEEECccccc
Confidence 99999999999988 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.7e-17 Score=150.48 Aligned_cols=138 Identities=13% Similarity=0.092 Sum_probs=101.1
Q ss_pred hcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc--------------chH--------HHHHHHHHhhccCCCc
Q 018128 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ--------------GHQ--------EFIVEVLMLSLLHHDN 102 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~--------------~~~--------~~~~e~~~l~~l~~p~ 102 (360)
.-|++++.||.|++|.||.|...+|+.||+|++...... ... ....|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 349999999999999999999988999999987532110 000 1234666777775444
Q ss_pred ccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe
Q 018128 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 182 (360)
Q Consensus 103 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~ 182 (360)
+.-..-+.. ...++||||++|.+|.++... .....++.||+.+|.+||+.| ++||||||.|||++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 432222212 234799999999888665411 134568899999999999999 99999999999998
Q ss_pred CCC----------ceEEeecCCccc
Q 018128 183 NDF----------NPKLSDFGLAKL 197 (360)
Q Consensus 183 ~~~----------~v~L~Dfg~~~~ 197 (360)
+++ .+.++||+.+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 776 389999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=1e-12 Score=115.20 Aligned_cols=144 Identities=15% Similarity=0.046 Sum_probs=113.8
Q ss_pred HhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.-..|++...++.|+.+.||.+... ++.+++|............+.+|+.+++.+. +..+.+++.+..+....++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3457999999999999999999866 6899999986532233456888999999884 6678899999988889999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------------------------------ 165 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------ 165 (360)
+++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876411 1223468899999999999810
Q ss_pred --------------------CCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 166 --------------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 166 --------------------~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
...++|||++|.||++++++.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0239999999999999876566799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=3.9e-11 Score=104.68 Aligned_cols=137 Identities=17% Similarity=0.092 Sum_probs=100.4
Q ss_pred hcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCc--ccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN--LVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~--i~~~~~~~~~~~~~~lv~e~ 122 (360)
..|.+....+.|..+.||.+...+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++.+..+.+..++|||+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345554444456669999998777888999987544 2345778888888885433 56688888877888999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------------------------------- 165 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------- 165 (360)
++|.+|. ... .. ...++.+++..|..||...
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998873 211 11 1256777888888888643
Q ss_pred ------------------CCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 166 ------------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 166 ------------------~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
...++|||++|.||++++++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=2.2e-10 Score=105.08 Aligned_cols=143 Identities=15% Similarity=0.173 Sum_probs=106.1
Q ss_pred cccceeccCCCeEEEEEEecCCCEEEEEEcc--cCC-ccchHHHHHHHHHhhccC--CCcccceeEEEEeC---CeeEEE
Q 018128 48 REANLIGEGGFGKVYKGRLESGQLVAIKQLN--HEG-LQGHQEFIVEVLMLSLLH--HDNLVTLIGYCTSG---DQRLLV 119 (360)
Q Consensus 48 ~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~--~~~-~~~~~~~~~e~~~l~~l~--~p~i~~~~~~~~~~---~~~~lv 119 (360)
...+.|+.|..+.||.+... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. ...++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34668899999999999876 4689999876 322 123456788999999886 44578888888766 347999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA---------------------------------- 165 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------- 165 (360)
||+++|.++.+.. ...++......++.+++.+|..||...
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999987764321 234678888899999999999999731
Q ss_pred ---------------------CCCeeeCCCCCCcEEEeCCCc--eEEeecCCccc
Q 018128 166 ---------------------NPPVIYRDLKSANILLDNDFN--PKLSDFGLAKL 197 (360)
Q Consensus 166 ---------------------~~~i~H~di~p~NIlv~~~~~--v~L~Dfg~~~~ 197 (360)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=2.3e-10 Score=102.42 Aligned_cols=188 Identities=20% Similarity=0.207 Sum_probs=120.3
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCc--ccceeEEEEeCC---eeEEEEEec
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDN--LVTLIGYCTSGD---QRLLVYEYM 123 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~--i~~~~~~~~~~~---~~~lv~e~~ 123 (360)
.+.++.|..+.||.+. ..+++|+.... .....+..|...++.+. +.. +.+++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4578999999999864 46899985432 33467888999998873 332 344544433333 347999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-------------------------------------- 165 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------------- 165 (360)
+|.+|.+... ..++......++.+++..+..||+..
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988765331 33667777788888888888888621
Q ss_pred -----------------CCCeeeCCCCCCcEEEeC--CCceEEeecCCccccCCCCCcceeccc---ccc-------ccc
Q 018128 166 -----------------NPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPVGDNTHVSTRV---MGT-------YGY 216 (360)
Q Consensus 166 -----------------~~~i~H~di~p~NIlv~~--~~~v~L~Dfg~~~~~~~~~~~~~~~~~---~~~-------~~y 216 (360)
...++|||++|.||++++ ++.+.++||+.+............... .+. ..|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 123899999999999998 456789999988643211100000000 000 011
Q ss_pred --cc-ccccccCCCCcchhhHHHHHHHHHHHhCCCccc
Q 018128 217 --CA-PEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 251 (360)
Q Consensus 217 --~a-PE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~ 251 (360)
.. |+.... .....+.|+++.++|.+.+|..+|-
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 111110 1223689999999999999988763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=8e-07 Score=77.67 Aligned_cols=134 Identities=18% Similarity=0.126 Sum_probs=98.3
Q ss_pred eeccCCCe-EEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 52 LIGEGGFG-KVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 52 ~Lg~G~~g-~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
.+..|..+ .||..... .+..+++|+-... ....+..|...++.+. +--+.+++.++.+.+..++||++++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 33445444 68988765 4678999975432 3456788999888774 32377888888999999999999999888
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------------------------------------- 165 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------------- 165 (360)
.+..... ......+..++...|..||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7766331 1233457778888888888531
Q ss_pred ------------CCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 166 ------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 166 ------------~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
...++|||+++.||++++++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0138999999999999987777799999886
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=6.2e-07 Score=80.06 Aligned_cols=136 Identities=20% Similarity=0.176 Sum_probs=94.7
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCC---cccceeEEEE-eCCeeEEEEEecCC
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD---NLVTLIGYCT-SGDQRLLVYEYMPM 125 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p---~i~~~~~~~~-~~~~~~lv~e~~~~ 125 (360)
.+.++.|....||.+ +..+++|+... ......+..|..+++.+.+. .+.+++.+.. .....++||++++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 457888888899988 56789998422 22346788999999998642 3566666664 44567899999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA---------------------------------------- 165 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------------- 165 (360)
.++.+... ..++......++.++...|..||+..
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88766321 12345555556666666666666432
Q ss_pred -----------------CCCeeeCCCCCCcEEEeC---CCc-eEEeecCCccc
Q 018128 166 -----------------NPPVIYRDLKSANILLDN---DFN-PKLSDFGLAKL 197 (360)
Q Consensus 166 -----------------~~~i~H~di~p~NIlv~~---~~~-v~L~Dfg~~~~ 197 (360)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 123799999999999987 455 47999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.2e-06 Score=79.95 Aligned_cols=81 Identities=7% Similarity=-0.038 Sum_probs=55.9
Q ss_pred cccee-ccCCCeEEEEEEec-------CCCEEEEEEcccCC---ccchHHHHHHHHHhhccC-C--CcccceeEEEEeC-
Q 018128 49 EANLI-GEGGFGKVYKGRLE-------SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLH-H--DNLVTLIGYCTSG- 113 (360)
Q Consensus 49 i~~~L-g~G~~g~v~~~~~~-------~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~-~--p~i~~~~~~~~~~- 113 (360)
..+.| +.|..+.+|.+... +++.+++|+..... ......+..|+.+++.+. + -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 35677 88888999988754 26789999865432 112245777888888774 2 3567778776554
Q ss_pred --CeeEEEEEecCCCCHH
Q 018128 114 --DQRLLVYEYMPMGSLE 129 (360)
Q Consensus 114 --~~~~lv~e~~~~~sL~ 129 (360)
...++|||+++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999886654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.22 E-value=1.4e-05 Score=70.40 Aligned_cols=83 Identities=19% Similarity=0.253 Sum_probs=62.2
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-C--CcccceeEEEEeCCeeE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-H--DNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~--p~i~~~~~~~~~~~~~~ 117 (360)
++.+....-.+.+|.|..+.||.++..+|+.+++|+...........+..|+..|+.+. . --+++++.+ + ..+
T Consensus 11 ~l~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~ 86 (288)
T 3f7w_A 11 ELTGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRT 86 (288)
T ss_dssp HHHCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTE
T ss_pred HhcCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--Cce
Confidence 45567778888999999999999999999999999876555455567888999888874 2 134455544 2 246
Q ss_pred EEEEecCCCC
Q 018128 118 LVYEYMPMGS 127 (360)
Q Consensus 118 lv~e~~~~~s 127 (360)
+|||++++..
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=2.7e-05 Score=71.93 Aligned_cols=75 Identities=15% Similarity=0.044 Sum_probs=49.6
Q ss_pred cceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-------cchHHHHHHHHHhhccCC--C-cccceeEEEEeCCeeEE
Q 018128 50 ANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-------QGHQEFIVEVLMLSLLHH--D-NLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-------~~~~~~~~e~~~l~~l~~--p-~i~~~~~~~~~~~~~~l 118 (360)
.+.||.|..+.||.+... .++.+++|....... .....+..|.++++.+.. | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568899999999999754 478899997643211 123456778888887742 3 34455543 4456789
Q ss_pred EEEecCCC
Q 018128 119 VYEYMPMG 126 (360)
Q Consensus 119 v~e~~~~~ 126 (360)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=3.8e-05 Score=69.22 Aligned_cols=141 Identities=16% Similarity=0.242 Sum_probs=77.5
Q ss_pred ceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-----CCccccee-E--EEEeCCeeEEEEEe
Q 018128 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----HDNLVTLI-G--YCTSGDQRLLVYEY 122 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----~p~i~~~~-~--~~~~~~~~~lv~e~ 122 (360)
+.|+.|..+.||.+...++ .+++|+.... ...+..|+.+++.+. .|.++... + +....+..+++|++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4465567889999987654 5999988652 233444555555442 34443311 0 12346678999999
Q ss_pred cCCCCHH-----------H---Hhccc-CCC----CC----C-CCHHH-------------------------------H
Q 018128 123 MPMGSLE-----------D---HLYDL-EPD----QE----P-LSWNT-------------------------------R 147 (360)
Q Consensus 123 ~~~~sL~-----------~---~i~~~-~~~----~~----~-l~~~~-------------------------------~ 147 (360)
++|.++. . .++.. ... .. . -.+.. +
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9885432 0 11110 000 00 0 01111 1
Q ss_pred HHHHHHHHHHHHHHHh--------C--CCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 148 MKIAVGAARGLEYLHC--------K--ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 148 ~~i~~qi~~al~~LH~--------~--~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
..+...+..++..|+. . ....++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223345566653 0 12339999999999999888899999999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.10 E-value=3.1e-05 Score=64.24 Aligned_cols=141 Identities=14% Similarity=0.046 Sum_probs=93.7
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
.+|.+.+.. .+.++++.++|.++.|.+.+|..+-....+ ...=+.|..|++..+|+|.+.+ ..+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 478888877 568999999999999999998887322211 1223457899999999998763 1110
Q ss_pred eecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccccC
Q 018128 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285 (360)
Q Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
.....+.|||... ...+.+.=|||||+++|.-+--..|-+
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~---------------------------------- 137 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN---------------------------------- 137 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT----------------------------------
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc----------------------------------
Confidence 1233467888653 345678889999999999887544321
Q ss_pred CCChhhHHHHHHHHhhhccc-------------------------CCCCCCCHHHHHHHHhh
Q 018128 286 RYPRRCLNYAVAVTAMCLNE-------------------------EANFRPLINDIVVALDY 322 (360)
Q Consensus 286 ~~~~~~~~~l~~li~~~l~~-------------------------dp~~Rpt~~eil~~L~~ 322 (360)
.+.+++..|-+||..|... .+..|+++++|++.=..
T Consensus 138 -eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 138 -EERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp -EEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred -cchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 1335666778888888755 34688999998876443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.95 E-value=9.3e-05 Score=65.93 Aligned_cols=76 Identities=20% Similarity=0.149 Sum_probs=59.9
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC---CCcccceeEEEEeCCeeEEEEEecCC
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH---HDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~---~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
-.+.|+.|....+|.+... +..+++|+.... ....+..|...|+.+. ...+++++.+.......++|||++++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3467899999999999875 678999986533 3566788988888873 35688888888878889999999988
Q ss_pred CCH
Q 018128 126 GSL 128 (360)
Q Consensus 126 ~sL 128 (360)
.++
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.0002 Score=66.66 Aligned_cols=74 Identities=19% Similarity=0.169 Sum_probs=45.0
Q ss_pred ccceeccCCCeEEEEEEecCCCEEEEEEcccC------C-c--cchHHHHHHHHHhhc-cCCCcccceeEEEEeCCeeEE
Q 018128 49 EANLIGEGGFGKVYKGRLESGQLVAIKQLNHE------G-L--QGHQEFIVEVLMLSL-LHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~------~-~--~~~~~~~~e~~~l~~-l~~p~i~~~~~~~~~~~~~~l 118 (360)
-.+.||.|..+.||.+.. +++.+++|..... . . .....+..|+..+.. .....+.+++.+. ....++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356789999999999965 3678999943221 1 0 122233333333221 1223566666654 567789
Q ss_pred EEEec-CC
Q 018128 119 VYEYM-PM 125 (360)
Q Consensus 119 v~e~~-~~ 125 (360)
|||++ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00014 Score=64.33 Aligned_cols=71 Identities=7% Similarity=0.016 Sum_probs=44.4
Q ss_pred cceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcc-cceeEEEEeCCeeEEEEEec-CCCC
Q 018128 50 ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYM-PMGS 127 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i-~~~~~~~~~~~~~~lv~e~~-~~~s 127 (360)
.+.|+.|....+|.+ +.+++|+..... ........|+.+++.+..-++ .+++.+ +.+..+++++++ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 788988999999998 568999876432 111223457777776642222 455543 344457899999 6644
Q ss_pred H
Q 018128 128 L 128 (360)
Q Consensus 128 L 128 (360)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.74 E-value=0.0011 Score=59.11 Aligned_cols=160 Identities=15% Similarity=0.104 Sum_probs=85.8
Q ss_pred cccHHHHHHHhhccccc-----ceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-----CCcc
Q 018128 34 SFTFRELAIATRNFREA-----NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----HDNL 103 (360)
Q Consensus 34 ~~~~~~~~~~~~~y~i~-----~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----~p~i 103 (360)
.++..++.-.-.+|.+. +.|+.|....+|.+...++ .+++|+.... .....+..|+.+++.+. .|.+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 35556666555667653 3566688889999987655 6899988653 12244556777766653 2333
Q ss_pred ccee---EEEEeCCeeEEEEEecCCCCHHH--------------Hhcc----cCCCC-CCCC---HHHHHH---------
Q 018128 104 VTLI---GYCTSGDQRLLVYEYMPMGSLED--------------HLYD----LEPDQ-EPLS---WNTRMK--------- 149 (360)
Q Consensus 104 ~~~~---~~~~~~~~~~lv~e~~~~~sL~~--------------~i~~----~~~~~-~~l~---~~~~~~--------- 149 (360)
+... .+....+..++++++++|.++.. -++. +.... .... +...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 3211 01223456789999998754311 0111 11000 0011 111000
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 150 ---IAVGAARGLEYLHCK----ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 150 ---i~~qi~~al~~LH~~----~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
+-..+...+..++.. ....++|+|+++.||++++++.+.++||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133344445421 11239999999999999987666899998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.0005 Score=61.72 Aligned_cols=142 Identities=13% Similarity=0.050 Sum_probs=71.2
Q ss_pred ceeccCCCeE-EEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-C-CcccceeEEEEeCCeeEEEEEecCCCC
Q 018128 51 NLIGEGGFGK-VYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-H-DNLVTLIGYCTSGDQRLLVYEYMPMGS 127 (360)
Q Consensus 51 ~~Lg~G~~g~-v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~-p~i~~~~~~~~~~~~~~lv~e~~~~~s 127 (360)
+.|+.|+... +|.+...++..+++|....... ..+..|+.+++.+. + -.+.+++.+.. ...+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 4565555444 5676654467788886543321 23344666666553 2 23556665532 23378999997766
Q ss_pred HHHHhccc---------------------CCC-CCCCCHHHHH-------HHH-------------HHHHHHHHHHH---
Q 018128 128 LEDHLYDL---------------------EPD-QEPLSWNTRM-------KIA-------------VGAARGLEYLH--- 162 (360)
Q Consensus 128 L~~~i~~~---------------------~~~-~~~l~~~~~~-------~i~-------------~qi~~al~~LH--- 162 (360)
+.+++... ... -..+...... .+. ..+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443210 000 0112221110 000 01111222221
Q ss_pred hCCCCCeeeCCCCCCcEEEeCC----CceEEeecCCccc
Q 018128 163 CKANPPVIYRDLKSANILLDND----FNPKLSDFGLAKL 197 (360)
Q Consensus 163 ~~~~~~i~H~di~p~NIlv~~~----~~v~L~Dfg~~~~ 197 (360)
......++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1112349999999999999874 6789999998874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00054 Score=63.93 Aligned_cols=72 Identities=18% Similarity=0.241 Sum_probs=48.3
Q ss_pred cceeccCCCeEEEEEEecC--------CCEEEEEEcccCCccchHHHHHHHHHhhccCCCc-ccceeEEEEeCCeeEEEE
Q 018128 50 ANLIGEGGFGKVYKGRLES--------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~-i~~~~~~~~~~~~~~lv~ 120 (360)
.+.|+.|-...+|.+...+ ++.+++|+..... ....+..|+.+++.+...+ ..+++..+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4577788889999998652 5789999884421 1245567888888875323 356665543 2 3889
Q ss_pred EecCCCC
Q 018128 121 EYMPMGS 127 (360)
Q Consensus 121 e~~~~~s 127 (360)
+|++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9987633
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0015 Score=58.26 Aligned_cols=161 Identities=13% Similarity=0.073 Sum_probs=88.5
Q ss_pred ccccHHHHHHHhhcccc-----cceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCC--cccc
Q 018128 33 RSFTFRELAIATRNFRE-----ANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD--NLVT 105 (360)
Q Consensus 33 ~~~~~~~~~~~~~~y~i-----~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p--~i~~ 105 (360)
..++...+.-.-.+|-+ .+.|+ |....||.+...+|+.+++|...... .....+..|..+++.+... .+++
T Consensus 9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence 34455555444444433 34566 88889999887777789999986432 2345666787777766311 1333
Q ss_pred eeEE-----EEeCCeeEEEEEecCCCCHH-----H------H---hcc----cCC-CCCCCCHHH---------------
Q 018128 106 LIGY-----CTSGDQRLLVYEYMPMGSLE-----D------H---LYD----LEP-DQEPLSWNT--------------- 146 (360)
Q Consensus 106 ~~~~-----~~~~~~~~lv~e~~~~~sL~-----~------~---i~~----~~~-~~~~l~~~~--------------- 146 (360)
++.. ....+..+++|++++|.++. . . ++. ... .....+...
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 3322 22345668899999774321 0 0 111 000 001111111
Q ss_pred -------HHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 147 -------RMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 147 -------~~~i~~qi~~al~~LH~~-~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
....+..++..+..+-.. ....++|||+++.||+++ + .+.++||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 111222222223322111 122389999999999998 4 899999987753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0029 Score=57.86 Aligned_cols=142 Identities=18% Similarity=0.230 Sum_probs=82.6
Q ss_pred cceeccCCCeEEEEEEec--------CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEE
Q 018128 50 ANLIGEGGFGKVYKGRLE--------SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~--------~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+.|..|-...+|.+... +++.+++|+.... ........+|..+++.+. +.-..+++..+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 346766888899999864 2578999986432 234566678999988874 3333566665543 2999
Q ss_pred EecCCCCHHHH-----------------hcccC-CCCCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 018128 121 EYMPMGSLEDH-----------------LYDLE-PDQEPL--SWNTRMKIAVGAAR-------------------GLEYL 161 (360)
Q Consensus 121 e~~~~~sL~~~-----------------i~~~~-~~~~~l--~~~~~~~i~~qi~~-------------------al~~L 161 (360)
|+++|.+|..- ++... .-+... -+..+..+..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99987554310 01110 011112 23455555544422 12222
Q ss_pred ----HhCC-CCCeeeCCCCCCcEEEeCC----CceEEeecCCcc
Q 018128 162 ----HCKA-NPPVIYRDLKSANILLDND----FNPKLSDFGLAK 196 (360)
Q Consensus 162 ----H~~~-~~~i~H~di~p~NIlv~~~----~~v~L~Dfg~~~ 196 (360)
...+ ...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 2249999999999999876 789999999886
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0015 Score=61.36 Aligned_cols=74 Identities=16% Similarity=0.065 Sum_probs=46.4
Q ss_pred cceeccCCCeEEEEEEecC-CCEEEEEEcccCCccchHHHHHHHHHhhccCCCcc-cceeEEEEeCCeeEEEEEecCCCC
Q 018128 50 ANLIGEGGFGKVYKGRLES-GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-VTLIGYCTSGDQRLLVYEYMPMGS 127 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i-~~~~~~~~~~~~~~lv~e~~~~~s 127 (360)
.+.|+.|-...+|.+...+ +..+++|+..... ...-....|+.+++.+...++ .+++..+. + .+|++|++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567778889999998764 5789999875432 111122578888888864334 56666652 2 35999997744
Q ss_pred H
Q 018128 128 L 128 (360)
Q Consensus 128 L 128 (360)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0038 Score=56.16 Aligned_cols=29 Identities=17% Similarity=0.269 Sum_probs=26.4
Q ss_pred CeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 168 PVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 168 ~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
.++|||+.+.||+++.++.+.|+||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 39999999999999988889999998776
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0015 Score=59.53 Aligned_cols=73 Identities=11% Similarity=0.043 Sum_probs=43.2
Q ss_pred cceeccCCCeEEEEEEecC---------CCEEEEEEcccCCccchHHHHHHHHHhhccCCCc-ccceeEEEEeCCeeEEE
Q 018128 50 ANLIGEGGFGKVYKGRLES---------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~-i~~~~~~~~~~~~~~lv 119 (360)
.+.|+.|....+|.+...+ ++.+++|+..... ........|..+++.+...+ +.+++... . .++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567778888999997653 2689999875431 11112356777777774223 44565443 2 3689
Q ss_pred EEecCCCC
Q 018128 120 YEYMPMGS 127 (360)
Q Consensus 120 ~e~~~~~s 127 (360)
|++++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.011 Score=54.89 Aligned_cols=74 Identities=11% Similarity=0.067 Sum_probs=47.5
Q ss_pred cceeccCCCeEEEEEEecC--------CCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEE
Q 018128 50 ANLIGEGGFGKVYKGRLES--------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+.|..|-...+|.+...+ ++.+++|+.... ....-...+|..+++.+. +.-..++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 4567778888999998653 578999986543 222223456888777774 33345555433 2 36899
Q ss_pred EecCCCCH
Q 018128 121 EYMPMGSL 128 (360)
Q Consensus 121 e~~~~~sL 128 (360)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99988553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.43 E-value=0.019 Score=52.77 Aligned_cols=29 Identities=28% Similarity=0.283 Sum_probs=24.6
Q ss_pred eeeCCCCCCcEEEe------CCCceEEeecCCccc
Q 018128 169 VIYRDLKSANILLD------NDFNPKLSDFGLAKL 197 (360)
Q Consensus 169 i~H~di~p~NIlv~------~~~~v~L~Dfg~~~~ 197 (360)
++|+|+.+.||++. +++.+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999993 456799999998863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.00 E-value=0.61 Score=38.45 Aligned_cols=123 Identities=11% Similarity=0.119 Sum_probs=81.7
Q ss_pred HHHHhhccCCCcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 018128 91 EVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170 (360)
Q Consensus 91 e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 170 (360)
|+..|. ..+|+++.. .+..+++.+.+.++.-+. ...|- .-+..+....+.++.+|+....+++ . -+
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~-~----r~ 101 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNR-T----RY 101 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGG-S----SE
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcc--cCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhc-C----ce
Confidence 444443 258888876 566777776666665432 22222 1245788999999999998774443 2 47
Q ss_pred eCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcc
Q 018128 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 250 (360)
Q Consensus 171 H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf 250 (360)
|--++|+|++++.++.+++.--|.... ++|. ..+...=+-.+=|++..+++++..|
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEEecceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 778999999999999999976654331 2232 1122223446678889999999888
Q ss_pred c
Q 018128 251 D 251 (360)
Q Consensus 251 ~ 251 (360)
+
T Consensus 158 e 158 (215)
T 4ann_A 158 D 158 (215)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.08 E-value=2.2 Score=35.27 Aligned_cols=115 Identities=11% Similarity=0.087 Sum_probs=78.7
Q ss_pred CCCcccceeEEEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeCCCCCC
Q 018128 99 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE-YLHCKANPPVIYRDLKSA 177 (360)
Q Consensus 99 ~~p~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~~i~H~di~p~ 177 (360)
.||++ -..+..+++.+.+.++.-+++.=...+ +.++....+.++.+|+.... +++ . -+|--++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS--S---SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEeCc
Confidence 58888 455557778877878766443333344 44788999999999987655 333 3 577789999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCccc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 251 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~ 251 (360)
|++++.++.+++.-.|.-. -++|..+ +..-=+-++=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE-------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETT-------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcc-------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999998666543 2344321 212223456778888999888875
|
| >3eps_A Isocitrate dehydrogenase kinase/phosphatase; ATP-binding, glyoxylate bypass, nucleotide-binding, protein phosphatase; HET: AMP ATP; 2.80A {Escherichia coli O157} PDB: 3lcb_A* 3lc6_A* | Back alignment and structure |
|---|
Probab=83.24 E-value=22 Score=33.45 Aligned_cols=133 Identities=14% Similarity=0.032 Sum_probs=96.1
Q ss_pred eeccCCCeEEEEEEecCCCEEEEEEcccC----CccchHHHHHHHHHhhccCCCcccce---eEEE--------------
Q 018128 52 LIGEGGFGKVYKGRLESGQLVAIKQLNHE----GLQGHQEFIVEVLMLSLLHHDNLVTL---IGYC-------------- 110 (360)
Q Consensus 52 ~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~----~~~~~~~~~~e~~~l~~l~~p~i~~~---~~~~-------------- 110 (360)
.+.-|--|.|.++..-.+-++|.|++... .....+.++..+.+.++ |..+-+. .++.
T Consensus 313 i~APGikGmVM~VFTLPSf~~VFKvIKD~F~p~K~~tr~~Vk~KY~LVK~--hDRVGRMADT~Efsn~~fp~~Rfs~eLL 390 (578)
T 3eps_A 313 IEAPGIRGMVMLVFTLPGFDRVFKVIKDKFAPQKEMSAAHVRACYQLVKE--HDRVGRMADTQEFENFVLEKRHISPALM 390 (578)
T ss_dssp EECSSCCCSSEEEEECTTCSEEEEEECSSCCTTCCCCHHHHHHHHHHHHT--SCCTTTBCCCEEEEEEEEEGGGBCHHHH
T ss_pred EECCCCCceEEEEEcCCCCceEEEEEccCCCCccccCHHHHHHHHHHHHh--hhhhhhhhhhhhhhcccCchhhCCHHHH
Confidence 46678899999998777888999998643 23345677777777763 4444333 2221
Q ss_pred ------------EeCCeeE---EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 018128 111 ------------TSGDQRL---LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 175 (360)
Q Consensus 111 ------------~~~~~~~---lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~ 175 (360)
.+++.+. +.+|.- ...|.-++++ -+..++...+.+.-.||+.|-..| |..||.-
T Consensus 391 ~EL~~~~ps~le~~gd~liIkHlYiERR-MtPLNLYL~~-------a~~~~~~~av~eYG~AIKqLAaAN---IFPGDML 459 (578)
T 3eps_A 391 ELLLQEAAEKITDLGEQIVIRHLYIERR-MVPLNIWLEQ-------VEGQQLRDAIEEYGNAIRQLAAAN---IFPGDML 459 (578)
T ss_dssp HHHHHHSGGGEEEETTEEEEEEEEEEEC-CEEHHHHHHH-------CCTHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred HHHHHhCCccEEEcCCeeEeeeeeeecc-ccchhHHHhh-------CCHHHHHHHHHHHHHHHHHHHHhc---CCCcccc
Confidence 1233322 333432 4567777744 356778889999999999999999 9999999
Q ss_pred CCcEEEeCCCceEEeecCCccc
Q 018128 176 SANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 176 p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
.+|+=|+..|+|.+=|++-...
T Consensus 460 ~KNFGVTRhgRVVFYDYDEI~y 481 (578)
T 3eps_A 460 FKNFGVTRHGRVVFYDYDEICY 481 (578)
T ss_dssp GGGEEECTTCCEEECCGGGCEE
T ss_pred cccCCccccceEEEecccceee
Confidence 9999999999999999987654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 360 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-76 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-51 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (598), Expect = 3e-76
Identities = 84/287 (29%), Positives = 126/287 (43%), Gaps = 26/287 (9%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLH 99
I IG G FG VYKG+ VA+K LN Q Q F EV +L
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 100 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
H N++ +GY T Q +V ++ SL HL+ +E + IA A+G++
Sbjct: 63 HVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMD 118
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YLH K +I+RDLKS NI L D K+ DFGLA + +H ++ G+ + AP
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 220 EYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276
E + +SD+Y+FG+VL EL+TG+ + + + D K
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV- 234
Query: 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323
C + A CL ++ + RPL I+ +++ L
Sbjct: 235 -----------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 7e-69
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 28/282 (9%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD 101
+ + +G G FG+V+ G VA+K L +G F+ E ++ L H
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
LV L T + ++ EYM GSL D L P L+ N + +A A G+ ++
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
+ I+RDL++ANIL+ + + K++DFGLA+L + + APE
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 181
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGRKA--MDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279
G T+KSD++SFG++L E++T + ++ + QNL R
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---------- 231
Query: 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321
P C + +C E RP + + L+
Sbjct: 232 --------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (546), Expect = 3e-68
Identities = 74/313 (23%), Positives = 132/313 (42%), Gaps = 41/313 (13%)
Query: 35 FTFRELAIATRNFREA---------NLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEG 81
FTF + A R F + +IG G FG+V G L + VAIK L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 82 L-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE 140
+ ++F+ E ++ H N++ L G T +++ E+M GSL+ L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 141 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200
+ + + G A G++YL ++RDL + NIL++++ K+SDFGL++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 201 GDNTHVSTRV---MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 257
+ T + APE K T SD++S+G+V+ E+++ +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE--------- 231
Query: 258 EQNLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
RP+ + ++ ++ P C + + C ++ N RP I
Sbjct: 232 --------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 317 VVALDYLVSQRDS 329
V LD ++ +S
Sbjct: 284 VNTLDKMIRNPNS 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-67
Identities = 68/277 (24%), Positives = 112/277 (40%), Gaps = 26/277 (9%)
Query: 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 104
++ +G G FG V G+ VAIK + EG EFI E ++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
L G CT ++ EYM G L ++L + +++ +EYL K
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
++RDL + N L+++ K+SDFGL++ D S + PE M
Sbjct: 120 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 225 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLVDPLL 283
K + KSDI++FGV++ E+ + K P+ + + L
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGK-----------------MPYERFTNSETAEHIAQGL 218
Query: 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320
P + C +E+A+ RP ++ +
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (541), Expect = 1e-67
Identities = 71/297 (23%), Positives = 130/297 (43%), Gaps = 24/297 (8%)
Query: 33 RSFTFRELAIATRNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVE 91
S + + + + + +G G +G+VY+G + VA+K L + ++ +EF+ E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 92 VLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 151
++ + H NLV L+G CT ++ E+M G+L D+L E +++ +S + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMA 121
Query: 152 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 211
+ +EYL K I+RDL + N L+ + K++DFGL++L GD
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 177
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271
+ APE K ++KSD+++FGV+L E+ T + D
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------ID 221
Query: 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328
+ L++ P C + C + RP +I A + + +
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 2e-67
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 40 LAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG-HQEFIVEVLMLSL 97
+ + +F + + +G G G V+K SG ++A K ++ E + I E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 98 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
+ +V G S + + E+M GSL+ L + K+++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKG 116
Query: 158 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
L YL K +++RD+K +NIL+++ KL DFG++ ++ +GT Y
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYM 170
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+PE +++SDI+S G+ L+E+ GR
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-66
Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 24/279 (8%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVT 105
IG G FG V+ G + VAIK + EG ++FI E ++ L H LV
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 106 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
L G C LV+E+M G L D+L + + T + + + G+ YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 166 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG 225
VI+RDL + N L+ + K+SDFG+ + D ST + +PE
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 226 KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 285
+ + KSD++SFGV++ E+ + K ++ E V +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VEDISTGFRL 221
Query: 286 RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324
PR + + C E RP + ++ L +
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-65
Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 28/297 (9%)
Query: 53 IGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS 112
IG+G FG+V++G+ G+ VA+K + + E+ +L H+N++ I
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 113 GD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--- 165
+ Q LV +Y GSL D+L ++ ++ +K+A+ A GL +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 166 --NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEY 221
P + +RDLKS NIL+ + ++D GLA +T +GT Y APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 222 AMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSK-GQGEQNLVSWSRPFLKDQKK 274
+ ++DIY+ G+V E+ + + Q + S P +++ +K
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 275 FV--HLVDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328
V + P + R+ L + C R I L L Q
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-65
Identities = 69/282 (24%), Positives = 112/282 (39%), Gaps = 32/282 (11%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 102
++ IG G +G+ K R G+++ K+L++ + Q + EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 103 LVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
+V L V EY G L + +++ L +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 161 LHCK--ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
H + V++RDLK AN+ LD N KL DFGLA++ + +T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 219 PEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278
PE KSDI+S G +L EL PF L
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM------------------PPF--TAFSQKEL 222
Query: 279 VDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDIV 317
+ G++ R Y + LN + RP + +I+
Sbjct: 223 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 7e-65
Identities = 77/286 (26%), Positives = 122/286 (42%), Gaps = 27/286 (9%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHD 101
I + R +G+G FG+V+ G VAIK L G + F+ E ++ L H+
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHE 72
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
LV L + + +V EYM GSL D L + L + +A A G+ Y+
Sbjct: 73 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
++RDL++ANIL+ + K++DFGLA+L + + APE
Sbjct: 130 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEA 185
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLVD 280
A+ G+ T+KSD++SFG++L EL T + P+ ++ + V+
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGR-----------------VPYPGMVNREVLDQVE 228
Query: 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL-DYLVS 325
P C + C +E RP + L DY S
Sbjct: 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (522), Expect = 1e-64
Identities = 72/315 (22%), Positives = 119/315 (37%), Gaps = 48/315 (15%)
Query: 37 FRELAIATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQ-EFI 89
L N IGEG FG+V++ R E +VA+K L E Q +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 90 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD--------------- 134
E +++ + N+V L+G C G L++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 135 -----LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 189
P PLS ++ IA A G+ YL ++RDL + N L+ + K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 190 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 249
+DFGL++ D + PE + T +SD++++GVVL E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL- 240
Query: 250 MDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN 308
+P+ ++ ++ V P C + +C ++
Sbjct: 241 ----------------QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPA 284
Query: 309 FRPLINDIVVALDYL 323
RP I L +
Sbjct: 285 DRPSFCSIHRILQRM 299
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-64
Identities = 72/307 (23%), Positives = 118/307 (38%), Gaps = 40/307 (13%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGH-QEFIVEVLM 94
+G G FGKV + ++ VA+K L + + E+ +
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 95 LS-LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD--------------LEPDQ 139
LS L +H N+V L+G CT G L++ EY G L + L +E D+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
L + + A+G+ +L K I+RDL + NILL + K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
N V + APE + T +SD++S+G+ L EL + +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-------- 248
Query: 260 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 319
P + KF ++ P + C + + RP IV
Sbjct: 249 -------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 320 LDYLVSQ 326
++ +S+
Sbjct: 302 IEKQISE 308
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-64
Identities = 76/295 (25%), Positives = 130/295 (44%), Gaps = 29/295 (9%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRLESGQ-----LVAIKQLNHEGLQGHQ-EFIVEVLML 95
I +IG G FG+VYKG L++ VAIK L + + +F+ E ++
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 96 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 155
H N++ L G + +++ EYM G+L+ L + S + + G A
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIA 120
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY 214
G++YL N ++RDL + NIL++++ K+SDFGL++ L + T+ ++
Sbjct: 121 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 215 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274
+ APE K T SD++SFG+V+ E++T + + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------------WELSNHE 221
Query: 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 329
+ ++ P C + + C +E RP DIV LD L+ DS
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 7e-64
Identities = 74/281 (26%), Positives = 119/281 (42%), Gaps = 32/281 (11%)
Query: 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 104
+ + IG+G FG V G G VA+K + ++ Q F+ E +++ L H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 105 TLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
L+G L +V EYM GSL D+L + L + +K ++ +EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
++RDL + N+L+ D K+SDFGL K +T + APE
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALR 173
Query: 224 SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVHLVDPL 282
K + KSD++SFG++L E+ + + P+ + K V V+
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGR-----------------VPYPRIPLKDVVPRVEKG 216
Query: 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323
P C V C + +A RP + L+++
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 5e-63
Identities = 69/304 (22%), Positives = 124/304 (40%), Gaps = 35/304 (11%)
Query: 38 RELAIATRNFREANL-IGEGGFGKVYKGRL---ESGQLVAIKQLNHEGLQGH-QEFIVEV 92
++L + N A++ +G G FG V +G + VAIK L + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 93 LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 152
++ L + +V LIG C + +LV E G L L +E + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 153 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM 211
+ G++YL K ++RDL + N+LL N K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 212 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-K 270
+ APE K + +SD++S+GV + E ++ + +P+
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----------------KPYKKM 216
Query: 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY----LVSQ 326
+ + ++ P C A+ + C + RP + + L S+
Sbjct: 217 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
Query: 327 RDSH 330
+ H
Sbjct: 277 VEGH 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 6e-63
Identities = 70/305 (22%), Positives = 117/305 (38%), Gaps = 49/305 (16%)
Query: 46 NFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEGLQGHQE-FIVEV-LMLSL 97
N ++G G FGKV VA+K L + +E + E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 98 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY-------------------DLEPD 138
H+N+V L+G CT L++EY G L ++L + E D
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 139 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198
L++ + A A+G+E+L K ++RDL + N+L+ + K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 258
N V + APE G T+KSD++S+G++L E+ +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV---------- 264
Query: 259 QNLVSWSRPF--LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
P+ + F L+ P + C ++ RP ++
Sbjct: 265 -------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 317 VVALD 321
L
Sbjct: 318 TSFLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-62
Identities = 63/279 (22%), Positives = 112/279 (40%), Gaps = 32/279 (11%)
Query: 49 EANLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDNL 103
E +G G FG V KG + + VA+K L +E E + E ++ L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
V +IG C + + +LV E +G L +L + +++ + G++YL
Sbjct: 71 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYA 222
++RDL + N+LL K+SDFGL+K L + T + APE
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KDQKKFVHLVDP 281
K + KSD++SFGV++ E + + +P+ + +++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQ-----------------KPYRGMKGSEVTAMLEK 225
Query: 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320
P C + +C + RP + + L
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-62
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 25/274 (9%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNL 103
++ +GEG +G+V + + VA+K ++ + + + E+ + +L+H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
V G+ G+ + L EY G L D + + + G+ YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+ +RD+K N+LLD N K+SDFGLA + + + ++ GT Y APE
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 224 SGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282
+ D++S G+VL ++ G D ++ + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKK 223
Query: 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
+ ++ + +A+ L E + R I DI
Sbjct: 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-62
Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 39/284 (13%)
Query: 45 RNFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 101
R + IG G F VYKG E+ VA +L L Q F E ML L H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 102 NLVTLIGYCTSGDQR----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 157
N+V S + +LV E M G+L+ +L + + +G
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKG 124
Query: 158 LEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
L++LH + PP+I+RDLK NI + + K+ D GLA L + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK-- 274
APE K D+Y+FG+ +LE+ T P+ + Q
Sbjct: 180 MAPEM-YEEKYDESVDVYAFGMCMLEMATSE------------------YPYSECQNAAQ 220
Query: 275 -FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
+ + + + + + + C+ + + R I D++
Sbjct: 221 IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-62
Identities = 74/303 (24%), Positives = 126/303 (41%), Gaps = 41/303 (13%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQL---VAIKQLNHEGL-QGHQEFIVEV-LMLSLLHH 100
+ + ++IGEG FG+V K R++ L AIK++ H++F E+ ++ L HH
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD------------LEPDQEPLSWNTRM 148
N++ L+G C L EY P G+L D L LS +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 149 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208
A ARG++YL I+RDL + NIL+ ++ K++DFGL++ V T
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 184
Query: 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268
+ A E T SD++S+GV+L E+++ P+
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----------------TPY 227
Query: 269 L-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327
+ + P C + + C E+ RP I+V+L+ ++ +R
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 328 DSH 330
++
Sbjct: 288 KTY 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-61
Identities = 75/289 (25%), Positives = 126/289 (43%), Gaps = 32/289 (11%)
Query: 46 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHH 100
+F E +IG G FG VY G L A+K LN G +F+ E +++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 101 DNLVTLIGYCTSGDQR-LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
N+++L+G C + L+V YM G L + + + + + + A+G++
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMK 144
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYC 217
+L K ++RDL + N +LD F K++DFGLA+ D+ H T +
Sbjct: 145 FLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277
A E + K T KSD++SFGV+L EL+T + N + L+ ++
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQGRRLL-- 254
Query: 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326
P C + V C + +A RP +++V + + S
Sbjct: 255 ---------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 2e-61
Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 37/278 (13%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHD 101
+F +G+G FG VY R +S ++A+K L L + EV + S L H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
N++ L GY + L+ EY P+G++ L A L Y
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 122
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H K VI+RD+K N+LL + K++DFG + P + T + GT Y PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEM 175
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281
K D++S GV+ E + G+ PF + +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPF--EANTYQETYKR 215
Query: 282 LLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
+ + P A + + L + RP++ +++
Sbjct: 216 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 3e-61
Identities = 70/282 (24%), Positives = 115/282 (40%), Gaps = 38/282 (13%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH---QEFIVEVLMLSLLH 99
+ F + IG G FG VY R + + ++VAIK++++ G Q + Q+ I EV L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 100 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 159
H N + G LV EY + + ++PL + GA +GL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 160 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 219
YLH +I+RD+K+ NILL KL DFG A + + +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAP 180
Query: 220 EYAMS---GKLTLKSDIYSFGVVLLELITGRKAM-DLSKGQGEQNLVSWSRPFLKDQKKF 275
E ++ G+ K D++S G+ +EL + + +++ ++ P L+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----- 235
Query: 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317
Y CL + RP ++
Sbjct: 236 ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-61
Identities = 63/278 (22%), Positives = 117/278 (42%), Gaps = 31/278 (11%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 104
+ +G+G FGKVYK + E+ L A K ++ + + ++++VE+ +L+ H N+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
L+ + ++ E+ G+++ + +LE PL+ + + L YLH
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN 129
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
+I+RDLK+ NIL D + KL+DFG++ +GT + APE M
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMC 184
Query: 225 -----GKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278
K+D++S G+ L+E+ +L+ + + P L
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-------- 236
Query: 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
P R + CL + + R + +
Sbjct: 237 --------QPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-60
Identities = 62/293 (21%), Positives = 129/293 (44%), Gaps = 31/293 (10%)
Query: 47 FREANLIGEGGFGKVYKGRL-----ESGQLVAIKQLNHEG-LQGHQEFIVEVLMLSLLHH 100
F++ ++G G FG VYKG + VAIK+L + ++E + E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
++ L+G C + +L + + MP G L D++ + ++ + + V A+G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
L + +++RDL + N+L+ + K++DFGLAKL + + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQKKFVHLV 279
+ T +SD++S+GV + EL+T +P+ + ++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS-----------------KPYDGIPASEISSIL 226
Query: 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 332
+ P C + C +A+ RP ++++ + + V
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-59
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN 102
+ + IG+G G VY + +GQ VAI+Q+N + + I E+L++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V + GD+ +V EY+ GSL D + + + + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
VI+RD+KS NILL D + KL+DFG + + ++GT + APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVV 188
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD---QKKFVHLV 279
K DI+S G++ +E+I G P+L + + ++
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE------------------PPYLNENPLRALYLIAT 230
Query: 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
+ + P + CL+ + R ++
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-58
Identities = 75/289 (25%), Positives = 114/289 (39%), Gaps = 34/289 (11%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGL---QGHQEFIVEVLM 94
I ++ R +G+G FG V +G ++ VA+K L + L + +FI EV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 95 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
+ L H NL+ L G + ++ V E P+GSL D L Q T + AV
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQV 120
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGT 213
A G+ YL + I+RDL + N+LL K+ DFGL + P D+ +V
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 214 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF--LKD 271
+ +CAPE + + SD + FGV L E+ T + P+ L
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----------------EPWIGLNG 220
Query: 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320
+ + P C V C + RP + L
Sbjct: 221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-57
Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 34/293 (11%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRL------ESGQLVAIKQLNHEG-LQGHQEFIVEVLM 94
+A + +G+G FG VY+G E VAIK +N ++ EF+ E +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 95 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRM 148
+ + ++V L+G + G L++ E M G L+ +L L P P S + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 149 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 208
++A A G+ YL+ ++RDL + N ++ DF K+ DFG+ + D
Sbjct: 137 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268
+ + + +PE G T SD++SFGVVL E+ T + +P+
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----------------QPY 236
Query: 269 -LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 320
++ + V P C + + MC RP +I+ ++
Sbjct: 237 QGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-57
Identities = 61/292 (20%), Positives = 101/292 (34%), Gaps = 38/292 (13%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHD 101
+F+ ++GEG F V R L + + AIK L + E ++S L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
V L ++ Y G L ++ LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H +I+RDLK NILL+ D + +++DFG AK+ + +GT Y +PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281
SD+++ G ++ +L+ G PF +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------------------PPF--RAGNEYLIFQK 221
Query: 282 LLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 331
++ Y P + A + L +A R ++ +HP
Sbjct: 222 IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK-----AHP 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-55
Identities = 67/300 (22%), Positives = 123/300 (41%), Gaps = 39/300 (13%)
Query: 46 NFREANLIGEGGFGKVYKGR------LESGQLVAIKQLNHEGLQG-HQEFIVEV-LMLSL 97
+ +G G FG+V + + + VA+K L H+ + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 98 LHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYD------------LEPDQEPLSW 144
HH N+V L+G CT G +++ E+ G+L +L + ++ L+
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 145 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 204
+ + A+G+E+L + I+RDL + NILL K+ DFGLA+ +
Sbjct: 134 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 205 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 264
+ APE T++SD++SFGV+L E+ + +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY------------- 237
Query: 265 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324
P +K ++F + R P C + E + RP +++V L L+
Sbjct: 238 --PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-55
Identities = 75/307 (24%), Positives = 121/307 (39%), Gaps = 43/307 (14%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRL--------ESGQLVAIKQLNHEGLQGH-QEFIVEV 92
+ +GEG FG+V VA+K L + + + I E+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 93 -LMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQ 139
+M + H N++ L+G CT ++ EY G+L ++L P +
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199
E LS + A ARG+EYL + I+RDL + N+L+ D K++DFGLA+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 259
D +T + APE T +SD++SFGV+L E+ T
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG----------- 235
Query: 260 NLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318
P+ ++ L+ P C N + C + + RP +V
Sbjct: 236 ------SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
Query: 319 ALDYLVS 325
LD +V+
Sbjct: 290 DLDRIVA 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-54
Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 29/290 (10%)
Query: 42 IATRNFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGLQGHQE-FIVEVLMLS 96
I IGEG FG V++G VAIK + +E F+ E L +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 97 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
H ++V LIG T + ++ E +G L L + L + + A +
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLST 119
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
L YL + ++RD+ + N+L+ ++ KL DFGL++ + +++ +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKW 175
Query: 217 CAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276
APE + T SD++ FGV + E++ + D +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVK-------------PFQGVKNNDVIGRI 222
Query: 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326
+ L P C ++ C + + RP ++ L ++ +
Sbjct: 223 ENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 2e-53
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 12/205 (5%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 104
++ +G G FG V++ +G A K + + E+ +S+L H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
L ++ +++YE+M G L + + D + +S + ++ +GL ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 165 ANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
++ DLK NI+ + KL DFGL D GT + APE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVA 197
Query: 223 MSGKLTLKSDIYSFGVVLLELITGR 247
+ +D++S GV+ L++G
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 173 bits (440), Expect = 1e-51
Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 19/231 (8%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---QGHQEFIVEVLMLSLLH-- 99
+F +IG GGFG+VY R ++G++ A+K L+ + + QG + E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 100 -HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
+V + + D+ + + M G L HL E A GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR----FYAAEIILGL 120
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 218
E++H N V+YRDLK ANILLD + ++SD GLA +GT+GY A
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 219 PEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268
PE G +D +S G +L +L+ G K + + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 3e-51
Identities = 50/274 (18%), Positives = 100/274 (36%), Gaps = 26/274 (9%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 104
+ +G G FG V++ +G++ K +N E+ +++ LHH L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
L + +L+ E++ G L D + + +S + A GL+++H
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 165 ANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+++ D+K NI+ + K+ DFGLA + + T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIV 200
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282
+ +D+++ GV+ L++G ++ + + V D
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP--------------FAGEDDLETLQNVKRCDWE 246
Query: 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
A L +E R ++D
Sbjct: 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-50
Identities = 72/271 (26%), Positives = 111/271 (40%), Gaps = 32/271 (11%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSL-LHH 100
+F ++G+G FGKV+ ++ Q AIK L + + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
L + + + V EY+ G L H+ + A GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQF 118
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
LH K ++YRDLK NILLD D + K++DFG+ K +GD GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280
+ K D +SFGV+L E++ G+ PF ++ +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------------------SPFHGQDEEELFHSI 215
Query: 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 311
+ + YPR A + E R
Sbjct: 216 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 2e-49
Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 9/203 (4%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE-FIVEVLMLSLLHHDNLV 104
+ +++G G F +V + +LVAIK + + L+G + E+ +L + H N+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
L SG L+ + + G L D + + + + ++ ++YLH
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
+ LD D +SDFGL+K+ D V + GT GY APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQ 183
Query: 225 GKLTLKSDIYSFGVVLLELITGR 247
+ D +S GV+ L+ G
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 165 bits (419), Expect = 4e-49
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 45 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHH 100
++F+ +G G FG+V+ R +G+ A+K L E + ++ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
++ + G Q ++ +Y+ L+ L + A LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
LH + +IYRDLK NILLD + + K++DFG AK P V+ + GT Y APE
Sbjct: 120 LH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGRK 248
+ D +SFG+++ E++ G
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 9e-49
Identities = 38/199 (19%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
+G G FG V++ S + K + +G E+ +L++ H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 111 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170
S ++ ++++E++ + + + L+ + L++LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 171 YRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 228
+ D++ NI+ + K+ +FG A+ GDN + + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVS 181
Query: 229 LKSDIYSFGVVLLELITGR 247
+D++S G ++ L++G
Sbjct: 182 TATDMWSLGTLVYVLLSGI 200
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (412), Expect = 2e-48
Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG---HQEFIVEVLMLSLLHHDN 102
+ ++G GG +V+ R L + VA+K L + + + F E + L+H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 103 LVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
+V + + G +V EY+ +L D ++ + P++ +++ A + L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQAL 124
Query: 159 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYC 217
+ H +I+RD+K ANI++ K+ DFG+A+ + G++ + V+GT Y
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+PE A + +SD+YS G VL E++TG
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (410), Expect = 3e-48
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 27/219 (12%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL---------QGHQEFIVEV-LM 94
N+ ++G G V + + + A+K ++ G + + + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 95 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
+ H N++ L + LV++ M G L D+L + + LS KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRAL 119
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 214
+ LH +++RDLK NILLD+D N KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 215 GYCAPEYAMSG------KLTLKSDIYSFGVVLLELITGR 247
Y APE + D++S GV++ L+ G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 9e-48
Identities = 61/283 (21%), Positives = 107/283 (37%), Gaps = 26/283 (9%)
Query: 51 NLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG-----HQEFIVEVLMLSLLHHDNLV 104
+ +GEG F VYK R + Q+VAIK++ ++ + E+ +L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 105 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 164
L+ LV+++M D ++ + L+ + + +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 165 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 224
+++RDLK N+LLD + KL+DFGLAK G T + T Y APE
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 225 GKL-TLKSDIYSFGVVLLELITGRKAMD----------LSKGQGEQNLVSWSRPFLKDQK 273
++ + D+++ G +L EL+ + + + G W
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
+ + + + R
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 21/290 (7%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH-QEFIVEVLMLSLLHHD 101
+ + IGEG +G V + VAIK+++ Q + Q + E+ +L H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
N++ + + + Y+ + LY L Q LS + RGL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPE 220
H V++RDLK +N+LL+ + K+ DFGLA+ P D+T T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 221 YAMSGKLTLKS-DIYSFGVVLLELITGR-------------KAMDLSKGQGEQNLVSWSR 266
++ K KS DI+S G +L E+++ R + + +++L
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
++ + + + R + A+ + L + R +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-46
Identities = 69/313 (22%), Positives = 114/313 (36%), Gaps = 43/313 (13%)
Query: 37 FRELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGH------QEFI 89
FR+ + + +G G F V K R +G A K + + ++
Sbjct: 3 FRQENVDDY-YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 90 VEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 149
EV +L + H N++TL + +L+ E + G L+D ++E L+ +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATE 117
Query: 150 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTH 205
G+ YLH + + + DLK NI+L + P K+ DFGLA D +
Sbjct: 118 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGN 171
Query: 206 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 265
+ GT + APE L L++D++S GV+ L++G Q
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------- 222
Query: 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV-------V 318
+ V V+ Y A L ++ R I D +
Sbjct: 223 -----ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277
Query: 319 ALDYLVSQRDSHP 331
+S SHP
Sbjct: 278 DTQQALSSAWSHP 290
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-46
Identities = 66/293 (22%), Positives = 107/293 (36%), Gaps = 26/293 (8%)
Query: 43 ATRNFREANLIGEGGFGKVYKGR--LESGQLVAIKQLNHEGLQGHQE--FIVEVLMLSLL 98
A + + IGEG +GKV+K R G+ VA+K++ + + I EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 99 ---HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVG 153
H N+V L CT + ++ L + + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 154 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 213
RGL++LH V++RDLK NIL+ + KL+DFGLA++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 214 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD----------LSKGQGEQNLVS 263
Y APE + D++S G + E+ + + G
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
W R ++ F H ++ + CL R
Sbjct: 239 WPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-45
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 46 NFREANLIGEGGFGKVYKGRL-ESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLV 104
++ + +IG G FG VY+ +L +SG+LVAIK++ + + E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 105 TLIGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
L + S ++ LV +Y+P + ++ L R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSL 135
Query: 159 EYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
Y+H + +RD+K N+LLD D KL DFG AK + + + Y
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRA 190
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGR 247
+ T D++S G VL EL+ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-45
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 102
NF++ IGEG +G VYK R +G++VA+K++ + I E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V L+ + ++ LV+E++ + + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
V++RDLK N+L++ + KL+DFGLA+ V + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILL 175
Query: 223 MSGKLTLKSDIYSFGVVLLELITGR 247
+ DI+S G + E++T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 4e-45
Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 30/293 (10%)
Query: 39 ELAIATRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSL 97
EL + R +R IG G FG +Y G + +G+ VAIK + H + +E + +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKM 58
Query: 98 LHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
+ + I +C GD ++V E + + + S T + +A
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMIS 114
Query: 157 GLEYLHCKANPPVIYRDLKSANIL---LDNDFNPKLSDFGLAKLGPVGDNT-----HVST 208
+EY+H K I+RD+K N L + DFGLAK +
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 209 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 268
+ GT Y + + + + + D+ S G VL+ G K ++ +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------Y 225
Query: 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321
+ +K + +L YP Y C + + +P + +
Sbjct: 226 ERISEKKMSTPIEVLCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (387), Expect = 7e-45
Identities = 59/284 (20%), Positives = 110/284 (38%), Gaps = 21/284 (7%)
Query: 46 NFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNL 103
+ IGEG +G VYK + G+ A+K++ E I E+ +L L H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
V L + + +LV+E++ + + L T + G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+ V++RDLK N+L++ + K++DFGLA+ + + ++ +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMG 174
Query: 224 SGKLTLKSDIYSFGVVLLELITGRK----------AMDLSKGQGEQNLVSWSRPF-LKDQ 272
S K + DI+S G + E++ G M + + G N +W L
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
+ +PL + + + + + L + N R
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-44
Identities = 61/206 (29%), Positives = 86/206 (41%), Gaps = 13/206 (6%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHD 101
+F L+G+G FGKV R +G+ A+K L E + E + E +L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
L L + D+ V EY G L HL E + A + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------RARFYGAEIVSAL 118
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
+ V+YRD+K N++LD D + K++DFGL K G T GT Y APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEV 176
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGR 247
D + GVV+ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (378), Expect = 2e-43
Identities = 45/298 (15%), Positives = 91/298 (30%), Gaps = 31/298 (10%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLL-HHDNL 103
+++ IGEG FG +++G L + Q VAIK + E LL +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGI 63
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
+ + G +LV + + L+ S T A ++ +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 164 KANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAKLGPVGDNT-----HVSTRVMGT 213
K ++YRD+K N L+ + + DFG+ K + GT
Sbjct: 120 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 214 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273
Y + + + + + D+ + G V + + G K + +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------E 226
Query: 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 331
+ N + P + + ++ + ++
Sbjct: 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-42
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 21/207 (10%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE------FIVEVLMLSLLH--HDN 102
L+G GGFG VY G + VAIK + + + E +EV++L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
++ L+ + D +L+ E L+D ++ L + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 163 CKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
V++RD+K NIL+D N KL DFG L V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEW 180
Query: 222 AMSGKL-TLKSDIYSFGVVLLELITGR 247
+ + ++S G++L +++ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-42
Identities = 52/274 (18%), Positives = 89/274 (32%), Gaps = 32/274 (11%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEV-LMLSLLHHDNLVTLIGY 109
++G G GKV + + + A+K L + EV L ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 73
Query: 110 C----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 165
L+V E + G L + D + + +I ++YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 166 NPPVIYRDLKSANILLDNDFNP---KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+ +RD+K N+L + KL+DFG AK ++ T Y APE
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282
K D++S GV++ L+ G L + + +P
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPF-----YSNHGLAISPGMKTRIRMGQYEFPNP- 239
Query: 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 316
+ L E R I +
Sbjct: 240 ----EWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-41
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQG--HQEFIVEVLMLSLLHHDN 102
+ + IG+G FG+V+K R ++GQ VA+K++ E + + E+ +L LL H+N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 103 LVTLIGYCTSGDQR--------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 154
+V LI C + LV+++ L + + ++
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQML 126
Query: 155 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS--TRVMG 212
GL Y+H +++RD+K+AN+L+ D KL+DFGLA+ + N+ + T +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 213 TYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 247
T Y PE + + D++ G ++ E+ T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-41
Identities = 52/265 (19%), Positives = 104/265 (39%), Gaps = 11/265 (4%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDN 102
+ + IGEG +G V+K + E+ ++VA+K++ + + E+ +L L H N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 103 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 162
+V L S + LV+E+ D + L +GL + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 163 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 222
+ V++RDLK N+L++ + KL++FGLA+ + S V+ +
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLF 174
Query: 223 MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282
+ + D++S G + EL + + +Q + ++++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 283 LHGRYPRRCLNYAVAVTAMCLNEEA 307
+ YP ++ LN
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATG 259
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-40
Identities = 45/204 (22%), Positives = 85/204 (41%), Gaps = 10/204 (4%)
Query: 47 FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNL 103
+R+ +G G +G V +G VAIK+L + E+ +L + H+N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 104 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 163
+ L+ T + ++ + E L + + +GL Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 164 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM 223
+RDLK N+ ++ D K+ DFGLA+ ++ ++ V+ +
Sbjct: 140 AGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILN 192
Query: 224 SGKLTLKSDIYSFGVVLLELITGR 247
+ T DI+S G ++ E+ITG+
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 4e-40
Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 16/206 (7%)
Query: 46 NFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQE---FIVEVLMLSLLHHD 101
F +G G FG+V + ESG A+K L+ + + ++ + E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 102 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 161
LV L +V EY+ G + HL S A EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL 157
Query: 162 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 221
H +IYRDLK N+L+D +++DFG AK T + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 222 AMSGKLTLKSDIYSFGVVLLELITGR 247
+S D ++ GV++ E+ G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 9e-37
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 46 NFREANLIGEGGFGKVYKGRL----ESGQLVAIKQLNHEGL----QGHQEFIVEVLMLSL 97
NF ++G G +GKV+ R ++G+L A+K L + + + E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 98 L-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
+ LVTL + + L+ +Y+ G L HL +E + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVL 140
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 216
LE+LH +IYRD+K NILLD++ + L+DFGL+K V D T + GT Y
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEY 196
Query: 217 CAPEYAMSGK--LTLKSDIYSFGVVLLELITGR 247
AP+ G D +S GV++ EL+TG
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 2e-36
Identities = 39/241 (16%), Positives = 89/241 (36%), Gaps = 23/241 (9%)
Query: 27 KEKSGARSFTFRELAIATRN---FREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL 82
+ + + N ++ +G G + +V++ + + + V +K L
Sbjct: 14 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK- 72
Query: 83 QGHQEFIVEV-LMLSLLHHDNLVTLIGYCTSGDQRL--LVYEYMPMGSLEDHLYDLEPDQ 139
++ E+ ++ +L N++TL R LV+E++ +
Sbjct: 73 --KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------- 123
Query: 140 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLG 198
+ L+ + L+Y H +++RD+K N+++D++ +L D+GLA+
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF- 179
Query: 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 258
+ RV Y D++S G +L +I ++ +
Sbjct: 180 -YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 259 Q 259
Q
Sbjct: 239 Q 239
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-34
Identities = 44/207 (21%), Positives = 88/207 (42%), Gaps = 10/207 (4%)
Query: 44 TRNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLN--HEGLQGHQEFIVEVLMLSLLHH 100
++ + +G G +G V ++G VA+K+L+ + + + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 101 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 160
+N++ L+ T + + L + + L+ + + RGL+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 161 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 220
+H +RDLK +N+ ++ D K+ DFGLA+ + ++ V +
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEI 189
Query: 221 YAMSGKLTLKSDIYSFGVVLLELITGR 247
DI+S G ++ EL+TGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-34
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 22/212 (10%)
Query: 45 RNFREANLIGEGGFGKVYKGR-LESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHD 101
+ ++ IG G G V + VAIK+L+ + E++++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 102 NLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 155
N+++L+ T LV E M + Q L +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQML 129
Query: 156 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 215
G+++LH +I+RDLK +NI++ +D K+ DFGLA+ + + T + T
Sbjct: 130 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRY 183
Query: 216 YCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 247
Y APE + DI+S G ++ E++ +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (303), Expect = 5e-32
Identities = 40/223 (17%), Positives = 83/223 (37%), Gaps = 17/223 (7%)
Query: 52 LIGEGGFGKVYKGR-LESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYC 110
+G G F V+ + + + VA+K + + + + E+ +L ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 111 TSGDQRLLVYEYMPMGSL------------EDHLYDLEPDQEPLSWNTRMKIAVGAARGL 158
+ +LL + + + + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 159 EYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 217
+Y+H + +I+ D+K N+L++ D L +A LG T + T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 218 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 260
+PE + +DI+S ++ ELITG + +G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 8e-21
Identities = 21/160 (13%), Positives = 43/160 (26%), Gaps = 29/160 (18%)
Query: 51 NLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL----------QGHQEFIVEVLMLSLLHH 100
L+GEG V+ E +K G F V + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 101 DNLVTLIGYCTSG----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 156
L L G + ++ E + L ++
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDMILE 114
Query: 157 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196
+ + + +++ DL N+L+ + + DF +
Sbjct: 115 EVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 360 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.87 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.28 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.32 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=380.44 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=206.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||+|+||+||+|++. +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999876 6999999998765432 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+++|+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999984 4567999999999999999999999999 9999999999999999999999999998654444
Q ss_pred CcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... .. .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~--------------~~~~~ 222 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS--------------DWKEK 222 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HH--------------HHHTT
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HH--------------HHhcC
Confidence 4444555789999999999988776 57899999999999999999999643321110 00 00000
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.........++.++.+||.+||+.||.+|||+.|++
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 111112345678899999999999999999999997
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=381.89 Aligned_cols=248 Identities=26% Similarity=0.346 Sum_probs=210.6
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
++|++.+.||+|+||+||+|.+. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999875 69999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++|+|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-- 169 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--
Confidence 99999998843 46999999999999999999999999 999999999999999999999999999864322
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
........||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ....
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~---------~~~~ 234 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIAT---------NGTP 234 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH---------HCSC
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHh---------CCCC
Confidence 223345679999999999999999999999999999999999999996322110 0000000 0011
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
....+..++.++.+||.+||+.||.+|||+.|++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1123556788999999999999999999999997
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-54 Score=379.04 Aligned_cols=266 Identities=31% Similarity=0.480 Sum_probs=209.0
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCC--ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEG--LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
|++..++|++.+.||+|+||+||+++.+ ..||||++.... ....+.+.+|+.+++.++||||+++++++. +...+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 4566789999999999999999999865 359999986543 334567889999999999999999999865 45689
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 80 lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceee
Confidence 99999999999999965 4467999999999999999999999999 99999999999999999999999999976
Q ss_pred cCCCCCcceeccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .. ......
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~----~~~~~~-- 225 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--II----FMVGRG-- 225 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HHHHHT--
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HH----HHHhcC--
Confidence 544444444455679999999999864 3589999999999999999999999964321110 00 000000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
...+ .....+..++.++.++|.+||+.||.+|||+.+|++.|+.|...
T Consensus 226 ---~~~p-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 226 ---YLSP-DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ---SCCC-CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCC-cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0000 01123456778999999999999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=374.57 Aligned_cols=245 Identities=26% Similarity=0.413 Sum_probs=207.6
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++++.||+|+||+||+|++. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999876 68999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999954 457999999999999999999999999 99999999999999999999999999975332
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~---------- 218 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISR---------- 218 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT----------
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHc----------
Confidence 2 223457999999999999999999999999999999999999999643211 00000000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
....++..++.++.+||.+||+.||.+|||+.|+++
T Consensus 219 --~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 011245567889999999999999999999999984
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-54 Score=380.47 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=221.7
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
+.|++..++|++.+.||+|+||+||+|.+. +++.||+|++... ....+++.+|+.+++.++||||+++++++.+.+..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 456677889999999999999999999876 5889999998654 34567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999865 34567999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 197 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..... .........++..|+|||++.+..++.++|||||||++|+|++|..||...... ....
T Consensus 164 ~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----------------~~~~ 226 (287)
T d1opja_ 164 LMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVY 226 (287)
T ss_dssp TCCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------------HHHH
T ss_pred ecCCC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----------------HHHH
Confidence 64332 222333455788999999999999999999999999999999977765422110 0111
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
+.+........+..++.++.+||.+||+.||++|||+.|+++.|+.+..+
T Consensus 227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11112223345667888999999999999999999999999999988543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-54 Score=377.54 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=198.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEe--CCeeEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTS--GDQRLLV 119 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~--~~~~~lv 119 (360)
.+|++.+.||+|+||+||++++. +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+ ....|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999875 6899999998765433 34568899999999999999999998854 4568999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
|||+++|+|.+++......+..+++..++.++.||+.||.|||+++ ..+|+||||||+|||++.++.+||+|||++..
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765556678999999999999999999999864 23499999999999999999999999999986
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
... .........||+.|+|||++.+..++.++|||||||++|+|++|..||...... +.....
T Consensus 164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i--------- 226 (269)
T d2java1 164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKI--------- 226 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHH---------
T ss_pred ccc--CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHH---------
Confidence 432 222234467899999999999999999999999999999999999999632211 000000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ......+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 227 -~~-~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 227 -RE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -HH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -Hc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 0111235567889999999999999999999999983
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=371.17 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=205.4
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
.++|++.+.||+|+||+||++++.+++.||||++.... ...+++.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 46899999999999999999998888899999987643 44578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++|+|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999865 4567899999999999999999999999 99999999999999999999999999975433222
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhC-CCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||++.+..++.++||||||+++|||+++ .+||..... ...... +...
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~-----------i~~~ 218 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVED-----------ISTG 218 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHH-----------HHHT
T ss_pred -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHHH-----------HHhc
Confidence 222335688999999999999999999999999999999995 445542111 000000 1111
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
.....+..++.++.++|.+||+.||++|||++||++.|++|..
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223355667889999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=379.06 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=206.5
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++++.||+|+||+||+|++. +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999875 69999999986532 234467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++|+|.+++.. .+.+++..++.++.|++.||.|||+++ |+||||||+|||+++++.++|+|||++.....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999854 467999999999999999999999999 99999999999999999999999999987554
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ..+..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~----------~~i~~ 224 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIF----------QKIIK 224 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH----------HHHHT
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHH----------HHHHc
Confidence 44444445567999999999999999999999999999999999999999743211 000 01111
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ...++..++.++.+||.+||+.||.+|||++|++.
T Consensus 225 ~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 225 L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp T--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0 11345567888999999999999999999999765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-53 Score=375.46 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=209.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
+.|++.+.||+|+||+||+|++. +++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 57999999999999999999875 68999999998776667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++|+|.+++.+ ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.... ..
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~--~~ 163 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RT 163 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH--HH
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC--CC
Confidence 99999999865 3467999999999999999999999999 9999999999999999999999999986421 11
Q ss_pred cceecccccccccccccccc-----cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 204 THVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~-----~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
........||+.|+|||++. +..++.++|||||||++|+|++|..||........ ......
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~-------- 229 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAK-------- 229 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHH--------
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHc--------
Confidence 12233467999999999984 45689999999999999999999999964321110 000000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 230 -~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 230 -SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -SCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111234567889999999999999999999999973
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-52 Score=374.05 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=204.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CC---CEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SG---QLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~---~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
.++|++.+.||+|+||+||+|++. ++ ..|++|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 468999999999999999999875 23 3588888765433 334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
||||+++|+|.+++.. ..+.+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++...
T Consensus 105 v~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998865 4567999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcce---ecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcccc
Q 018128 199 PVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 199 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
........ .....++..|+|||.+.+..++.++|||||||++|||+| |..||...... ...
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~------------ 243 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVI------------ 243 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH------------
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHH------------
Confidence 43322211 122357889999999999999999999999999999998 89999633211 000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
..+....+...+..++..+.++|.+||+.||++|||+.||++.|+++....
T Consensus 244 --~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 244 --NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp --HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 011111222345677889999999999999999999999999999987654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=364.13 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=214.6
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
.++|++.+.||+|+||+||+++.++++.||+|++.... ...+++.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 36899999999999999999999888899999987654 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999755 4567899999999999999999999999 99999999999999999999999999975443322
Q ss_pred cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhccccc
Q 018128 204 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPL 282 (360)
Q Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (360)
.......++..|+|||++.+..++.++||||||+++|||+| |..||....... . ...+...
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~--------------~~~i~~~ 217 (258)
T d1k2pa_ 156 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---T--------------AEHIAQG 217 (258)
T ss_dssp -CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---H--------------HHHHHTT
T ss_pred -eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---H--------------HHHHHhC
Confidence 22334568999999999999999999999999999999998 899997433211 0 0011111
Q ss_pred ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhh
Q 018128 283 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 322 (360)
Q Consensus 283 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~ 322 (360)
.+...|...+..+.+||.+||+.||++|||++++++.|..
T Consensus 218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2223456677899999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-53 Score=371.36 Aligned_cols=264 Identities=26% Similarity=0.410 Sum_probs=214.9
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
++|++..++|++.+.||+|+||+||+|.+++++.||||++.... ...+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 35566778999999999999999999998888899999987553 445679999999999999999999998754 5679
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 84 iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEE
Confidence 999999999999988542 2346999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.... .........++..|+|||++.+..++.++|||||||++|+|+||..|+...... ... ..
T Consensus 159 ~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~~-----------~~ 221 (272)
T d1qpca_ 159 IEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEV-----------IQ 221 (272)
T ss_dssp CSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHH-----------HH
T ss_pred ccCC-ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HHH-----------HH
Confidence 4332 222334456889999999999899999999999999999999966554321110 000 00
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
.+....+...+..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 222 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 011112223456678889999999999999999999999999987743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.7e-52 Score=377.45 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=209.5
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEec
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYM 123 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~ 123 (360)
++|++.+.||+|+||+||+|++. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999875 69999999998776666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC--CCceEEeecCCccccCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~--~~~v~L~Dfg~~~~~~~~ 201 (360)
++|+|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+|||++. ++.+||+|||++......
T Consensus 106 ~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999854 4467999999999999999999999999 999999999999964 578999999999864332
Q ss_pred CCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......... .
T Consensus 180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~--------~ 242 (350)
T d1koaa2 180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD--------W 242 (350)
T ss_dssp ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC--------C
T ss_pred ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC--------C
Confidence 2233467899999999999999999999999999999999999999643211 0000110000 0
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.........++.++.+||.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111122456788999999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-51 Score=375.27 Aligned_cols=252 Identities=19% Similarity=0.244 Sum_probs=210.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++.+.||+|+||+||+|++. +|+.||+|++..........+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999875 6999999999877656667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe--CCCceEEeecCCccccCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD--NDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~--~~~~v~L~Dfg~~~~~~~ 200 (360)
+++|+|.+++.. .+.++++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999988754 4567999999999999999999999999 99999999999997 568999999999986543
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
.. ......+++.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ..
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~--------~~ 244 (352)
T d1koba_ 182 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKR--------CD 244 (352)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHH--------CC
T ss_pred CC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh--------CC
Confidence 22 2334568999999999999999999999999999999999999996332110 0000000 00
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
..........++.++.+||.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111223467788999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-52 Score=372.35 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=192.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
.++|++.+.||+|+||+||+|++. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 577999999999999999999876 6899999998765432 23567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe---CCCceEEeecCCcccc
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLG 198 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~---~~~~v~L~Dfg~~~~~ 198 (360)
|+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||++. +++.+||+|||++...
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999953 567999999999999999999999999 99999999999994 5788999999999753
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........
T Consensus 161 ~~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~------- 224 (307)
T d1a06a_ 161 DP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKA------- 224 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTT-------
T ss_pred cC---CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhcc-------
Confidence 22 222334679999999999999999999999999999999999999996322110 00001100
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...........++.++.+||.+||+.||.+|||+.|+++
T Consensus 225 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 225 -EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 001111233567788999999999999999999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=374.62 Aligned_cols=264 Identities=26% Similarity=0.406 Sum_probs=213.7
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEecC-C-----CEEEEEEcccCC-ccchHHHHHHHHHhhcc-CCCcccceeEEE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLES-G-----QLVAIKQLNHEG-LQGHQEFIVEVLMLSLL-HHDNLVTLIGYC 110 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~-~-----~~v~vK~~~~~~-~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~ 110 (360)
.|++..++|++++.||+|+||+||+|++.. + ..|++|.+.... ......+.+|+.++..+ +||||+++++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 355667899999999999999999997642 2 368999886542 33446788999999988 899999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEP-------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 171 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~-------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H 171 (360)
.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+|
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH 187 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 187 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 999999999999999999999966331 1245899999999999999999999999 999
Q ss_pred CCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcc
Q 018128 172 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAM 250 (360)
Q Consensus 172 ~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf 250 (360)
|||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999986544444444455678999999999999999999999999999999997 89999
Q ss_pred cccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHh
Q 018128 251 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 321 (360)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~ 321 (360)
....... .+.+++....+...+..++.++.+||.+||+.||++|||++||++.|.
T Consensus 268 ~~~~~~~----------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHH----------------HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 6432110 011111122233456677889999999999999999999999999885
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=378.21 Aligned_cols=266 Identities=22% Similarity=0.285 Sum_probs=206.9
Q ss_pred HHhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 42 IATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 42 ~~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
+..++|++.+.||+|+||+||+|++. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999875 689999999876532 3346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
|||+++++|.+++.+ .+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||++...
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999964 4569999999999999999999997 48 999999999999999999999999999753
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc-cc------------
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WS------------ 265 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~~------------ 265 (360)
.. .......||..|+|||++.+..++.++||||+||++|+|++|+.||............. ..
T Consensus 156 ~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 156 ID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred CC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 21 12234579999999999999999999999999999999999999996543211000000 00
Q ss_pred ------hhhhhc---ccc----chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 266 ------RPFLKD---QKK----FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 266 ------~~~~~~---~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.....+ ... .................+.++.+||.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000 000 00000000000111235678999999999999999999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=366.09 Aligned_cols=251 Identities=24% Similarity=0.292 Sum_probs=206.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc------cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL------QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~------~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.++|++++.||+|+||+||+|++. +|+.||+|++.+... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 478999999999999999999875 699999999865432 2356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC----ceEEeec
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----NPKLSDF 192 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~----~v~L~Df 192 (360)
++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||+++ ++||||||+||+++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999954 457999999999999999999999999 99999999999998776 4999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 272 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
|++...... .......+++.|+|||++.+..++.++||||+||++|+|++|..||....... .........
T Consensus 162 G~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVN 232 (293)
T ss_dssp TTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTC
T ss_pred hhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHhcC
Confidence 999864322 22334568999999999999999999999999999999999999997432111 000000000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. ......+...+.++.+||.+||+.||.+|||++|+++
T Consensus 233 ~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 Y--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000112356778999999999999999999999983
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=362.99 Aligned_cols=259 Identities=26% Similarity=0.368 Sum_probs=212.1
Q ss_pred Hhhcccccce-eccCCCeEEEEEEec---CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 43 ATRNFREANL-IGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 43 ~~~~y~i~~~-Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
...+|.+.+. ||+|+||+||+|.+. ++..||||++..... ...+.+.+|++++++++||||+++++++.+ +..+
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3467888885 999999999999754 355799999875432 334678999999999999999999999865 5689
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+++|+|.+++.. .+..+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 85 lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence 99999999999999854 4567999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcc-eecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccc
Q 018128 198 GPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKF 275 (360)
Q Consensus 198 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~------------- 222 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM------------- 222 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH-------------
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH-------------
Confidence 54433322 2234568899999999999999999999999999999998 89999743211 010
Q ss_pred hhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 276 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
..+....+...+..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus 223 -~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 223 -AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111112224466788899999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=361.51 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=197.0
Q ss_pred ccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe----CCeeEEE
Q 018128 47 FREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS----GDQRLLV 119 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~----~~~~~lv 119 (360)
|++.+.||+|+||+||+|.+. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 478889999999999999876 588999999875532 334578899999999999999999999865 3457899
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEe-CCCceEEeecCCcccc
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLG 198 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~-~~~~v~L~Dfg~~~~~ 198 (360)
|||+++++|.+++.+ ...+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||++...
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999954 467999999999999999999999873 4599999999999996 4789999999999753
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhc
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ......
T Consensus 166 ~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~~i---------- 225 (270)
T d1t4ha_ 166 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRV---------- 225 (270)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHH----------
T ss_pred cCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHHHH----------
Confidence 221 2234679999999998865 59999999999999999999999996322110 000000
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........++...+.++.++|.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0001111123345667999999999999999999999983
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=364.81 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=210.4
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
.+|++..++|++.+.||+|+||+||+|++++++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 34445568999999999999999999998888889999986553 445789999999999999999999999854 5679
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+++|+|..++.. ...+.+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++..
T Consensus 88 lv~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp EEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhh
Confidence 99999999999999865 23456999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
..... ........+++.|+|||++.+..++.++||||||+++|+|++|..|+...... .. ...
T Consensus 163 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~-----------~~~ 225 (285)
T d1fmka3 163 IEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----RE-----------VLD 225 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-----------HHH
T ss_pred ccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HH-----------HHH
Confidence 43222 22333466899999999999999999999999999999999976665422110 00 001
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
.+....+...+..++.++.++|.+||+.||++||++++|++.|+....
T Consensus 226 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 111112233456778899999999999999999999999999988654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=368.81 Aligned_cols=248 Identities=28% Similarity=0.349 Sum_probs=209.7
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
-++|++++.||+|+||+||+|++. +|+.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 368999999999999999999875 69999999987542 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999854 567999999999999999999999999 9999999999999999999999999998533
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
. ........+||+.|+|||++.+..++.++|||||||++|+|++|.+||....... .......
T Consensus 157 ~--~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~--------- 219 (337)
T d1o6la_ 157 S--DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILM--------- 219 (337)
T ss_dssp C--TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH---------
T ss_pred c--CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhc---------
Confidence 2 2223344679999999999999999999999999999999999999997433110 0001100
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
....+|..++.++.+||.+||+.||.+|++ ++|+++
T Consensus 220 ---~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 220 ---EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 012345677888999999999999999994 888876
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-51 Score=366.39 Aligned_cols=245 Identities=28% Similarity=0.381 Sum_probs=202.0
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
+.|++.+.||+|+||+||+|++. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 46999999999999999999865 6899999998765433 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+.+++|..++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999988876663 3567999999999999999999999999 99999999999999999999999999975322
Q ss_pred CCCcceeccccccccccccccccc---CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchh
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... . ...
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~----------~~~ 225 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A----------LYH 225 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------H----------HHH
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------H----------HHH
Confidence 233579999999999864 468999999999999999999999996322110 0 000
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
+.........+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 226 i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 00001111123456788999999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=359.80 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=206.9
Q ss_pred hhcccccceeccCCCeEEEEEEecC-C----CEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLES-G----QLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~-~----~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
.+.|++.++||+|+||+||+|..+. + ..||||.+...... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4679999999999999999997653 2 46999998654332 3356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+|||++.++++.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998865 4567999999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCC-cceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 198 GPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 198 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
...... ........+|..|+|||++.+..++.++|||||||++|||+++..|+...... . ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~-----------~~~ 223 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----H-----------EVM 223 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H-----------HHH
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----H-----------HHH
Confidence 433222 22233356889999999999999999999999999999999976655321110 0 011
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
..+....+...+..++..+.++|.+||+.||++|||+.||++.|+++....
T Consensus 224 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 111122233455677889999999999999999999999999999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=357.89 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=200.4
Q ss_pred ceeccCCCeEEEEEEec---CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEecCC
Q 018128 51 NLIGEGGFGKVYKGRLE---SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM 125 (360)
Q Consensus 51 ~~Lg~G~~g~v~~~~~~---~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~~~~ 125 (360)
+.||+|+||+||+|.+. .++.||+|++..... ...+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999754 356899999865432 234578999999999999999999999865 457899999999
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCCcc
Q 018128 126 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 205 (360)
Q Consensus 126 ~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~ 205 (360)
|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++|+|||++..........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999854 567999999999999999999999999 9999999999999999999999999998654433322
Q ss_pred -eecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhcccccc
Q 018128 206 -VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL 283 (360)
Q Consensus 206 -~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (360)
......+++.|+|||++.+..++.++||||||+++|||++ |..||...... . ....+....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~--------------~~~~i~~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E--------------VTAMLEKGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H--------------HHHHHHTTC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---H--------------HHHHHHcCC
Confidence 2334568899999999999999999999999999999998 89999643211 0 011111112
Q ss_pred cCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhh
Q 018128 284 HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 323 (360)
Q Consensus 284 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l 323 (360)
+...+..++.++.+||.+||+.||.+|||+.+|++.|+..
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 2344667888999999999999999999999999888765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=360.04 Aligned_cols=261 Identities=24% Similarity=0.355 Sum_probs=203.6
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecC----CCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCCe
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLES----GQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQ 115 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~ 115 (360)
++..++|++++.||+|+||+||+|.+.. +..|++|.+..... ...+.+.+|+.+++.++||||+++++++. ++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 4556899999999999999999997642 35688888865433 33467889999999999999999999985 567
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 82 ~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp CEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhh
Confidence 8999999999999998765 4567999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
........ .......++..|+|||++.+..++.++|||||||++|+|++ |.+||....... .. ...
T Consensus 156 ~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~---~~i------ 222 (273)
T d1mp8a_ 156 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRI------ 222 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HHH------
T ss_pred eeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HH---HHH------
Confidence 75433222 22334568899999999999999999999999999999998 888986433211 00 000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
........+..++..+.+||.+||+.||.+|||+.||++.|+.+...
T Consensus 223 -----~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 223 -----ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01111234567888999999999999999999999999999988654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=358.52 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=205.5
Q ss_pred HHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe-CCeeEEE
Q 018128 41 AIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLV 119 (360)
Q Consensus 41 ~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-~~~~~lv 119 (360)
++..++|++.+.||+|+||.||+|+.+ |+.||+|++... ...+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 445678999999999999999999986 788999999654 344678999999999999999999998854 4668999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++....
T Consensus 80 ~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp ECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecC
Confidence 9999999999999652 2235899999999999999999999998 9999999999999999999999999997532
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchhc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 278 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (360)
. ......++..|+|||.+.+..++.++||||||+++|||++ |.+||...... +. ...
T Consensus 155 ~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~--------------~~~ 212 (262)
T d1byga_ 155 S-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV--------------VPR 212 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GH--------------HHH
T ss_pred C-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HH--------------HHH
Confidence 2 2223457889999999999999999999999999999998 67777632211 11 111
Q ss_pred ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 279 VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 279 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
+....+...+..++.++.+||.+||+.||.+|||+.++++.|++++..
T Consensus 213 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 111233345667788999999999999999999999999999998653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=363.43 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=207.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCC----EEEEEEcccC-CccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQ----LVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~----~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~l 118 (360)
.+|++++.||+|+||+||+|.+. +|+ .||+|.+... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 56999999999999999999865 344 5888887643 334457899999999999999999999999765 5677
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 198 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~ 198 (360)
+++++.+++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8888989999998876 5678999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhccccchh
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 277 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
.............+|..|+|||++.+..++.++|||||||++|+|+| |..||....... +..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----------------~~~ 224 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISS 224 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----------------HHH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----------------HHH
Confidence 55444444444568999999999999999999999999999999998 788886432111 111
Q ss_pred cccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 278 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 278 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
.+....+...+..++..+.++|.+||+.||.+|||+.|+++.|.++...
T Consensus 225 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1111222234567888999999999999999999999999999988654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-50 Score=362.38 Aligned_cols=244 Identities=27% Similarity=0.394 Sum_probs=207.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccC---CccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHE---GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~---~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++++.||+|+||+||+|++. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999875 6999999998653 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
||+++++|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998854 567899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ..+..
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~----------~~i~~ 215 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTY----------EKILN 215 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH----------HHHHH
T ss_pred c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHH----------HHHHc
Confidence 2 23467999999999999999999999999999999999999999643211 000 01111
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
. ...++..++.++.++|.+||+.||.+|+ |++++++
T Consensus 216 ~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 216 A--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 0 1134556778899999999999999996 8999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=359.55 Aligned_cols=251 Identities=17% Similarity=0.221 Sum_probs=205.9
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.++|++++.||+|+||+||+|.+. +++.||+|++.... .+...+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 368999999999999999999876 68899999997664 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC--CceEEeecCCccccCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND--FNPKLSDFGLAKLGPV 200 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~--~~v~L~Dfg~~~~~~~ 200 (360)
+++++|.+++.. .+..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ ..++|+|||++.....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999954 3457999999999999999999999999 9999999999999754 4799999999986433
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. .......+++.|+|||...+..++.++|||||||++|+|++|..||....... ...........
T Consensus 157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~~~------ 221 (321)
T d1tkia_ 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYT------ 221 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCC------
T ss_pred C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC------
Confidence 2 22334568999999999999999999999999999999999999997432110 00011110000
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
........++.++.+||.+||+.||.+|||+.|+++
T Consensus 222 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 --FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011245778999999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.3e-50 Score=355.14 Aligned_cols=260 Identities=23% Similarity=0.295 Sum_probs=204.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc---chHHHHHHHHHhhccCCCcccceeEEEEeCC----e
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ---GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----Q 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~---~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~----~ 115 (360)
.++|++.+.||+|+||+||+|++. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 478999999999999999999875 6999999999765433 2346889999999999999999999987654 3
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+|||++.++.++++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998854 457999999999999999999999999 999999999999999999999999988
Q ss_pred cccCCCCCc-ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 196 KLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 196 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~- 231 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDP- 231 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCC-
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCC-
Confidence 754332222 2334467999999999999999999999999999999999999999643211 00001111000
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC-CHHHHHHHHhhhh
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLV 324 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~eil~~L~~l~ 324 (360)
.........++.++.++|.+||+.||.+|| |++++++.|.++.
T Consensus 232 -------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 -------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 001112345678899999999999999999 8999999998875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-50 Score=360.92 Aligned_cols=267 Identities=26% Similarity=0.399 Sum_probs=216.0
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCcc-chHHHHHHHHHhhccCCCcccceeEEE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLLHHDNLVTLIGYC 110 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l~~p~i~~~~~~~ 110 (360)
.+++...++|++.+.||+|+||+||+|+.. +++.||||++...... ...++.+|+.+++.++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345566789999999999999999999854 3578999998765433 345789999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 170 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~--------------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~ 170 (360)
.+....+++||++.+++|.+++..... ....+++..++.++.|++.||.|||+++ ++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 999999999999999999999965321 2335899999999999999999999999 99
Q ss_pred eCCCCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCC-Cc
Q 018128 171 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KA 249 (360)
Q Consensus 171 H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~-~p 249 (360)
||||||+|||++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999997644444444444567889999999999999999999999999999999985 56
Q ss_pred ccccCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 250 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 250 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
|....... . .. .+.. ......+..++.++.+||.+||+.||.+|||+.||++.|++|.
T Consensus 243 ~~~~~~~e---~---~~----------~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEE---V---IY----------YVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHH---H---HH----------HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHH---H---HH----------HHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 75332111 0 00 0000 1112235567788999999999999999999999999999885
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=358.87 Aligned_cols=266 Identities=29% Similarity=0.416 Sum_probs=214.5
Q ss_pred HHHHhhcccccceeccCCCeEEEEEEecC--------CCEEEEEEcccCCcc-chHHHHHHHHHhhcc-CCCcccceeEE
Q 018128 40 LAIATRNFREANLIGEGGFGKVYKGRLES--------GQLVAIKQLNHEGLQ-GHQEFIVEVLMLSLL-HHDNLVTLIGY 109 (360)
Q Consensus 40 ~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~--------~~~v~vK~~~~~~~~-~~~~~~~e~~~l~~l-~~p~i~~~~~~ 109 (360)
|.+..++|++++.||+|+||.||+|+... +..||+|++...... ...++.+|...+..+ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 44667899999999999999999997532 247999998765432 346788888888887 79999999999
Q ss_pred EEeCCeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 018128 110 CTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 177 (360)
Q Consensus 110 ~~~~~~~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~ 177 (360)
+.++...++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ ++||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 9999999999999999999999965432 2356899999999999999999999999 999999999
Q ss_pred cEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCcc
Q 018128 178 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 256 (360)
Q Consensus 178 NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~ 256 (360)
|||++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |.+||......
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999986555555555556778999999999999999999999999999999998 68888633211
Q ss_pred CccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 257 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
. .. ..+........+..++.++.+||.+||+.||.+|||+.||++.|++|.+
T Consensus 245 ~---~~--------------~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 E---LF--------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H---HH--------------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---HH--------------HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 0 00 1111112223455677889999999999999999999999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=359.46 Aligned_cols=272 Identities=24% Similarity=0.354 Sum_probs=208.5
Q ss_pred ccHHHHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccce
Q 018128 35 FTFRELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTL 106 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~ 106 (360)
+..+.|++..++|++.+.||+|+||.||+|++. +++.||+|++..... .....+..|...+.++ +||||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 355778888899999999999999999999753 246899999875433 2345677777777776 68999999
Q ss_pred eEEEEeC-CeeEEEEEecCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 018128 107 IGYCTSG-DQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 173 (360)
Q Consensus 107 ~~~~~~~-~~~~lv~e~~~~~sL~~~i~~~~~------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~d 173 (360)
++++... ...++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 9987654 568999999999999999965321 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCC-Ccccc
Q 018128 174 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KAMDL 252 (360)
Q Consensus 174 i~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~-~pf~~ 252 (360)
|||+|||++.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|+|++|. +||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654444444445567999999999999999999999999999999999875 57753
Q ss_pred cCccCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 253 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
..... . ....+........+..++.++.++|.+||+.||++|||+.|+++.|+++..
T Consensus 240 ~~~~~--~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 240 VKIDE--E--------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCCSH--H--------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH--H--------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22110 0 001111111223455677889999999999999999999999999998864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-49 Score=362.02 Aligned_cols=244 Identities=25% Similarity=0.306 Sum_probs=206.7
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++|++++.||+|+||+||+|++. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999875 69999999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCC
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 200 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~ 200 (360)
|++.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999954 457999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhccc
Q 018128 201 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVD 280 (360)
Q Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .... .+..
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~----------~i~~ 252 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYE----------KIVS 252 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH----------HHHH
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHH----------HHhc
Confidence 2 23357999999999999999999999999999999999999999632211 0000 0110
Q ss_pred ccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 281 PLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 281 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
. ....+..++.++.++|.+||+.||.+|+ |++++++
T Consensus 253 ~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 1123556788899999999999999994 8999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=352.40 Aligned_cols=258 Identities=30% Similarity=0.417 Sum_probs=201.0
Q ss_pred hhcccccceeccCCCeEEEEEEec--CC--CEEEEEEcccCCc---cchHHHHHHHHHhhccCCCcccceeEEEEeCCee
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE--SG--QLVAIKQLNHEGL---QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~--~~--~~v~vK~~~~~~~---~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~ 116 (360)
.++|++.+.||+|+||.||+|+.. ++ ..||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 478999999999999999999754 23 3689998865432 234578999999999999999999999965 467
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
++||||++++++.+++.. ....+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence 899999999999998865 3456999999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCcce-ecccccccccccccccccCCCCcchhhHHHHHHHHHHHh-CCCcccccCccCccchhccchhhhhcccc
Q 018128 197 LGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 197 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
.......... .....++..|+|||++.+..++.++||||||+++|||++ |.+||....... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~---------- 223 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------I---------- 223 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H----------
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------H----------
Confidence 7544433332 233457789999999999999999999999999999998 899996332111 0
Q ss_pred chhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhh
Q 018128 275 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 324 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~ 324 (360)
...+.....+...+..++..+.+||.+||+.||++|||+.+|++.|.+.+
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 11111112222345567788999999999999999999999999998763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-49 Score=349.93 Aligned_cols=250 Identities=24% Similarity=0.269 Sum_probs=205.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc---------hHHHHHHHHHhhccC-CCcccceeEEEEe
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG---------HQEFIVEVLMLSLLH-HDNLVTLIGYCTS 112 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~---------~~~~~~e~~~l~~l~-~p~i~~~~~~~~~ 112 (360)
.++|++.+.||+|+||+||+|++. +++.||+|++....... .+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999875 68999999987653321 235788999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
.+..|+||||+++++|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999954 457999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCcceeccccccccccccccccc------CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccch
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 266 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 266 (360)
|++....... ......||..|+|||.+.+ ..++.++||||+||++|+|++|..||........ ..
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------~~ 225 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LR 225 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH------HH
Confidence 9998643322 2334678999999998863 4578899999999999999999999974321110 00
Q ss_pred hhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 267 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
...... ..........++.++.+||.+||+.||++|||+.|++
T Consensus 226 ~i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 226 MIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 111100 0111122346788999999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=355.92 Aligned_cols=270 Identities=26% Similarity=0.383 Sum_probs=221.3
Q ss_pred HHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhcc-CCCcccceeEEE
Q 018128 39 ELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLL-HHDNLVTLIGYC 110 (360)
Q Consensus 39 ~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l-~~p~i~~~~~~~ 110 (360)
.|++..++|++++.||+|+||.||+|+.. +++.||+|++..... .....+.+|+.+++.+ +||||+++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 46677789999999999999999999752 467899999976543 3345688999999998 699999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLEP--------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 176 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p 176 (360)
.+....++||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ ++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 999999999999999999999976331 2346899999999999999999999999 99999999
Q ss_pred CcEEEeCCCceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhC-CCcccccCc
Q 018128 177 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLSKG 255 (360)
Q Consensus 177 ~NIlv~~~~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g-~~pf~~~~~ 255 (360)
+||+++.++.++++|||.+................+++.|+|||.+.+..++.++||||||+++|+|+++ .+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999875554444555567789999999999999999999999999999999995 555542221
Q ss_pred cCccchhccchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 256 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
. ..+.+++....+...+...+.++.+||.+||+.||.+|||+.+|++.|+++.+..
T Consensus 254 ~----------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 254 D----------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp S----------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H----------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 1 0111122222233445567888999999999999999999999999999886653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=352.37 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=209.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCC--EEEEEEcccC-CccchHHHHHHHHHhhcc-CCCcccceeEEEEeCCeeEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQ--LVAIKQLNHE-GLQGHQEFIVEVLMLSLL-HHDNLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~--~v~vK~~~~~-~~~~~~~~~~e~~~l~~l-~~p~i~~~~~~~~~~~~~~l 118 (360)
-++|++.+.||+|+||+||+|.+. ++. .|+||.+... .....+.+.+|+++++.+ +||||+++++++.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 378999999999999999999865 344 4677877543 233456799999999998 79999999999999999999
Q ss_pred EEEecCCCCHHHHhccc------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCc
Q 018128 119 VYEYMPMGSLEDHLYDL------------EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN 186 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~ 186 (360)
||||+++|+|.+++... ......+++..++.++.||+.||.|||+++ ++||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999999653 234578999999999999999999999999 999999999999999999
Q ss_pred eEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCC-cccccCccCccchhccc
Q 018128 187 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQNLVSWS 265 (360)
Q Consensus 187 v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~-pf~~~~~~~~~~~~~~~ 265 (360)
+||+|||++.... .........++..|+|||.+.+..++.++||||||+++|+|++|.. ||.......
T Consensus 166 ~kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------- 234 (309)
T d1fvra_ 166 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------- 234 (309)
T ss_dssp EEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------
T ss_pred eEEcccccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------
Confidence 9999999997432 2222234568899999999999999999999999999999999764 664322110
Q ss_pred hhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
+...+....+...+..++.++.+||.+||+.||++|||++||++.|+++....
T Consensus 235 ---------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 235 ---------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 00111111223445677889999999999999999999999999999997654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=358.54 Aligned_cols=247 Identities=28% Similarity=0.405 Sum_probs=203.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCC---ccchHHHHHHHHHhh-ccCCCcccceeEEEEeCCeeEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEG---LQGHQEFIVEVLMLS-LLHHDNLVTLIGYCTSGDQRLLV 119 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~---~~~~~~~~~e~~~l~-~l~~p~i~~~~~~~~~~~~~~lv 119 (360)
++|++++.||+|+||+||+|++. +++.||+|++.+.. ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999876 69999999986532 223345566666554 68999999999999999999999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 199 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~ 199 (360)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++....
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999954 457899999999999999999999999 9999999999999999999999999998533
Q ss_pred CCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcc
Q 018128 200 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 279 (360)
Q Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
. .........||+.|+|||++.+..++.++|||||||++|+|++|..||....... . ......
T Consensus 155 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~---~~~i~~--------- 217 (320)
T d1xjda_ 155 L--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L---FHSIRM--------- 217 (320)
T ss_dssp C--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHH---------
T ss_pred c--ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---H---HHHHHc---------
Confidence 2 2233344679999999999999999999999999999999999999997432110 0 000000
Q ss_pred cccccCCCChhhHHHHHHHHhhhcccCCCCCCCHH-HHHH
Q 018128 280 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 318 (360)
Q Consensus 280 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~-eil~ 318 (360)
....++..++.++.+||.+||+.||.+||++. ++++
T Consensus 218 ---~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 218 ---DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01134556788899999999999999999996 6754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-49 Score=360.88 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=200.9
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc---cchHHHH---HHHHHhhccCCCcccceeEEEEeCCeeE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL---QGHQEFI---VEVLMLSLLHHDNLVTLIGYCTSGDQRL 117 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~---~~~~~~~---~e~~~l~~l~~p~i~~~~~~~~~~~~~~ 117 (360)
++|++.+.||+|+||+||+|++. +|+.||+|++..... .....+. .++.+++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999876 699999999864322 1222333 3467777788999999999999999999
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++.+|.+||+|||++..
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999954 467899999999999999999999999 99999999999999999999999999986
Q ss_pred cCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccch
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 276 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (360)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------------- 219 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------- 219 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH-------------
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------
Confidence 43321 234579999999999874 568999999999999999999999997433211110000
Q ss_pred hcccccccCCCChhhHHHHHHHHhhhcccCCCCCCC-----HHHHHH
Q 018128 277 HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 318 (360)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-----~~eil~ 318 (360)
.. .......+..++.++.+||.+||+.||.+||| ++|+++
T Consensus 220 ~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 MT--LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HS--SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred hc--ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 01111234567788999999999999999999 688875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=352.27 Aligned_cols=260 Identities=23% Similarity=0.258 Sum_probs=194.1
Q ss_pred ccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccc-----hHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 49 EANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQG-----HQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 49 i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~-----~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
.+++||+|+||+||+|++. +|+.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999875 69999999986543221 34688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+.++++..+. ..+..+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~-- 152 (299)
T d1ua2a_ 82 METDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-- 152 (299)
T ss_dssp CSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--
T ss_pred hcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCC--
Confidence 9887666555 35677999999999999999999999999 99999999999999999999999999975332
Q ss_pred Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhccc----hhhhhccccch
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWS----RPFLKDQKKFV 276 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~----~~~~~~~~~~~ 276 (360)
.........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ..... ...........
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 153 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2223334578999999998864 467999999999999999999999996433211000 00000 00000000000
Q ss_pred hccc-ccccC----CCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 277 HLVD-PLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 277 ~~~~-~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.... ..... ......+.++.+||.+||+.||++|||++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 0000 00000 01124567899999999999999999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=354.98 Aligned_cols=249 Identities=20% Similarity=0.220 Sum_probs=197.9
Q ss_pred hcccccc-eeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhc-cCCCcccceeEEEEe----CCeeE
Q 018128 45 RNFREAN-LIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSL-LHHDNLVTLIGYCTS----GDQRL 117 (360)
Q Consensus 45 ~~y~i~~-~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~-l~~p~i~~~~~~~~~----~~~~~ 117 (360)
++|++.+ .||+|+||+||+|++. +++.||+|++.. ...+.+|+.++.+ .+||||+++++++.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5898875 6999999999999875 699999999853 3567789988655 489999999999875 46689
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC---CCceEEeecCC
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGL 194 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~---~~~v~L~Dfg~ 194 (360)
+|||||++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 999999999999999652 2457999999999999999999999999 999999999999975 45799999999
Q ss_pred ccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhcccc
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 274 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
+....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------------ 225 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 225 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------------
Confidence 98643322 234467999999999999999999999999999999999999999643321110000
Q ss_pred chhccccc--ccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 275 FVHLVDPL--LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 275 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
...+.... ........++.++.+||.+||+.||.+|||+.|+++
T Consensus 226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000000 001112356788999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=347.04 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=200.3
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++++.||+|+||+||+|++. +++.||+|++..... .....+.+|++++++++||||+++++++.+....|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999875 699999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++.+ ++.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~- 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV- 154 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccC-
Confidence 9965 55555533 24567999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCcceecccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhc----cchhhhhccccc
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS----WSRPFLKDQKKF 275 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~----~~~~~~~~~~~~ 275 (360)
.........++..|+|||++.... ++.++||||+|+++|+|++|..||.......... ... ............
T Consensus 155 -~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 155 -PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp -CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred -CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 223334457999999999877655 5789999999999999999999996433211000 000 000000000000
Q ss_pred hhc---ccccccCC---CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 276 VHL---VDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 276 ~~~---~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... ........ .....+.++.+||.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 00000000 11245678999999999999999999999984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=341.61 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=205.4
Q ss_pred cceeccCCCeEEEEEEecC----CCEEEEEEcccC-CccchHHHHHHHHHhhccCCCcccceeEEEEe-CCeeEEEEEec
Q 018128 50 ANLIGEGGFGKVYKGRLES----GQLVAIKQLNHE-GLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-GDQRLLVYEYM 123 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~----~~~v~vK~~~~~-~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-~~~~~lv~e~~ 123 (360)
.++||+|+||+||+|.+.. ...||||.+... .....+++.+|++++++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 6789999999999998643 236899998643 33445779999999999999999999999765 45789999999
Q ss_pred CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCCC
Q 018128 124 PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 203 (360)
Q Consensus 124 ~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~~ 203 (360)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999865 5567888999999999999999999999 99999999999999999999999999986443322
Q ss_pred c--ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccccchhcccc
Q 018128 204 T--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP 281 (360)
Q Consensus 204 ~--~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
. .......++..|+|||.+.+..++.++||||||+++|||++|..||...... .+.......
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~i~~----------- 249 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQ----------- 249 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHT-----------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHc-----------
Confidence 2 2223356889999999999999999999999999999999988887532211 111111111
Q ss_pred cccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 282 LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 282 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
..+...+..++.++.+||.+||+.||++||++.||++.|+.+...
T Consensus 250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111223456778899999999999999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=349.51 Aligned_cols=268 Identities=25% Similarity=0.407 Sum_probs=218.2
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEec------CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEE
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLE------SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYC 110 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~------~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~ 110 (360)
++|++..++|++++.||+|+||+||+|.+. .+..||||++..... .....+.+|+.++++++||||+++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 356777899999999999999999999753 257899999875432 3335688999999999999999999999
Q ss_pred EeCCeeEEEEEecCCCCHHHHhcccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCC
Q 018128 111 TSGDQRLLVYEYMPMGSLEDHLYDLE------PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND 184 (360)
Q Consensus 111 ~~~~~~~lv~e~~~~~sL~~~i~~~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~ 184 (360)
......++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCC
Confidence 99999999999999999999986422 12345789999999999999999999999 9999999999999999
Q ss_pred CceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCC-CcccccCccCccchhc
Q 018128 185 FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KAMDLSKGQGEQNLVS 263 (360)
Q Consensus 185 ~~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~-~pf~~~~~~~~~~~~~ 263 (360)
+.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++|. .||...... .
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~ 243 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q 243 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------H
Confidence 999999999998654444444445557899999999999999999999999999999999985 666432211 0
Q ss_pred cchhhhhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhh
Q 018128 264 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 325 (360)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~ 325 (360)
....+.+ ......+..++..+.++|.+||+.||++|||+.+|++.|++...
T Consensus 244 ----------~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 ----------VLRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----------HHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----------HHHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0111111 11123355677889999999999999999999999999987743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=344.80 Aligned_cols=239 Identities=23% Similarity=0.360 Sum_probs=198.2
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc------chHHHHHHHHHhhccC--CCcccceeEEEEeCC
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ------GHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGD 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~------~~~~~~~e~~~l~~l~--~p~i~~~~~~~~~~~ 114 (360)
.++|++.+.||+|+||+||+|++. +|+.||+|++...... ...++.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 478999999999999999999875 6899999998754322 1234668999999886 899999999999999
Q ss_pred eeEEEEEecCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-CCceEEeec
Q 018128 115 QRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDF 192 (360)
Q Consensus 115 ~~~lv~e~~~~-~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-~~~v~L~Df 192 (360)
..++|||++.+ +++.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+|||++. ++.++|+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999975 578888744 467999999999999999999999999 999999999999985 478999999
Q ss_pred CCccccCCCCCcceecccccccccccccccccCCC-CcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhc
Q 018128 193 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 271 (360)
Q Consensus 193 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 271 (360)
|++...... ......||..|+|||++.+..+ +.++|||||||++|+|++|..||.... .....
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~ 219 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG 219 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhc
Confidence 999753322 2234679999999999987665 577999999999999999999996321 00100
Q ss_pred cccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 272 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
...++..++.++.+||.+||+.||.+|||++|++
T Consensus 220 ------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 220 ------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp ------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 0123445678899999999999999999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-47 Score=340.97 Aligned_cols=264 Identities=22% Similarity=0.292 Sum_probs=200.8
Q ss_pred hcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYEY 122 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e~ 122 (360)
++|++.+.||+|+||+||+|++.+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999998899999999876533 2346889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCCC
Q 018128 123 MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 202 (360)
Q Consensus 123 ~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~~ 202 (360)
+.++.+..+. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~- 153 (286)
T d1ob3a_ 82 LDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153 (286)
T ss_dssp CSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC-
Confidence 9776555555 24678999999999999999999999999 999999999999999999999999999764322
Q ss_pred Ccceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccc-hhc----cchhhhhccccch
Q 018128 203 NTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVS----WSRPFLKDQKKFV 276 (360)
Q Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~----~~~~~~~~~~~~~ 276 (360)
........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... ... .............
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 222333468889999999875 457899999999999999999999996432111000 000 0000000000000
Q ss_pred hc------ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 277 HL------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 277 ~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.. .............+..+.+||.+||+.||++|||++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00 000111122345677899999999999999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=341.92 Aligned_cols=276 Identities=25% Similarity=0.309 Sum_probs=203.4
Q ss_pred hhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEeCC----eeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~----~~~lv 119 (360)
..+|.+.+.||+|+||+||+|+.. |+.||+|++..... .......|+..+..++||||+++++++.+.+ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 467899999999999999999875 88999999865432 1222334566666789999999999987654 57899
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-----NPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
|||+++|+|.+++++ .++++...+.++.|++.||.|+|... ..+|+||||||+|||++.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999964 46899999999999999999999630 11299999999999999999999999999
Q ss_pred ccccCCCCCcc--eecccccccccccccccccCC------CCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc-cc
Q 018128 195 AKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSGK------LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WS 265 (360)
Q Consensus 195 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~~ 265 (360)
+.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||............. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98654333221 223467999999999987543 5779999999999999999998885433221111000 00
Q ss_pred hhhhhccccchhcccccccCCC-----ChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhccC
Q 018128 266 RPFLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 328 (360)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~~ 328 (360)
.... ............+... +......+.+++.+||+.||.+|||+.||++.|++|..+.+
T Consensus 235 ~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 235 DPSV--EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SCCH--HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cchH--HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 0000 0000011111111111 33456779999999999999999999999999999977654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=342.43 Aligned_cols=265 Identities=24% Similarity=0.294 Sum_probs=197.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-C-CCEEEEEEcccCCc--cchHHHHHHHHHhhcc---CCCcccceeEEEEe----
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-S-GQLVAIKQLNHEGL--QGHQEFIVEVLMLSLL---HHDNLVTLIGYCTS---- 112 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~-~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l---~~p~i~~~~~~~~~---- 112 (360)
.++|++++.||+|+||+||+|++. + ++.||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 479999999999999999999874 4 66799999865422 2233456677776665 79999999998853
Q ss_pred -CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEee
Q 018128 113 -GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 191 (360)
Q Consensus 113 -~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~D 191 (360)
....+++||+++++++...... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3467899999988666544433 5677999999999999999999999999 99999999999999999999999
Q ss_pred cCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hcc-----c
Q 018128 192 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VSW-----S 265 (360)
Q Consensus 192 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~-----~ 265 (360)
||++... ..........||+.|+|||++.+.+++.++||||+||++|+|++|..||........... ... .
T Consensus 160 fg~~~~~---~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCC---CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhh---cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 9998742 223334556799999999999999999999999999999999999999974432110000 000 0
Q ss_pred hhhhhccccchhc---ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 266 RPFLKDQKKFVHL---VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 266 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
..+.......... ........+....+..+.+||.+||+.||.+|||+.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0000000000000 000001123345677899999999999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-45 Score=329.21 Aligned_cols=266 Identities=18% Similarity=0.183 Sum_probs=210.9
Q ss_pred HhhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEE
Q 018128 43 ATRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 43 ~~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~ 120 (360)
.+++|++.+.||+|+||+||+|++. +|+.||+|++.... ....+.+|++.++.+. |+|++.+++++.+....++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 4689999999999999999999876 68999999875542 2345677888888886 489999999999999999999
Q ss_pred EecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC-----CCceEEeecCCc
Q 018128 121 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-----DFNPKLSDFGLA 195 (360)
Q Consensus 121 e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~-----~~~v~L~Dfg~~ 195 (360)
|++ +++|.+++.. .+..++...+..++.|++.||.+||++| ++||||||+|||++. ++.++|+|||++
T Consensus 81 e~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccccee
Confidence 999 7799998865 4567999999999999999999999999 999999999999964 568999999999
Q ss_pred cccCCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhh
Q 018128 196 KLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 270 (360)
Q Consensus 196 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 270 (360)
......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 865433222 123345799999999999999999999999999999999999999974433222111110000000
Q ss_pred ccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhcc
Q 018128 271 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 327 (360)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~~ 327 (360)
..... .....++.++.+++..|++.+|++||+++.+.+.|+.+..+.
T Consensus 234 -~~~~~---------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 234 -STPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -HSCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -CCChH---------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00000 112345678999999999999999999999999998886544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-45 Score=328.76 Aligned_cols=263 Identities=22% Similarity=0.238 Sum_probs=203.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCc-ccceeEEEEeCCeeEEEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDN-LVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~-i~~~~~~~~~~~~~~lv~e 121 (360)
+++|++.+.||+|+||+||+|++. +|+.||+|++..... ..++..|+++++.++|++ |..+..++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 568999999999999999999875 689999998765432 345788999999998665 5555666788888999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeC---CCceEEeecCCcccc
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLG 198 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~---~~~v~L~Dfg~~~~~ 198 (360)
++ +++|.+.+.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++. +..++|+|||++...
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 5677776654 4577999999999999999999999999 999999999999853 457999999999865
Q ss_pred CCCCCc-----ceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-ccchhhhhcc
Q 018128 199 PVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSRPFLKDQ 272 (360)
Q Consensus 199 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~ 272 (360)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-- 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-- 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH--
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC--
Confidence 433322 2233457999999999999999999999999999999999999999754332221111 00000000
Q ss_pred ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHHHHhhhhhc
Q 018128 273 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 326 (360)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~~L~~l~~~ 326 (360)
.. .......++.++.+++.+||+.||++||++.++.+.|+.+...
T Consensus 235 -----~~----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 235 -----TP----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -----SC----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----CC----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 00 0011235678899999999999999999999999999887543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=335.76 Aligned_cols=268 Identities=26% Similarity=0.312 Sum_probs=198.3
Q ss_pred cccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcccceeEEEEe------CCeeEE
Q 018128 46 NFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQRLL 118 (360)
Q Consensus 46 ~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~------~~~~~l 118 (360)
+|+..++||+|+||+||+|++. +|+.||+|++..... ...+|+.+++.++||||+++++++.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 7999999999999999999876 699999999865532 23469999999999999999999853 335789
Q ss_pred EEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeecCCccc
Q 018128 119 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKL 197 (360)
Q Consensus 119 v~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg~~~~ 197 (360)
||||++++ +.+.+..+......+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999664 44444433345678999999999999999999999999 99999999999999775 899999999986
Q ss_pred cCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch-hc----cchhhhhc
Q 018128 198 GPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL-VS----WSRPFLKD 271 (360)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~----~~~~~~~~ 271 (360)
..... ......++..|+|||.+.+ ..++.++||||+||++|+|++|..||........... .. ........
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 43322 2334578999999998764 5789999999999999999999999964432110000 00 00000000
Q ss_pred -c-----ccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH--HHhhhh
Q 018128 272 -Q-----KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLV 324 (360)
Q Consensus 272 -~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~--~L~~l~ 324 (360)
. ...................+.++.+||.+||+.||++|||+.|+++ .++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0 0000000001111123456778999999999999999999999996 355553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=326.07 Aligned_cols=264 Identities=20% Similarity=0.257 Sum_probs=204.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeCCeeEEEEE
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGDQRLLVYE 121 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~~~~lv~e 121 (360)
++|++++.||+|+||+||+|++. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999875 689999999865433 335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccccCCC
Q 018128 122 YMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 201 (360)
Q Consensus 122 ~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~~~~~ 201 (360)
++.+++|..++. ..+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||.+......
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 998888877774 4678899999999999999999999999 999999999999999999999999999864322
Q ss_pred CCcceecccccccccccccccccCC-CCcchhhHHHHHHHHHHHhCCCcccccCccCcc-c-hhccchh----h------
Q 018128 202 DNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-N-LVSWSRP----F------ 268 (360)
Q Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~-~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~-~-~~~~~~~----~------ 268 (360)
........++..|.|||++.+.. ++.++||||+||++|+|++|..||......... . ....... .
T Consensus 155 --~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22333345778899999887654 689999999999999999999997432221100 0 0000000 0
Q ss_pred hhccccchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 269 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.......................+..+.+|+.+||+.||.+|||++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0000000001111111123446677899999999999999999999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-45 Score=331.64 Aligned_cols=259 Identities=17% Similarity=0.264 Sum_probs=198.5
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEe--CCeeEEE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTS--GDQRLLV 119 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~--~~~~~lv 119 (360)
.++|++++.||+|+||+||+|++. +++.||+|++... ....+.+|+.+++.++ ||||+++++++.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 368999999999999999999875 6999999998643 3567889999999995 9999999999874 4568999
Q ss_pred EEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCC-ceEEeecCCcccc
Q 018128 120 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLG 198 (360)
Q Consensus 120 ~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~-~v~L~Dfg~~~~~ 198 (360)
|||+.+++|..+. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++ .++|+|||++...
T Consensus 111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 9999999987654 46999999999999999999999999 99999999999998765 6999999999854
Q ss_pred CCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccch--h---------ccch
Q 018128 199 PVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL--V---------SWSR 266 (360)
Q Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~--~---------~~~~ 266 (360)
.... ......+|..|+|||.+.+. .++.++||||+||++|+|++|..||........... . .+..
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 181 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred cCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 3322 23445689999999998765 579999999999999999999999965432211000 0 0000
Q ss_pred hh-hhccccchhc--------ccccccCCCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 267 PF-LKDQKKFVHL--------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 267 ~~-~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. .......... .............+.++.+||.+||+.||.+|||++|+|+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000000000 1111111223456778999999999999999999999983
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=335.93 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=195.3
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc-cchHHHHHHHHHhhccCCCcccceeEEEEeCC----eeE
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL-QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD----QRL 117 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~-~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~----~~~ 117 (360)
+.+|++++.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 468999999999999999999865 799999999875532 23457889999999999999999999986543 234
Q ss_pred EEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 118 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 118 lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
++++++.+++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 44555668999999954 46999999999999999999999999 99999999999999999999999999975
Q ss_pred cCCCCCcc-eecccccccccccccccc-cCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhcc-----chhhhh
Q 018128 198 GPVGDNTH-VSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW-----SRPFLK 270 (360)
Q Consensus 198 ~~~~~~~~-~~~~~~~~~~y~aPE~~~-~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-----~~~~~~ 270 (360)
........ ......++..|+|||++. +..++.++||||+||++|+|++|..||.............. ......
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 43322221 223456899999999985 45678999999999999999999999964432111000000 000000
Q ss_pred c-----cccchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 271 D-----QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 271 ~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
. .............. ......+.++.+||.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000000000000 012244567899999999999999999999995
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=331.12 Aligned_cols=267 Identities=23% Similarity=0.309 Sum_probs=193.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe--------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS-------- 112 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~-------- 112 (360)
-++|++++.||+|+||+||+|++. +|+.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 379999999999999999999875 699999999865532 334678899999999999999999998754
Q ss_pred CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeec
Q 018128 113 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 192 (360)
Q Consensus 113 ~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Df 192 (360)
....++|||++.++.+.... .....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 34678999999776555443 35678999999999999999999999999 999999999999999999999999
Q ss_pred CCccccCCCCCc--ceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-ccchhh
Q 018128 193 GLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-SWSRPF 268 (360)
Q Consensus 193 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~ 268 (360)
|++......... .......+|..|+|||++.+. .++.++||||+||++|+|++|..||............ .....+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999754432221 222335689999999998754 6899999999999999999999999643221110000 000000
Q ss_pred ----hhcc--ccchhcccccccCCC-------ChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 269 ----LKDQ--KKFVHLVDPLLHGRY-------PRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 269 ----~~~~--~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
.... ............... ......++.+||.+||+.||++|||++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 0000 000000000000000 012245678999999999999999999999
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=336.01 Aligned_cols=261 Identities=25% Similarity=0.332 Sum_probs=194.6
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCcc--chHHHHHHHHHhhccCCCcccceeEEEEeCC------
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQ--GHQEFIVEVLMLSLLHHDNLVTLIGYCTSGD------ 114 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~--~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~~------ 114 (360)
.++|++++.||+|+||+||+|.+. +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 479999999999999999999875 6999999999754332 3457889999999999999999999997654
Q ss_pred eeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCC
Q 018128 115 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 194 (360)
Q Consensus 115 ~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~ 194 (360)
..|+||||+ +.+|..++. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 668888774 357999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCcceeccccccccccccccccc-CCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc-----cchhh
Q 018128 195 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-----WSRPF 268 (360)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~~~ 268 (360)
+...... .....++..|+|||++.+ ..++.++||||+||++|+|++|..||............. ....+
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 9864322 234568999999999876 457899999999999999999999996443211000000 00000
Q ss_pred hhc-----cccchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 269 LKD-----QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 269 ~~~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
... .............. ......+.++.+||.+||+.||.+|||+.|+|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000000000 122355678899999999999999999999996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=330.37 Aligned_cols=252 Identities=28% Similarity=0.362 Sum_probs=202.8
Q ss_pred hcccccceeccCCCeEEEEEEec----CCCEEEEEEcccCCc----cchHHHHHHHHHhhccCC-CcccceeEEEEeCCe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE----SGQLVAIKQLNHEGL----QGHQEFIVEVLMLSLLHH-DNLVTLIGYCTSGDQ 115 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~----~~~~v~vK~~~~~~~----~~~~~~~~e~~~l~~l~~-p~i~~~~~~~~~~~~ 115 (360)
++|++++.||+|+||+||+|+.. +|+.||+|++..... ...+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 77999999999999999999752 478999999865422 334568889999999976 899999999999999
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+++||++.+++|.+++.. ...+++..++.++.||+.||.|+|+++ ++||||||+||+++.++.++|+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999954 456789999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCcceecccccccccccccccccC--CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhccchhhhhccc
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 273 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 273 (360)
........ .......+++.|+|||.+.+. .++.++|||||||++|+|++|..||........... ......
T Consensus 177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~---- 249 (322)
T d1vzoa_ 177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRIL---- 249 (322)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHH----
T ss_pred hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcc----
Confidence 75433222 223346789999999998754 468899999999999999999999975432211110 000000
Q ss_pred cchhcccccccCCCChhhHHHHHHHHhhhcccCCCCCC-----CHHHHHH
Q 018128 274 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 318 (360)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----t~~eil~ 318 (360)
.....++..++.++.+||.+||+.||.+|| |++|+++
T Consensus 250 --------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 --------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001134557888999999999999999999 5788874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=330.40 Aligned_cols=260 Identities=23% Similarity=0.279 Sum_probs=190.1
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEe------CCe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTS------GDQ 115 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~------~~~ 115 (360)
++|++++.||+|+||+||+|++. +|+.||||++..... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999876 699999999976533 233568899999999999999999999953 467
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.|+||||+.+ ++.+.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||++
T Consensus 97 ~~iv~Ey~~~-~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSE-EHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccch-HHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 8999999966 455555 245899999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccch---------hcc--
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL---------VSW-- 264 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~---------~~~-- 264 (360)
.... .........+|..|+|||++.+..++.++||||+||++|+|++|..||........... .++
T Consensus 167 ~~~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hccc---cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 7432 23333455789999999999999999999999999999999999999964331100000 000
Q ss_pred -----chhhhhc-----cccchhcccccccC---CCChhhHHHHHHHHhhhcccCCCCCCCHHHHH
Q 018128 265 -----SRPFLKD-----QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 317 (360)
Q Consensus 265 -----~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil 317 (360)
...+... .............. ......+.++.+||.+||+.||++|||++|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0000000 00001111111111 11234677899999999999999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=328.66 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=194.0
Q ss_pred hhcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCc--cchHHHHHHHHHhhccCCCcccceeEEEEeC-----Ce
Q 018128 44 TRNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGL--QGHQEFIVEVLMLSLLHHDNLVTLIGYCTSG-----DQ 115 (360)
Q Consensus 44 ~~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~--~~~~~~~~e~~~l~~l~~p~i~~~~~~~~~~-----~~ 115 (360)
.++|++.+.||+|+||+||+|++. +|+.||+|++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999865 699999999976533 3345788999999999999999999998532 33
Q ss_pred eEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceEEeecCCc
Q 018128 116 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 195 (360)
Q Consensus 116 ~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~ 195 (360)
.+++++++.+++|.+++. .+++++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 456667778999999993 457999999999999999999999999 999999999999999999999999998
Q ss_pred cccCCCCCcceecccccccccccccccccC-CCCcchhhHHHHHHHHHHHhCCCcccccCccCccchh-c----cchhhh
Q 018128 196 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV-S----WSRPFL 269 (360)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~----~~~~~~ 269 (360)
.... .......++..|+|||...+. .++.++|||||||++|+|++|..||............ . ......
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 7422 223345688999999987765 4689999999999999999999999643321100000 0 000000
Q ss_pred hc-----cccchhcccccccCC---CChhhHHHHHHHHhhhcccCCCCCCCHHHHHH
Q 018128 270 KD-----QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 318 (360)
Q Consensus 270 ~~-----~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~eil~ 318 (360)
.. ............... .....+.++.+||.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 000000000000000 11245678899999999999999999999994
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-40 Score=302.01 Aligned_cols=286 Identities=17% Similarity=0.177 Sum_probs=200.4
Q ss_pred hcccccceeccCCCeEEEEEEec-CCCEEEEEEcccCCccchHHHHHHHHHhhccC-----------CCcccceeEEEEe
Q 018128 45 RNFREANLIGEGGFGKVYKGRLE-SGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----------HDNLVTLIGYCTS 112 (360)
Q Consensus 45 ~~y~i~~~Lg~G~~g~v~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----------~p~i~~~~~~~~~ 112 (360)
+||++++.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 57999999999999999999875 69999999997653 23456778888888775 5789999888754
Q ss_pred --CCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCcEEEeCCC----
Q 018128 113 --GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDF---- 185 (360)
Q Consensus 113 --~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~di~p~NIlv~~~~---- 185 (360)
....++++.++..+......... .....+++..++.++.||+.||.|||+ .| |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 45666777766544333222221 356778999999999999999999997 77 99999999999997655
Q ss_pred --ceEEeecCCccccCCCCCcceecccccccccccccccccCCCCcchhhHHHHHHHHHHHhCCCcccccCccCccchhc
Q 018128 186 --NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 263 (360)
Q Consensus 186 --~v~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~s~~sDiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 263 (360)
.++++|||.+..... ......+++.|+|||++.+..++.++||||+||++++|++|..||.............
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 389999999875322 2234569999999999999999999999999999999999999997544322111100
Q ss_pred cch-----------hhhhccccchh---------cccc----------cccCCCChhhHHHHHHHHhhhcccCCCCCCCH
Q 018128 264 WSR-----------PFLKDQKKFVH---------LVDP----------LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 313 (360)
Q Consensus 264 ~~~-----------~~~~~~~~~~~---------~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 313 (360)
... ........... .... ..........+.++.+||.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 000 00000000000 0000 00112356778899999999999999999999
Q ss_pred HHHHHHHhhhhhccCCCCCCCCCCCCCCCCCCCCcccC
Q 018128 314 NDIVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQG 351 (360)
Q Consensus 314 ~eil~~L~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (360)
+|+| .|||-++........-|.++...
T Consensus 323 ~e~L-----------~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 323 GGLV-----------NHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HHHH-----------TCGGGTTCTTCTTCCCTTSCTTC
T ss_pred HHHh-----------cCcccCCCCCcccCCCCCcccCC
Confidence 9998 56665544444444444444443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=6.9e-24 Score=175.89 Aligned_cols=165 Identities=13% Similarity=0.038 Sum_probs=119.6
Q ss_pred ccccceeccCCCeEEEEEEecCCCEEEEEEcccCCcc------------------chHHHHHHHHHhhccCCCcccceeE
Q 018128 47 FREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQ------------------GHQEFIVEVLMLSLLHHDNLVTLIG 108 (360)
Q Consensus 47 y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~------------------~~~~~~~e~~~l~~l~~p~i~~~~~ 108 (360)
+.+++.||+|+||+||.|.+.+|+.||+|++...... .......|...+..+.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4578999999999999999888999999986532110 0123456888888999999988876
Q ss_pred EEEeCCeeEEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCcEEEeCCCceE
Q 018128 109 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 188 (360)
Q Consensus 109 ~~~~~~~~~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~~i~H~di~p~NIlv~~~~~v~ 188 (360)
+. ..+++||++++..+.+ ++......++.|++.+|.+||+++ ++||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 53 2379999998754432 333445789999999999999999 9999999999999965 488
Q ss_pred EeecCCccccCCCCCcceeccccccccccccc-----ccccCCCCcchhhHHHHHHH
Q 018128 189 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----YAMSGKLTLKSDIYSFGVVL 240 (360)
Q Consensus 189 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~s~~sDiwslG~il 240 (360)
|+|||.+......... .|.... .+....++.++|+||+.--+
T Consensus 143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999998753322111 111110 01245678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.87 E-value=1.3e-08 Score=86.64 Aligned_cols=149 Identities=17% Similarity=0.072 Sum_probs=107.3
Q ss_pred HHHHHHhhcccccceeccCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCee
Q 018128 38 RELAIATRNFREANLIGEGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQR 116 (360)
Q Consensus 38 ~~~~~~~~~y~i~~~Lg~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~ 116 (360)
.++...-.+|++.+..+.++.+.||.+..+ ++.+++|+...........+..|...+..+. +--+.+++.+..+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 455556678888887666666789988755 6678889876654444556777888877664 33367778888888999
Q ss_pred EEEEEecCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 018128 117 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------------------------- 165 (360)
Q Consensus 117 ~lv~e~~~~~sL~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------- 165 (360)
++||++++|.++.+.... . .....++.++...+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~-----~----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED-----E----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTT-----C----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccc-----c----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999999888665521 1 112335666777777777521
Q ss_pred -------------------------CCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 166 -------------------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 166 -------------------------~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0138999999999999987666799999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.28 E-value=6.4e-06 Score=69.01 Aligned_cols=130 Identities=18% Similarity=0.096 Sum_probs=88.4
Q ss_pred eeccCC-CeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC--CCcccceeEEEEeCCeeEEEEEecCCCCH
Q 018128 52 LIGEGG-FGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH--HDNLVTLIGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 52 ~Lg~G~-~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~--~p~i~~~~~~~~~~~~~~lv~e~~~~~sL 128 (360)
.+..|. .+.||.+....+..+++|...... ...+..|...++.+. .-.+.+++.+..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444444 368999988888889999765443 234666777777663 22367788888888889999999988655
Q ss_pred HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 018128 129 EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------------------------------------- 165 (360)
Q Consensus 129 ~~~i~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~------------------------------------------- 165 (360)
.+. ..... ..+.++...|..||...
T Consensus 94 ~~~---------~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSS---------HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTS---------CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccc---------cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 321 11211 23345555566666421
Q ss_pred ------------CCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 166 ------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 166 ------------~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
...++|+|+.|.||+++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0138999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=1.4e-05 Score=71.58 Aligned_cols=76 Identities=14% Similarity=0.034 Sum_probs=49.3
Q ss_pred cceeccCCCeEEEEEEecC-CCEEEEEEcccC------C-ccchHHHHHHHHHhhccC--CC-cccceeEEEEeCCeeEE
Q 018128 50 ANLIGEGGFGKVYKGRLES-GQLVAIKQLNHE------G-LQGHQEFIVEVLMLSLLH--HD-NLVTLIGYCTSGDQRLL 118 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~-~~~v~vK~~~~~------~-~~~~~~~~~e~~~l~~l~--~p-~i~~~~~~~~~~~~~~l 118 (360)
.+.||.|....||.+...+ ++.+++|.-... . .....+...|++.|+.+. .| .+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998654 778999964321 1 112345667888887663 23 45555544 5566789
Q ss_pred EEEecCCCC
Q 018128 119 VYEYMPMGS 127 (360)
Q Consensus 119 v~e~~~~~s 127 (360)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.44 E-value=0.00092 Score=57.32 Aligned_cols=159 Identities=13% Similarity=-0.010 Sum_probs=85.0
Q ss_pred ccHHHHHHHhhcccccceec-----cCCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccC-----CCccc
Q 018128 35 FTFRELAIATRNFREANLIG-----EGGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-----HDNLV 104 (360)
Q Consensus 35 ~~~~~~~~~~~~y~i~~~Lg-----~G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-----~p~i~ 104 (360)
++.++++-.-.+|-+++... .|--.+.|.++.++|+ +++|++.... ....+..|+..+..+. .|..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 56778888888898876544 4556889999888654 9999986542 2345555666666553 23222
Q ss_pred cee---EEEEeCCeeEEEEEecCCCCHHH--------------Hhcc----cCCC-CC------------------CCCH
Q 018128 105 TLI---GYCTSGDQRLLVYEYMPMGSLED--------------HLYD----LEPD-QE------------------PLSW 144 (360)
Q Consensus 105 ~~~---~~~~~~~~~~lv~e~~~~~sL~~--------------~i~~----~~~~-~~------------------~l~~ 144 (360)
... .+.........++.+..+..... .++. .... .. ....
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 211 11223445566666654432110 0000 0000 00 0001
Q ss_pred HHHHHHHHHHHHHHHHHHhCC-CCCeeeCCCCCCcEEEeCCCceEEeecCCcc
Q 018128 145 NTRMKIAVGAARGLEYLHCKA-NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 196 (360)
Q Consensus 145 ~~~~~i~~qi~~al~~LH~~~-~~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~ 196 (360)
......+..+...+...+..+ ..+++|+|+.++||+++++...-++||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222333333333333221 1239999999999999988777899999885
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.36 E-value=0.00069 Score=58.54 Aligned_cols=139 Identities=14% Similarity=0.061 Sum_probs=79.3
Q ss_pred CCCeEEEEEEecCCCEEEEEEcccCCccchHHHHHHHHHhhccCCCcc-----cce--eEEEEeCCeeEEEEEecCCCCH
Q 018128 56 GGFGKVYKGRLESGQLVAIKQLNHEGLQGHQEFIVEVLMLSLLHHDNL-----VTL--IGYCTSGDQRLLVYEYMPMGSL 128 (360)
Q Consensus 56 G~~g~v~~~~~~~~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~~p~i-----~~~--~~~~~~~~~~~lv~e~~~~~sL 128 (360)
+....||.+..++|++|++|+.... ....+++..|...+..+...++ +.. -..+......+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 3356899999999999999997654 3345678888888777642111 111 1223456778889998865321
Q ss_pred H------------------HHhcccCC-CCCC-------------------CC---HHHHHHHHHHHHHHHHHHHhCC-C
Q 018128 129 E------------------DHLYDLEP-DQEP-------------------LS---WNTRMKIAVGAARGLEYLHCKA-N 166 (360)
Q Consensus 129 ~------------------~~i~~~~~-~~~~-------------------l~---~~~~~~i~~qi~~al~~LH~~~-~ 166 (360)
. ........ .... ++ .......+.+++..+...-... .
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 1 11111000 0011 11 1122333344443333332121 2
Q ss_pred CCeeeCCCCCCcEEEeCCCceEEeecCCccc
Q 018128 167 PPVIYRDLKSANILLDNDFNPKLSDFGLAKL 197 (360)
Q Consensus 167 ~~i~H~di~p~NIlv~~~~~v~L~Dfg~~~~ 197 (360)
..++|+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 238999999999999743 45899998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.32 E-value=0.00066 Score=60.37 Aligned_cols=72 Identities=18% Similarity=0.239 Sum_probs=49.3
Q ss_pred cceeccCCCeEEEEEEecC--------CCEEEEEEcccCCccchHHHHHHHHHhhccC-CCcccceeEEEEeCCeeEEEE
Q 018128 50 ANLIGEGGFGKVYKGRLES--------GQLVAIKQLNHEGLQGHQEFIVEVLMLSLLH-HDNLVTLIGYCTSGDQRLLVY 120 (360)
Q Consensus 50 ~~~Lg~G~~g~v~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~e~~~l~~l~-~p~i~~~~~~~~~~~~~~lv~ 120 (360)
++.|+.|-...+|++...+ .+.+++++.... .......+|..+++.+. +.-..+++.++.+ ++|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 4578778889999998643 356888887632 33345667888888875 4444577776643 5889
Q ss_pred EecCCCC
Q 018128 121 EYMPMGS 127 (360)
Q Consensus 121 e~~~~~s 127 (360)
+|++|.+
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9987643
|